Citrus Sinensis ID: 004049
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 776 | 2.2.26 [Sep-21-2011] | |||||||
| Q7XUF4 | 710 | Cyclin-dependent kinase G | yes | no | 0.891 | 0.974 | 0.575 | 0.0 | |
| A2XUW1 | 710 | Cyclin-dependent kinase G | N/A | no | 0.891 | 0.974 | 0.575 | 0.0 | |
| Q6K5F8 | 693 | Cyclin-dependent kinase G | no | no | 0.881 | 0.987 | 0.534 | 0.0 | |
| A2X6X1 | 693 | Cyclin-dependent kinase G | N/A | no | 0.880 | 0.985 | 0.533 | 0.0 | |
| P21127 | 795 | Cyclin-dependent kinase 1 | yes | no | 0.412 | 0.402 | 0.667 | 1e-131 | |
| P24788 | 784 | Cyclin-dependent kinase 1 | yes | no | 0.412 | 0.408 | 0.661 | 1e-129 | |
| Q9UQ88 | 783 | Cyclin-dependent kinase 1 | yes | no | 0.412 | 0.408 | 0.661 | 1e-129 | |
| P46892 | 436 | Cyclin-dependent kinase 1 | no | no | 0.422 | 0.752 | 0.650 | 1e-125 | |
| Q9VPC0 | 952 | Serine/threonine-protein | yes | no | 0.418 | 0.341 | 0.604 | 1e-119 | |
| Q54RB2 | 358 | Cyclin-dependent kinase 1 | yes | no | 0.402 | 0.871 | 0.576 | 1e-107 |
| >sp|Q7XUF4|CDKG2_ORYSJ Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. japonica GN=CDKG-2 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/780 (57%), Positives = 522/780 (66%), Gaps = 88/780 (11%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGRHG YRD E R+RE + + SRR SK++ +H +G
Sbjct: 1 MAAGRHGGYRDYEARERELDAEASRR----SKEQ-------QHHHHPSG----------- 38
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSE 120
R ++ D R S S+G G S R LS + D+EPGE+ S
Sbjct: 39 RHQRGDSDPRCEADRRRDGGRSRGGRELSNGYGHRRSPPPRS-RLSARLGDREPGEVLSG 97
Query: 121 SGSDD-------AAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD-----S 168
S SDD A E S +D E VV SP +KRKFSPI+WDRD S
Sbjct: 98 SASDDSGGRPHRARENGVSSSSRDGE--SVVAASASSP-SKKRKFSPIIWDRDSPKPMHS 154
Query: 169 DMGKSRLVATALPPPPSLPKAYWKSPT-VVPEGGVCISPIKSSLNNNLQSVSPLIPPVAA 227
D+ K + ++P LP P +PE + ++ + V P +
Sbjct: 155 DVAKGKKAVDSVPTELPLPPPPPLPPQDHIPE--------RLAVEKSPMDVEPAV----- 201
Query: 228 RSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGE 287
A ESP L Q H E V ++E+Y+ RNIS+SRWA N
Sbjct: 202 ------ASESPEQL-------QEHAESRV-MEEEEEYSTMRNISTSRWAGANDD------ 241
Query: 288 ISEDEELPKRRKKMPV-SDSLQTRARNKFLSPELSEV--KRIGSERSRSRSSESDERGDR 344
E+E P R+KK +DS + R K LSPEL EV I R+ SRSS+S
Sbjct: 242 --EEEGAPHRKKKSASPADSAELGQRKKALSPELGEVVASDISGGRTMSRSSDSGR---- 295
Query: 345 ARSLSGDEYHGHESEKGDYMEIDEDHNNNDSVGG--SDTDSEDENDSCGTPEPAGPPQRS 402
L DE E +K DYM++D D + N + S DSE E TPEP PP R
Sbjct: 296 ---LGADENEDLEVDKDDYMDVDRDDDGNSDIANHQSGMDSEYEVRRSETPEPVKPPHRC 352
Query: 403 INMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE 462
INMLQGCRSVDEFERLNKI+EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE
Sbjct: 353 INMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE 412
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
INILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLKG+ME MKQP+SQSEVKCLMLQ
Sbjct: 413 INILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEVKCLMLQ 472
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
LLEG+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL+RQYGSPLKPYT LVVTLWYRA
Sbjct: 473 LLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRA 532
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PELLLG+K+YSTAIDMWS+GCIMAELL+KEPLFNGK+EF+QLDKIF+TLGTPNEKIWPG+
Sbjct: 533 PELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKIFRTLGTPNEKIWPGY 592
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
+KLPGVKVNF+K YN LR KFPA SF+G P+LS+AGFDLLN+LLTYDP+KR++A+AAL
Sbjct: 593 AKLPGVKVNFVKQPYNRLRDKFPAASFSGRPILSEAGFDLLNNLLTYDPEKRLSADAALQ 652
Query: 703 HDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
H+WFREVPLPKSKDFMPTFPA + DRR +R +KSPDPLEEQR KEL QG +G + L+G
Sbjct: 653 HEWFREVPLPKSKDFMPTFPALNELDRRTKRYLKSPDPLEEQRLKEL-QGNIG-NRGLFG 710
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|A2XUW1|CDKG2_ORYSI Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. indica GN=CDKG-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/780 (57%), Positives = 522/780 (66%), Gaps = 88/780 (11%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGRHG YRD E R+RE + + SRR SK++ +H +G
Sbjct: 1 MAAGRHGGYRDYEARERELDAEASRR----SKEQ-------QHHHHPSG----------- 38
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSE 120
R ++ D R S S+G G S R LS + D+EPGE+ S
Sbjct: 39 RHQRGDSDPRCEADRRRDGGRSRGGRELSNGYGHRRSPPPRS-RLSARLGDREPGEVLSG 97
Query: 121 SGSDD-------AAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD-----S 168
S SDD A E S +D E VV SP +KRKFSPI+WDRD S
Sbjct: 98 SASDDSGGRPHRARENGVSSSSRDGE--SVVAASASSP-SKKRKFSPIIWDRDSPKPMHS 154
Query: 169 DMGKSRLVATALPPPPSLPKAYWKSPT-VVPEGGVCISPIKSSLNNNLQSVSPLIPPVAA 227
D+ K + ++P LP P +PE + ++ + V P +
Sbjct: 155 DVAKGKKAVDSVPTELPLPPPPPLPPQDHIPE--------RLAVEKSPMDVEPAV----- 201
Query: 228 RSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGE 287
A ESP L Q H E V ++E+Y+ RNIS+SRWA N
Sbjct: 202 ------ASESPEQL-------QEHAESRV-MEEEEEYSTMRNISTSRWAGANDD------ 241
Query: 288 ISEDEELPKRRKKMPV-SDSLQTRARNKFLSPELSEV--KRIGSERSRSRSSESDERGDR 344
E+E P R+KK +DS + R K LSPEL EV I R+ SRSS+S
Sbjct: 242 --EEEGAPHRKKKSASPADSAELGQRKKALSPELGEVVASDISGGRTMSRSSDSGR---- 295
Query: 345 ARSLSGDEYHGHESEKGDYMEIDEDHNNNDSVGG--SDTDSEDENDSCGTPEPAGPPQRS 402
L DE E +K DYM++D D + N + S DSE E TPEP PP R
Sbjct: 296 ---LGADENEDLEVDKDDYMDVDRDDDGNSDIANHQSGMDSEYEVRRSETPEPVKPPHRC 352
Query: 403 INMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE 462
INMLQGCRSVDEFERLNKI+EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE
Sbjct: 353 INMLQGCRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE 412
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
INILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLKG+ME MKQP+SQSEVKCLMLQ
Sbjct: 413 INILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEVKCLMLQ 472
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
LLEG+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL+RQYGSPLKPYT LVVTLWYRA
Sbjct: 473 LLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRA 532
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PELLLG+K+YSTAIDMWS+GCIMAELL+KEPLFNGK+EF+QLDKIF+TLGTPNEKIWPG+
Sbjct: 533 PELLLGTKEYSTAIDMWSVGCIMAELLAKEPLFNGKTEFEQLDKIFRTLGTPNEKIWPGY 592
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
+KLPGVKVNF+K YN LR KFPA SF+G P+LS+AGFDLLN+LLTYDP+KR++A+AAL
Sbjct: 593 AKLPGVKVNFVKQPYNRLRDKFPAASFSGRPILSEAGFDLLNNLLTYDPEKRLSADAALQ 652
Query: 703 HDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
H+WFREVPLPKSKDFMPTFPA + DRR +R +KSPDPLEEQR KEL QG +G + L+G
Sbjct: 653 HEWFREVPLPKSKDFMPTFPALNELDRRTKRYLKSPDPLEEQRLKEL-QGNIG-NRGLFG 710
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6K5F8|CDKG1_ORYSJ Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. japonica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/758 (53%), Positives = 489/758 (64%), Gaps = 74/758 (9%)
Query: 1 MAAGRHGVYRDNEF-RDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDR 59
MAAG HG YR E R+RE ++ VSRR SK+ + + H RD
Sbjct: 1 MAAGSHGGYRGYEVAREREHDVGVSRR----SKEHYHHR-------------HPSRHRDS 43
Query: 60 VRVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSS 119
R R + NG + G + D+EPGE+S
Sbjct: 44 ERRRDGGRSGGRELSNG-YSHRRDSPRPPPRRRPSEG-----------RTEDREPGEVSG 91
Query: 120 ESGSDDAAEIE-SVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDDSDMGKSRLVAT 178
SGS+ + E + ++N V++V + + +KRK SP++WDR+ S
Sbjct: 92 GSGSERSGERPMKTGEPRENGVTRVSKEEAKMSPSKKRKQSPVIWDRNGSK-------RQ 144
Query: 179 ALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAARSVEYAAPESP 238
A P + + ++ + P+ SSL++ SP+I V+ V
Sbjct: 145 ARDPVRGIREVDAVVAEIIMHQSHSL-PVMSSLSSIGDGHSPMILDVSVDKV-------- 195
Query: 239 VGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISEDEELPKRR 298
Q + + + ++E Y RNI +SRWA D G+ E+ +PK++
Sbjct: 196 ----------QEYEKNRIVDEEEEGYPTMRNILTSRWA-------DAGDEEENVFVPKKK 238
Query: 299 KKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEYHGHES 358
K + DS++ + K SPE EV S RS SRSS+S L G E
Sbjct: 239 KSVSPVDSIERGSTKKVTSPESGEVLVYNSVRSSSRSSDSG-------VLQGSANRDLEV 291
Query: 359 EKGDYMEIDEDHNNNDSVGGS-DTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFER 417
EKGD ++++E +++ G D+D E E+ TPE P+R INMLQGCRSVDEFER
Sbjct: 292 EKGDNIDVEEAADDDYPAGHLLDSDFEGEDCRSETPECTRSPRRCINMLQGCRSVDEFER 351
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
LN I+EGTYGVV+R RDK+TGEIVALKKVKMEKEREGFPLTSLRE+NILLSFHHPSIV+V
Sbjct: 352 LNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNILLSFHHPSIVEV 411
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
KEVVVGSN IFMVMEYMEHDLKG+METMKQP+SQSEVKCLMLQLLEG+KYLHDNWVLH
Sbjct: 412 KEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEVKCLMLQLLEGVKYLHDNWVLH 471
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLKTSNLLLNNRGELKICDFGL+RQYGSPLKPYT LVVTLWYRAPELLLG+K YSTAID
Sbjct: 472 RDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRAPELLLGAKDYSTAID 531
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657
MWSLGCIM ELLSK PLFNGKSE DQLDKIF+TLGTP+E IWPG+SKLPG V F K +
Sbjct: 532 MWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDENIWPGYSKLPGATVKFGKQTH 591
Query: 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDF 717
N LR KF A SFTG P+LS+AGFDLLN LLTYDP+KRI+AE ALNH+WFRE+PLP+SKDF
Sbjct: 592 NRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRISAEDALNHEWFRELPLPRSKDF 651
Query: 718 MPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
MPTFPA + QDRR ++ MKSPDPLEEQR KE QG G
Sbjct: 652 MPTFPALNEQDRRFKKHMKSPDPLEEQRMKE--QGNNG 687
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A2X6X1|CDKG1_ORYSI Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. indica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/759 (53%), Positives = 488/759 (64%), Gaps = 76/759 (10%)
Query: 1 MAAGRHGVYRDNEF-RDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDR 59
MAAG HG YR E R+RE ++ VSRR SK+ + + H RD
Sbjct: 1 MAAGSHGGYRGYEVAREREHDVGVSRR----SKEHYHHR-------------HPSRHRDS 43
Query: 60 VRVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSS 119
R R + NG + G + D+EPGE+S
Sbjct: 44 ERRRDGGRSGGRELSNG-YSHRRDSPRPPPRRRPSEG-----------RTEDREPGEVSG 91
Query: 120 ESGSDDAAEIESVSKV-KDNEVSKVVENGNQSPLERKRKFSPIVWDRDDSDMGKSRLVAT 178
SGS+ + E ++ ++N V++V + + +KRK SP++WDR+ S
Sbjct: 92 GSGSERSGERPMKTREPRENGVTRVSKEEAKMSPSKKRKQSPVIWDRNGSQ-------RQ 144
Query: 179 ALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAARSVEYAAPESP 238
A P + + ++ + P+ SSL++ SP+I V+ V
Sbjct: 145 ARDPVRGIREVDAVVAEIIMHQSHSL-PVMSSLSSIGDGHSPMILDVSVDKV-------- 195
Query: 239 VGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISEDEELPKRR 298
Q + + + ++E Y RNI +SRWA D G+ E+ +PK++
Sbjct: 196 ----------QEYEKNRIVDEEEEGYPTMRNILTSRWA-------DAGDEEENVFVPKKK 238
Query: 299 KKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEYHGHES 358
K + DS++ + K SPE EV S RS SRSS+S L G E
Sbjct: 239 KSVSPVDSIERGSTKKVTSPESGEVLVYNSVRSSSRSSDSG-------VLQGSANRDLEV 291
Query: 359 EKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCG--TPEPAGPPQRSINMLQGCRSVDEFE 416
EKGD +++ E ++D G DS+ E + C TPE P+R INMLQGCRSVDEFE
Sbjct: 292 EKGDNIDV-EKAADDDYPAGHLLDSDFEGEDCRSETPECTRSPRRCINMLQGCRSVDEFE 350
Query: 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476
RLN I+EGTYGVV+R RDK+TGEIVALKKVKMEKEREGFPLTSLRE+NILLSFHHPSIV+
Sbjct: 351 RLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNILLSFHHPSIVE 410
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
VKEVVVGSN IFMVMEYMEHDLKG+METMKQP+SQSEVKCLMLQLLEG+KYLHDNWVL
Sbjct: 411 VKEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEVKCLMLQLLEGVKYLHDNWVL 470
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
HRDLKTSNLLLNNRGELKICDFGL+RQYGSPLKPYT LVVTLWYRAPELLLG+K YSTAI
Sbjct: 471 HRDLKTSNLLLNNRGELKICDFGLSRQYGSPLKPYTQLVVTLWYRAPELLLGAKDYSTAI 530
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
DMWSLGCIM ELLSK PLFNGKSE DQLDKIF+TLGTP+E IWPG+SKLPG V F K
Sbjct: 531 DMWSLGCIMGELLSKGPLFNGKSEIDQLDKIFRTLGTPDENIWPGYSKLPGATVKFGKQT 590
Query: 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716
+N LR KF A SFTG P+LS+AGFDLLN LLTYDP+KRI+AE ALNH+WFRE+PLP+SKD
Sbjct: 591 HNRLRDKFRAVSFTGGPMLSEAGFDLLNRLLTYDPEKRISAEDALNHEWFRELPLPRSKD 650
Query: 717 FMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
FMPTFPA + QDRR ++ MKSPDPLEEQ KE QG G
Sbjct: 651 FMPTFPALNEQDRRFKKHMKSPDPLEEQWMKE--QGNNG 687
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 219/328 (66%), Positives = 269/328 (82%), Gaps = 8/328 (2%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN
Sbjct: 429 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINT 488
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 489 ILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLR 548
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +VVTLWYRAPEL
Sbjct: 549 GVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLWYRAPEL 608
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTA+DMWS+GCI ELL+++PLF GKSE DQ++K+FK LGTP+EKIWPG+S+L
Sbjct: 609 LLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIWPGYSEL 668
Query: 646 PGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P V K+ F +H YN LRK+F A +LSD GFDL+N LTY P +RI+AE L H+
Sbjct: 669 PAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAEDGLKHE 721
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMR 732
+FRE PLP PT+PA+ Q R R
Sbjct: 722 YFRETPLPIDPSMFPTWPAKSEQQRVKR 749
|
Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P24788|CD11B_MOUSE Cyclin-dependent kinase 11B OS=Mus musculus GN=Cdk11b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 462 bits (1190), Expect = e-129, Method: Compositional matrix adjust.
Identities = 217/328 (66%), Positives = 267/328 (81%), Gaps = 8/328 (2%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN
Sbjct: 418 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINT 477
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 478 ILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLS 537
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +VVTLWYRAPEL
Sbjct: 538 GVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLWYRAPEL 597
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTA+DMWS+GCI ELL+++PLF GKS+ DQ++KIFK LGTP+EKIWPG++ L
Sbjct: 598 LLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKIFKDLGTPSEKIWPGYNDL 657
Query: 646 PGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P V K+ F ++ YN LRK+F A +LSD GFDL+N LTY P +RI AE L H+
Sbjct: 658 PAVKKMTFSEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYYPGRRINAEDGLKHE 710
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMR 732
+FRE PLP PT+PA+ Q R R
Sbjct: 711 YFRETPLPIDPSMFPTWPAKSEQQRVKR 738
|
Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UQ88|CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 217/328 (66%), Positives = 267/328 (81%), Gaps = 8/328 (2%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN
Sbjct: 417 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINT 476
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 477 ILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLR 536
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +VVT WYRAPEL
Sbjct: 537 GVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTQWYRAPEL 596
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTA+DMWS+GCI ELL+++PLF G SE DQ++K+FK LGTP+EKIWPG+S+L
Sbjct: 597 LLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGNSEIDQINKVFKELGTPSEKIWPGYSEL 656
Query: 646 PGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P V K+ F +H YN LRK+F A +LSD GFDL+N LTY P +RI+AE L H+
Sbjct: 657 PVVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRISAEDGLKHE 709
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMR 732
+FRE PLP PT+PA+ Q R R
Sbjct: 710 YFRETPLPIDPSMFPTWPAKSEQQRVKR 737
|
Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P46892|CD11B_RAT Cyclin-dependent kinase 11B OS=Rattus norvegicus GN=Cdk11b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-125, Method: Compositional matrix adjust.
Identities = 220/338 (65%), Positives = 268/338 (79%), Gaps = 10/338 (2%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFPLTS+REIN
Sbjct: 70 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPLTSIREINT 129
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 130 ILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLS 189
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL + G LK+ DFGLAR+YGSPLK YT +VVTLWYRAPEL
Sbjct: 190 GVKHLHDNWILHRDLKTSNLLLTHAGILKVGDFGLAREYGSPLKAYTPVVVTLWYRAPEL 249
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTA DMWS+GCI ELL+++PLF GKS+ DQ++KIFK +GTP+EKIWPG+S+L
Sbjct: 250 LLGAKEYSTACDMWSVGCIFGELLTQKPLFPGKSDIDQINKIFKDIGTPSEKIWPGYSEL 309
Query: 646 PGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P V K+ F + YN LRK+F A +LSD GFDL+N LTY P +RI AE L H+
Sbjct: 310 PAVKKMTFSELPYNNLRKRFGA-------LLSDQGFDLMNKFLTYYPGRRINAEDGLKHE 362
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
+FRE PLP PT+PA+ Q R SP P E
Sbjct: 363 YFRETPLPIDPSMFPTWPAKSEQQCVKRG--TSPKPPE 398
|
Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9VPC0|KP58_DROME Serine/threonine-protein kinase PITSLRE OS=Drosophila melanogaster GN=Pitslre PE=1 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 209/346 (60%), Positives = 258/346 (74%), Gaps = 21/346 (6%)
Query: 388 DSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK 447
D G P P P +QGCRSV+EF+ LN+I+EGTYGVVYRA+DK+T EIVALK++K
Sbjct: 536 DDKGIPLPNYYPG-----VQGCRSVEEFQCLNRIEEGTYGVVYRAKDKRTNEIVALKRLK 590
Query: 448 MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM 507
MEKE+EGFP+TSLREIN LL HP+IV V+E+VVGSN+D IF+VM+Y+EHDLK LMETM
Sbjct: 591 MEKEKEGFPITSLREINTLLKGQHPNIVTVREIVVGSNMDKIFIVMDYVEHDLKSLMETM 650
Query: 508 K---QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564
K Q F EVKCL QLL + +LHDNW+LHRDLKTSNLLL+++G LK+ DFGLAR+Y
Sbjct: 651 KNRKQSFFPGEVKCLTQQLLRAVAHLHDNWILHRDLKTSNLLLSHKGILKVGDFGLAREY 710
Query: 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624
GSP+K YT LVVTLWYRAPELLL S YST ID+WS+GCI AE L PLF GKSE D+L
Sbjct: 711 GSPIKKYTSLVVTLWYRAPELLLCSPVYSTPIDVWSVGCIFAEFLQMLPLFPGKSEIDEL 770
Query: 625 DKIFKTLGTPNEKIWPGFSKLPGVK------VNFIKHQYNLLRKKFPATSFTGSPVLSDA 678
++IFK LGTPNEKIWPG+++LP VK F ++ + LRK F + S+
Sbjct: 771 NRIFKELGTPNEKIWPGYTELPAVKNMLSQNSQFTEYPVSQLRKHFQEKT-------SEM 823
Query: 679 GFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQ 724
G LL LLTYDP +R++A+AAL H +F+E+PLP PT+PA+
Sbjct: 824 GLSLLQGLLTYDPKQRLSADAALKHGFFKELPLPIDPSMFPTWPAK 869
|
Acts as a negative regulator of the normal cell cycle progression. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q54RB2|CDK11_DICDI Cyclin-dependent kinase 11 OS=Dictyostelium discoideum GN=cdk11 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-107, Method: Compositional matrix adjust.
Identities = 185/321 (57%), Positives = 237/321 (73%), Gaps = 9/321 (2%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
CRSVD F++L I+EG +GVVY A+DK+T EIVALKK+KME+EREG P+TS+REI +L+
Sbjct: 45 ACRSVDCFKKLYTINEGAFGVVYCAQDKETEEIVALKKIKMEREREGIPITSVREIKVLM 104
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
H +IV +KE+V+G N++SIFM ME+++HDL+GLME +K+PF SE+K L+ QLL G+
Sbjct: 105 ELKHDNIVQIKEIVLGKNINSIFMAMEFIDHDLRGLMEVIKKPFLPSEIKTLIQQLLNGV 164
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
Y+HDNWV+HRDLKT+NLL N+G LKI DFGLAR+YGSPLKP + VVTLWYRAPELLL
Sbjct: 165 SYMHDNWVIHRDLKTANLLYTNKGVLKIADFGLAREYGSPLKPLSKGVVTLWYRAPELLL 224
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
++ Y+ AID+WS+GCI AE++SKE L G SE DQ+DKIFK GTP EK WP F KLP
Sbjct: 225 DTEIYTPAIDIWSVGCIFAEIISKEVLLQGSSEIDQMDKIFKLFGTPTEKSWPAFFKLPL 284
Query: 648 VK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K N YN L+ KFP ++D FDLLN LL +P+ RI+A AL H +F
Sbjct: 285 AKYFNLTDQPYNNLKSKFPH--------ITDNAFDLLNKLLELNPEARISASDALKHPYF 336
Query: 707 REVPLPKSKDFMPTFPAQHAQ 727
E P P+ MPT+P+ H +
Sbjct: 337 FENPQPRDPLLMPTWPSSHKK 357
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 776 | ||||||
| 224110752 | 746 | predicted protein [Populus trichocarpa] | 0.952 | 0.990 | 0.734 | 0.0 | |
| 255547862 | 754 | cdk10/11, putative [Ricinus communis] gi | 0.960 | 0.988 | 0.741 | 0.0 | |
| 359473713 | 754 | PREDICTED: cyclin-dependent kinase G-2-l | 0.954 | 0.982 | 0.734 | 0.0 | |
| 224102321 | 702 | predicted protein [Populus trichocarpa] | 0.895 | 0.990 | 0.711 | 0.0 | |
| 356512351 | 746 | PREDICTED: cyclin-dependent kinase G-2-l | 0.931 | 0.969 | 0.716 | 0.0 | |
| 356525136 | 745 | PREDICTED: cyclin-dependent kinase G-2-l | 0.935 | 0.974 | 0.701 | 0.0 | |
| 449435041 | 752 | PREDICTED: cyclin-dependent kinase G-2-l | 0.947 | 0.977 | 0.677 | 0.0 | |
| 297841455 | 756 | kinase family protein [Arabidopsis lyrat | 0.935 | 0.960 | 0.652 | 0.0 | |
| 15220477 | 752 | protein kinase-like protein [Arabidopsis | 0.942 | 0.972 | 0.661 | 0.0 | |
| 17064846 | 752 | putative protein kinase [Arabidopsis tha | 0.939 | 0.969 | 0.652 | 0.0 |
| >gi|224110752|ref|XP_002315624.1| predicted protein [Populus trichocarpa] gi|222864664|gb|EEF01795.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/769 (73%), Positives = 631/769 (82%), Gaps = 30/769 (3%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGRHG Y DNEF+D+ES+ ++ + ++AYSKD+ Y+RI N N E N +G V + RD
Sbjct: 1 MAAGRHGGYHDNEFKDQESDFELLKEDFAYSKDQ--YDRIGNGNAE-NDRGQVHHLRDSA 57
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGS--CGLREPELSLKAVDKEPGELS 118
RVRQKD+KE V G SSS S GGG S CG S++A DKEPGELS
Sbjct: 58 RVRQKDIKETGVTNGGYRSSSSRSDSGSSGGGGALRSRRCGF-----SVRATDKEPGELS 112
Query: 119 SESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD-----SDMGKS 173
SESGSDDA + ES + K +EV KV +P+E+KRKFSP+VWDRDD S
Sbjct: 113 SESGSDDAIDPESHAH-KGSEVLKV------TPVEKKRKFSPVVWDRDDKATSSLSKSWS 165
Query: 174 RLVATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAARSVEYA 233
A ALPPPP LPKAY +SP V+P+GGV ISP+ S ++ L V SV +
Sbjct: 166 SPAAAALPPPPPLPKAYRQSPNVIPDGGVEISPVIS-----IELAFSLKGSVVKGSVGNS 220
Query: 234 APESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISEDEE 293
APES + LASSP EQW N+QE +H++DEDYAP RNISSSRWA GN+SP DEGEI ED+E
Sbjct: 221 APESSIELASSPVEEQWGNDQEAQHIEDEDYAPMRNISSSRWADGNNSPVDEGEIVEDQE 280
Query: 294 LPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEY 353
+PKRRKKMP +SL R RNK +P+ +++R GS+ +R RSSESDERG ARS SGD++
Sbjct: 281 VPKRRKKMPHLESLDFRVRNKSSTPDPGDLRREGSDAARGRSSESDERGTCARSSSGDDH 340
Query: 354 HGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVD 413
G++S + DYMEID++H+NNDS +D + EDENDS TPEPAGPPQRSINMLQGCRSVD
Sbjct: 341 PGNDSGRDDYMEIDDEHDNNDS--DTDPEDEDENDSHETPEPAGPPQRSINMLQGCRSVD 398
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS
Sbjct: 399 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 458
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME+M+QPFSQSEVKCLMLQLLEG KYLHDN
Sbjct: 459 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMESMRQPFSQSEVKCLMLQLLEGTKYLHDN 518
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG+KQYS
Sbjct: 519 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGAKQYS 578
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
TAIDMWSLGCIMAELLSK+PLFNGK+E DQLDKIF+ LGTPNE IWPGFSKLPGVKVNF+
Sbjct: 579 TAIDMWSLGCIMAELLSKDPLFNGKTEVDQLDKIFRILGTPNETIWPGFSKLPGVKVNFV 638
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713
K QYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAALNHDWFREVPLPK
Sbjct: 639 KQQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAALNHDWFREVPLPK 698
Query: 714 SKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
SKDFMPTFPAQHAQDRR+RRMMKSPDPLEEQRRKELQQGELG L+G
Sbjct: 699 SKDFMPTFPAQHAQDRRLRRMMKSPDPLEEQRRKELQQGELGT-GGLFG 746
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547862|ref|XP_002514988.1| cdk10/11, putative [Ricinus communis] gi|223546039|gb|EEF47542.1| cdk10/11, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/771 (74%), Positives = 649/771 (84%), Gaps = 26/771 (3%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGRHG Y DNEF +RE+AYSK++ Y+RI N N E+ G V RDR
Sbjct: 1 MAAGRHGGYHDNEF---------PKREFAYSKED--YDRIGNGNRENERPGRVRDVRDRG 49
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGS--CGLREPELSLKAVDKEPGELS 118
RVRQKD+KEREV+ NGG+ SSSSR+DSG S GG G G R E + +A+D+EPGELS
Sbjct: 50 RVRQKDIKEREVV-NGGYRSSSSRTDSGGSSGGSGGDVHAGPRRCEFAARAIDREPGELS 108
Query: 119 SESGSDDAAEIE-SVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDDSDM---GKSR 174
SESGSDDA E E V+K KD+EVS ++ENG ++P+E+KRKFSPIVWDRDD ++ KSR
Sbjct: 109 SESGSDDAIEYELQVNKNKDSEVSTILENGIRNPMEKKRKFSPIVWDRDDKEVTNSSKSR 168
Query: 175 L--VATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAARSVEY 232
+ LPPPP LPKAY KSP V+ +GG+ ISP KSS N NL+ SP+ VA + Y
Sbjct: 169 VSPAVPTLPPPPPLPKAYRKSPNVILDGGLEISPTKSSSNQNLRFSSPVKDTVAKGLLRY 228
Query: 233 AAPESPVGLASSPPRE-QWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISED 291
+A ESPVGLA+ P E Q+ N+ E E ++D+DY PTRNISSSRWAAGN+SP DEGEI +D
Sbjct: 229 SASESPVGLAALPLEERQFGNDHEAELIEDDDYVPTRNISSSRWAAGNNSPIDEGEIVDD 288
Query: 292 EELPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGD 351
+E+PKRRKK + +SL R RN+ +P+L ++K GS+ ++ RSSESDE RARSLSGD
Sbjct: 289 QEMPKRRKKSHL-ESLDFRLRNRSSTPDLGDLKIEGSDGAKVRSSESDELA-RARSLSGD 346
Query: 352 EYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRS 411
+Y G++++K DYME DE+ N+D G SD +SE+ENDS TPEPAGPPQRS+NML GCRS
Sbjct: 347 DYLGNDTDKDDYMETDEE--NDDRSGHSDRNSENENDSRATPEPAGPPQRSVNMLLGCRS 404
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
VDEFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH
Sbjct: 405 VDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 464
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME+MKQPFSQSEVKCLMLQLLEG+KYLH
Sbjct: 465 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMESMKQPFSQSEVKCLMLQLLEGVKYLH 524
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG+KQ
Sbjct: 525 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGAKQ 584
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YSTAIDMWSLGCIMAELLSKEPLFNGK+EFDQLDKIF+ LGTPNE IWPGFSKLPGVKVN
Sbjct: 585 YSTAIDMWSLGCIMAELLSKEPLFNGKTEFDQLDKIFRILGTPNETIWPGFSKLPGVKVN 644
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711
F+KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAA+NH+WFREVPL
Sbjct: 645 FVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAAINHEWFREVPL 704
Query: 712 PKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
PKSKDFMPTFPAQHAQDRR+RR++KSPDPLEEQRRKELQQGELG L+G
Sbjct: 705 PKSKDFMPTFPAQHAQDRRLRRILKSPDPLEEQRRKELQQGELGT-GGLFG 754
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359473713|ref|XP_002266306.2| PREDICTED: cyclin-dependent kinase G-2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1055 bits (2728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/762 (73%), Positives = 633/762 (83%), Gaps = 21/762 (2%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGRHG YRDNEF++RES+LDVSRR +AYSKDE Y+R RN N E G + +R+R
Sbjct: 1 MAAGRHGGYRDNEFKERESDLDVSRRNFAYSKDE--YDRSRNGNRE----GRIRDSRERN 54
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSE 120
RVRQKD+KERE I G SSS S GGGG R S++ D+EPGELSSE
Sbjct: 55 RVRQKDIKERESINGGYRSSSSRSDSGSSGGGGGVP----RRCVFSVRTADREPGELSSE 110
Query: 121 SGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD---SDMGKSRLVA 177
SGSDD E ES + +NE SKV ENG +SPL+RKRKFSPIVWDR+D ++ KSR+ +
Sbjct: 111 SGSDDGIESESQA---NNEFSKV-ENGIRSPLDRKRKFSPIVWDREDKESNNSSKSRIAS 166
Query: 178 TALPPPPSLP--KAYWKSPTVVPEGGVCISPIKSS-LNNNLQSVSPLIPPVAARSVEYAA 234
TA PP P K Y +SP ++ + G+ +SP K+S + + SP +PPVA SV
Sbjct: 167 TATALPPPPPLPKTYRQSPKLIQDEGMRVSPAKNSKIQRSQLPPSPSLPPVAPLSVTLDV 226
Query: 235 PESPVGLASSPPREQ-WHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISEDEE 293
SP+ L +S P+EQ W NE+E + ++DEDY PTRNISSSRWA +SP DEGEI +DEE
Sbjct: 227 SSSPIELNTSSPQEQRWSNEKEADQIEDEDYVPTRNISSSRWADEANSPVDEGEILDDEE 286
Query: 294 LPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEY 353
+PKRRKKM +S+ L+ R K +SPEL E+KR GSE +R++S++SDERG+R RS + ++Y
Sbjct: 287 IPKRRKKMFLSEGLEPRVLKKSVSPELGELKREGSEGARAKSTDSDERGNRGRSGTREDY 346
Query: 354 HGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVD 413
+ S++ DYMEI++ HNN+ S SDTDSE EN S TPEPA PPQRS+NMLQGCRSVD
Sbjct: 347 PDNNSDRNDYMEIEDYHNNDASARQSDTDSEHENVSRETPEPALPPQRSVNMLQGCRSVD 406
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
EFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS
Sbjct: 407 EFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 466
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN
Sbjct: 467 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 526
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG+KQYS
Sbjct: 527 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGAKQYS 586
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
TAIDMWSLGCIMAELLSKEPLFNGK+E DQ+DKIF+TLGTP+E IWPGFSKLPGVKVNF+
Sbjct: 587 TAIDMWSLGCIMAELLSKEPLFNGKTELDQIDKIFRTLGTPSETIWPGFSKLPGVKVNFV 646
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713
KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAALNHDWFREVPLPK
Sbjct: 647 KHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAALNHDWFREVPLPK 706
Query: 714 SKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
SKDFMPTFPAQHAQDRR+RR+MKSPDPLEEQRRKELQQGELG
Sbjct: 707 SKDFMPTFPAQHAQDRRVRRIMKSPDPLEEQRRKELQQGELG 748
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102321|ref|XP_002312637.1| predicted protein [Populus trichocarpa] gi|222852457|gb|EEE90004.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2596), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/769 (71%), Positives = 606/769 (78%), Gaps = 74/769 (9%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGR+ DNE RD ES+ ++SR ++ YSKD+F +RI N N E+ DR
Sbjct: 1 MAAGRYRGCHDNESRDHESDSELSREDFPYSKDKF--DRIENGNGEN----------DRG 48
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSG--SCGLREPELSLKAVDKEPGELS 118
R KD++EREV G SS S GG G CGL S +A D+EPGELS
Sbjct: 49 R---KDIREREVTNGGYSSSSGRSDSGSSGSGGAHGPRKCGL-----SARATDREPGELS 100
Query: 119 SESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD-----SDMGKS 173
SESGSDDA + ES + KD+EV KVVENG ++P+E+KRKFSPIVWDRDD S S
Sbjct: 101 SESGSDDAIDSESHAH-KDSEVLKVVENGTRTPVEKKRKFSPIVWDRDDKPVSNSSKSGS 159
Query: 174 RLVATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAARSVEYA 233
TALPPPP LPKAY +SP+ +PEGGV ISP
Sbjct: 160 PPAVTALPPPPPLPKAYRQSPSFIPEGGVGISP--------------------------- 192
Query: 234 APESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEISEDEE 293
EQW N+QE EH++DEDY P RNISSSRWAAGN+SP DEGEI ED+E
Sbjct: 193 --------------EQWGNDQEAEHIEDEDYVPMRNISSSRWAAGNNSPVDEGEIVEDQE 238
Query: 294 LPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEY 353
+PKRRKKMP S+ L +RARNK +P+ + KR GS+ +R RSSESDERG AR LSGD+Y
Sbjct: 239 IPKRRKKMPHSEFLDSRARNKLSTPDPGDFKREGSDVARGRSSESDERGTCARPLSGDDY 298
Query: 354 HGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVD 413
HG++S + DYM+IDE+HNN+DS D D +DE+DSC TPEPAGPPQRS+NMLQGCRSVD
Sbjct: 299 HGNDSGRDDYMDIDEEHNNSDS----DIDPKDEDDSCETPEPAGPPQRSVNMLQGCRSVD 354
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS
Sbjct: 355 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 414
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+VDVKEVVVGS+LDSIFMVMEYMEHDLKGLME+M+QPFSQSEVKCLMLQLLEG+KYLHDN
Sbjct: 415 VVDVKEVVVGSSLDSIFMVMEYMEHDLKGLMESMRQPFSQSEVKCLMLQLLEGVKYLHDN 474
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK YTHLVVTLWYRAPELLLG KQYS
Sbjct: 475 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKTYTHLVVTLWYRAPELLLGGKQYS 534
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
T IDMWSLGCIMAELLSK PLFNGK+E DQLDKIF+ LGTPNE IWPGFSKLPGVKVNF+
Sbjct: 535 TTIDMWSLGCIMAELLSKGPLFNGKTEVDQLDKIFRILGTPNETIWPGFSKLPGVKVNFV 594
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713
KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAAL HDWFREVPLPK
Sbjct: 595 KHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAALKHDWFREVPLPK 654
Query: 714 SKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
SKDFMPTFPAQHAQDRR+RR+ KSPDPLEEQRRKELQQGELG L+G
Sbjct: 655 SKDFMPTFPAQHAQDRRLRRIRKSPDPLEEQRRKELQQGELGT-GGLFG 702
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512351|ref|XP_003524883.1| PREDICTED: cyclin-dependent kinase G-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2506), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/772 (71%), Positives = 619/772 (80%), Gaps = 49/772 (6%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRRE-YAYSKDEFAYERIRNSNHESNGQGHVPY--AR 57
MAAGRHG YR+NEFR+RES+L+VSRR +A SK++ Y+R+ SNG G V +R
Sbjct: 1 MAAGRHGGYRENEFRERESKLEVSRRGGFANSKED--YDRV------SNGGGDVVRGGSR 52
Query: 58 DRVRVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGEL 117
DRVRVRQKD+KERE +NGG SSS S G G CG S+K+VD+EPGEL
Sbjct: 53 DRVRVRQKDIKERE-DVNGGGYRSSSSRSDSGSSGLGPRQCGF-----SVKSVDREPGEL 106
Query: 118 SSESGSDDAAEIESVSKVKDNEVSKVVENGNQSPL--ERKRKFSPIVWDRDDSDM----- 170
SSESGSDDA E E KD EV+ + E QSP ERKRKFSPIVWD+DD ++
Sbjct: 107 SSESGSDDATESEP--GAKDTEVAMLEETRTQSPPAPERKRKFSPIVWDQDDKEVNESSR 164
Query: 171 --GKSRLVATALPPPPSLPKAY--WKSPTVVPEGGVCISPIKSSLNNNLQ--SVSPLIPP 224
G + V ALPPPP LPK + +SP V P GGV I +K+ LQ + S + P
Sbjct: 165 VRGSTSAVKGALPPPPPLPKVFCQLQSPNV-PNGGVEIHLVKNRETEELQLNAASKVTLP 223
Query: 225 VAARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPAD 284
SP GL S PP+ +W N+QE EH + EDY PTRNISSSRWAAG++SP D
Sbjct: 224 ------------SPSGLHSLPPKGRWDNDQEAEHPEGEDYIPTRNISSSRWAAGDNSPVD 271
Query: 285 EGEISEDEELPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDR 344
EGEI DEE+PKRR+++ + L R RNK LSPE S+V+ G ER+R+RSSES+ERG R
Sbjct: 272 EGEILNDEEMPKRRRRVS-PELLDGRLRNKLLSPEESKVE--GIERARARSSESEERGVR 328
Query: 345 ARSLSGDEYHGHESEKGDYMEIDEDHNNND-SVGGSDTDSEDENDSCGTPEPAGPPQRSI 403
R+ SGD++ G ESEK DYMEID ++ SV SDTDSEDE+D TPEP PQR++
Sbjct: 329 GRTSSGDDFPGIESEKDDYMEIDAQGGESETSVSHSDTDSEDEDDGQETPEPPAQPQRAV 388
Query: 404 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREI 463
NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE+EGFPLTSLREI
Sbjct: 389 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEKEGFPLTSLREI 448
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQL 523
NILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLKGLME MKQPFSQSEVKCLM+QL
Sbjct: 449 NILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGLMEAMKQPFSQSEVKCLMIQL 508
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
LEG+KYLHDNWVLHRDLKTSNLLLNNRG+LKICDFGLARQYGSPLKPYTHLVVTLWYRAP
Sbjct: 509 LEGVKYLHDNWVLHRDLKTSNLLLNNRGDLKICDFGLARQYGSPLKPYTHLVVTLWYRAP 568
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
ELLLG+KQYSTAIDMWSLGCIMAELLSKEPLFNGK+EFDQLDKIF+ LGTPNE IWPGFS
Sbjct: 569 ELLLGAKQYSTAIDMWSLGCIMAELLSKEPLFNGKTEFDQLDKIFRILGTPNETIWPGFS 628
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
KLPGVKVNF+KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAALNH
Sbjct: 629 KLPGVKVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAALNH 688
Query: 704 DWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
+WFREVPLPKSK+FMPTFPAQHAQDRR+RR+ KSPDPLEEQRRKELQQGE G
Sbjct: 689 EWFREVPLPKSKEFMPTFPAQHAQDRRVRRIYKSPDPLEEQRRKELQQGETG 740
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356525136|ref|XP_003531183.1| PREDICTED: cyclin-dependent kinase G-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/768 (70%), Positives = 608/768 (79%), Gaps = 42/768 (5%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAA RHG YR+NEF++RES+L+VSRR +A SK++ Y+R+RN +G +RDRV
Sbjct: 1 MAASRHGGYRENEFKERESKLEVSRRGFANSKED--YDRVRNGGGGEVVRGG---SRDRV 55
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSE 120
RVRQKD+KERE + NGG SSS S G G CG S+KAVD+EPGELSSE
Sbjct: 56 RVRQKDIKEREGV-NGGGYRSSSSRSDSGSSGLGPRRCGF-----SVKAVDREPGELSSE 109
Query: 121 SGSDDAAEIESVSKVKDNEVSKVVENGNQSPL--ERKRKFSPIVWDRDD---SDMGKSRL 175
SGSDDA IES +K +EV+ + E SP ERKRKFSPIVWD+DD +++ K R+
Sbjct: 110 SGSDDA--IESEPGLKGSEVAMLEETRTLSPPVPERKRKFSPIVWDQDDKEVNELSKVRV 167
Query: 176 VATALPPPPSLPKAYW-------KSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAAR 228
A+A+ P +SP P GV I P+K+ LQ AA
Sbjct: 168 SASAVKVAALPPPPPLPKVFRQSQSPNA-PNSGVEIVPVKNRETEELQLN-------AAS 219
Query: 229 SVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEI 288
+V + SP GL S PP+ +W N+QE EH + EDY PTRNISSSRWAAG++SP DEGEI
Sbjct: 220 NVTLS---SPSGLHSLPPKGKWDNDQEAEHPEGEDYVPTRNISSSRWAAGDNSPVDEGEI 276
Query: 289 SEDEELPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSL 348
DEE+PK R ++ D L R RNK LSPE S+V+ G ER+R+RSSES+ERG R R+
Sbjct: 277 LNDEEMPKSRWRVS-PDLLDGRLRNKLLSPEESKVE--GIERARARSSESEERGARGRTS 333
Query: 349 SGDEYHGHESEKGDYMEID-EDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQ 407
SGD+Y G SEK DYME+D + + S+ SDTDSEDE+D TPEP PQR+ NMLQ
Sbjct: 334 SGDDYPG--SEKDDYMEVDVQGGKSETSISHSDTDSEDEDDGRETPEPTAQPQRTFNMLQ 391
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE+EGFPLTSLREINILL
Sbjct: 392 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEKEGFPLTSLREINILL 451
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
SFHHP IVDVKEVVVGS+LDSIFMVMEYMEHDLKGLME MKQPFSQSEVKCLM+QLLEG+
Sbjct: 452 SFHHPYIVDVKEVVVGSSLDSIFMVMEYMEHDLKGLMEAMKQPFSQSEVKCLMIQLLEGV 511
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL
Sbjct: 512 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 571
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
G+KQYSTAIDMWSLGCIMAELLSKEPLFNG++EFDQLDKIF+ LGTPNE IWPGFSKLPG
Sbjct: 572 GAKQYSTAIDMWSLGCIMAELLSKEPLFNGRTEFDQLDKIFRILGTPNETIWPGFSKLPG 631
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
VKVNF+KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAE ALNH+WFR
Sbjct: 632 VKVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEDALNHEWFR 691
Query: 708 EVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
EVPLPKSK+FMPTFPAQHAQDRR+RR+ KSPDPLEEQRRKELQQGE G
Sbjct: 692 EVPLPKSKEFMPTFPAQHAQDRRVRRIYKSPDPLEEQRRKELQQGETG 739
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435041|ref|XP_004135304.1| PREDICTED: cyclin-dependent kinase G-2-like [Cucumis sativus] gi|449494879|ref|XP_004159672.1| PREDICTED: cyclin-dependent kinase G-2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 940 bits (2430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/779 (67%), Positives = 612/779 (78%), Gaps = 44/779 (5%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRV 60
MAAGR G YRD + +DR+S DV+ +E YER R N ESN + RDR+
Sbjct: 1 MAAGRMGGYRDYDMKDRDSSFDVTAKE--------GYERGRGGNRESN-KSRGRDVRDRI 51
Query: 61 RVRQKDVKEREVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSE 120
RVRQKD+KEREV G S S S S S GG S GL++ L ++ +D+EPGELSSE
Sbjct: 52 RVRQKDIKEREV----GNGSLRSSSKSDSGSSGGIASHGLKQKVLVVRTMDREPGELSSE 107
Query: 121 SGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD-----SDMGKSRL 175
SGSDDA + S + K++E +KVVENG +SP E+KRKFSPIVWDRDD S K
Sbjct: 108 SGSDDATD--SGLRSKNSESAKVVENGIRSPPEKKRKFSPIVWDRDDKEETTSTRNKVAK 165
Query: 176 VATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSP--LIPPV----AARS 229
ATA P PK +SP + + + + +S P L PP +AR
Sbjct: 166 AATASSVPS--PKGQKQSPNAI------LDTLDDMHTADGRSKDPEYLQPPSLVESSARD 217
Query: 230 V---EYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEG 286
+ E++A SP +S+ R+ W N+ E E+ D+DYAPTRNISSSRWAAGN++P DEG
Sbjct: 218 LGSDEFSANGSPRMPSSASLRKPWENDLEAENFGDDDYAPTRNISSSRWAAGNNTPGDEG 277
Query: 287 EISEDEELPKRRKKMPVSDSLQ-TRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRA 345
EI DEE+PKRRK P+S+SL+ ++ + K L+PE+ EVKR GSE + +RSSES ERG+R+
Sbjct: 278 EIL-DEEMPKRRKTTPISESLEGSKVQRKSLTPEIGEVKRQGSE-AGTRSSESTERGERS 335
Query: 346 RSLSGDEYHGHESEKGDYMEI-DEDHNNNDSVGGSDTDSEDENDSCGTPEPAG-PPQRSI 403
RS S + Y G +SEK + M++ DE + S SDTDSEDE +S EP+G PPQRS+
Sbjct: 336 RSSSANHYLG-DSEKDEGMDLGDEIRRMDTSSSRSDTDSEDETESPEEAEPSGHPPQRSV 394
Query: 404 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREI 463
NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKK+GE+VALKKVKMEKEREGFP+TSLREI
Sbjct: 395 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKSGEVVALKKVKMEKEREGFPMTSLREI 454
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQL 523
NILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLK LMETMKQPFSQSEVKCLMLQL
Sbjct: 455 NILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQPFSQSEVKCLMLQL 514
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
LEG+KYLHDNWVLHRDLKTSNLL+NN+GELKICDFGLARQYGSPLK YTH+VVTLWYRAP
Sbjct: 515 LEGVKYLHDNWVLHRDLKTSNLLMNNQGELKICDFGLARQYGSPLKTYTHMVVTLWYRAP 574
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
ELLLG+++YSTAIDMWSLGCIMAELLSK+PLFNGK+E DQLDKIF+TLGTPNE IWPGFS
Sbjct: 575 ELLLGTRKYSTAIDMWSLGCIMAELLSKQPLFNGKTEVDQLDKIFRTLGTPNETIWPGFS 634
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
KLPGV+VNF+KHQYNLLRKKFPATSFTGSPVLSD+GFDLLN LLTYDP+KRITAEAALNH
Sbjct: 635 KLPGVRVNFVKHQYNLLRKKFPATSFTGSPVLSDSGFDLLNKLLTYDPEKRITAEAALNH 694
Query: 704 DWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYG 762
+WF EVPLPKSK+FMPTFPAQHAQDRR+RR+MKSPDPLEEQRRKELQQGELG S L+G
Sbjct: 695 EWFSEVPLPKSKEFMPTFPAQHAQDRRLRRVMKSPDPLEEQRRKELQQGELGT-SGLFG 752
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841455|ref|XP_002888609.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297334450|gb|EFH64868.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2370), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/779 (65%), Positives = 577/779 (74%), Gaps = 53/779 (6%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYER---IRNSNHESNGQGHVPYAR 57
MAAGR+ Y D+E RD+ES SRR+ AYS +++ + R + N N HV +
Sbjct: 1 MAAGRNLRYPDHELRDQESNSRFSRRDSAYSNEDYDHVRNGALDNEKGRVNNLRHVDSGK 60
Query: 58 DRVRVRQKDVKEREVIINGGFCSSSSRSDSGSSG---GGGSGSCGLREPELSLKAVDKEP 114
DR R R K+ ++N GF S+S+ GS G C S ++VD+EP
Sbjct: 61 DRDRFRPGARKQENEMVNSGF--RLSKSNPGSREVLLDRGPKRC-----VFSARSVDREP 113
Query: 115 GELSSESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDDSDMGKSR 174
GELSSESGSDD IES S VK+N K VEN QSP+E+KRKFSPIVWDRDD D +S
Sbjct: 114 GELSSESGSDDL--IESESLVKNNGGVKEVENRVQSPVEKKRKFSPIVWDRDDHD--RSN 169
Query: 175 LVATALPPPPSLP-------KAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLIPPVAA 227
L P + K +SP+V G SP KS+++ + P+ V+A
Sbjct: 170 LSRNEKPVDVTPLPPPPPLIKRSSQSPSVSCGGNSHFSPAKSNMHQD-----PVEVGVSA 224
Query: 228 RSVEYAAPESPVGLASSPPREQWHN------EQEVEHVDDEDYAPTRNISSSRWAAGNSS 281
SV +P V ++S EQ N +++ H+++E+ PTR+ISSSRWAAGNSS
Sbjct: 225 VSVIALSPS--VEMSSLCVVEQSSNAGQDGKQEDATHLEEEENMPTRHISSSRWAAGNSS 282
Query: 282 PADEGEISEDEELPKRRKK-MPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDE 340
P DE EI E+ KRRKK PV Q R RNK +PE+ E+ R G RSS+SDE
Sbjct: 283 PTDEREIVEEVGASKRRKKPFPV----QGRLRNKSQTPEVGELVREGY-----RSSDSDE 333
Query: 341 RGDRARSLSGDEYHGHESEKGDYMEIDEDH----NNNDSVGGSDTDSEDENDSCGTPEPA 396
RG + S D++ ++ KGD MEIDE+ N +DS+ S+TDS+DE TPEPA
Sbjct: 334 RGHHSLPGSRDDFEEKDAVKGDKMEIDEEEHRRGNTSDSL--SETDSDDEYGRHETPEPA 391
Query: 397 GPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFP 456
P RSINMLQGCRSVDEFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGFP
Sbjct: 392 STPLRSINMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGFP 451
Query: 457 LTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEV 516
LTSLREINILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLK LMETMKQ FSQSEV
Sbjct: 452 LTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEV 511
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
KCLMLQLLEG+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV
Sbjct: 512 KCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 571
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
TLWYRAPELLLG+KQYSTAIDMWSLGCIMAELL K PLFNGK+EFDQLDKIF+ LGTPNE
Sbjct: 572 TLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNE 631
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT 696
IWPGFSKLPGVKVNF+KHQYNLLRKKFPATSFTG+PVLSDAGFDLLN LLTYDP++RIT
Sbjct: 632 SIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRIT 691
Query: 697 AEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
+ AL HDWFREVPLPKSKDFMPTFPAQHAQDRR RRM+KSPDPLEEQRRKEL Q ELG
Sbjct: 692 VDEALKHDWFREVPLPKSKDFMPTFPAQHAQDRRGRRMVKSPDPLEEQRRKELTQTELG 750
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15220477|ref|NP_176925.1| protein kinase-like protein [Arabidopsis thaliana] gi|238478996|ref|NP_001154456.1| protein kinase-like protein [Arabidopsis thaliana] gi|12324671|gb|AAG52294.1|AC011020_1 putative protein kinase [Arabidopsis thaliana] gi|17065202|gb|AAL32755.1| putative protein kinase [Arabidopsis thaliana] gi|332196545|gb|AEE34666.1| protein kinase-like protein [Arabidopsis thaliana] gi|332196546|gb|AEE34667.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/770 (66%), Positives = 581/770 (75%), Gaps = 39/770 (5%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYAR--D 58
MAAGR+ Y D+E RD+ES SRR+ AY+ ++ Y +RN + NG+G V R D
Sbjct: 1 MAAGRNIRYPDHELRDQESNSRFSRRDSAYANED--YNHVRNGAID-NGKGRVSNLRHGD 57
Query: 59 RVRVRQKDVKEREVIINGGFCSSSSRSDSGSSG---GGGSGSCGLREPELSLKAVDKEPG 115
R R++ +E +++ GF S+S+ GS G CG S ++VD+EPG
Sbjct: 58 RDRIKSGARQEENKMVSSGF--RLSKSNPGSREVFIDLGPKRCGF-----SARSVDREPG 110
Query: 116 ELSSESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDD---SDMGK 172
ELSSESGSDD E ES++KV N V K VEN QSP+E+KRKFSPIVWDRDD S++ +
Sbjct: 111 ELSSESGSDDLIESESLAKV--NGVVKEVENRAQSPVEKKRKFSPIVWDRDDHERSNLSR 168
Query: 173 SR--LVATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNN--LQSVSPLIPPVAAR 228
+ + T LPPPP L K +SP+V G SP KS ++ + VS + P +
Sbjct: 169 NEKPVEVTPLPPPPPLVKRSSQSPSVSCGGNSHYSPAKSDMHQDPVEVGVSAVSMPALSP 228
Query: 229 SVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGEI 288
SVE + S + S EQ ++ H+++++ PTR+ISSSRWAAGNSSP DE EI
Sbjct: 229 SVEMS---SLCVVEQSSNAEQDDKQEHATHLEEDENMPTRHISSSRWAAGNSSPTDEVEI 285
Query: 289 SEDEELPKRRKK-MPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARS 347
E+ KRRKK PV Q R RN +PE+ E+ R G RSS+SDERG +
Sbjct: 286 VEEVGEKKRRKKPFPV----QGRFRNTSQTPEVGELVREGY-----RSSDSDERGHHSLP 336
Query: 348 LSGDEYHGHESEKGDYMEIDED-HNNNDSVGG-SDTDSEDENDSCGTPEPAGPPQRSINM 405
S D++ ++ K D MEIDE+ H +SV S+TDS+DE TPEPA P RSINM
Sbjct: 337 GSRDDFEERDAVKSDKMEIDEEEHRRENSVDSLSETDSDDEYVRHETPEPASTPLRSINM 396
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSVDEFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGFPLTSLREINI
Sbjct: 397 LQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGFPLTSLREINI 456
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
LLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLK LMETMKQ FSQSEVKCLMLQLLE
Sbjct: 457 LLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEVKCLMLQLLE 516
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL
Sbjct: 517 GVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 576
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+KQYSTAIDMWSLGCIMAELL K PLFNGK+EFDQLDKIF+ LGTPNE IWPGFSKL
Sbjct: 577 LLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNESIWPGFSKL 636
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
PGVKVNF+KHQYNLLRKKFPATSFTG+PVLSDAGFDLLN LLTYDP++RIT AL HDW
Sbjct: 637 PGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRITVNEALKHDW 696
Query: 706 FREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
FREVPLPKSKDFMPTFPAQHAQDRR RRM+KSPDPLEEQRRKEL Q ELG
Sbjct: 697 FREVPLPKSKDFMPTFPAQHAQDRRGRRMVKSPDPLEEQRRKELTQTELG 746
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17064846|gb|AAL32577.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/772 (65%), Positives = 574/772 (74%), Gaps = 43/772 (5%)
Query: 1 MAAGRHGVYRDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYAR--D 58
MAAGR+ Y D+E RD+ES SRR+ AY+ ++ Y +RN + NG+G V R D
Sbjct: 1 MAAGRNIRYPDHELRDQESNSRFSRRDSAYANED--YNHVRNGAID-NGKGRVSNLRHGD 57
Query: 59 RVRVRQKDVKEREVIINGGFCSSSSRSDSGSSG---GGGSGSCGLREPELSLKAVDKEPG 115
R R++ +E +++ GF S+S+ GS G CG S ++VD+EPG
Sbjct: 58 RDRIKSGARQEENKMVSSGF--RLSKSNPGSREVFIDLGPKRCGF-----SARSVDREPG 110
Query: 116 ELSSESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDRDDSDMGKSRL 175
ELSSESGSDD E ES++KV N V K VEN QSP+E+KRKFSPIVWDRDD + +S L
Sbjct: 111 ELSSESGSDDLIESESLAKV--NGVVKEVENRAQSPVEKKRKFSPIVWDRDDHE--RSNL 166
Query: 176 VATALPPPPSLP-------KAYWKSPTVVPEGGVCISPIKSSLNNN--LQSVSPLIPPVA 226
P S K +SP+V G SP KS ++ + VS + P
Sbjct: 167 SRNEKPVEVSPLPPPPPLVKRSSQSPSVSCGGNSHYSPAKSDMHQDPVEVGVSAVSMPAL 226
Query: 227 ARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEG 286
+ SVE + S + S E+ ++ H+++++ PTR+ISSSRWAAGNSSP DE
Sbjct: 227 SPSVEMS---SLCVVEQSSNAEKDDKQEHATHLEEDENMPTRHISSSRWAAGNSSPTDEV 283
Query: 287 EISEDEELPKRRKK-MPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRA 345
EI E+ KRRKK PV Q R RN +PE+ E+ R G RSS+SDERG +
Sbjct: 284 EIVEEVGEKKRRKKPFPV----QGRFRNTSQTPEVGELVREGY-----RSSDSDERGHHS 334
Query: 346 RSLSGDEYHGHESEKGDYMEIDED-HNNNDSVGG-SDTDSEDENDSCGTPEPAGPPQRSI 403
S D++ ++ K D MEIDE+ H +SV S+TDS+DE TPEPA P RSI
Sbjct: 335 LPGSRDDFEERDAVKSDKMEIDEEEHRRENSVDSLSETDSDDEYVRHETPEPASTPLRSI 394
Query: 404 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREI 463
NMLQGCRSVDEFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGFPLTSLREI
Sbjct: 395 NMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGFPLTSLREI 454
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQL 523
NILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLK LMETMKQ FSQSEVKCLMLQL
Sbjct: 455 NILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSEVKCLMLQL 514
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
LEG+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP
Sbjct: 515 LEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 574
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
ELLLG+KQYSTAIDMWSLGCIMAELL K PLFNGK+EFDQLDKIF+ LGTPNE IWPGFS
Sbjct: 575 ELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPNESIWPGFS 634
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
KLPGVKVNF+KHQYNLLRKKFPATSFTG+PVLSDAGFDLLN LLTYDP++RIT AL H
Sbjct: 635 KLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRITVNEALKH 694
Query: 704 DWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
DWFREVPLPKSKDFMPTFPAQHAQDRR RRM+KSPDPLEEQRRKEL Q ELG
Sbjct: 695 DWFREVPLPKSKDFMPTFPAQHAQDRRGRRMVKSPDPLEEQRRKELTQTELG 746
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 776 | ||||||
| TAIR|locus:2008595 | 752 | AT1G67580 [Arabidopsis thalian | 0.827 | 0.853 | 0.694 | 4.7e-240 | |
| TAIR|locus:2158554 | 612 | CDKG1 "cyclin-dependent kinase | 0.452 | 0.573 | 0.662 | 9.2e-139 | |
| UNIPROTKB|J9NTS7 | 782 | CDK11A "Uncharacterized protei | 0.485 | 0.482 | 0.588 | 7.7e-128 | |
| UNIPROTKB|E1BWQ7 | 772 | CDC2L1 "Uncharacterized protei | 0.422 | 0.424 | 0.659 | 1.6e-127 | |
| ZFIN|ZDB-GENE-041212-74 | 800 | cdk11b "cyclin-dependent kinas | 0.474 | 0.46 | 0.586 | 1.4e-126 | |
| UNIPROTKB|F1NJL5 | 772 | CDC2L1 "Uncharacterized protei | 0.422 | 0.424 | 0.659 | 4e-126 | |
| UNIPROTKB|P21127 | 795 | CDK11B "Cyclin-dependent kinas | 0.661 | 0.645 | 0.486 | 7.2e-124 | |
| MGI|MGI:88353 | 784 | Cdk11b "cyclin-dependent kinas | 0.622 | 0.616 | 0.497 | 8.2e-123 | |
| UNIPROTKB|F1RJC5 | 784 | CDK11B "Uncharacterized protei | 0.652 | 0.645 | 0.493 | 1.3e-122 | |
| UNIPROTKB|J9P8L3 | 748 | CDK11A "Uncharacterized protei | 0.657 | 0.681 | 0.478 | 1.7e-122 |
| TAIR|locus:2008595 AT1G67580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2235 (791.8 bits), Expect = 4.7e-240, Sum P(2) = 4.7e-240
Identities = 463/667 (69%), Positives = 518/667 (77%)
Query: 106 SLKAVDKEPGELSSESGSDDAAEIESVSKVKDNEVSKVVENGNQSPLERKRKFSPIVWDR 165
S ++VD+EPGELSSESGSDD E ES++KV N V K VEN QSP+E+KRKFSPIVWDR
Sbjct: 101 SARSVDREPGELSSESGSDDLIESESLAKV--NGVVKEVENRAQSPVEKKRKFSPIVWDR 158
Query: 166 DD---SDMGKSR--LVATALPPPPSLPKAYWKSPTVVPEGGVCISPIKSSLNNN-LQ-SV 218
DD S++ ++ + T LPPPP L K +SP+V G SP KS ++ + ++ V
Sbjct: 159 DDHERSNLSRNEKPVEVTPLPPPPPLVKRSSQSPSVSCGGNSHYSPAKSDMHQDPVEVGV 218
Query: 219 SPLIPPVAARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWAAG 278
S + P + SVE + S + S EQ ++ H+++++ PTR+ISSSRWAAG
Sbjct: 219 SAVSMPALSPSVEMS---SLCVVEQSSNAEQDDKQEHATHLEEDENMPTRHISSSRWAAG 275
Query: 279 NSSPADEGEISEDEELPKRRKK-MPVSDSLQTRARNKFLSPELSEVKXXXXXXXXXXXXX 337
NSSP DE EI E+ KRRKK PV Q R RN +PE+ E+
Sbjct: 276 NSSPTDEVEIVEEVGEKKRRKKPFPV----QGRFRNTSQTPEVGELVREGYRSSDSDERG 331
Query: 338 XXXXXXXXXXLSGDEYHGHESEKGDYMEIDED-HNNNDSVGG-SDTDSEDENDSCGTPEP 395
S D++ ++ K D MEIDE+ H +SV S+TDS+DE TPEP
Sbjct: 332 HHSLPG-----SRDDFEERDAVKSDKMEIDEEEHRRENSVDSLSETDSDDEYVRHETPEP 386
Query: 396 AGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF 455
A P RSINMLQGCRSVDEFERLNKIDEGTYGVVYRA+DKKTGEIVALKKVKMEKEREGF
Sbjct: 387 ASTPLRSINMLQGCRSVDEFERLNKIDEGTYGVVYRAKDKKTGEIVALKKVKMEKEREGF 446
Query: 456 PLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE 515
PLTSLREINILLSFHHPSIVDVKEVVVGS+LDSIFMVMEYMEHDLK LMETMKQ FSQSE
Sbjct: 447 PLTSLREINILLSFHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKALMETMKQRFSQSE 506
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575
VKCLMLQLLEG+KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV
Sbjct: 507 VKCLMLQLLEGVKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 566
Query: 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
VTLWYRAPELLLG+KQYSTAIDMWSLGCIMAELL K PLFNGK+EFDQLDKIF+ LGTPN
Sbjct: 567 VTLWYRAPELLLGAKQYSTAIDMWSLGCIMAELLMKAPLFNGKTEFDQLDKIFRILGTPN 626
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
E IWPGFSKLPGVKVNF+KHQYNLLRKKFPATSFTG+PVLSDAGFDLLN LLTYDP++RI
Sbjct: 627 ESIWPGFSKLPGVKVNFVKHQYNLLRKKFPATSFTGAPVLSDAGFDLLNKLLTYDPERRI 686
Query: 696 TAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
T AL HDWFREVPLPKSKDFMPTFPAQHAQDRR RRM+KSPDPLEEQRRKEL Q ELG
Sbjct: 687 TVNEALKHDWFREVPLPKSKDFMPTFPAQHAQDRRGRRMVKSPDPLEEQRRKELTQTELG 746
Query: 756 IHSDLYG 762
L+G
Sbjct: 747 -SGGLFG 752
|
|
| TAIR|locus:2158554 CDKG1 "cyclin-dependent kinase G1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 9.2e-139, Sum P(2) = 9.2e-139
Identities = 241/364 (66%), Positives = 292/364 (80%)
Query: 365 EIDEDHNNNDSVGGSDTDS-EDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDE 423
++ D N+ SD D E E+ TP G +NM+ G RSV+EF++LNKI+E
Sbjct: 253 KLSADGNSGREYYSSDHDELEHEDQDSLTP---G----EMNMMFGSRSVNEFQKLNKINE 305
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKER-E---GFPLTSLREINILLSFHHPSIVDVKE 479
GTYG+VY+ARD+KT EIVALKK+KM+++R E GFPLTSLREINILLS +HP+IV+VKE
Sbjct: 306 GTYGIVYKARDEKTKEIVALKKIKMKEDRFEEEYGFPLTSLREINILLSCNHPAIVNVKE 365
Query: 480 VVVGSNLDS-IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
VVVG D+ ++MVME++EHDL+G+M+ K+PFS SEVKCLM+QLL+G+KYLH NW++HR
Sbjct: 366 VVVGGKNDNDVYMVMEHLEHDLRGVMDRRKEPFSTSEVKCLMMQLLDGLKYLHTNWIIHR 425
Query: 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
DLK SNLL+NN GELKICDFG+ARQYGSP+KPYT +V+T WYR PELLLG+K+YSTA+DM
Sbjct: 426 DLKPSNLLMNNCGELKICDFGMARQYGSPIKPYTQMVITQWYRPPELLLGAKEYSTAVDM 485
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658
WS+GCIMAELLS++PLF GKSE DQL KIF LGTPNE IWPGFS P K F YN
Sbjct: 486 WSVGCIMAELLSQKPLFPGKSELDQLQKIFAVLGTPNEAIWPGFSSFPNAKAKFPTQPYN 545
Query: 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFM 718
+LRKKFPA SF G +LS+ GFDLLNSLLT DP+KR+T E ALNH WF EVPLPKSKDFM
Sbjct: 546 MLRKKFPAISFVGGQILSERGFDLLNSLLTLDPEKRLTVEDALNHGWFHEVPLPKSKDFM 605
Query: 719 PTFP 722
PT+P
Sbjct: 606 PTYP 609
|
|
| UNIPROTKB|J9NTS7 CDK11A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 7.7e-128, Sum P(4) = 7.7e-128
Identities = 229/389 (58%), Positives = 291/389 (74%)
Query: 357 ESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCG-TP-EPAGPPQRSINMLQGCRSVDE 414
+ + GD E +E+ + T+ + DS +P E + + LQGCRSV+E
Sbjct: 365 DRDSGDSEEGEEEAGEGTPQSSALTEGDFVPDSPALSPIELKQELPKYLPALQGCRSVEE 424
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN +L HP+I
Sbjct: 425 FQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINTILKAQHPNI 484
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
V V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL G+K+LHDNW
Sbjct: 485 VTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLRGVKHLHDNW 544
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +VVTLWYRAPELLLG+K+YST
Sbjct: 545 ILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLWYRAPELLLGAKEYST 604
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK-VNFI 653
A+DMWS+GCI ELL+++PLF GKSE DQ++K+FK LGTP+EKIWPG++ LP VK + F
Sbjct: 605 AVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIWPGYNDLPAVKKMTFT 664
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713
++ YN LRK+F A +LSD GFDL+N LTY P +R++AE L H++FRE PLP
Sbjct: 665 EYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGRRVSAEDGLKHEYFRETPLPI 717
Query: 714 SKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
PT+PA+ Q R R SP P E
Sbjct: 718 DPSMFPTWPAKSEQQRVKRGT--SPRPPE 744
|
|
| UNIPROTKB|E1BWQ7 CDC2L1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 1.6e-127, Sum P(4) = 1.6e-127
Identities = 223/338 (65%), Positives = 274/338 (81%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN
Sbjct: 406 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINT 465
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L H +IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 466 ILKAQHLNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLR 525
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLKPYT +VVTLWYRAPEL
Sbjct: 526 GVKHLHDNWILHRDLKTSNLLLSHSGILKVGDFGLAREYGSPLKPYTPVVVTLWYRAPEL 585
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTAIDMWS+GCI ELL+++PLF GKSE DQ++K+FK LGTP+EKIWPG+++L
Sbjct: 586 LLGAKEYSTAIDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIWPGYNEL 645
Query: 646 PGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P VK + F ++ YN LRK+F A +LSD GFDL+N+ LTY P +RITAE L H+
Sbjct: 646 PAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNNFLTYYPARRITAEDGLKHE 698
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
+FRE PLP PT+PA+ Q R R SP P E
Sbjct: 699 YFRETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 734
|
|
| ZFIN|ZDB-GENE-041212-74 cdk11b "cyclin-dependent kinase 11B" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 1.4e-126, Sum P(4) = 1.4e-126
Identities = 230/392 (58%), Positives = 291/392 (74%)
Query: 356 HESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPE----PAGPPQRSINM------ 405
H+SE E +E+ + D + S TPE P PP + +
Sbjct: 372 HDSEVSAEEE-EEEEEEVEEEEAVDVTPQSHAPSA-TPEERYIPESPPVSPVELKKELPK 429
Query: 406 ----LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR 461
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLR
Sbjct: 430 YLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLR 489
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLML 521
EIN +L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+
Sbjct: 490 EINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMI 549
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYR 581
QLL G+++LHDNW+LHRDLKTSNLLL+++G LKI DFGLAR+YGSPLKPYT +VVTLWYR
Sbjct: 550 QLLRGVRHLHDNWILHRDLKTSNLLLSHKGILKIGDFGLAREYGSPLKPYTPVVVTLWYR 609
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
+P+LLLG+K+YSTA+DMWS+GCI ELL+++PLF GKSE DQ++KIFK LG+P+EKIWPG
Sbjct: 610 SPDLLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKIFKDLGSPSEKIWPG 669
Query: 642 FSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
+S+ P VK + F ++ YN LRK+F A +LSD GFDL+N LTY P KRI+A+ A
Sbjct: 670 YSEPPAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYCPAKRISADEA 722
Query: 701 LNHDWFREVPLPKSKDFMPTFPAQHAQDRRMR 732
L H++FRE PLP PT+PA+ Q R R
Sbjct: 723 LKHEYFRESPLPIDPSMFPTWPAKSEQQRVKR 754
|
|
| UNIPROTKB|F1NJL5 CDC2L1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 4.0e-126, Sum P(3) = 4.0e-126
Identities = 223/338 (65%), Positives = 274/338 (81%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI 465
LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN
Sbjct: 406 LQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINT 465
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+L H +IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL
Sbjct: 466 ILKAQHLNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLR 525
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLKPYT +VVTLWYRAPEL
Sbjct: 526 GVKHLHDNWILHRDLKTSNLLLSHSGILKVGDFGLAREYGSPLKPYTPVVVTLWYRAPEL 585
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LLG+K+YSTAIDMWS+GCI ELL+++PLF GKSE DQ++K+FK LGTP+EKIWPG+++L
Sbjct: 586 LLGAKEYSTAIDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTPSEKIWPGYNEL 645
Query: 646 PGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P VK + F ++ YN LRK+F A +LSD GFDL+N+ LTY P +RITAE L H+
Sbjct: 646 PAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNNFLTYYPARRITAEDGLKHE 698
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
+FRE PLP PT+PA+ Q R R SP P E
Sbjct: 699 YFRETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 734
|
|
| UNIPROTKB|P21127 CDK11B "Cyclin-dependent kinase 11B" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 7.2e-124, Sum P(2) = 7.2e-124
Identities = 262/539 (48%), Positives = 343/539 (63%)
Query: 217 SVSPLIPPVAARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDY-APTRNISSS-- 273
S SP PP E P G A P R Q + + E +++ D + ++IS S
Sbjct: 232 SRSPPRPP--RERFELGDGRKP-GEAR-PARAQKPAQLKEEKMEERDLLSDLQDISDSER 287
Query: 274 RWAAGNSSPADEGEISEDEELPKRRKKMPVSDSLQTRARNKFLSPELSEVKXXXXXXXXX 333
+ ++ SS A+ G SE+EE + ++ S S ++ + E E
Sbjct: 288 KTSSAESSSAESGSGSEEEEEEEEEEEEEGSTSEESEEEEEEEEEEEEETGSNSEEASEQ 347
Query: 334 XXXXXXXXXXXXXXLSGDEYH-------GHESEKGDYMEIDEDHNNNDSVGGSDTDSEDE 386
+E H + + G+ E +E+ + T+ +
Sbjct: 348 SAEEVSEEEMSEDEERENENHLLVVPESRFDRDSGESEEAEEEVGEGTPQSSALTEGDYV 407
Query: 387 NDSCG-TP-EPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK 444
DS +P E + + LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK
Sbjct: 408 PDSPALSPIELKQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALK 467
Query: 445 KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLM 504
++KMEKE+EGFP+TSLREIN +L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LM
Sbjct: 468 RLKMEKEKEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLM 527
Query: 505 ETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564
ETMKQPF EVK LM+QLL G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+Y
Sbjct: 528 ETMKQPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREY 587
Query: 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624
GSPLK YT +VVTLWYRAPELLLG+K+YSTA+DMWS+GCI ELL+++PLF GKSE DQ+
Sbjct: 588 GSPLKAYTPVVVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQI 647
Query: 625 DKIFKTLGTPNEKIWPGFSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLL 683
+K+FK LGTP+EKIWPG+S+LP VK + F +H YN LRK+F A +LSD GFDL+
Sbjct: 648 NKVFKDLGTPSEKIWPGYSELPAVKKMTFSEHPYNNLRKRFGA-------LLSDQGFDLM 700
Query: 684 NSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
N LTY P +RI+AE L H++FRE PLP PT+PA+ Q R R SP P E
Sbjct: 701 NKFLTYFPGRRISAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 757
|
|
| MGI|MGI:88353 Cdk11b "cyclin-dependent kinase 11B" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 8.2e-123, Sum P(2) = 8.2e-123
Identities = 256/515 (49%), Positives = 331/515 (64%)
Query: 248 EQWHNEQEV--EHVDDEDY-APTRNISSS--RWAAGNSSPADEGEISEDEELPKRRKKMP 302
E N + V E V++ D + ++IS S + ++ SS A+ G SE+EE + ++
Sbjct: 244 EMGDNRKPVKEEKVEERDLLSDLQDISDSERKTSSAESSSAESGSGSEEEEEEEEEEE-- 301
Query: 303 VSDSLQTRARNKFLSPELSEVKXXXXXXXXXXXXXXXXXXXXXXXLSGDEYHGHESEKGD 362
+ T ++ E E + +S DE +E+
Sbjct: 302 -EEEGSTSEESEEEEEEEEEEEEEETGSNSEEASEQSAEEVSDEEMSEDEDRENENHILV 360
Query: 363 YMEIDEDHNNNDSVGGSDTDSEDENDSCGTPE----PAGPPQRSINM----------LQG 408
E D ++ DS G + E S E P P I + LQG
Sbjct: 361 VPESRFDRDSGDSEEGEEEVGEGTPQSSAPTEGDYVPDSPALSPIELKQELPKYLPALQG 420
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
CRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EGFP+TSLREIN +L
Sbjct: 421 CRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINTILK 480
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF EVK LM+QLL G+K
Sbjct: 481 AQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLSGVK 540
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +VVTLWYRAPELLLG
Sbjct: 541 HLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPVVVTLWYRAPELLLG 600
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+K+YSTA+DMWS+GCI ELL+++PLF GKS+ DQ++KIFK LGTP+EKIWPG++ LP V
Sbjct: 601 AKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKIFKDLGTPSEKIWPGYNDLPAV 660
Query: 649 K-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
K + F ++ YN LRK+F A +LSD GFDL+N LTY P +RI AE L H++FR
Sbjct: 661 KKMTFSEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYYPGRRINAEDGLKHEYFR 713
Query: 708 EVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
E PLP PT+PA+ Q R R SP P E
Sbjct: 714 ETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 746
|
|
| UNIPROTKB|F1RJC5 CDK11B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1179 (420.1 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
Identities = 261/529 (49%), Positives = 339/529 (64%)
Query: 217 SVSPLIPPVAARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWA 276
S SPL PP E PV R+ + Q+V D E T + SS
Sbjct: 238 SRSPLRPP--RERFELGDGRKPVKEEKVEERDLLSDLQDVS--DSE--RKTSSAESSSAE 291
Query: 277 AGNSSPADEGEISEDEELPKRRKKMPVSDSLQTR-ARNKFLSP-ELSEVKXXXXXXXXXX 334
+G+ S +E S EE R+ PVS + +TR ++ P LS +
Sbjct: 292 SGSGSEEEEQSTSGSEEDAAERRP-PVSGASKTRWVCDEASGPGRLSREEVSEEDVSEEE 350
Query: 335 XXXXXXXXXXXXXLSGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPE 394
D G ESE+G+ E E + ++ ++ D ++ + E
Sbjct: 351 EREDDNHVLVVPESRFDRDSG-ESEEGEE-EAGEGTPQSSAL--TEGDFVPDSPALSPIE 406
Query: 395 PAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG 454
+ + LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EG
Sbjct: 407 LKQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG 466
Query: 455 FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQS 514
FP+TSLREIN +L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF
Sbjct: 467 FPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPG 526
Query: 515 EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574
EVK LM+QLL G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +
Sbjct: 527 EVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPV 586
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
VVTLWYRAPELLLG+K+YSTA+DMWS+GCI ELL+++PLF GKS+ DQ++K+FK LGTP
Sbjct: 587 VVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSDIDQINKVFKDLGTP 646
Query: 635 NEKIWPGFSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693
+EKIWPG++ LP VK + F ++ YN LRK+F A +LSD GFDL+N LTY P +
Sbjct: 647 SEKIWPGYNDLPAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGR 699
Query: 694 RITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
R++AE L H++FRE PLP PT+PA+ Q R R SP P E
Sbjct: 700 RVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 746
|
|
| UNIPROTKB|J9P8L3 CDK11A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1174 (418.3 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 253/529 (47%), Positives = 331/529 (62%)
Query: 217 SVSPLIPPVAARSVEYAAPESPVGLASSPPREQWHNEQEVEHVDDEDYAPTRNISSSRWA 276
S SPL PP E PV R+ + Q+V D E + + SS+
Sbjct: 198 SRSPLRPP--RERFELTDGRKPVKEEKMEERDLLSDLQDVS--DSERKSSSAESSSAESG 253
Query: 277 AGNSSPADEGEISEDEELPKRRKKMPVSDSLQTRARNKFLSPELSEVKXXXXXXXXXXXX 336
+G+ +E E E+EE + + + S + S
Sbjct: 254 SGSEEEEEEEEEEEEEEEEEGSSSEESEEEEEEEEETGSNSEDASGQSAEEVSEDEMSED 313
Query: 337 XXXXXXXXXXXLSGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCG-TP-E 394
+ + + + GD E +E+ + T+ + DS +P E
Sbjct: 314 GERESENHVLVVPESRF---DRDSGDSEEGEEEAGEGTPQSSALTEGDFVPDSPALSPIE 370
Query: 395 PAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG 454
+ + LQGCRSV+EF+ LN+I+EGTYGVVYRA+DKKT EIVALK++KMEKE+EG
Sbjct: 371 LKQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG 430
Query: 455 FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQS 514
FP+TSLREIN +L HP+IV V+E+VVGSN+D I++VM Y+EHDLK LMETMKQPF
Sbjct: 431 FPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIVMNYVEHDLKSLMETMKQPFLPG 490
Query: 515 EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574
EVK LM+QLL G+K+LHDNW+LHRDLKTSNLLL++ G LK+ DFGLAR+YGSPLK YT +
Sbjct: 491 EVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGILKVGDFGLAREYGSPLKAYTPV 550
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
VVTLWYRAPELLLG+K+YSTA+DMWS+GCI ELL+++PLF GKSE DQ++K+FK LGTP
Sbjct: 551 VVTLWYRAPELLLGAKEYSTAVDMWSVGCIFGELLTQKPLFPGKSEIDQINKVFKDLGTP 610
Query: 635 NEKIWPGFSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693
+EKIWPG++ LP VK + F ++ YN LRK+F A +LSD GFDL+N LTY P +
Sbjct: 611 SEKIWPGYNDLPAVKKMTFTEYPYNNLRKRFGA-------LLSDQGFDLMNKFLTYFPGR 663
Query: 694 RITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLE 742
R++AE L H++FRE PLP PT+PA+ Q R R SP P E
Sbjct: 664 RVSAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQRVKRGT--SPRPPE 710
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q7XUF4 | CDKG2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5756 | 0.8917 | 0.9746 | yes | no |
| A2XUW1 | CDKG2_ORYSI | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5756 | 0.8917 | 0.9746 | N/A | no |
| A2X6X1 | CDKG1_ORYSI | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5335 | 0.8801 | 0.9855 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.946 |
| 3rd Layer | 2.7.11.23 | 0.946 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_X0468 | hypothetical protein (746 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 776 | |||
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.0 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-178 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-169 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-151 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-128 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-122 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-122 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-117 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-111 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-110 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-109 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-109 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-104 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-104 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-102 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-102 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-98 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-98 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-98 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-98 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-94 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-92 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-92 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-91 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-90 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-85 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-80 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-78 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-77 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-76 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-75 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-72 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-71 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-71 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-70 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-70 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-67 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-67 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-66 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-65 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-65 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-64 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-63 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-63 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-60 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-59 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-57 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-56 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-56 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-56 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-54 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-50 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-48 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-46 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-43 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-41 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-39 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-38 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-29 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-28 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-27 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-25 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-21 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-12 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 633 bits (1634), Expect = 0.0
Identities = 239/299 (79%), Positives = 263/299 (87%), Gaps = 7/299 (2%)
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
CRSVDE+E+LN+I+EGTYGVVYRARDKKTGEIVALKK+KMEKE+EGFP+TSLREINILL
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK 60
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+IV VKEVVVGSNLD I+MVMEY+EHDLK LMETMKQPF QSEVKCLMLQLL G+
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
+LHDNW+LHRDLKTSNLLLNNRG LKICDFGLAR+YGSPLKPYT LVVTLWYRAPELLLG
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG 180
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+K+YSTAIDMWS+GCI AELL+K+PLF GKSE DQL+KIFK LGTP EKIWPGFS+LPG
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240
Query: 649 K-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K F K+ YN LRKKFPA S LSD GFDLLN LLTYDP KRI+AE AL H +F
Sbjct: 241 KKKTFTKYPYNQLRKKFPALS------LSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 511 bits (1319), Expect = e-178
Identities = 199/315 (63%), Positives = 241/315 (76%), Gaps = 9/315 (2%)
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
CRSV EFE+LN+I EGTYG+VYRARD +GEIVALKKV+M+ ER+G P++SLREI +LL+
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+IV++KEVVVG +LDSIF+VMEY E DL L++ M PFS+S+VKCLMLQLL G++
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YLH+N+++HRDLK SNLLL ++G LKI DFGLAR YG P KP T VVTLWYRAPELLLG
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+TAIDMW++GCI+AELL+ +PL GKSE +QLD I + LGTPNE IWPGFS LP V
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242
Query: 649 KVNFIKHQ-YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
+ Q YN L+ KFP LS+AG LLN LL YDP KR TAE AL +F+
Sbjct: 243 GKFTLPKQPYNNLKHKFPW--------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
Query: 708 EVPLPKSKDFMPTFP 722
E PLP + MPTFP
Sbjct: 295 EKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 487 bits (1257), Expect = e-169
Identities = 152/292 (52%), Positives = 201/292 (68%), Gaps = 10/292 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E+L K+ EGTYGVVY+ARDKKTGEIVALKK++++ E EG P T+LREI++L HP+I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
V + +V+ +++V EY + DLK ++ P S + +K +M QLL G+ Y H +
Sbjct: 61 VKLLDVIHTER--KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+LHRDLK N+L+N G LK+ DFGLAR +G PL+ YTH VVTLWYRAPE+LLGSK YST
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654
A+D+WS+GCI AE+++ +PLF G SE DQL KIF+ LGTP E+ WPG +KLP K F K
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238
Query: 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
L K P L G DLL+ +L Y+P KRI+A+ AL H +F
Sbjct: 239 FPPKDLEKVLPR--------LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 442 bits (1139), Expect = e-151
Identities = 150/294 (51%), Positives = 210/294 (71%), Gaps = 9/294 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E++ +I EGTYG VY+AR+KKTGE+VALKK++ME E+EGFP+T++REI +L HP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
V +KE+V SI+MV EYM+HDL GL+++ + F++S++KC M QLLEG++YLH N
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-PYTHLVVTLWYRAPELLLGSKQYS 593
+LHRD+K SN+L+NN G LK+ DFGLAR Y YT+ V+TLWYR PELLLG+ +Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
+DMWS+GCI+AEL +P+F G +E +QL+KIF+ G+P ++ WPG SKLP +
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 654 KHQY-NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K Y LR+ F ++ + DLL+ LLT DP KRI+A+ AL H++F
Sbjct: 241 KKPYKRRLREFF-------KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 385 bits (990), Expect = e-128
Identities = 142/308 (46%), Positives = 195/308 (63%), Gaps = 14/308 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFHH 471
+E+ K+ EGTY VVY+ARDK+TG IVA+KK+K ++ ++G T+LREI +L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
P+I+ + + V + +I +V E+ME DL+ +++ + +++K ML L G++YLH
Sbjct: 62 PNIIGL--LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
NW+LHRDLK +NLL+ + G LK+ DFGLAR +GSP + TH VVT WYRAPELL G++
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
Y +DMWS+GCI AELL + P G S+ DQL KIF+ LGTP E+ WPG + LP V
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-DYVE 238
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711
F L++ FPA SD DLL LLT +P+KRITA AL H +F P
Sbjct: 239 FKPFPPTPLKQIFPA--------ASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290
Query: 712 PKSKDFMP 719
P +P
Sbjct: 291 PTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 370 bits (951), Expect = e-122
Identities = 148/318 (46%), Positives = 205/318 (64%), Gaps = 26/318 (8%)
Query: 407 QGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL 466
GC + ++E L K+ EGT+G VY+AR KTG +VALKK+ M E++GFP+T+LREI IL
Sbjct: 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 467 LSFHHPSIVDVKEVVV------GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM 520
HP++V + ++ V S++MV YM+HDL GL+E ++S++KC M
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKP--------- 570
LQLLEGI YLH+N +LHRD+K +N+L++N+G LKI DFGLAR Y G P P
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 571 -YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
YT+LVVT WYR PELLLG ++Y+TA+D+W +GC+ AE+ ++ P+ GKS+ DQL IFK
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQY-NLLRKKFPATSFTGSPVLSDAGFDLLNSLLT 688
GTP E+ WPG+ LPG + Y L ++F + + G DLL+ LL+
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-------GKLGPE-GLDLLSKLLS 293
Query: 689 YDPDKRITAEAALNHDWF 706
DP KR+TA AL H +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 368 bits (947), Expect = e-122
Identities = 150/293 (51%), Positives = 204/293 (69%), Gaps = 11/293 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++++ KI EGTYGVVY+ARDK TGEIVALKK+++E E EG P T++REI++L +HP+I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + +VV N +++V E+++ DLK M++ +K + QLL+GI Y H +
Sbjct: 61 VRLLDVVHSEN--KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
VLHRDLK NLL++ G LK+ DFGLAR +G P++ YTH VVTLWYRAPE+LLGS+QYS
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS 178
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
T +D+WS+GCI AE++++ PLF G SE DQL +IF+TLGTP+E +WPG + LP K F
Sbjct: 179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K L K P L + G DLL+ +L YDP KRI+A+AAL H +F
Sbjct: 239 KWARQDLSKVVPN--------LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 353 bits (908), Expect = e-117
Identities = 152/293 (51%), Positives = 202/293 (68%), Gaps = 11/293 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+++L KI EGTYGVVY+ARDK TGEIVA+KK+K+ E EG P T+LREI +L +HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ + +V + +++V E+M+ DL L++ ++ +S +K + QLL+G+ + H +
Sbjct: 61 IKLLDVF--RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+LHRDLK NLL+N G LK+ DFGLAR +GSP++PYTH VVT WYRAPELLLG K YST
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP-GVKVNFI 653
+D+WS+GCI AELLS+ PLF GKSE DQL KIF+TLGTP+ ++WP F+ L K +F
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K L K FP S DLL+ +L YDP KRITAE AL H +F
Sbjct: 239 KKAGMPLPKLFPN--------ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 338 bits (869), Expect = e-111
Identities = 144/293 (49%), Positives = 202/293 (68%), Gaps = 11/293 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F+++ KI EGTYGVVY+AR+K TGE+VALKK++++ E EG P T++REI++L +HP+I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + +V+ N +++V E++ DLK M+ + +K + QLL+G+ + H +
Sbjct: 62 VKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
VLHRDLK NLL+N G +K+ DFGLAR +G P++ YTH VVTLWYRAPE+LLG K YS
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
TA+D+WSLGCI AE++++ LF G SE DQL +IF+TLGTP+E +WPG + LP K +F
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
K K P L + G DLL+ +L YDP+KRI+A+AAL H +F
Sbjct: 240 KWARQDFSKVVPP--------LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 336 bits (863), Expect = e-110
Identities = 153/308 (49%), Positives = 205/308 (66%), Gaps = 18/308 (5%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
G R VD+F+ + +I EGTYG VY+ARDK TGE+VALKKV+++ E+EGFP+T++REI IL
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 468 SFHHPSIVDVKEVVVGSN--LD------SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCL 519
+H +IV++KE+V LD + ++V EYM+HDL GL+E+ FS+ +K
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-PLKPYTHLVVTL 578
M QLLEG+ Y H LHRD+K SN+LLNN+G++K+ DFGLAR Y S +PYT+ V+TL
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
WYR PELLLG ++Y AID+WS GCI+ EL +K+P+F E QL+ I + G+P +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 639 WPGFSKLPGVKVNFIKHQYNL-LRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
WP KLP K QY LR++F SF +P L DLL+ +LT DP KR TA
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEF---SFIPTPAL-----DLLDHMLTLDPSKRCTA 293
Query: 698 EAALNHDW 705
E ALN W
Sbjct: 294 EEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 335 bits (860), Expect = e-109
Identities = 128/296 (43%), Positives = 187/296 (63%), Gaps = 14/296 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ L +I EG +G+V++A+D++TGE VALKKV + + G P +LREI L + HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 474 IVDVKEVV-VGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+V + +V GS +VMEYM DL ++ ++P +++VK M LL+G+ Y+H
Sbjct: 61 VVKLLDVFPHGS---GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP-LKPYTHLVVTLWYRAPELLLGSKQ 591
N ++HRDLK +NLL++ G LKI DFGLAR + + Y+H V T WYRAPELL G+++
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV-KV 650
Y +D+W++GCI AELL+ PLF G+++ +QL +F+TLGTPNE+ WPG + LP K+
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
F + + L + FP S DLL LL YDP KR++A AL H +F
Sbjct: 238 TFPESKPIPLEEIFPDA--------SPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 334 bits (858), Expect = e-109
Identities = 140/295 (47%), Positives = 203/295 (68%), Gaps = 12/295 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ ++ KI EGTYGVVY+ R+KKTG+IVA+KK+++E E EG P T++REI++L HP+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLH 531
IV +++V++ + ++++ E++ DLK ++++ Q VK + Q+L+GI + H
Sbjct: 61 IVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
VLHRDLK NLL++N+G +K+ DFGLAR +G P++ YTH VVTLWYRAPE+LLGS +
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YST +D+WS+G I AE+ +K+PLF+G SE DQL +IF+ LGTP E +WPG + LP K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
F K + LR L + G DLL +L YDP KRI+A+ ALNH +F
Sbjct: 239 FPKWKKGSLRSAVKN--------LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 323 bits (830), Expect = e-104
Identities = 133/309 (43%), Positives = 186/309 (60%), Gaps = 17/309 (5%)
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
C V ++E+L KI +GT+G V++AR KKT +IVALKKV ME E+EGFP+T+LREI IL
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 469 FHHPSIVDVKEV----VVGSNLD--SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
H ++V++ E+ N S ++V E+ EHDL GL+ F+ SE+K +M
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP----YTHLVVTL 578
LL G+ Y+H N +LHRD+K +N+L+ G LK+ DFGLAR + YT+ VVTL
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
WYR PELLLG + Y IDMW GCIMAE+ ++ P+ G +E QL I + G+ ++
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247
Query: 639 WPGFSKLPGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
WPG KL K+ + Q ++++ V DL++ LL DP KRI A
Sbjct: 248 WPGVDKLELFKKMELPQGQKRKVKERLKPY------VKDPHALDLIDKLLVLDPAKRIDA 301
Query: 698 EAALNHDWF 706
+ ALNHD+F
Sbjct: 302 DTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 322 bits (827), Expect = e-104
Identities = 146/302 (48%), Positives = 210/302 (69%), Gaps = 16/302 (5%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
+D++E++ KI EGTYGVVY+ARD+ T E +ALKK+++E+E EG P T++REI++L H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE--VKCLMLQLLEGIKY 529
+IV +++VV + +++V EY++ DLK M++ F+++ +K + Q+L GI Y
Sbjct: 61 GNIVRLQDVV--HSEKRLYLVFEYLDLDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAY 117
Query: 530 LHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
H + VLHRDLK NLL++ R LK+ DFGLAR +G P++ +TH VVTLWYRAPE+LLG
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
S+ YST +D+WS+GCI AE+++++PLF G SE D+L KIF+ LGTPNE+ WPG + LP
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 649 KVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
K F K+P T P L AG DLL+ +L DP KRITA AAL H++F+
Sbjct: 238 KSAF---------PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 708 EV 709
++
Sbjct: 289 DL 290
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 136/324 (41%), Positives = 189/324 (58%), Gaps = 41/324 (12%)
Query: 415 FERLNKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHH 471
+E I GTYG VY+A+ K K G+ A+KK K +KE+ G ++ REI +L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLM----ETMKQPFSQSEVKCLMLQLLEGI 527
++V + EV + S++++ +Y EHDL ++ + + S VK L+ Q+L G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 528 KYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPYTHL---VVTLWY 580
YLH NWVLHRDLK +N+L+ RG +KI D GLAR + +PLKP L VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTL 631
RAPELLLG++ Y+ AID+W++GCI AELL+ EP+F G+ DQL++IF+ L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPV---------LSDAGFDL 682
GTP EK WP K+P +Y+ L K F ++ + + GFDL
Sbjct: 242 GTPTEKDWPDIKKMP---------EYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 683 LNSLLTYDPDKRITAEAALNHDWF 706
L LL YDP KRITAE AL H +F
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-102
Identities = 136/295 (46%), Positives = 188/295 (63%), Gaps = 15/295 (5%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E+L KI EGTYG V++A++++T EIVALK+V+++ + EG P ++LREI +L H +I
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
V + +V+ + +V EY + DLK ++ VK M QLL+G+ + H +
Sbjct: 62 VRLYDVLHSDK--KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
VLHRDLK NLL+N GELK+ DFGLAR +G P++ Y+ VVTLWYR P++L G+K YST
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179
Query: 595 AIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
+IDMWS GCI AEL + PLF G DQL +IF+ LGTP E+ WPG SKLP K
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK--PY 237
Query: 654 KHQYNLLRKKFPATSFTGS--PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+PAT+ + P L+ G DLL +LL +P +RI+AE AL H +F
Sbjct: 238 PM--------YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 305 bits (784), Expect = 3e-98
Identities = 135/300 (45%), Positives = 183/300 (61%), Gaps = 21/300 (7%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL---SFHH 471
+E L +I EG YG VY+ARD TG VALKKV++ EG PL++LREI +L SF H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 472 PSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGI 527
P+IV + +V G D + +V E+++ DL + +P +K LM QLL G+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
+LH + ++HRDLK N+L+ + G++KI DFGLAR Y + T +VVTLWYRAPE+LL
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLL 179
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
S Y+T +DMWS+GCI AEL + PLF G SE DQLDKIF +G P+E+ WP LP
Sbjct: 180 QS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP- 237
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGS-PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ +F Y SF P + + G DLL +LT++P KRI+A AL H +F
Sbjct: 238 -RSSF--PSY-------TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 303 bits (779), Expect = 6e-98
Identities = 114/293 (38%), Positives = 161/293 (54%), Gaps = 40/293 (13%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E L K+ EG++G VY ARDKKTG++VA+K +K +K ++ LREI IL HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNI 59
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + +V + D +++VMEY E DL L++ + S+ E + + Q+L ++YLH
Sbjct: 60 VRLYDVFE--DEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
++HRDLK N+LL+ G +K+ DFGLARQ K T V T Y APE+LLG K Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK-LTTFVGTPEYMAPEVLLG-KGYG 174
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
A+D+WSLG I+ ELL+ +P F G DQL ++FK +G P P
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--------- 222
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+S DL+ LL DP+KR+TAE AL H +F
Sbjct: 223 ---------------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 304 bits (781), Expect = 8e-98
Identities = 145/303 (47%), Positives = 192/303 (63%), Gaps = 18/303 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH- 471
D +E+L KI EGTYG VY+ARDK TG++VALKK ++E + EG P T+LREI++L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 472 PSIV---DVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ----PFSQSEVKCLMLQLL 524
IV DV+ V + S+++V EY++ DLK M++ + P +K M QLL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+G+ + H + V+HRDLK NLL++ +G LKI D GL R + P+K YTH +VTLWYRAP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
E+LLGS YST +D+WS+GCI AE+ K+PLF G SE QL IFK LGTP E++WPG S
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
KL +L R + P LS G DLL +L YDP KRI+A+AAL H
Sbjct: 241 KLRDWHEFPQWKPQDLSR------AV---PDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
Query: 704 DWF 706
+F
Sbjct: 292 PYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 304 bits (780), Expect = 8e-98
Identities = 139/294 (47%), Positives = 196/294 (66%), Gaps = 13/294 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F++L K+ EGTY VY+ R++ TGEIVALK++ ++ E EG P T++REI+++ H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMET--MKQPFSQSEVKCLMLQLLEGIKYLHD 532
V + +V+ N + +V EYM+ DLK M+T ++ + VK QLL+GI + H+
Sbjct: 61 VRLHDVIHTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
N VLHRDLK NLL+N RGELK+ DFGLAR +G P+ +++ VVTLWYRAP++LLGS+ Y
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
ST+ID+WS+GCIMAE+++ PLF G + DQL KIF+ +GTP E WPG S+LP K F
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
++ L++ FP G DLL+ LL +P+ RI+A AL H WF
Sbjct: 239 PRYPPQDLQQLFPHADPL--------GIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = 4e-94
Identities = 121/333 (36%), Positives = 184/333 (55%), Gaps = 19/333 (5%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E L I G YGVV A DK+TG VA+KK+ + LREI +L H +I
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 475 VDVKEVVV---GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+ + +++ + + +++V E ME DL ++++ QP + ++ + Q+L G+KYLH
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLH 120
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRAPELLLG 588
V+HRDLK SN+L+N+ +LKICDFGLAR L VVT WYRAPELLL
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
S +Y+ AID+WS+GCI AELL+++PLF G+ DQL+ I + LGTP+E+ +
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS-EKA 239
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
+ N++K +K + F G+ DLL +L +DP KRITA+ AL H + +
Sbjct: 240 R-NYLKSLPKKPKKPL-SKLFPGASPE---AIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
Query: 709 V------PLPKSKDFMPTFPAQHAQDRRMRRMM 735
+ P+ K F + ++ ++
Sbjct: 295 LHDPEDEPVAKPPFDFDFFDDDELTEEELKELI 327
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 292 bits (748), Expect = 3e-92
Identities = 139/331 (41%), Positives = 200/331 (60%), Gaps = 40/331 (12%)
Query: 410 RSVDE-FERLNK-IDEGTYGVVYRARDKKTGEIVALKKVK-------MEKERE-----GF 455
S+ E + + + EGTYG V +A D TG+IVA+KKVK + K+R+ G
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 456 PLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE 515
T+LRE+ I+ H +I+ + +V V D I +VM+ M DLK +++ K ++S+
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDR-KIRLTESQ 120
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL------- 568
VKC++LQ+L G+ LH + +HRDL +N+ +N++G KI DFGLAR+YG P
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 569 -------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621
+ T VVTLWYRAPELL+G+++Y A+DMWS+GCI AELL+ +PLF G++E
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFD 681
DQL +IF+ LGTPNE WP KLP + ++ + K T F P SD D
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAKKLP------LYTEFTPRKPKDLKTIF---PNASDDAID 291
Query: 682 LLNSLLTYDPDKRITAEAALNHDWFREVPLP 712
LL SLL +P +RI+A+ AL H++F+ PLP
Sbjct: 292 LLQSLLKLNPLERISAKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 3e-92
Identities = 112/293 (38%), Positives = 155/293 (52%), Gaps = 34/293 (11%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E L K+ G++G VY+A+ K TG+IVA+K +K E+ T+ REI IL HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + + D +++VMEY E DL + P S+ E K + LQ+L G++YLH N
Sbjct: 61 VRLIDAFEDK--DHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
++HRDLK N+LL+ G +KI DFGLA++ T V T WY APE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
+D+WSLG I+ ELL+ +P F+G++ DQL I + LG P E P +S
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG-------- 229
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
S+ DL+ L DP KR TAE L H WF
Sbjct: 230 ----------------------SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 287 bits (737), Expect = 3e-91
Identities = 124/297 (41%), Positives = 181/297 (60%), Gaps = 11/297 (3%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++ +++L+K+ EG+Y VY+ R K TG++VALK++++E E EG P T++RE ++L H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKH 62
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +++ ++ +V EY++ DLK M+ S V+ + QLL G+ Y H
Sbjct: 63 ANIVTLHDII--HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
VLHRDLK NLL++ RGELK+ DFGLAR P K Y++ VVTLWYR P++LLGS +
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEKIWPGFSKLPGVK- 649
YST++DMW +GCI E+ + PLF G ++ DQL KIF+ LGTP E+ WPG S P K
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+F + L P G +L L Y+P KRI+A A+ H +F
Sbjct: 241 YSFPFYPPRPLINHAPRLDRIPH------GEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 285 bits (733), Expect = 1e-90
Identities = 128/299 (42%), Positives = 181/299 (60%), Gaps = 23/299 (7%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-PLTSLREINILLSF-HHP 472
++ + ++ +GT+G VY AR+K+TGE+VA+KK M+K+ + +LRE+ L HP
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLH 531
+IV +KEV + D ++ V EYME +L LM+ K PFS+S ++ ++ Q+L+G+ ++H
Sbjct: 59 NIVKLKEVFREN--DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+ HRDLK NLL++ +KI DFGLAR+ S PYT V T WYRAPE+LL S
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEILLRSTS 175
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YS+ +D+W+LGCIMAEL + PLF G SE DQL KI LGTP ++ WP KL K+
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS-KLG 234
Query: 652 FIKHQYNLLRKKFPATSFTGS----PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
F +FP + T P S DL+ +L +DP KR TA AL H +F
Sbjct: 235 F----------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 270 bits (693), Expect = 7e-85
Identities = 116/298 (38%), Positives = 162/298 (54%), Gaps = 14/298 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++E L + EG YGVV + R+K TGEIVA+KK K ++ E T+LRE+ +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV++KE +++V EY+E L L+E V+ + QLL+ I Y H
Sbjct: 61 NIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+ ++HRD+K N+L++ G LK+CDFG AR P P T V T WYRAPELL+G
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP---GV 648
Y +D+W++GCIMAELL EPLF G S+ DQL I K LG FS P GV
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+L R ++P +S D L + L DP +R+T + L H +F
Sbjct: 239 AFPEPSQPESLER-RYPG-------KVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 6e-80
Identities = 132/358 (36%), Positives = 182/358 (50%), Gaps = 54/358 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ L+ I EG YG+V A K TG VA+KK+ E + F +LREI IL F H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHE 63
Query: 473 SIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+I+ + +++ + +S +++V E ME DL L++T Q S ++ + Q+L G+KY
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKY 121
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYRAPELL 586
+H VLHRDLK SNLLLN +LKICDFGLAR T V T WYRAPE++
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE---------- 636
L SK Y+ AID+WS+GCI+AE+LS PLF GK QL+ I LGTP++
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 637 -----KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691
K P K+P K FP DLL+ +LT++P
Sbjct: 242 ARNYIKSLPFKPKVP-------------WNKLFPNA--------DPKALDLLDKMLTFNP 280
Query: 692 DKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKEL 749
KRIT E AL H + + P + P D + D L +++ KEL
Sbjct: 281 HKRITVEEALAHPYLEQYHDPSDE---PVAEEPFPFD------FELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 8e-78
Identities = 119/315 (37%), Positives = 173/315 (54%), Gaps = 44/315 (13%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV------KMEKEREGFPLTSLREINILLS 468
+E L K+ +G YG+V++A D++T E+VALKK+ + +R + REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR------TFREIMFLQE 62
Query: 469 F-HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDL-----KGLMETMKQPFSQSEVKCLMLQ 522
HP+IV + V+ N I++V EYME DL ++E + + +M Q
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-------HKRYIMYQ 115
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR----QYGSPLKP-YTHLVVT 577
LL+ +KY+H V+HRDLK SN+LLN+ +K+ DFGLAR +P P T V T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN-- 635
WYRAPE+LLGS +Y+ +DMWS+GCI+ E+L +PLF G S +QL+KI + +G P+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235
Query: 636 --EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693
E I F+ + + RK P SD DLL LL ++P+K
Sbjct: 236 DIESIKSPFAA------TMLDSLPSRPRKPLD----ELLPKASDDALDLLKKLLVFNPNK 285
Query: 694 RITAEAALNHDWFRE 708
R+TAE AL H + +
Sbjct: 286 RLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 2e-77
Identities = 123/295 (41%), Positives = 183/295 (62%), Gaps = 10/295 (3%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++ + +L+K+ EGTY V++ R K T +VALK++++E E EG P T++RE+++L + H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKH 62
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +++ + +V EY++ DLK ++ S VK M QLL G+ Y H
Sbjct: 63 ANIVTLHDIIHTER--CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+LHRDLK NLL+N +GELK+ DFGLAR P K Y++ VVTLWYR P++LLGS +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YST IDMW +GCI+ E+ + P+F G + ++L IF+ LGTP E+ WPG + + +
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR-S 239
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
++ QY +P L G DLL+SLL Y+ RI+AEAAL H +F
Sbjct: 240 YLFPQYR------AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 3e-76
Identities = 131/302 (43%), Positives = 181/302 (59%), Gaps = 10/302 (3%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
G ++ + +L K+ EGTY V++ R K T +VALK++++E E EG P T++RE+++L
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
H +IV + ++V S+ +V EY++ DLK M+ S VK + Q+L G+
Sbjct: 60 DLKHANIVTLHDIVHTDK--SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
Y H VLHRDLK NLL+N RGELK+ DFGLAR P K Y++ VVTLWYR P++LL
Sbjct: 118 AYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
GS +YST IDMW +GCI E+ S PLF G + D+L IF+ LGTP E+ WPG S
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
K YN + K P +P L G +LL L Y+ KRI+AE A+ H +FR
Sbjct: 238 FK------NYNFPKYK-PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
Query: 708 EV 709
+
Sbjct: 291 SL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 8e-75
Identities = 125/302 (41%), Positives = 179/302 (59%), Gaps = 10/302 (3%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
G ++ + +L+K+ EGTY VY+ R K T +VALK++++E E EG P T++RE+++L
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
H +IV + +++ S+ +V EY++ DLK ++ + VK + QLL G+
Sbjct: 60 DLKHANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
Y H VLHRDLK NLL+N RGELK+ DFGLAR P K Y++ VVTLWYR P++LL
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
GS YST IDMW +GCI E+ + PLF G + +QL IF+ LGTP E+ WPG
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS--- 234
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
F + Y K +P L G +LL+ LL ++ KRI+AE A+ H +F
Sbjct: 235 -NEEFKSYNYP---KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
Query: 708 EV 709
+
Sbjct: 291 CL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 2e-72
Identities = 114/306 (37%), Positives = 175/306 (57%), Gaps = 13/306 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ + I G YGVV A D ++G+ VA+KK+ + +LRE+ IL F H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 473 SIVDVKEVVV--GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+I+ +++++ G++ +++VM+ ME DL ++ + QP ++ ++ + QLL G+KY+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYI 123
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY----THLVVTLWYRAPELL 586
H V+HRDLK SNLL+N EL+I DFG+AR S + T V T WYRAPELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
L +Y+TAIDMWS+GCI AE+L + LF GK+ QL I LG+P+E++ L
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV------LN 237
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ + ++ L +K P P S DLL+ +L +DP++RIT E AL H +
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
Query: 707 REVPLP 712
+ P
Sbjct: 298 AQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 1e-71
Identities = 121/300 (40%), Positives = 181/300 (60%), Gaps = 19/300 (6%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL---SFH 470
++E + +I G YG VY+ARD +G VALK V+++ +G PL+++RE+ +L +F
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 471 HPSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEG 526
HP+IV + +V S D + +V E+++ DL+ ++ + P +K LM Q L G
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+ +LH N ++HRDLK N+L+ + G++K+ DFGLAR Y + T +VVTLWYRAPE+L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVL 179
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
L S Y+T +DMWS+GCI AE+ ++PLF G SE DQL KIF +G P E WP
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP------ 232
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
V + ++ R P S P + ++G LL +LT++P KRI+A AL H +F
Sbjct: 233 -RDVTLPRGAFS-PRGPRPVQSVV--PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 2e-71
Identities = 111/295 (37%), Positives = 161/295 (54%), Gaps = 22/295 (7%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVD 476
L KI EGT+ V +A+ +KTG+ A+K +K + + + +LREI L HP+I+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ EV+ + +V E M+ +L L++ K+P + VK M QLL+ + ++H N +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
HRD+K N+L+ + LK+ DFG R Y P PYT + T WYRAPE LL Y
Sbjct: 123 HRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
+D+W++GC+ E+LS PLF G +E DQ+ KI LGTP+ +V
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA------------EVLKKFR 227
Query: 656 QYNLLRKKFPATSFTGSPVL----SDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ + FP+ TG L S G DLL LL YDPD+RITA+ AL H +F
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 5e-70
Identities = 119/300 (39%), Positives = 182/300 (60%), Gaps = 11/300 (3%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D +E+L K+ EG+Y VY+ + K G++VALK +++++E EG P T++RE ++L H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHA 63
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV + +++ +++ +V EY+ DL M+ VK + QLL G+ Y+H
Sbjct: 64 NIVLLHDII--HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
++LHRDLK NLL+++ GELK+ DFGLAR P Y++ VVTLWYR P++LLGS +Y
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
ST +DMW +GCI E++ F G + DQL++IF LGTPNE WPG LP K
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241
Query: 652 -FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
F + LR+ + S+ + DL + LL P R++A+AAL+H++F ++P
Sbjct: 242 RFTLYSPKNLRQAWNKLSYV------NHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-70
Identities = 117/300 (39%), Positives = 178/300 (59%), Gaps = 20/300 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKT--GEIVALKKVKMEKEREGFPLTSLREINILLSFH-H 471
+E + ++ +G YG+V AR+ +T E VA+KK+ ++ +LRE+ +L F H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 472 PSIVDV--KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+I + ++V N + +++ E ME DL ++ + QP + + + + Q+L G+KY
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY 120
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK----PY-THLVVTLWYRAPE 584
+H VLHRDLK NLL+N ELKICDFGLAR + S + T V T WYRAPE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGF-SENPGENAGFMTEYVATRWYRAPE 179
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
++L + Y+ AID+WS+GCI+AELL ++P+F GK DQL++I + LGTP+E+ S+
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET---LSR 236
Query: 645 LPGVKV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
+ K N+I+ N+ +K F + F P + DLL LL +DP KRI+ E AL H
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFE-SIF---PNANPLALDLLEKLLAFDPTKRISVEEALEH 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 1e-67
Identities = 116/290 (40%), Positives = 165/290 (56%), Gaps = 12/290 (4%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
I G YG+V A++ +T E VA+KK+ + +LREI +L H +++ +K++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 481 VVGSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+ + ++ +++V E M+ DL ++ + Q S + + QLL G+KY+H VLH
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK SNLLLN +LKICDFGLAR T VVT WYRAPELLL +Y+TAID
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAID 191
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657
+WS+GCI AELL ++PLF GK QL I + LG+P+E+ GF + + +I+
Sbjct: 192 VWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL-GFIRNEKAR-RYIRSLP 249
Query: 658 NLLRKKFPATSFTGS-PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
P SF P + DLL +L +DP KRIT E AL H +
Sbjct: 250 Y-----TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 2e-67
Identities = 116/297 (39%), Positives = 166/297 (55%), Gaps = 23/297 (7%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
L K+ EG+Y VY+ + G++VALK + M+ E EG P T++RE ++L H +IV +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLL 68
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+++ +++ V EYM DL M V+ M QLL G+ Y+H +LH
Sbjct: 69 HDII--HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK NLL++ GELK+ DFGLAR P + Y+ VVTLWYR P++LLG+ YS+A+D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 598 MWSLGCIMAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK-- 654
+W GCI E+L +P F G S+ F+QL+KI+ LG P E WPG SKLP K +
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246
Query: 655 --HQYNLLRKKF---PATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
Q ++ K+ P DL + +L P RI+A+ AL H +F
Sbjct: 247 KPQQLRVVWKRLSRPPKAE------------DLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 1e-66
Identities = 110/309 (35%), Positives = 164/309 (53%), Gaps = 25/309 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D ++ L+ + G YG V A D KTG VA+KK+ + + RE+ +L H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 473 SIVDVKEV----VVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V + +++V M DL +++ Q S ++ L+ Q+L G+K
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLK 132
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK SN+ +N ELKI DFGLAR + Y V T WYRAPE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 189
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE----KIWPGFSK 644
Y+ +D+WS+GCIMAELL+ + LF G DQL +I +GTP+E KI ++
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTG-SPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
N+I+ + KK F+G +P+ DLL +L DPDKRITA AL H
Sbjct: 250 ------NYIQ-SLPQMPKKDFKEVFSGANPLA----IDLLEKMLVLDPDKRITAAEALAH 298
Query: 704 DWFREVPLP 712
+ E P
Sbjct: 299 PYLAEYHDP 307
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 2e-65
Identities = 122/301 (40%), Positives = 186/301 (61%), Gaps = 20/301 (6%)
Query: 414 EFERLNKIDEGTYGVVYRARD-KKTGEIVALKKVKMEKEREGFPLTSLREINILL---SF 469
++E + +I EG YG V++ARD K G VALK+V+++ EG PL+++RE+ +L +F
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 470 HHPSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQPFSQSE-VKCLMLQLLE 525
HP++V + +V S D + +V E+++ DL ++ + +P +E +K +M QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+ +LH + V+HRDLK N+L+ + G++K+ DFGLAR Y S T +VVTLWYRAPE+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEV 180
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
LL S Y+T +D+WS+GCI AE+ ++PLF G S+ DQL KI +G P E+ WP L
Sbjct: 181 LLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
P + F + P F + + G DLL LT++P KRI+A +AL+H +
Sbjct: 240 P--RQAFHS------KSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
Query: 706 F 706
F
Sbjct: 290 F 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 4e-65
Identities = 128/323 (39%), Positives = 186/323 (57%), Gaps = 49/323 (15%)
Query: 420 KIDEGTYGVVYRAR--DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
K+ GTYG VY+A+ D K + ALK++ E G +++ REI +L HP+++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLME------TMKQPFS--QSEVKCLMLQLLEGIKY 529
++V + + ++++ +Y EHDL +++ K+P +S VK L+ Q+L+GI Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 530 LHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRA 582
LH NWVLHRDLK +N+L+ RG +KI D G AR + SPLKP L VVT WYRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTLGT 633
PELLLG++ Y+ AID+W++GCI AELL+ EP+F+ + E DQLD+IF +G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS----------DAGFDLL 683
P +K W K+P +Y L+K F T++ S ++ F LL
Sbjct: 244 PADKDWEDIRKMP---------EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLL 294
Query: 684 NSLLTYDPDKRITAEAALNHDWF 706
LLT DP KRIT+E AL +F
Sbjct: 295 QKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 1e-64
Identities = 104/297 (35%), Positives = 172/297 (57%), Gaps = 14/297 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++E L + EG+YG+V + + K+TG+IVA+KK ++ + ++REI +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
++V++ EV +++V E+++H + +E +S V+ + Q+L GI++ H
Sbjct: 61 NLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+ ++HRD+K N+L++ G +K+CDFG AR +P + YT V T WYRAPELL+G +Y
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP---GVK 649
A+D+W++GC++ E+L+ EPLF G S+ DQL I K LG + F K P G++
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ +K L K+FP LS DL L DPD R ++ L+H++F
Sbjct: 239 LPEVKEIEP-LEKRFPK--------LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 2e-63
Identities = 124/323 (38%), Positives = 182/323 (56%), Gaps = 49/323 (15%)
Query: 420 KIDEGTYGVVYRAR--DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
K+ GTYG VY+A+ D K ALK++ E G +++ REI +L HP+++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLME------TMKQP--FSQSEVKCLMLQLLEGIKY 529
++V + ++++ +Y EHDL +++ K+P + VK L+ Q+L+GI Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 530 LHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRA 582
LH NWVLHRDLK +N+L+ RG +KI D G AR + SPLKP L VVT WYRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTLGT 633
PELLLG++ Y+ AID+W++GCI AELL+ EP+F+ + E DQLD+IF +G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS----------DAGFDLL 683
P +K W K+P +++ L K F ++T ++ F LL
Sbjct: 244 PADKDWEDIKKMP---------EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 684 NSLLTYDPDKRITAEAALNHDWF 706
LLT DP KRIT+E A+ +F
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 4e-63
Identities = 111/309 (35%), Positives = 172/309 (55%), Gaps = 38/309 (12%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLT---SLREINILLSF 469
+++E+L+KI EG+YGVV++ R+++TG+IVA+KK E E P+ +LREI +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV---ESEDDPVIKKIALREIRMLKQL 57
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP++V++ EV + +V EY +H + +E + + +K ++ Q L+ + +
Sbjct: 58 KHPNLVNLIEVFRRKR--KLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
H + +HRD+K N+L+ +G++K+CDFG AR P YT V T WYRAPELL+G
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
QY +D+W++GC+ AELL+ +PL+ GKS+ DQL I KTLG + P ++
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQI---- 227
Query: 650 VNFIKHQY------------NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
F +Q+ L KFP S SP L L L DP +R++
Sbjct: 228 --FSTNQFFKGLSIPEPETREPLESKFPNIS---SPAL-----SFLKGCLQMDPTERLSC 277
Query: 698 EAALNHDWF 706
E L H +F
Sbjct: 278 EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 4e-61
Identities = 114/309 (36%), Positives = 167/309 (54%), Gaps = 30/309 (9%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK------MEKEREGFPLTSLREINILL 467
+ E I G +GVV+ D + G+ VALKK+ + +R RE+ +L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR------VFRELKMLC 54
Query: 468 SFHHPSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLL 524
F H +++ +++ ++D I++V E M+ DL ++ + QP S VK + Q+L
Sbjct: 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQIL 113
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-QYGSPLKPYTHLVVTLWYRAP 583
G+KYLH +LHRD+K NLL+N+ LKICDFGLAR + K T VVT +YRAP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
E+L+GS+ Y++A+D+WS+GCI AELL + LF +S QLD I LGTP+
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS------LE 227
Query: 644 KLPGVKVNFIKHQYNLLR--KKFPATS--FTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699
+ H +LR K P+ +T S + LL +L +DPDKRI+A
Sbjct: 228 AMRSACEGARAH---ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 700 ALNHDWFRE 708
AL H + E
Sbjct: 285 ALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 3e-60
Identities = 81/190 (42%), Positives = 118/190 (62%), Gaps = 5/190 (2%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
+ EG +G VY ARDKKTG+ VA+K +K E LREI IL +HP+IV + V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEEL-LREIEILKKLNHPNIVKLYGV 59
Query: 481 VVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
+ + +++VMEY E LK L++ + S+ E+ ++LQ+LEG++YLH N ++HRD
Sbjct: 60 F--EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 540 LKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
LK N+LL++ G++K+ DFGL++ S +V T Y APE+LLG YS D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 599 WSLGCIMAEL 608
WSLG I+ EL
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 117/299 (39%), Positives = 166/299 (55%), Gaps = 18/299 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+ L ++ G YG V A DK+TGE VA+KK+ + E F + RE+ +L H ++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 475 VDVKEV----VVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + +V V G ++VM YM+ DL+ + M P S+ +V+ L+ Q+L G+KY+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYI 133
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H ++HRDLK NL +N ELKI DFGLAR + + Y VVT WYRAPE++L
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILNWM 190
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
Y+ +D+WS+GCIMAE+L+ + LF GK DQL +I K G P + KL
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF---VQKLEDKAA 247
Query: 651 -NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
++IK RK F +T F P S DLL +L D DKR+TA AL H +F
Sbjct: 248 KSYIKSLPKYPRKDF-STLF---PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 115/298 (38%), Positives = 158/298 (53%), Gaps = 16/298 (5%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
I +G+YGVV A D TGE VA+KK+ E LREI +L HP IV++K +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 481 VVGSN---LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
++ + I++V E ME DL +++ + + + QLL +KY+H V H
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFH 126
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQY---GSPLKPYTHLVVTLWYRAPELLLGS--KQY 592
RDLK N+L N +LKICDFGLAR +T V T WYRAPE L GS +Y
Sbjct: 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKY 185
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
+ AID+WS+GCI AE+L+ +PLF GK+ QLD I LGTP+ + S++ K
Sbjct: 186 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET---ISRVRNEKA-- 240
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
+ + +RKK P P LL LL +DP R TAE AL +F+ +
Sbjct: 241 -RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 3e-56
Identities = 98/298 (32%), Positives = 151/298 (50%), Gaps = 51/298 (17%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
FE L KI +G +G VY+AR K+TG+ VA+K +K+E + + + + EI IL HP+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPN 58
Query: 474 IVDVKEVVVGSNL--DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
IV GS L D +++VME+ LK L+++ Q ++S++ + +LL+G++YL
Sbjct: 59 IVKY----YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H N ++HRD+K +N+LL + GE+K+ DFGL+ Q S K +V T ++ APE++ G K
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ-LSDTKARNTMVGTPYWMAPEVING-K 172
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
Y D+WSLG EL +P P +S+LP +K
Sbjct: 173 PYDYKADIWSLGITAIELAEGKP--------------------P-------YSELPPMKA 205
Query: 651 NF---IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
F L + + F D L L +P+KR TAE L H +
Sbjct: 206 LFKIATNGPPGLRNPEKWSDEFK----------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 4e-56
Identities = 116/298 (38%), Positives = 170/298 (57%), Gaps = 15/298 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++FE L + EG YGVV + R K+T EIVA+KK K +E E T+LRE+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV++KE +++V EY+E ++ L+E M +V+ + QL++ I + H
Sbjct: 61 NIVELKEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP-YTHLVVTLWYRAPELLLGSKQ 591
N ++HRD+K NLL+++ LK+CDFG AR YT V T WYR+PELLLG+
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGT-PNE--KIWPGFSKLPGV 648
Y A+DMWS+GCI+ EL +PLF G+SE DQL I K LG P E K++ + G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ + H +L R+ + G +LS DL+ +LL +P R E LNH F
Sbjct: 238 RFPAVNHPQSLERR------YLG--ILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-56
Identities = 120/339 (35%), Positives = 182/339 (53%), Gaps = 26/339 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D + L ++ G YG V A D++TG VA+KK+ + E F + RE+ +L H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 473 SIVDVKEVVVG-SNLD---SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V +LD ++VM +M DL LM+ K S+ ++ L+ Q+L+G+K
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQMLKGLK 132
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK NL +N ELKI DFGLARQ S + Y VVT WYRAPE++L
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY---VVTRWYRAPEVILN 189
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+ +D+WS+GCIMAE+L+ +PLF G DQL +I K GTP+++ KL
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF---VQKLQSE 246
Query: 649 KV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
N++K +K F + +P+ ++L +L D + RITA AL H +F
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPL----AVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 708 EVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRR 746
E P+ + P P + D + LEE +R
Sbjct: 303 EFHDPEDETEAP--PYDDSFDEVDQ-------SLEEWKR 332
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 106/300 (35%), Positives = 154/300 (51%), Gaps = 29/300 (9%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG 483
G+ G+V+ A D + VA+KK+ + + +LREI I+ H +IV V EV+
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKVYEVLGP 73
Query: 484 SN------------LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
S L+S+++V EYME DL ++E + P S+ + M QLL G+KY+H
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIH 131
Query: 532 DNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPLKPYTHL---VVTLWYRAPELLL 587
VLHRDLK +N+ +N LKI DFGLAR +L +VT WYR+P LLL
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG-TPNEKIWPGFSKLP 646
Y+ AIDMW+ GCI AE+L+ +PLF G E +Q+ I +++ E + +P
Sbjct: 192 SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP 251
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
N LR P ++ D L +LT++P R+TAE AL H +
Sbjct: 252 SFVRNDGGEPRRPLRDLLPG--------VNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 4e-54
Identities = 85/297 (28%), Positives = 142/297 (47%), Gaps = 53/297 (17%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINILLSFH 470
+E + +I +G++G VY R K G++ LK++ + EKERE +L E+ IL +
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKLN 57
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK---QPFSQSEVKCLMLQLLEG 526
HP+I+ E + +VMEY + DL ++ K +PF + ++ +QL
Sbjct: 58 HPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPEL 585
+KYLH +LHRD+K N+ L + G +K+ DFG+++ S + VV T +Y +PEL
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPEL 174
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
K Y+ D+WSLGC++ EL + + F G++ + KI
Sbjct: 175 CQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI------------------ 215
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
L+ ++P S L +L++SLL DP++R + L
Sbjct: 216 --------------LKGQYPPIPSQYSSELR----NLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 100/288 (34%), Positives = 155/288 (53%), Gaps = 12/288 (4%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
L + G +G+V ARD+ TG+ VA+KK+ + RE+ +L H +I+ +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
++ + S L+ I+ V E + DL L+ + +P + ++ + Q+L G+KY+H V+H
Sbjct: 75 SDIFI-SPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVH 131
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK SN+L+N +LKICDFGLAR + Y V T +YRAPE++L ++Y +D
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGY---VSTRYYRAPEIMLTWQKYDVEVD 188
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657
+WS GCI AE+L +PLF GK +Q I LGTP + + + F++
Sbjct: 189 IWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN--TLRFVQS-- 244
Query: 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
L K+ P + DLL +L +DP KRI+A AL H +
Sbjct: 245 --LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 2e-50
Identities = 89/298 (29%), Positives = 140/298 (46%), Gaps = 43/298 (14%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHHP 472
E+ R + G++G VY A DK TGE++A+K V++ + E L +L REI IL S HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYM-EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV +++ + +EY+ L L++ + ++ Q+LEG+ YLH
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP-YTHLVV-TLWYRAPELLLGS 589
N ++HRD+K +N+L+++ G +K+ DFG A++ G T V T ++ APE++ G
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 590 KQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+ Y A D+WSLGC + E+ + K P + L KI + P
Sbjct: 179 E-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE------------- 224
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
P LS+ D L L DP KR TA+ L H +
Sbjct: 225 ---------------IPEH-------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 1e-48
Identities = 107/305 (35%), Positives = 162/305 (53%), Gaps = 17/305 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ++ L+ + G YG V A D KTG VA+KK+ + + RE+ +L H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 473 SIVDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V + + +++V M DL +++ Q + V+ L+ Q+L G+K
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLK 134
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK SNL +N ELKI DFGLAR + Y V T WYRAPE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 191
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+ +D+WS+GCIMAELL+ LF G DQL I + +GTP ++ K+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL---LKKISSE 248
Query: 649 KV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
N+I+ + + F A F G+ L+ DLL +L D DKRITA AL H +F
Sbjct: 249 SARNYIQSLTQMPKMNF-ANVFIGANPLA---VDLLEKMLVLDSDKRITAAQALAHAYFA 304
Query: 708 EVPLP 712
+ P
Sbjct: 305 QYHDP 309
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-47
Identities = 103/307 (33%), Positives = 164/307 (53%), Gaps = 15/307 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ++ L + G YG V A D + + VA+KK+ + + RE+ +L H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V N + +++V M DL +++ Q S V+ L+ QLL G+K
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLK 132
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK SN+ +N EL+I DFGLARQ + Y V T WYRAPE++L
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLN 189
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+ +D+WS+GCIMAELL + LF G DQL +I + +GTP+ ++ S
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
K +I+ ++ ++ F G+ L+ DLL +L D DKRI+A AL H +F +
Sbjct: 250 K--YIQSLPHMPQQDLKKI-FRGANPLA---IDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 709 VPLPKSK 715
P+ +
Sbjct: 304 YHDPEDE 310
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 103/334 (30%), Positives = 158/334 (47%), Gaps = 49/334 (14%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSF-HH 471
+ L K+ EG++G VY ARD+K +VALK + + E + LREI IL S H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIK 528
P+IV + + S+++VMEY++ L+ L++ + + P S+SE ++ Q+L ++
Sbjct: 58 PNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 529 YLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSP------LKPYTHLVVTLWYR 581
YLH ++HRD+K N+LL+ + +K+ DFGLA+ P + V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 582 APELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLF---NGKSEFDQLDKIFKTLGTPNE 636
APE+LLG S++ D+WSLG + ELL+ P F S Q KI L TP+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS- 234
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT 696
S + ++S A DLL LL DP R++
Sbjct: 235 --------------------------LASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 697 AEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRR 730
+ + L+HD + L +S P A R
Sbjct: 269 SSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302
|
Length = 384 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 9e-46
Identities = 109/333 (32%), Positives = 169/333 (50%), Gaps = 49/333 (14%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++ L I G G+V A D TG+ VA+KK+ + + RE+ ++ +H +I
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 475 VDVKEVVV-GSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + V +L+ +++VME M+ +L + ++ + L+ Q+L GIK+L
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMDLDHERMSYLLYQMLCGIKHL 134
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELLLG 588
H ++HRDLK SN+++ + LKI DFGLAR G+ + PY VVT +YRAPE++LG
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG 191
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL-PG 647
Y +D+WS+GCIM E++ LF G DQ +KI + LGTP+++ S+L P
Sbjct: 192 MG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF---MSRLQPT 247
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF----------------DLLNSLLTYDP 691
V+ Y R K+ SF + D F DLL+ +L DP
Sbjct: 248 VR------NYVENRPKYAGYSF--EELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299
Query: 692 DKRITAEAALNHD----WFR----EVPLPKSKD 716
+KRI+ + AL H W+ E P P D
Sbjct: 300 EKRISVDDALQHPYINVWYDPSEVEAPPPAPYD 332
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 91/297 (30%), Positives = 144/297 (48%), Gaps = 49/297 (16%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++ L KI EG G VY+A D+ TG+ VA+KK+++ K+ + + EI I+ HP+I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNI 77
Query: 475 VD-VKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
VD +VG D +++VMEYM+ L ++ ++ ++ + ++L+G++YLH
Sbjct: 78 VDYYDSYLVG---DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
V+HRD+K+ N+LL+ G +K+ DFG A Q +V T ++ APE++ K Y
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 593 STAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFK--TLGTPNEKIWPGFSKLPGVK 649
+D+WSLG IM E+ EP + L +F T G P
Sbjct: 194 GPKVDIWSLG-IMCIEMAEGEPPY---LREPPLRALFLITTKGIPP-------------- 235
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+K+ SP D LN L DP+KR +AE L H +
Sbjct: 236 ---LKNPEKW------------SPEFK----DFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 5e-44
Identities = 88/291 (30%), Positives = 149/291 (51%), Gaps = 45/291 (15%)
Query: 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVK 478
+ I G +GVVY+ + +TG+ VA+K++ +EK +E + ++EI++L + HP+IV
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ S DS+++++EY E G L + +K+ PF +S V + Q+L+G+ YLH+ V
Sbjct: 66 GSIETS--DSLYIILEYAE---NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
+HRD+K +N+L G +K+ DFG+A + K +V T ++ APE++ S STA
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTA 179
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
D+WSLGC + ELL+ P + + + + +F+ + + + G S P +K
Sbjct: 180 SDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHPPLPEGIS--PELK------ 228
Query: 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
D L DP+ R TA+ L H W
Sbjct: 229 -------------------------DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 88/302 (29%), Positives = 149/302 (49%), Gaps = 52/302 (17%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
I +G YG V+ A+ K TG+I A+K + K + R+ L E +IL P +V +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 480 VVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
G ++++VMEY+ DL L+E + + + + +++ ++YLH N ++HR
Sbjct: 61 SFQGKK--NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 539 DLKTSNLLLNNRGELKICDFGLARQ--------YGSPLKPYTHLVVTLWYRAPELLLGSK 590
DLK N+L+++ G LK+ DFGL++ K +V T Y APE++LG +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-Q 176
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
+S +D WSLGCI+ E L P F+G++ ++IF + I G K+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIF-------QNILNG-------KI 218
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA---LNHDWFR 707
+ + +SD DL++ LL DP+KR+ A++ NH +F+
Sbjct: 219 EWPE-----------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
Query: 708 EV 709
+
Sbjct: 262 GI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 2e-41
Identities = 120/377 (31%), Positives = 190/377 (50%), Gaps = 60/377 (15%)
Query: 365 EIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERL-NKIDE 423
++DE+ ++++ G D D E D+ IN RS ++ +L N I
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMIDN------------DIN-----RSPNKSYKLGNIIGN 76
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV--- 480
G++GVVY A T E VA+KKV + P RE+ I+ + +H +I+ +K+
Sbjct: 77 GSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYT 130
Query: 481 -VVGSNLDSIFM--VMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNW 534
N +IF+ VME++ + M+ VK QL + Y+H +
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190
Query: 535 VLHRDLKTSNLLLNNRGE-LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
+ HRDLK NLL++ LK+CDFG A+ + + ++ + + +YRAPEL+LG+ Y+
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRFYRAPELMLGATNYT 249
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK----IWPGFS--KLPG 647
T ID+WSLGCI+AE++ P+F+G+S DQL +I + LGTP E + P ++ K P
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD 309
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
VK L+K FP G+P D + ++ L Y+P KR+ AL +F
Sbjct: 310 VKPKD-------LKKVFP----KGTP---DDAINFISQFLKYEPLKRLNPIEALADPFFD 355
Query: 708 E-----VPLPKSKDFMP 719
+ + LPK D +P
Sbjct: 356 DLRDPCIKLPKYIDKLP 372
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-40
Identities = 105/331 (31%), Positives = 166/331 (50%), Gaps = 46/331 (13%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+++L I G G+V A D G VA+KK+ + + + RE+ +L +H +I
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 475 VDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + V +++VME M+ +L + + + L+ Q+L GIK+L
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELLLG 588
H ++HRDLK SN+++ + LKI DFGLAR + + PY VVT +YRAPE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRYYRAPEVILG 196
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y +D+WS+GCIM EL+ +F G DQ +K+ + LGTP+ + P V
Sbjct: 197 MG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL--QPTV 253
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF---------------DLLNSLLTYDPDK 693
+ N++++ R ++P SF + D F DLL+ +L DPDK
Sbjct: 254 R-NYVEN-----RPQYPGISFE--ELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305
Query: 694 RITAEAALNHD----WF----REVPLPKSKD 716
RI+ + AL H W+ E P P+ D
Sbjct: 306 RISVDEALRHPYITVWYDPAEAEAPPPQIYD 336
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 89/304 (29%), Positives = 141/304 (46%), Gaps = 54/304 (17%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKV---KM-EKEREGFPLTSLREINILLSF 469
++E L I +G++G V + R K G+I+ K++ M EKE++ L S E+NIL
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ--QLVS--EVNILREL 56
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLME---TMKQPFSQSEVKCLMLQLLE 525
HP+IV + ++ + ++++VMEY E DL L++ ++ + + ++ QLL
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 526 GIKYLH-----DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
+ H N VLHRDLK +N+ L+ +K+ DFGLA+ G V T +Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
+PE L Y D+WSLGC++ EL + P F ++ QL KI
Sbjct: 177 MSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARN-QLQL----------ASKIKE 224
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
G K I ++Y S +++ S+L DPDKR + E
Sbjct: 225 G-------KFRRIPYRY------------------SSELNEVIKSMLNVDPDKRPSTEEL 259
Query: 701 LNHD 704
L
Sbjct: 260 LQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 88/298 (29%), Positives = 137/298 (45%), Gaps = 66/298 (22%)
Query: 424 GTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
G++G V R K TG++ A+K K K+ K +E +L E NIL +HP IV
Sbjct: 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE--VEHTLTERNILSRINHPFIV----- 56
Query: 481 VVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
L + +++V+EY +L + + FS+ + +++ ++YLH
Sbjct: 57 ----KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEYLHS 111
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLLGSKQ 591
+++RDLK N+LL+ G +K+ DFGLA++ S T+ T Y APE+LLG K
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKE-LSSEGSRTNTFCGTPEYLAPEVLLG-KG 169
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
Y A+D WSLG ++ E+L+ +P F + + +KI K L
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------------DPL------ 210
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---AEAALNHDWF 706
+FP LS DL++ LL DP KR+ AE H +F
Sbjct: 211 -----------RFPEF-------LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 9e-39
Identities = 103/326 (31%), Positives = 167/326 (51%), Gaps = 36/326 (11%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++ L I G G+V A D VA+KK+ + + + RE+ ++ +H +I
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 475 VDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + V +++VME M+ +L + ++ + L+ Q+L GIK+L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELLLG 588
H ++HRDLK SN+++ + LKI DFGLAR G+ + PY VVT +YRAPE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG 192
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK--LP 646
Y +D+WS+GCIM E++ + LF G+ DQ +K+ + LGTP P F K P
Sbjct: 193 MG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP----CPEFMKKLQP 247
Query: 647 GVKVNFIKHQYNL----LRKKFPATSFTG----SPVLSDAGFDLLNSLLTYDPDKRITAE 698
V+ N+++++ K FP + F + + + DLL+ +L DP KRI+ +
Sbjct: 248 TVR-NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 699 AALNHDWFR--------EVPLPKSKD 716
AL H + E P P+ D
Sbjct: 307 EALQHPYINVWYDPAEVEAPPPQIYD 332
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 92/304 (30%), Positives = 141/304 (46%), Gaps = 51/304 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ER+ + +G+ GVVY+ R K TG+I ALKK+ + E F LRE+ L S P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+V I +V+EYM+ DL + + +P + + Q+L+G+
Sbjct: 60 YVVKCYGAFYKEG--EISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLD 113
Query: 529 YLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
YLH ++HRD+K SNLL+N++GE+KI DFG+++ + L V T+ Y +PE +
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 588 GSKQYSTAIDMWSLGCIMAEL-LSKEPLF--NGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
G + YS A D+WSLG + E L K P S F+ + I P
Sbjct: 174 G-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGP---------- 219
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
+L PA F S D +++ L DP KR +A L H
Sbjct: 220 -----------PPSL-----PAEEF------SPEFRDFISACLQKDPKKRPSAAELLQHP 257
Query: 705 WFRE 708
+ ++
Sbjct: 258 FIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-37
Identities = 105/325 (32%), Positives = 161/325 (49%), Gaps = 34/325 (10%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++ L I G G+V A D VA+KK+ + + + RE+ ++ +H +I
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 475 VDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + V +++VME M+ +L + ++ + L+ Q+L GIK+L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELLLG 588
H ++HRDLK SN+++ + LKI DFGLAR G+ + PY VVT +YRAPE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG 199
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK--LP 646
Y +D+WS+GCIM E++ LF G DQ +K+ + LGTP P F K P
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP----CPEFMKKLQP 254
Query: 647 GVKV---NFIKHQYNLLRKKFPATSFTG----SPVLSDAGFDLLNSLLTYDPDKRITAEA 699
V+ N K+ K FP F + + + DLL+ +L D KRI+ +
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 700 ALNHD----WF----REVPLPKSKD 716
AL H W+ E P PK D
Sbjct: 315 ALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 80/303 (26%), Positives = 139/303 (45%), Gaps = 56/303 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHH 471
+ F L I +G++G VY+A DK+T ++VA+K + +E+ + + + +EI L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRS 58
Query: 472 PSIVDVKE-VVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
P I + GS L +++MEY L++ ++ + ++ ++L G++Y
Sbjct: 59 PYITKYYGSFLKGSKL---WIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEY 113
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH+ +HRD+K +N+LL+ G++K+ DFG++ Q S + V T ++ APE++ S
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
Y D+WSLG EL EP P + P ++
Sbjct: 174 G-YDEKADIWSLGITAIELAKGEP--------------------PLSDLHP-------MR 205
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGF-----DLLNSLLTYDPDKRITAEAALNHD 704
V F L+ K P P L F D ++ L DP +R +A+ L H
Sbjct: 206 VLF------LIPKNNP-------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252
Query: 705 WFR 707
+ +
Sbjct: 253 FIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 80/340 (23%), Positives = 128/340 (37%), Gaps = 106/340 (31%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----------K---VKMEKEREGFPLT 458
D+F+ I EG++ V A++K+T + A+K K VK+EKE LT
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE----VLT 56
Query: 459 SLREINILLSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQP 510
L HP I+ L ++++ V+EY + +L +
Sbjct: 57 RLN--------GHPGII---------KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS- 98
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570
+ + ++L ++YLH ++HRDLK N+LL+ +KI DFG A+ P
Sbjct: 99 LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
Query: 571 Y--------------------THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
V T Y +PELL K + D+W+LGCI+ ++L+
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLT 217
Query: 611 KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFT 670
+P F G +E+ KI K +Y+ P
Sbjct: 218 GKPPFRGSNEYLTFQKILKL-------------------------EYSFPPNFPPDAK-- 250
Query: 671 GSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWF 706
DL+ LL DP R+ + H +F
Sbjct: 251 ----------DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 418 LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFH 470
K+ EG +G VY+ + K VA+K +K E++ E F LRE I+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF----LREARIMRKLD 59
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP++V + V + +++VMEYME DL + + S S++ LQ+ G++Y
Sbjct: 60 HPNVVKLLGVCTEE--EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-----------PLKPYTHLVVTL 578
L +HRDL N L+ +KI DFGL+R P++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR--------- 168
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W APE L K +++ D+WS G ++ E+ +
Sbjct: 169 WM-APESLKEGK-FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 83/302 (27%), Positives = 142/302 (47%), Gaps = 56/302 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHH 471
+ F+ L K+ EG+YG VY+A K+TG++VA+K V +E++ L + +EI+IL
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDS 57
Query: 472 PSIVDVKEVVVGSNL--DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
P IV GS +++VMEY + +M+ + ++ E+ ++ Q L+G++
Sbjct: 58 PYIVKYY----GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YLH N +HRD+K N+LLN G+ K+ DFG++ Q + ++ T ++ APE++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 589 SKQYSTAIDMWSLG--CI-MAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
Y+ D+WSLG I MAE K P + +
Sbjct: 174 IG-YNNKADIWSLGITAIEMAE--GKPPYSD----------------------------I 202
Query: 646 PGVKVNF-IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
++ F I ++ P + + S D + L DP++R +A L H
Sbjct: 203 HPMRAIFMIPNK--------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254
Query: 705 WF 706
+
Sbjct: 255 FI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 37/216 (17%)
Query: 415 FERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVK---MEKEREGFPLTSLREINILL 467
E K+ EG +G VY+ + T VA+K +K E+ERE F L E +I+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMK 56
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
HP+IV + V + +++V EYM DL + + + ++ + LQ+ +G
Sbjct: 57 KLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR------QYGS------PLKPYTHL 574
++YL +HRDL N L+ +KI DFGL+R Y P+K
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----- 169
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W APE L K +++ D+WS G ++ E+ +
Sbjct: 170 ----WM-APESLKDGK-FTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 87/299 (29%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++E + +I GTYG VY+ARD TGE+VA+K +K+E + F + +EI++L HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQ-QEISMLKECRHP 60
Query: 473 SIVDVKEVVVGSNL--DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+IV GS L D +++VMEY L+ + + + P S+ ++ + + L+G+ Y
Sbjct: 61 NIVAY----FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH+ +HRD+K +N+LL G++K+ DFG++ Q + + + T ++ APE+
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 590 KQ--YSTAIDMWSLG--CI-MAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
++ Y D+W+LG I +AEL P+F+
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQP--PMFD---------------------------- 206
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
L ++ F+ + + FP S D + LT DP KR TA L H
Sbjct: 207 LHPMRALFL-----ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 87/306 (28%), Positives = 138/306 (45%), Gaps = 57/306 (18%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++R NKI GT+G VY A + TGE++A+K+++++ E+ +L HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 474 IVDVKEVVVGSNLDSIFMVMEYME--------HDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+V V V IFM EY + L E + + ++ LQLLE
Sbjct: 61 LVKYYGVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYT--------LQLLE 110
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY----THLVVTLWYR 581
G+ YLH + ++HRD+K +N+ L++ G +K+ DFG A + + L T Y
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 582 APELLLGSKQ--YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639
APE++ G K + A D+WSLGC++ E+ + GK + +LD F+ +
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMAT------GKRPWSELDNEFQIM-------- 216
Query: 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699
+++ P S LS G D L+ L DP KR TA
Sbjct: 217 -----------------FHVGAGHKP--PIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257
Query: 700 ALNHDW 705
L H +
Sbjct: 258 LLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 418 LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFH 470
K+ EG +G VY+ VA+K +K E++ E F LRE I+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF----LREARIMRKLD 59
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+IV + V + + +VMEYM DL L + + S S++ LQ+ G++
Sbjct: 60 HPNIVKLLGVCTEE--EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL------WYRA 582
YL +HRDL N L+ +KI DFGL+R L + V W A
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYKVKGGKLPIRWM-A 172
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLS 610
PE L ++++ D+WS G ++ E+ +
Sbjct: 173 PESLK-EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 35/237 (14%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINILLSFH 470
F+ L K+ +G+YG VY+ + + ALK+V + +KERE ++ EI IL S +
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE----DAVNEIRILASVN 57
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLM---ETMKQPFSQSEVKCLMLQLLEG 526
HP+I+ KE + N + +VMEY DL + + ++ + E+ + +QLL G
Sbjct: 58 HPNIISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR---------QYGSPLKPYTHLVVT 577
++ LH+ +LHRDLK++N+LL +KI D G+++ Q G+P
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH--------- 166
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
Y APE+ G + YS D+WSLGC++ E+ + P F +S D K+ + P
Sbjct: 167 --YMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 83/304 (27%), Positives = 147/304 (48%), Gaps = 48/304 (15%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--REGFPLTSLREINILLSFHHP 472
+ KI EG+ G+V A DK TG VA+KK+ + K+ RE E+ I+ + HP
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL----FNEVVIMRDYQHP 76
Query: 473 SIVDV-KEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+IV++ +VG D +++VME++E L ++ + ++ ++ + L +L+ + +L
Sbjct: 77 NIVEMYSSYLVG---DELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFL 131
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H V+HRD+K+ ++LL + G +K+ DFG Q + LV T ++ APE++
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRL 190
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
Y T +D+WSLG ++ E++ EP + + + +I + P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPP---------------- 233
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
+K+ + + SP L L+ +L DP +R TA LNH + +
Sbjct: 234 -KLKNLHKV------------SPRLRS----FLDRMLVRDPAQRATAAELLNHPFLAKAG 276
Query: 711 LPKS 714
P S
Sbjct: 277 PPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 419 NKIDEGTYGVVYRA--RDKKTGEI-VALKKVK---MEKEREGFPLTSLREINILLSFHHP 472
K+ EG +G VY+ + K VA+K +K E+ER+ F L+E ++ HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHP 56
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCL-MLQLLE----- 525
++V + V + +++V+EYME DL + + F E L + LL
Sbjct: 57 NVVRLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 526 --GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----W 579
G++YL +HRDL N L+ +KI DFGL+R Y W
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRW 173
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
APE L +++ D+WS G ++ E+ +
Sbjct: 174 M-APESLK-DGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 88/297 (29%), Positives = 137/297 (46%), Gaps = 50/297 (16%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKM-------EKEREGFPLTSLR-EINILLSFHHP 472
I +GTYG VY A + TGE++A+K+V++ R+ + +LR EI L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV SIF+ EY+ G F + V+ Q+LEG+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQ----YGSPLKPYTHLVVTLWYRAPELL-L 587
+LHRDLK NLL++ G KI DFG++++ Y + + ++++ APE++
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MSMQGSVFWMAPEVIHS 184
Query: 588 GSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
S+ YS +D+WSLGC++ E+ + + P S+ + + +FK LG
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPW----SDEEAIAAMFK-LGN------------- 226
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
++ P S LS D LN+ T +PD R TA L H
Sbjct: 227 --------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 84/303 (27%), Positives = 139/303 (45%), Gaps = 52/303 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHH 471
D+ E L ++ G GVV + + TG+I+A+K +++E E + LRE++IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI--LRELDILHKCNS 58
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P IV + I + MEYM+ L +++ ++ + + + + +L+G+ YL
Sbjct: 59 PYIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116
Query: 531 HDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKPYTHLVVTLWYRAPELLLG 588
H+ ++HRD+K SN+L+N+RG++K+CDFG++ Q S K + V T Y APE + G
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQG 173
Query: 589 SKQYSTAIDMWSLGCIMAELLSKE-----PLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
+ YS D+WSLG + EL + F+ L I P
Sbjct: 174 ND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--EPP--------P 222
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
+LP KF F D +N L DP +R + + L H
Sbjct: 223 RLPS--------------GKFSP-DFQ----------DFVNLCLIKDPRERPSYKELLEH 257
Query: 704 DWF 706
+
Sbjct: 258 PFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 75/218 (34%), Positives = 118/218 (54%), Gaps = 22/218 (10%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR-EINILLSF- 469
FE + I EGTYG VY+AR KKTG++VA+K + + ++ E ++ E NIL +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYS 60
Query: 470 HHPSIVD-----VKEVVVGSNLDSIFMVMEYMEH----DL-KGLMETMKQPFSQSEVKCL 519
+HP+I +K+ G N D +++VME DL KGL + + + + +
Sbjct: 61 NHPNIATFYGAFIKKNPPG-NDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYI 118
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
+ + L G+ YLH+N V+HRD+K N+LL E+K+ DFG++ Q S L + T +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 580 YRAPELLLGSKQ----YSTAIDMWSLGCIMAELLSKEP 613
+ APE++ +Q Y D+WSLG EL +P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 45/285 (15%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
+FE LNKI +G++GVV++ K + A+K++ + K ++ E +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 474 IVDVKEVVVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
I+ E + + +VMEY E H L L +P + +V +Q+L G+ +
Sbjct: 61 IIRYYESFLDKGK--LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH +LHRD+K+ NL L+ +KI D G+A+ +V T +Y +PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCED 175
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
K Y+ D+W+LG ++ E + + F+ ++ + KI
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---------------------- 213
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
+R FP S S L+ L++ LT D +R
Sbjct: 214 ----------IRGVFPPVSQMYSQQLA----QLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 85/308 (27%), Positives = 146/308 (47%), Gaps = 55/308 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK--KVKMEKEREGFPLTSLREINILLSFH 470
D +E + ++ +G +G VY+A+ K+TG A K +++ E+E E F + EI+IL
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF----MVEIDILSECK 60
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+IV + E + +++++E+ + L +M +++ ++ +++ + Q+LE + +
Sbjct: 61 HPNIVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL-- 587
LH + V+HRDLK N+LL G++K+ DFG++ + S L+ + T ++ APE++
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 588 --GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK----TLGTPNEKIWPG 641
Y D+WSLG + EL EP + + L KI K TL P+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS-----K 233
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
+S SF D L S L DPD R TA L
Sbjct: 234 WSS-----------------------SFN----------DFLKSCLVKDPDDRPTAAELL 260
Query: 702 NHDWFREV 709
H + +
Sbjct: 261 KHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 47/298 (15%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
L I +G +G VY A+ + TG+ A+K +K +T+++ ++ S
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 478 KEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
K + D +++VMEY+ D L++T+ + K + +++ G++ LH ++
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
HRD+K NLL++ G LK+ DFGL+R K V T Y APE +LG
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILGVGD-DKMS 174
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
D WSLGC++ E L P F+ TP + ++
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHA--------------ETP-DAVFD---------------- 203
Query: 657 YNLLRKK--FPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA---EAALNHDWFREV 709
N+L ++ +P S DL+N LL DP KR+ A + +H +F+ +
Sbjct: 204 -NILSRRINWPEEVKEF---CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 81/295 (27%), Positives = 127/295 (43%), Gaps = 55/295 (18%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKE---REGFPLTSLREINILLSFHHPSIVDVKEV 480
G +G V + K ALK VK K G E IL +HP IV K
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVK--KRHIVETGQQEHIFSEKEILEECNHPFIV--KLY 59
Query: 481 VVGSNLDSIFMVMEYMEHDLKG--LMETMKQP--FSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ I+M+MEY G L ++ F + + + ++ +YLH+ ++
Sbjct: 60 RTFKDKKYIYMLMEYC----LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK NLLL++ G +K+ DFG A++ S K +T T Y APE++L K Y ++
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN-KGYDFSV 173
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
D WSLG ++ ELL+ P F + D + +I+ + N K+
Sbjct: 174 DYWSLGILLYELLTGRPPFGE-DDEDPM-EIYNDILKGNGKL------------------ 213
Query: 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWF 706
+FP + A DL+ LL +P++R+ + H WF
Sbjct: 214 ------EFP-------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 11/221 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++RL I G YG VYR + TG +VALK + ++ + RE+ +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQS-- 59
Query: 475 VDVKEVV--VGSNLD--SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+ GS L ++++MEY E ++ LM+ P ++ + ++ ++L +KY
Sbjct: 60 -QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKY 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+H V+HRD+K +N+L+ N G +K+CDFG+A + V T ++ APE++
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT 630
K Y T D+WSLG + E+ + P ++ F + I K+
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 73/213 (34%), Positives = 115/213 (53%), Gaps = 24/213 (11%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV------KMEKEREGFPLTSLREINILLS 468
F L +I G++G VY ARD +T E+VA+KK+ EK ++ ++E+ L
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-----IIKEVRFLQQ 71
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+ ++ K + + + ++VMEY ++E K+P + E+ + L+G+
Sbjct: 72 LRHPNTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YLH + +HRD+K N+LL G +K+ DFG A S + P V T ++ APE++L
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSA----SLVSPANSFVGTPYWMAPEVILA 185
Query: 589 --SKQYSTAIDMWSLG--CI-MAELLSKEPLFN 616
QY +D+WSLG CI +AE K PLFN
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAE--RKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 63/306 (20%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHH 471
FE L I +G +G V + + T ++ A+K K K ++ + L E IL +H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNV--LNERRILQELNH 59
Query: 472 PSIVDVKEVVVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQL 523
P +V NL +++++V++ + DL+ + FS+ +VK + ++
Sbjct: 60 PFLV---------NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV-KFSEEQVKFWICEI 109
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+ ++YLH ++HRD+K N+LL+ +G + I DF +A + +P T T Y AP
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAP 168
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
E+L + YS A+D WSLG E L K P + G S T ++I
Sbjct: 169 EVLC-RQGYSVAVDWWSLGVTAYECLRGKRP-YRGHSR------------TIRDQI---- 210
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI--TAEAA 700
R K S D +N LL DP KR+ +
Sbjct: 211 ------------------RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDL 252
Query: 701 LNHDWF 706
NH +F
Sbjct: 253 KNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 65/215 (30%), Positives = 118/215 (54%), Gaps = 12/215 (5%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEK----EREGFPLTSLREINILLSFHHPSIVDVKE 479
G + Y+ARD KTG ++A+K+V + E+E +EI ++ +HP I+ +
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 480 VVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
+ ++F+ E+M + + F ++ + QLL G+ YLH+N ++HRD
Sbjct: 71 ATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRD 128
Query: 540 LKTSNLLLNNRGE-LKICDFGLARQYGSPLKP----YTHLVVTLWYRAPELLLGSKQYST 594
+K +NLL+++ G+ L+I DFG A + + L+ T+ + APE+L G +QY
Sbjct: 129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGR 187
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
+ D+WS+GC++ E+ + +P +N + + L IFK
Sbjct: 188 SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 92/317 (29%), Positives = 146/317 (46%), Gaps = 52/317 (16%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREIN-------IL 466
+F+ L ++ +G YG V+ A+ K TGEIVALK+ M+K L L E+ IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKR--MKKSL----LFKLNEVRHVLTERDIL 55
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
+ +V K + + + +++ MEY+ D + L+ S+ + M ++ E
Sbjct: 56 TTTKSEWLV--KLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFE 112
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPE 584
+ LH+ +HRDLK N L++ G +K+ DFGL++ + Y + VV + Y APE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPE 168
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+L G K Y +D WSLGC++ E L P F+G TPNE
Sbjct: 169 VLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNE-------- 205
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
N + L R + F LSD +DL+ L+ + + E NH
Sbjct: 206 ---TWENLKYWKETLQRPVYDDPRFN----LSDEAWDLITKLINDPSRRFGSLEDIKNHP 258
Query: 705 WFREVPLPKSKDFMPTF 721
+F+EV + ++ P F
Sbjct: 259 FFKEVDWNELRELKPPF 275
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 91/312 (29%), Positives = 143/312 (45%), Gaps = 67/312 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKK------VKMEKEREGFPLTSLREINIL 466
D+FE + + G++G V R K +G+ ALK VK+++ L E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRIL 55
Query: 467 LSFHHPSIVDVKEVVVGSNLD--SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQL 523
S HP +V++ GS D ++++VMEY+ +L + + F + + Q+
Sbjct: 56 QSIRHPFLVNL----YGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQV 110
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-LVVTLWYRA 582
+ ++YLH +++RDLK NLLL++ G +KI DFG A++ +K T+ L T Y A
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR----VKGRTYTLCGTPEYLA 166
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE++L SK Y A+D W+LG ++ E+L+ P F D +I+ EKI G
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFD----DNPIQIY-------EKILEG- 213
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TA 697
KV F + DL+ +LL D KR+
Sbjct: 214 ------KVRFPSFFSPDAK-------------------DLIRNLLQVDLTKRLGNLKNGV 248
Query: 698 EAALNHDWFREV 709
NH WF +
Sbjct: 249 NDIKNHPWFAGI 260
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 71/301 (23%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSL-REINILLSFHHPSIV 475
+ G++G VY + G+ A+K+V + + +E + L +EI +L HP+IV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEA--VKQLEQEIALLSKLQHPNIV 65
Query: 476 DVKEVVVGSNL--DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+G+ D++++ +E + L L++ F + ++ Q+L G++YLHD
Sbjct: 66 QY----LGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQY----------GSPLKPYTHLVVTLWYRA 582
+HRD+K +N+L++ G +K+ DFG+A+Q GSP ++ A
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP-----------YWMA 169
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE++ Y A D+WSLGC + E+ + +P + S+ + + +FK +G E
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFK-IGRSKE------ 219
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
LP + P LSD D + L DP R TA L
Sbjct: 220 --LPPI----------------PDH-------LSDEAKDFILKCLQRDPSLRPTAAELLE 254
Query: 703 H 703
H
Sbjct: 255 H 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 70/206 (33%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHHPS 473
F L +I G++G VY ARD +T E+VA+KK+ ++ + +E+ L HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
++ K + + + ++VMEY L+E K+P + E+ + L+G+ YLH +
Sbjct: 87 SIEYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG--SKQ 591
++HRD+K N+LL G++K+ DFG A S P V T ++ APE++L Q
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSA----SIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 592 YSTAIDMWSLGCIMAELLS-KEPLFN 616
Y +D+WSLG EL K PLFN
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 17/228 (7%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINILLSFH 470
+ + + +G +G R + +V K+V + EKER +L EI IL
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERR----DALNEIVILSLLQ 57
Query: 471 HPSIVDVKEVVVGSNLD--SIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEG 526
HP+I+ +D ++ + MEY ++ Q F + V + Q++
Sbjct: 58 HPNII----AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+ Y+H +LHRD+KT N+ L G +K+ DFG+++ GS +V T +Y +PEL
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
G +Y+ D+W+LGC++ ELL+ + F+ + + + KI + TP
Sbjct: 174 QG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 72/235 (30%), Positives = 125/235 (53%), Gaps = 13/235 (5%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+E + KI EG++G +Y A+ K E +K++ + K S +E+ +L HP+I
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP----FSQSEVKCLMLQLLEGIKYL 530
V + +F+VMEY D LM+ + + FS+ ++ +Q+ G+K++
Sbjct: 62 VTFFASFQENG--RLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 531 HDNWVLHRDLKTSNLLLNNRGEL-KICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
HD +LHRD+K+ N+ L+ G + K+ DFG+ARQ ++ V T +Y +PE + +
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE-ICQN 176
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+ Y+ D+WSLGC++ EL + + F G + + KI + P I P FS+
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 84/311 (27%), Positives = 133/311 (42%), Gaps = 61/311 (19%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D++E + I G VVY A E VA+K++ +EK + +E+ + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHP 59
Query: 473 SIVDV-KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQ-----SEVKCLMLQLLEG 526
++V VVG D +++VM Y+ L++ MK + + + + ++ ++L+G
Sbjct: 60 NVVKYYTSFVVG---DELWLVMPYLSGG--SLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG----LARQYGSPLKPYTHLVVTLWYRA 582
++YLH N +HRD+K N+LL G +KI DFG LA K V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE++ Y D+WS G EL + G P +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELAT---------------------GAA-----P-Y 207
Query: 643 SKLPGVKV-------NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
SK P +KV + + KK+ SF +++ L DP KR
Sbjct: 208 SKYPPMKVLMLTLQNDPPSLETGADYKKYSK-SFR----------KMISLCLQKDPSKRP 256
Query: 696 TAEAALNHDWF 706
TAE L H +F
Sbjct: 257 TAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHHPS 473
F L +I G++G VY ARD + E+VA+KK+ ++ + +E+ L HP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+ + + + + ++VMEY L+E K+P + E+ + L+G+ YLH +
Sbjct: 77 TIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG--SKQ 591
++HRD+K N+LL+ G +K+ DFG A S + P V T ++ APE++L Q
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 592 YSTAIDMWSLGCIMAELLS-KEPLFN 616
Y +D+WSLG EL K PLFN
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 71/202 (35%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVV 482
+GTYG+VY ARD T +A+K++ R PL EI + H +IV +
Sbjct: 18 KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL--HEEIALHSYLKHRNIVQY----L 71
Query: 483 GSNLDSIFMVMEYMEH----DLKGLMETMKQPFSQSE--VKCLMLQLLEGIKYLHDNWVL 536
GS+ ++ F + +ME L L+ + P +E + Q+LEG+KYLHDN ++
Sbjct: 72 GSDSENGFFKI-FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 537 HRDLKTSNLLLNN-RGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELL-LGSKQYS 593
HRD+K N+L+N G +KI DFG +++ + P T TL Y APE++ G + Y
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG-INPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 594 TAIDMWSLGCIMAELLSKEPLF 615
D+WSLGC + E+ + +P F
Sbjct: 190 APADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 13/210 (6%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++E++ + G +G+V+ R K ++V +K++ +E+ + L + E +L HP+
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-----FSQSEVKCLMLQLLEGIK 528
I++ E + ++ +VMEY G + Q + + +Q+L +
Sbjct: 61 IIEYYENFLEDK--ALMIVMEYAP---GGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGE-LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
++H +LHRDLKT N+LL+ +KI DFG+++ S K YT +V T Y +PEL
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCE 174
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617
G K Y+ D+W+LGC++ EL S + F
Sbjct: 175 G-KPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS-LREINILLSFHHPS 473
F L++I G++G VY A + T E+VA+KK+ ++ ++E+ L HP+
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
++ K + + + ++VMEY L+E K+P + E+ + L+G+ YLH +
Sbjct: 83 TIEYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG--SKQ 591
++HRD+K N+LL G++K+ DFG A S P V T ++ APE++L Q
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTPYWMAPEVILAMDEGQ 196
Query: 592 YSTAIDMWSLGCIMAELLSKEP-LFN 616
Y +D+WSLG EL ++P LFN
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 72/229 (31%), Positives = 126/229 (55%), Gaps = 33/229 (14%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME------KEREGFPLTSL-REINILLSFHHPS 473
I G++G VY + +GE++A+K+V++ K+R+ L +L REI +L H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 474 IVDVKEVVVGSNLDS----IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
IV +GS+LD+ IF+ EY+ + F ++ V+ + Q+L+G+ Y
Sbjct: 68 IVQY----LGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY------GSPLKPYTHLVVTLWYRAP 583
LH+ ++HRD+K +N+L++N+G +KI DFG++++ L ++++ AP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 584 ELLLGSKQ--YSTAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFK 629
E++ KQ Y+ D+WSLGC++ E+L K P + QL IFK
Sbjct: 182 EVV---KQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 67/312 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREI-------NI 465
D+ ER+ + GT+G V+ RD+ + ALK + + + + L++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE------VIRLKQEQHVHNEKRV 54
Query: 466 LLSFHHPSIVDVKEVVVGSNLDS--IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
L HP I+ + + D ++M+MEY+ +L + + FS S +
Sbjct: 55 LKEVSHPFIIRL----FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASE 109
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
++ ++YLH +++RDLK N+LL+ G +K+ DFG A++ + +T L T Y A
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWT-LCGTPEYLA 166
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE ++ SK ++ A+D W+LG ++ E+L P F + F +KI
Sbjct: 167 PE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------------- 210
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TA 697
L G K+ F +H +L K DL+ LL D +R+ A
Sbjct: 211 --LAG-KLEFPRH-LDLYAK------------------DLIKKLLVVDRTRRLGNMKNGA 248
Query: 698 EAALNHDWFREV 709
+ NH WF+ V
Sbjct: 249 DDVKNHRWFKSV 260
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 62/211 (29%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM-----EKEREGFPLTSLREINIL 466
+ F+ KI +G + VVY+A G +VALKKV++ K R+ L+EI++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ----DCLKEIDLL 56
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQ---PFSQSEVKCLMLQ 522
HP+++ + +N +I V+E + DL +++ K+ + + +Q
Sbjct: 57 KQLDHPNVIKYLASFIENNELNI--VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
L ++++H ++HRD+K +N+ + G +K+ D GL R + S LV T +Y +
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 583 PELLLGSKQYSTAIDMWSLGCI---MAELLS 610
PE + + Y+ D+WSLGC+ MA L S
Sbjct: 175 PERIHENG-YNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 59/203 (29%), Positives = 115/203 (56%), Gaps = 13/203 (6%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKV---KME-KEREGFPLTSLREINILLSF 469
++ ++ KI EG++G + K+ G+ +K++ KM KERE S +E+ +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE----ESRKEVAVLSNM 56
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQ-PFSQSEVKCLMLQLLEGI 527
HP+IV +E + ++++VM+Y E DL + + F + ++ +Q+ +
Sbjct: 57 KHPNIVQYQESFEENG--NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
K++HD +LHRD+K+ N+ L G +K+ DFG+AR S ++ + T +Y +PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173
Query: 588 GSKQYSTAIDMWSLGCIMAELLS 610
++ Y+ D+W+LGC++ E+ +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 86/304 (28%), Positives = 147/304 (48%), Gaps = 50/304 (16%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
E KI EG+ G+V AR+K +G VA+K + + K++ L E+ I+ + H ++
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHQNV 80
Query: 475 VDV-KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLHD 532
V++ K +VG L +++ME+++ L + + Q ++ ++ + +L+ + YLH
Sbjct: 81 VEMYKSYLVGEEL---WVLMEFLQGG--ALTDIVSQTRLNEEQIATVCESVLQALCYLHS 135
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
V+HRD+K+ ++LL G +K+ DFG Q + LV T ++ APE++ Y
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
T +D+WSLG ++ E++ EP P FS P V
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEP--------------------------PYFSDSP---VQA 225
Query: 653 IKHQYNLLRKKFPAT---SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+K LR P + SPVL D L +LT +P +R TA+ L+H + +
Sbjct: 226 MKR----LRDSPPPKLKNAHKISPVLRD----FLERMLTREPQERATAQELLDHPFLLQT 277
Query: 710 PLPK 713
LP+
Sbjct: 278 GLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 63/205 (30%), Positives = 113/205 (55%), Gaps = 10/205 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++FE + +I GTYG VY+AR+ TGE+ A+K +K+E E F + +EI ++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQ-QEIIMMKDCKHS 66
Query: 473 SIVDVKEVVVGSNL--DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+IV GS L D +++ ME+ + + P S+S++ + + L+G+ YL
Sbjct: 67 NIV----AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H +HRD+K +N+LL + G +K+ DFG++ Q + + + T ++ APE+ +
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 591 Q--YSTAIDMWSLGCIMAELLSKEP 613
+ Y+ D+W++G EL +P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 66/213 (30%), Positives = 120/213 (56%), Gaps = 8/213 (3%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV-K 478
KI EG+ G+V A +K TG+ VA+KK+ + K++ L E+ I+ +HH ++VD+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENVVDMYN 86
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
+VG D +++VME++E + T + ++ ++ + L +L + YLH+ V+HR
Sbjct: 87 SYLVG---DELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
D+K+ ++LL + G +K+ DFG Q + LV T ++ APE ++ Y T +D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDI 201
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631
WSLG ++ E++ EP + + + +I L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ L+++ EG G V + R K TG I ALK + LRE+ I S P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCL---MLQLLEGIK 528
IV + + SI + MEY E L + + +K+ + K L +L+G+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-KPYTHLVVTLWYRAPELLL 587
YLH ++HRD+K SN+LL +G++K+CDFG++ + + L +T T +Y APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQ 176
Query: 588 GSKQYSTAIDMWSLGCIMAEL 608
G K YS D+WSLG + E+
Sbjct: 177 G-KPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 80/268 (29%), Positives = 136/268 (50%), Gaps = 37/268 (13%)
Query: 417 RLNK-IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFP--LTSLR-EINILLSFHHP 472
R K + +G +G VY D TG +A+K+V + + + +L EI +L + H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYME----HD-LK---GLMETMKQPFSQSEVKCLMLQLL 524
IV + SIFM EYM D LK L ET+ + +++ Q+L
Sbjct: 65 RIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTR--------QIL 114
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ------YGSPLKPYTHLVVTL 578
EG++YLH N ++HRD+K +N+L ++ G +K+ DFG +++ G+ +K T T
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG---TP 171
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
++ +PE++ G + Y D+WS+GC + E+L+++P + EF+ + IFK P
Sbjct: 172 YWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPQ 227
Query: 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPA 666
P S + NF++ + KK P+
Sbjct: 228 LP--SHVSPDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 67/235 (28%), Positives = 131/235 (55%), Gaps = 17/235 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFH 470
+ +E + ++ +G +G VY+A++K+TG + A K + K E+E E + + EI+IL S
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY----MVEIDILASCD 60
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+IV + + N ++++++E+ + +M +++P ++ +++ + Q LE + Y
Sbjct: 61 HPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL-- 587
LH+N ++HRDLK N+L G++K+ DFG++ + ++ + T ++ APE+++
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 588 --GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK----TLGTPNE 636
+ Y D+WSLG + E+ EP + + L KI K TL P+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 86/345 (24%), Positives = 139/345 (40%), Gaps = 76/345 (22%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINILLS 468
D+FE + I G +G V+ RDK TG++ A+K ++ +++ + E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA---ERDILAD 57
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
P IV K + + +++VMEYM DL L+ K F + + + +L+ +
Sbjct: 58 ADSPWIV--KLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARFYIAELVLAL 114
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS--------------------- 566
+H +HRD+K N+L++ G +K+ DFGL ++
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 567 ----PLKPYTHL----VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK 618
K V T Y APE+L G Y D WSLG I+ E+L P F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 619 SEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDA 678
+ T N KI +N+ + FP P +S
Sbjct: 234 T----------LQETYN-KI-----------INWKESLR------FPPD-----PPVSPE 260
Query: 679 GFDLLNSLLTYDPDKRIT-AEAALNHDWFREVPLPKSKDFMPTFP 722
DL+ LL DP+ R+ E +H +F+ + ++ P F
Sbjct: 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFV 304
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 81/298 (27%), Positives = 139/298 (46%), Gaps = 48/298 (16%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL--REINILLSFHH 471
++ R KI +G G VY A D TG+ VA+K++ ++++ P L EI ++ H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKH 75
Query: 472 PSIVD-VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGIKY 529
P+IV+ + +VG D +++VMEY+ L + + + + ++ + + L+ +++
Sbjct: 76 PNIVNYLDSYLVG---DELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 189
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
K Y +D+WSLG + E++ EP + ++ L I T GTP
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPE-------------- 234
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
LS D LN L D +KR +A+ L H + +
Sbjct: 235 -------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 70/235 (29%), Positives = 129/235 (54%), Gaps = 15/235 (6%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ R KI +G G V+ A D TG+ VA+K++ ++K+ + + + EI ++ +P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPN 77
Query: 474 IVD-VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLH 531
IV+ + +VG D +F+VMEY+ L + + + ++++ + + L+ +++LH
Sbjct: 78 IVNFLDSFLVG---DELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++ K
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKA 191
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN----EKIWPGF 642
Y +D+WSLG + E++ EP + ++ L + T GTP EK+ P F
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQNPEKLSPIF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 10/210 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ L + EG++G + + + A+K++++ K S +E +L HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPN 59
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP----FSQSEVKCLMLQLLEGIKY 529
IV KE +++VMEY D LM+ +K F + + +Q+ G+++
Sbjct: 60 IVAFKESFEADG--HLYIVMEYC--DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+H+ VLHRD+K+ N+ L G++K+ DFG AR SP V T +Y PE + +
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWEN 174
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
Y+ D+WSLGCI+ EL + + F S
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 81/296 (27%), Positives = 143/296 (48%), Gaps = 42/296 (14%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV-K 478
KI EG+ G+V A K +G++VA+KK+ + K++ L E+ I+ + H ++V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 84
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
+VG D +++VME++E + T + ++ ++ + L +L+ + LH V+HR
Sbjct: 85 SYLVG---DELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
D+K+ ++LL + G +K+ DFG Q + LV T ++ APE L+ Y +D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDI 199
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658
WSLG ++ E++ EP + F++ P + ++ N N
Sbjct: 200 WSLGIMVIEMVDGEPPY-----FNE----------------PPLKAMKMIRDNLPPKLKN 238
Query: 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
L + SP L GF L+ LL DP +R TA L H + + P
Sbjct: 239 LHKV---------SPSLK--GF--LDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 7e-23
Identities = 64/223 (28%), Positives = 123/223 (55%), Gaps = 11/223 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ R KI +G G VY A D TG+ VA++++ ++++ + + + EI ++ +P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPN 78
Query: 474 IVD-VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLH 531
IV+ + +VG D +++VMEY+ L + + + + ++ + + L+ +++LH
Sbjct: 79 IVNYLDSYLVG---DELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++ K
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKA 192
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
Y +D+WSLG + E++ EP + ++ L + T GTP
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 64/242 (26%), Positives = 127/242 (52%), Gaps = 20/242 (8%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGE-IVALKKV--------KMEKEREGFPLTSLREIN 464
E+ L + G +G VY+ R K G+ ++ALK++ K ++ER+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 465 ILL-SFHHPSIVDVKEVVVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCL 519
I+ HP+IV + + + D +++VM+ +E + ++ KQ F++ + +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 520 MLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL 578
+Q++ ++YLH + ++HRDL +N++L ++ I DFGLA+Q K T +V T+
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTI 177
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP-NEK 637
Y PE ++ ++ Y D+W+ GCI+ ++ + +P F + KI + + P E
Sbjct: 178 LYSCPE-IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236
Query: 638 IW 639
++
Sbjct: 237 MY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 69/233 (29%), Positives = 119/233 (51%), Gaps = 30/233 (12%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI-LLSF 469
+++ E L +I GT G VY+ R KKTG ++A+K+++ +E L ++++ L S
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI-LMDLDVVLKSH 71
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
P IV + ++ D +F+ ME M L L++ ++ P + + + + +++ + Y
Sbjct: 72 DCPYIVKCYGYFI-TDSD-VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 530 LHDNW-VLHRDLKTSNLLLNNRGELKICDFGLA----------RQYGSPLKPYTHLVVTL 578
L + V+HRD+K SN+LL+ G +K+CDFG++ R G
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA---------- 179
Query: 579 WYRAPELLLGSK---QYSTAIDMWSLGCIMAELLSKE-PLFNGKSEFDQLDKI 627
Y APE + +Y D+WSLG + EL + + P N K+EF+ L KI
Sbjct: 180 -YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 65/223 (29%), Positives = 122/223 (54%), Gaps = 11/223 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++ R KI +G G VY A D TG+ VA+K++ ++++ + + + EI ++ +P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPN 77
Query: 474 IVD-VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLH 531
IV+ + +VG D +++VMEY+ L + + + + ++ + + L+ + +LH
Sbjct: 78 IVNYLDSYLVG---DELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++ K
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKA 191
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
Y +D+WSLG + E++ EP + ++ L + T GTP
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 10/204 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
++E + ++ GTYG VY+AR+ TGE+ A+K +K+E + F L +EI ++ H +
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQ-QEIFMVKECKHCN 67
Query: 474 IVDVKEVVVGSNL--DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
IV GS L + +++ MEY + + P S+ ++ + + L+G+ YLH
Sbjct: 68 IV----AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+HRD+K +N+LL + G++K+ DFG+A + + + + T ++ APE+ K
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 592 --YSTAIDMWSLGCIMAELLSKEP 613
Y+ D+W++G EL +P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F +L +I +G++G V++ D +T ++VA+K + +E+ + +EI +L P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 64
Query: 475 VDVKEVVVGSNL--DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
GS L ++++MEY+ L PF + ++ ++ ++L+G+ YLH
Sbjct: 65 TKY----YGSYLKGTKLWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+HRD+K +N+LL+ +G++K+ DFG+A Q V T ++ APE++ S Y
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-Y 178
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
+ D+WSLG EL EP PN + P ++V F
Sbjct: 179 DSKADIWSLGITAIELAKGEP--------------------PNSDMHP-------MRVLF 211
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
L K + TG S + +++ L DP R TA+ L H +
Sbjct: 212 -------LIPKNNPPTLTGE--FSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 417 RLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKE---REGFPLTSLREINILLSF 469
+ ++ EG +G V R TGE VA+K + E R F REI IL +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE----REIEILRTL 63
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
H +IV K V S+ ++MEY+ L+ ++ + + + Q+ +G+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--------QYGSPLKPYTHLVVTLWY 580
YL +HRDL N+L+ + +KI DFGLA+ Y WY
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP----IFWY 179
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
APE L SK +S+A D+WS G + EL +
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 421 IDEGTYGVVYRARDKKTGE---IVALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
I G +G V R R K G+ VA+K +K +K+R F L E +I+ F HP+I
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNI 67
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+ ++ VV S + ++ EYME+ L + F+ ++ ++ + G+KYL +
Sbjct: 68 IRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRAPELLLGSK 590
+HRDL N+L+N+ K+ DFGL+R+ YT + W APE + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPE-AIAYR 183
Query: 591 QYSTAIDMWSLGCIMAELLS 610
++++A D+WS G +M E++S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-22
Identities = 65/235 (27%), Positives = 126/235 (53%), Gaps = 17/235 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK--KVKMEKEREGFPLTSLREINILLSFH 470
+ +E + ++ +G +G VY+A++K+TG + A K + K E+E E + + EI IL + +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY----MVEIEILATCN 67
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP IV + +++++E+ + +M + + ++ +++ + Q+LE ++Y
Sbjct: 68 HPYIVKLLGAFYWDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL--- 586
LH ++HRDLK N+LL G++K+ DFG++ + L+ + T ++ APE++
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 587 -LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK----TLGTPNE 636
+ Y D+WSLG + E+ EP + + L KI K TL P++
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 72/245 (29%), Positives = 127/245 (51%), Gaps = 39/245 (15%)
Query: 417 RLNKI-DEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR------EINILLSF 469
RL K+ +G +G VY D TG +A+K+V+ + E P TS EI +L +
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNL 61
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYM-----EHDLK---GLMETMKQPFSQSEVKCLML 521
H IV + ++ + ME+M + LK L E + + +++
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-------- 113
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY------GSPLKPYTHLV 575
Q+LEG+ YLH N ++HRD+K +N+L ++ G +K+ DFG +++ G+ +K T
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG-- 171
Query: 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
T ++ +PE++ G + Y D+WS+GC + E+L+++P + +EF+ + IFK P
Sbjct: 172 -TPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
Query: 636 EKIWP 640
+ P
Sbjct: 227 NPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-21
Identities = 94/367 (25%), Positives = 168/367 (45%), Gaps = 54/367 (14%)
Query: 363 YMEIDEDHNNNDSVGGSDTDSEDENDSCGTP--EPAGPPQRSINMLQGCRSVDEFERLNK 420
Y +I + + S S ++S+D++D P + A S+ + +
Sbjct: 25 YSDISDG-DLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLG----------YTVIKT 73
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
+ G+ G V+ A + V LK G T+L E +L + +HPS++ +K+
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSVIRMKDT 125
Query: 481 VVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL 540
+V + MV+ + DL + +P + + Q+LEG++YLH ++HRD+
Sbjct: 126 LVSGAITC--MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDV 183
Query: 541 KTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWS 600
KT N+ +N+ ++ I D G A Q+ + L T+ APE+L K Y++ D+WS
Sbjct: 184 KTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADIWS 241
Query: 601 LGCIMAELLS-------------KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
G ++ E+L+ +E + + S L KI TL E+ F + PG
Sbjct: 242 AGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS---HLLKIISTLKVHPEE----FPRDPG 294
Query: 648 VKV--NFIKHQYNLLRK---KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
++ FI +L R+ ++P P+ D F L++ +LT+D R +AE LN
Sbjct: 295 SRLVRGFI-EYASLERQPYTRYPCFQRVNLPI--DGEF-LVHKMLTFDAAMRPSAEEILN 350
Query: 703 HDWFREV 709
+ F ++
Sbjct: 351 YPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR---EINILLSFHHPSIVD 476
++ +G++G VY +DKK LK +K E P +++ E +L HP+IV
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 477 VKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQP---FSQSEVKCLMLQLLEGIKYLHD 532
+ D+ ++ EY E DL +E +K S+++V +QLL G+ Y+H
Sbjct: 67 FHASFLER--DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+LHRDLK N+ L N LKI DFG++R T T +Y +PE L + Y
Sbjct: 125 RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGY 182
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKS 619
+ D+WSLGCI+ E+ F G++
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQN 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 86/328 (26%), Positives = 139/328 (42%), Gaps = 51/328 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLS 468
+F+ + + G +G V R+K TG+I A+K +K +E F E +IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSF---FEEERDILSI 57
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
+ P I ++ D++++VMEY DL L+ + F + + + +L+ I
Sbjct: 58 SNSPWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELL 586
+H +HRD+K N+L++ G +K+ DFG A + + + L V T Y APE+L
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 587 L-----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
G Y D WSLG I E++ G+S F + KT
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIY------GRSPFHE-GTSAKTYN--------- 219
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
N + Q L KFP P +S DL+ SLL +R+ E
Sbjct: 220 ---------NIMNFQRFL---KFPE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261
Query: 702 NHDWFREVPLPKSKDFMPTF-PAQHAQD 728
H +F ++ ++ +P F P + D
Sbjct: 262 CHPFFSKIDWNNIRNSLPPFVPTLKSDD 289
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F +L KI +G++G V++ D +T ++VA+K + +E+ + +EI +L P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 64
Query: 475 VDVKEVVVGSNLD--SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
GS L ++++MEY+ L P ++++ ++ ++L+G+ YLH
Sbjct: 65 TKY----YGSYLKDTKLWIIMEYLGGG-SALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+HRD+K +N+LL+ GE+K+ DFG+A Q V T ++ APE++ S Y
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-Y 178
Query: 593 STAIDMWSLGCIMAELLSKEP 613
+ D+WSLG EL EP
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 81/338 (23%), Positives = 139/338 (41%), Gaps = 84/338 (24%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLR-EINILLS 468
F+++ + +G G V+ R K TG++ ALK K +M K + + + E IL +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK---VKRVLTEQEILAT 57
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEY-MEHDLKGLMETMKQP---FSQSEVKCLMLQLL 524
HP + + + +VM+Y +L L++ +QP S+ + ++L
Sbjct: 58 LDHPFLPTLYASFQTE--TYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVL 113
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP----------------L 568
++YLH +++RDLK N+LL+ G + + DF L++Q +
Sbjct: 114 LALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 569 KPYTHLVV-------------TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF 615
T Y APE++ G + +A+D W+LG ++ E+L F
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232
Query: 616 NGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVL 675
G + D+ F N+L+K+ +F GSP +
Sbjct: 233 KGSNR----DETF----------------------------SNILKKEV---TFPGSPPV 257
Query: 676 SDAGFDLLNSLLTYDPDKRI----TAEAALNHDWFREV 709
S + DL+ LL DP KR+ A H +FR V
Sbjct: 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 62/202 (30%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F +L +I +G++G VY+ D +T E+VA+K + +E+ + +EI +L P I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYI 64
Query: 475 VDVKEVVVGSNLDS--IFMVMEYMEHDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLH 531
GS L ++++MEY+ ++ +K P ++ + ++ ++L+G+ YLH
Sbjct: 65 TRY----YGSYLKGTKLWIIMEYLGGG--SALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+HRD+K +N+LL+ +G++K+ DFG+A Q V T ++ APE++ S
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA- 177
Query: 592 YSTAIDMWSLGCIMAELLSKEP 613
Y D+WSLG EL EP
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 75/316 (23%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
DE E L+++ +G YG VY+ + TG +A+K++++E + F + E++IL P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSP 59
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVK------CLMLQLLEG 526
IVD +++M MEYM+ G ++ + +E + +++G
Sbjct: 60 YIVDFYGAFFIEG--AVYMCMEYMD---AGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114
Query: 527 IKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW------ 579
+K+L + ++HRD+K +N+L+N G++K+CDFG++ LV +L
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----------LVASLAKTNIGC 164
Query: 580 --YRAPELL-----LGSKQYSTAIDMWSLGCIMAELLSKE---PLFNGKSEFDQLDKIFK 629
Y APE + + Y+ D+WSLG + E+ P + F QL I
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224
Query: 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTY 689
G P P LP SD D + L
Sbjct: 225 --GDP-----PT---LP--------------------------SGYSDDAQDFVAKCLNK 248
Query: 690 DPDKRITAEAALNHDW 705
P++R T L H W
Sbjct: 249 IPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 84/303 (27%), Positives = 125/303 (41%), Gaps = 66/303 (21%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR-EINILL---SFHHPSIVDVKE 479
G +G V A KKTGE+ A+K +K + SL E I S HP +V
Sbjct: 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV---- 65
Query: 480 VVVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
NL D + VMEY DL +M FS+ ++ G++YLH
Sbjct: 66 -----NLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+N +++RDLK NLLL+ G +KI DFGL ++ + T + APE+L
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TS 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
Y+ A+D W LG ++ E+L E F G E + D I +E +P F
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRF--------- 223
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWF 706
LS ++ LL +P++R+ AE +F
Sbjct: 224 -----------------------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
Query: 707 REV 709
R++
Sbjct: 261 RDI 263
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 74/301 (24%), Positives = 134/301 (44%), Gaps = 57/301 (18%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINIL-LSFHHPSIVDV 477
+ +G++G V A K T E+ A+K +K + + + T + E +L L+ HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLTQL 61
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDN 533
D +F VMEY + G LM +++ F + + +++ G+++LH+
Sbjct: 62 HSCF--QTKDRLFFVMEY----VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
+++RDLK N+LL++ G +KI DFG+ ++ + T Y APE+L Y
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YG 174
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
A+D W+LG ++ E+L+ + F G E + I + +V +
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------------EVRYP 216
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWFRE 708
+ LS +L S LT +P+KR+ + H +FRE
Sbjct: 217 RW-------------------LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
Query: 709 V 709
+
Sbjct: 258 I 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 15/235 (6%)
Query: 392 TPEPAGPPQRSINMLQGCR---SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM 448
+ S S+ E ER+N+I G G VY+ + TG + ALK +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 449 EKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMK 508
E + REI IL +HP++V ++ + I +++E+M+ G +E
Sbjct: 110 NHE-DTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMD---GGSLEG-T 162
Query: 509 QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568
+ + + Q+L GI YLH ++HRD+K SNLL+N+ +KI DFG++R +
Sbjct: 163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222
Query: 569 KPYTHLVVTLWYRAPELL---LGSKQYS-TAIDMWSLGCIMAEL-LSKEPLFNGK 618
P V T+ Y +PE + L Y A D+WSLG + E L + P G+
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
+ + +G+YG V R + G+ +KK+ + + +E +L HP+IV
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 478 KEVVVGSNLDSIFMVMEYME-----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+E G + +++VM + E H LK E + +++V +Q+ ++YLH+
Sbjct: 65 RESWEGED-GLLYIVMGFCEGGDLYHKLK---EQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+LHRDLKT N+ L +K+ D G+AR + + L+ T +Y +PE L +K Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPY 179
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGK 618
+ D+W+LGC + E+ + + FN K
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 69/240 (28%), Positives = 123/240 (51%), Gaps = 38/240 (15%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR------EINILLSFHHPSI 474
+ +G +G VY D TG +A K+V+ + E P TS EI +L + H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERI 66
Query: 475 VDVKEVVVGSNLDSIFMVMEYM-----EHDLKG---LMETMKQPFSQSEVKCLMLQLLEG 526
V + ++ + MEYM + LK L E++ + +++ Q+LEG
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR--------QILEG 118
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY------GSPLKPYTHLVVTLWY 580
+ YLH N ++HRD+K +N+L ++ G +K+ DFG +++ G+ ++ T T ++
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYW 175
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
+PE++ G + Y D+WSLGC + E+L+++P + +E++ + IFK P P
Sbjct: 176 MSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D+FE+L ++ G GVV + + +G I+A K + +E + +RE+ +L + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSP 59
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE--VKCLMLQLLEGIKYL 530
IV SI ME+M D L + +K+ E + + + +L G+ YL
Sbjct: 60 YIVGFYGAFYSDGEISI--CMEHM--DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL 115
Query: 531 HDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ ++HRD+K SN+L+N+RGE+K+CDFG++ Q + V T Y +PE L G+
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGT 173
Query: 590 KQYSTAIDMWSLGCIMAELL 609
Y+ D+WSLG + E+
Sbjct: 174 -HYTVQSDIWSLGLSLVEMA 192
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 86/308 (27%), Positives = 139/308 (45%), Gaps = 61/308 (19%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREIN----ILLSF 469
+FE + G++G V A+ K TGE A+K +K +RE + ++ + IL+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK---KREILKMKQVQHVAQEKSILMEL 75
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP---FSQSEVKCLMLQLLEG 526
HP IV++ N ++ ++E++ + G + T + F K +L+
Sbjct: 76 SHPFIVNMMCSFQDEN--RVYFLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLA 130
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+YLH +++RDLK NLLL+N+G +K+ DFG A++ P + +T L T Y APE +
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRTFT-LCGTPEYLAPE-V 186
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
+ SK + A+D W++G ++ E ++ P F FD D F+ EKI G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF-----FD--DTPFRIY----EKILAG----- 230
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAAL 701
R KFP + A DL+ LL D KR+
Sbjct: 231 --------------RLKFP------NWFDGRAR-DLVKGLLQTDHTKRLGTLKGGVADVK 269
Query: 702 NHDWFREV 709
NH +F
Sbjct: 270 NHPYFHGA 277
|
Length = 329 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 52/304 (17%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKV------KMEKEREGFPLTSLREINILL 467
E+ + + +G YG VY G+++A+K+V + E+E L E+++L
Sbjct: 1 EWTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLK 57
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
S H +IV + N SIFM E++ + P + Q+L+G+
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ------YGSPLKPYTHLVVTLWYR 581
YLH+N V+HRD+K +N++L G +K+ DFG AR+ +G+ + T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
APE++ S Y D+WS+GC + E+ + +P + D+L +F I
Sbjct: 176 APEVINESG-YGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF--------YIGAH 223
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
+P + +F S A D + S LT D +R +A L
Sbjct: 224 RGLMPRLPDSF-----------------------SAAAIDFVTSCLTRDQHERPSALQLL 260
Query: 702 NHDW 705
HD+
Sbjct: 261 RHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHPSIVDVK 478
+ +G +G V + K TG++ A KK+ K K+R+G + +L E IL IV +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM-ALNEKKILEKVSSRFIVSLA 59
Query: 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLHDNWVL 536
D + +VM M DLK + + +P F ++ Q++ G+++LH ++
Sbjct: 60 YAF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+RDLK N+LL++ G ++I D GLA + G +K T Y APE+L G + Y
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQG-EVYDF 173
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSE 620
++D ++LGC + E+++ F + E
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 51/294 (17%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINILLSFHHPSIVDVKEV 480
+G++G V A K T E A+K +K + E + T + + L++ HP + +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL--F 62
Query: 481 VVGSNLDSIFMVMEYMEHDLKG--LMETMKQP--FSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ +F VMEY L G LM ++ F ++ + +++ G+++LH ++
Sbjct: 63 CTFQTKEHLFFVMEY----LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK N+LL+ G +KI DFG+ ++ + + T Y APE+L G K Y+ ++
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESV 177
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
D WS G ++ E+L + F+G+ E D++F ++ N++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDE----DELFDSI--LNDRPH----------------- 214
Query: 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL-NHDWFREV 709
FP +S D L+ L DP KR+ + + H +FR +
Sbjct: 215 -------FPRW-------ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 20/220 (9%)
Query: 420 KIDEGTYGVVYRAR-DKKTGEI--VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476
K+ +G++GVV R G++ VA+K +K +K + L+E I+ S H +++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIR 60
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP----FSQSEVKCLMLQLLEGIKYLHD 532
+ VV+ + MV E L L++ +++ F S + +Q+ G++YL
Sbjct: 61 LYGVVLT---HPLMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT---HLVVTLWYRAPELLLGS 589
+HRDL N+LL + ++KI DFGL R Y HL V + APE L +
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRT 174
Query: 590 KQYSTAIDMWSLGCIMAELLS--KEPLFNGKSEFDQLDKI 627
+ +S A D+W G + E+ + +EP + G S L KI
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 415 FERLNKIDEGTYGVV----YRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH 470
+R+ + EG +G V Y TGE VA+K +K E +EI IL + +
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY 64
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
H +IV K + + I ++ME++ LK + K + + +Q+ +G+ Y
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT---HLVVTLWYRAPELL 586
L +HRDL N+L+ + ++KI DFGL + + + YT L +++ APE L
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 587 LGSKQYSTAIDMWSLGCIMAELLS 610
+ SK Y A D+WS G + ELL+
Sbjct: 185 IQSKFY-IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ E ++ + G G V + + TG ++A K V + + LRE+ I+ P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-VRKQILRELQIMHECRSP 63
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
IV + N +I M ME+M+ L + + P + + + ++EG+ YL+
Sbjct: 64 YIVSFYGAFLNEN--NICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY 120
Query: 532 D-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
+ + ++HRD+K SN+L+N+RG++K+CDFG++ + + + V T Y +PE + G K
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGK 178
Query: 591 QYSTAIDMWSLGCIMAELL 609
Y+ D+WSLG + EL
Sbjct: 179 -YTVKSDVWSLGISIIELA 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 63/231 (27%), Positives = 116/231 (50%), Gaps = 31/231 (13%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVK-----MEKEREGFPLTSLREINILLSFHHPSIVDV 477
+G++G V A K GE A+K +K ++ + E T + + + L++ +P + +
Sbjct: 5 KGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVE---CTMVEKRVLALAWENPFLTHL 61
Query: 478 KEVVVGSNLDSIFMVMEYMEH-DL------KGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ +F VME++ DL KG + + F +E+ C G+++L
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-------GLQFL 112
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H +++RDLK N++L+ G +KI DFG+ ++ + T Y APE+L G K
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL--GTPNEKIW 639
Y+ ++D WS G ++ E+L + F+G E D++F+++ TP+ W
Sbjct: 173 -YTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFESIRVDTPHYPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 423 EGTYGVV----YRARDKKTGEIVALKKVKME---KEREGFPLTSLREINILLSFHHPSIV 475
EG +G V Y + TGE+VA+K +K E + G+ +EINIL + +H +IV
Sbjct: 14 EGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHENIV 69
Query: 476 DVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNW 534
K + ++MEY+ L L + + K + +++ Q+ EG+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV---------TLWYRAPEL 585
+HRDL N+LL+N +KI DFGLA+ P H WY A E
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSK 611
L +K +S A D+WS G + ELL+
Sbjct: 182 LKENK-FSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 65/239 (27%), Positives = 115/239 (48%), Gaps = 39/239 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM-----EKEREGFPLTSLREINILL 467
D+ E + ++ G YGVV + R TG I+A+K+++ E++R L +++I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKR------LLMDLDISM 54
Query: 468 -SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP---FSQSEVKCLMLQL 523
S P V + +++ ME M+ L + + + + + + +
Sbjct: 55 RSVDCPYTVTFYGALFREG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 524 LEGIKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFG--------LARQYGSPLKPYTHL 574
++ ++YLH V+HRD+K SN+L+N G++K+CDFG +A+ + KPY
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYM-- 170
Query: 575 VVTLWYRAPELL---LGSKQYSTAIDMWSLGCIMAEL-LSKEPLFNGKSEFDQLDKIFK 629
APE + L K Y D+WSLG M EL + P + K+ F QL ++ +
Sbjct: 171 -------APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM-EKEREGFPLTSLREINILLSF-HHP 472
FE + + GTYG VY+ R KTG++ A+K + + E E E L EIN+L + HH
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHR 73
Query: 473 SIVD-----VKEVVVGSNLDSIFMVMEYM-EHDLKGLMETMK-QPFSQSEVKCLMLQLLE 525
+I +K+ G + D +++VME+ + L++ K + + + ++L
Sbjct: 74 NIATYYGAFIKKSPPGHD-DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+ +LH + V+HRD+K N+LL E+K+ DFG++ Q + + T ++ APE+
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 586 LLGSKQ----YSTAIDMWSLGCIMAELLSKEP 613
+ + Y D+WSLG E+ P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 26/202 (12%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINIL---LSFHHPSIVD 476
I +GT+G VY+ R K T I A+K + K E + ++ E NIL L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 477 VK-EVVVGSNLDSIFMVMEYM---------EHDLKGLMETMKQPFSQSEVKCLMLQLLEG 526
+K S+L ++V +YM + + + FS+ K + +L+
Sbjct: 61 LKFSFQTDSDL---YLVTDYMSGGELFWHLQKEGR---------FSEDRAKFYIAELVLA 108
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+++LH +++RDLK N+LL+ G + +CDFGL++ + K T Y APE+L
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 587 LGSKQYSTAIDMWSLGCIMAEL 608
L K Y+ +D WSLG ++ E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 419 NKIDEGTYGVV----YRARDKKTGEIVALKKVKMEKEREG---FPLTSLREINILLSFHH 471
++ G +G V Y + K E VA+K +K E G F LRE +++ H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEF----LREASVMAQLDH 55
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
P IV + V G + + +VME LK L + ++ S++K L Q+ G+ Y
Sbjct: 56 PCIVRLIGVCKG---EPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAY 110
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-------------PLKPYTHLVV 576
L +HRDL N+LL NR + KI DFG++R G+ PLK
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------- 163
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
WY APE + K +S+ D+WS G + E S
Sbjct: 164 --WY-APECINYGK-FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 418 LNKIDEGTYGVV----YRARDKKTGEIVALKKVK--MEKEREGFPLTSLREINILLSFHH 471
+ ++ +G +G V Y TGE+VA+KK++ + F REI IL S H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE----REIEILKSLQH 64
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+IV K V + ++ +VMEY+ + L+ ++ ++ ++ Q+ +G++YL
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLA------------RQYG-SPLKPYTHLVVT 577
+HRDL T N+L+ + +KI DFGL R+ G SP+
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--------- 175
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
WY APE L SK +S A D+WS G ++ EL +
Sbjct: 176 FWY-APESLTESK-FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 67/221 (30%), Positives = 115/221 (52%), Gaps = 31/221 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINILLS 468
D +E + I +GTYG VY+ +KK G + A+K + +++E E E NIL S
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA-------EYNILQS 74
Query: 469 F-HHPSIVDV------KEVVVGSNLDSIFMVMEY-----MEHDLKGLMETMKQPFSQSEV 516
+HP++V + +VG L ++V+E + +KGL+ Q ++ +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQL---WLVLELCNGGSVTELVKGLLIC-GQRLDEAMI 130
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
++ L G+++LH+N ++HRD+K +N+LL G +K+ DFG++ Q S V
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 577 TLWYRAPELLLGSKQYSTA----IDMWSLGCIMAELLSKEP 613
T ++ APE++ +QY + D+WSLG EL +P
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS--LREINILLSFH 470
E + +I G +G+V+ G + +KV ++ REG + E +++
Sbjct: 4 SELTLVQEIGSGQFGLVWL------GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP +V + V + I +V E+MEH L + + FSQ + + L + EG+ Y
Sbjct: 58 HPKLVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGSPLKPYTHLVVTLWYRAPE 584
L + V+HRDL N L+ +K+ DFG+ R QY S T + + +PE
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS----TGTKFPVKWSSPE 171
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSK 611
+ SK YS+ D+WS G +M E+ S+
Sbjct: 172 VFSFSK-YSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 62/220 (28%), Positives = 116/220 (52%), Gaps = 19/220 (8%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVK-----MEKEREGFPLTSLREINIL-LSFHHPSIVD 476
+G++G V+ A K T + A+K +K M+ + E ++ E +L L++ HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSLAWEHPFLTH 60
Query: 477 VKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ +++F VMEY+ DL +++ + F +++ G+++LH +
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSKGI 117
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
++RDLK N+LL+ G +KI DFG+ ++ T Y APE+LLG K Y+T+
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTS 176
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
+D WS G ++ E+L + F+G E +++F+++ N
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMDN 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPS 473
FE + + GTYG VY+ R KTG++ A+K + + + E +EIN+L + HH +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRN 64
Query: 474 IVDVKEVVVGSNL----DSIFMVMEYM-EHDLKGLMETMK-QPFSQSEVKCLMLQLLEGI 527
I + N D +++VME+ + L++ K + + + ++L G+
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
+LH + V+HRD+K N+LL E+K+ DFG++ Q + + T ++ APE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 588 GSKQ----YSTAIDMWSLGCIMAELLSKEP 613
+ Y D+WSLG E+ P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 87/324 (26%), Positives = 138/324 (42%), Gaps = 56/324 (17%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIVD 476
+ +GT+G V R+K +G+ A+K +K E K+ LT R +L + HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESR---VLKNTRHPFLTS 59
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
+K D + VMEY+ + ++ FS+ + +++ + YLH ++
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK NL+L+ G +KI DFGL ++ + T Y APE +L Y A+
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAV 176
Query: 597 DMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
D W LG +M E++ + P +N E K+F+ + E I
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM--EDI----------------- 212
Query: 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVP 710
KFP T LS LL+ LL DP+KR+ A+ + H +F V
Sbjct: 213 -------KFPRT-------LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258
Query: 711 LPK--SKDFMPTFPAQHAQDRRMR 732
K +P F Q + R
Sbjct: 259 WQDVYDKKLVPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 83/300 (27%), Positives = 132/300 (44%), Gaps = 60/300 (20%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIVDVK 478
+GT+G V R+K TG+ A+K +K E K+ LT R +L + HP + +K
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR---VLQNTRHPFLTALK 61
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
D + VMEY + ++ FS+ + +++ + YLH V++R
Sbjct: 62 YSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 539 DLKTSNLLLNNRGELKICDFGLARQ---YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
DLK NL+L+ G +KI DFGL ++ G+ +K + T Y APE +L Y A
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAPE-VLEDNDYGRA 175
Query: 596 IDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654
+D W LG +M E++ + P +N E K+F+ + E+I
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM--EEI---------------- 212
Query: 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREV 709
+FP T LS LL LL DP +R+ A+ + H +F +
Sbjct: 213 --------RFPRT-------LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 68/244 (27%), Positives = 123/244 (50%), Gaps = 37/244 (15%)
Query: 417 RLNKI-DEGTYGVVYRARDKKTGEIVALKKVKM-----EKEREGFPLTSLREINILLSFH 470
RL K+ G +G VY D TG +A+K+V E +E L EI +L +
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC--EIQLLKNLR 62
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYM-----EHDLKG---LMETMKQPFSQSEVKCLMLQ 522
H IV + + + +EYM + LK L E + + +++ Q
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--------Q 114
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY------GSPLKPYTHLVV 576
+L+G+ YLH N ++HRD+K +N+L ++ G +K+ DFG +++ G+ +K T
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG--- 171
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
T ++ +PE++ G + Y D+WS+ C + E+L+++P + +E++ + IFK P +
Sbjct: 172 TPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
Query: 637 KIWP 640
+ P
Sbjct: 228 PMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 421 IDEGTYGVVYRARDKKTG--EI-VALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
I G +G V R K G EI VA+K +K EK+R F L E +I+ F HP+I
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPNI 67
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+ ++ VV S + +V EYME+ L + F+ ++ ++ + G+KYL D
Sbjct: 68 IHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKPYTHL--VVTLWYRAPELLLGSK 590
+HRDL N+L+N+ K+ DFGL+R P YT + + + APE + +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYR 184
Query: 591 QYSTAIDMWSLGCIMAELLS 610
++++A D+WS G +M E++S
Sbjct: 185 KFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKM-----EKEREGFPLTSLREINILLSFHHPSI 474
KI G + VYRA G VALKKV++ K R ++EI++L +HP++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA----DCIKEIDLLKQLNHPNV 64
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP---FSQSEVKCLMLQLLEGIKYL 530
+ + N + +V+E + DL +++ K+ + V +QL ++++
Sbjct: 65 IKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H V+HRD+K +N+ + G +K+ D GL R + S LV T +Y +PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHEN 181
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNG 617
Y+ D+WSLGC++ E+ + + F G
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 22/219 (10%)
Query: 423 EGTYGVVYRAR---DKKTGEIVA---LKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476
+G YG V++ R TG+I A LKK + + ++ T E NIL + HP IVD
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK-AERNILEAVKHPFIVD 64
Query: 477 -VKEVVVGSNLDSIFMVMEYMEHDLKG---LMETMKQPFSQSEVKCLML-QLLEGIKYLH 531
+ G L ++++EY L G M ++ + C L ++ +++LH
Sbjct: 65 LIYAFQTGGKL---YLILEY----LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLLGSK 590
+++RDLK N+LL+ +G +K+ DFGL ++ TH T+ Y APE+L+ S
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAPEILMRSG 176
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
+ A+D WSLG +M ++L+ P F ++ +DKI K
Sbjct: 177 -HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 16/213 (7%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM-----EKEREGFPLTSLREINILLS 468
F+ KI G + VYRA + VALKKV++ K R+ ++EI++L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ----DCVKEIDLLKQ 58
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP---FSQSEVKCLMLQLL 524
+HP+++ + + N + +V+E + DL +++ K+ + V +QL
Sbjct: 59 LNHPNVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
++++H V+HRD+K +N+ + G +K+ D GL R + S LV T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617
+ Y+ D+WSLGC++ E+ + + F G
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 85/316 (26%), Positives = 138/316 (43%), Gaps = 71/316 (22%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINILLS 468
D +E + I +GTYG V++ +KK G A+K + +++E E E NIL +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-------EYNILKA 70
Query: 469 FH-HPSIVDV------KEVVVGSNLDSIFMVMEYME----HDL-KGLM---ETMKQPFSQ 513
HP++V K+V G D +++V+E DL KG + E M++P
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNG---DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-- 125
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573
+ ++ + L G+++LH N +HRD+K +N+LL G +K+ DFG++ Q S
Sbjct: 126 --IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 574 LVVTLWYRAPELLLGSKQ----YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
V T ++ APE++ +Q Y D+WSLG EL +P ++ + +FK
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK 240
Query: 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTY 689
P + HQ L +F D + LT
Sbjct: 241 IPRNPPPTL----------------HQPELWSNEFN---------------DFIRKCLTK 269
Query: 690 DPDKRITAEAALNHDW 705
D +KR T L H +
Sbjct: 270 DYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEI-VALKKVKMEKE----REGFPLTSLREINILLS 468
E L ++ G +GVV+ K G+I VA +KM +E + F + E +++
Sbjct: 5 ELTFLKELGSGQFGVVHLG--KWRGKIDVA---IKMIREGAMSEDDF----IEEAKVMMK 55
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGI 527
HP++V + V + IF+V EYM + L + K + + + E +
Sbjct: 56 LSHPNLVQLYGVC--TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVV 576
+YL N +HRDL N L+ +K+ DFGLAR QY S P+K
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK------- 166
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ PE+ S+ +S+ D+WS G +M E+ S
Sbjct: 167 ---WAPPEVFDYSR-FSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 64/199 (32%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D+FER++++ G GVV + + K +G I+A K + +E + +RE+ +L + P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE--VKCLMLQLLEGIKYL 530
IV I + ME+M D L + +K+ E + + + +L G+ YL
Sbjct: 64 YIVGFYGAFYSDG--EISICMEHM--DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 531 HD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ + ++HRD+K SN+L+N+RGE+K+CDFG++ Q + V T Y +PE L G+
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGT 177
Query: 590 KQYSTAIDMWSLGCIMAEL 608
YS D+WS+G + EL
Sbjct: 178 -HYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 17/200 (8%)
Query: 421 IDEGTYGVVYRARDKKTGE---IVALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
I G +G V+R K G VA+K +K EK+R+ F L E +I+ F H +I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF----LSEASIMGQFSHHNI 68
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+ ++ VV + ++ EYME+ L + FS ++ ++ + G+KYL D
Sbjct: 69 IRLEGVV--TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKPYTHL--VVTLWYRAPELLLGSK 590
+HRDL N+L+N+ E K+ DFGL+R P YT + + + APE + +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYR 185
Query: 591 QYSTAIDMWSLGCIMAELLS 610
++++A D+WS G +M E++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 63/207 (30%), Positives = 111/207 (53%), Gaps = 23/207 (11%)
Query: 420 KIDE----GTYGVVYRARDKKTGE---IVALKKVK---MEKEREGFPLTSLREINILLSF 469
KI+E G +G V R R K G+ VA+K +K EK+R F L E +I+ F
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEASIMGQF 62
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+I+ ++ VV S + ++ E+ME+ L + F+ ++ ++ + G+K
Sbjct: 63 DHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLV---VTLWYRAP 583
YL + +HRDL N+L+N+ K+ DFGL+R + + YT + + + + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLS 610
E + +++++A D+WS G +M E++S
Sbjct: 181 E-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 72/300 (24%), Positives = 137/300 (45%), Gaps = 58/300 (19%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVK-----MEKEREGFPLTSLREINIL-LSFHHPSIVD 476
+G++G V AR K++G + A+K +K + + E ++ E IL L+ +HP +
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVE----CTMTEKRILSLARNHPFLTQ 60
Query: 477 VKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ D +F VME++ DL ++ ++ F ++ + ++ + +LHD +
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGI 117
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
++RDLK N+LL++ G K+ DFG+ ++ K + T Y APE +L Y +
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
+D W++G ++ E+L F ++E D + I +E ++P +
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTW------------- 218
Query: 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA------EAALNHDWFREV 709
LS D+L + +T +P R+ + EA L H +F+E+
Sbjct: 219 -------------------LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPL-TSLREINIL-LSFHHPSIVDVKEV 480
+G++G V A K T E+ A+K +K + + + ++ E IL L+ HP + +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC 64
Query: 481 VVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
D +F VMEY+ DL ++ ++ F + + ++ + +LH + V++RD
Sbjct: 65 F--QTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 540 LKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMW 599
LK N+LL+ G K+ DFG+ ++ T T Y APE +L +Y ++D W
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWW 180
Query: 600 SLGCIMAELLSKEPLFNGKSEFDQLDKI 627
+LG +M E+++ +P F +E D + I
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-17
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 15/216 (6%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG 483
G G V A+ GE A+K V ME E + E+ LL+ SIV E
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102
Query: 484 S------NLDSIFMVMEY-----MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
N+ I +V++Y + ++K +T + F + E L +Q+L + ++H
Sbjct: 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT--HLVVTLWYRAPELLLGSK 590
++HRD+K++N+LL + G +K+ DFG ++ Y + + T +Y APE+ K
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RK 220
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDK 626
YS DM+SLG ++ ELL+ + F+G++ + + K
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG 483
G G VY+A T I+A+K + ++ E + E+ IL P I+
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFYGAFFV 70
Query: 484 SNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTS 543
N I + E+M+ + + + + + + +++G+ YL +LHRD+K S
Sbjct: 71 EN--RISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSLKILHRDVKPS 124
Query: 544 NLLLNNRGELKICDFGLARQY-GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLG 602
N+L+N RG++K+CDFG++ Q S K Y V T Y APE + G +QY D+WSLG
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISG-EQYGIHSDVWSLG 180
Query: 603 CIMAEL 608
EL
Sbjct: 181 ISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIVDVK 478
+GT+G V R+K TG A+K ++ E K+ +T R +L + HP + +K
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR---VLQNTRHPFLTALK 61
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
D + VMEY + ++ F++ + +++ ++YLH V++R
Sbjct: 62 YAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
D+K NL+L+ G +KI DFGL ++ S T Y APE +L Y A+D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 599 WSLGCIMAELL-SKEPLFNGKSE 620
W LG +M E++ + P +N E
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 20/230 (8%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF 469
R +EF K+ G +G V+ K VA+K +K + + E+ L
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQK--EVQALKRL 59
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQPFSQSEVKCLML----QLL 524
H ++ + V + ++++ E ME KG L+ ++ P Q ++ Q+
Sbjct: 60 RHKHLISLFAVCSVG--EPVYIITELME---KGSLLAFLRSPEGQVLPVASLIDMACQVA 114
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-KPYTHLVVTLWYRAP 583
EG+ YL + +HRDL N+L+ K+ DFGLAR + + W AP
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAP 173
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSK----EPLFNGKSEFDQLDKIFK 629
E +ST D+WS G ++ E+ + P N +DQ+ ++
Sbjct: 174 E-AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 61/199 (30%), Positives = 109/199 (54%), Gaps = 11/199 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D+FE+++++ G GVV++ K +G I+A K + +E + +RE+ +L + P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 63
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE--VKCLMLQLLEGIKYL 530
IV I + ME+M D L + +K+ E + + + +++G+ YL
Sbjct: 64 YIVGFYGAFYSDG--EISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 531 HD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ + ++HRD+K SN+L+N+RGE+K+CDFG++ Q + V T Y +PE L G+
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGT 177
Query: 590 KQYSTAIDMWSLGCIMAEL 608
YS D+WS+G + E+
Sbjct: 178 -HYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 59/212 (27%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHP 472
F + +G +G V + + TG++ A KK+ K K+R+G + +L E IL +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKQILEKVNSR 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYL 530
+V + D++ +V+ M DLK + M P F + ++ G++ L
Sbjct: 61 FVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLG 588
H +++RDLK N+LL++ G ++I D GLA + G ++ V T+ Y APE ++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPE-VVK 174
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE 620
+++Y+ + D W LGC++ E++ + F + E
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKME---KEREGFPLTSLREINILLSFHHPSIVD 476
KI +G +G VY+ K E VA+K + + F L+E IL + HP+IV
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKF----LQEAEILKQYDHPNIV- 55
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE---GIKYLHDN 533
K + V I++VME + L+ +++ ++ VK L+ L+ G++YL
Sbjct: 56 -KLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQ-----YGS-------PLKPYTHLVVTLWYR 581
+HRDL N L+ LKI DFG++R+ Y P+K +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK----------WT 162
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSK 611
APE L +Y++ D+WS G ++ E S
Sbjct: 163 APE-ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-16
Identities = 76/249 (30%), Positives = 119/249 (47%), Gaps = 36/249 (14%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINI 465
G ++E+E + KI G +G V+ + K+T E K + KERE L + E+N+
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL--VIEVNV 65
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLM---L 521
+ H +IV + + ++++ME+ + DL ++ + F + E ++
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 522 QLLEGIKYLHD-------NWVLHRDLKTSNLLL-----------------NNRGELKICD 557
QLL + Y H+ VLHRDLK N+ L N R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 558 FGLARQYGSPLKPYTHLVV-TLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLF 615
FGL++ G ++ H V T +Y +PELLL +K Y DMW+LGCI+ EL S + F
Sbjct: 186 FGLSKNIG--IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 616 NGKSEFDQL 624
+ + F QL
Sbjct: 244 HKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 92/393 (23%), Positives = 151/393 (38%), Gaps = 51/393 (12%)
Query: 337 ESDERGDRARSLSGDEYHGHESEKGDYMEIDEDHN-NNDSVGGSDTDSEDENDSCGTP-- 393
G S S D + D D + + + D C P
Sbjct: 22 IFSLTGGTDTSDSKD--TTGDKFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCE 79
Query: 394 -EPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVY--RARDKKTGEIVALKKVKMEK 450
+ P + M ++ L+ + G+ G V+ + + V +K V K
Sbjct: 80 TTSSSDPASVVRM--------QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK 131
Query: 451 EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP 510
REI+IL + H +I+ + ++ MVM + DL ++ P
Sbjct: 132 TPG-------REIDILKTISHRAII--NLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-GP 181
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG-SPLK 569
+ + +LLE + YLH ++HRD+KT N+ L+ + DFG A + P
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 570 PYTH-LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKE-PLF--NGKSEFDQLD 625
P + TL +PE LL Y D+WS G ++ E+ K LF KS QL
Sbjct: 242 PQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300
Query: 626 KIFKTLGTPNEKIWPGFSKLP-GVKVNFIKH--QYNLLRKKFPATSFTGSPVLSDAGFD- 681
I + + ++ P + P N KH QY + + P +T PV+ G
Sbjct: 301 SIIRCM-----QVHP--LEFPQNGSTNLCKHFKQYA-IVLRPP---YTIPPVIRKYGMHM 349
Query: 682 ----LLNSLLTYDPDKRITAEAALNHDWFREVP 710
L+ +LT+D + R +A+ L+ F + P
Sbjct: 350 DVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382
|
Length = 392 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 45/227 (19%)
Query: 421 IDEGTYGVVYRAR-----DKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFHHP 472
+ EG +G V+ + E+VA+K +K R+ F RE +L +F H
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDF----EREAELLTNFQHE 68
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGL-------------METMKQPFSQSEVKC 518
+IV V D MV EYMEH DL ++ + S++
Sbjct: 69 NIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 519 LMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT------ 572
+ +Q+ G+ YL +HRDL T N L+ +KI DFG++R YT
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRV 180
Query: 573 --HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLF 615
H ++ + + PE ++ K ++T D+WS G ++ E+ + K+P +
Sbjct: 181 GGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 9/211 (4%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILL-SFHHPSIVD 476
I +G++G V A+ K G+ A+K K + K++E + + R N+LL + HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAER--NVLLKNVKHPFLVG 60
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ D ++ V++Y+ ++ F + + ++ + YLH ++
Sbjct: 61 LHYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK N+LL+++G + + DFGL ++ K + T Y APE+L + Y +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTV 177
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
D W LG ++ E+L P F + + D I
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 71/251 (28%), Positives = 107/251 (42%), Gaps = 60/251 (23%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLR-EINILL 467
D+FE + I G +G V + K TG I A+KK++ +EKE+ +R E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA----HVRAERDILA 56
Query: 468 SFHHPSIVDVKEVVVGSNLDS--IFMVMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQ 522
+P +V + S D ++++MEY+ G M T+ K F++ E + + +
Sbjct: 57 EADNPWVVKLYY----SFQDENYLYLIMEYLP---GGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL------------ARQYGSPLKP 570
+ I +H +HRD+K NLLL+ +G +K+ DFGL R L
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 571 YTHL--------------------------VVTLWYRAPELLLGSKQYSTAIDMWSLGCI 604
V T Y APE+ L Y+ D WSLG I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVI 228
Query: 605 MAELLSKEPLF 615
M E+L P F
Sbjct: 229 MYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALK-----KVKMEKEREGFPLTSLREINILLSFHHPSIV 475
I G +G VY R TG++ A+K ++KM K+ E L ++++ + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 476 DVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ D + +++ M + FS+ E++ +++ G++++H+ +V
Sbjct: 61 CMTYAF--HTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
++RDLK +N+LL+ G ++I D GLA + S KP+ V T Y APE+L Y ++
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
D +SLGC++ +LL G S F Q
Sbjct: 177 ADWFSLGCMLFKLL------RGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-16
Identities = 52/148 (35%), Positives = 83/148 (56%), Gaps = 7/148 (4%)
Query: 487 DSIFMVMEYMEH-DL-KGLMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKT 542
D + ++MEY DL K + + +K+ PF + EV L Q++ + +H ++HRDLK+
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 543 SNLLLNNRGELKICDFGLARQYGS--PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWS 600
+N+ L G +K+ DFG ++QY L + T +Y APE L K+YS DMWS
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWS 256
Query: 601 LGCIMAELLSKEPLFNGKSEFDQLDKIF 628
LG I+ ELL+ F G S+ + + ++
Sbjct: 257 LGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-16
Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 35/288 (12%)
Query: 376 VGGSDTDSEDENDSCGTPEPAGPP--QRSINMLQGCRSVDEFERLNKIDEGTYGVVY--- 430
S D ++ P P + L R +D+ + G +G ++
Sbjct: 115 SDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDD------LPAGAFGKIFICA 168
Query: 431 -----------RARDKKTGEIVALKKVKMEKEREGFPLTSL--REINILLSFHHPSIVDV 477
R + +++ ++ + G EI L +H +I+ +
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQS----EVKCLMLQLLEGIKYLHDN 533
+E++ + + +M+ + + DL M + + + +M QLL ++Y+HD
Sbjct: 229 EEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-LVVTLWYRAPELLLGSKQY 592
++HRD+K N+ LN G++ + DFG A + + + + V T+ +PE+L G Y
Sbjct: 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-Y 345
Query: 593 STAIDMWSLGCIMAELLSKE--PLF-NGKSEFDQLDKIFKTLGTPNEK 637
D+WS G I+ ++LS + P+ G QL KI +L +E+
Sbjct: 346 CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE 393
|
Length = 501 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 60/224 (26%), Positives = 113/224 (50%), Gaps = 13/224 (5%)
Query: 418 LNKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
L + +G++G V+ R G++ A+K +K + + + E +IL +HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM--ETMKQPFSQSEVKCLMLQLLEGIKYLH 531
V + ++++++++ DL + E M F++ +VK + +L + +LH
Sbjct: 61 VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLH 115
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+++RDLK N+LL+ G +K+ DFGL+++ K T+ Y APE ++ +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT-LGTP 634
++ + D WS G +M E+L+ F GK + + I K LG P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 86/312 (27%), Positives = 136/312 (43%), Gaps = 56/312 (17%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLT-SLREINILLSFHHPSIVDVKE 479
I +G++G V + R + T I ALK ++ +T +L E +L + P IV +K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 480 VVVGSNLDSIFMVMEYME-----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ + +++V+ ++ H L+ + F S + +LL ++ LH
Sbjct: 60 -FSFQSPEKLYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLHKFN 113
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
V++RDLK N+LL+ +G + +CDFGL + T Y APELLLG Y+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTK 172
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654
A+D W+LG ++ E+L+ P F ++ + KI L P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI---LQEP-------------------- 209
Query: 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA---LNHDWFREVPL 711
LR FP DA DLL LL+ DP +R+ A NH +F ++
Sbjct: 210 -----LR--FP------DGFDRDAK-DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255
Query: 712 PK--SKDFMPTF 721
K K P F
Sbjct: 256 KKLLMKGIQPPF 267
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-16
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS---LREINILLSFHH 471
++ + I +G G VY A D VALKK++ ++ PL LRE I H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSENPLLKKRFLREAKIAADLIH 61
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQPFS-------QSEVKCLM--- 520
P IV V + S+ D ++ M Y+E + LK L++++ Q S ++ V +
Sbjct: 62 PGIVPVYSIC--SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR------------QYGSPL 568
++ I+Y+H VLHRDLK N+LL GE+ I D+G A
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 569 KPYTHLVV------TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y+ + + T Y APE LLG S + D+++LG I+ ++L+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 78/315 (24%), Positives = 142/315 (45%), Gaps = 68/315 (21%)
Query: 415 FERLNKIDEGTYGVVYRARD---KKTGEIVALKKVK----MEKER-------EGFPLTSL 460
FE L + G YG V+ R G++ A+K +K ++K + E L ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMET---MKQPFSQSEVK 517
R L++ H+ D K + ++++Y+ G + T ++ F++SEV+
Sbjct: 62 RRCPFLVTLHYAFQTDTK----------LHLILDYVN---GGELFTHLYQREHFTESEVR 108
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-LVV 576
+ +++ + +LH +++RD+K N+LL++ G + + DFGL++++ + + +
Sbjct: 109 VYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 577 TLWYRAPELLL-GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
T+ Y APE++ GS + A+D WSLG + ELL+ F E + +I + +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-- 226
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
SK P FP T +S D + LL DP KR+
Sbjct: 227 -------SKPP-----------------FPKT-------MSAEARDFIQKLLEKDPKKRL 255
Query: 696 TAEAA---LNHDWFR 707
A A NH +F+
Sbjct: 256 GANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALK-----KVKMEK-------EREGFPLTSLREINILL- 467
I G +G VY R TG++ A+K ++KM++ ER L S + ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 468 ---SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLL 524
+FH P D + +++ M + FS++E++ +++
Sbjct: 62 MSYAFHTP--------------DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
G++++H+ +V++RDLK +N+LL+ G ++I D GLA + S KP+ V T Y APE
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS-VGTHGYMAPE 165
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625
+L Y ++ D +SLGC++ +LL F D+ +
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 69/293 (23%), Positives = 130/293 (44%), Gaps = 56/293 (19%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-PLTSLREINI--LLSFHHPSIVD 476
K+ +G +G V + K T ++ K +K + F + E + L+ +P+ +
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN----FNAI----EPMVHQLMK-DNPNFIK 73
Query: 477 VKEVVVGSNLDSIFMVMEYM-EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ V + L ++M+Y+ + DL L++ + S++EVK ++ QL+E + LH + +
Sbjct: 74 LYYSV--TTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 536 LHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+H D+K N+L + + + +CD+GL + G+P + TL Y +PE + G Y
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKG-HNYDV 185
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654
+ D W++G + ELL+ GK F +E++ L +K
Sbjct: 186 SFDWWAVGVLTYELLT------GKHPFK---------EDEDEELDL--ESL-------LK 221
Query: 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR-ITAEAALNHDWF 706
Q KK P +S D + S+L Y+ + R + H +
Sbjct: 222 RQQ----KKLPFIK-----NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 81/317 (25%), Positives = 142/317 (44%), Gaps = 69/317 (21%)
Query: 414 EFERLNKIDEGTYGVVYRARD---KKTGEIVALKKVK----MEKER-------EGFPLTS 459
FE L + G YG V+ R TG++ A+K ++ ++K + E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 460 LREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMET---MKQPFSQSEV 516
+R+ L++ H+ + K + ++++Y+ G M T + FS+ EV
Sbjct: 61 VRQSPFLVTLHYAFQTEAK----------LHLILDYVS---GGEMFTHLYQRDNFSEDEV 107
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-LV 575
+ +++ +++LH +++RD+K N+LL++ G + + DFGL++++ S K T+
Sbjct: 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
T+ Y APE++ G + A+D WSLG ++ ELL+ G S F
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT------GASPF-------------- 207
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
L G + + +L+ P SF G P DLL+ LL DP KR+
Sbjct: 208 --------TLEGERNTQSEVSRRILKCDPPFPSFIG-PEAQ----DLLHKLLRKDPKKRL 254
Query: 696 -----TAEAALNHDWFR 707
A H +F+
Sbjct: 255 GAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-15
Identities = 85/321 (26%), Positives = 142/321 (44%), Gaps = 52/321 (16%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F L G G + D KT E V +K +R G + E +IL + +HPSI
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA----GQRGG----TATEAHILRAINHPSI 145
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ +K + +++ + DL + K+ + ++ + +L I+YLH+N
Sbjct: 146 IQLKGTFTYNKFTC--LILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENR 202
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLA---------RQYGSPLKPYTHLVVTLWYRAPEL 585
++HRD+K N+ +N+ G++ + DFG A + YG T+ APE
Sbjct: 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG--------WAGTIATNAPE- 253
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLS-KEPLF-----NGKSEFD-QLDKIFKTLGT-PNEK 637
LL Y A+D+WS G ++ E+ + + LF +G + D Q+ I + GT PNE
Sbjct: 254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE- 312
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKF---PATSFTGSPVLSDAGFD---LLNSLLTYDP 691
P + Y L KK P + + L + D L+ +L +D
Sbjct: 313 -------FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTN-LYELPIDLEYLICKMLAFDA 364
Query: 692 DKRITAEAALNHDWFREVPLP 712
R +AEA L+ F+++P P
Sbjct: 365 HHRPSAEALLDFAAFQDIPDP 385
|
Length = 391 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIVD 476
+ +GT+G V ++K TG A+K +K E K+ LT R +L + HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR---VLQNSRHPFLTA 59
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH-DNWV 535
+K D + VMEY + ++ FS+ + +++ + YLH + V
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQY---GSPLKPYTHLVVTLWYRAPELLLGSKQY 592
++RDLK NL+L+ G +KI DFGL ++ G+ +K + T Y APE +L Y
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG---TPEYLAPE-VLEDNDY 173
Query: 593 STAIDMWSLGCIMAELL-SKEPLFNGKSE 620
A+D W LG +M E++ + P +N E
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLSFHHPSIVDVK 478
I G+Y V R KKT I A+K VK E + E + + +HP +V +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+F V+EY+ DL M+ ++ + + ++ + YLH+ +++
Sbjct: 63 SCF--QTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIY 119
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK N+LL++ G +K+ D+G+ ++ P + T Y APE+L G + Y ++D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 178
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFD 622
W+LG +M E+++ G+S FD
Sbjct: 179 WWALGVLMFEMMA------GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 418 LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVKMEKE---REGFPLTSLREINILLSF 469
L ++ EG +G VY+ ++ + VA+K +K E ++ F +E ++
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEF----RQEAELMSDL 65
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM---------------ETMKQPFSQ 513
HP+IV + V M+ EY+ H DL + ET+K
Sbjct: 66 QHPNIVCLLGVCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPL--KP 570
S+ + +Q+ G++YL + +HRDL N L+ +KI DFGL+R Y +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
L+ W PE +L K ++T D+WS G ++ E+ S
Sbjct: 184 SKSLLPVRWM-PPEAILYGK-FTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 39/194 (20%)
Query: 441 VALKKVK---MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497
VA+K ++ + RE F L+E+ IL P+I + V + M+MEYME
Sbjct: 49 VAVKVLRPDASDNAREDF----LKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYME 102
Query: 498 H-DL-------KGLMETMKQPFSQSEVKCLM---LQLLEGIKYLHD-NWVLHRDLKTSNL 545
+ DL + L+ Q+ G++YL N+V HRDL T N
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV-HRDLATRNC 161
Query: 546 LLNNRGELKICDFGLARQ-Y--------GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
L+ +KI DFG++R Y G P + + A E +L K ++T
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP-------IRWMAWESVLLGK-FTTKS 213
Query: 597 DMWSLGCIMAELLS 610
D+W+ G + E+L+
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS--LREINILLSFHH 471
E + ++ G +GVV G+ A KV ++ EG + E +++ H
Sbjct: 5 ELTFMKELGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH 58
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P +V + V +++V E+ME+ L + + S+ + + + EG++YL
Sbjct: 59 PKLVQLYGVCTQQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLW 579
N +HRDL N L+++ G +K+ DFG+ R +Y S P+K
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK---------- 166
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLFNGKSEFDQLDKI 627
+ PE+ SK YS+ D+WS G +M E+ + K P F KS ++ ++ I
Sbjct: 167 WSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMP-FEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKK--TGEIVALKKVKMEKEREGFPLTS--LREINILLS 468
+ E + I +G +G V++AR E + VKM KE + + RE ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 469 FHHPSIVDVKEV-VVGSNLDSIFMVMEYMEH-DLKGLMETM------------------- 507
F HP+IV + V VG + +F EYM + DL +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLF---EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 508 --KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565
P S +E C+ Q+ G+ YL + +HRDL T N L+ +KI DFGL+R
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 566 SP--LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
S K + + + + PE + ++ Y+T D+W+ G ++ E+ S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 81/345 (23%), Positives = 140/345 (40%), Gaps = 90/345 (26%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK-----MEKEREGFPLTSLREINILL 467
++FE + I G YG VY R K+T + A+KK+ + + + E +IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQ----QVFVERDILT 56
Query: 468 SFHHPSIVDVKEVVVGSNLDSIF----------MVMEYMEH-DLKGLMETMKQPFSQSEV 516
+P +V S+F MVMEY+E D L++ +
Sbjct: 57 FAENPFVV------------SMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMA 103
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR---------QYGSP 567
+ + + ++YLH+ ++HRDLK NLL+ + G +K+ DFGL++ Y
Sbjct: 104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 568 LKPYT------HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621
++ T + T Y APE++L + Y +D W++G I+ E L F G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFG---- 218
Query: 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFD 681
D +++F + + ++ WP G L D
Sbjct: 219 DTPEELFGQVIS-DDIEWPE-----------------------------GDEALPADAQD 248
Query: 682 LLNSLLTYDPDKRITAEAALN---HDWFREVP----LPKSKDFMP 719
L++ LL +P +R+ A H +F + L + +F+P
Sbjct: 249 LISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIP 293
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/212 (28%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHP 472
F + + +G +G V + + TG++ A K++ K K+R+G + +L E IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM-ALNEKQILEKVNSQ 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYL 530
+V++ D++ +V+ M DLK + M P F + ++L G++ L
Sbjct: 61 FVVNLAYAY--ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLG 588
H ++RDLK N+LL++ G ++I D GLA + G ++ V T+ Y APE +L
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPE-VLN 174
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE 620
+++Y+ + D W LGC++ E++ + F G+ E
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
L ++ G +GVV + + ++ +KM KE + E +++ H +V +
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVA----IKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 478 KEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
V + I++V EYM + L + + F S++ + + EG+ YL +
Sbjct: 65 YGVC--TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 537 HRDLKTSNLLLNNRGELKICDFGLAR-----QYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
HRDL N L++++G +K+ DFGL+R +Y S + + V + PE+LL SK
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG--SKFPVR--WSPPEVLLYSK- 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625
+S+ D+W+ G +M E+ S GK +++ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSL-----GKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 15/219 (6%)
Query: 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDV 477
+K+ G YG VY KK VA+K +K + E E F L+E ++ HP++V +
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQL 67
Query: 478 KEVVVGSNLDSIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ V + +++ E+M + L L E +Q + + + Q+ ++YL
Sbjct: 68 --LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLAR-QYGSPLKPYTHLVVTLWYRAPELLLGSKQYST 594
+HRDL N L+ +K+ DFGL+R G + + + APE L +K +S
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 184
Query: 595 AIDMWSLGCIMAEL----LSKEPLFNGKSEFDQLDKIFK 629
D+W+ G ++ E+ +S P + ++ L+K ++
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 56/222 (25%), Positives = 114/222 (51%), Gaps = 13/222 (5%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINILLSFHH 471
+F L + +G++G V A K T E+ A+K +K + + + T + + + L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKY 529
P + + +D ++ VMEY+ LM ++Q F + + ++ G+ +
Sbjct: 61 PFLTQLHSCF--QTVDRLYFVMEYVNGG--DLMYHIQQVGKFKEPQAVFYAAEISVGLFF 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH +++RDLK N++L++ G +KI DFG+ +++ T Y APE ++
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE-IIAY 175
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631
+ Y ++D W+ G ++ E+L+ +P F+G+ E D++F+++
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 57/222 (25%), Positives = 112/222 (50%), Gaps = 13/222 (5%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINILLSFHH 471
+F L + +G++G V A K T E+ A+K +K + + + T + + + L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKY 529
P + + +D ++ VMEY+ LM ++Q F + ++ G+ +
Sbjct: 61 PFLTQLHSCF--QTMDRLYFVMEYVNGG--DLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH +++RDLK N++L+ G +KI DFG+ ++ K T Y APE++
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-Y 175
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631
+ Y ++D W+ G ++ E+L+ +P F+G+ E D++F+++
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 61/186 (32%), Positives = 86/186 (46%), Gaps = 11/186 (5%)
Query: 429 VYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488
VY+ R K+ VA+K +K E E+ +RE I+ +P IV + V L
Sbjct: 15 VYKMRKKQID--VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-- 69
Query: 489 IFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547
+VME L + K + S V LM Q+ G+KYL +HRDL N+LL
Sbjct: 70 -MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128
Query: 548 NNRGELKICDFGLARQYGSPLKPYTHLVVTLW---YRAPELLLGSKQYSTAIDMWSLGCI 604
N+ KI DFGL++ G+ Y W + APE + K +S+ D+WS G
Sbjct: 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGIT 187
Query: 605 MAELLS 610
M E S
Sbjct: 188 MWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 58/225 (25%), Positives = 114/225 (50%), Gaps = 19/225 (8%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINILLSFHH 471
+F L + +G++G V A K T E+ A+K +K + + + T + + + LS
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKY 529
P + + +D ++ VMEY+ LM ++Q F + ++ G+ +
Sbjct: 61 PFLTQLHSCF--QTMDRLYFVMEYVNGG--DLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY---GSPLKPYTHLVVTLWYRAPELL 586
LH +++RDLK N++L++ G +KI DFG+ ++ G K + T Y APE +
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIAPE-I 172
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631
+ + Y ++D W+ G ++ E+L+ + F G+ E D++F+++
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 15/193 (7%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
I EG +G V + + TG+ VA+K +K + + F L E ++ HH ++V +
Sbjct: 13 IIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLLG 66
Query: 480 VVVGSNLDSIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
V++ + L ++VME M +L + T + S ++ L + EG++YL ++H
Sbjct: 67 VILHNGL---YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDL N+L++ G K+ DFGLAR + + W APE L K++S+ D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKW-TAPE-ALKHKKFSSKSD 179
Query: 598 MWSLGCIMAELLS 610
+WS G ++ E+ S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 53/241 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ + L +I G +G V + K +G I+A+K+++ + +E LL
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLL----- 50
Query: 473 SIVDVKEVVVGSNLDSI-------------FMVMEYMEHDL----KGLMETMKQPFSQSE 515
+D+ V+ S+ I ++ ME M+ L K + E +K +
Sbjct: 51 --MDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEI 108
Query: 516 VKCLMLQLLEGIKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFGL--------ARQYGS 566
+ + + ++ + YL + ++HRD+K SN+LL+ G +K+CDFG+ A+ +
Sbjct: 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA 168
Query: 567 PLKPYTHLVVTLWYRAPELLLGSKQ--YSTAIDMWSLGCIMAEL-LSKEPLFNGKSEFDQ 623
+PY APE + S + Y D+WSLG + E+ K P S FDQ
Sbjct: 169 GCRPYM---------APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219
Query: 624 L 624
L
Sbjct: 220 L 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
I +G++G V A+ K G A+K K + K++E + + R + +L + HP +V +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+ + ++ V++Y+ ++ F + + ++ I YLH +++
Sbjct: 62 HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK N+LL+++G + + DFGL ++ P + + T Y APE +L + Y +D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVD 178
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657
W LG ++ E+L P F + D I L P +LPG K
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---LHKP--------LQLPGGK-------- 219
Query: 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL----NHDWF 706
+ A DLL LL D +R+ A+A NH +F
Sbjct: 220 ------------------TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 48/214 (22%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFHHPSIVD 476
K+ G +G V+ T + VA+K +K M E F L+E I+ H +V
Sbjct: 13 KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPE--AF----LQEAQIMKKLRHDKLVQ 65
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLML--------QLLEGIK 528
+ V S + I++V EYM L++ +K E K L L Q+ EG+
Sbjct: 66 LYAVC--SEEEPIYIVTEYMSKG--SLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMA 117
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QY----GS--PLKPYTHLVVT 577
YL +HRDL N+L+ KI DFGLAR +Y G+ P+K
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-------- 169
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611
W APE + ++ D+WS G ++ E+++
Sbjct: 170 -W-TAPEAANYGR-FTIKSDVWSFGILLTEIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 421 IDEGTYGVVYRARDKK-----TGEI-VALKKVK---MEKEREGFPLTSLREINILLSFHH 471
+ G +G VY +G I VA+K ++ ++E++ F L+E +++ +F+H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF----LKEAHLMSNFNH 58
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYME-----HDLKGLMETMKQP--FSQSEVKCLMLQLL 524
P+IV + V + + + +++ME ME L+ P + E+ + L +
Sbjct: 59 PNIVKLLGVCLLN--EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE-----LKICDFGLARQ-YGSPL--KPYTHLVV 576
+G YL +HRDL N L++ +G +KI DFGLAR Y S K L+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W APE LL K ++T D+WS G +M E+L+
Sbjct: 177 VRWM-APESLLDGK-FTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 424 GTYGVVYRA--RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVV 481
G +G V + + KK+ + VA+K +K + LRE N++ +P IV + +
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65
Query: 482 VGSNLDSIFMVMEYMEHDLKGLMETMKQP--FSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
+ +VME E L L + +++ ++ + L+ Q+ G+KYL + +HRD
Sbjct: 66 EAESW---MLVMELAE--LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 540 LKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYRAPELLLGSKQYSTAI 596
L N+LL + KI DFGL++ G+ Y TH + + APE + K +S+
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKS 179
Query: 597 DMWSLGCIMAELLS 610
D+WS G +M E S
Sbjct: 180 DVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS-LREINILLSF 469
+ E + I +G +G V + G+ VA+K +K + + L E +++ +
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----DDSTAAQAFLAEASVMTTL 57
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-----LMETMKQPFSQSEVKCLMLQLL 524
HP++V + VV+ N +++V EYM KG L + + ++ L +
Sbjct: 58 RHPNLVQLLGVVLQGN--PLYIVTEYMA---KGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-------PLKPYTHLVVT 577
EG++YL + +HRDL N+L++ K+ DFGLA++ P+K
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK-------- 164
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE L K++ST D+WS G ++ E+ S
Sbjct: 165 --WTAPE-ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 52/212 (24%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 415 FERLNKIDEGTYGVVYRARD---KKTGEIVALKKVK----------MEKER-EGFPLTSL 460
FE L + G YG V+ R +G++ A+K +K E R E L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM 520
R+ L++ H+ D K + ++++Y+ + ++ F + EV+
Sbjct: 62 RQSPFLVTLHYAFQTDTK----------LHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLW 579
+++ +++LH +++RD+K N+LL++ G + + DFGL++++ + T+
Sbjct: 112 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 580 YRAPELLLGSKQ-YSTAIDMWSLGCIMAELLS 610
Y AP+++ G + A+D WS+G +M ELL+
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLSFHHPSIVDVK 478
I G+Y V R KK +I A+K VK E + E + + +P +V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+F+V+EY+ DL M+ ++ + + ++ + +LH+ +++
Sbjct: 63 SCF--QTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFYAAEICIALNFLHERGIIY 119
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK N+LL+ G +K+ D+G+ ++ P + T Y APE+L G ++Y ++D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVD 178
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFD 622
W+LG +M E+++ G+S FD
Sbjct: 179 WWALGVLMFEMMA------GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 8/213 (3%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSFHHPSIVDVKEVV 481
+G +G V + K TG++ A KK+ K +++ +L E IL + P IV++
Sbjct: 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF 62
Query: 482 VGSNLDSIFMVMEYMEH-DLK-GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
+ + +VM M DLK + ++ V Q+ GI +LH +++RD
Sbjct: 63 --ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 540 LKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMW 599
+K N+LL+++G ++ D GLA + K T T Y APE+L + YS +D +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILK-EEPYSYPVDWF 178
Query: 600 SLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTL 631
++GC + E+++ + P + K + + + +TL
Sbjct: 179 AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 73/311 (23%), Positives = 130/311 (41%), Gaps = 48/311 (15%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
+G +G V + + TG++ A KK+ K K+R+G+ ++ E IL H IV +
Sbjct: 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE-GAMVEKRILAKVHSRFIVSLAYA 61
Query: 481 VVGSNLDSIFMVMEYMEH-DLKGLMETMKQP---FSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ +VM M DL+ + + + F + Q++ G+++LH ++
Sbjct: 62 F--QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK N+LL+N G ++I D GLA + T + APELL G ++Y ++
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSV 178
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
D ++LG + E+++ F + E K +
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGE---------------------------------KVE 205
Query: 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711
L+++ S T S A +LL DP+KR+ + H FR++
Sbjct: 206 NKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265
Query: 712 PKSKDFMPTFP 722
+ + M P
Sbjct: 266 RQLEAGMLPPP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 53/211 (25%), Positives = 102/211 (48%), Gaps = 7/211 (3%)
Query: 421 IDEGTYGVVYRAR---DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
I +G++G V AR ++K + L+K + K++E + S R + +L + HP +V +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
D ++ V++Y+ ++ F + + ++ + YLH +++
Sbjct: 62 HFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK N+LL+++G + + DFGL ++ + T Y APE +L + Y +D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVD 178
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628
W LG ++ E+L P F ++ + D I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/236 (27%), Positives = 120/236 (50%), Gaps = 13/236 (5%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHP 472
F + +G +G V + + TG++ A KK+ K K+R+G + +L E IL +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSR 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYL 530
+V + D++ +V+ M DLK + M P F + +L G++ L
Sbjct: 61 FVVSLAYAY--ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLG 588
+++RDLK N+LL++RG ++I D GLA Q G ++ V T+ Y APE ++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPE-VIN 174
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+++Y+ + D W LGC++ E++ + F + E + +++ + + E+ FS+
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFP----LTSLREINILLSFHHPSIV 475
+I G +G V+ R + VA+K RE P L+E IL + HP+IV
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC-----RETLPPDLKAKFLQEARILKQYSHPNIV 56
Query: 476 DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ + V + I++VME ++ D + T E+ ++ G++YL
Sbjct: 57 --RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV--VTLWYRAPELLLGSKQY 592
+HRDL N L+ + LKI DFG++R+ + T + + + + APE L +Y
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRY 173
Query: 593 STAIDMWSLGCIMAELLS 610
S+ D+WS G ++ E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 420 KIDEGTYGVVYRAR-----DKKTGEIVALKKVK--MEKEREGFPLTSLREINILLSFHHP 472
++ EG +G V+ A ++ +VA+K +K + R+ F RE +L + H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH----REAELLTNLQHE 67
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG----------LMETMKQP--FSQSEVKCL 519
IV V V D + MV EYM+H DL LM +P +QS++ +
Sbjct: 68 HIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVT 577
Q+ G+ YL +HRDL T N L+ +KI DFG++R S + H ++
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLF 615
+ + PE ++ ++++T D+WSLG ++ E+ + K+P +
Sbjct: 186 IRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 421 IDEGTYGVVYR------ARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
I +G +G VY K + +L ++ +E E F L+E I+ F HP++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF----LKEGIIMKDFSHPNV 58
Query: 475 VDVKEVVVGSNLD---SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLM---LQLLEGI 527
+ + +G L S +V+ YM+H DL+ + + VK L+ LQ+ +G+
Sbjct: 59 LSL----LGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGM 111
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGSPLKPYTHLVVTLWYRA 582
+YL +HRDL N +L+ +K+ DFGLAR +Y S +T + + + A
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-HNHTGAKLPVKWMA 170
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSK 611
E L K ++T D+WS G ++ EL+++
Sbjct: 171 LESLQTQK-FTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALK----KVKMEKEREGFPLTSLREINILL-SFHHPSIV 475
I +G++G V A+ K G+ A+K K+ + ++ + + E N+LL + HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMA---ERNVLLKNVKHPFLV 59
Query: 476 DVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ + ++ V++++ ++ F + + ++ + YLH +
Sbjct: 60 GLHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ-YST 594
++RDLK N+LL+++G + + DFGL ++ + T T Y APE++ KQ Y
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQPYDN 175
Query: 595 AIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628
+D W LG ++ E+L P F + + D I
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 460 LREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME----------HDLKGLMETMKQ 509
L+EI I+ P+I+ + V + S D + M+ EYME H+ + E
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 510 PF-SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GS 566
S S + + Q+ G+KYL +HRDL T N L+ +KI DFG++R G
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 567 PLKPYTHLVVTL-WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ V+ + W +LLG +++TA D+W+ G + E+L+
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 413 DEFERLNKIDEGTYGVVYR--ARDKKTGEI---VALKKVKME---KEREGFPLTSLREIN 464
++ + ++ +G++G+VY A+ GE VA+K V +ER F L E +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF----LNEAS 61
Query: 465 ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQ--------PFSQS 514
++ F+ +V + VV S +VME M DLK L + P +
Sbjct: 62 VMKEFNCHHVVRLLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 515 EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ--YGSPLKPYT 572
+ + ++ +G+ YL +HRDL N ++ +KI DFG+ R +
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
++ + + APE L ++T D+WS G ++ E+ +
Sbjct: 180 KGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSF 469
E E++ + G +G VY+ GE VA+K ++ E + L E ++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV 66
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM---LQLLEG 526
HP +V + + + S + ++ + M L L++ ++ + L+ +Q+ +G
Sbjct: 67 DHPHVVRLLGICLSS---QVQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY--THLVVTLWYRAPE 584
+ YL + ++HRDL N+L+ +KI DFGLA+ K Y V + + A E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLS--KEP 613
+L + Y+ D+WS G + EL++ +P
Sbjct: 182 SIL-HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 421 IDEGTYGVVYRARDKKT----GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476
+ G +G V+ A+ K GE + L K + + E RE+++ H ++V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 477 VKEVVVGSNLDSIFMVMEYME-HDLKGLMETMK--------QPFSQSEVKCLMLQLLEGI 527
+ + + +M++EY + DLK + K P S + L Q+ G+
Sbjct: 73 LLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELL 586
+L + +HRDL N L++++ E+K+ L++ Y S + ++ L + APE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPL 614
+ST D+WS G +M E+ ++ L
Sbjct: 191 Q-EDDFSTKSDVWSFGVLMWEVFTQGEL 217
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 420 KIDEGTYGVVYRA--------RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++ EG +G V+ A +DK + ALK + R+ F RE +L + H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQ----REAELLTNLQH 66
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK---------QPFSQ------SE 515
IV V D + MV EYM+H DL + QP S+
Sbjct: 67 EHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTH 573
+ + Q+ G+ YL +HRDL T N L+ +KI DFG++R S + H
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLF 615
++ + + PE ++ ++++T D+WS G I+ E+ + K+P F
Sbjct: 185 TMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 60/313 (19%), Positives = 127/313 (40%), Gaps = 35/313 (11%)
Query: 427 GVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN 485
+V+ A+ K T +VA+KK+ ++ +E L +EI HP+I+ + +
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNILPYVTSFIVDS 72
Query: 486 LDSIFMVMEYMEH----DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLK 541
+++V M + DL L + + + ++ +L + Y+H +HR +K
Sbjct: 73 --ELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 542 TSNLLLNNRGELKICDFGLARQ-----------YGSPLKPYTHLVVTLWYRAPELLLGSK 590
S++LL+ G++ + + + P V L + +PE+L +
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP----KSSVKNLPWLSPEVLQQNL 184
Query: 591 Q-YSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Q Y+ D++S+G EL + P + + L+K+ T+ +K S P
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK-----STYPLY 239
Query: 649 KVNFIKHQYNLLRK-KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
+ + + + + + + S+ + L DP+ R +A LNH +F+
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299
Query: 708 EVPLPKSKDFMPT 720
+ + +
Sbjct: 300 QC--KRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/221 (28%), Positives = 114/221 (51%), Gaps = 19/221 (8%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV--KMEKEREGFPLTSLREINILLSFHHP 472
F + + +G +G V + + TG++ A KK+ K K+R+G + +L E IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-ALNEKQILEKVNSR 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYL 530
+V + D++ +V+ M DLK + M + F + ++ G++ L
Sbjct: 61 FVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLG 588
H +++RDLK N+LL++ G ++I D GLA G +K V T+ Y APE ++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPE-VVK 174
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
+++Y+ + D W+LGC++ E+++ G+S F Q K K
Sbjct: 175 NERYTFSPDWWALGCLLYEMIA------GQSPFQQRKKKIK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLSFHHPSIVDVK 478
I G+Y V KKT I A+K +K E + E + + +HP +V +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
+F V+E++ DL M+ ++ + + ++ + +LH+ +++
Sbjct: 63 SCF--QTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISLALNFLHERGIIY 119
Query: 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAID 597
RDLK N+LL+ G +K+ D+G+ ++ P + T Y APE+L G + Y ++D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 178
Query: 598 MWSLGCIMAELLSKEPLFNGKSEFD 622
W+LG +M E+++ G+S FD
Sbjct: 179 WWALGVLMFEMMA------GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 11/192 (5%)
Query: 423 EGTYGVVYRA--RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
+G +G V++ +DK VA+K K + +E + L E IL + HP+IV K +
Sbjct: 5 KGNFGEVFKGTLKDKTP---VAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIV--KLI 58
Query: 481 VVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539
V + I++VME + D + K ++ L G+ YL +HRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 540 LKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL-VVTLWYRAPELLLGSKQYSTAIDM 598
L N L+ LKI DFG++RQ + + L + + + APE L +YS+ D+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESDV 177
Query: 599 WSLGCIMAELLS 610
WS G ++ E S
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 32/197 (16%)
Query: 460 LREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQ------ 513
L+EI I+ +P+I+ + V V D + M+ EYME+ + ++ S
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 514 ------SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--G 565
+ + + +Q+ G+KYL +HRDL T N L+ N +KI DFG++R G
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 566 SPLKPYTHLVVTL-WYRAPELLLGSKQYSTAIDMWSLGCIMAE-----------LLSKEP 613
+ V+ + W +LLG +++TA D+W+ G + E LLS E
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 614 LFNGKSEF--DQLDKIF 628
+ EF +Q +I+
Sbjct: 241 VIENTGEFFRNQGRQIY 257
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLT-----SLREINILLS-------FH 470
EGT+G ++ L K KE E F T S ++ +LL
Sbjct: 16 EGTFGRIFYG---------ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM-------ETMKQPFSQSEVKCLMLQ 522
H +I+ + V + + + F++ YM +LK + Q S ++ + +Q
Sbjct: 67 HQNILPILHVCI-EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS-------PLKP 570
+ G+ YLH V+H+D+ N +++ ++KI D L+R Y P+K
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E L+ +K+YS+A D+WS G ++ EL++
Sbjct: 185 --------WM-ALESLV-NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 96/345 (27%), Positives = 138/345 (40%), Gaps = 81/345 (23%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---------------MEKEREGF 455
S F+ L+ + EGT+G V A D+K E A+K V+ MEK R+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 456 PLTSLREINILLSFH----HPSIVDVKEVVVGSNL-DSIFMVMEYMEHDLKGLMETMKQP 510
P + I F H IV K G L D I M+H P
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMPK---YGPCLLDWI------MKHG----------P 227
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNW-VLHRDLKTSNLLL----------NNRG------EL 553
FS + ++ Q + Y H ++H DLK N+L+ NR +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 554 KICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKE 612
+ICD G T +V T YR+PE++LG YST DMWS+GCI+ EL + +
Sbjct: 288 RICDLGGC---CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGK 342
Query: 613 PLFNGKSEFDQLDKIFKTLGT-PNEKIWPGFSKLPGVKVNFI-----------KHQYNLL 660
L++ + L + KTLG P+E W G ++ + KH +
Sbjct: 343 LLYDTHDNLEHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIA 400
Query: 661 RKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
R + P +L DL+ LL YD KR+ A H +
Sbjct: 401 RAR-PVREVIRDDLLC----DLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 420 KIDEGTYGVVYRA--RDKKTGEI-VALKKVKMEKE---REGFPLTSLREINILLSFHHPS 473
I EG +G VY+ + +I VA+K K RE F L+E I+ F HP
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF----LQEAYIMRQFDHPH 68
Query: 474 IVDVKEVVVGSNLDSIFMVME-YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
IV + V+ + +++VME +L+ ++ K + + QL + YL
Sbjct: 69 IVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL---WYRAPELLLGS 589
+HRD+ N+L+++ +K+ DFGL+R Y Y L W APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWM-APE-SINF 182
Query: 590 KQYSTAIDMWSLGCIMAELLS--KEPLF 615
+++++A D+W G M E+L +P
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 25/200 (12%)
Query: 437 TGEIVALKKVKMEKEREGFPLTSL-REINILLSFHHPSIVD-VKEVVVGSNLDSIFMVME 494
TG VA+K ++ + E RE + +HP+IV + L +F V E
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL--LFAVFE 59
Query: 495 YME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-- 551
Y+ L+ ++ E LMLQ+L+ + H+ ++HRDLK N++++ G
Sbjct: 60 YVPGRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 552 -ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST-----------AIDMW 599
K+ DFG+ L P +LG+ Y D++
Sbjct: 119 PHAKVLDFGI-----GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 600 SLGCIMAELLSKEPLFNGKS 619
+ G I E L+ + + G S
Sbjct: 174 AWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 5/158 (3%)
Query: 452 REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPF 511
+ G+ +S+ E +L HP+++ + +V V L +V+ DL + +P
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTC--LVLPKYRSDLYTYLGARLRPL 257
Query: 512 SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA-RQYGSPLKP 570
++V + QLL I Y+H ++HRD+KT N+L+N ++ + DFG A GS P
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 571 YTHLVV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAE 607
+ + + T+ APE+L G Y+ ++D+WS G ++ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
E + L I +G +G V + G VA+K +K + + F L E +++ H +
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSN 60
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEV--KCLM---LQLLEGIK 528
+V + V+V +++V EYM KG + + +S + CL+ L + E ++
Sbjct: 61 LVQLLGVIVEEK-GGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YL N +HRDL N+L++ K+ DFGL ++ S + L V + APE L
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVK--WTAPEALR- 172
Query: 589 SKQYSTAIDMWSLGCIMAELLS 610
K++ST D+WS G ++ E+ S
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 16/226 (7%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKERE-GFPLTSLREINIL 466
++F+ + I G +G V R K + ++ A+K K +M K + F E +I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDIM 97
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
+ IV + + ++MVMEYM DL LM P + + +++
Sbjct: 98 AHANSEWIVQLHYAF--QDDKYLYMVMEYMPGGDLVNLMSNYDIP--EKWARFYTAEVVL 153
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPE 584
+ +H +HRD+K N+LL+ G LK+ DFG + + V T Y +PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 585 LLL---GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
+L G Y D WS+G + E+L + F S KI
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 70/266 (26%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR-EINILLSFHH 471
D+FE L I G +G V + K TG I A+K ++ E + +R E +IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLEGIK 528
+V K + +++++ME++ G M T+ K S+ + + + + I
Sbjct: 61 AWVV--KMFYSFQDKRNLYLIMEFLP---GGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA-------------------------RQ 563
+H +HRD+K NLLL+ +G +K+ DFGL +
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 564 YGSPLKPYT----------HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613
S K T V T Y APE+ + + Y+ D WSLG IM E+L P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYP 234
Query: 614 LFNGKSEFDQLDKIF---KTLGTPNE 636
F ++ + K+ +TL P E
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 420 KIDEGTYGVVYRA--------RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++ EG +G V+ A +DK + ALK+ E R+ F RE +L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQ----REAELLTVLQH 66
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH------------DLKGLMETMKQPFSQ---SEV 516
IV + V + + MV EYM H D K L Q ++
Sbjct: 67 QHIV--RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHL 574
+ Q+ G+ YL +HRDL T N L+ +KI DFG++R S +
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLF 615
++ + + PE +L ++++T D+WS G ++ E+ + K+P +
Sbjct: 185 MLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 13/224 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
D+FE + I G +G V + K T I A+K K +M K E R N+L++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNG 58
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEY-MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
I + N +++VM+Y + DL L+ + + + + +++ I
Sbjct: 59 DCQWITTLHYAFQDEN--YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLL 587
+H +HRD+K N+LL+ G +++ DFG + + + V T Y +PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 588 ----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
G +Y D WSLG M E+L E F +S + KI
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 48/266 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINILLS 468
++FE L I G +G V + K TG + A+K ++ +EKE+ G + + R+I +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDILV--- 56
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
S+ VK + +++++ME++ + K ++ E + + + + I
Sbjct: 57 -EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA-------------------------RQ 563
+H +HRD+K NLLL+++G +K+ DFGL +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 564 YGSPLKPYT----------HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613
S K T V T Y APE+ + Y+ D WSLG IM E+L P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 614 LFNGKSEFDQLDKIF---KTLGTPNE 636
F ++ + K+ +TL P E
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 42/212 (19%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
L K+ G +G V+ T VA+K +K M+ P L E I+ HP +
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKL 63
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLML-----QLLEGIKY 529
+ + V + I++V E M++ G + Q + +K L Q+ G+ Y
Sbjct: 64 IQLYAVCTLE--EPIYIVTELMKY---GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-----------PLKPYTHLVVTL 578
L +HRDL N+L+ K+ DFGLAR P+K
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--------- 169
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE L ++ +S D+WS G ++ E+++
Sbjct: 170 -WTAPEAALYNR-FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 400 QRSINMLQGCR-SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGF 455
+ +IN ++ R +++E + I G +G V R K T ++ A+K K +M K +
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 456 PLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP---- 510
R+I ++F + V V+ + ++MVMEYM DL LM P
Sbjct: 89 FFWEERDI---MAFANSPWV-VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 511 -FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP-L 568
F +EV + L+ I H +HRD+K N+LL+ G LK+ DFG + +
Sbjct: 145 RFYTAEV----VLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197
Query: 569 KPYTHLVVTLWYRAPELLL---GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625
V T Y +PE+L G Y D WS+G + E+L + F S
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 626 KI 627
KI
Sbjct: 258 KI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 35/206 (16%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
K+ G +G V+ ++ +K K+ P L E N++ HP +V +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVA----IKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 480 VVVGSNLDSIFMVMEYMEHDLKGLMETMKQP----FSQSEVKCLMLQLLEGIKYLHDNWV 535
VV + I+++ EYME+ L++ +K P + +++ + Q+ EG+ ++
Sbjct: 69 VVTQ---EPIYIITEYMENG--SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLAR---------QYGS--PLKPYTHLVVTLWYRAPE 584
+HRDL+ +N+L++ KI DFGLAR + G+ P+K + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----------WTAPE 173
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLS 610
+ ++ D+WS G ++ E+++
Sbjct: 174 -AINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 36/118 (30%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
E + + K+ + ++ C Q+ +G+++L +HRDL N+LL+ +KIC
Sbjct: 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKIC 221
Query: 557 DFGLARQ-YGSPLKPYTH---LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
DFGLAR Y P Y + L + APE + + Y+ D+WS G ++ E+ S
Sbjct: 222 DFGLARDIYKDP--DYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 508 KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGS 566
K P + ++ C Q+ G+++L +HRDL N+LL+ +KICDFGLAR Y
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 567 P---LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P K L L + APE + K Y+T D+WS G ++ E+ S
Sbjct: 228 PDYVRKGSARL--PLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 413 DEFERLNKIDEGTYGVVY----RARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
D L + G +G VY R RD E+ K E E L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 469 FHHPSIVDVKEVVVGSNLDSI--FMVMEYMEH-DLKGLME----TMKQPFSQSEVKCLML 521
F+H +IV + +G + + + F+++E M DLK + ++P S + M
Sbjct: 66 FNHQNIVRL----IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT-----MK 116
Query: 522 QLLE-------GIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQ-YGS---- 566
LL G KYL +N +HRD+ N LL +G KI DFG+AR Y +
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 567 -------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P+K + PE L +++ D+WS G ++ E+ S
Sbjct: 177 KGGRAMLPIK----------WMPPEAFL-DGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 27/165 (16%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK------------MEKEREGFPLT 458
S++EF + I G +G VY R K ++ A+K VK ++ ER+ L+
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 459 SLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM-EHDLKGLMETMKQPFSQSEVK 517
P IV + + +N ++++VMEY+ D+K L+ + F +
Sbjct: 62 K-----------SPFIVHLYYSLQSAN--NVYLVMEYLIGGDVKSLLH-IYGYFDEEMAV 107
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562
+ ++ + YLH + ++HRDLK N+L++N G +K+ DFGL++
Sbjct: 108 KYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 16/235 (6%)
Query: 401 RSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPL 457
R I LQ ++++ + I G +G V R K + ++ A+K K +M K +
Sbjct: 33 RKIRKLQ--MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 458 TSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEV 516
R+I ++F + V V+ + ++MVMEYM DL LM P +
Sbjct: 91 WEERDI---MAFANSPWV-VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWA 144
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
K +++ + +H ++HRD+K N+LL+ G LK+ DFG + V
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 577 -TLWYRAPELLL---GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
T Y +PE+L G Y D WS+G + E+L + F S KI
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 505 ETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ- 563
E K+P + ++ Q+ G+++L +HRDL N+LL+ +KICDFGLAR
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 564 YGSPLKPYTH---LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y P Y + L + APE + K Y+T D+WS G ++ E+ S
Sbjct: 224 YKDP--DYVRKGDARLPLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
D+FE L I G +G V + K TG++ A+K K +M K E RE +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE---TACFREERDVLVN 57
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEY-MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+ +++++VM+Y + DL L+ + + + + +++ I
Sbjct: 58 GDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-------TLWYR 581
+H +HRD+K N+LL+ G +++ DF GS L+ V T Y
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADF------GSCLRLLADGTVQSNVAVGTPDYI 170
Query: 582 APELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
+PE+L G +Y D WSLG M E+L E F +S + KI
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 54/221 (24%), Positives = 107/221 (48%), Gaps = 37/221 (16%)
Query: 418 LNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
+ ++ E +G +Y+ G ++VA+K +K + + +E +++ HHP+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ-QEASLMAELHHPN 68
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKC-------------- 518
IV + VV + + M+ EY+ DL + M+ P S+V C
Sbjct: 69 IVCLLGVV--TQEQPVCMLFEYLNQGDLHEFL-IMRSP--HSDVGCSSDEDGTVKSSLDH 123
Query: 519 -----LMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP----LK 569
+ +Q+ G++YL ++ +H+DL N+L+ + +KI D GL+R+ S ++
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P + L + + PE ++ K +S+ D+WS G ++ E+ S
Sbjct: 184 PKSLLPIR--WMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 66/281 (23%), Positives = 116/281 (41%), Gaps = 66/281 (23%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLR-EINILLS 468
++F + I +G +G V + K TG+I A+K K +M K+ + L ++ E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ---LAHVKAERDVLAE 57
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLE 525
P +V + + ++++ME++ G + TM FS+ + M + +
Sbjct: 58 SDSPWVVSLYYSFQDAQY--LYLIMEFLP---GGDLMTMLIKYDTFSEDVTRFYMAECVL 112
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA---------RQYGSPL-------- 568
I+ +H +HRD+K N+L++ G +K+ DFGL+ Y L
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 569 --KPYTHLVVTLW----------------------------YRAPELLLGSKQYSTAIDM 598
+ V ++ Y APE+ L + Y D
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDW 231
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIF---KTLGTPNE 636
WSLG IM E L P F ++ + KI +TL P++
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDD 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 35/234 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ + + K+ G +G V+ ++ VK K P + L E I+ H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVA----VKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + VV + + I++V EYM L L + + + + Q+ G+ Y+
Sbjct: 62 KLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLW 579
+HRDL+++N+L+ + KI DFGLAR +Y + P+K
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK---------- 168
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLSK----EPLFNGKSEFDQLDKIFK 629
+ APE L + ++ D+WS G ++ EL++K P N + +Q+++ ++
Sbjct: 169 WTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 9/223 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSFHH 471
++FE L I G +G V + K ++ A+K + K E + E ++L++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEY-MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
I + N ++++VM+Y + DL L+ + + + + +++ I +
Sbjct: 61 QWITTLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLL-- 587
H +HRD+K N+L++ G +++ DFG + + + V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 588 --GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628
G +Y D WSLG M E+L E F +S + KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVKMEK-EREGFPLTSLRE 462
E R + EG +G V +A D VA+K +K + E++ L S E
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY----------------MEHDLKGLMET 506
+ ++ H +I+++ V +++V+EY E+
Sbjct: 68 MMKMIG-KHKNIINLLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 507 MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QY 564
++ +Q ++ Q+ G+++L +HRDL N+L+ +KI DFGLAR +
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ T+ + + + APE L + Y+ D+WS G ++ E+ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
K+ +G +G V+ T + +K K P L+E ++ H +V +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVA----IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 480 VVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQ----SEVKCLMLQLLEGIKYLHDNWV 535
VV + + I++V EYM L++ +K + ++ + Q+ G+ Y+
Sbjct: 69 VV---SEEPIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLWYRAPE 584
+HRDL+ +N+L+ K+ DFGLAR +Y + P+K + APE
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----------WTAPE 173
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSK----EPLFNGKSEFDQLDKIFK 629
L + ++ D+WS G ++ EL +K P + DQ+++ ++
Sbjct: 174 AALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 449 EKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETM 507
+K+R GF L E L F H +IV ++ V+ N ++ +V EYM + L +
Sbjct: 47 DKQRRGF----LAEALTLGQFDHSNIVRLEGVITRGN--TMMIVTEYMSNGALDSFLRKH 100
Query: 508 KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567
+ ++ ++ L G+KYL + +H+ L +L+N+ KI F ++ S
Sbjct: 101 EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160
Query: 568 LKPYTHL---VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
YT + LW APE + +S+A D+WS G +M E++S
Sbjct: 161 -AIYTTMSGKSPVLW-AAPEAI-QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREI----NILLSF 469
EF+++ + G +G VY+ GE V + V +++ RE + +EI ++ S
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASV 66
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM---LQLLEG 526
+P + + + + S + I +M + L++ +++ + L+ +Q+ +G
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPF-----GCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRAP 583
+ YL + ++HRDL N+L+ +KI DFGLA+ G+ K Y H V + + A
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY-HAEGGKVPIKWMAL 180
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLS 610
E +L + Y+ D+WS G + EL++
Sbjct: 181 ESIL-HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 423 EGTYGVVYRAR---DKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIV 475
EG +G V + D + VA+K +K++ E E F L E + F HP+++
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF----LSEAACMKDFDHPNVM 64
Query: 476 DVKEVVV-GSNLDSI---FMVMEYMEH-DLKGLMETMK---QPFS---QSEVKCLMLQLL 524
+ V S+L I +++ +M+H DL + + P Q+ +K M+ +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FMVDIA 123
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLV-VTLWYRA 582
G++YL + +HRDL N +L + + DFGL+++ Y + + + + A
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSK 611
E L + Y++ D+W+ G M E+ ++
Sbjct: 184 IE-SLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALK-KVKMEKEREGFPLTSLR---EINILLSF 469
E +R+ + G +G VY+ GE V + +K+ E G P ++ E I+ S
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASM 66
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM---LQLLEG 526
HP +V + V + +I +V + M H L++ + + + L+ +Q+ +G
Sbjct: 67 DHPHLVRLLGVCLSP---TIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL--VVTLWYRAPE 584
+ YL + ++HRDL N+L+ + +KI DFGLAR K Y + + + A E
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK 618
+ ++++ D+WS G + EL++ F GK
Sbjct: 182 -CIHYRKFTHQSDVWSYGVTIWELMT----FGGK 210
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 24/172 (13%)
Query: 460 LREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK---------- 508
L+E+ IL P+I+ + V V D + M+ EYME+ DL + +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 509 --------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560
S S + + LQ+ G+KYL +HRDL T N L+ +KI DFG+
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 561 ARQY--GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+R G + V+ + + A E +L K ++TA D+W+ G + E+L
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLS 468
++F + + G++G V A K I +K K+ K+++ + S R+I L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI--LNY 87
Query: 469 FHHPSIVDVKEVVVGSNLDS--IFMVMEYMEHDLKGLMETM--KQPFSQSEVKCL-MLQL 523
+HP V++ GS D +++V+E++ + G T + ++V C Q+
Sbjct: 88 INHPFCVNLY----GSFKDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+ +YL +++RDLK NLLL+ G +K+ DFG A+ + + YT L T Y AP
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT-LCGTPEYIAP 197
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF 615
E+LL + + A D W+LG + E+L P F
Sbjct: 198 EILL-NVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 39/208 (18%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKM-EKEREGFPLTSLREINILLSFHHPSIVDVK 478
K+ G +G V+ A K + VA+K +K E F L E N++ + H +V +
Sbjct: 13 KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAF----LAEANVMKTLQHDKLVKLH 67
Query: 479 EVVVGSNLDSIFMVMEYMEH----DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
VV + I+++ E+M D E KQP + + Q+ EG+ ++
Sbjct: 68 AVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK--LIDFSAQIAEGMAFIEQRN 122
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLWYRAP 583
+HRDL+ +N+L++ KI DFGLAR +Y + P+K + AP
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----------WTAP 172
Query: 584 ELL-LGSKQYSTAIDMWSLGCIMAELLS 610
E + GS ++ D+WS G ++ E+++
Sbjct: 173 EAINFGS--FTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTG-----EIVALKKVKMEKEREGFPLTSLREINILLS 468
+FE + I EG +G V RA KK G I LK+ E + F E+ +L
Sbjct: 5 KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA----GELEVLCK 58
Query: 469 F-HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP--------FSQSEVKCL 519
HHP+I+++ + N +++ +EY + L++ +++ F++
Sbjct: 59 LGHHPNIINL--LGACENRGYLYIAIEYAPYG--NLLDFLRKSRVLETDPAFAKEHGTAS 114
Query: 520 ML---QLLE-------GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569
L QLL+ G++YL + +HRDL N+L+ KI DFGL+R +K
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK 174
Query: 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ W L Y+T D+WS G ++ E++S
Sbjct: 175 KTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 40/171 (23%)
Query: 460 LREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQPFSQSEVKC 518
L E N++ + H +V + VV + + I+++ EYM KG L++ +K S K
Sbjct: 49 LEEANLMKTLQHDKLVRLYAVV--TKEEPIYIITEYMA---KGSLLDFLK---SDEGGKV 100
Query: 519 LM-------LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS 566
L+ Q+ EG+ Y+ +HRDL+ +N+L++ KI DFGLAR +Y +
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
Query: 567 ------PLKPYTHLVVTLWYRAPELL-LGSKQYSTAIDMWSLGCIMAELLS 610
P+K + APE + GS ++ D+WS G ++ E+++
Sbjct: 161 REGAKFPIK----------WTAPEAINFGS--FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 423 EGTYGVVYRAR---DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
+G +G V A+ + + + VA+K +K + LRE + F HP+++ +
Sbjct: 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIG 68
Query: 480 VVVGSN----LDSIFMVMEYMEH-DLKG--LMETM-KQPFS---QSEVKCLMLQLLEGIK 528
V + S L +++ +M+H DL LM + ++PF+ Q+ V+ M+ + G++
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-FMIDIASGME 127
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS------------PLKPYTHLVV 576
YL +HRDL N +LN + + DFGL+++ S P+K
Sbjct: 128 YLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK------- 180
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611
W L Y+T D+W+ G M E++++
Sbjct: 181 --WLALES--LADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 421 IDEGTYGVVYRARDKKTG-----EIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSI 474
I EG +G V +AR KK G I +K+ + + F E+ +L HHP+I
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----GELEVLCKLGHHPNI 58
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP--------FSQSEVKCLML---QL 523
+++ + + +++ +EY H L++ +++ F+ + L QL
Sbjct: 59 INL--LGACEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 524 LE-------GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
L G+ YL +HRDL N+L+ KI DFGL+R +K +
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W L Y+T D+WS G ++ E++S
Sbjct: 175 VRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
K+ +G +G V+ T ++ +K K P L+E I+ H +V +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVA----IKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 480 VVVGSNLDSIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537
VV + + I++V E+M L L E + ++ + Q+ +G+ Y+ +H
Sbjct: 69 VV---SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 538 RDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLWYRAPELL 586
RDL+ +N+L+ + KI DFGLAR +Y + P+K + APE
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK----------WTAPEAA 175
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSK 611
L + ++ D+WS G ++ EL++K
Sbjct: 176 LYGR-FTIKSDVWSFGILLTELVTK 199
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 77/276 (27%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
F ++ + G +G V AR T + A+K +LR+ ++LL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMK--------------TLRKKDVLLRNQVAHV 48
Query: 475 VDVKEVVVGSN-------------LDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLM 520
++++ ++ D+++ VM+Y+ D+ L+ M F + + +
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYI 107
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL-------------------- 560
+L ++ +H +HRD+K N+L++ G +K+ DFGL
Sbjct: 108 AELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167
Query: 561 ------ARQYGSP--------LKPYTH-------------LVVTLWYRAPELLLGSKQYS 593
+ ++G P LKP LV T Y APE+LL + Y+
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YT 226
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
D WS+G I+ E+L +P F ++ + K+
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 43/225 (19%)
Query: 418 LNKIDEGTYGVVYR--ARDKKTGEI---VALKKVKME---KEREGFPLTSLREINILLSF 469
L ++ +G++G+VY ARD GE VA+K V +ER F L E +++ F
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF----LNEASVMKGF 66
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQ---------PFSQSEVKCL 519
+V + VV S +VME M H DLK + +++ P + E+ +
Sbjct: 67 TCHHVVRLLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY---------GSPLKP 570
++ +G+ YL+ +HRDL N ++ + +KI DFG+ R G L P
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAEL--LSKEP 613
+ APE L ++T+ DMWS G ++ E+ L+++P
Sbjct: 185 VR-------WMAPE-SLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 74/343 (21%), Positives = 124/343 (36%), Gaps = 86/343 (25%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSFHHPS 473
F ++ I G +G V R T + A+K + K + E +IL +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+V K + D+++ VM+Y+ D+ L+ + F + + + +L I+ +H
Sbjct: 63 VV--KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK 119
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGL---------ARQYGS----------------- 566
+HRD+K N+L++ G +K+ DFGL ++ Y
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 567 ----PLKPY------------TH-LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL 609
LKP H LV T Y APE+LL Y+ D WS+G I+ E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 610 SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSF 669
+P F + + K+ W +P Q
Sbjct: 239 VGQPPFLADTPAETQLKV---------INWETTLHIP--------SQAK----------- 270
Query: 670 TGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL---NHDWFREV 709
LS DL+ L + R+ A H +F+ +
Sbjct: 271 -----LSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 9/128 (7%)
Query: 489 IFMVMEYMEH-DLKGLMETMKQPFSQSE-VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLL 546
I ++ EY + DL + ++ F E + Q+ +G+ +L +HRDL N+L
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 547 LNNRGELKICDFGLARQYGSP----LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLG 602
L + +KICDFGLAR + +K L V + APE + Y+ D+WS G
Sbjct: 174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK--WMAPESIFNC-VYTFESDVWSYG 230
Query: 603 CIMAELLS 610
++ E+ S
Sbjct: 231 ILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 29/189 (15%)
Query: 434 DKKTGEIVALKKVKMEKEREGFPLTSL--REINILLSFHHPSIVDVKEVVVGSNLDSIFM 491
D +T + LK G +S RE ++ P++V + + +V DS+F+
Sbjct: 14 DTRTQQTFILK---------GLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFL 62
Query: 492 VMEYME------HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNL 545
V+++ E H K L + VK +++ + LH ++ RDL +N+
Sbjct: 63 VLQHAEGGKLWSHISKFLN------IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 546 LLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIM 605
LL++RG +++ F ++ V Y APE + G + + A D WSLG I+
Sbjct: 117 LLDDRGHIQLTYFS---RWSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAIL 172
Query: 606 AELLSKEPL 614
ELL+ + L
Sbjct: 173 FELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 48/314 (15%)
Query: 429 VYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV-VVGSNLD 487
VY AR TG +V ++ +E E E+ + F HP+I+ V GS L
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75
Query: 488 SI--FMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544
I FM LK E M S++ + ++ L G+ YLH N +HR++K S+
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGM----SEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 545 LLLNNRGELKICDFGLARQY-----GSPLK-----PYTHLVVTLWYRAPELLLGSKQ--- 591
+L++ G + + GL+ Y G K P V W +PELL +Q
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELL---RQDLY 185
Query: 592 -YSTAIDMWSLGCIMAELLSKEPLF-------------NGKSEFDQLDKIFKTLGTPNEK 637
Y+ D++S+G EL + F G F + +
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245
Query: 638 IWPGFSKLPG--VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
G G V + R + P+ S S A +L+ L DP+KR
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPS-----SKTFSPAFQNLVELCLQQDPEKRP 300
Query: 696 TAEAALNHDWFREV 709
+A + L+H +F++V
Sbjct: 301 SASSLLSHAFFKQV 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLW 579
Q+ G++YL +HRDL N+L+ +KI DFGLAR + K T+ + +
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE L + Y+ D+WS G +M E+ +
Sbjct: 205 WMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 418 LNKIDEGTYGVVYRARDKKTG-----EIVALKKVKMEKE---REGFPLTSLREINILLSF 469
+ ++ E +G VY+ T + VA+K +K + E RE F E +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFK----HEAMMRSRL 65
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM---------------ETMKQPFSQ 513
HP+IV + VV + M+ Y H DL + +T+K
Sbjct: 66 QHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPY 571
++ ++ Q+ G+++L + V+H+DL T N+L+ ++ +KI D GL R+ + K
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ ++ + + +PE ++ K +S D+WS G ++ E+ S
Sbjct: 184 GNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 428 VVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487
V AR K TGE V ++++ +E E+++ F+HP+IV + + N
Sbjct: 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-- 72
Query: 488 SIFMVMEYMEH-DLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNL 545
+++V +M + K L+ T S+ + ++ +L+ + Y+H +HR +K S++
Sbjct: 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132
Query: 546 LLNNRGELKICDFGLAR-----QYGSPLK-----PYTHLVVTLWYRAPELLLGSKQ-YST 594
L++ G K+ GL +G L+ P + V W +PE+L + Q Y
Sbjct: 133 LISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL-SPEVLQQNLQGYDA 189
Query: 595 AIDMWSLGCIMAEL 608
D++S+G EL
Sbjct: 190 KSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR----EINILLSFHHPSIVDVK 478
EG +G V +A + V ++ +E + LR E N+L +HP ++ K
Sbjct: 10 EGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI--K 67
Query: 479 EVVVGSNLDSIFMVMEYMEH-DLKG-LMETMK----------------------QPFSQS 514
S + +++EY ++ L+ L E+ K + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 515 EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR---QYGSPLKPY 571
++ Q+ G++YL + ++HRDL N+L+ ++KI DFGL+R + S +K
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ W A E L Y+T D+WS G ++ E+++
Sbjct: 188 KGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 423 EGTYGVVYRARDKKTGEI--VALKKVKM----EKEREGFPLTSLREINILLSFHHPSIVD 476
EG +G V + + I VA+K +K+ E E F L E + F HP+++
Sbjct: 9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMR 64
Query: 477 VKEV----VVGSNLDSIFMVMEYMEH-DLKGLMETMK---QPF---SQSEVKCLMLQLLE 525
+ V V S +++ +M+H DL + + P +Q VK M +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIAS 123
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAP 583
G++YL +HRDL N +LN + + DFGL+++ G + + + + A
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSK 611
E L + Y+T D+WS G M E+ ++
Sbjct: 184 E-SLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 457 LTSLREINILLSFHHPSIVDVKEVVVGSNLDSI--FMVMEYMEH-DLKG-------LMET 506
L L+E+ +HP+++ +G ++SI +V+E+ DLK ++
Sbjct: 40 LLFLQEVQPYRELNHPNVL----QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQ 95
Query: 507 MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA-RQYG 565
M Q + C ++ G+ +LH +H DL N L +KI D+GLA QY
Sbjct: 96 MAQKDVLQRMAC---EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152
Query: 566 SP-LKPYTHLVVTLWYRAPELL------LGSKQYSTAIDMWSLGCIMAEL 608
V L + APEL+ L K + ++WSLG M EL
Sbjct: 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 503 LMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562
L + + + ++ Q+ G+++L +HRDL N+LL +KICDFGLAR
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 563 ------QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y S K T L V + APE + Y+T D+WS G ++ E+ S
Sbjct: 286 DIMHDSNYVS--KGSTFLPVK--WMAPESIF-DNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 53/250 (21%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR-EINILLSFHHPS 473
F ++ + G +G V A T + A+K ++ + + ++ E +IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+V K + D+++ VM+Y+ D+ L+ M + F + + + +L I+ +H
Sbjct: 63 VV--KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHK 119
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR-----------QYGSPLKPYTHLVVTLW-- 579
+HRD+K N+L++ G +K+ DFGL Q GS ++ + LW
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 580 ----------------------------------YRAPELLLGSKQYSTAIDMWSLGCIM 605
Y APE+LL K Y+ D WS+G I+
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL 238
Query: 606 AELLSKEPLF 615
E+L +P F
Sbjct: 239 FEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEI----VALKKVKMEKEREGFPLTSLREINILLSF 469
E +L + G +G V++ G+ VA+K ++ R+ F + + + S
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG-SL 66
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM---LQLLEG 526
H IV + + G++L +V + L++ ++Q + + L+ +Q+ +G
Sbjct: 67 DHAYIVRLLGICPGASLQ---LVTQLSPLG--SLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYRAP 583
+ YL ++ ++HR+L N+LL + ++I DFG+A K Y H W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLS 610
+L G +Y+ D+WS G + E++S
Sbjct: 182 SILFG--RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 421 IDEGTYGVVYRARDKKTG-----EIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSI 474
I EG +G V +AR KK G I +K+ + + F E+ +L HHP+I
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----GELEVLCKLGHHPNI 70
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQP------------------FSQSEV 516
+++ + + +++ +EY H L++ +++ S ++
Sbjct: 71 INL--LGACEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
+ G+ YL +HRDL N+L+ KI DFGL+R +K +
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W L Y+T D+WS G ++ E++S
Sbjct: 187 VRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 505 ETMKQPFSQSEVKCLM---LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+T K P Q K L+ Q+ G++YL +HRDL N+L+ +KI DFGLA
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 562 RQYGSP--LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613
R + K T+ + + + APE L + Y+ D+WS G ++ E+ +
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTLW 579
Q+ G++YL +HRDL N+L+ +KI DFGLAR + K T+ + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE L + Y+ D+WS G ++ E+ +
Sbjct: 208 WMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 10/203 (4%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFH 470
E +++ + G +G VY+ GE V + KV E L E ++
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P + + + + S + + +M Y L + K ++ +Q+ +G+ YL
Sbjct: 68 SPYVCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL---VVTLWYRAPELLL 587
+ ++HRDL N+L+ + +KI DFGLAR Y H V + + A E +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY-HADGGKVPIKWMALESIL 184
Query: 588 GSKQYSTAIDMWSLGCIMAELLS 610
++++ D+WS G + EL++
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 17/98 (17%)
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY---------GSPLKPYT 572
Q+ G+++L +HRDL N+L+ +KICDFGLAR GS P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP-- 304
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
L + APE + + Y+T D+WS G ++ E+ +
Sbjct: 305 -----LKWMAPESIFNN-LYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTLW 579
Q+ G++YL +HRDL N+L+ +KI DFGLAR K ++ + +
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE L + Y+ D+WS G +M E+ +
Sbjct: 202 WMAPEALF-DRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 420 KIDEGTYGVVYRARDK-----KTGEIVALKKVKME---KEREGFPLTSLREINILLSFHH 471
++ +G++G+VY K + VA+K V +ER F L E +++ F+
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEASVMKEFNC 68
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCL-----MLQLL- 524
+V + VV S ++ME M DLK + +++ + V+ M+Q+
Sbjct: 69 HHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 525 ---EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR---QYGSPLKPYTHLVVTL 578
+G+ YL+ N +HRDL N ++ +KI DFG+ R + K L+
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAEL--LSKEP 613
W +PE L ++T D+WS G ++ E+ L+++P
Sbjct: 187 WM-SPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 509 QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567
P ++ Q+ +G+ +L +HRD+ N+LL + KICDFGLAR +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 568 ---LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+K L V + APE + Y+ D+WS G ++ E+ S
Sbjct: 267 NYVVKGNARLPVK--WMAPESIFDC-VYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP----LKPYTHLVVT 577
Q+ +G+ +L +HRDL N+LL + KICDFGLAR + +K L V
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ APE + Y+ D+WS G ++ E+ S
Sbjct: 282 --WMAPESIFNC-VYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 21/46 (45%), Positives = 32/46 (69%)
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+K +M Q+L G++ LH ++HRD+K NLL+ G++KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 18/165 (10%)
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCL 519
+++ H +V + V V D MV EY++ L + K S +
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV 106
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-------LKICDFGLARQYGSPLKPYT 572
QL + YL D ++H ++ N+L+ G +K+ D G+ +
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSRE 162
Query: 573 HLVVTLWYRAPELL-LGSKQYSTAIDMWSLGCIMAELLS--KEPL 614
V + + APE + G + A D WS G + E+ S +EPL
Sbjct: 163 ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 27/140 (19%)
Query: 490 FMVMEYME-HDLKGLMETMK-------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLK 541
+VME+ DLKG + + + P + + C ++ G+ +LH N +H DL
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC---EIALGLLHLHKNNFIHSDLA 127
Query: 542 TSNLLLNNRGELKICDFGLARQ------YGSPLKPYTHLVVTLWYRAPELL------LGS 589
N LL +KI D+GL+ Y +P + + V L + APEL+ L
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW----VPLRWIAPELVDEVHGNLLV 183
Query: 590 KQYSTAIDMWSLGCIMAELL 609
+ ++WSLG + EL
Sbjct: 184 VDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 33/179 (18%)
Query: 411 SVDEFERLNKIDEGTYGVVYRA-----RDKKTGEIVALKKVKMEKEREGFPLTSLREI-- 463
D+F K+ EG +GVVY+A + KK G+ V LKK E + +R
Sbjct: 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEYGAVEIWMNERVRRACP 188
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM-EHDLKGLMETMKQPFSQSE------- 515
N F + E V D ++V Y E L LM++ + P++
Sbjct: 189 NSCADFVY----GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQ 244
Query: 516 ------------VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLA 561
++ +M Q+L + LH ++HRD+K N++ + G KI D G A
Sbjct: 245 DLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 9/79 (11%)
Query: 485 NLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTS 543
I VMEY+E LK L+ + + + L G LH ++H DL TS
Sbjct: 72 ENFII--VMEYIEGEPLKDLINSNGMEELE---LSREIGRLVGK--LHSAGIIHGDLTTS 124
Query: 544 NLLLNNRGELKICDFGLAR 562
N++L+ G++ + DFGLA
Sbjct: 125 NMILSG-GKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 14/114 (12%)
Query: 500 LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559
L ++E +P ++ E+ + LQ L ++ LH L T + LL G
Sbjct: 3 LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DG 54
Query: 560 LARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613
P + APE++ G + Y+ D++SLG + E L E
Sbjct: 55 SVAFKT----PEQSRPDPYF-MAPEVIQG-QSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 31/206 (15%)
Query: 443 LKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI--FMVMEYME-HD 499
LK KE+ F L++ + HP+I+ +G +++I +V EY E D
Sbjct: 30 LKANASSKEQNEF----LQQGDPYRILQHPNILQC----LGQCVEAIPYLLVFEYCELGD 81
Query: 500 LKGLMETMKQPFSQSEVKCLMLQ-----LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELK 554
LK + + S++ L+LQ + G+ ++H + LH DL N L + +K
Sbjct: 82 LKSYLSQEQWHRRNSQL--LLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVK 139
Query: 555 ICDFGL--ARQYGSPLKPYTHLVVTLWYRAPEL-------LLGSKQYSTAIDMWSLGCIM 605
+ D+G+ +R ++ V L + APEL L+ ++Q + ++W+LG +
Sbjct: 140 VGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS-NVWALGVTL 198
Query: 606 AELL--SKEPLFNGKSEFDQLDKIFK 629
EL + +P ++ S+ + L+ + K
Sbjct: 199 WELFENAAQP-YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 776 | |||
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.16 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.04 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.85 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.75 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.49 | |
| PLN02236 | 344 | choline kinase | 96.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.1 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.53 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.36 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.88 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.63 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.44 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.25 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.42 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.49 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.26 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 89.02 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 88.21 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 87.81 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-67 Score=551.37 Aligned_cols=341 Identities=70% Similarity=1.147 Sum_probs=321.2
Q ss_pred ccccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC
Q 004049 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN 485 (776)
Q Consensus 406 ~~~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~ 485 (776)
+.+|+++++|+.++.|++|+||.||+|+++.|++.||+|.++++....++....++||++|.+++|||||.+.++.++.+
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
.+.+|||||||+++|..++..+.++|...+++.++.|+|.||+|||.++|+||||||+|+|++..|.+||+|||||+.++
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
++...++..+.|.||+|||++.+.+.|+.++||||+|||+.||++++|.|.|.++.+|+++||+.+|+|++.+||++..+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcc-hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCcchh
Q 004049 646 PGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQ 724 (776)
Q Consensus 646 p~~~-~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~~~~ 724 (776)
|..+ .++.++.++.++.+|+... +++.+++||+.||.+||.+|+||.|+|+|.||.+.|+|..+.++|+||..
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~------lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k 382 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALS------LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAK 382 (419)
T ss_pred chhhccccCCCCchhhhhhccccc------cchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccc
Confidence 9984 8999999999999998754 78999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhhcCCCcHHHHHHHHhhhc
Q 004049 725 HAQDRRMRRMMKSPDPLEEQRRKELQQG 752 (776)
Q Consensus 725 ~~~~~~~r~~~~~~~p~~~qr~ke~~q~ 752 (776)
..++..-+.....+.........++.+.
T Consensus 383 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 410 (419)
T KOG0663|consen 383 SEQQRVKRGTSPRPPEGSQLGDDDLKET 410 (419)
T ss_pred cccccCCCCCCCCCCcchhhccchHhhh
Confidence 8888765555555544444444444433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=513.86 Aligned_cols=321 Identities=50% Similarity=0.885 Sum_probs=287.2
Q ss_pred cccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 407 QGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 407 ~~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
...+..+.|+.+++||+|+||.||+|++..||+.||+|++..+.....+.....+||.||++|.||||++|.+.......
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 34456789999999999999999999999999999999999998888888999999999999999999999999987766
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|||||||+++|..++....-.|++.+++.||+||+.||+|||++||+|||||..|||||.+|.+||+|||||+++..
T Consensus 191 ~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 78999999999999999998888899999999999999999999999999999999999999999999999999997754
Q ss_pred CC-CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 567 PL-KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 567 ~~-~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. ..++..+.|+||+|||+|+|...|+.++|+||+||||.||++|+|.|.+.++.+|+.+||+.+|.|.+..|+ ..++
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kL 349 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL 349 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccC
Confidence 33 357888999999999999999999999999999999999999999999999999999999999999999999 7778
Q ss_pred CCcchhhhhhh-hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCcchh
Q 004049 646 PGVKVNFIKHQ-YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQ 724 (776)
Q Consensus 646 p~~~~~~~~~~-~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~~~~ 724 (776)
|.+..-...+. ...++..+ ..++..+.+||..||..||.+|.||.++|+|+||...+++..+..+|.++..
T Consensus 350 P~~~~~kp~~~y~r~l~E~~--------~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s 421 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETF--------KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPS 421 (560)
T ss_pred CcccccCCCCcccchHHHHh--------ccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcc
Confidence 85433222222 22233322 2489999999999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHHhhc
Q 004049 725 HAQDRRMRRMMK 736 (776)
Q Consensus 725 ~~~~~~~r~~~~ 736 (776)
+.-+.+.++..+
T Consensus 422 ~E~~~K~r~e~~ 433 (560)
T KOG0600|consen 422 HELDAKRRREQK 433 (560)
T ss_pred hhHHHHHHHHHh
Confidence 888776665543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-58 Score=466.83 Aligned_cols=296 Identities=47% Similarity=0.879 Sum_probs=268.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|..++.||+|.||.||+|++..||+.||||+|+.....++.....+|||++|+.++|+||+.|+++| ...+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEE
Confidence 578899999999999999999999999999999999888888888999999999999999999999999 556689999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
+||++.+|...+......|+..+++.|+.+++.||+|||.++|+||||||.|+||+.+|.+||+|||+|+.+.++....+
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998888888
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+.|.||+|||+++|.+.|+..+||||.|||+.||+.+.|.|.|.++.+|+..||+.+|+|.+..||++..+|++..-
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~- 238 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI- 238 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH-
Confidence 8899999999999999999999999999999999999999999999999999999999999999999999999975321
Q ss_pred hhhhhhHhhhcCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFT-GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPT 720 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~-~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~ 720 (776)
. .+|..... .-+-.+.++.|||.+||.+||.+|+||.|+|+|+||...|.|....-+|.
T Consensus 239 ~---------~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~ 298 (318)
T KOG0659|consen 239 Q---------QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPI 298 (318)
T ss_pred h---------cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcC
Confidence 1 12221111 12347888899999999999999999999999999999887766554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-56 Score=461.14 Aligned_cols=288 Identities=38% Similarity=0.676 Sum_probs=252.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++.|+.+.++|+|+||+||+++++.||+.||||++..........+..++||.+|++|+|+|+|.|+++| .....++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhL 78 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHL 78 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEE
Confidence 3679999999999999999999999999999999976655555556778999999999999999999999 55668999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||||+.+.+..+......++...++.|++|++.|+.|||+++||||||||+||||+.+|.+||||||+|+.+..+...+
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 99999999999999998999999999999999999999999999999999999999999999999999999998788889
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
+.++.|.||+|||++.|...|++++||||+||++.||++|.|.|.+.++.+|+..|...+|........-|.+.+-+..-
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 99999999999999999889999999999999999999999999999999999999999998765544444443322111
Q ss_pred -hh-hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 -FI-KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 -~~-~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+. ......++.+|| .++..+.||+++||..||.+|++++|+|.||||..+
T Consensus 239 ~lP~~~~~epLe~k~p--------~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYP--------KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ecCCCCCccchhhhcc--------cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 00 111223444444 478899999999999999999999999999999653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=468.27 Aligned_cols=273 Identities=32% Similarity=0.503 Sum_probs=241.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+++.+.|++.||+|++++....+. .......|..||..++||+||.++..| ++..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeE
Confidence 45899999999999999999999999999999999988765443 345667899999999999999999999 666799
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||+||+.|+.+..+.+..+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||||+..-....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999988888888888999999999999999999999999999999999999999999999999999997655556
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...++|||+.|||||++.+ ..|+.++|||||||+||+||+|.+||.+.+....+++|.+.-.
T Consensus 181 ~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~----------------- 242 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL----------------- 242 (357)
T ss_pred ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----------------
Confidence 6677999999999999998 5799999999999999999999999999999999999876521
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHHcCcCcCCCCCCCC--CCCCCCcc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI----TAEAALNHDWFREVPLPKS--KDFMPTFP 722 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp----Ta~EIL~HPwf~~i~~pk~--~~~~~~~~ 722 (776)
...+..++.+++|||++||+.||.+|+ ++.+|.+||||..+.|.+. ..+.|.|.
T Consensus 243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~ 302 (357)
T KOG0598|consen 243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFK 302 (357)
T ss_pred -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCee
Confidence 011224899999999999999999997 6899999999999998643 34445443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=467.48 Aligned_cols=263 Identities=35% Similarity=0.521 Sum_probs=224.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-----CccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
+.|.+.+.||.|+||.|.+|+.+.||+.||||++++...... ......+|++||++|+|||||+++++| ...+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~~d 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EVPD 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ecCC
Confidence 678999999999999999999999999999999987653321 122346899999999999999999999 4556
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEeeccccccc
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKICDFGLARQY 564 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~DFGlA~~~ 564 (776)
..||||||++|+.+....-.++.+.+..-+.+++||+.||.|||++||+||||||+||||..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 889999999976544444456779999999999999999999999999999999999999876 78999999999988
Q ss_pred CCCCCCccccccccccCCchhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD-QLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~--~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~-~l~kI~~~lg~p~~~~wp~ 641 (776)
+ ....+.++||||.|.|||++.+.+ .|..++|||||||+||.+|+|.+||....... ..++|.++-...-...|.
T Consensus 330 g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~- 407 (475)
T KOG0615|consen 330 G-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD- 407 (475)
T ss_pred c-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh-
Confidence 6 556778899999999999997632 35568999999999999999999998876655 777777765444333332
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.+|.++++||.+||..||++|||+.|+|+||||+.++.
T Consensus 408 --------------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 408 --------------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred --------------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 28999999999999999999999999999999997764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=475.90 Aligned_cols=285 Identities=42% Similarity=0.717 Sum_probs=249.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..++|.++++||.|+||.||+|+.+.++..||||.++..... .....-+||++.|++|. |||||+|++++.+.+. .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 457899999999999999999999999999999999765432 22344579999999999 9999999999976543 89
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+|||||+.+|++++..+++.|++..++.|+.||++||+|+|.+|++|||||||||||.....|||+|||||+.+.+ ..
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-kp 164 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-KP 164 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-CC
Confidence 99999999999999999999999999999999999999999999999999999999999989999999999998854 46
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
+++.++.|.||+|||+|.....|+.++||||+|||++|+.+-+|.|.|.++.+++.+|...+|+|....|+.-..+.
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La--- 241 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA--- 241 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH---
Confidence 78889999999999999998999999999999999999999999999999999999999999999999998632111
Q ss_pred hhhhhhhhhHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..+.-.+|.... ..-+..+.++.+||.+||.+||.+||||.|+|+||||+..
T Consensus 242 --------~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 242 --------SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred --------HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 111111221111 1123489999999999999999999999999999999863
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=448.41 Aligned_cols=293 Identities=50% Similarity=0.897 Sum_probs=263.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC-cceeeEEEeccC----C
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS-IVDVKEVVVGSN----L 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn-IV~l~~~~~~~~----~ 486 (776)
...|+.+++||+|+||+||+|+.+.+|+.||+|++......++......+|+.+|+.|+|+| ||.|++++...+ .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999988777777888899999999999999 999999996544 2
Q ss_pred CeeEEEeeehhhhhhhHHhhcc---CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 487 DSIFMVMEYMEHDLKGLMETMK---QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~---~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
..+||||||+.-+|..++.... ..++...++.+++||+.||+|||+++|+||||||.||||+..|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3789999999999999998876 4689999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
+.-+...+++.++|.||+|||++.|...|+..+||||+|||++||+++++.|.+.++.+++..|+..+|+|++..||+..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 87788888999999999999999998899999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcchhhhhhh-hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 644 KLPGVKVNFIKHQ-YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 644 ~lp~~~~~~~~~~-~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.++.++..|.... ...+... .+..++.+.+|+.+||+++|.+|+||..+|.||||+..+.+
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~--------~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSI--------LPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred ccccccccCcCCCCccchHHh--------ccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 9998876443322 1112211 22355789999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=466.91 Aligned_cols=256 Identities=32% Similarity=0.493 Sum_probs=230.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|...+.||+|+|++||.+++..+|..||+|++.+... ......+..+||+|.+.|+|||||+++.+| ++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence 569999999999999999999999999999999977553 334456678999999999999999999999 55669999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|+|+|..+.+..+.+..++|+|.+|++|++||+.||.|||+++|||||||..||||+.+.++||+|||||+.+..+....
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999966666666678899999999999999999999999999999999999999999999999999999998666667
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
.+.||||.|+|||++.. ..++..+||||+||+||.||+|+|||...+..+.+.+|...-..
T Consensus 176 ~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~------------------ 236 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS------------------ 236 (592)
T ss_pred ceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc------------------
Confidence 78999999999999997 56899999999999999999999999999999999988664221
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+|.+++|||.+||+.||.+|||+++||.|+||..
T Consensus 237 -------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 237 -------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 12248999999999999999999999999999999954
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=462.30 Aligned_cols=280 Identities=31% Similarity=0.468 Sum_probs=239.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecch-hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|+++..||+|+||.||+|+.+.||..||+|++++.. .........+.|..||....+|+||+|+..| ++.+++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence 6799999999999999999999999999999999998765 3445566778899999999999999999999 667799
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC---
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS--- 566 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s--- 566 (776)
||||||++|+-...++...+.|++..+++|+.+++.||+.||++|+|||||||+|+|||..||+||+||||++-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999877777777788999999999999999999999999999999999999999999999999999853310
Q ss_pred --------------------CCC------------------------CccccccccccCCchhhccCCCCCccchhhhHH
Q 004049 567 --------------------PLK------------------------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLG 602 (776)
Q Consensus 567 --------------------~~~------------------------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLG 602 (776)
... .....+|||.|||||+|.+ +.|+..+||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence 000 0123579999999999999 5599999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHH
Q 004049 603 CIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDL 682 (776)
Q Consensus 603 vlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DL 682 (776)
|||||||.|.|||.+.+..+...+|++-..+ ..|.....++++++||
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------------------------l~fP~~~~~s~eA~DL 422 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------------------------LKFPEEVDLSDEAKDL 422 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------------------------ccCCCcCcccHHHHHH
Confidence 9999999999999999999999999763111 1122233478999999
Q ss_pred HHHhcccCCCCCCC---HHHHHcCcCcCCCCCCCCCCCCCCcchhhHH
Q 004049 683 LNSLLTYDPDKRIT---AEAALNHDWFREVPLPKSKDFMPTFPAQHAQ 727 (776)
Q Consensus 683 L~kLL~~DP~kRpT---a~EIL~HPwf~~i~~pk~~~~~~~~~~~~~~ 727 (776)
|.+||+ ||.+|+. ++||.+||||+.|.|.......+.|.++...
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 999999 9999995 8999999999999998876666666655443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=431.51 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=232.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||.|+||.|.+++.+.+|..||+|++++... ...+.....+|..+|+.+.||+++.+++.| .+..++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeE
Confidence 56899999999999999999999999999999999987653 223344567899999999999999999988 455699
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||||++|+.+..+....++|++..+++|++||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999877777777789999999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
..+.||||.|+|||++.. +.|+.++|||||||++|||+.|.+||...+....+++|+.+...
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~---------------- 259 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK---------------- 259 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc----------------
Confidence 567899999999999988 67999999999999999999999999999999999999876211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPK 713 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk 713 (776)
| +..++.+++|||.+||+.|-.+|. ...+|.+||||+.+.|.+
T Consensus 260 --------------f-------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 260 --------------F-------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred --------------C-------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 1 235899999999999999999995 578999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=449.16 Aligned_cols=264 Identities=30% Similarity=0.483 Sum_probs=231.8
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
.....+|.+++.||.|+|++||+|+.+.+++.||||++.+... .+...+...+|-.+|.+| .||.|++|+..| ++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecc
Confidence 4567899999999999999999999999999999999976653 334445566899999999 799999999999 555
Q ss_pred CeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 487 DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
..+|+|+||++ |+|+.++... +.|++..+++|+.||+.||+|||++|||||||||+|||||.++++||+|||.|+.+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 68999999998 5677777664 789999999999999999999999999999999999999999999999999998774
Q ss_pred CCC-----------C--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004049 566 SPL-----------K--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632 (776)
Q Consensus 566 s~~-----------~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg 632 (776)
... . ...+++||..|.+||+|.. ...++.+|||+||||||+||.|.|||.+.++.-.+++|++...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 211 1 1256899999999999987 6689999999999999999999999999999999999988743
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.. ++.+++.+.|||.++|..||.+|+|+.||.+||||..|.|.
T Consensus 305 ~f-------------------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 305 EF-------------------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred cC-------------------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 32 23478899999999999999999999999999999999875
Q ss_pred C
Q 004049 713 K 713 (776)
Q Consensus 713 k 713 (776)
.
T Consensus 348 n 348 (604)
T KOG0592|consen 348 N 348 (604)
T ss_pred h
Confidence 3
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=433.40 Aligned_cols=296 Identities=40% Similarity=0.677 Sum_probs=248.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec---cCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG---SNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~---~~~~~l 489 (776)
..|..++.||.|+||.|+.|.++.+|..||||++..........+..++|+.+|+.++|+||+.+++++.. .....+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666899999999999999999999999999997665555667788999999999999999999999965 445679
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC--C
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS--P 567 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s--~ 567 (776)
|+|+|+|+.+|...+.. ++.|++..+..+++|||.||+|+|+.||+||||||.|||++.+..+||||||||+.... .
T Consensus 102 YiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999998888877765 44599999999999999999999999999999999999999999999999999998743 2
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
....+..+.|.||+|||++.....|+.++||||+||||.|||+|++.|.|.+..+|++.|+..+|+|.+..+..+.....
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34457789999999999999888999999999999999999999999999999999999999999997765433221000
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~ 716 (776)
..+++ .+ ...|...| ..-+..++.+.|||.+||.+||.+|+|++|+|+||||.....|..+.
T Consensus 261 --r~yi~----sl-p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 261 --RPYIK----SL-PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred --HHHHH----hC-CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 00111 11 11121121 12346899999999999999999999999999999999988776655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=457.58 Aligned_cols=275 Identities=29% Similarity=0.465 Sum_probs=237.6
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCC
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNL 486 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~ 486 (776)
...+++|.+++.||+|+||+|++|..+.+++.||||++++...- .......+.|..|+.... ||++++|+..| +..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccC
Confidence 34679999999999999999999999999999999999887643 333445667888888775 99999999999 555
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+++|+||||+.|+. ..+....+.|++..+++|++.|+.||+|||++||||||||.+|||||.+|++||+||||++..-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 69999999999877 33444457899999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......++||||.|||||++.+ ..|+.++|||||||||||||+|..||.++++.+.++.|+.. +..+|.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----~~~yP~----- 589 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----EVRYPR----- 589 (694)
T ss_pred CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----CCCCCC-----
Confidence 5667788999999999999998 67999999999999999999999999999999999999764 222221
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCCCC--CCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLPKS--KDFMP 719 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~pk~--~~~~~ 719 (776)
++|.++.++|++||++||++|+. +.+|.+||||+.|.|.+. ..+.|
T Consensus 590 ---------------------------~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 590 ---------------------------FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred ---------------------------cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 38999999999999999999995 589999999999998653 33445
Q ss_pred Ccchh
Q 004049 720 TFPAQ 724 (776)
Q Consensus 720 ~~~~~ 724 (776)
.|.+.
T Consensus 643 Pf~P~ 647 (694)
T KOG0694|consen 643 PFVPT 647 (694)
T ss_pred CCCcc
Confidence 55443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=422.13 Aligned_cols=300 Identities=27% Similarity=0.430 Sum_probs=254.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+.|++.+.||+|.|+.||++.++.||+.+|+|+|+...........+.+|+.|.+.|+|||||+|++.+ +.....||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEE
Confidence 3679999999999999999999999999999999988776666677788999999999999999999998 44558899
Q ss_pred Eeeehhhhh-hhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEeecccccccCCC
Q 004049 492 VMEYMEHDL-KGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g~L-l~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~DFGlA~~~~s~ 567 (776)
|||++.|+. ...+.++ ..++|..+..+++||+.||.|||.+||||||+||+|+||... .-+||+|||+|..+. .
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999754 4444433 568999999999999999999999999999999999999643 459999999999987 5
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......++|||.|||||++.. ..|+..+|||+.|||||.||.|.+||.+.+...+++.|+++-...+.+.|+.
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~------ 238 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT------ 238 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc------
Confidence 566677899999999999987 5699999999999999999999999999999999999999877666666654
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCcchhhHH
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQ 727 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~~~~~~~ 727 (776)
+++++++||++||..||.+|+|+.|+|+|||+++-
T Consensus 239 ---------------------------is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r------------------ 273 (355)
T KOG0033|consen 239 ---------------------------VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR------------------ 273 (355)
T ss_pred ---------------------------CCHHHHHHHHHHhccChhhhccHHHHhCCchhcch------------------
Confidence 89999999999999999999999999999999752
Q ss_pred HHHHHHhhcCCCcHHHHHHHHhhhccccccccccccceeeeeeecccC
Q 004049 728 DRRMRRMMKSPDPLEEQRRKELQQGELGIHSDLYGEIVCTILSTRFLA 775 (776)
Q Consensus 728 ~~~~r~~~~~~~p~~~qr~ke~~q~~~~~~~~~~~~~~~~~~~~r~~~ 775 (776)
.++..++..++....-|+ .....+|.+++..+|.++||++
T Consensus 274 -~~~As~~H~~dtvd~lrk-------fNarRKLKgavLtav~s~r~~s 313 (355)
T KOG0033|consen 274 -ERVASAIHRQDTVDCLKK-------FNARRKLKGAILTTVIATRNLS 313 (355)
T ss_pred -HHHHHHhhhHHHHHHHHH-------hhHHHHHHHHHHHHHHhccccc
Confidence 234444444444333333 3345567788888888888874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=427.40 Aligned_cols=261 Identities=31% Similarity=0.474 Sum_probs=224.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++++.++.||+|..|+||+|+++.|++.+|+|+|.... ......++.+|++|++.++||+||.+|+.|+.... .++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEE
Confidence 3467889999999999999999999999999999995433 23345677899999999999999999999976654 699
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+|+.++.+....+.++|.....++.+|++||.|||. ++||||||||+||||+..|.+||||||.+..+.+.
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999987666666666889999999999999999999995 99999999999999999999999999999987654
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-----SEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-----s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
...+++||..|||||.+.+ ..|+.++||||||++|+||++|+.||... +..+++..|+.. |+..+
T Consensus 233 ~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---ppP~l------ 302 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PPPRL------ 302 (364)
T ss_pred hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CCCCC------
Confidence 6688999999999999998 57999999999999999999999999774 445566666443 21111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
|. ..+|+++++||..||++||.+|+|+.|+|+|||+++...
T Consensus 303 --------------------P~------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 303 --------------------PE------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred --------------------Cc------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 11 138999999999999999999999999999999987543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=414.45 Aligned_cols=285 Identities=42% Similarity=0.800 Sum_probs=238.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||.|+||+||+|.++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 5789999999999999999999999999999999975432 2223456789999999999999999999844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.+++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 99999998888887766678999999999999999999999999999999999999999999999999998664444444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.|....|+.+.....+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 55688999999999987667899999999999999999999999999999999999999999999999876543322110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.. ... .........+.++.+++|||.+||++||.+|||+.|||+||||
T Consensus 241 ~~----~~~---~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LF----PQY---RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cc----Ccc---CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 000 0000111224578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=432.87 Aligned_cols=258 Identities=33% Similarity=0.495 Sum_probs=226.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~ 486 (776)
..+.|.+.+.||+|+||+|++|.+..++..||+|++...... ......+.+|+.+++.+. ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 457899999999999999999999999999999988765322 123445568999999999 999999999996554
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeeccccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQY 564 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~ 564 (776)
++|+|||||.| +|++.+.. .++|.|.+++.+|+||+.||+|||++||+||||||+||||+.+ +++||+|||++...
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred -eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 69999999996 78888877 7889999999999999999999999999999999999999999 99999999999987
Q ss_pred CCCCCCccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
........+.|||+.|+|||++.+.. +.+.++|||||||+||.|++|..||...+...++.+|.++.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~------------ 239 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE------------ 239 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC------------
Confidence 43456778899999999999999866 55689999999999999999999999988877877765541
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVL-SDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~l-S~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
+..+..+ |.++++||.+||..||.+|+|+.+|+.||||+.
T Consensus 240 -------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 -------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1112236 999999999999999999999999999999997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=422.43 Aligned_cols=284 Identities=38% Similarity=0.638 Sum_probs=237.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC---eeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD---SIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~---~l~ 490 (776)
.|...+.+|.|+||.||.|....++..||||++-.+.... -+|+.||+.+.|||||+|+.+|...... ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4888999999999999999999999999999986544321 2799999999999999999998754443 567
Q ss_pred EEeeehhhhhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccccCC
Q 004049 491 MVMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~~s 566 (776)
|||||++-+|...+... +..++.-.++-|+.||++||.|||..||+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~- 177 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV- 177 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec-
Confidence 89999999998887753 6789999999999999999999999999999999999999976 999999999999884
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
...+..+...|..|+|||++.|...|+.++||||.||++.||+.|++.|.|++..+|+..|++.+|+|+.+....
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~----- 252 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS----- 252 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh-----
Confidence 345567788999999999999999999999999999999999999999999999999999999999998664322
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+.++....+..+....- .. ......++++.|||.++|+++|.+|.++.|+|.||||.+...+
T Consensus 253 -mn~~y~~~~~p~ik~~~~-~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 -MNPNYTEFKFPQIKAHPW-HK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred -cCcccccccCcccccccc-ee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 111221111111111110 00 1234588999999999999999999999999999999987554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=384.04 Aligned_cols=287 Identities=46% Similarity=0.829 Sum_probs=262.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|...++||+|+||+||+|+.+.+++.||+|.+..+...++.....++||-+|+.|+|.|||+++++... ...+-||
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35777899999999999999999999999999999988888888899999999999999999999999843 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
+|||..+|..++...++.++.+.++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+++.++-+...+.
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988877788
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
..+.|.||++|.++.|.+-|+...|+||.|||+.|+.. |.|.|.+.+..+|+.+||..+|.|.+..||.+.++|+++..
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 88999999999999999999999999999999999986 89999999999999999999999999999999999998765
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+........+..| .++...+|||+++|.-+|.+|++|+++|+||||...
T Consensus 240 p~ypattswsqivp--------~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVP--------KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhh--------hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 44433333333333 367778999999999999999999999999999753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=440.54 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=234.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecch-hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.++-|++.+.||.|+.|.|.+|++..||+.+|||+|.+.. ........+.+||-||+.|.||||+++|++| ++..++
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~l 87 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHL 87 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceE
Confidence 3466999999999999999999999999999999998763 4444556778999999999999999999999 566799
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||+||+.|+-+..+.-.+++|++.++.++++||+.||.|||..+|+||||||+|+|||..++|||+|||+|..- .+..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gk 166 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGK 166 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCCc
Confidence 999999997766666666789999999999999999999999999999999999999999999999999999865 4556
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...+.||+|.|.|||++.|.++.+.++||||+|||||.||+|..||++++-..++.++.++.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------------ 228 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------------ 228 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------------
Confidence 77889999999999999998888999999999999999999999999988888888886652
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
|..+..++.+++|||.+||.+||.+|+|.+||++|||+.+..-
T Consensus 229 -------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 229 -------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 3344569999999999999999999999999999999988653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=422.63 Aligned_cols=272 Identities=26% Similarity=0.387 Sum_probs=228.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|.-|+||+|..+.++..+|+|++.+.... .....+...|.+||..+.||+++.||..| +....+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~ 152 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYS 152 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--ecccee
Confidence 467899999999999999999999999999999999877643 33445667899999999999999999999 445689
Q ss_pred EEEeeehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC-
Q 004049 490 FMVMEYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS- 566 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s- 566 (776)
|||||||.|+ |..+++.. .+.|++..+++|+.+|+.||+|||..|||+|||||+||||.++|+|+|+||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999975 44444433 45699999999999999999999999999999999999999999999999998753310
Q ss_pred --------------------------------C-C----------------------CCccccccccccCCchhhccCCC
Q 004049 567 --------------------------------P-L----------------------KPYTHLVVTLWYRAPELLLGSKQ 591 (776)
Q Consensus 567 --------------------------------~-~----------------------~~~~~~~GT~~Y~APEvl~g~~~ 591 (776)
. . .....++||-.|+|||++.|. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-G 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-G 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-C
Confidence 0 0 012346899999999999994 5
Q ss_pred CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCC
Q 004049 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTG 671 (776)
Q Consensus 592 ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~ 671 (776)
++.++|||+|||+|||||.|..||.|.+..+.+..|+..- ..|..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-----------------------------------l~Fp~ 356 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-----------------------------------LKFPE 356 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-----------------------------------CcCCC
Confidence 7999999999999999999999999999999988886531 12233
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCC----HHHHHcCcCcCCCCCCCCCCCCCC
Q 004049 672 SPVLSDAGFDLLNSLLTYDPDKRIT----AEAALNHDWFREVPLPKSKDFMPT 720 (776)
Q Consensus 672 ~~~lS~~~~DLL~kLL~~DP~kRpT----a~EIL~HPwf~~i~~pk~~~~~~~ 720 (776)
.+.++.+++|||++||.+||.+|+. |.||.+||||++++|.-.....|.
T Consensus 357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP 409 (459)
T KOG0610|consen 357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPP 409 (459)
T ss_pred CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCC
Confidence 3458899999999999999999998 999999999999999744433333
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=412.75 Aligned_cols=290 Identities=40% Similarity=0.771 Sum_probs=237.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||.|+||+||+|.++.+++.||||++...... .....+.+|+.+++.+.||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 47899999999999999999999999999999999754322 223456789999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 99999999988888777789999999999999999999999999999999999999999999999999997654433444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS-EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
...++|+.|+|||++.+...++.++|||||||+||+|++|.+||.+.. ..+.+..++..++.|....|+.....+....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 556789999999999876678999999999999999999999998754 4567788888888888888887655443221
Q ss_pred hhhh-hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIK-HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~-~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.... .....+...+. ....+..+.+||.+||++||.+|||+.|||+||||+.++
T Consensus 241 ~~~~~~~~~~~~~~~~------~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 241 ERFTLYSPKNLRQAWN------KLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccCCccHHHHhh------ccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1000 00000111111 112567899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=411.41 Aligned_cols=296 Identities=46% Similarity=0.860 Sum_probs=251.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCc----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.+..|+.+..||+|+||.||+|..+.++. .||||+++.++...+......+|+.+++.|+||||+.|..+|... .
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 45789999999999999999997665543 799999998887777788889999999999999999999999764 5
Q ss_pred CeeEEEeeehhhhhhhHHhhc----cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC----CcEEEeec
Q 004049 487 DSIFMVMEYMEHDLKGLMETM----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR----GELKICDF 558 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~----~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~----g~iKL~DF 558 (776)
..++|++||.+++|+..+... .+.++...++.|+.||+.|+.|||++.|+||||||.||||..+ |.+||+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 689999999999999888653 3458999999999999999999999999999999999999987 89999999
Q ss_pred ccccccCCCCCCc---cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---------hHHHHHH
Q 004049 559 GLARQYGSPLKPY---THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS---------EFDQLDK 626 (776)
Q Consensus 559 GlA~~~~s~~~~~---~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s---------~~~~l~k 626 (776)
|+++.+.++..+. ...+.|.||+|||++.|...|++++|||++|||+.|||+-.|.|.+.. ..+++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999998776655 335789999999999999999999999999999999999999998753 2478999
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhh---hhH--hhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ---YNL--LRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~---~~~--l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
||..+|+|.+..||.+.++|.........+ +.. +.+. +.....-++.+.+||.+||++||-+|+||.++|
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~-----~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKY-----YHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHH-----HHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 999999999999999999987633222211 111 1110 111223456689999999999999999999999
Q ss_pred cCcCcCCCCCC
Q 004049 702 NHDWFREVPLP 712 (776)
Q Consensus 702 ~HPwf~~i~~p 712 (776)
+|+||.+.++|
T Consensus 336 eh~yF~~d~lp 346 (438)
T KOG0666|consen 336 EHPYFTEDPLP 346 (438)
T ss_pred cccccccCCCC
Confidence 99999998766
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=408.15 Aligned_cols=306 Identities=65% Similarity=1.114 Sum_probs=259.2
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
|..+++|++++.||.|+||.||+|.++.++..||+|++..............+|+.++++++|+||+++++++.+.....
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 45778999999999999999999999999999999999765544444445678999999999999999999997766567
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|+||||+.+++..++......+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 89999999998888887766789999999999999999999999999999999999999999999999999998775443
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.+....|+.+...+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 34444566889999999987667899999999999999999999999999999999999999999999999877655432
Q ss_pred ch-hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCcc
Q 004049 649 KV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFP 722 (776)
Q Consensus 649 ~~-~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~~ 722 (776)
.. .........+... ...++..+.+||.+||.+||.+|||+.++|.||||+..+++..+..+|+||
T Consensus 243 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 243 GKFTLPKQPYNNLKHK--------FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccccCCCCCchHHh--------ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11 1111111111111 123688999999999999999999999999999999999999889999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=416.79 Aligned_cols=263 Identities=32% Similarity=0.497 Sum_probs=224.6
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..+++|.+.+.||.|+||+||+|+++.++..||||.|.+.........-+..||.||+.|+|||||.|++++.. .+.+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeE
Confidence 45689999999999999999999999999999999998776444444556789999999999999999999954 5599
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC------CcEEEeecccccc
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR------GELKICDFGLARQ 563 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~------g~iKL~DFGlA~~ 563 (776)
|||||||.|+.+..+....+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999965555555556689999999999999999999999999999999999999875 4699999999998
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
+. +.....+.||++.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..+++..|.++....+
T Consensus 165 L~-~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-------- 234 (429)
T KOG0595|consen 165 LQ-PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-------- 234 (429)
T ss_pred CC-chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC--------
Confidence 85 4456677999999999999986 6799999999999999999999999999999888876644321110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..+..++....+|+..+|+.+|..|.+..+-+.|+++..-+
T Consensus 235 --------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 --------------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred --------------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 01113566677999999999999999999999999998755
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=421.42 Aligned_cols=270 Identities=30% Similarity=0.483 Sum_probs=227.8
Q ss_pred cccccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC------------ccchHHHHHHHHhCCCC
Q 004049 405 MLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF------------PLTSLREINILLSFHHP 472 (776)
Q Consensus 405 ~~~~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~------------~~~~~rEi~iL~~L~HP 472 (776)
-.+.+..+++|++++.||+|.||+|.+|++..+++.||||++.+....... .....+||.||++|+||
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 345566789999999999999999999999999999999999765422111 12456899999999999
Q ss_pred CcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 473 nIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
|||+|+++.-+...+.+|||+|||..+-..+.-..+.-|++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999999988888899999999997655554443333999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCC-----CCCCccccccccccCCchhhcc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 004049 553 LKICDFGLARQYGS-----PLKPYTHLVVTLWYRAPELLLG---SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624 (776)
Q Consensus 553 iKL~DFGlA~~~~s-----~~~~~~~~~GT~~Y~APEvl~g---~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l 624 (776)
+||+|||.+..+.. ........+|||.|+|||.+.+ ....+.+.|||||||+||.|+.|+.||.+....+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999987622 1222344789999999999987 234578999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
.+|.+.-- .|...+.+...++|||.+||++||++|+++.+|..||
T Consensus 329 ~KIvn~pL-----------------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 DKIVNDPL-----------------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHhcCcc-----------------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 99976411 1122234788999999999999999999999999999
Q ss_pred CcCCC
Q 004049 705 WFREV 709 (776)
Q Consensus 705 wf~~i 709 (776)
|...-
T Consensus 374 wvt~~ 378 (576)
T KOG0585|consen 374 WVTRD 378 (576)
T ss_pred eeccC
Confidence 99764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=427.38 Aligned_cols=256 Identities=33% Similarity=0.564 Sum_probs=231.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+....+.....+.+|+.|++.|+|||||.++++| +...++++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEE
Confidence 3679999999999999999999999999999999987766665566678999999999999999999999 55569999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|+||+.|+|..++.. .+.|+|+.++.++.+++.||.|||+++|+|||+||.||||+..|++||||||+|+.........
T Consensus 79 Vte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 79 VTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred EehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 999999977776665 5679999999999999999999999999999999999999999999999999999988777777
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
+..-|||.|||||++.+ ..|+..+|+||||||||||++|+|||...+-.++...|... +..||.
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----~v~~p~---------- 221 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----PVKPPS---------- 221 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----CCCCcc----------
Confidence 88899999999999997 77999999999999999999999999999888888888654 122221
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..|..+.+||..+|.+||.+|+|..++|.|||.++
T Consensus 222 ----------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 ----------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ----------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 37899999999999999999999999999999876
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=400.77 Aligned_cols=290 Identities=44% Similarity=0.801 Sum_probs=241.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|.+++.||+|+||.||+|+++.++..||+|.++.... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 80 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLT 80 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEE
Confidence 35789999999999999999999999999999999975542 2233456789999999999999999999854 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99999999888888776677999999999999999999999999999999999999999999999999999865444344
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.|....|+.+.......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK- 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh-
Confidence 4456789999999999876678999999999999999999999999999999999999999999888888754332110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.... ....+...+...+.++.++++||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 240 ---~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 ---NYNF---PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred ---hhhc---CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 00001111122345889999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=403.29 Aligned_cols=277 Identities=30% Similarity=0.458 Sum_probs=243.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|+.++.||+|.||+|.+++.+.+++.||||++++...- .......+.|-.+|+..+||++..|...| +..+.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceE
Confidence 468999999999999999999999999999999999877632 23344567899999999999999999888 556699
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+.|+.+.+.......|++..+++|-.+|+.||.|||+++||+||||.+|+|||.+|+|||+||||++.-.....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999998888888888999999999999999999999999999999999999999999999999999998767777
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...++||||.|+|||++.. ..|+.++|||.+||++|||+||+.||+..+...++..|+..-
T Consensus 324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------------ 384 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------------ 384 (516)
T ss_pred eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------------
Confidence 7888999999999999987 679999999999999999999999999999888888775531
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCCC--CCCCCCcc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPKS--KDFMPTFP 722 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk~--~~~~~~~~ 722 (776)
.+||. .++++++.||..||.+||.+|+ .|.||.+|+||..+.|... +.+.|.|.
T Consensus 385 ------------~kFPr-------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfK 445 (516)
T KOG0690|consen 385 ------------LKFPR-------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFK 445 (516)
T ss_pred ------------ccCCc-------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCC
Confidence 12222 4899999999999999999998 5899999999999988643 45566666
Q ss_pred hhhHH
Q 004049 723 AQHAQ 727 (776)
Q Consensus 723 ~~~~~ 727 (776)
++...
T Consensus 446 PqVtS 450 (516)
T KOG0690|consen 446 PQVTS 450 (516)
T ss_pred CCccc
Confidence 55443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=402.71 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=220.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+.+|+++++||+|+||.||++++..+|..||.|.|+..............|+.+|++|+|||||+++++-..++..-++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 45789999999999999999999999999999999986555544456678899999999999999999855445555699
Q ss_pred EEeeehh-hhhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhcc--CC--cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 491 MVMEYME-HDLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHD--NW--VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs--~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
||||||. |+|...+. +.++.++|..+|.|+.||+.||.+||. .. |+||||||.||+|+.+|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999998 45555543 335679999999999999999999998 44 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.+.+......+.+|||.||+||++.. ..|+.++|||||||++|||+.-++||.+++-..+..+|.++-..|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~------- 248 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL------- 248 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC-------
Confidence 99887777788999999999999998 5699999999999999999999999999988888888876632211
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
| ....|..+..||..||..||..||+. +|+++.+
T Consensus 249 ---p-------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 249 ---P-------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred ---c-------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 0 01378899999999999999999986 5555544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=396.35 Aligned_cols=280 Identities=40% Similarity=0.680 Sum_probs=226.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+++.++||||+++++++. ....+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence 4699999999999999999999999999999999765444444556778999999999999999999984 44589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-CCc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-KPY 571 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~~~ 571 (776)
|||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9999998888777666789999999999999999999999999999999999999999999999999998764322 223
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+..+...+....
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG- 236 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc-
Confidence 34678999999999987 4589999999999999999999999999888887777766655544332222111111000
Q ss_pred hhhhhhhHhhhcCCCCC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATS------FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~------~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..++... ......++..+.+||.+||++||.+|||+.++|+||||
T Consensus 237 ----------~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 ----------LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ----------cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000 00112478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=423.50 Aligned_cols=290 Identities=35% Similarity=0.563 Sum_probs=232.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-C-----CCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-H-----PSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-H-----PnIV~l~~~~~~~~~ 486 (776)
.+|++++.||+|+||.|.+|.+..|++.||||+++.... +......|+.||..|+ | -|||+++++|...
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-- 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-- 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--
Confidence 489999999999999999999999999999999986543 2345567999999997 3 3999999999654
Q ss_pred CeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC--CcEEEeecccccc
Q 004049 487 DSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR--GELKICDFGLARQ 563 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~--g~iKL~DFGlA~~ 563 (776)
+++|||+|.+.-+|..++...+ .+|+...++.++.||+.||.+||+.||||+|||||||||..- ..|||+|||.|+.
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 5999999999999999998764 579999999999999999999999999999999999999764 4799999999998
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .+ +.+.+..|+|||+|.| ..|+.+.||||||||++||++|.|+|.|.++.+|+..|+..+|.|+..++..+.
T Consensus 341 ~~q~--vy-tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQR--VY-TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCc--ce-eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6532 33 7889999999999999 679999999999999999999999999999999999999999999866544332
Q ss_pred CCCCcchh--------------------hhhhhhh--HhhhcCCCCCCCCCC----CCCHHHHHHHHHhcccCCCCCCCH
Q 004049 644 KLPGVKVN--------------------FIKHQYN--LLRKKFPATSFTGSP----VLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 644 ~lp~~~~~--------------------~~~~~~~--~l~~~~p~~~~~~~~----~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
+.-.+... .....+. ......|...-.... .-...+.|||.+||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 21110000 0000000 111122211111111 223467899999999999999999
Q ss_pred HHHHcCcCcCCCCC
Q 004049 698 EAALNHDWFREVPL 711 (776)
Q Consensus 698 ~EIL~HPwf~~i~~ 711 (776)
.++|+||||.....
T Consensus 497 ~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 497 AQALNHPFLTGTSL 510 (586)
T ss_pred HHHhcCcccccccc
Confidence 99999999996543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=401.02 Aligned_cols=291 Identities=38% Similarity=0.616 Sum_probs=229.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l~ 490 (776)
+|++.+.||+|+||.||+|+++.++..||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754332223345778999999999999999999886432 23589
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-- 568 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-- 568 (776)
+||||+.++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999999888777654 4569999999999999999999999999999999999999999999999999997643221
Q ss_pred -CCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+...++..+....+.|....+..+....
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122446899999999998652 468899999999999999999999999998888888888887776554333221100
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.......+....+.......+.++..+.+||.+||..||.+|||+.+||+||||+.+..
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ------ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred ------HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00011111111121111122347888999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=391.60 Aligned_cols=282 Identities=40% Similarity=0.758 Sum_probs=228.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-CCcEEEEEEeecchhccCCccchHHHHHHHHhC---CCCCcceeeEEEec---cC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-TGEIVALKKVKMEKEREGFPLTSLREINILLSF---HHPSIVDVKEVVVG---SN 485 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~---~~ 485 (776)
.+|++++.||+|+||+||+|.+.. ++..||||++............+.+|+.+++.+ .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 478899999976554444444566788887766 69999999998852 23
Q ss_pred CCeeEEEeeehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 486 LDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...+|+||||+.+++..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4568999999999888877654 345899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|+...+.|....|+....
T Consensus 161 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 161 SFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred cCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 433 33345678999999999977 5689999999999999999999999999999999999999988887777765433
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
++..... ......+.. ..+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 239 ~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFH--SKSAQPIEK--------FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhcc--CCCCCCHHH--------HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 3221100 000000000 113478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=408.49 Aligned_cols=261 Identities=36% Similarity=0.584 Sum_probs=230.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
...|++.+.||+|.||.||+++.+.||+.||+|++++...... ......+|+.||++|. |||||.++++|.+ ...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 3679999999999999999999999999999999987654322 2346779999999998 9999999999954 4589
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC----CcEEEeeccccccc
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR----GELKICDFGLARQY 564 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~----g~iKL~DFGlA~~~ 564 (776)
|+|||+|.|+ |.+.+... .+++..+..++.||+.|+.|||+.||+||||||+|||+... +.+|++|||++...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999964 55555554 39999999999999999999999999999999999999743 47999999999988
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. .......|||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+......+|..+......+.|+.
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~--- 264 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD--- 264 (382)
T ss_pred cC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc---
Confidence 65 566778999999999999986 5799999999999999999999999999999999999988766666666654
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
++..+++||+.||..||.+|+|+.++|+|||++....
T Consensus 265 ------------------------------is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 265 ------------------------------ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred ------------------------------cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 7899999999999999999999999999999998643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=390.03 Aligned_cols=289 Identities=43% Similarity=0.790 Sum_probs=238.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||.|+||.||+|.++.++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 457899999999999999999999999999999998754322 223456789999999999999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.........
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99999999988888776778999999999999999999999999999999999999999999999999999865443333
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.|....|+.+........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 44456799999999998766688999999999999999999999999998899999999999888888876533221100
Q ss_pred -hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 -NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 -~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.+.......+ ....+.+++.+++||.+||+.||.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCL--------HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccH--------HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000000000 011235788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=416.99 Aligned_cols=283 Identities=33% Similarity=0.572 Sum_probs=225.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc------CC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS------NL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~------~~ 486 (776)
.+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 57999999999999999999999999999999885432 2234799999999999999999987532 12
Q ss_pred CeeEEEeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeeccccc
Q 004049 487 DSIFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~ 562 (776)
..+++||||+++++..++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 35779999999987766543 356799999999999999999999999999999999999999665 69999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++.+|+..++.|....+..+
T Consensus 220 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 76432 23345688999999999987667999999999999999999999999999999999999998888765433211
Q ss_pred CCCCCc-chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 643 SKLPGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 643 ~~lp~~-~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
. +.+ ...+.......+...+| ...+.++++||.+||++||.+|||+.|+|+||||+.+..
T Consensus 299 ~--~~~~~~~~~~~~~~~l~~~~p-------~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 299 N--PNYADIKFPDVKPKDLKKVFP-------KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred c--hhhhcccCCccCchhHHHHhc-------cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0 000 00000000011111122 247889999999999999999999999999999987653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=399.82 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=212.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
+.||+|+||.||+|+++.+++.||||+++..... ......+++|+.+|+.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999999999999999999765422 2223456789999999999999999999844 458999999999
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
++.+.........+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 75554444456689999999999999999999999999999999999999999999999999998654333444557899
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~ 657 (776)
+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+....+..+.....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------------------------- 212 (323)
T cd05571 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------- 212 (323)
T ss_pred ccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence 99999999987 5689999999999999999999999988776666555533210
Q ss_pred hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 658 ~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||..||.+|| ++.+||+||||+.+.+.
T Consensus 213 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 213 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01123788999999999999999999 89999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=384.56 Aligned_cols=283 Identities=49% Similarity=0.927 Sum_probs=234.8
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||.|+||.||+|+++.++..||||++............+.+|+.+++.+.||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 5899999999999999999999999999999997654444344567789999999999999999999954 45899999
Q ss_pred eehhhhhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEHDLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.+++..++.... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 999988877775433 569999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..++..++.+....|+.+..++.+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 45577899999999987666789999999999999999999999999988888888888888888888765544432211
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
+.......+. .....++.++.+||.+||..||.+|||+.+||.||||
T Consensus 239 ~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLR--------SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhH--------HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1110000000 1123488999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=403.12 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=214.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|.++.+++.||||++...... ......+.+|+.++..++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 4799999999999999999999999999999999764322 2223456679999999999999999999844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC---
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--- 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--- 568 (776)
||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 99999865444444445689999999999999999999999999999999999999999999999999987543210
Q ss_pred --------------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 004049 569 --------------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFN 616 (776)
Q Consensus 569 --------------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~ 616 (776)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01134589999999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC---
Q 004049 617 GKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--- 693 (776)
Q Consensus 617 ~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--- 693 (776)
+.+..+.+.+|........ +| ....+++.+++||.+||. +|.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~----------------------------~p-----~~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 238 SETPQETYKKVMNWKETLI----------------------------FP-----PEVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred CCCHHHHHHHHHcCcCccc----------------------------CC-----CcCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 8888777777654211110 01 112378899999999886 4554
Q ss_pred CCCHHHHHcCcCcCCCCCCC
Q 004049 694 RITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 694 RpTa~EIL~HPwf~~i~~pk 713 (776)
||++.|||+||||+.+++..
T Consensus 284 r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHhCCCCCCCCCHHH
Confidence 57999999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=402.63 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=239.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..=|.+.+.||+|.|+.|.+|++.-||..||||+|.+.+........+.+|+..|+.++|||||+||++. ..+..+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEE
Confidence 3558889999999999999999999999999999998887766666788999999999999999999999 55669999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-CCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+|+-.+ +|.+++.+....|.|..+++|++||+.|+.|||+..+|||||||+||++. .-|-+||+|||++..+. +..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccc
Confidence 9999985 89999999999999999999999999999999999999999999998765 56899999999998884 556
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
..++.||++.|.|||++.|..+..+++||||||||||.|+||++||...++-+.+-.|+...++
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt---------------- 237 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT---------------- 237 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc----------------
Confidence 7788999999999999999877789999999999999999999999999999999888775332
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~ 716 (776)
.+..+|.+++|||..||..||.+|.+.++|..|+|++.+..+-...
T Consensus 238 ---------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 238 ---------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred ---------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence 2345899999999999999999999999999999999988765543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=383.50 Aligned_cols=281 Identities=41% Similarity=0.771 Sum_probs=227.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC---CCCCcceeeEEEecc---CCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF---HHPSIVDVKEVVVGS---NLD 487 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~~---~~~ 487 (776)
+|++++.||+|+||+||+|.++.+++.||+|.++.............+|+.+++.+ .||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999976543333334556788877766 699999999988532 234
Q ss_pred eeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+++||||+.+++..++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 689999999998887776543 4599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+.+++...+.+....|+.....+
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 161 Q-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred c-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 2 22344678999999999987 568999999999999999999999999999999999999988887777676533222
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.... ... .+.......+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 239 ~~~~--~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAF--SPR--------GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc--CCC--------CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100 000 0000001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=385.49 Aligned_cols=271 Identities=33% Similarity=0.489 Sum_probs=231.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC--c----cchHHHHHHHHhCC-CCCcceeeEEEeccC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF--P----LTSLREINILLSFH-HPSIVDVKEVVVGSN 485 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~--~----~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~ 485 (776)
..|+..+.||.|..++|.++.++.+|..+|+|+|......... . ....+|+.||+++. ||+|++++++| +.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ES 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cC
Confidence 5688889999999999999999999999999999754422211 1 23357999999985 99999999999 45
Q ss_pred CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
...+++|+|.|+.+.+..+.+..-.+++.+.+.||+||+.|++|||.++||||||||+|||++++.++||+|||+|+++.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 55899999999955555555556779999999999999999999999999999999999999999999999999999984
Q ss_pred CCCCCccccccccccCCchhhc-----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLL-----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~-----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
+.......||||+|+|||.+. +...|+..+|+|++|+|||.||.|.+||......-.+..|+.+...+..+.|.
T Consensus 175 -~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 175 -PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred -CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 456677789999999999985 34569999999999999999999999999988888888898887766666554
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMP 719 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~ 719 (776)
+ +|...+|||.+||+.||.+|+|+.|+|.||||.++.......+-|
T Consensus 254 d---------------------------------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 254 D---------------------------------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred h---------------------------------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 3 788999999999999999999999999999997765444444444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=399.85 Aligned_cols=261 Identities=32% Similarity=0.501 Sum_probs=210.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.+|...+.||+|+||.||++.++.+|..+|||.+....... ...+.+|+.+|.+|+|||||++++.........++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46888999999999999999999999999999997663222 4456799999999999999999997533322368999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCC---C
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGS---P 567 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s---~ 567 (776)
|||+.+ +|..++...+.+|++..++.|++||+.||.|||++|||||||||+||||+. ++.+||+|||+++.... .
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999996 555556555548999999999999999999999999999999999999999 79999999999987753 1
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
........||+.|||||++........++|||||||++.||+||.+||... .....+..|......| .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---~-------- 243 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---E-------- 243 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---C--------
Confidence 122345789999999999986233345999999999999999999999763 2222232322211111 1
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.+..+|.++++||.+||.+||.+||||.++|+|||.+...
T Consensus 244 ------------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 ------------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1234899999999999999999999999999999998743
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=376.82 Aligned_cols=258 Identities=30% Similarity=0.459 Sum_probs=226.6
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++++|++.+.||+|.||.||+|+.+.++..||+|++.+.... ......+.+|++|-..|+||||+++|++|.++ .
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--K 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--c
Confidence 34679999999999999999999999999999999999776533 34445667899999999999999999999655 4
Q ss_pred eeEEEeeehh-hhhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 488 SIFMVMEYME-HDLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
.+||++||.. |.++..+.. ....|++..+..|+.|++.||.|||.++||||||||+|+|+...|.+||+|||.+....
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 8999999998 455555542 45679999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.....+.|||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.+.+|.+.-..
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------------ 240 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------------ 240 (281)
T ss_pred --CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc------------
Confidence 455677999999999999988 56899999999999999999999999999988888888765211
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..++..+.|||.+||.++|.+|++..|++.|||+..
T Consensus 241 -------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 -------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 12358999999999999999999999999999999965
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.40 Aligned_cols=283 Identities=47% Similarity=0.816 Sum_probs=233.8
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||.|+||.||+|.++.+|..||+|.++...........+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4899999999999999999999999999999997654444444567789999999999999999999854 45899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 99999988888776678999999999999999999999999999999999999999999999999999876544444445
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL-FNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P-F~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..++..++.+....|+.....+......
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 67889999999998766689999999999999999998766 56677778888899888888877776655444321100
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
........ ....+.++..+.+||.+||..||.+|||+.+||.||||
T Consensus 239 ~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSL--------VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchh--------hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00000000 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=411.85 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=224.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
...|....+||+|+.|.||.|....+++.||||.+....... ..-+++|+.+|+.++|+|||.+++.|.-. +.+++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEE
Confidence 356888899999999999999999999999999998765432 34567999999999999999999988544 58999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||++|+.+..+.... .|+|.++..|+++++.||+|||.+||||||||.+|||+..+|.+||+|||+|.++.......
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999976555555433 49999999999999999999999999999999999999999999999999999997777677
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
.+.+|||.|||||++.. +.|++++||||||+++.||+-|+|||-..+....+..|... |.|...
T Consensus 427 ~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk-------------- 490 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK-------------- 490 (550)
T ss_pred ccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC--------------
Confidence 88999999999999987 67999999999999999999999999988888877776543 333222
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+|..++|||.+||+.|+.+|++|.|||+||||+.
T Consensus 491 -------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 -------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 22349999999999999999999999999999999954
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=397.31 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=217.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++.+.||+|+||.||+|+++.+++.||||++...... ......+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 458899999999999999999999999999999999765322 2223456789999999999999999999954 4589
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.|+ |...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999864 544444 4567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..|.....
T Consensus 172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence 234689999999999987 5589999999999999999999999998877776666643210
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
..+..++..+++||.+||+.||.+|++ +.+||+||||..+.+.
T Consensus 233 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 233 ---------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001237788999999999999999997 7999999999987554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=391.44 Aligned_cols=284 Identities=40% Similarity=0.759 Sum_probs=221.2
Q ss_pred EeeeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 418 LNKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
..+||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999976 467899999986432 22346789999999999999999999976666789999999
Q ss_pred hhhhhhhHHhhc--------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----cCCCcEEEeecccccc
Q 004049 496 MEHDLKGLMETM--------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQ 563 (776)
Q Consensus 496 ~~g~Ll~~l~~~--------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL----d~~g~iKL~DFGlA~~ 563 (776)
+.+++..++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 999887766432 2358999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 004049 564 YGSPLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTL 631 (776)
Q Consensus 564 ~~s~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---------~~~l~kI~~~l 631 (776)
+..... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 653322 233468899999999998866789999999999999999999999976543 46788899999
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSF--TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~--~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
+.|....|+.+...+............... ......+ ......+..++|||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccC-cccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 998888887765544321111100000000 0000000 0112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=390.01 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=215.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+.+.||||+++++++. +...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 4799999999999999999999999999999999754321 122345678999999999999999999884 4458999
Q ss_pred Eeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.++ |..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 79 LMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred EEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999864 545544 4567999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+....+..+......
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------- 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE----------------- 216 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC-----------------
Confidence 234679999999999987 55899999999999999999999999988877777666543100
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
+ +..++..+++||.+||+.||.+|++ +.++|+||||+.+.+.
T Consensus 217 -------------~-------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 217 -------------F-------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred -------------C-------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 0 1236788999999999999999995 9999999999887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=385.81 Aligned_cols=291 Identities=81% Similarity=1.303 Sum_probs=246.7
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+.+++|++.+.||.|+||.||+|.++.+++.||+|.++...........+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 45678999999999999999999999999999999998665444444456789999999999999999999876655789
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||||+.++|..++......+++.+++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999999988888776666799999999999999999999999999999999999999999999999999987765444
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||........+.+++..++.|....|+.+..++...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 44556789999999999875667899999999999999999999999999999999999999999888888776665443
Q ss_pred -hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 650 -VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 650 -~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..+.......+...++.. .++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPAL------SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhcccccc------CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 222222222333333321 168899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=397.28 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=224.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+|++.+.||+|+||+|-+|+....|+.||||.|++.... +.....+.+||+||..|+||||+++|++| ++.+.++|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEE
Confidence 5799999999999999999999999999999999877643 33445678999999999999999999999 67779999
Q ss_pred Eeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||..++ |++++. ..+.|++.+++.+++||+.|+.|||.++++|||||.+|||||.++++||+||||+..+. ..+.
T Consensus 131 vMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~-~~kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-DKKF 208 (668)
T ss_pred EEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-cccH
Confidence 99999865 555554 45679999999999999999999999999999999999999999999999999999874 4467
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
..++||+|.|.+||++.|..+-++.+|-|||||+||.|+.|..||++.+...++.+|-++-+.-
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---------------- 272 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---------------- 272 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----------------
Confidence 7889999999999999998777899999999999999999999999999888888886652211
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
+.-+..+.-||++||..||.+|.|+.+|-.|-|+.
T Consensus 273 ----------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 273 ----------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 12455677899999999999999999999999984
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=397.11 Aligned_cols=294 Identities=32% Similarity=0.557 Sum_probs=228.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~ 486 (776)
.+++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||++++++|.... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999999999999999755433333456678999999999999999999985432 2
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|+||||+.+++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 3579999999998777653 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..++..++.|...++......
T Consensus 176 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 252 (359)
T cd07876 176 N-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT- 252 (359)
T ss_pred C-ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH-
Confidence 2 22344688999999999987 56899999999999999999999999999988888888888777654432211000
Q ss_pred Ccchhhhhhhh----hHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 647 GVKVNFIKHQY----NLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 647 ~~~~~~~~~~~----~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
...+..... ..+...++...+ ......+..+++||.+||+.||.+|||+.|||+||||+.+..+
T Consensus 253 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 253 --VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred --HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 000000000 000000111000 1122457889999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=400.00 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=214.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|..++||||++++++|.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999976432 22223445689999999999999999999954 558999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-- 569 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-- 569 (776)
||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++..+.....
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999998654443334456799999999999999999999999999999999999999999999999999875432110
Q ss_pred ------------------------------------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCC
Q 004049 570 ------------------------------------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613 (776)
Q Consensus 570 ------------------------------------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~ 613 (776)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 1113479999999999987 568999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 004049 614 LFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693 (776)
Q Consensus 614 PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k 693 (776)
||.+.+....+..+....... .+.....+++.+++||.+||. +|.+
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~~~~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL---------------------------------QFPDEVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc---------------------------------CCCCCCCCCHHHHHHHHHHcc-CHhh
Confidence 999888777666664321100 001112378999999999997 9999
Q ss_pred CCC---HHHHHcCcCcCCCCCC
Q 004049 694 RIT---AEAALNHDWFREVPLP 712 (776)
Q Consensus 694 RpT---a~EIL~HPwf~~i~~p 712 (776)
|++ +.++|+||||+.+.+.
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCHH
Confidence 998 9999999999987653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=394.31 Aligned_cols=267 Identities=28% Similarity=0.436 Sum_probs=220.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||+|.+..+++.||||+++..... ......+.+|+.+|..++||||+++++++. ....+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence 3699999999999999999999999999999999765422 122345678999999999999999999984 4558999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~ 155 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YA 155 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---cc
Confidence 999998654444444556799999999999999999999999999999999999999999999999999986543 33
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+.........+.+.
T Consensus 156 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------- 223 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD----------- 223 (333)
T ss_pred CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC-----------
Confidence 45689999999999987 468999999999999999999999999888777766664421111100000
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
.....++.++.+||.+||..+|.+|+|+.+|++||||..+++...
T Consensus 224 ------------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~ 268 (333)
T cd05600 224 ------------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNEL 268 (333)
T ss_pred ------------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHH
Confidence 000237899999999999999999999999999999998766443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.04 Aligned_cols=298 Identities=44% Similarity=0.815 Sum_probs=257.9
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec-----
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG----- 483 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~----- 483 (776)
|.....|+.+.+||+|.||.||+|+.+.+++.||+|++..+....++....++|+.+|..|+|+|++.+++++..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 344567999999999999999999999999999999998888888899999999999999999999999887742
Q ss_pred -cCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 484 -SNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 484 -~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.....+||||.+|+++|..++.....+|+..+++.++.+|+.||.|+|...|+|||+|++|+||+.+|.+||+|||+++
T Consensus 93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2234589999999999999999988899999999999999999999999999999999999999999999999999997
Q ss_pred ccCCC----CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 563 QYGSP----LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 563 ~~~s~----~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
.+... ...++..+.|.+|++||.+.|...|+++.|||..|||+.+|+++.+.|.+.++..++..|-..+|....+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 66322 12356678899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchh----hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 639 WPGFSKLPGVKVN----FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 639 wp~~~~lp~~~~~----~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
||++..+|-+..- ..+.++..+..+.. +-.-.+++.|||.+||.+||.+|++++++|+|.||..-+.|
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~k------p~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLK------PYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcc------cccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 9999887743221 22223333322222 22346789999999999999999999999999999876654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.39 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=213.3
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+|..+.|+||+.+++++.. .+.+|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEE
Confidence 88999999999999999999999999999998765422 2223356789999999999999999999844 45899999
Q ss_pred eehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.++ |...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETV 158 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Cee
Confidence 999864 54444332 346999999999999999999999999999999999999999999999999999875322 233
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.........+...+....
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 221 (285)
T cd05631 159 RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---------------- 221 (285)
T ss_pred cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----------------
Confidence 45689999999999987 5689999999999999999999999987765443333333211110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLPK 713 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~pk 713 (776)
......++..+.+||.+||+.||.+||| ++++++||||..+.+.+
T Consensus 222 -----------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 222 -----------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred -----------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 0112237889999999999999999997 89999999999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=395.22 Aligned_cols=265 Identities=29% Similarity=0.486 Sum_probs=219.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|++..+++.||||+++...... .....+.+|+.+|..+.||||+++++++. ....+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 47999999999999999999999999999999997654322 33345678999999999999999999884 4558999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-- 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-- 568 (776)
||||+.| +|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999986 55555544 4679999999999999999999999999999999999999999999999999998764432
Q ss_pred ---------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH
Q 004049 569 ---------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621 (776)
Q Consensus 569 ---------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~ 621 (776)
.......||+.|+|||++.+ ..++.++|||||||+||+|++|..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 22344679999999999987 46899999999999999999999999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-AEAA 700 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-a~EI 700 (776)
....+|....... .+.....+++.+.+||.+||. ||.+|++ +.+|
T Consensus 237 ~~~~~i~~~~~~~---------------------------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 237 ETYNKIINWKESL---------------------------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred HHHHHHhccCCcc---------------------------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 6666664421110 011112268899999999998 9999999 9999
Q ss_pred HcCcCcCCCCCCCCC
Q 004049 701 LNHDWFREVPLPKSK 715 (776)
Q Consensus 701 L~HPwf~~i~~pk~~ 715 (776)
|+||||+.+++....
T Consensus 283 l~hp~~~~~~~~~~~ 297 (350)
T cd05573 283 KSHPFFKGIDWENLR 297 (350)
T ss_pred hcCCCcCCCCHHHHh
Confidence 999999998765433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=396.65 Aligned_cols=294 Identities=31% Similarity=0.538 Sum_probs=231.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~ 486 (776)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999999999999999754433333456678999999999999999999885322 2
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 3589999999998877664 3589999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .......+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+.+++..++.|...+++.+....
T Consensus 179 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 179 S-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 22345688999999999987 568999999999999999999999999999999999999888877655443322110
Q ss_pred Ccchhhhhhhh----hHhhhcCCCCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 647 GVKVNFIKHQY----NLLRKKFPATS----FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 647 ~~~~~~~~~~~----~~l~~~~p~~~----~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
..+..... ......++... .......+..+++||.+||+.||.+|||+.++|+||||..+..+
T Consensus 257 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 257 ---RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred ---HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 00000000 00000111110 11122356789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=399.93 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=212.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|+.+.||||++++++|.. ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 59999999999999999999999999999999975432 22223456789999999999999999999954 4589999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC----
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP---- 567 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~---- 567 (776)
|||+.|+ |..++. ....+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLI-RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999864 555554 3467999999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------------CCCccccccccccCCchhhccCCCCCccchhhhHHHH
Q 004049 568 -------------------------------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCI 604 (776)
Q Consensus 568 -------------------------------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvl 604 (776)
.......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 001123579999999999987 568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHH
Q 004049 605 MAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLN 684 (776)
Q Consensus 605 LyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~ 684 (776)
||+|++|.+||.+.+..+...++....... .+.....+++++++||.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~~li~ 284 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------------------------HIPPQAKLSPEASDLII 284 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------------------------CCCCcccCCHHHHHHHH
Confidence 999999999999887766665554321110 01112247899999999
Q ss_pred HhcccCCCCCCC---HHHHHcCcCcCCCCCC
Q 004049 685 SLLTYDPDKRIT---AEAALNHDWFREVPLP 712 (776)
Q Consensus 685 kLL~~DP~kRpT---a~EIL~HPwf~~i~~p 712 (776)
+|+ .+|.+|++ +.++++||||+.+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 986 59999997 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=401.22 Aligned_cols=283 Identities=26% Similarity=0.372 Sum_probs=220.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
...|++++.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.|+|||||+++++|.. ....|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 4679999999999999999999999999999997532 235689999999999999999999854 457899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC-CCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-PLKP 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s-~~~~ 570 (776)
||||+.+++...+.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... ....
T Consensus 161 v~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999999888777655 35699999999999999999999999999999999999999999999999999975422 1223
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS-------EFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-------~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.... ...++..|+..++.++..+.....
T Consensus 240 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345689999999999987 568999999999999999999998775432 345677787777766543321100
Q ss_pred CCCCcchhhhhhhhhHhhhc--CCC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKK--FPA--TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~--~p~--~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.............. .+. ..+.....++.++.+||.+||++||.+||||.|+|+||||+.++.+
T Consensus 319 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 319 ------ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred ------HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 00000000000000 000 0111112356788999999999999999999999999999987654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=399.13 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=211.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|.+++.||+|+||+||+|.++.+++.||||++..... .......+.+|+.+|+.+.||||++++++|.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999875432 22223456689999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
||||+.| +|..++. ....|++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 79 IMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999986 4555544 456799999999999999999999999999999999999999999999999999963311000
Q ss_pred ----------------------------------------------CccccccccccCCchhhccCCCCCccchhhhHHH
Q 004049 570 ----------------------------------------------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGC 603 (776)
Q Consensus 570 ----------------------------------------------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGv 603 (776)
.....+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence 0012579999999999987 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHH
Q 004049 604 IMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLL 683 (776)
Q Consensus 604 lLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL 683 (776)
+||+|++|.+||.+.+..+.+..|....... .+.....++..+.+||
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~dli 283 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL---------------------------------YFPDDIHLSVEAEDLI 283 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---------------------------------CCCCCCCCCHHHHHHH
Confidence 9999999999999888777766665321100 0111123788999999
Q ss_pred HHhcccCCCCC---CCHHHHHcCcCcCCCCCC
Q 004049 684 NSLLTYDPDKR---ITAEAALNHDWFREVPLP 712 (776)
Q Consensus 684 ~kLL~~DP~kR---pTa~EIL~HPwf~~i~~p 712 (776)
.+||+ +|.+| +|+.++|.||||+.+.+.
T Consensus 284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99998 77776 599999999999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=398.52 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=210.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|+.++||||+++++++.. .+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 59999999999999999999999999999999976432 22233456789999999999999999999954 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC----
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL---- 568 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~---- 568 (776)
|||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999864443333445679999999999999999999999999999999999999999999999999975431000
Q ss_pred -------------------------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHH
Q 004049 569 -------------------------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIM 605 (776)
Q Consensus 569 -------------------------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlL 605 (776)
......+||+.|+|||++.+ ..|+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 00124579999999999987 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHH
Q 004049 606 AELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNS 685 (776)
Q Consensus 606 yELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~k 685 (776)
|+|++|.+||...+.......+......+ .+.....+++++++||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~~~~~~~s~~~~dli~~ 285 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTL---------------------------------HIPPQVKLSPEAVDLITK 285 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcccccc---------------------------------CCCCCCCCCHHHHHHHHH
Confidence 99999999998877666555553321110 001112378999999999
Q ss_pred hcccC--CCCCCCHHHHHcCcCcCCCCCC
Q 004049 686 LLTYD--PDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 686 LL~~D--P~kRpTa~EIL~HPwf~~i~~p 712 (776)
||..+ |..|+++.+||+||||+.+.+.
T Consensus 286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 286 LCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HccCcccccCCCCHHHHhcCcccCCCChh
Confidence 77554 4459999999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=394.62 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=216.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCC-cEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTG-EIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg-~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||.|+||.||+|.++.++ ..||+|++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 4578999999999999999999876654 68999999754422 2233456789999999999999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|+||||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999986544444444567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+.......|......
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 246 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--------------- 246 (340)
T ss_pred --cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 245689999999999987 55889999999999999999999999988877666666443110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||+.||.+|+ |+.++++||||+.+++.
T Consensus 247 ----------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 247 ----------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 1123788899999999999999996 89999999999987654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=398.70 Aligned_cols=287 Identities=38% Similarity=0.636 Sum_probs=228.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l~ 490 (776)
+|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999998643322222345678999999999999999999985432 12689
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-C
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-K 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~ 569 (776)
+||||+.+++...+.. ...|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999888777654 4579999999999999999999999999999999999999999999999999998653221 2
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|...++.|....+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~----- 234 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE----- 234 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-----
Confidence 233457899999999998866789999999999999999999999999999999999999888775432211000
Q ss_pred hhhhhhhhhHhhhcC--CC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKF--PA--TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~--p~--~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.. ......... +. ..+......+..+.+||.+||++||.+|||+.++|+||||+...
T Consensus 235 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 -GA---RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred -HH---HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00 000000000 00 00112234688999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=378.41 Aligned_cols=283 Identities=51% Similarity=0.934 Sum_probs=235.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||.|+||.||+|+++.++..||||++............+.+|+.++++++||||+++++++. ....+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 489999999999999999999999999999998765444444456778999999999999999999984 455899999
Q ss_pred eehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.+++..++... ...+++..++.++.||+.||+|||+.||+|+||+|+|||++.++.+||+|||++...........
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 99998877776543 35699999999999999999999999999999999999999999999999999987654444445
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+.+++...+.+....||.+..++.....+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 55678999999998876667889999999999999999999999999989999999999988888888655544332222
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.......+... .+.++..+++||.+||+.||.+|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKV--------VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHH--------cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 21111111111 13478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=403.67 Aligned_cols=286 Identities=25% Similarity=0.405 Sum_probs=218.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC------CCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH------PSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H------PnIV~l~~~~~~~~ 485 (776)
.++|++++.||+|+||+||+|.+..+++.||||+++.... .......|+.++..++| ++|+.++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 4789999999999999999999999999999999964321 12234567777777754 4588888888544
Q ss_pred CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCC-------------
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRG------------- 551 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g------------- 551 (776)
..++||||+++.++|+.++... +.|++.+++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 3579999999988888877653 579999999999999999999997 5999999999999998765
Q ss_pred ---cEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004049 552 ---ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628 (776)
Q Consensus 552 ---~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~ 628 (776)
.+||+|||++.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..|.
T Consensus 283 ~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 49999999886532 23345789999999999987 568999999999999999999999999999999998888
Q ss_pred HhcCCCCCCCCCCCCCCCCcchhhhhhh--------hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQ--------YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 629 ~~lg~p~~~~wp~~~~lp~~~~~~~~~~--------~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
..++.++..++..+.. .... .+.... ...+.. +...........++.+.|||.+||++||.+|||+.||
T Consensus 359 ~~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGT-EEAR-LLYNSAGQLRPCTDPKHLAR-IARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHcCCCCHHHHhhccc-hhHH-HHhhhcccccccCCHHHHHh-hhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 8888776543322110 0000 000000 000000 0000000111235678899999999999999999999
Q ss_pred HcCcCcCCC
Q 004049 701 LNHDWFREV 709 (776)
Q Consensus 701 L~HPwf~~i 709 (776)
|+||||+..
T Consensus 436 L~Hp~~~~~ 444 (467)
T PTZ00284 436 TTHPYVLKY 444 (467)
T ss_pred hcCcccccc
Confidence 999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=391.38 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=210.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
+.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+.+.||||+++++++. ..+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 3689999999999999999999999999765322 222345678999999999999999999984 4458999999998
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 76554444555679999999999999999999999999999999999999999999999999997643333344556899
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~ 657 (776)
+.|+|||++.+ ..++.++|||||||+||+|++|..||...+....+..+....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------------------- 211 (328)
T cd05593 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------------------------- 211 (328)
T ss_pred cCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--------------------------
Confidence 99999999987 568999999999999999999999998877665555442210
Q ss_pred hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 658 ~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
...+..++..+.+||.+||..||.+|+ ++.+||+||||..+.+
T Consensus 212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 -----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred -----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001123788999999999999999997 8999999999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=393.57 Aligned_cols=293 Identities=31% Similarity=0.554 Sum_probs=229.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~ 486 (776)
.+++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999999999999999999754433333455678999999999999999999885432 2
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 3579999999998776664 3589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..++..++.+...++..+..
T Consensus 172 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 247 (355)
T cd07874 172 S-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-- 247 (355)
T ss_pred c-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH--
Confidence 2 23345688999999999987 5689999999999999999999999999998888888888877765444332110
Q ss_pred Ccchhhhhhhhh----HhhhcCCCC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQYN----LLRKKFPAT----SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~~----~l~~~~p~~----~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
....+...... .+...++.. ........+..+++||.+||..||.+|||+.|||+||||+....
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 248 -TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred -HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 00001000000 000000100 01112345678899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=386.33 Aligned_cols=272 Identities=26% Similarity=0.404 Sum_probs=223.0
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
...++|++...||.|..++||+|+.+.++..||||++..+..... ...+.+|+..|..++||||+.++..|+.+ ..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD--SEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec--cee
Confidence 356899999999999999999999999999999999998876554 56778999999999999999999999665 489
Q ss_pred EEEeeehh-hhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 490 FMVMEYME-HDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 490 ~LVmEy~~-g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
++||.||. |++++++... ...|+|..+..|+++++.||.|||.+|-||||||+.||||+.+|.+||+|||.+..+...
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999998 4666666554 456999999999999999999999999999999999999999999999999987665432
Q ss_pred CCC----ccccccccccCCchhh-ccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 568 LKP----YTHLVVTLWYRAPELL-LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 568 ~~~----~~~~~GT~~Y~APEvl-~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
... +.+++||++|||||++ .....|+.++|||||||+..||.+|..||..-.....+-.- ..+.|+....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t--- 254 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLT--- 254 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCccc---
Confidence 221 2667999999999995 44567999999999999999999999999877665544322 2233322211
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..++ ......++..++.+|..||++||.+||||.++|+|+||+....
T Consensus 255 ~~~~----------------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLD----------------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCC----------------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 0000 0111126678999999999999999999999999999998653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=397.60 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=212.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+|++++.||+|+||.||+|+++.+++.||||++..... .......+.+|+.+|+.+.||||++++++|.. .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999965432 22233456789999999999999999999954 458999
Q ss_pred Eeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC---
Q 004049 492 VMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--- 567 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--- 567 (776)
||||+.|+ |..++. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...
T Consensus 79 v~E~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 79 VMDYIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999864 555554 4567999999999999999999999999999999999999999999999999998533100
Q ss_pred ----------------------------------------CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHH
Q 004049 568 ----------------------------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAE 607 (776)
Q Consensus 568 ----------------------------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyE 607 (776)
.......+||+.|+|||++.+ ..++.++|||||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 000123579999999999987 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 004049 608 LLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLL 687 (776)
Q Consensus 608 LLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL 687 (776)
|++|.+||.+.+..+.+..+....... .+.....++..+.+||.+|+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------------------~~~~~~~~s~~~~~li~~l~ 283 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTL---------------------------------HIPSQAKLSREASDLILRLC 283 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccc---------------------------------cCCCCCCCCHHHHHHHHHHh
Confidence 999999999887766655553221100 00111237889999999977
Q ss_pred ccCCCCCC---CHHHHHcCcCcCCCCCCC
Q 004049 688 TYDPDKRI---TAEAALNHDWFREVPLPK 713 (776)
Q Consensus 688 ~~DP~kRp---Ta~EIL~HPwf~~i~~pk 713 (776)
.+|.+|+ |+.++|+||||+.+.+..
T Consensus 284 -~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 284 -CGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred -cCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 5999999 999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=386.87 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=208.6
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhh
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD 499 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~ 499 (776)
||+|+||+||+|.++.+++.||||++..... .......+.+|+.+|..++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 22223456789999999999999999998844 45899999999875
Q ss_pred hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccccc
Q 004049 500 LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579 (776)
Q Consensus 500 Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~ 579 (776)
.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 44444444567999999999999999999999999999999999999999999999999999865333333455689999
Q ss_pred cCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhH
Q 004049 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNL 659 (776)
Q Consensus 580 Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~ 659 (776)
|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 159 y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------------------------- 209 (312)
T cd05585 159 YLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------------------------- 209 (312)
T ss_pred cCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC----------------------------
Confidence 999999987 568999999999999999999999998877766665554320
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcCCCCC
Q 004049 660 LRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI---TAEAALNHDWFREVPL 711 (776)
Q Consensus 660 l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp---Ta~EIL~HPwf~~i~~ 711 (776)
+..+..++..+.+||.+||..||.+|| ++.++|+||||....+
T Consensus 210 ---------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 210 ---------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 001123788999999999999999997 5899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=389.50 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=212.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
+.||+|+||.||++.++.+|..||+|++...... ......+.+|+.+++.++||||++++++|.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 4699999999999999999999999999765422 2223455689999999999999999999854 458999999999
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 76555555556679999999999999999999999999999999999999999999999999987643333334456899
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~ 657 (776)
+.|+|||++.+ ..++.++|||||||+||+|++|..||...+....+..+.....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------- 212 (323)
T cd05595 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------- 212 (323)
T ss_pred cCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence 99999999987 5689999999999999999999999988777666655533210
Q ss_pred hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 658 ~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
..+..+++.+.+||.+||..||.+|+ ++.++|+||||..+.+.
T Consensus 213 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 213 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01123788999999999999999998 89999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=391.00 Aligned_cols=289 Identities=34% Similarity=0.595 Sum_probs=227.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~ 487 (776)
.++|.+++.||.|+||+||+|.+..++..||||++............+.+|+.+|+.++||||++++++|... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4789999999999999999999999999999999975433323334566899999999999999999887532 124
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|++|+++.+++..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 579999999887766654 34699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+.+..+....+.+....+..+....
T Consensus 171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (343)
T cd07878 171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH- 247 (343)
T ss_pred --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh-
Confidence 23456899999999999876678999999999999999999999999988888888888877766554433221100
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
....... ...++...+ ......++.+.+||.+||..||.+|||+.|+|+||||.....+
T Consensus 248 -----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 248 -----ARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred -----HHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 0000000 000111000 0012357788999999999999999999999999999886544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=394.91 Aligned_cols=265 Identities=27% Similarity=0.392 Sum_probs=215.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|.++.+++.||||++..... .......+..|+.++..++||||+++++++. ....+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 479999999999999999999999999999999975432 2223345667999999999999999999984 4558999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC---
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--- 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--- 568 (776)
||||+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999875444444445679999999999999999999999999999999999999999999999999987542110
Q ss_pred --------------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 004049 569 --------------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFN 616 (776)
Q Consensus 569 --------------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~ 616 (776)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 01124579999999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-
Q 004049 617 GKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI- 695 (776)
Q Consensus 617 ~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp- 695 (776)
+.+....+.+|....... .+| ....++..+++||.+|+. ||.+|+
T Consensus 238 ~~~~~~~~~~i~~~~~~~----------------------------~~p-----~~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 238 SETPQETYRKVMNWKETL----------------------------VFP-----PEVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred CCCHHHHHHHHHcCCCce----------------------------ecC-----CCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 888777776665321100 001 111378899999999874 999998
Q ss_pred --CHHHHHcCcCcCCCCCCCC
Q 004049 696 --TAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 696 --Ta~EIL~HPwf~~i~~pk~ 714 (776)
++.+|++||||+.++|...
T Consensus 284 ~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CCCHHHHhcCCCCCCCCHHHH
Confidence 5899999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=385.88 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=213.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCC-CcceeeEEEeccCCCeeEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHP-SIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HP-nIV~l~~~~~~~~~~~l~L 491 (776)
+|++++.||+|+||.||+|+++.+++.||||++...... ......+..|+.++..+.|+ +|+.+++++.. .+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 589999999999999999999999999999999765422 22234566899999999765 58888888844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 99999865444444445679999999999999999999999999999999999999999999999999987543333344
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..|......
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------------ 219 (324)
T cd05587 159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------ 219 (324)
T ss_pred eeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 45689999999999987 56899999999999999999999999988877777666432110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCcCcCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWFREVPLP 712 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-----~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||..||.+|+++ .++++||||+.+.+.
T Consensus 220 -------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 220 -------------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred -------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 012378899999999999999999976 899999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=389.00 Aligned_cols=271 Identities=26% Similarity=0.397 Sum_probs=221.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|.+.+.||+|+||+||+|.++.+++.||||+++.... .......+.+|+.+++.++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 469999999999999999999999999999999986543 22223446689999999999999999998844 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999975 566666665578999999999999999999999999999999999999999999999999999876433222
Q ss_pred -ccccccccccCCchhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 571 -YTHLVVTLWYRAPELLLG-----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g-----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
....+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+....+.+|+......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---------- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 233578999999999863 3457899999999999999999999998887777766665431100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMP 719 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~ 719 (776)
.+...+.++..+.+||.+||+ ||.+|||+.++++||||+.+.+.......+
T Consensus 229 -----------------------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~ 279 (330)
T cd05601 229 -----------------------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLP 279 (330)
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCC
Confidence 111123478999999999998 999999999999999999887654433333
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=386.44 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=211.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|+++.+++.||||++..... .......+..|+.++..+ .||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999976542 222234556788888876 69999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 86544444444567999999999999999999999999999999999999999999999999998765333334455689
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..|......
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------------------- 214 (320)
T cd05590 159 TPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV----------------------- 214 (320)
T ss_pred CccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC-----------------------
Confidence 999999999987 56899999999999999999999999998887777766542110
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA------EAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa------~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||+.||.+|+++ .++++||||+.+.+.
T Consensus 215 --------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 215 --------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred --------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 112378899999999999999999998 999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.46 Aligned_cols=291 Identities=50% Similarity=0.949 Sum_probs=239.2
Q ss_pred ccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC--
Q 004049 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN-- 485 (776)
Q Consensus 408 ~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~-- 485 (776)
+|..+++|++++.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 456679999999999999999999999999999999999765444333445678999999999999999999875433
Q ss_pred ----CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 486 ----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 486 ----~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
...+|+||+|+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 2357999999999888877766668999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-----------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 004049 562 RQYGSPL-----------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT 630 (776)
Q Consensus 562 ~~~~s~~-----------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~ 630 (776)
....... ...+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7653221 11233467899999999877666899999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCCcchhhhh-hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 631 LGTPNEKIWPGFSKLPGVKVNFIK-HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 631 lg~p~~~~wp~~~~lp~~~~~~~~-~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+.+....|+.+..++........ .....+...+ ..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--------GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHc--------ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 888888888877666543321110 0001111111 1256788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.13 Aligned_cols=280 Identities=42% Similarity=0.774 Sum_probs=219.4
Q ss_pred eeeecCCceEEEEEEECC--CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKK--TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~--tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
.+||+|+||+||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999999754 56889999886432 223467899999999999999999999766667899999999
Q ss_pred hhhhhhHHhhc--------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----cCCCcEEEeeccccccc
Q 004049 497 EHDLKGLMETM--------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQY 564 (776)
Q Consensus 497 ~g~Ll~~l~~~--------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL----d~~g~iKL~DFGlA~~~ 564 (776)
.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 99887776432 2358999999999999999999999999999999999999 56679999999999876
Q ss_pred CCCCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 004049 565 GSPLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTLG 632 (776)
Q Consensus 565 ~s~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---------~~~l~kI~~~lg 632 (776)
..... ......||+.|+|||++.+...++.++|||||||+||+|++|.+||..... ..++..++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 54322 223467899999999998766789999999999999999999999976442 356778888889
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhh---h--hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQ---Y--NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~---~--~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+....|+.+...+.......... + ..+..... ......+..+++||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYME----KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhh----cccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888877655443211000000 0 00000000 1122356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=388.27 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=210.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
+.||+|+||+||+|.++.++..||+|++...... ......+..|+.++..+.||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 3699999999999999999999999999765422 1223455689999999999999999998844 458999999999
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
++.+..+......+++.+++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 76555555556679999999999999999999997 89999999999999999999999999998764333333445689
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+....+..+.....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (325)
T cd05594 159 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------ 213 (325)
T ss_pred CcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 999999999987 5689999999999999999999999988776665555432210
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
..+..+++.+.+||.+||+.||.+|+ ++.++|+||||..+.+.
T Consensus 214 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 214 -------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01123788999999999999999997 99999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.10 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=214.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+|++++.||+|+||.||+|+++.++..||||++...... .........|+.++..+ +|++|+.+++++.. .+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 589999999999999999999999999999999765422 22223456688888777 58999999998844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 99999864444333445679999999999999999999999999999999999999999999999999998654333344
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------ 219 (323)
T cd05616 159 KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA------------------ 219 (323)
T ss_pred ccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence 55789999999999987 56899999999999999999999999998887777766543110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||+.||.+|++ ..++++||||+.++|.
T Consensus 220 -------------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 220 -------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred -------------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01237889999999999999999997 4899999999988754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.70 Aligned_cols=256 Identities=30% Similarity=0.429 Sum_probs=211.3
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHH---HhCCCCCcceeeEEEeccCCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINIL---LSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL---~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
|++++.||+|+||.||+|.++.+++.||||+++..... ......+.+|+.++ ..+.||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 78899999999999999999999999999999765322 22223455666555 56679999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.|+.+..... ...|++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 9999999754443333 356999999999999999999999999999999999999999999999999998764433334
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~----------------- 219 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR----------------- 219 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 455789999999999987 56899999999999999999999999988877777666443110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
.+..++..+.+||.+||+.||.+|| ++.++++||||+.+.+
T Consensus 220 --------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 220 --------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred --------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 1123788999999999999999999 7999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=390.35 Aligned_cols=283 Identities=25% Similarity=0.336 Sum_probs=219.3
Q ss_pred CCeeEEeeeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.|+||||++++++|.. ...+|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 57999999999999999999764 35678999987542 234589999999999999999999843 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
+||||+.+++..++ .....|++.+++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++..+.....
T Consensus 163 lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 99999999888877 4456799999999999999999999999999999999999999999999999999976643221
Q ss_pred -CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS---EFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s---~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.. ...++..|++.++..+..+...
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~---- 316 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN---- 316 (392)
T ss_pred ccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc----
Confidence 2234679999999999987 568999999999999999999999997654 3456667777665443332111
Q ss_pred CCcchhhhhhh---hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 646 PGVKVNFIKHQ---YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 646 p~~~~~~~~~~---~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
....+.... ....+..+..........++.++.+||.+||++||++|||+.+||.||||++.++.
T Consensus 317 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 317 --GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred --cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 011111100 00111111111111223467789999999999999999999999999999987654
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=384.39 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=212.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|+++.+++.||||+++..... ......+..|+.++..+ +||||++++++|.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 3689999999999999999999999999765422 22233456788888866 79999999999954 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 86544444444567999999999999999999999999999999999999999999999999999865433344455789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..|......
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~----------------------- 214 (321)
T cd05591 159 TPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL----------------------- 214 (321)
T ss_pred CccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 999999999987 56899999999999999999999999998888877777543110
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-------TAEAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-------Ta~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||+.||.+|+ ++.++++||||..+.+.
T Consensus 215 --------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 215 --------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred --------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 1123788999999999999999999 99999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.63 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=207.3
Q ss_pred CeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKER--EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~ 487 (776)
+|++++.||+|+||+||+|++. .+++.||+|++...... ......+..|+.+|..+. ||||+.+++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 5899999999999999999864 57899999999764322 122334568999999995 999999999884 445
Q ss_pred eeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.++ |...+. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 79 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 899999999864 444443 456799999999999999999999999999999999999999999999999999986533
Q ss_pred CCC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 567 PLK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 567 ~~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
... .....+||+.|+|||++.+...++.++|||||||+||+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------- 226 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----------- 226 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 222 22346899999999999875568899999999999999999999997543222111111110000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
....+..++..+.+||.+||..||.+|| ++.++|+||||+.+.+
T Consensus 227 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 227 ----------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0011224788999999999999999999 8899999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=391.81 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=217.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.||+|+++.++..||||++....... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 4578999999999999999999999999999999997543222 222345689999999999999999998844 4589
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.|+ |..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999864 5554433 468999999999999999999999999999999999999999999999999998764322
Q ss_pred C-CccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K-PYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~-~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. .....+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|+......
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---------- 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL---------- 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC----------
Confidence 1 23456899999999999753 247899999999999999999999999988777777765431111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~ 711 (776)
.+.....++..+++||.+||+.+|.+ |+|+.+||+||||+...+
T Consensus 267 -----------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 267 -----------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred -----------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 01112237899999999999999998 999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=374.21 Aligned_cols=290 Identities=47% Similarity=0.843 Sum_probs=238.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+|++++.||.|+||.||+|.+..+++.||||.+...... ......+..|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999999999999999765433 2223445679999999999999999999955 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.++|..++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.........
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 99999977777777654447999999999999999999999999999999999999999999999999999877654444
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.|....|+.+...+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 44456788999999997766788999999999999999999999999998899999999888888887776655443211
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
..... ..+ ........+..+.+||.+||.+||.+|||+.++|.||||+..+.+..
T Consensus 239 ~~~~~-------~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 239 FKPFP-------PTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccC-------Ccc--hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00000 000 00111346789999999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.35 Aligned_cols=289 Identities=50% Similarity=0.903 Sum_probs=238.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++.+.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEE
Confidence 367999999999999999999999999999999986654333334556789999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+++...+.... ..+++..++.++.||+.||+|||++||+|+||||+|||++. ++.+||+|||++........
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99999988877775533 33788999999999999999999999999999999999985 45799999999987654434
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||......+.+.+++...+.|....|.++..++.+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 44456778999999998775668899999999999999999999999998888899999999999999998877666542
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..+.... +.......+.++..+.+||.+||+.||.+||++.++|.||||+.+.
T Consensus 239 ~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWP--------PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccCC--------CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 2211000 0000011345788999999999999999999999999999998764
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=369.71 Aligned_cols=284 Identities=44% Similarity=0.809 Sum_probs=236.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999999999999997655434444567889999999999999999999854 55899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-CCcc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-KPYT 572 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~~~~ 572 (776)
||+.++|...+......+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 999777877777666789999999999999999999999999999999999999999999999999998764332 1234
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh-
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN- 651 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~- 651 (776)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+......+..++..++.+....||.+..++.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5678999999999987666799999999999999999999999999999999999999998888888876654432110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
+.......+.. ..+..+..+.+||.+||..||.+|||+.++|+||||.
T Consensus 239 ~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEE--------IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHH--------hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000000001 1124678999999999999999999999999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=369.92 Aligned_cols=286 Identities=50% Similarity=0.869 Sum_probs=233.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCC---Ce
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNL---DS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~---~~ 488 (776)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765544444556778999999995 6999999998854321 23
Q ss_pred eEEEeeehhhhhhhHHhhcc----CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccc
Q 004049 489 IFMVMEYMEHDLKGLMETMK----QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQ 563 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~----~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~ 563 (776)
+|+||||+.+++..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 79999999998887776532 35899999999999999999999999999999999999998 89999999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
+...........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.+++..++.|....|+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 65444444455778999999999775668999999999999999999999999999999999999988888888887654
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
....... +.......+. ...+.++..+.+||.+||..||.+|||+.++|.||||+
T Consensus 241 ~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHE-FPQWKPQDLS--------RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhh-cCcccchhHH--------HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 4332110 0000000000 11134788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=370.43 Aligned_cols=291 Identities=45% Similarity=0.799 Sum_probs=232.8
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---- 485 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---- 485 (776)
..+++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 4567899999999999999999999999999999998765444333445568999999999999999999885432
Q ss_pred --CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 486 --LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 486 --~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
...+|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 235799999999988888877666799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCC----CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 564 YGSPLK----PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 564 ~~s~~~----~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
+..... ......++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+....+..+....+..+...|
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 643221 1233567889999999877556788999999999999999999999998888888888887777777777
Q ss_pred CCCCCCCCcch-hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 640 PGFSKLPGVKV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 640 p~~~~lp~~~~-~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
|.......... .+...........+ .....+..+.+||.+||..||.+|||++++|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l------~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERL------KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhc------ccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 76543322110 00000000011111 111356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=381.58 Aligned_cols=254 Identities=29% Similarity=0.449 Sum_probs=210.1
Q ss_pred EeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 418 LNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKER--EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++.||+|+||.||+|++. .+++.||||+++..... ......+..|+.+|+.++||||++++++|.. ...+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999864 57899999999764321 1222345689999999999999999999854 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.|+.+.........+.+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999754444444456799999999999999999999999999999999999999999999999999976543333445
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..+.....
T Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-------------------- 217 (323)
T cd05584 159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-------------------- 217 (323)
T ss_pred ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 5689999999999987 4578999999999999999999999998877776666644210
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
..++.+++.+.+||.+||+.||.+|| ++.++++||||....+
T Consensus 218 -----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 218 -----------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11224788999999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=368.99 Aligned_cols=284 Identities=43% Similarity=0.804 Sum_probs=230.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 57899999999999999999999999999999998754322 223446789999999999999999999854 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 99999998888877666689999999999999999999999999999999999999999999999999987653332233
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS-EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.... ..+++..+.+.++.+....|+..........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 334578899999999875668899999999999999999999997766 5677888888888888888877654432211
Q ss_pred hhh-hhhhhHhhhcCCCCCCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFI-KHQYNLLRKKFPATSFTGSPVLS--DAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~-~~~~~~l~~~~p~~~~~~~~~lS--~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
... ......+...++ .++ ..+.+||.+||+.||.+|||+.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAP--------RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCc--------CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 000000111111 133 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=384.41 Aligned_cols=282 Identities=27% Similarity=0.385 Sum_probs=213.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|++++.||+|+||.||+|.+..++..||+|+... .....|+.+|+.++||||+++++++... ...|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 579999999999999999999999999999997532 2335799999999999999999998544 478999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.+++..++......+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++...... ....
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 214 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFL 214 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-cccc
Confidence 999999999888877778999999999999999999999999999999999999999999999999999754322 2234
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHhcCCCCCCCCCCC
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSE---------FDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~---------~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
...||+.|+|||++.+ ..++.++|||||||+||+|+++ .++|..... ...+..++..++..+..+....
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4679999999999987 5689999999999999999985 445543211 2344455555554433322110
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.......+... ....+..+..........++..+.+||.+||++||.+||||.|||+||||+++
T Consensus 294 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 294 --GSRLVRGFIEY-ASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred --ccHHHHHHHhh-cccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 00000001000 00000011111111123467788999999999999999999999999999863
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=380.18 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=207.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|+++.++..||||+++..... .........|+.++..+ .||||+++++++.. .+++||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999999865422 22233456788888754 89999999999954 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+......+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 86544433444567999999999999999999999999999999999999999999999999998754333334456789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.... +
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~---------------------- 213 (316)
T cd05620 159 TPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P---------------------- 213 (316)
T ss_pred CcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C----------------------
Confidence 999999999987 568999999999999999999999999887766665553221 0
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-EAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-~EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||..||.+|+++ .++++||||+.+.+.
T Consensus 214 -------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 -------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 0012378899999999999999999998 589999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=388.41 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=215.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.||+|.++.+++.||+|++.+.... ......+.+|+.+++.+.||||+++++++.. ...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEE
Confidence 457899999999999999999999999999999999754322 1222345689999999999999999999854 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.| +|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999986 55555543 368999999999999999999999999999999999999999999999999998764322
Q ss_pred C-CccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K-PYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~-~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. .....+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+..|+.....+.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 267 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--------- 267 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---------
Confidence 2 23456899999999999753 2378899999999999999999999999887777777754321110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~ 711 (776)
+.....++..+++||..||+.++.+ |+|+.++|+||||+...+
T Consensus 268 ------------------------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 268 ------------------------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred ------------------------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 1111237889999999999866654 889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=371.57 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=205.9
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhh
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD 499 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~ 499 (776)
||+|+||+||++.++.+++.||+|++....... .....+..|+.+|+.++||||+++++++.. ...+|+||||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 799999999999999999999999997543222 122345689999999999999999998843 45799999999865
Q ss_pred -hhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccc
Q 004049 500 -LKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575 (776)
Q Consensus 500 -Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~ 575 (776)
|...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...........
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 4333322 245699999999999999999999999999999999999999999999999999987654444444568
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 159 g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------- 216 (280)
T cd05608 159 GTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--------------------- 216 (280)
T ss_pred CCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc---------------------
Confidence 9999999999987 568899999999999999999999997654432222222211100
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPK 713 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk 713 (776)
....+..++..+.+||.+||+.||.+|| |++++|+||||+.+.+.+
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 217 ------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred ------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 0011224788999999999999999999 899999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=367.43 Aligned_cols=282 Identities=48% Similarity=0.892 Sum_probs=233.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||.|+||.||+|+++.++..||||+++..... .....+.+|+.+++.++||||+++++++... +.+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 489999999999999999999999999999999765422 2234566899999999999999999999554 5789999
Q ss_pred eehhhhhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEHDLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.+++..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 999998888776544 569999999999999999999999999999999999999999999999999998665443344
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+|..|++||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++.....|....|+.+...+.....
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 45577899999999987666889999999999999999999999999988999999988888887777665544433222
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
+........... .+.++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQL--------FPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHH--------hhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 211111111111 12368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=379.39 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=207.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHh-CCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLS-FHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~-L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|.+..+++.||||+++..... .........|..++.. +.||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999999865422 2222334567777765 479999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 86544444444567999999999999999999999999999999999999999999999999999865433344455789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+....+..+.....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (316)
T cd05592 159 TPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP------------------------ 213 (316)
T ss_pred CccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999987 5589999999999999999999999998887776666533210
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-EAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-~EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||..||.+||++ .++++||||..+.+.
T Consensus 214 -------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 214 -------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence 0012378889999999999999999986 589999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=381.10 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=208.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHH-HHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREIN-ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~-iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|.++.+++.||||++...... ......+..|+. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 3699999999999999999999999999765322 112233445555 4678999999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 97555444445668999999999999999999999999999999999999999999999999999764333334455689
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------------ 213 (323)
T cd05575 159 TPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL------------------------ 213 (323)
T ss_pred ChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999987 5689999999999999999999999998877766666643210
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPwf~~i~~p 712 (776)
...+.++..+.+||.+||+.||.+||++ .++|+||||..+.+.
T Consensus 214 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 214 -------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0112368899999999999999999987 699999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.93 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=211.0
Q ss_pred eeeecCCceEEEEEEE---CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARD---KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~---k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
+.||+|+||.||++++ +.+++.||+|++............+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 6799999999999976 4678999999998654333333455689999999999999999999854 4589999999
Q ss_pred hhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 496 MEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 496 ~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
+.+ +|...+ .....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 80 ~~~~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 986 454444 445679999999999999999999999999999999999999999999999999998765443444557
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...+....+..+.....
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------------------- 215 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------------------- 215 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 89999999999987 5578999999999999999999999998877776666643211
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||+.||.+||| +.+++.||||+.+.+.
T Consensus 216 ---------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 216 ---------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 011237889999999999999999999 7889999999987653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=377.69 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=213.8
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~L 491 (776)
+|++++.||+|+||.||+|.++.+++.||||++...... ......+..|+.++..+. |++|+++++++.. .+.+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 488999999999999999999999999999999765422 222344567888888886 5778889888844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|+.+..+......|++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 99999865444444445679999999999999999999999999999999999999999999999999998654333334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------------ 219 (323)
T cd05615 159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------ 219 (323)
T ss_pred cCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence 45679999999999987 56899999999999999999999999988877777766543110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||..||.+|++ ..++++||||+.+.+.
T Consensus 220 -------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 220 -------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred -------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 01236788999999999999999997 5899999999988654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=378.68 Aligned_cols=267 Identities=24% Similarity=0.380 Sum_probs=215.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||+++++.+++.||||++.+... .......+.+|+.++..++|+||+.++++|.. ..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975332 22223346689999999999999999999854 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
||||+.| +|..++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999975 66666655566799999999999999999999999999999999999999999999999999976543222
Q ss_pred CccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.....+||+.|+|||++.+ ...++.++|||||||+||+|++|..||.+.+..+.+..|........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 2223579999999999963 24578899999999999999999999998877776666643211000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~pk 713 (776)
++ .....++..+++||.+||+.++.+ |+++.++|+||||..+++..
T Consensus 229 ------------------~~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 229 ------------------FP----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred ------------------CC----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 00 011237889999999999775554 78999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=380.31 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=204.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|.++.+++.||||+++...... .....+.+|+.++..+ +||||++++++|.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999998654322 2223466899999988 69999999999854 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+....+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 87544444444568999999999999999999999999999999999999999999999999999754333334455789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD-----QLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~-----~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.+
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 215 (329)
T cd05588 159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------------------- 215 (329)
T ss_pred CccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH----------------------
Confidence 999999999987 568999999999999999999999996321100 0000000
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCcCcCCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT------AEAALNHDWFREVPLP 712 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT------a~EIL~HPwf~~i~~p 712 (776)
.+.. .....+..++..+.+||.+||..||.+|+| +.++++||||..+.+.
T Consensus 216 -------~~~~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 216 -------VILE----KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred -------HHHc----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 0000 011112347889999999999999999997 7899999999887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.08 Aligned_cols=286 Identities=40% Similarity=0.728 Sum_probs=229.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..+|.+++.||+|+||.||+|.++.++..||||++..... ......+.+|+.+|+.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 4689999999999999999999999999999999865432 2223456789999999999999999999854 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++++..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 99999988888777666678999999999999999999999999999999999999999999999999998654433334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+++.|+|||++.+...++.++|||||||+||+|++|.+||.+.+. .+.+.++...++.|....|+....++....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 4456799999999987655678899999999999999999999976543 466777777788887777776655554322
Q ss_pred hhhhhhhh-HhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFIKHQYN-LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~~~~~~-~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+...... .+... ......+..+.+||.+||..||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~------~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVV------WKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhh------ccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 21110000 00000 0011236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=366.93 Aligned_cols=282 Identities=52% Similarity=0.954 Sum_probs=234.8
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|++++.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++.. ....|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999997655444444567789999999999999999999854 468999999
Q ss_pred ehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 495 YMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 495 y~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
|+.+++..++.... ..+++..++.++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++............
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 99888777766543 36999999999999999999999999999999999999999999999999999866544333444
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
..++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+.+++...+.|....|+....++.....+.
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 56789999999987755678999999999999999999999999998888889999888888887777655554332222
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....... ....+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 239 ~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDL--------SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccch--------hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111111 11234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=378.57 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=210.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|.++.++..||||+++..... ......+..|+.++..+ .||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999999865422 22233456788999888 69999999999854 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 87555444445567999999999999999999999999999999999999999999999999998754333333445689
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~------------------------ 213 (318)
T cd05570 159 TPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV------------------------ 213 (318)
T ss_pred CccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999987 5689999999999999999999999998877666665533210
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCcCcCCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWFREVPLP 712 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-----~EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||..||.+|||+ .++++||||+.+.+.
T Consensus 214 -------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 214 -------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred -------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 0112378899999999999999999999 999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=369.77 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=214.0
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|++++.||+|+||+||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 3889999999999999999999999999999997543222 222345689999999999999999999844 4589999
Q ss_pred eeehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.++ |...+... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cc
Confidence 9999864 54444332 346999999999999999999999999999999999999999999999999999875332 22
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------------- 221 (285)
T ss_pred cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------------
Confidence 334588999999999987 5689999999999999999999999988765544444332211100
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPKSK 715 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk~~ 715 (776)
...+..++..+.+||.+||..||.+|| ++.++++||||...++.+.+
T Consensus 222 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05605 222 ------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273 (285)
T ss_pred ------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence 001123788899999999999999999 99999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=380.31 Aligned_cols=274 Identities=24% Similarity=0.413 Sum_probs=237.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
+.+|.++..||+|+||+|.+|..+.+...||||+++++..- .....-.+.|-.+|.... -|++++++..| +..+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhe
Confidence 46899999999999999999999999999999999887633 333334456777777664 68999999999 667799
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+.|+.+.+..+.-++|.|..|.+|+.+|+-||-|||++|||+||||.+|||||.+|++||+|||+++..--...
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 99999999877777777778899999999999999999999999999999999999999999999999999997666666
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...++||||.|+|||++.- .+|+.++||||+||+|||||.|++||.+.++.++++.|+...-.
T Consensus 506 TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs---------------- 568 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS---------------- 568 (683)
T ss_pred ceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc----------------
Confidence 7788999999999999986 67999999999999999999999999999999999999765211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCcCcCCCCCCCCC--CCCCCcc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWFREVPLPKSK--DFMPTFP 722 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-----~EIL~HPwf~~i~~pk~~--~~~~~~~ 722 (776)
| +..+|.++.++...+|.+.|.+|+.+ .+|-.||||+.|.|.+.+ .+.|.|.
T Consensus 569 --------------y-------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfk 627 (683)
T KOG0696|consen 569 --------------Y-------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFK 627 (683)
T ss_pred --------------C-------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCC
Confidence 1 12389999999999999999999965 789999999999998764 4566665
Q ss_pred hhh
Q 004049 723 AQH 725 (776)
Q Consensus 723 ~~~ 725 (776)
+..
T Consensus 628 Pk~ 630 (683)
T KOG0696|consen 628 PKI 630 (683)
T ss_pred Ccc
Confidence 543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=376.50 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=207.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHh-CCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLS-FHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~-L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|++..+++.||||+++..... .........|+.++.. +.||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999999865421 2223345567888876 489999999999854 45899999999
Q ss_pred hh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccc
Q 004049 497 EH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575 (776)
Q Consensus 497 ~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~ 575 (776)
.| +|...+. ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 79 ~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 86 4544443 456799999999999999999999999999999999999999999999999999976433333344568
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~--------------------- 213 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P--------------------- 213 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------------
Confidence 9999999999987 568999999999999999999999999887766665553210 0
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCcCcCCCCCC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE-AALNHDWFREVPLP 712 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~-EIL~HPwf~~i~~p 712 (776)
..+..++..+.+||.+||+.||.+||++. ++++||||+.+.+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 00123788899999999999999999996 99999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=382.42 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=205.7
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC---CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF---HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
||+|+||+||+|+++.+++.||||++...... .........|..++..+ .||||+.++.++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 79999999999999999999999999754322 11223345677777665 69999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.++.+.........+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 86544444444667999999999999999999999999999999999999999999999999999765443344456789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+...++.++|||||||+||+|++|..||.+.+..+.+..|......
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------- 215 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR----------------------- 215 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 999999999987566899999999999999999999999988776666555332100
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHHcCcCcCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI----TAEAALNHDWFREVP 710 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp----Ta~EIL~HPwf~~i~ 710 (776)
++ ...++..+.+||.+||..||.+|| ++.++|+||||..+.
T Consensus 216 -------~~------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 216 -------FP------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred -------CC------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 00 113688999999999999999998 799999999998765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.34 Aligned_cols=293 Identities=25% Similarity=0.353 Sum_probs=214.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||++++..++..||+|++..... ......+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 4789999999999999999999999999999999975432 1123457789999999999999999999854 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.++.+..+......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--c
Confidence 999999754444444456799999999999999999999986 6999999999999999999999999999766432 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc--
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV-- 648 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~-- 648 (776)
.....||+.|+|||++.+ ..++.++|||||||+||+|++|..||......+....+...........+......+..
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 344679999999999987 56899999999999999999999999876654433222111100001111100000000
Q ss_pred --------chhhhhhhhhHhhhcCCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 --------KVNFIKHQYNLLRKKFPAT-SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 --------~~~~~~~~~~~l~~~~p~~-~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
................... .......++.++++||.+||++||++|||+.+||+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000000000000000000 0111234788999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.19 Aligned_cols=281 Identities=37% Similarity=0.693 Sum_probs=221.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|+++..||+|+||.||+|.++.+++.||+|++............+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46999999999999999999999999999999987554333333456789999999999999999999854 4588999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||++++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99999888777766666799999999999999999999999999999999999999999999999999987754433334
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.........+.... +
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 233 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ-----F 233 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc-----c
Confidence 45688999999999875668899999999999999999999999888877776666554332111000000000 0
Q ss_pred hhhhhhHhhhcCCCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 653 IKHQYNLLRKKFPATSF-----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~-----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
... ...+.... ...+.++..+.+||.+||..||++|||+.++|.||||
T Consensus 234 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKG------LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccc------ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 00000000 0012368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=383.60 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=214.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 118 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 45899999999999999999999999999999999975332 12222345689999999999999999999854 4589
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.|+ |..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999864 5555433 458999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+....+.+|+......
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---------- 266 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---------- 266 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 223456899999999999753 237899999999999999999999999988877777775432111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~ 711 (776)
.+.....++..+++||.+||..++.+ |+++.+|++||||+..++
T Consensus 267 -----------------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 267 -----------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -----------------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 01112247899999999999844443 789999999999988554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.56 Aligned_cols=289 Identities=45% Similarity=0.823 Sum_probs=228.1
Q ss_pred CeeEEeeeecCCceEEEEEEECC--CCcEEEEEEeecch-hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKK--TGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~--tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.|++++.||+|+||.||+|.++. ++..||||.+.... ..........+|+.+++.++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 89999999997643 2223344567899999999999999999999776557899
Q ss_pred EEeeehhhhhhhHHhhc----cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC----CCcEEEeeccccc
Q 004049 491 MVMEYMEHDLKGLMETM----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN----RGELKICDFGLAR 562 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~----~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~----~g~iKL~DFGlA~ 562 (776)
+||||+.+++..++... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999998877766432 236899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHh
Q 004049 563 QYGSPLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---------DQLDKIFKT 630 (776)
Q Consensus 563 ~~~s~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---------~~l~kI~~~ 630 (776)
....... .....++|+.|+|||++.+...++.++|||||||+||+|++|.+||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 2234578999999999987667899999999999999999999999866543 467777888
Q ss_pred cCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 631 LGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPAT----SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 631 lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~----~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
++.+....|+.+...+....... ......++.. .+......+..+.+||.+||..||.+|||+.+|++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMK----DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhh----hccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 88777776665554443322100 0000111100 000012477889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=379.29 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=207.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHH-HHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREIN-ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~-iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|.++.+|+.||||++...... ......+..|+. +++.++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 3699999999999999999999999999765322 122233445555 4677999999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 97655444455678999999999999999999999999999999999999999999999999999764333344456789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------- 212 (325)
T cd05604 159 TPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------- 212 (325)
T ss_pred ChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 999999999987 568899999999999999999999999887776666654321
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCcCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWFREVPL 711 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPwf~~i~~ 711 (776)
....+.++..+.+||.+||..||.+||++ .+|++||||..+.+
T Consensus 213 ------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 ------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00112378889999999999999999976 59999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=378.55 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=203.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|.++.+++.||+|+++...... .....+.+|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 46999999999999999999999999998654322 1223456788888776 79999999999854 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.++.+.........+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 97554444445567999999999999999999999999999999999999999999999999999764333334455789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-----DQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-----~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 216 (329)
T cd05618 159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------------------- 216 (329)
T ss_pred CccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------------------
Confidence 999999999987 56899999999999999999999999532100 000000000
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCcCcCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT------AEAALNHDWFREVPL 711 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT------a~EIL~HPwf~~i~~ 711 (776)
.... ....+..++..+.+||.+||..||.+||| +.++++||||+.+.+
T Consensus 217 -------i~~~-----~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 217 -------ILEK-----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------HhcC-----CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0000 01112347889999999999999999998 589999999998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=389.94 Aligned_cols=259 Identities=30% Similarity=0.508 Sum_probs=233.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|+.++.||+|+||.+++++++..++.|++|.|..............+|+.++++++|||||.+++.|+..+ ..+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEE
Confidence 47899999999999999999999999999999999988766666667889999999999999999999996543 34999
Q ss_pred Eeeehhhh-hhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEHD-LKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||+||+|+ +.+.+...+ .-|++..+..|+.||+.||.|||++.|+|||||+.|||++.++.|+|+|||+|+.+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999975 555555544 5699999999999999999999999999999999999999999999999999999987765
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...+.+||+.||.||++.+ ..|+.++|||||||++|||++-+++|.+.+...++.+|+.....|...
T Consensus 162 ~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~------------ 228 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS------------ 228 (426)
T ss_pred hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc------------
Confidence 7778999999999999998 679999999999999999999999999999999999999887555332
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..+.+++.||..||..+|..||++.++|.+|.++.
T Consensus 229 ------------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 229 ------------------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 37889999999999999999999999999998874
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=381.88 Aligned_cols=261 Identities=28% Similarity=0.391 Sum_probs=206.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+|+.++|+||+++++++. ....+|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEE
Confidence 34779999999999999999999999999999999864321 122345678999999999999999999984 455899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.++.+.. ...+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 9999999754322 234678888999999999999999999999999999999999999999999999876544444
Q ss_pred ccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
....+||..|+|||++.. ...++.++|||||||+||+|++|+.||......+....+......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------------- 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS------------- 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-------------
Confidence 456789999999998843 233567899999999999999999999743322211111111000
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
........++..+++||.+||..||++|||+.|||+||||.+...
T Consensus 292 --------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 292 --------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred --------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 001112247889999999999999999999999999999987543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=362.04 Aligned_cols=281 Identities=40% Similarity=0.667 Sum_probs=222.4
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
|++++.||+|+||.||+|.+..++..||+|+++...... ......+|+.++.++. |+||+++++++.......+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678999999999999999999999999999987543221 1233457999999986 99999999999765446899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
||+.++++..+......+++.+++.++.||+.||.|||+.||+||||||+|||++. +.+||+|||++...... .....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-~~~~~ 157 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-PPYTE 157 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-CCcCC
Confidence 99999998888776678999999999999999999999999999999999999999 99999999999876432 23344
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
..++..|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...+...+.........+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 57899999999886656678999999999999999999999999998888888887776655432111100000000000
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
......+. ...+.++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLR--------KLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHH--------HHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00000000 0112468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.82 Aligned_cols=266 Identities=23% Similarity=0.366 Sum_probs=215.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||+++++.+++.||+|++..... .......+..|+.++..++|+||+.+++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 479999999999999999999999999999999965332 22222345679999999999999999999844 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999975 66667666567899999999999999999999999999999999999999999999999999976533222
Q ss_pred CccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.....+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+..+.+.+|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 2234679999999999863 3458899999999999999999999999888777777765431100
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPLP 712 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~p 712 (776)
.+|. ....++..+++||.+||+.++.+ |+++.++++||||+.+.+.
T Consensus 228 -----------------~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 228 -----------------QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred -----------------cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 0000 01237899999999999776554 6899999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=365.98 Aligned_cols=289 Identities=49% Similarity=0.889 Sum_probs=237.1
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---- 485 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---- 485 (776)
..+++|++.+.||.|+||.||+|.++.+++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4568899999999999999999999999999999999765444444456678999999999999999999885432
Q ss_pred ----CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 486 ----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 486 ----~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
...+|+||||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 2378999999999888887766667999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 562 RQYGSPL-KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 562 ~~~~s~~-~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
....... .......++..|+|||++.+...++.++|||||||++|+|++|++||...+....+..+....+.+....||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 8764332 222334568889999998765567899999999999999999999999999999999999988888888888
Q ss_pred CCCCCCCcchhh-hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 641 GFSKLPGVKVNF-IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 641 ~~~~lp~~~~~~-~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+...+...... ........+ .....++..+.+||.+||..||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLR--------EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchh--------hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 765544321100 000000000 1112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=375.59 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=206.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHH-HHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREIN-ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~-iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|+++.++..||+|++...... ......+..|+. +++.++||||+++++++. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 3699999999999999999999999999765422 122233445554 578899999999999884 445899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 97555444445567999999999999999999999999999999999999999999999999998764333333455689
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (321)
T cd05603 159 TPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP------------------------- 212 (321)
T ss_pred CcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence 999999999987 568999999999999999999999999887666665553320
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCcCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWFREVPL 711 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPwf~~i~~ 711 (776)
...++..+..+.+||.+||+.||.+|+++ .++++|+||..+.+
T Consensus 213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 ------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 00112367889999999999999999975 59999999987655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.20 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=207.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHH-HHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREIN-ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~-iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|+++.+++.||+|++....... .....+..|.. +++.+.||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 36999999999999999999999999997643221 11223344444 5678899999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 97555444445667999999999999999999999999999999999999999999999999999765433334456789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------------------ 213 (325)
T cd05602 159 TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL------------------------ 213 (325)
T ss_pred CccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc------------------------
Confidence 999999999987 5689999999999999999999999998887777666644210
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HHHcCcCcCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE----AALNHDWFREVPL 711 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~----EIL~HPwf~~i~~ 711 (776)
...+.++..+.+||.+||+.||.+|+++. ++++|+||..+.|
T Consensus 214 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 214 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 01124788999999999999999999875 8999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=385.97 Aligned_cols=284 Identities=22% Similarity=0.305 Sum_probs=213.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|||||++++++.. ....||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 235689999999999999999998854 357899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-- 569 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-- 569 (776)
||+|+.++|..++......|++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 999999999888877667899999999999999999999999999999999999999999999999999986533211
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS-------EFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-------~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.....+||+.|+|||++.+ ..++.++||||||||||||++|..++.... ...++.+++......... ++..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~-~~~~ 395 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE-FPQH 395 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc-CCCC
Confidence 1234679999999999987 568999999999999999999876543221 123455555543332211 2211
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.. ......+........+..+....|.....++..+.+||.+||++||.+|||+.|||+||||+.
T Consensus 396 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AG-SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cc-hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 000000000000001111122222222346778999999999999999999999999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=416.76 Aligned_cols=274 Identities=26% Similarity=0.387 Sum_probs=231.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.|.+++++.|++.||+|++++...- ......|..|..||..-..+.|++++..| ++..++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~L 150 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--QDERYL 150 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccce
Confidence 458999999999999999999999999999999999764322 22234567899999999999999999999 556699
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC-
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~- 567 (776)
||||||++| +|+.++.... ++++.-|++|+.+|+.||.-||+.|+|||||||+|||||..|||||+|||.|-.+...
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999985 6777777665 8999999999999999999999999999999999999999999999999999877633
Q ss_pred CCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
...+...+|||.|++||+|.. .+.|+..+|||||||++||||.|..||+.++-.+.+-+|++.-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~---------- 299 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES---------- 299 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh----------
Confidence 334566799999999999952 256999999999999999999999999999999999999765111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcCCCCCCCCCCCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---AEAALNHDWFREVPLPKSKDFMPT 720 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT---a~EIL~HPwf~~i~~pk~~~~~~~ 720 (776)
..|.....+|..++|||+++|+. |..|+. +.++..||||.+++|.......|+
T Consensus 300 -----------------------l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 300 -----------------------LSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred -----------------------cCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 11112234999999999998875 888998 999999999999999655444444
Q ss_pred c
Q 004049 721 F 721 (776)
Q Consensus 721 ~ 721 (776)
+
T Consensus 356 ~ 356 (1317)
T KOG0612|consen 356 V 356 (1317)
T ss_pred C
Confidence 3
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=387.19 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=219.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|..+++||+|+||.||+|.+..+++.||||++..+... .....+.+|+.+|.+++++||.++|+.|.... .+.++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~--~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHHH
Confidence 3588889999999999999999999999999999876543 23456778999999999999999999997654 78999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+...-+...+..+.+.++..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+.++........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999866555556666779999999999999999999999999999999999999999999999999999877766668
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
+++||+.|||||++.+ ..|+.++||||||++.|||++|.|||........+..| +....|
T Consensus 170 tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~PP------------ 229 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSAPP------------ 229 (467)
T ss_pred cccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCCCC------------
Confidence 8999999999999996 67999999999999999999999999776553222222 111111
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+.+ .+|+.+++||..||.+||+.||+|.++|+|+|++.
T Consensus 230 ---------------~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 ---------------RLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---------------cccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1111 58999999999999999999999999999999987
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=376.93 Aligned_cols=293 Identities=33% Similarity=0.584 Sum_probs=229.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~ 487 (776)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||++++++|.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999999999999999998654333233345668999999999999999999885332 23
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999988777653 2899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+.++...++.|...++..+.....
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 F-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred C-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 2 2344578999999999987 5689999999999999999999999999998899999998888876554333221100
Q ss_pred cchhhhhhhh----hHhhhcC-----CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQY----NLLRKKF-----PATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~----~~l~~~~-----p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+..... ..+.+.+ +..........+..+.+||.+||+.||.+|||+.|||+||||+.+-.+
T Consensus 250 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 250 ---NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred ---HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0000000 0000111 111111122456788999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=374.09 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=215.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||++.++.+++.||||++..... .......+..|+.++..+.|+||+.+++++.. .+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 479999999999999999999999999999999975332 12222345678999999999999999999854 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
||||+.| +|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999985 56666665567899999999999999999999999999999999999999999999999999987643322
Q ss_pred CccccccccccCCchhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGS----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~----~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...+..+.+.+|......+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---------- 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----------
Confidence 12335799999999998652 3578899999999999999999999998877776666644211100
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~pk~ 714 (776)
++. ....++..+++||.+||+.++.+ |++++++++||||+.+.|...
T Consensus 229 ------------------~p~----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 229 ------------------FPS----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred ------------------CCC----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 000 01237889999999999976655 569999999999998766443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=379.69 Aligned_cols=268 Identities=25% Similarity=0.408 Sum_probs=222.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..+.|...+.||+|+||.||-++.+.||+.||+|.+.+..... .-....+.|..||.+++.++||.+-.+| +..+.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCce
Confidence 4578999999999999999999999999999999997655332 2234567899999999999999998888 556799
Q ss_pred EEEeeehhhhhhhHHh-hcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 490 FMVMEYMEHDLKGLME-TMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~-~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||..|+|+.+.+++ +.+ ..|++..+++|+++|+.||++||..+||+|||||+|||||+.|++.|+|+|||..+..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 9999999975554444 333 3699999999999999999999999999999999999999999999999999998853
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
..+....+||.+|||||++.+.. |+..+|||||||+||+|+.|+.||....+....+.|-+..-+-
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~------------- 405 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED------------- 405 (591)
T ss_pred CCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-------------
Confidence 34555669999999999999854 9999999999999999999999998765544333332221111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPKSK 715 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk~~ 715 (776)
...++ ..+|+++++|.+.+|++||.+|+ +++++.+||||+.++|....
T Consensus 406 -------------~~ey~-------~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 406 -------------PEEYS-------DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred -------------hhhcc-------cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 11122 24899999999999999999999 46799999999999987653
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=372.66 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=204.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||+||+|.++.+++.||+|++....... .....+.+|+.++..+ +||||+.+++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 46999999999999999999999999998654322 2233466899999888 59999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+..+......+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 87544444444567999999999999999999999999999999999999999999999999999764333334456789
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF------DQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~------~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++|..||...... +.+..++..
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------- 217 (327)
T cd05617 159 TPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------------------- 217 (327)
T ss_pred CcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------------------
Confidence 999999999987 56899999999999999999999999643211 111111110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT------AEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT------a~EIL~HPwf~~i~~p 712 (776)
.....+..++..+.+||.+||..||.+|++ +.++++||||+.+.+.
T Consensus 218 ----------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 218 ----------------KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ----------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 001112347889999999999999999998 5799999999988754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=360.89 Aligned_cols=286 Identities=35% Similarity=0.652 Sum_probs=223.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||.|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++. ....+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 4699999999999999999999999999999998654433333445678999999999999999999984 45689999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99999877776666566799999999999999999999999999999999999999999999999999987654444445
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...++..|+|||++.+...++.++|||||||++|+|++|.+||......+.+..+....+.........+...+..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 234 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF---- 234 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh----
Confidence 5678999999999987566788999999999999999999999988887777777765544321110000000000
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..................+.++..+.+||.+||..||.+|||+.++|+||||
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 --AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred --hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000000001123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.53 Aligned_cols=259 Identities=35% Similarity=0.586 Sum_probs=211.0
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998776444333344569999999999999999999955 558899999
Q ss_pred ehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 495 YMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 495 y~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
|+.+ +|..++. ....+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++............
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9998 5655555 5567999999999999999999999999999999999999999999999999999764333344556
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
..+|..|+|||++.....++.++||||||+++|+|++|..||...........+........
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------ 219 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL------------------ 219 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH------------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc------------------
Confidence 78899999999998336789999999999999999999999988744444433332211000
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..... ........+.+||.+||..||++|||+.++|+||||
T Consensus 220 -------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 220 -------PSSSQ-----QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------HHHTT-----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------ccccc-----ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00000 000123788999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=358.10 Aligned_cols=282 Identities=54% Similarity=0.963 Sum_probs=237.6
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|++.+.||.|.||.||+|+...+++.||+|++............+..|+.+++.+.|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 677889999999999999999999999999998765444445566789999999999999999999854 468999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
|+.+++..++......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.............
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 99998888887765679999999999999999999999999999999999999999999999999998775544444455
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
.++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+....|+.+..++.....+..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 67889999999987557899999999999999999999999999999999999999999988888877665532222221
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.........+ +.++..+.+||.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~--------~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVL--------PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhc--------ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111111 2357899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=391.24 Aligned_cols=261 Identities=26% Similarity=0.476 Sum_probs=226.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|+|+..||.|+||+||+|..+.++-..|.|+|...... ....++-||.||..+.||+||.|++.|+.++ .++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseE--ELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEE--ELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchh--HHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEEE
Confidence 5689999999999999999999999999999999765433 2566788999999999999999999886655 79999
Q ss_pred eeehhhhh-hhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHDL-KGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~L-l~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
.|||.|+- ...+......|++.++..+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+..........
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999864 45566778899999999999999999999999999999999999999999999999999987765555566
Q ss_pred cccccccccCCchhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 572 THLVVTLWYRAPELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.+++|||+|||||+++ ...+|++++|||||||+|.||.-+.||...-+....+-+|.+. .|+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT----------- 254 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT----------- 254 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc-----------
Confidence 7799999999999985 3467999999999999999999999999988888877777553 1211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
+.-+..++..+.|||.+||.+||..||++.+||+||||+.++.
T Consensus 255 ---------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 255 ---------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred ---------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 1223357889999999999999999999999999999998764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.61 Aligned_cols=291 Identities=38% Similarity=0.686 Sum_probs=234.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc--CCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~--~~~~l~ 490 (776)
++|++.+.||.|+||.||+|.++.++..||+|++............+.+|+.+|+.++||||++++++|... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999999999999999999976543333445667899999999999999999987532 335789
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
+||||+.+++..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999999887776654 45699999999999999999999999999999999999999999999999999976533221
Q ss_pred ---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 ---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.....+++..|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+.|+...+..+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~- 242 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD- 242 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh-
Confidence 1234578999999999876566899999999999999999999999999888889889888888876655433211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFT----GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~----~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
......+.++..... ..+.++..+.+||.+||+.||.+|||+.++|.||||.+.+.+..
T Consensus 243 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 243 ---------RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred ---------hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 000000111111000 11346899999999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.78 Aligned_cols=285 Identities=52% Similarity=0.959 Sum_probs=234.0
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|++++.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.+.||||+++++++.......+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999876533334456778999999999999999999986543368999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-Cccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-PYTH 573 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-~~~~ 573 (776)
|+.+++..++......+++.+++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 999988888776656899999999999999999999999999999999999999999999999999987654321 2333
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh-h
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN-F 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~-~ 652 (776)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..++...+.+....|+.+..+...... .
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 467889999998877566889999999999999999999999999999999999999998888888876554211000 0
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.......+...+. ..++..+.+||.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFK-------HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000001111111 1148899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.26 Aligned_cols=285 Identities=40% Similarity=0.700 Sum_probs=228.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.++.+++.||||+++...........+.+|+.+++.+.|+||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36999999999999999999999999999999987654444445667899999999999999999999955 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-Cc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-PY 571 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-~~ 571 (776)
|||+.++++..+......+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988877776667799999999999999999999999999999999999999999999999999987654432 34
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch-
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV- 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~- 650 (776)
....++..|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+.+..+...++......+..+...+....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 4567899999999998854789999999999999999999999998888777777766665544433322221111100
Q ss_pred hhhhh-hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFIKH-QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~~~-~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+... ........+ ...++..+.+||.+||..+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRY-------PGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhc-------CCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 000011111 12368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.28 Aligned_cols=294 Identities=39% Similarity=0.658 Sum_probs=231.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC---Cee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL---DSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~---~~l 489 (776)
.+|.+++.||+|+||+||+|.+..++..||||.+............+.+|+.+++.++||||+++++++..... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 57999999999999999999999999999999987543333334456789999999999999999998754322 358
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||||+.+++...+.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999999888777654 45799999999999999999999999999999999999999999999999999987644333
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..+...++.+....|..+.. ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~- 241 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN-EKA- 241 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc-hhh-
Confidence 344567899999999987645689999999999999999999999999888888888888777766554422111 000
Q ss_pred hhhhhhhhhHhhhcCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATS-FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~-~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
..+.+. + ...+... ....+.++..+.+||.+||+.||.+|||+.++|+||||..+..+..
T Consensus 242 ~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 242 RRYIRS----L-PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hHHHHh----c-CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 000000 0 0000000 0112357899999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=346.28 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=212.3
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|++++.||.|+||.||++.++.+++.||+|.+............+.+|+.+++.++|+||+++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48999999999999999999999999999999976543333344567899999999999999999887432 34689999
Q ss_pred eehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.+ ++...+... ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99985 565555543 4569999999999999999999999999999999999999999999999999998775444444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......+
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------------- 221 (257)
T cd08223 160 STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP----------------- 221 (257)
T ss_pred ccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----------------
Confidence 55678999999999987 568889999999999999999999998777655555543321100
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 -------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.97 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=203.3
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhh
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD 499 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~ 499 (776)
||+|+||.||++.++.+|+.||+|.+........ ....+..|+++++.++||||+++++++. ....+|+||||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 7999999999999999999999999975433221 2234457999999999999999999984 445899999999864
Q ss_pred -hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 500 -LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 500 -Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
|...+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......||
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCC
Confidence 54444332 346899999999999999999999999999999999999999999999999999876432 233446789
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~ 657 (776)
+.|+|||++.+ ..++.++|||||||+||+|++|..||...........+......
T Consensus 158 ~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 212 (277)
T cd05607 158 NGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE------------------------ 212 (277)
T ss_pred CCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc------------------------
Confidence 99999999987 45899999999999999999999999765432222222111000
Q ss_pred hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCcCCCCCCCC
Q 004049 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWFREVPLPKS 714 (776)
Q Consensus 658 ~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPwf~~i~~pk~ 714 (776)
..++ .....++.++.+||.+||++||.+||++ .+++.||||+.+.++..
T Consensus 213 ----~~~~----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~ 265 (277)
T cd05607 213 ----DEVK----FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265 (277)
T ss_pred ----cccc----cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence 0000 0012378899999999999999999999 77889999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=387.85 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=215.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC-----
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----- 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----- 486 (776)
.++|.+.+.||+|+||+||+|.+..+++.||||++............+.+|+.+|..+.|+||++++..+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999997654333334456789999999999999999887753321
Q ss_pred -CeeEEEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 487 -DSIFMVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 487 -~~l~LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
..+++||||+.+ +|...+... ...|++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 137899999985 566655432 356999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 562 RQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 562 ~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
+.+.... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+..+.+..+......+
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~----- 264 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----- 264 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC-----
Confidence 8654321 22345689999999999987 568999999999999999999999999887766666654431111
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.++.+++.+.+||.+||..||.+|||+.++|+|||++..
T Consensus 265 -------------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 -------------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -------------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 112478899999999999999999999999999998753
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=363.15 Aligned_cols=289 Identities=46% Similarity=0.770 Sum_probs=232.8
Q ss_pred CCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccC------------CccchHHHHHHHHhCCCCCcceeeE
Q 004049 413 DEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG------------FPLTSLREINILLSFHHPSIVDVKE 479 (776)
Q Consensus 413 ~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HPnIV~l~~ 479 (776)
++|..+ +.||.|+||+||+|.++.+++.||||++........ ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 567654 679999999999999999999999999865432210 1124678999999999999999999
Q ss_pred EEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 480 VVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 480 ~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
++.. ...+|+||||+.+++...+.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 88 ~~~~--~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEec--CCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9854 458999999999988777754 4569999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--------------CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 004049 560 LARQYGS--------------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625 (776)
Q Consensus 560 lA~~~~s--------------~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~ 625 (776)
++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9976541 11122234568899999999876667999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
.++..++.|....|+....++........ ....+. ......+..+.+||.+||..||.+|||+.++|.|||
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPR-KPKDLK--------TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcC-CcccHH--------HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 99999998888888876544422110000 000000 112246888999999999999999999999999999
Q ss_pred cCCCCCCC
Q 004049 706 FREVPLPK 713 (776)
Q Consensus 706 f~~i~~pk 713 (776)
|+..+.+.
T Consensus 316 ~~~~~~~~ 323 (335)
T PTZ00024 316 FKSDPLPC 323 (335)
T ss_pred cCCCCCCC
Confidence 99876553
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=366.42 Aligned_cols=287 Identities=25% Similarity=0.415 Sum_probs=211.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||.|+||.||+|.++.++..||+|++...... .....+.+|+.+|+.++||||++++++|.. ...+|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 7899999999999999999999999999999998754321 123456789999999999999999999955 4589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.+ +|..++. ....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+... .
T Consensus 82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 158 (333)
T ss_pred EecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--c
Confidence 999986 4555544 456799999999999999999999975 7999999999999999999999999999765332 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCCCCCCCC-CCCC--
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT--LGTPNEKIWPG-FSKL-- 645 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~--lg~p~~~~wp~-~~~l-- 645 (776)
....+||..|+|||++.+ ..++.++|||||||++|+|++|..||......... .++.. .+.+....... ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccc
Confidence 234578999999999987 56889999999999999999999999876543332 22211 11111000000 0000
Q ss_pred ------CCcc--hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 646 ------PGVK--VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 646 ------p~~~--~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
+... ...............+. .....++.++++||.+||++||.+|||+.+||.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPK---LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCcc---CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 00000000000000010 11123678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=371.44 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=206.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcE-EEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEI-VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~-VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++.+.+.||.|+||+||++.++ |.. ||||++............+.+|+.+|.+|+|||||++++++..... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 45666677999999999999997 445 9999997655333335678899999999999999999999954322 6899
Q ss_pred Eeeehhhhh-hhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCC-cccCCCCCCCeeecCCC-cEEEeecccccccCCC
Q 004049 492 VMEYMEHDL-KGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNW-VLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g~L-l~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~g-IvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~ 567 (776)
||||++++. ..++.. .+..|+...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999654 444444 2678999999999999999999999999 99999999999999998 9999999999877543
Q ss_pred CCCccccccccccCCchhhcc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g-~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
....+...||+.|||||++.+ ...|+.++|||||||+||||+||..||.+....+....+......|.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~----------- 266 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP----------- 266 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 334444789999999999995 26799999999999999999999999999887555544433322211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+ +..+++.+..||..|+..||.+||+..+|+.
T Consensus 267 -----------------~-------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -----------------I-------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------------C-------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1 1127788899999999999999999988764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.40 Aligned_cols=282 Identities=53% Similarity=0.917 Sum_probs=233.3
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 677889999999999999999999999999987654443344567789999999999999999999854 468999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
|+.+++...+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.............
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 99998888887766789999999999999999999999999999999999999999999999999998775544344445
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC-cchhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG-VKVNFI 653 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~-~~~~~~ 653 (776)
.++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+++.++...++.+....|+.+..... ....+.
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 7889999999998755789999999999999999999999999999999999998888887777766543211 000000
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.. .........+.++..+.+||.+||..||.+||++.++|+||||
T Consensus 239 ~~--------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KK--------AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cc--------cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 0000001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=357.67 Aligned_cols=261 Identities=24% Similarity=0.411 Sum_probs=207.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|++.+.||+|+||.||++.+..+++.||||.+........ ....+.+|+.+++.++|+||+.+++.+.. .+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 37888999999999999999999999999999875432221 12345689999999999999999998854 4589999
Q ss_pred eeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.| +|...+... ...+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~ 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cc
Confidence 999986 455555332 346999999999999999999999999999999999999999999999999999765322 22
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....||..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+......
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------------- 219 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------------- 219 (285)
T ss_pred ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------------
Confidence 234578999999999987 56899999999999999999999999765332111111110000
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPL 711 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~ 711 (776)
.... ....+++.+.+||.+||+.||.+||| +.++++||||+++.+
T Consensus 220 ---------~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 220 ---------VQEE-------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred ---------hhhh-------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 0000 11237888999999999999999999 999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=365.09 Aligned_cols=292 Identities=41% Similarity=0.689 Sum_probs=226.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l 489 (776)
++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 689999999999999999999999999999999864321 222345678999999999999999998875432 2358
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+.+++...+.. ..|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99999999987776643 5699999999999999999999999999999999999999999999999999976543221
Q ss_pred ---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 ---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+...++.+....+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 12335789999999998765668999999999999999999999999888888888887777766544332211100
Q ss_pred CcchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
.......... .+...+ ...+..+..+.+||.+||+.||.+|||+.++|+||||..+.-+..
T Consensus 242 ------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 242 ------ARNYIKSLPF-KPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred ------hhhHHhhcCc-CCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 0000000000 000000 011246888999999999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.99 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=213.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|+..+.||.|+||+||+|.+..+++.||+|++....... .....+.+|+.+|+.++|+||+.+++++.. .+.+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 3788899999999999999999999999999997543222 122345789999999999999999998844 4589999
Q ss_pred eeehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.++ +...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 157 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ES 157 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cc
Confidence 9999964 54444433 346999999999999999999999999999999999999999999999999999765322 22
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+..........
T Consensus 158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV------------- 223 (285)
T ss_pred ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc-------------
Confidence 344678999999999987 568999999999999999999999998876655554443332111110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
....++..+.+||..||..||.+||| +.++++|+||+.+++.
T Consensus 224 --------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 224 --------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred --------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 11236788899999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=362.36 Aligned_cols=292 Identities=41% Similarity=0.684 Sum_probs=234.3
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l~ 490 (776)
+|++.+.||.|+||.||+|++..++..||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 489999999999999999999999999999999765433334456788999999999999999999885432 24689
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-- 568 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-- 568 (776)
+||+|+.+++...+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999887777654 3489999999999999999999999999999999999999999999999999998775432
Q ss_pred -CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|..+....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 238 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK- 238 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc-
Confidence 123445789999999999885478999999999999999999999999999999999999988887766554211110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
...+... ....-+.......+.++..+.+||.+||++||.+|||+.++|+||||+.+..+
T Consensus 239 -~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 239 -ARNYLKS----LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred -hhhHHhh----cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0011110 00000000001123478899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=402.21 Aligned_cols=267 Identities=30% Similarity=0.462 Sum_probs=216.6
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
...+++|++++.||+|+||+||+|.++.++..||+|++............+..|+.+|..|.|||||+++++|.......
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34568999999999999999999999999999999999765433333456778999999999999999999997766678
Q ss_pred eEEEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccC-------CcccCCCCCCCeeecC--------
Q 004049 489 IFMVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDN-------WVLHRDLKTSNLLLNN-------- 549 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~-------gIvHrDLKPeNILLd~-------- 549 (776)
+||||||+.+ +|..++... ...|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999985 666665442 35799999999999999999999984 4999999999999964
Q ss_pred ---------CCcEEEeecccccccCCCCCCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 004049 550 ---------RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619 (776)
Q Consensus 550 ---------~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s 619 (776)
.+.+||+|||++..+... ......+||+.|+|||++.+. ..++.++||||||||||+|++|.+||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999999876432 223456899999999998653 458899999999999999999999998766
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004049 620 EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699 (776)
Q Consensus 620 ~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E 699 (776)
....+..++... |. ++ ....+..+.+||..||.++|.+|||+.|
T Consensus 248 ~~~qli~~lk~~--p~----------------------------lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 248 NFSQLISELKRG--PD----------------------------LP------IKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred cHHHHHHHHhcC--CC----------------------------CC------cCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 555443332221 00 00 0125788999999999999999999999
Q ss_pred HHcCcCcCCCCCC
Q 004049 700 ALNHDWFREVPLP 712 (776)
Q Consensus 700 IL~HPwf~~i~~p 712 (776)
+|.||||+.+..+
T Consensus 292 lL~h~~ik~i~~p 304 (1021)
T PTZ00266 292 CLGYQIIKNVGPP 304 (1021)
T ss_pred HhccHHHhhcCCC
Confidence 9999999876543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.57 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=213.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|.+.+.||+|+||.||+|.++.++..|++|.+............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 5889999999999999999999999999999987654333334567789999999999999999999854 45899999
Q ss_pred eehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.| +|..++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 99985 566665553 4579999999999999999999999999999999999999999999999999998765544444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd08529 159 NTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP----------------- 220 (256)
T ss_pred hccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 45678999999999987 458899999999999999999999998887666665554321110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||+.+|++||++.++++|||+
T Consensus 221 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 -------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 001367889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=358.15 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=210.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
+.||+|+|+.|--+....+|..||||+|.+.. ........+|++++.+++ |+||++|+++| ++...+|||||-|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceEEEEEeccc
Confidence 57999999999999999999999999997763 333567789999999996 99999999999 55668999999999
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEeecccccccCCC-------
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICDFGLARQYGSP------- 567 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~~~~s~------- 567 (776)
|+.+-..+.....|+|.++..++++|+.||.|||.+||+||||||+|||..... -+|||||.|...+...
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 754444444456799999999999999999999999999999999999997654 4899999998654311
Q ss_pred CCCccccccccccCCchhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHH
Q 004049 568 LKPYTHLVVTLWYRAPELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------------FDQLDKIF 628 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---------------~~~l~kI~ 628 (776)
.....+.+|+..|||||++. ....|+++.|.||||||||.||+|.+||.|.-. ..+++.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12234578999999999873 235699999999999999999999999977521 23445554
Q ss_pred HhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 629 ~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+.+.+++..| ..+|.+++|||..||..|+..|+++.++|+|||++.
T Consensus 320 EGkYeFPdkdW---------------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 320 EGKYEFPDKDW---------------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccCCcCChhhh---------------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 44444444333 238999999999999999999999999999999998
Q ss_pred CCCC
Q 004049 709 VPLP 712 (776)
Q Consensus 709 i~~p 712 (776)
+...
T Consensus 367 ~~~e 370 (463)
T KOG0607|consen 367 CAPE 370 (463)
T ss_pred cchh
Confidence 7544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.37 Aligned_cols=300 Identities=36% Similarity=0.620 Sum_probs=229.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC----C
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----D 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----~ 487 (776)
.++|.+++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467999999999999999999999999999999986543222223456789999999999999999999854321 2
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||+|+.+++..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4689999997766666543 56999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+.++++..+.+...++..+.....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 23456789999999997655688999999999999999999999999888888888877655544333222211000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCcc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFP 722 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~~ 722 (776)
..+. ..+....+.......+.++..+.+||.+||..||.+|||+.++|.||||+....+......+.+.
T Consensus 249 --~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd07880 249 --KNYV----KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYD 317 (343)
T ss_pred --HHHH----HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCcc
Confidence 0000 00000000000011245788999999999999999999999999999999876554444444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.93 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=207.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc---CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE---GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+.|++.+.||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++++.||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 56999999999999999999999999999999986543221 122356789999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+.++.+..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998654433333446799999999999999999999999999999999999999999999999999976532211
Q ss_pred C---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 P---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 1 133568899999999987 45889999999999999999999999876555444433221100
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
...+..++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 ----------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01112378889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=354.55 Aligned_cols=260 Identities=30% Similarity=0.459 Sum_probs=211.4
Q ss_pred cccCCCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec--c
Q 004049 409 CRSVDEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG--S 484 (776)
Q Consensus 409 ~~~~~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~--~ 484 (776)
...+++|.+- +.||-|-.|+|..+.++.|++.+|+|++... .+..+|+++--.. .|||||.++++|.. .
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3456788775 6799999999999999999999999998543 2345788875554 59999999999953 3
Q ss_pred CCCeeEEEeeehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecc
Q 004049 485 NLDSIFMVMEYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFG 559 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFG 559 (776)
...++.+|||.++|+ |+..+... .+.|+|.++..|++||..|+.|||+.+|+||||||+|+|+.. +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 445788999999975 44445443 346999999999999999999999999999999999999975 4569999999
Q ss_pred cccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCC
Q 004049 560 LARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF----DQLDKIFKTLGTPN 635 (776)
Q Consensus 560 lA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~----~~l~kI~~~lg~p~ 635 (776)
+|+.... .....+.|-||.|.|||++-. ..|+...|+|||||++|.||||.|||++.... ....+|..+...++
T Consensus 210 FAK~t~~-~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 210 FAKETQE-PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccCC-CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 9997654 345566799999999999976 55999999999999999999999999876532 23344444433333
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.+-| ..+|.+++|+|+.||..+|.+|+|+.+++.|||+.+..
T Consensus 288 ~pEW---------------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 288 EPEW---------------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ChhH---------------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 3333 23899999999999999999999999999999998753
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=352.13 Aligned_cols=262 Identities=27% Similarity=0.469 Sum_probs=213.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|++++.||.|+||.||+|.+..++..||+|++...... ....+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence 5699999999999999999999999999999998654321 23456789999999999999999999854 4489999
Q ss_pred eeehhhhhh-hHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHDLK-GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~Ll-~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 999997654 4444545679999999999999999999999999999999999999999999999999987654333334
Q ss_pred cccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 572 THLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++..... + .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------~------ 234 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-P------T------ 234 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-c------c------
Confidence 45678999999999853 23468899999999999999999999987665544444322110 0 0
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
...+..++..+.+||.+||..||.+||++.++|+||||..+...
T Consensus 235 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 235 ---------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 00112367889999999999999999999999999999877654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.07 Aligned_cols=297 Identities=36% Similarity=0.648 Sum_probs=233.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~ 487 (776)
.++|++++.||.|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 47899999999999999999999999999999998654322223345668999999999999999998774332 13
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+|+||+.++|..++.. ..|++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998888777654 46999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+......+..++...+.+.+.++..+....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 247 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES- 247 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh-
Confidence 3445789999999998765567899999999999999999999999998888899998888777766554432110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFT-GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPT 720 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~-~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~ 720 (776)
...+... + .......+. ....++..+.+||.+||..||.+|||+.+||+||||+++..+......+.
T Consensus 248 -~~~~~~~----~-~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~ 315 (343)
T cd07851 248 -ARNYIQS----L-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPP 315 (343)
T ss_pred -HHHHHHh----c-cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccc
Confidence 0000000 0 000000000 01236889999999999999999999999999999998766554443333
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.14 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=213.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||.|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEE
Confidence 6799999999999999999999989999999998654322 23456789999999999999999999854 4588999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.+ +|..++......|++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 999987 4555555556679999999999999999999999999999999999999999999999999987664433334
Q ss_pred cccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 572 THLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
....+|+.|+|||++.. ...++.++|||||||++|+|++|.+||...+....+.++..... +
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~------- 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-------P------- 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-------C-------
Confidence 45678999999999852 23467899999999999999999999988766555544432210 0
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+..+..++..+.+||.+||..||.+||++.++|+||||...
T Consensus 227 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 --------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 011122477889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.15 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=214.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||.|+||.||++.+..+++.||+|++...... ......+.+|+++|+++.||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 4699999999999999999999999999999999754322 2223456789999999999999999999854 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|...+.. ...|++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999965 55555544 467999999999999999999999999999999999999999999999999999876443
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....++++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV------------------ 215 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence 334578999999999976 4578999999999999999999999988775555555432200
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
..+..++..+++||.+||..||.+|+ ++.++++||||+.+.+.
T Consensus 216 -------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 216 -------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 01123678899999999999999999 99999999999988754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=380.61 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=212.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC-CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT-GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t-g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+.+|+.+|+.++|||||++++++.. .+.+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER--QAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEE
Confidence 4599999999999999999998877 788999977543221 12345679999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.| +|...+.. ...+|++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999985 55554432 2457999999999999999999999999999999999999999999999999999876432
Q ss_pred CC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP----------- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 21 2345679999999999987 568999999999999999999999999888777776665432111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+..++..+.+||.+||..||.+|||+.++|.|+|++.+
T Consensus 291 -------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 291 -------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 011378899999999999999999999999999999753
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=363.33 Aligned_cols=294 Identities=38% Similarity=0.662 Sum_probs=229.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++.+.||.|+||.||+|.+..++..||||.+............+.+|+.+++++ +||||+++++++...+...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35789999999999999999999998999999998864332222234566899999999 99999999999866555678
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
|+||||+.++|...+... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999998887776543 78999999999999999999999999999999999999999999999999998664322
Q ss_pred ----CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 ----KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ----~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.......||..|+|||++.+...++.++|||||||++|+|++|++||.+......+.++....+.+....+..+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1223457899999999987766788999999999999999999999999988888888888766554432221100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.............-........+.++..+.+||.+||+.||.+|||+.++|+||||++...+
T Consensus 243 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 243 ------PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred ------hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00000000000000000001122378899999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.26 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=217.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+..|+.+|+.+.||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999999999999999997653221 233456789999999999999999999844 458999
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.| +|..++... ...|++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999986 555555432 35799999999999999999999999999999999999999999999999999875532111
Q ss_pred -----------------------------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh
Q 004049 570 -----------------------------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE 620 (776)
Q Consensus 570 -----------------------------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~ 620 (776)
......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1123468899999999987 4578999999999999999999999988877
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----
Q 004049 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---- 696 (776)
Q Consensus 621 ~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT---- 696 (776)
...+..+..... . +.....++..+.+||.+||..||.+|||
T Consensus 238 ~~~~~~~~~~~~-----~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 238 DETFSNILKKEV-----T------------------------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HHHHHHHhcCCc-----c------------------------------CCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 666655542110 0 0011126889999999999999999999
Q ss_pred HHHHHcCcCcCCCCCCCCCC
Q 004049 697 AEAALNHDWFREVPLPKSKD 716 (776)
Q Consensus 697 a~EIL~HPwf~~i~~pk~~~ 716 (776)
+.++|+||||+.+.++....
T Consensus 283 ~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 283 AAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHHHcCchhhcCChhhccc
Confidence 99999999999988775543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.31 Aligned_cols=290 Identities=24% Similarity=0.361 Sum_probs=211.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||+|+||.||++.+..++..||+|.+..... ......+.+|++++..++||||++++++|.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 469999999999999999999999999999999865422 1123456789999999999999999999954 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.|+.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--cc
Confidence 9999864444444445679999999999999999999997 68999999999999999999999999998765332 23
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch-
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV- 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~- 650 (776)
...++++.|+|||++.+ ..++.++|||||||++|+|++|..||...+... ...++....... .++.....+....
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~ 231 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEG--EAKESHRPVSGHPP 231 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccc--cccCCcccccCCCC
Confidence 44688999999999876 558899999999999999999999998765433 233322211000 0000000000000
Q ss_pred --hhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 651 --NFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 651 --~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
................... .....++.++.+||.+||..||.+|||+.+||+||||+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0000000011110100000 011237889999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=340.80 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=212.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||.|+||.||+|.+..++..||+|++............+..|+.+++.++||||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875443333334567899999999999999999988766666789999
Q ss_pred eehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhc-----cCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 494 EYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLH-----DNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLH-----s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
||+.+ +|...+... ..++++.+++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99985 555555443 467999999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
...........+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 228 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----------- 228 (265)
T ss_pred cCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-----------
Confidence 554433445678999999999987 45889999999999999999999999887755444444221100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..+..++..+.+||.+||..+|.+|||+.+||+|||+
T Consensus 229 -------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 -------------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0012367889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=360.00 Aligned_cols=287 Identities=39% Similarity=0.682 Sum_probs=224.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~~ 488 (776)
++|.+.+.||.|+||.||+|+++.++..||||++............+.+|+.+++.+.||||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999999999999998754333333445678999999999999999999885432 235
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|+||||+..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 7999999987655443 34699999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..++...+.+...+++.+.....
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA- 247 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch-
Confidence 223457889999999987755688999999999999999999999999888888888888776655443332211100
Q ss_pred chhhhhhhhhHhhhcCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFT-GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~-~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
..+.. ....++...+. ..+..+..+.+||.+||+.||.+|||+.++|.||||+.+...
T Consensus 248 -~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 248 -KSYIK-----SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred -HHHHh-----hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 00011111110 113467889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.27 Aligned_cols=291 Identities=35% Similarity=0.614 Sum_probs=229.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~ 487 (776)
.++|++++.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4789999999999999999999999999999999975432222234567899999999999999999988532 123
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|++++++.+++..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 5789999987777665543 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+|..|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+....+.+....++.+....
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 249 (345)
T cd07877 173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES- 249 (345)
T ss_pred --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh-
Confidence 23345789999999998775568899999999999999999999999888888888888877766655544332110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTG-SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~-~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
... +......++...+.. ....+..+++||.+||..||.+|||+.++|.||||++...|..
T Consensus 250 -----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 250 -----ARN-YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred -----HHH-HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 000 000011112111111 1136888999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.94 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=221.0
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
-|.++.+||+|+||.||+|.++.+|+.+|||.+..+. ....+..||.||.++..|++|++|+.|.. ...+++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeeh
Confidence 4888999999999999999999999999999997544 24567899999999999999999997743 34689999
Q ss_pred eehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||. |+..+.+..++++|+++++..+++..|.||+|||...-||||||..||||+.+|++||+|||.|.++.......+
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9998 677888888899999999999999999999999999999999999999999999999999999999877666778
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
+.+|||.|||||++.. -.|+..+||||||++..||.-|+|||..-.....+..| |.
T Consensus 188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------PT----------------- 243 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------PT----------------- 243 (502)
T ss_pred ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------cC-----------------
Confidence 8999999999999987 45899999999999999999999999765433222111 11
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
-|...|..+..+|+++.|||++||.++|++|-||.++++|||++..+
T Consensus 244 -----------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 244 -----------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11222333445899999999999999999999999999999998764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.67 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=205.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|+++.+++.||+|++...... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 36799999999999999999999999999999998644221 12346689999999999999999999854 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++.+..+.....++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999965444433445679999999999999999999999999999999999999999999999999998764433333
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....+++.|+|||.+.+ ...++.++|||||||++|+|++|.+||...........+......
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 227 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---------------- 227 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC----------------
Confidence 45678999999998853 244788999999999999999999999654433222111110000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
...+.....++..+.+||++||..||++|||+++||+|+|
T Consensus 228 ----------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 228 ----------------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----------------CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0001111236789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.58 Aligned_cols=287 Identities=21% Similarity=0.300 Sum_probs=205.4
Q ss_pred EEeeeecC--CceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 417 RLNKIDEG--TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 417 il~~LG~G--sfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
++++||+| +|++||++.++.+|+.||||++............+.+|+.+++.++||||++++++|... +.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 56789999 789999999999999999999976543333334556799999999999999999999554 58899999
Q ss_pred ehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC---
Q 004049 495 YMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--- 569 (776)
Q Consensus 495 y~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--- 569 (776)
|+.+ ++.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9985 555555443 34699999999999999999999999999999999999999999999999987544321111
Q ss_pred ----CccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 570 ----PYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 570 ----~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
......++..|+|||++.+. ..|+.++|||||||++|+|++|..||........+...... ..+.. +. ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~-~~-~~~ 235 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG--TVPCL-LD-TTT 235 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC--Ccccc-cc-ccc
Confidence 11223567889999999763 35889999999999999999999999876654443333221 11000 00 000
Q ss_pred CCC-----------cchhhhhhhh-hHhh-hcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 645 LPG-----------VKVNFIKHQY-NLLR-KKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 645 lp~-----------~~~~~~~~~~-~~l~-~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
++. ....+..... .... .............+++.+++||.+||++||.+|||+.+||+||||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000 0000000000 0000 000000011123467899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.49 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=206.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.+.+.||.|+||.||+|++..+++.||+|+++..... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Confidence 36799999999999999999999999999999998754321 12345689999999999999999999854 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||++++.+..+....+.+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 99999864444444445679999999999999999999999999999999999999999999999999997664433333
Q ss_pred cccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....|+..|+|||++. ....++.++|||||||++|+|++|.+||........+..+......+ .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--~------------ 229 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP--P------------ 229 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC--C------------
Confidence 4568899999999984 22457889999999999999999999997655433332221110000 0
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
.+.....++..+.+||.+||..||++|||+.+||+|||
T Consensus 230 ------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 230 ------------------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------------------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00011136778899999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=376.15 Aligned_cols=256 Identities=31% Similarity=0.511 Sum_probs=222.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.-|.-++.||.|+||.||.|++..+...||||++...... ......++.|+..|++|.|||+|.+.++|.-+. ..+|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHH
Confidence 3488889999999999999999999999999999765422 223457889999999999999999999997654 6799
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||||-|+-.+++.-.+++|-+.++..|+.+.+.||.|||+++.||||||..||||...|.+||+|||.|... .+.
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~----~PA 179 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM----APA 179 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----Cch
Confidence 9999999988888888899999999999999999999999999999999999999999999999999999765 345
Q ss_pred cccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.+++|||.|||||+|. ..+.|+-++|||||||+..||.-.+||+...+....+..|...-. |.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-Pt-------------- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PT-------------- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CC--------------
Confidence 7799999999999995 356799999999999999999999999888877777777644311 10
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...+.+|+.+..||..||++-|.+|||++++|.|+|+..-
T Consensus 245 --------------------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 --------------------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------------------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 0123478999999999999999999999999999999753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.39 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=206.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC----CC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~----~~ 487 (776)
+.|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.++..+ +||||+++++++.... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 568899999999999999999999999999999865431 224567899999998 6999999999986432 24
Q ss_pred eeEEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 488 SIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
.+|+||||+.+ +|..++... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 68999999986 566655543 3569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
..........|++.|+|||++.+ ...|+.++|||||||++|+|++|..||...........+... +.
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~------ 233 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA------ 233 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC------
Confidence 43334455789999999999863 235788999999999999999999999765443333222110 00
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 234 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 --------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000112367889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.05 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=211.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999999899999999986543322 34567789999999999999999998854 4589999
Q ss_pred eeehhh-hhhhHHhhc--cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 493 MEYMEH-DLKGLMETM--KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~--~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||+.+ ++...+... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999986 455555432 24699999999999999999999999999999999999999999999999999987654322
Q ss_pred C----ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 P----YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 ~----~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
. ....+|+..|+|||++.....++.++|+|||||++|+|++|..||...+....+.++.... + . .++.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~-~~~~---- 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--P-P-SLET---- 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--C-C-CcCC----
Confidence 2 2345789999999999875468999999999999999999999998776655555543321 0 0 0000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
......++..+.+||.+||..||.+|||+.+||+||||
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 230 -----------------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00012478889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=344.13 Aligned_cols=280 Identities=45% Similarity=0.807 Sum_probs=221.2
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC---CCCCcceeeEEEeccCC---Ce
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF---HHPSIVDVKEVVVGSNL---DS 488 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~~~~---~~ 488 (776)
|++.+.||.|+||.||+|.++.+++.||||++............+.+|+.+++.+ .||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999976544333334556788877766 59999999999865432 23
Q ss_pred eEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|++|||+.+++..++.... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999988877766543 36999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.+++.....+....|+.....+.
T Consensus 161 -~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 161 -MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred -cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 22234567899999999987 4588999999999999999999999999999999999988776665554443221110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.. +....+.......+.++..+.+||.+||+.||.+||++.++|.||||
T Consensus 239 ~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SS----------FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hh----------cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00000000001112367888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=380.89 Aligned_cols=291 Identities=24% Similarity=0.353 Sum_probs=206.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCC-cEEEEEEee--------------cc-hhccCCccchHHHHHHHHhCCCCCc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTG-EIVALKKVK--------------ME-KEREGFPLTSLREINILLSFHHPSI 474 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg-~~VAIK~i~--------------~~-~~~~~~~~~~~rEi~iL~~L~HPnI 474 (776)
.+++|++++.||+|+||+||+|..+... ..+++|.+. +. .........+.+|+.+|+.|+||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998765332 222222111 00 0111112345689999999999999
Q ss_pred ceeeEEEeccCCCeeEEEeeehhhhhhhHHhhc----cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 475 V~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~----~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
|++++++.. .+..|+||+++.++++.++... .......+++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 226 v~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999954 4578999999998887766542 2234567788999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCC--CChHHHHHH
Q 004049 551 GELKICDFGLARQYGSPLK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL-FNG--KSEFDQLDK 626 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P-F~~--~s~~~~l~k 626 (776)
+.+||+|||++..+..... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..+ |.. .....++.+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999987654322 2234689999999999987 5689999999999999999998754 432 344566667
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhh-hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKH-QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~-~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
++..+..+... +|.. ......++.. .+......++ .+.....++..+.+||.+||++||.+|||+.|+|.|||
T Consensus 383 ~~~~~~~~~~~-~p~~---~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 383 IIDSLSVCDEE-FPDP---PCKLFDYIDSAEIDHAGHSVP--PLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHhcccChhh-cCCc---HHHHHHHhhhhhcccCccchh--hHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 76665544332 2210 0000011100 0000000000 01112236778899999999999999999999999999
Q ss_pred cCCCC
Q 004049 706 FREVP 710 (776)
Q Consensus 706 f~~i~ 710 (776)
|....
T Consensus 457 f~~~~ 461 (501)
T PHA03210 457 FSAEE 461 (501)
T ss_pred hhcCC
Confidence 98753
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=339.47 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=210.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.+..++..+|+|++...... ....+.+|+.+++.++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 6799999999999999999999999999999999755322 34567789999999999999999999854 4589999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.++ +..++......+++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999975 444454444789999999999999999999999999999999999999999999999999998765433334
Q ss_pred cccccccccCCchhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~--~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....++..|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 224 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-------------- 224 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------------
Confidence 456789999999998763 2578899999999999999999999987765555444322210000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
........+..+.+||.+||..||..|||+.+||.|+|
T Consensus 225 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011125678899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=346.74 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=211.3
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|++++.||.|+||.||+|.+..++..+++|.+...... ....+.+|+.+++.+.||||+++++++.. ....|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH--HHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 378889999999999999999999999999998644321 23456789999999999999999999854 45889999
Q ss_pred eehhhhhhh-HHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEHDLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g~Ll~-~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.++.+. .+.....++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999975544 4444456799999999999999999999999999999999999999999999999999976543333334
Q ss_pred ccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 573 HLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
...+|+.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------------- 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------------
Confidence 5678999999999842 2457789999999999999999999998877666655554321100
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...+..++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 --------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00112367889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=354.99 Aligned_cols=293 Identities=38% Similarity=0.686 Sum_probs=228.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCC--CcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec--cCCCe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKT--GEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG--SNLDS 488 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~t--g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~--~~~~~ 488 (776)
+|++.+.||.|+||.||++.+..+ +..||||++............+.+|+.+++.+ .||||+++++++.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999888 89999999865433322344567899999999 59999999987532 23346
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|++|+|+.++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 899999999888777654 4579999999999999999999999999999999999999999999999999998654322
Q ss_pred C----CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K----PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~----~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..++..++.|+...+..+..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 123357899999999987655689999999999999999999999999999999999999988776544332211
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
.... .+. ......+...+ ...+.++..+.+||.+||+.||.+|||+.++|.||||+++..+..
T Consensus 240 ~~~~--~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~ 303 (332)
T cd07857 240 PKAQ--NYI-----RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303 (332)
T ss_pred hhHH--HHH-----HhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence 1000 000 00001111111 112346889999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.45 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=205.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++++.||||+++++++.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 468899999999999999999999999999999865421 1122456789999999999999999999955 4578999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~ 151 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAK 151 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--ccc
Confidence 999998665443 34789999999999999999999999999999999999999999999999999866432 234
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ---LDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~---l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
..+||..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.........
T Consensus 152 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------- 217 (279)
T cd06619 152 TYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------- 217 (279)
T ss_pred CCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------------
Confidence 4689999999999987 5689999999999999999999999965321110 0011111000000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
+ .......+..+.+||.+||..||.+||++.++|+||||+...
T Consensus 218 ---------------~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 218 ---------------P---VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ---------------C---CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 0 001123678899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.72 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=205.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHH-HHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI-LLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~i-L~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||.||+|.++.+|..||||+++...... ....+..|+.+ ++.+.||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 47999999999999999999999999999999987643221 12344556665 566789999999999854 447999
Q ss_pred EeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||++|++..++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999987766654 235699999999999999999999997 9999999999999999999999999999866432
Q ss_pred CCCccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~-s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.......++..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+.+..+..... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~------- 226 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---P------- 226 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---C-------
Confidence 122335788999999988642 34688999999999999999999999642 22333333322100 0
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.++ ...++..+.+||.+||..+|.+|||+.++|+||||+...
T Consensus 227 -------------------~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 -------------------QLP------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -------------------CCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 112678899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=359.01 Aligned_cols=291 Identities=36% Similarity=0.603 Sum_probs=221.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC-------
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN------- 485 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~------- 485 (776)
.+|.+.+.||.|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 679999999999999999999999999999999865432 23345678999999999999999998764332
Q ss_pred -----CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecc
Q 004049 486 -----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFG 559 (776)
Q Consensus 486 -----~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFG 559 (776)
...+|+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 135799999999877766643 46999999999999999999999999999999999999985 5578999999
Q ss_pred cccccCCCCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 560 LARQYGSPLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 560 lA~~~~s~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
++........ ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+.......++.....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976532211 1123467889999998876566889999999999999999999999998888888777766443322
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
..+..+...- ...... .......+. ....+.++.++.+||.+||+.||.+|||+.++|.||||+.+..|+.
T Consensus 241 ~~~~~~~~~~---~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~ 311 (342)
T cd07854 241 EDRNELLNVI---PSFVRN--DGGEPRRPL--RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD 311 (342)
T ss_pred HHhhhhhhhh---hhhhhh--cccccCCCH--HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCcc
Confidence 2111110000 000000 000000000 0011347889999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=342.99 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=205.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc---CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE---GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+|+..+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36899999999999999999999999999999986543221 122346689999999999999999998866555678
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+++|||+.+ +|...+.. ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999986 45555543 4569999999999999999999999999999999999999999999999999987653211
Q ss_pred ---CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 ---KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ---~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||........+..+... +...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~~~-------- 228 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PTNP-------- 228 (266)
T ss_pred ccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CCCC--------
Confidence 11223568899999999987 56889999999999999999999999876544444333211 1100
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
..+..++..+.+|| +||..+|.+|||+.+||+||||+
T Consensus 229 ------------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 ------------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00123677888999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=338.20 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=210.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++||||+++++++... ..+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 679999999999999999999998899999999875532 35677899999999999999999998544 589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.+ +|..++......+++..++.++.||+.||.|||+.+|+|+||+|.||+++.++.++|+|||++..........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999996 5555665556789999999999999999999999999999999999999999999999999998775443333
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+... .
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~----------------- 215 (256)
T cd06612 157 NTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P----------------- 215 (256)
T ss_pred ccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-----------------
Confidence 44568999999999977 46889999999999999999999999876544333222110 0
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
...+..+..++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 216 --------------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 --------------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00111122467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.17 Aligned_cols=254 Identities=26% Similarity=0.472 Sum_probs=212.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++. ....+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence 589999999999999999999999999999998754433333346778999999999999999999984 445899999
Q ss_pred eehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.+ ++...+... ...+++.++..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99985 566665543 3468999999999999999999999999999999999999999999999999998765433333
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+.+..+......+
T Consensus 159 ~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd08218 159 RTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP----------------- 220 (256)
T ss_pred hhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC-----------------
Confidence 34568899999999977 457889999999999999999999998777666666554321100
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||..+|.+||++.++|+||||
T Consensus 221 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 -------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.03 Aligned_cols=258 Identities=30% Similarity=0.482 Sum_probs=209.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC----C
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~----~ 486 (776)
.++|++.+.||.|+||.||+|.++.+++.|++|++..... ....+.+|+.+++++ .|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4789999999999999999999999999999999875432 124567899999999 6999999999996533 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..+|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 568999999996 444444332 4679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
.............++..|+|||++.. ...++.++|||||||+||+|++|.+||........+.++.... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-- 236 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP-- 236 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC--
Confidence 66544333445678999999999854 2346789999999999999999999998665555444443210 00
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+.....++..+.+||.+||..||++|||+.++++|||+
T Consensus 237 -----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 -----------------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----------------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 001112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=369.36 Aligned_cols=253 Identities=32% Similarity=0.524 Sum_probs=216.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g 498 (776)
+.||.|.||+||-|+++.+|+.||||+|.+..........+.+|+.||..+.||.||.|...| +..+.+|+|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhcc
Confidence 789999999999999999999999999988776666666777899999999999999999988 566799999999999
Q ss_pred hhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEeecccccccCCCCCCcccc
Q 004049 499 DLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 499 ~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
+.+..+.. .+++|++...++++.||+.||.|||-+||+|+||||+||||... -.+||||||+|+.++.. ....+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence 98877665 46789999999999999999999999999999999999999754 46999999999998653 344567
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
+|||.|+|||++.+ +.|...-||||+|||+|.-|+|..||.... ++-++|.+.-..
T Consensus 727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFM--------------------- 782 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFM--------------------- 782 (888)
T ss_pred cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccc---------------------
Confidence 99999999999998 679999999999999999999999996543 333334332111
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
||...| ..++..++|||..||+..-.+|.|++..|.|||+|...
T Consensus 783 ---------yPp~PW---~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 783 ---------YPPNPW---SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ---------cCCCch---hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 111111 23899999999999999999999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=357.36 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=196.5
Q ss_pred CCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++.+.||.|+||.||+|.+ ..++..||||+++.... ......+.+|+.+|..+ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 6899999999999999999975 24467899999864321 12234577899999999 899999999988543 3
Q ss_pred CeeEEEeeehhh-hhhhHHhhc----------------------------------------------------------
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---------------------------------------------------------- 507 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---------------------------------------------------------- 507 (776)
..+|+||||+.+ +|..++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468999999985 555555432
Q ss_pred ---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--CccccccccccCC
Q 004049 508 ---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRA 582 (776)
Q Consensus 508 ---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~A 582 (776)
..+|++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 13588899999999999999999999999999999999999999999999999986532211 1123345688999
Q ss_pred chhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhh
Q 004049 583 PELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLR 661 (776)
Q Consensus 583 PEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~ 661 (776)
||++.+ ..++.++|||||||+||+|++ |.+||.+......+...+.....
T Consensus 245 PE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------- 295 (338)
T cd05102 245 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---------------------------- 295 (338)
T ss_pred cHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC----------------------------
Confidence 999987 568999999999999999997 99999876543333222221000
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 662 KKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 662 ~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..++..+.+||.+||..||.+|||+.+|++
T Consensus 296 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 -------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011247788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=367.67 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=209.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|++++.||.|+.+.||++.. .+...||+|++...........-+..||.+|.+|+ |.+||+|++|-+++ +.+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lYm 437 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLYM 437 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEEE
Confidence 5799999999999999999976 45567888877665555555667889999999996 99999999998774 48999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC-
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP- 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~- 570 (776)
||||-+.+|..++.+....++.-.+++|..|||.|+.++|++||||.||||.|+|+-. |.+||+|||+|..+......
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence 9999999999999887776766699999999999999999999999999999999975 89999999999987644332
Q ss_pred -ccccccccccCCchhhccCC----------CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 571 -YTHLVVTLWYRAPELLLGSK----------QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g~~----------~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
....+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. .+++++. .+..|+..+
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~-aI~~P~~~I- 592 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH-AITDPNHEI- 592 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH-hhcCCCccc-
Confidence 23469999999999996321 15678999999999999999999995422 1233332 223332211
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.||.. .-..++.++++.||..||.+|||+.++|+|||++-++.+
T Consensus 593 -----------------------efp~~------~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 593 -----------------------EFPDI------PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred -----------------------cccCC------CCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 01110 012238899999999999999999999999999876543
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.55 Aligned_cols=257 Identities=29% Similarity=0.488 Sum_probs=212.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|++++.||.|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+.+++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 569999999999999999999999999999999865432 223456789999999999999999999854 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.++.+..+.. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99998755544443 34699999999999999999999999999999999999999999999999999886644333334
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.... .+.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~----------------- 234 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE----------------- 234 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Ccc-----------------
Confidence 4678999999999876 557899999999999999999999998887665554443211 100
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+..+..+++.+.+||.+||..||.+|||+.+|++||||+..
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01112378889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.90 Aligned_cols=258 Identities=29% Similarity=0.512 Sum_probs=210.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
...+|++++.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.+.||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEE
Confidence 346899999999999999999999999999999998754322 23456789999999999999999999854 45899
Q ss_pred EEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.++ |..++. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 94 VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred EeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999864 555443 34689999999999999999999999999999999999999999999999999886543333
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........+..+... +.+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------------- 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE-------------- 235 (296)
T ss_pred ccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC--------------
Confidence 3344678999999999987 55789999999999999999999999877654443332211 1100
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...+..++..+.+||.+||..||++|||+.+||+||||...
T Consensus 236 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 -------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00112367889999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.40 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=208.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC---C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN---L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~---~ 486 (776)
..++|.+.+.||.|+||.||+|.++.+++.||+|++..... ....+.+|+.+++++ .||||+++++++.... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 45789999999999999999999999999999999864321 123456799999998 7999999999986432 2
Q ss_pred CeeEEEeeehhh-hhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..+|+||||+.+ +|..++. .....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999986 4544443 234579999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCC----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSK----QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~----~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
.............|+..|+|||++.... .++.++|||||||++|+|++|.+||........+..+.... ...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~~- 252 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PPT- 252 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CCC-
Confidence 7643332334457899999999986432 36789999999999999999999998776555544442210 000
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
......++..+.+||.+||..||++||++.+||+||||+
T Consensus 253 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ------------------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ------------------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 001112567889999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.21 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=214.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|+.++.||.|+||.||.++...++..+++|.+............+.+|+.++++++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999987654333344567789999999999999999999955 45899999
Q ss_pred eehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+.+ +|...+... ...+++.++..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 99985 666666554 3569999999999999999999999999999999999999999999999999998765443334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+
T Consensus 159 ~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd08221 159 ETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP----------------- 220 (256)
T ss_pred cccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 45678999999999987 447889999999999999999999998877777666664321110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 221 -------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 -------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 012367889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.67 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=211.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 468999999999999999999999999999999875431 12234567899999999999999999998654 589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
+||+.+ +|...+... ++++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999986 555555432 79999999999999999999999999999999999999999999999999998876543344
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+......
T Consensus 156 ~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------------ 216 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP------------------ 216 (274)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC------------------
Confidence 55678999999999987 44899999999999999999999999876654444333222100
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
. .. ...++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 217 --------------~--~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 --------------S--LE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred --------------C--Cc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0 00 01167789999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.59 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=212.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||.|+||.||++.++.+++.||||.+...... ......+.+|+.+++.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 4699999999999999999999999999999998765321 1223456689999999999999999999844 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC---
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--- 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--- 568 (776)
||||+.|+.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999875444444445679999999999999999999999999999999999999999999999999986421000
Q ss_pred ------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 569 ------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 569 ------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+.+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 234 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 234 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---
Confidence 01112467889999999877 56899999999999999999999999887766666555432110
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcCCCCCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---AEAALNHDWFREVPLPK 713 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT---a~EIL~HPwf~~i~~pk 713 (776)
+| .....++..+.+||.+||..||.+||+ +.++|+||||...++..
T Consensus 235 --~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 235 --WP-----------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred --CC-----------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 00 001137888999999999999999997 79999999998876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=346.15 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=206.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4689999999999999999999999999999998653211 112456789999999999999999998854 4589999
Q ss_pred eeehhhhhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 493 MEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||+.|+.+..+... ...+++..+..++.||+.||.|||. .||+|+||||+|||++.++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999997544443332 2379999999999999999999996 69999999999999999999999999999765332
Q ss_pred CCccccccccccCCchhhccCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSK-----QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~-----~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
......+++.|+|||++.+.. .++.++|||||||++|+|++|..||...........+......+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 228 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------- 228 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-------
Confidence 223456888999999986432 3578999999999999999999999765443333222211111100
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..++.++.++.+||.+||..+|.+||++.++++||||....
T Consensus 229 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 229 --------------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 01123788999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=371.27 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=225.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+..|.+++.||+|.|++|.+|++..|+..||||+|.+..........+.+|+++|+.|.|||||+++.+...+ ..+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeE
Confidence 45779999999999999999999999999999999988776655555678999999999999999999999554 4899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.++.+.......+.+.+.+++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+. ....
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-cccc
Confidence 999999976555555556678889999999999999999999999999999999999999999999999999886 4456
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
..++||++.|.|||++.+..+.++.+|+||||++||.|++|..||.+.+-..+....+.+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------------------- 271 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------------------- 271 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-------------------
Confidence 7789999999999999998888999999999999999999999999876554443332221
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
+..+-.++-++.+||+++|..+|.+|++++++..|.|.....
T Consensus 272 ------------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 272 ------------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ------------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 111224888999999999999999999999999999997543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.99 Aligned_cols=254 Identities=27% Similarity=0.500 Sum_probs=204.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-------CccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-------FPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-------~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.|.+...||.|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 36778899999999999999998999999998865432211 12345689999999999999999999854 4
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+++||||+.+..+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 58899999998754444444456799999999999999999999999999999999999999999999999999987642
Q ss_pred CCC------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 567 PLK------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 567 ~~~------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+..... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~ 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-------P 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC-------C
Confidence 211 1123468899999999987 4578899999999999999999999987665544443322100 0
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..+..++..+.+||.+||+.||.+||++.+||+||||
T Consensus 231 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 -----------------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0012367889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=371.57 Aligned_cols=277 Identities=26% Similarity=0.417 Sum_probs=236.4
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
...+.+++++..||-|+||.|=++........+|+|++++... ...+......|.+||..++.|+||++|..| .+..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccch
Confidence 3456789999999999999999999877766799999987653 333445667899999999999999999999 5556
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
++||+||-|-|+.+-.+....+.|++..+++|+..++.|++|||.+|||+|||||+|+||+.+|.+||.|||+|+.+++.
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999987766666666788999999999999999999999999999999999999999999999999999999766
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.+ ..++||||.|.|||++.+ +.++.++|.||||+++||||+|.|||.+.+....++.|++++...
T Consensus 574 ~K-TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------- 638 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------- 638 (732)
T ss_pred Cc-eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------------
Confidence 44 467999999999999998 568999999999999999999999999999999999998874321
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCCC--CCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLPK--SKDFMPT 720 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~pk--~~~~~~~ 720 (776)
.+ +..++..+.+||++|-..+|.+|+. +.+|.+|-||...+|.- ...+.|.
T Consensus 639 ---------------~~-------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pP 696 (732)
T KOG0614|consen 639 ---------------EF-------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPP 696 (732)
T ss_pred ---------------hc-------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCC
Confidence 11 1237888999999999999999995 89999999999988753 3344444
Q ss_pred cchh
Q 004049 721 FPAQ 724 (776)
Q Consensus 721 ~~~~ 724 (776)
+.+.
T Consensus 697 i~~~ 700 (732)
T KOG0614|consen 697 IIPS 700 (732)
T ss_pred cccc
Confidence 4433
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.16 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=206.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc---CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE---GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+|++.+.||+|+||.||+|.+..++..||||.+....... .....+.+|+.+++.+.||||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999986433211 112355679999999999999999998865545678
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+++ +|..++. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999986 4555544 34568999999999999999999999999999999999999999999999999997653211
Q ss_pred ---CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 ---KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ---~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+. ..+...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~-------- 228 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP-------- 228 (265)
T ss_pred ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCCC--------
Confidence 12233568999999999987 558899999999999999999999997665444443332 111110
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
..+..++..+.++|.+||. +|.+|||+.++|+|||+.
T Consensus 229 ------------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ------------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0112367888999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.87 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=205.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc----CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE----GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+|+..+.||+|+||.||++.+..++..||+|++....... .....+.+|+.+++.++|+||+++++++. ..+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 4788899999999999999999999999999987543211 12345678999999999999999999984 45589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~~ 568 (776)
++||||+.|..+..+.....++++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999754444444456799999999999999999999999999999999999998776 59999999998764332
Q ss_pred C----CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K----PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~----~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------- 227 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC----------
Confidence 1 1123468899999999977 568899999999999999999999997554333333222210000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
.....+..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00011224788899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.18 Aligned_cols=280 Identities=44% Similarity=0.735 Sum_probs=225.0
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
|.+.+.||.|+||+||+|....+++.||||.+...... .......+|+..++++. ||||+++++++.. ...+|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 67889999999999999999989999999998654321 11223457999999999 9999999999854 56899999
Q ss_pred eehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.+++...+.... ..+++.++..++.||+.+|.|||++||+|+||+|+|||++.++.++|+|||++...... ....
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~ 156 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYT 156 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcC
Confidence 999888888776654 57899999999999999999999999999999999999999999999999999876432 2334
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch-h
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV-N 651 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~-~ 651 (776)
...++..|+|||++.+...++.++|+||||+++|+|++|.+||...+..+.+.++...++.+....|+....+..... .
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 467899999999987656689999999999999999999999999999999999999888887766654322111000 0
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
+.......+. ...+..+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 237 ~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLH--------QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccHH--------HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000000000 0011247889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.90 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=210.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..+|.+++.||.|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 47899999999999999999999999999999998654322 23456789999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||++++.+..+.. ...+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 94 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 94 VMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred eecccCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999998654444333 3468999999999999999999999999999999999999999999999999998664433333
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+... +.+.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCC----------------
Confidence 45678999999999987 56789999999999999999999999776543332221110 1100
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
...+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 235 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 -----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 011223678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=370.20 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=215.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecch-hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.-|..++.||-|+||.|.++....|...||+|.+.+.. ...........|..||..-..+.||+||..| ++.+++|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence 46999999999999999999999999999999996543 4555566677899999999999999999988 66679999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC---
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--- 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--- 567 (776)
||+|++| ++..+++. .+-|.|..+++|+++|.+|+++.|..|+|||||||+|||||.+|+|||+|||||+-+.-.
T Consensus 707 VMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999996 55555555 457999999999999999999999999999999999999999999999999999744100
Q ss_pred ---------------------------------------CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHH
Q 004049 568 ---------------------------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAEL 608 (776)
Q Consensus 568 ---------------------------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyEL 608 (776)
.......+||+.|+|||+|.. ..|+..+||||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 001134579999999999987 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcc
Q 004049 609 LSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLT 688 (776)
Q Consensus 609 LtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~ 688 (776)
+.|++||-..+..+...+|++ |..+.. +...-.+|.++.+||.+| +
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~l~------------------------~~~~~~ls~e~~~li~kL-c 910 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNFLH------------------------IPYQGNLSKEALDLIQKL-C 910 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhccc------------------------cccccccCHHHHHHHHHH-h
Confidence 999999988776555444422 222111 111224899999999985 5
Q ss_pred cCCCCCC---CHHHHHcCcCcCCCCCCC
Q 004049 689 YDPDKRI---TAEAALNHDWFREVPLPK 713 (776)
Q Consensus 689 ~DP~kRp---Ta~EIL~HPwf~~i~~pk 713 (776)
-++..|+ .++++..||||+.|++..
T Consensus 911 ~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 911 CSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred cChhhhhcccchhhhhcCccccccchHh
Confidence 5789998 478899999999998753
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.31 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=207.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEecc----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGS----NL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~----~~ 486 (776)
.+.|++.+.||.|+||.||+|.+..+++.||+|++..... ....+..|+.+++.+ .||||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3679999999999999999999999999999999865432 123466789999998 699999999998532 34
Q ss_pred CeeEEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
..+|++|||+.+ ++..++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 578999999986 565555443 345899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
...........|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.... ..
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~---- 244 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PP---- 244 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---CC----
Confidence 443334455678999999999853 2457889999999999999999999997665444333221110 00
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
......++..+.+||.+||..||.+|||+.+||+||||
T Consensus 245 ----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 ----------------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00012367899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.89 Aligned_cols=275 Identities=25% Similarity=0.425 Sum_probs=225.1
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccch-HHHHHHHHhC-CCCCcceeeEEEeccCCC
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS-LREINILLSF-HHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~-~rEi~iL~~L-~HPnIV~l~~~~~~~~~~ 487 (776)
..+.+|.+++.||+|+|++|.+++++.|.+.||+|++++....+...... ..|-.+..+. +||++|-|+.+|.+ ..
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--es 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ES 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cc
Confidence 35789999999999999999999999999999999999876554433333 3576676665 69999999999954 45
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+++|.||++|+.+.+..+...+|+++.+++|..+|..||.|||++|||+||||.+|||||..|++||+|+|+++.--.+
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 89999999998777777777788999999999999999999999999999999999999999999999999999987677
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-------C-hHHHHHHHHHhcCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-------S-EFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-------s-~~~~l~kI~~~lg~p~~~~w 639 (776)
.....++||||.|+|||++.| ..|+..+|||+||++++||+.|+.||.-. + +.-+++-|+..
T Consensus 405 gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------- 474 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------- 474 (593)
T ss_pred CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---------
Confidence 777888999999999999998 67999999999999999999999999521 1 11122222111
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCcCcCCCCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT------AEAALNHDWFREVPLPK 713 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT------a~EIL~HPwf~~i~~pk 713 (776)
+.++|. .+|-.+-.+|+..|.+||.+|+. ..++..|+||+.+.|..
T Consensus 475 ---------------------qiripr-------slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 475 ---------------------QIRIPR-------SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred ---------------------cccccc-------eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 001111 26667778999999999999984 58999999999998864
Q ss_pred C--CCCCCCcchh
Q 004049 714 S--KDFMPTFPAQ 724 (776)
Q Consensus 714 ~--~~~~~~~~~~ 724 (776)
. +...|.|.++
T Consensus 527 leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 527 LEQKQVLPPFQPQ 539 (593)
T ss_pred HhhcccCCCCCCc
Confidence 3 3345555443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.19 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=206.6
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec---cC
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG---SN 485 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~---~~ 485 (776)
...++|++++.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+ .||||+++++++.. ..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 355899999999999999999999999999999998864321 123456799999999 69999999998753 23
Q ss_pred CCeeEEEeeehhhh-hhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 486 LDSIFMVMEYMEHD-LKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 486 ~~~l~LVmEy~~g~-Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
...+|+||||++|+ |..++. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 45789999999864 444443 23456899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~ 637 (776)
..............|++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+... .+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~--- 246 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP--- 246 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC---
Confidence 876443333344578999999999853 234788999999999999999999999776544433222111 00
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.....+..++..+.+||.+||..||.+|||+.+||+|+||
T Consensus 247 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -----------------------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0001112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.84 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=205.1
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH- 498 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g- 498 (776)
||.|+||+||+|.+..+++.||+|++....... .....+..|+.+|+.++||||+++++++. ..+.+|+||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence 699999999999999999999999997543222 22334568999999999999999999984 34589999999986
Q ss_pred hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 499 DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 499 ~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
+|...+.... ..+++.+++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..... ........++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCC
Confidence 5555554433 3699999999999999999999999999999999999999999999999999976543 2233345678
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~ 657 (776)
..|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 158 ~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 212 (277)
T cd05577 158 PGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------------ 212 (277)
T ss_pred CCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------------
Confidence 89999999987 44889999999999999999999999776542222222111000
Q ss_pred hHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCCC
Q 004049 658 NLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 658 ~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk~ 714 (776)
.....+..+++.+.+||.+||+.||.+|| ++.++|+||||..+.+.+.
T Consensus 213 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 213 ---------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ---------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 00111224688999999999999999999 9999999999998877544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.58 Aligned_cols=261 Identities=28% Similarity=0.510 Sum_probs=212.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|.....||.|+||.||++.+..++..||||.+...... ....+.+|+.+++.++||||+++++.+.. .+.+|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ--RRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH--HHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 4466678899999999999999999999999998653321 23446789999999999999999999854 4588999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.++.+..+.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...........
T Consensus 98 ~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 98 MEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred EeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99998765544443 34699999999999999999999999999999999999999999999999999976644433344
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+.......
T Consensus 177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 237 (292)
T cd06658 177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------ 237 (292)
T ss_pred eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------
Confidence 5678999999999876 558899999999999999999999998776655554443221100
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
+.....++..+.+||.+||..||.+|||+.++|+||||+....|.
T Consensus 238 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 ----------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ----------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001123678899999999999999999999999999999776554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=332.57 Aligned_cols=257 Identities=31% Similarity=0.513 Sum_probs=206.5
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|.+.+.||+|+||.||+|.+..+++.||+|.++...........+..|+.+++.++|+||+++++++. ....+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 488999999999999999999999999999999765443334456778999999999999999999884 445899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc--
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY-- 571 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~-- 571 (776)
||+.++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999865444444445568999999999999999999999999999999999999999999999999998764332222
Q ss_pred --cccccccccCCchhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 572 --THLVVTLWYRAPELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 572 --~~~~GT~~Y~APEvl~g~~--~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
....++..|+|||++.+.. .++.++|||||||++|+|++|..||..... ......+.. +.+ ...|
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~--~~~~------ 228 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHK--PPIP------ 228 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCC--CCCC------
Confidence 1356789999999997632 378899999999999999999999976532 222222211 100 0000
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 229 ------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 229 ------------------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111357888999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=334.85 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=203.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc----cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER----EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+|.+.+.||.|+||.||+|.. .++..+|+|++...... ......+.+|+.+|+.++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478889999999999999986 57889999998754321 1112346689999999999999999999854 4689
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP-- 567 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~-- 567 (776)
|+||||+.|+.+..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999987544444444467999999999999999999999999999999999999999999999999998765211
Q ss_pred ----CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 ----LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ----~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....+.. +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~--- 228 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-----P--- 228 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-----C---
Confidence 112234568999999999987 557899999999999999999999998765544433332211100 0
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.....++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 229 --------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 --------------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112378899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=347.99 Aligned_cols=290 Identities=34% Similarity=0.632 Sum_probs=226.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||.|+||.||+|.++.+++.||||++............+.+|+.+++.+.||||++++++|... ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEE
Confidence 34789999999999999999999999999999999865433333345667899999999999999999988543 34689
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.+++..++.. .++++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++..... .
T Consensus 87 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~ 161 (328)
T cd07856 87 FVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q 161 (328)
T ss_pred EEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence 9999998877666543 4689999999999999999999999999999999999999999999999999976532 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.+.++.++..++..+..... .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 239 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT--L 239 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh--H
Confidence 23456788999999987656689999999999999999999999998887777777777777765544322111000 0
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+. ..+....+.......+.++..+.+||.+||+.+|.+|||+.++|.||||+....|
T Consensus 240 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFV----QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHH----hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000 0000000000001123478899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.17 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=209.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++++.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4899999999999999999999999999999997654333334567789999999999999999998843 45899999
Q ss_pred eehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccccCCCCCC
Q 004049 494 EYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~~s~~~~ 570 (776)
||+.+ +|.+++... ...+++..+..++.||+.+|.|||++||+|+||||+|||++.+ +.++|+|||++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 99986 566666543 3458999999999999999999999999999999999999865 468999999998765432 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---------------- 220 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC----------------
Confidence 234578999999999987 557899999999999999999999998877666555554321110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++..+.+||.+||..||.+|||+.++|+||||
T Consensus 221 --------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 --------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred --------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.83 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=207.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+|++.+.||.|+||.||+|.+..++..||+|++....... .....+.+|++++++++||||+++++++. ....+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 4899999999999999999999999999999997654322 23456778999999999999999999884 45589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.|..+........++++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 157 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTT 157 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccc
Confidence 9999875444444444689999999999999999999999999999999999999999999999999998764332 234
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF--DQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~--~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
...|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.. ..+...... .
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~---------------- 217 (258)
T cd05578 158 STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A---------------- 217 (258)
T ss_pred ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c----------------
Confidence 4678899999999987 45899999999999999999999999876642 222111110 0
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHHcCcCc
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA--EAALNHDWF 706 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa--~EIL~HPwf 706 (776)
....+..++..+.+||.+||..||.+||++ .++++||||
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 -----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001122367899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.62 Aligned_cols=256 Identities=31% Similarity=0.553 Sum_probs=208.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+++++.+.||||+++++++... ..+|++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 4688899999999999999999999999999998765322 2234567899999999999999999998554 589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.+ +|..++......+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999994 6666665555789999999999999999999999 9999999999999999999999999999876533221
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS-----EFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-----~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ....+..+... +..
T Consensus 157 -~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~--------- 222 (265)
T cd06605 157 -KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPP--------- 222 (265)
T ss_pred -hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCC---------
Confidence 12678899999999987 568999999999999999999999996542 12222222111 000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.++ ...++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 223 -----------------~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 223 -----------------RLP------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----------------CCC------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 000 01168889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.88 Aligned_cols=256 Identities=32% Similarity=0.545 Sum_probs=211.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++... ..+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 3699999999999999999999999999999998765322 2245677899999999999999999998544 589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.+ +|..++.. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999995 45555443 4779999999999999999999999 99999999999999999999999999999877544444
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS---EFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s---~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~------------ 220 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP------------ 220 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC------------
Confidence 445678999999999877 568899999999999999999999997764 22223222211 00
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPV-LSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~-lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...... ++..+.+||.+||..+|.+|||+.++|+||||+.+
T Consensus 221 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 221 ---------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 001112 67889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.78 Aligned_cols=254 Identities=29% Similarity=0.497 Sum_probs=209.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|.+.+.||.|+||.||++.++.++..||+|.+............+.+|+.+++.++|+||+++++++. ....+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 488999999999999999999999999999999765433333445678999999999999999999884 455899999
Q ss_pred eehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc-EEEeecccccccCCCCCC
Q 004049 494 EYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-LKICDFGLARQYGSPLKP 570 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~-iKL~DFGlA~~~~s~~~~ 570 (776)
||+.+ +|...+.... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++. ++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99985 5666554433 35899999999999999999999999999999999999998864 699999999876544333
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+....+..+..... +
T Consensus 159 ~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~---------- 220 (257)
T cd08225 159 AYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-------A---------- 220 (257)
T ss_pred ccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-------C----------
Confidence 344578999999999876 4588999999999999999999999987765555544432110 0
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
...+.++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 221 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 -------------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=340.20 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=196.7
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhccCC-ccchHHHHHHHH---hCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-PLTSLREINILL---SFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~-~~~~~rEi~iL~---~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
.||+|+||.||++.+..+++.||+|.+......... .....+|..+++ ...||||+.+++++.. .+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 489999999999999999999999998654322111 122334444333 3479999999998854 4478999999
Q ss_pred hhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccc
Q 004049 496 MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575 (776)
Q Consensus 496 ~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~ 575 (776)
+.++.+..+......|++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ......
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcC
Confidence 997555444444567999999999999999999999999999999999999999999999999999765432 223357
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
||..|+|||.+.+...++.++|||||||++|+|++|..||......... .+......
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~---------------------- 213 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT---------------------- 213 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc----------------------
Confidence 8999999999875456889999999999999999999999754321111 11111000
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.....+..++..+.+||.+||..||.+|+ |+.++++||||+.+.+.
T Consensus 214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 00111234788999999999999999999 69999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=344.26 Aligned_cols=259 Identities=27% Similarity=0.502 Sum_probs=211.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|+....||.|+||.||+|.+..++..||||++...... ....+.+|+.++..+.||||+++++++.. ...+|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence 455566899999999999999999999999998654322 23456789999999999999999998854 45899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
||+.++.+..+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.........
T Consensus 98 e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 98 EFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred ecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999754444433 246899999999999999999999999999999999999999999999999999766544333445
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
.+++..|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+... + ..
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-~~---------------- 235 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---P-PP---------------- 235 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---C-CC----------------
Confidence 678999999999987 45899999999999999999999999877766555444221 0 00
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+.....++..+.+||.+||+.+|.+||++.++++||||.+...+
T Consensus 236 --------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 236 --------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred --------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 011112367889999999999999999999999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=342.95 Aligned_cols=256 Identities=29% Similarity=0.488 Sum_probs=211.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|.+++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 5699999999999999999999999999999998644321 1122356789999999999999999999965 347899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++...+......+++..+..++.||+.||.|||+.||+|+||+|.||+++.++.++|+|||++..... .
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----~ 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----A 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----C
Confidence 999999988888776667899999999999999999999999999999999999999999999999999876532 2
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+... .++ .
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-----~-------- 233 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP-----T-------- 233 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC-----C--------
Confidence 34578899999998852 345888999999999999999999999877665554443221 000 0
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.....++..+.+||.+||..||.+||++.+|+.||||...
T Consensus 234 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 --------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred --------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0011257788999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.83 Aligned_cols=263 Identities=22% Similarity=0.387 Sum_probs=206.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|+.++.||+|+||.||++.+..++..||||.+...... .....+.+|+.++.++. ||||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 5688889999999999999999999999999998754322 22345678999999996 9999999998854 347899
Q ss_pred EeeehhhhhhhHHh----hccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLME----TMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~----~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+|||+.+++..+.. .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99999875544332 224679999999999999999999997 5999999999999999999999999999976543
Q ss_pred CCCCccccccccccCCchhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~--~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. ......|++.|+|||++.+. ..++.++|||||||++|+|++|.+||..... ....+..........
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------- 230 (288)
T cd06616 161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------- 230 (288)
T ss_pred CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc-------
Confidence 22 22345789999999999874 3689999999999999999999999976542 222222211110000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
........++..+.+||.+||..||.+|||+.+|++||||+...
T Consensus 231 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 231 ----------------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ----------------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 00111123788999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.18 Aligned_cols=263 Identities=30% Similarity=0.492 Sum_probs=207.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|+.++.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+++++.++||||++++++|.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4699999999999999999999999999999998754321 223457789999999999999999999876666689999
Q ss_pred eeehhh-hhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 493 MEYMEH-DLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 493 mEy~~g-~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||+.+ +|..++. .....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999986 4544433 234568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-----FDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-----~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... .. +.
T Consensus 160 --~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~----~~-- 227 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PN----PE-- 227 (287)
T ss_pred --cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cc----hh--
Confidence 224567889999999876 5688999999999999999999999976522 2222222110 00 00
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
++. .......+++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 228 --------------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 228 --------------------LKD-EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred --------------------hcc-CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 000 000001246788999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.70 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=207.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++.+.||.|+||.||++.++.++..||+|.++..... .....+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 589999999999999999999999999999998654322 223456789999999999999999999854 45899999
Q ss_pred eehhh-hhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEH-DLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+++ ++...+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 99985 56666544 34568999999999999999999999999999999999999999999999999998765443334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....|++.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+....+..+......+
T Consensus 158 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 219 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP----------------- 219 (255)
T ss_pred ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-----------------
Confidence 45678999999999977 458999999999999999999999998876665555543321110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.+||.-
T Consensus 220 -------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 012367788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.25 Aligned_cols=259 Identities=30% Similarity=0.499 Sum_probs=203.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC--------ccchHHHHHHHHhCCCCCcceeeEEEeccC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF--------PLTSLREINILLSFHHPSIVDVKEVVVGSN 485 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~--------~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~ 485 (776)
+|.+.+.||.|+||.||+|.+..+++.||||.+......... ...+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 488899999999999999999999999999998643221111 1245679999999999999999998844
Q ss_pred CCeeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 486 LDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 486 ~~~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...+++||||+.++ |...+.. ...|++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 45899999999864 5444443 467999999999999999999999999999999999999999999999999999765
Q ss_pred CCCC--CCccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 565 GSPL--KPYTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 565 ~s~~--~~~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
.... .......++..|+|||++.... .++.++|+||||+++|+|++|..||........+..+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP------- 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC-------
Confidence 3221 1123356889999999987643 47899999999999999999999997654443333222110000
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.++. ...+.++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 232 ---------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ---------------------PIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------------cCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 0112368899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=332.79 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=204.8
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH- 498 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g- 498 (776)
||.|+||.||+|.+..++..||+|++...... ......+.+|+.+++.+.||||+++++++.. ...+|+||||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 79999999999999999999999999754322 2233557789999999999999999998854 4579999999986
Q ss_pred hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccccc
Q 004049 499 DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL 578 (776)
Q Consensus 499 ~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~ 578 (776)
+|...+. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ......++.
T Consensus 79 ~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILR-DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred cHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 4545444 34569999999999999999999999999999999999999999999999999998765432 223457899
Q ss_pred ccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS--EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 579 ~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s--~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
.|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ....+.++......
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 212 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK----------------------- 212 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-----------------------
Confidence 9999999876 558899999999999999999999998766 44444444321110
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPL 711 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~ 711 (776)
...+...+..+.+||.+||..||.+|+| +.|+++||||+...|
T Consensus 213 ------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 213 ------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 0111235788999999999999999999 999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.62 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=206.0
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+|+..+.||+|+||+||+|.+..++..|++|.+...... ......+.+|+.+++.++||||+++++++. ....+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence 477789999999999999999989999999998654321 112345678999999999999999999884 345899
Q ss_pred EEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
++|||+.+. |..++. ....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999864 544443 44569999999999999999999999999999999999999999999999999988664332
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......++..|+|||.+.....++.++|+|||||++|+|++|.+||...........+......+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 221 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP--------------- 221 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC---------------
Confidence 23456789999999998763348899999999999999999999997766444443332210000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..+..++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 222 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 --------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0112378889999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.93 Aligned_cols=254 Identities=31% Similarity=0.537 Sum_probs=213.3
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|.+.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|||++++++.+... ..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 58999999999999999999999999999999976544333445677899999999999999999998554 6899999
Q ss_pred eehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 494 EYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||+++ +|...+... ...+++.++..++.+|+.||.|||++||+|+||+|+|||++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99986 566665554 36799999999999999999999999999999999999999999999999999987755433
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 222 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--------------- 222 (258)
T ss_pred eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---------------
Confidence 3445678999999999877 458899999999999999999999998776555554443221000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+..++..+.++|.+||..+|.+|||+.++|+||||
T Consensus 223 ---------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 223 ---------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.07 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=200.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHH-HhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINIL-LSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL-~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||.|+||.||+|.+..+++.||||++...... ......+..|..++ ..+.||||+++++++.. .+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5689999999999999999999999998654321 11122334454444 45589999999999844 45899999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCC
Confidence 8754444444456799999999999999999999999999999999999999999999999999876532 234568
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+....+..+...... |+.
T Consensus 156 ~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~--------------- 214 (260)
T cd05611 156 TPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----WPE--------------- 214 (260)
T ss_pred CcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----CCC---------------
Confidence 8999999999874 4899999999999999999999999887766655555332110 000
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcCCCCC
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---AEAALNHDWFREVPL 711 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT---a~EIL~HPwf~~i~~ 711 (776)
.....++..+.+||.+||..||.+||| +.|+|.||||+.+.|
T Consensus 215 -------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 215 -------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 001137889999999999999999995 579999999988754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.95 Aligned_cols=288 Identities=32% Similarity=0.462 Sum_probs=223.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-----C---CCcceeeEEEe--
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-----H---PSIVDVKEVVV-- 482 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----H---PnIV~l~~~~~-- 482 (776)
.+|.+.++||+|.|++||+|.+..+.+.||+|+++-.. ......+.||.+|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 67999999999999999999999999999999997543 23456678999999984 2 47999999995
Q ss_pred ccCCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeec------------
Q 004049 483 GSNLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLN------------ 548 (776)
Q Consensus 483 ~~~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd------------ 548 (776)
+.+..++|||||++..+|+.++.... +.|+...++.|++|||.||.||| ..||||.||||+||||.
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 46677999999999999999988764 56999999999999999999999 56899999999999992
Q ss_pred --------------------------------------------------------------------------------
Q 004049 549 -------------------------------------------------------------------------------- 548 (776)
Q Consensus 549 -------------------------------------------------------------------------------- 548 (776)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------CC----------------------------------------------------CcEE
Q 004049 549 ----------------------NR----------------------------------------------------GELK 554 (776)
Q Consensus 549 ----------------------~~----------------------------------------------------g~iK 554 (776)
.. -.+|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 00 0157
Q ss_pred EeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC------ChHHHHHHHH
Q 004049 555 ICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK------SEFDQLDKIF 628 (776)
Q Consensus 555 L~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~------s~~~~l~kI~ 628 (776)
|+|||-|+++. ..++.-+.|..|+|||++.|. .|+..+||||++|+++||+||..+|... .+.+.+..|+
T Consensus 395 IaDlGNACW~~---khFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ 470 (590)
T KOG1290|consen 395 IADLGNACWVH---KHFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM 470 (590)
T ss_pred Eeeccchhhhh---hhhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence 77777777653 345556789999999999994 5999999999999999999999999643 3567889999
Q ss_pred HhcCCCCCCCC----------CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 004049 629 KTLGTPNEKIW----------PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE 698 (776)
Q Consensus 629 ~~lg~p~~~~w----------p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~ 698 (776)
..+|..+..+. ..-..+..+..-..-..++.+.++|.. +..-..++.|||.-||+++|++|+||.
T Consensus 471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~-----s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEW-----SEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCC-----CHHHHHHHHHHHHHHHhcCccccccHH
Confidence 98887653321 111111100000000112334444332 112345677999999999999999999
Q ss_pred HHHcCcCcCCCCCC
Q 004049 699 AALNHDWFREVPLP 712 (776)
Q Consensus 699 EIL~HPwf~~i~~p 712 (776)
++|+||||..++.+
T Consensus 546 ~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 546 QCLKHPWLNPVAGP 559 (590)
T ss_pred HHhcCccccCCCCC
Confidence 99999999988776
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.40 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=198.2
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhccCC-ccchHHHH---HHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-PLTSLREI---NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~-~~~~~rEi---~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
.||+|+||.||+|.+..+++.||||++......... ......|. .++....||||+.+++++.. .+.+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 489999999999999999999999998754322111 11223333 34455679999999999854 4589999999
Q ss_pred hhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccc
Q 004049 496 MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575 (776)
Q Consensus 496 ~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~ 575 (776)
+.|+.+..+......+++.+++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+... .....+
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcC
Confidence 997655554555667999999999999999999999999999999999999999999999999999765432 223457
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
|+..|+|||++.+...++.++|||||||++|+|++|..||.......... +......
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~---------------------- 213 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT---------------------- 213 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc----------------------
Confidence 99999999999864568899999999999999999999997653221111 1000000
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.....+..++..+.+||.+||..||.+|+ ++.++|+||||+.+.+.
T Consensus 214 -----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 214 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred -----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 00111223688999999999999999999 99999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.47 Aligned_cols=258 Identities=29% Similarity=0.540 Sum_probs=210.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|...+.||.|+||.||++.++.++..|++|++...... ....+.+|+.+++.+.||||+++++++.. .+..|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 455668999999999999999999999999988643221 23346789999999999999999999854 45789999
Q ss_pred eehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.|. |...+.. .++++.++..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++...........
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred eccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999864 4444443 5699999999999999999999999999999999999999999999999999876544333334
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+.... .+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------------ 233 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------------ 233 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC------------------
Confidence 4578999999999877 458899999999999999999999998877666555543321 00
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.......++..+.+||.+||..+|.+|||+.++|+||||+....+
T Consensus 234 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 234 ---------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ---------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 000112367889999999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=335.43 Aligned_cols=257 Identities=29% Similarity=0.549 Sum_probs=207.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~l~ 490 (776)
.|++++.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+. ||||+++++++.. ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 47888999999999999999999999999999865422 122345668999999997 9999999999854 45789
Q ss_pred EEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.|+ |..++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999874 5444432 4799999999999999999999999999999999999999999999999999987755444
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||...........+... .+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~--------------- 219 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP--------------- 219 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CC---------------
Confidence 4445678999999999876566789999999999999999999999776543332221110 00
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
+. + ....++..+.+||.+||..||.+|||+.+++.|+||++..
T Consensus 220 ---------------~~--~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 220 ---------------PR--L-EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ---------------CC--C-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00 0 0012677899999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.09 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=207.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||++.+..++..||+|++..... ......+.+|+.+++.++||||+++++++... ..+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEE
Confidence 4679999999999999999999999999999999865432 22345677899999999999999999999554 58999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.++.+..+....+.+++..+..++.+|+.||.|||+ .+|+|+||||+|||++.++.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence 99999976555554445679999999999999999999996 68999999999999999999999999998754322 1
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHhcCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-------LDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-------l~kI~~~lg~p~~~~wp~~~ 643 (776)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ +..++....
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----------- 226 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----------
Confidence 234578999999999876 4688999999999999999999999986543211 001111100
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
....+. + ....++..+.+||.+||..||.+|||+.++++|+||.+..
T Consensus 227 -----------------~~~~~~--~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 227 -----------------QEPPPR--L-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -----------------hccCCC--C-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000000 0 0012667899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.22 Aligned_cols=252 Identities=34% Similarity=0.588 Sum_probs=205.5
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH- 498 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g- 498 (776)
||.|+||.||++.+..+++.||+|++..... .......+.+|+.+++.+.||||+++++.+.. ...+|+||||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999965432 22234456789999999999999999988843 4589999999986
Q ss_pred hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--------C
Q 004049 499 DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--------P 570 (776)
Q Consensus 499 ~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--------~ 570 (776)
+|..++.. ...+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........ .
T Consensus 79 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 79 DLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 55555544 34799999999999999999999999999999999999999999999999999876533211 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..... .|+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--------- 222 (265)
T cd05579 158 DKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-----EWPE--------- 222 (265)
T ss_pred ccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----CCCc---------
Confidence 234567899999999987 4488999999999999999999999988776666555533110 0110
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHHcCcCcCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA---EAALNHDWFREVPL 711 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa---~EIL~HPwf~~i~~ 711 (776)
...++..+.+||.+||+.+|.+|||+ .++|+||||..+.|
T Consensus 223 ---------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 223 ---------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ---------------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 01157889999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.20 Aligned_cols=253 Identities=28% Similarity=0.484 Sum_probs=209.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~ 490 (776)
++|.+.+.||.|+||.||+|.++.++..||+|++...... ......+.+|+.++..+. ||||+++++++. ....+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 4799999999999999999999999999999998764321 122345678999999998 999999999884 445899
Q ss_pred EEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 491 MVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
+||||+. ++|...+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999996 456565554 4579999999999999999999999999999999999999999999999999998664322
Q ss_pred -------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004049 569 -------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629 (776)
Q Consensus 569 -------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~ 629 (776)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 12234567899999999876 4588899999999999999999999998876666555542
Q ss_pred hcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcC
Q 004049 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDW 705 (776)
Q Consensus 630 ~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPw 705 (776)
... ..+..++..+.+||.+||..||.+|||+ .++|+|||
T Consensus 237 ~~~-------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 237 LEY-------------------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred cCC-------------------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 211 1112367889999999999999999999 99999999
Q ss_pred c
Q 004049 706 F 706 (776)
Q Consensus 706 f 706 (776)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.99 Aligned_cols=244 Identities=16% Similarity=0.173 Sum_probs=198.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCCCCcceeeEEEec--cCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHHPSIVDVKEVVVG--SNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPnIV~l~~~~~~--~~~~~l~LVmEy 495 (776)
..||+|+++.||+|.. +|+.||||+++....... ....+.+|+.+|.+++||||+++++++.. .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 688999999975432211 12445689999999999999999999866 444578999999
Q ss_pred hhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 496 MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 496 ~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
+.++.+..+......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN 180 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence 9975444444445679999999999999999999998 58999999999999999999999999999866432 2345
Q ss_pred ccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 575 VVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
.||..|+|||++.+. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+.
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 242 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------------------ 242 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Confidence 789999999999752 4689999999999999999999999998877666666544321110
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||+.||.+|||+.+||+
T Consensus 243 -----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 -----------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01136788999999999999999999999985
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.87 Aligned_cols=252 Identities=31% Similarity=0.462 Sum_probs=207.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH- 498 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g- 498 (776)
.||+|+||+||-|+++.|....|||-|...... ...-+..||.+-+.|+|.|||++++.+ ...+++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--EVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch--hhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCC
Confidence 699999999999999999999999998654322 344567899999999999999999997 445688899999986
Q ss_pred hhhhHHhhccCCC--CHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCCCCCCccccc
Q 004049 499 DLKGLMETMKQPF--SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGSPLKPYTHLV 575 (776)
Q Consensus 499 ~Ll~~l~~~~~~L--se~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~~~~~~~~~ 575 (776)
+|..++...=++| +|..+.+|.+||+.||.|||.+.|||||||-+||||+. .|.+||+|||-++.+..-.....++.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 4556666666788 89999999999999999999999999999999999986 68999999999998865545556789
Q ss_pred cccccCCchhhc-cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 576 VTLWYRAPELLL-GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 576 GT~~Y~APEvl~-g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
||..|||||++- |...|+.++|||||||++.||.||+|||..-.... ..+|+. |.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-Gm--------------------- 793 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-GM--------------------- 793 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-cc---------------------
Confidence 999999999995 45679999999999999999999999996432211 111221 00
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
-......+..+|.+++.||.+|+..||..||+|.++|..||++.-
T Consensus 794 ----------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 794 ----------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 001111223489999999999999999999999999999999864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.95 Aligned_cols=254 Identities=32% Similarity=0.527 Sum_probs=210.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++.+.||.|+||.||++.+..+++.||+|.+............+.+|++++.+++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999999999999999997665433334567789999999999999999999854 45899999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
||+.+..+..+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 99987444433334467999999999999999999999999999999999999999999999999999877554433445
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
..++..|+|||.+.+ ..++.++|||+||+++|+|++|..||..........++....
T Consensus 159 ~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------- 215 (254)
T cd06627 159 VVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---------------------- 215 (254)
T ss_pred cccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC----------------------
Confidence 678999999999877 448899999999999999999999997765444333332110
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....+..++..+.+||.+||..+|++|||+.++|.||||
T Consensus 216 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 --------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001122478899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=332.34 Aligned_cols=284 Identities=29% Similarity=0.568 Sum_probs=227.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++++|+|.|+.||.|....++..++||+++.-. .+.+.+|+.||..|. ||||+.|+++..+......
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4689999999999999999999999999999999997654 245779999999997 9999999999987777778
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~~s~~ 568 (776)
.||+||+.......+ ...|+.-+++.|+.+|+.||.|||++||+|||+||.|++||.. -.++|+|||||.++ .+.
T Consensus 111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY-Hp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG 186 (338)
T ss_pred hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc-CCC
Confidence 899999986333222 2458899999999999999999999999999999999999975 57999999999987 455
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKE-PLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~-~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
..++..+.+..|--||++.....|+..-|+|||||+|+.|++.+ |.|.|.+..+|+-+|.+.+|+....-+-. .
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~-----K 261 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN-----K 261 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH-----H
Confidence 67777888999999999998888999999999999999999876 55689999999999999988643110000 0
Q ss_pred cchhhhhhhhhHhhhcCC---CCCC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFP---ATSF---TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p---~~~~---~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+.... ..++..+....+ ...| .....+++++.|||.++|.+|-++|+||.|++.||||..+
T Consensus 262 Y~i~L-dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 262 YQIDL-DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HccCC-ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 00000 011111111111 1111 1223467999999999999999999999999999999754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.25 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=200.8
Q ss_pred CCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+|++.+.||+|+||.||+|.++ ..+..||+|+++..... .....+.+|+.+|..++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 57999999999999999999875 45678999998754321 123456789999999999999999999854 4589
Q ss_pred EEEeeehhhhh-hhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDL-KGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~L-l~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.++. ..++......+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999754 44554445679999999999999999999999999999999999999999999999999876542211
Q ss_pred C-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 K-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 ~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+......|
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 228 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------------ 228 (266)
T ss_pred hhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC------------
Confidence 1 1112345678999999987 568999999999999999775 999998887776666553321111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 229 ------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.40 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=206.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh---ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE---REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+|++.+.||+|+||.||+|.++.++..||+|.+..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 469999999999999999999999999999998854321 11223456789999999999999999999866555678
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+++|||+.++ |...+. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999864 555544 34568999999999999999999999999999999999999999999999999998653211
Q ss_pred ---CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 ---KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ---~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.......++..|+|||++.+ ..++.++|||||||++|+|++|.+||........+.++.. .+....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~------- 229 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKPM------- 229 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCCC-------
Confidence 11234568999999999987 4578999999999999999999999987655544443321 111111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+..+++.+.+||.+||. +|.+|||+.++|.|||.
T Consensus 230 -------------------------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 230 -------------------------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 122478899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.75 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=206.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|..++.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 35778889999999999999999999999999986443221 23456789999999999999999999854 4579999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.++ +...+. ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.......
T Consensus 81 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999964 444443 3569999999999999999999999999999999999999999999999999998765433333
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.... ++
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~----------- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-------PP----------- 219 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-------CC-----------
Confidence 34578899999999987 468899999999999999999999997654443332221110 00
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.....++..+.+||.+||..+|.+|||+.++|+||||+...
T Consensus 220 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 220 ------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 00113677889999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.98 Aligned_cols=257 Identities=29% Similarity=0.508 Sum_probs=213.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+-|..++.||+|+||+||+|++..++..||||++....... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 44777889999999999999999999999999986543221 122356789999999999999999999855 457899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++...+.....++++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.... ..
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~ 174 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PA 174 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----CC
Confidence 99999998888887777789999999999999999999999999999999999999999999999999986532 22
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+..... +.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~-------------- 239 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-PT-------------- 239 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC--------------
Confidence 34678999999999852 24578899999999999999999999988776666555433210 00
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.....++..+.+||.+||+.+|.+||++.++|.||||+..+
T Consensus 240 --------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 240 --------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred --------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00123567889999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.18 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=208.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|+.++.||.|+||.||+|.+..++..||||++...... .....+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 3588889999999999999999999999999998754321 123456789999999999999999999954 4589999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.|+ |..++. ..++++.++..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999874 555443 3569999999999999999999999999999999999999999999999999997764433333
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+... .++
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~---------------- 219 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NPP---------------- 219 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CCC----------------
Confidence 44578899999999977 45789999999999999999999999876654443322111 000
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.....++..+.+||.+||..+|.+||++.++|+|+||.....
T Consensus 220 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 220 ------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 001125677889999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.30 Aligned_cols=257 Identities=31% Similarity=0.531 Sum_probs=208.5
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|.+.+.||+|+||.||+|.+..++..|++|++............+.+|+.+++++.||||+++++++.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 48889999999999999999999999999999976553333345677899999999999999999998654336899999
Q ss_pred eehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--C
Q 004049 494 EYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--P 570 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~ 570 (776)
||+.+ ++.+++.. ...+++.++..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99965 55555544 34899999999999999999999999999999999999999999999999999987754432 1
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ....+......
T Consensus 160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~----------------- 219 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSS----------------- 219 (260)
T ss_pred ccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcccc-----------------
Confidence 344678999999999977 4489999999999999999999999987652 11112111100
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
......+..++..+.+||.+||..||.+||++.++|+||||
T Consensus 220 ---------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ---------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00001122368899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.87 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=200.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.+.....||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEE
Confidence 3444456899999999999999999999999988654322 13456789999999999999999999854 4589999
Q ss_pred eeehhh-hhhhHHhhccCCC--CHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCCCC
Q 004049 493 MEYMEH-DLKGLMETMKQPF--SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGSPL 568 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~L--se~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~~ 568 (776)
|||+.+ +|...+......+ ++..+..++.||+.||.|||++||+||||||+|||++. .+.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999986 5555555444556 88999999999999999999999999999999999986 6799999999997664333
Q ss_pred CCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+++.|+|||++.+. ..++.++|||||||++|+|++|.+||................
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 227 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------- 227 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh----------------
Confidence 333345689999999998653 347889999999999999999999996533211110000000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.. ....+..+++.+++||.+||..+|.+|||+.+++.||||
T Consensus 228 --------------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 --------------KI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------------cc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00 000122478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.01 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=203.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC-----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG-----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg-----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
+++|++++.||+|+||.||+|.+...+ ..||+|.+...... .....+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-HHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 468999999999999999999876555 67999988643221 122346789999999999999999999853 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
...|++|||+.+ +|..++.... ..+++.++..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 578999999985 5655554321 458899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 004049 551 GELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI 627 (776)
+.++|+|||++....... .......+++.|+|||.+.+ ..++.++|||||||+||+|++ |..||.+.+..+....|
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999997653221 12234566889999999877 568999999999999999998 99999887776665555
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...... ..+..++..+.+||.+||..||.+|||+.+|++|
T Consensus 240 ~~~~~~------------------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLL------------------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcC------------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332110 0112478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.11 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=197.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECC----------------CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcce
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK----------------TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~----------------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~ 476 (776)
++|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+|..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence 679999999999999999998632 345799999865422 112345778999999999999999
Q ss_pred eeEEEeccCCCeeEEEeeehhh-hhhhHHhhcc------------------CCCCHHHHHHHHHHHHHHhhhhccCCccc
Q 004049 477 VKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537 (776)
Q Consensus 477 l~~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvH 537 (776)
+++++... ..+||||||+.+ +|..++.... ..+++..+..++.||+.||.|||++||+|
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999554 478999999985 5555543321 24788899999999999999999999999
Q ss_pred CCCCCCCeeecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh--CCC
Q 004049 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEP 613 (776)
Q Consensus 538 rDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt--G~~ 613 (776)
|||||+||||+.++.+||+|||++..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999986533211 1223455788999999876 568999999999999999986 668
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 004049 614 LFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693 (776)
Q Consensus 614 PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k 693 (776)
||...+..+.+..+.......... .....++.++..+.+||.+||..||.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQ-----------------------------VYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhcccc-----------------------------ccccCCCCCCHHHHHHHHHHccCCchh
Confidence 888776665555443321100000 001112347889999999999999999
Q ss_pred CCCHHHHH
Q 004049 694 RITAEAAL 701 (776)
Q Consensus 694 RpTa~EIL 701 (776)
|||+.+|.
T Consensus 292 RPs~~~i~ 299 (304)
T cd05096 292 RPSFSDIH 299 (304)
T ss_pred CcCHHHHH
Confidence 99999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.05 Aligned_cols=252 Identities=37% Similarity=0.604 Sum_probs=208.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++.+.||.|+||.||++.+..++..|++|++..... .....+.+|+.+++.+.||||+++++++... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 58899999999999999999998999999999976543 2335677899999999999999999998544 5789999
Q ss_pred eehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.+ +|...+......+++..+..++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 99995 56665555446899999999999999999999999999999999999999999999999999987654322 34
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+....+..+... ..+
T Consensus 156 ~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~------------------ 215 (253)
T cd05122 156 TMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP------------------ 215 (253)
T ss_pred ceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCC------------------
Confidence 5678999999999987 44789999999999999999999999877555444433221 000
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
.+.....++..+.+||.+||+.||.+|||+.++|+|||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 ---------------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00111124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=331.28 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=207.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
-|++++.||.|+||.||+|.+..++..||||++...... .....+.+|+.++..+.||||+++++++.. ...+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 478889999999999999999999999999998643321 223456789999999999999999999954 45889999
Q ss_pred eehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 494 EYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 494 Ey~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||+.++ +..++. ...+++..+..++.||+.||.|||+.||+|+||||.||+++.++.++|+|||++..+........
T Consensus 82 e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999864 444443 34689999999999999999999999999999999999999999999999999876644322333
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.... .+.
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~----------- 220 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-------PPT----------- 220 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-------CCC-----------
Confidence 4578899999999876 457889999999999999999999998766554444432110 000
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++..+.+||.+||..+|.+||++.++|+||||.+.
T Consensus 221 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 221 ------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 012367889999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=332.54 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=204.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++.+.||+|+||.||+|..+. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4789999999999999999997652 3558999988643211 112346689999999999999999999844 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK---------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~---------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
...|+||||+.+ +|..++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 578999999984 5666664321 235678899999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999875532211 1122345678999999887 568999999999999999998 7899988766665554432200
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CcCcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN------HDWFR 707 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~------HPwf~ 707 (776)
+ .....++..+.+||.+||+.||.+|||+.++++ ||||+
T Consensus 240 ~-----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 240 L-----------------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred C-----------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 0 001135788999999999999999999999987 99999
Q ss_pred CCCC
Q 004049 708 EVPL 711 (776)
Q Consensus 708 ~i~~ 711 (776)
.+.|
T Consensus 285 ~~~~ 288 (288)
T cd05061 285 EVSF 288 (288)
T ss_pred CCCC
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.01 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=212.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|..++.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++... ...|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 4488899999999999999999999999999998654221 12234567899999999999999999998543 47899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++...+.....++++.++..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... .
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~ 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence 999999988888777677899999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+......+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 243 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------- 243 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------
Confidence 34578899999999852 2457889999999999999999999998776655555554321100
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.....++..+.+||.+||+.+|.+|||+.++++|+|+...
T Consensus 244 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 --------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0112367788999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.60 Aligned_cols=247 Identities=25% Similarity=0.458 Sum_probs=194.8
Q ss_pred CCCeeEEeee--ecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKI--DEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~L--G~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+.|++.+.+ |.|+||.||++.++.++..+|+|++....... .|+.+...+ .||||++++++|... +.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~--~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL--KG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC--Ce
Confidence 3567776666 99999999999999999999999987543211 133333323 699999999999554 48
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGS 566 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s 566 (776)
+|+||||+++ +|..++.. ...+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999985 56666554 34899999999999999999999999999999999999999998 999999999986643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~l 645 (776)
. ....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.... ..
T Consensus 163 ~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 225 (267)
T PHA03390 163 P----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK----------- 225 (267)
T ss_pred C----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-----------
Confidence 2 23468999999999987 5588999999999999999999999975543221 11111111 00
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcCcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-AEAALNHDWFR 707 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-a~EIL~HPwf~ 707 (776)
.......++..+.+||.+||+.||.+|++ +++||+||||.
T Consensus 226 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 ----------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ----------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00111248899999999999999999996 59999999996
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.05 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=200.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcE----EEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEI----VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+|++++.||+|+||+||+|++..++.. ||||+++.... ......+.+|+.+++.+.||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 6799999999999999999998766654 89999864321 12234567899999999999999999998543 4
Q ss_pred eEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.++|++|+. |++.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 689999998 4677777766667999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCc--cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LKPY--THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~~~--~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.... ....++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+.. .++.....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~----------- 229 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGER----------- 229 (316)
T ss_pred CcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCC-----------
Confidence 2221 22334678999999987 568999999999999999997 99999876554433 33221100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+..++.++..+.+||.+||..||.+|||+.+++.+
T Consensus 230 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 ------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01112367788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.97 Aligned_cols=289 Identities=29% Similarity=0.485 Sum_probs=219.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC--C----CcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH--P----SIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--P----nIV~l~~~~~~~~ 485 (776)
..+|+++..||+|+||+|-.+.+..++..||||+++.-.. .....+-|+++|.++.+ | -+|++.+|| +-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hc
Confidence 4789999999999999999999999999999999975332 23445679999999942 2 377788888 66
Q ss_pred CCeeEEEeeehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---------------
Q 004049 486 LDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--------------- 549 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--------------- 549 (776)
.+++|||+|.++-++.+++..+ ..+|+..+++.|++||+.+++|||+.+|+|.||||+|||+..
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 7799999999998888888764 467999999999999999999999999999999999999942
Q ss_pred -----CCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 004049 550 -----RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624 (776)
Q Consensus 550 -----~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l 624 (776)
+..|+|+|||.|+..... ..+.+.|..|+|||++++ -.++.++||||+||||+||.+|...|+..++.+.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccC---cceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 235899999999875432 256789999999999999 56999999999999999999999999999988888
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCc---chhhhhhh-----hhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCC
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGV---KVNFIKHQ-----YNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRI 695 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~---~~~~~~~~-----~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRp 695 (776)
..+-..+|+++..+...-.+.... ...|.... ....+...|...+ .........++|||++||.+||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 777777886654432111000000 00000000 0000000000000 01112334688999999999999999
Q ss_pred CHHHHHcCcCcCCC
Q 004049 696 TAEAALNHDWFREV 709 (776)
Q Consensus 696 Ta~EIL~HPwf~~i 709 (776)
|+.|+|.||||...
T Consensus 399 Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 TLREALSHPFFARL 412 (415)
T ss_pred cHHHHhcCHHhhcC
Confidence 99999999999864
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.06 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=209.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||.|+||.||++.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 36899999999999999999999889999999998643221 23456789999999999999999999854 447899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ ++..++.. ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999986 45554433 35899999999999999999999999999999999999999999999999998766443333
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+...++..+... +.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~---------------- 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---------------- 233 (293)
T ss_pred cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC----------------
Confidence 344578999999999877 55789999999999999999999999876554433222110 000
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.+.....++..+.+||.+||..+|.+||++.++|.|+||+...
T Consensus 234 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 234 -----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0111223677899999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=322.77 Aligned_cols=252 Identities=30% Similarity=0.510 Sum_probs=208.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+|++.+.||.|+||.||++.++.++..||+|.+............+.+|+.+++.++|+||+++++++... ..+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 48999999999999999999999999999999976543333344567899999999999999999998544 6899999
Q ss_pred eehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 494 EYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||+.+ +|...+... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99976 455554432 356999999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP--------------- 220 (256)
T ss_pred CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------------
Confidence 2233568899999999987 568889999999999999999999998877655544442211000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
....++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 221 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 221 ---------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ---------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 011367889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.85 Aligned_cols=286 Identities=22% Similarity=0.312 Sum_probs=202.9
Q ss_pred eeeecC--CceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEG--TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~G--sfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
..||.| +||+||+|++..+++.||||++............+.+|+.+++.++||||++++++|.. ...+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 456666 99999999999999999999987544332233556789999999999999999999954 45789999999
Q ss_pred hh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC----
Q 004049 497 EH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP---- 570 (776)
Q Consensus 497 ~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~---- 570 (776)
.+ ++..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 86 555555443 245999999999999999999999999999999999999999999999999865432211111
Q ss_pred ---ccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 571 ---YTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 571 ---~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..++......+ | .....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~ 237 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---L-DITTFP 237 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---c-cccccc
Confidence 0112346679999999763 3478999999999999999999999988766555444443211110 0 000000
Q ss_pred Ccchhhhhhhhh--------Hhh------hcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 647 GVKVNFIKHQYN--------LLR------KKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 647 ~~~~~~~~~~~~--------~l~------~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.....+...... ... .............++..+++||++||+.||.+|||+.++|+||||..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000000000000 000 0000011111234678899999999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=350.25 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=196.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||+|++..+ +..||||+++...... ....+.+|+.+|+.+ .|+||+++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 36899999999999999999986543 3579999997543221 234567899999999 89999999999854
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc---------------------------------------------------------
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM--------------------------------------------------------- 507 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~--------------------------------------------------------- 507 (776)
...+|+||||+.+ +|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 4578999999985 555544321
Q ss_pred ------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--Cccc
Q 004049 508 ------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTH 573 (776)
Q Consensus 508 ------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~ 573 (776)
..++++.+++.|+.||+.||.|||++||+||||||+|||++.++++||+|||++........ ....
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12488899999999999999999999999999999999999999999999999986543221 1112
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+++.|+|||++.+ ..++.++|||||||+||+|++ |..||........+..+......+
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------------ 334 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------------ 334 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------------
Confidence 334678999999976 568999999999999999997 999997765443333332221000
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 335 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -----------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011236789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=372.73 Aligned_cols=148 Identities=29% Similarity=0.510 Sum_probs=127.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+++|.+++.||+|+||+||+|.+..+++.||||+++..... ......+.+|+.++..++||||++++.++.. ..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 57899999999999999999999999999999999754321 1122456689999999999999999988844 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
|||||+.| +|..++ .....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li-~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLL-HIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999976 455554 345579999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.86 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=201.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||++.++ .+..+|+|.+..... ....+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~i 76 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYI 76 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEE
Confidence 367999999999999999999875 456799998764322 1245678999999999999999999984 4457899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999985 566666555557999999999999999999999999999999999999999999999999999865332211
Q ss_pred c-cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 Y-THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 ~-~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+.+..+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------------- 220 (256)
T ss_pred ccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------------
Confidence 1 12244668999999876 568899999999999999999 99999888777776666442110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+...+..+.+||.+||..||.+|||+.+|++
T Consensus 221 ---------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ---------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011125678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=325.94 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=201.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++.+.||.|+||.||+|+++.+++.||||.+..... .......+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 679999999999999999999999999999998865322 122233567899999999999999999998543 58899
Q ss_pred Eeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|..++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999996 55544432 2345899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE--FDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~--~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ......+ .....++.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--------- 228 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL--------- 228 (267)
T ss_pred hHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC---------
Confidence 333344578899999999987 4578999999999999999999999965432 2222222 11111100
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 229 -------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 011266788999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.20 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=208.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++.+.||.|+||.||+|.+..+++.||||+++...... ....+..|+.++..+. ||||+++++++.. ...+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeec--CCeE
Confidence 4578999999999999999999999999999999997543221 2234566777776665 9999999999954 4579
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+.+..++......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999987777777666789999999999999999999997 699999999999999999999999999998664322
Q ss_pred CCccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGKS-EFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~s-~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.... ..+.+..++.... ..++
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~---- 240 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PSLP---- 240 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CCCC----
Confidence 22334678899999998753 247889999999999999999999996532 2333333322210 0000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 241 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 --------------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred --------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 011267889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=348.85 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=197.1
Q ss_pred CCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++.+.||+|+||+||+|++ ..++..||||+++.... ......+.+|+.+|..+ .||||+++++++.. .
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 5799999999999999999974 35677899999864332 12234567899999999 89999999999944 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------------------------------------------------------
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK--------------------------------------------------------- 508 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~--------------------------------------------------------- 508 (776)
...|+||||+.| +|..++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 578999999985 5655554321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC-
Q 004049 509 -----------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP- 570 (776)
Q Consensus 509 -----------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~- 570 (776)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 24788999999999999999999999999999999999999999999999999866432211
Q ss_pred -ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 -YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....++..|+|||++.+ ..++.++|||||||+||+|++ |.+||........+.+++.....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 335 (375)
T cd05104 272 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR--------------- 335 (375)
T ss_pred ccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc---------------
Confidence 112344667999999987 568999999999999999998 89999776544333333221000
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+...+.++.+||.+||..||.+|||+.+|++.
T Consensus 336 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 --------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00112357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.77 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=214.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..+.|++...||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++... ..+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEE
Confidence 34669999999999999999999998999999999975443 234567899999999999999999998654 5899
Q ss_pred EEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+. ++|.+++......+++.++..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999 566666665544799999999999999999999999999999999999999999999999999876644333
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.... .+
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--------------- 234 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IP--------------- 234 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CC---------------
Confidence 3344568899999999877 458999999999999999999999998776655544443210 00
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+.....++..+.+||.+||+.+|.+|||+.++|.|+||...
T Consensus 235 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 235 ------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 011112367889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.03 Aligned_cols=245 Identities=31% Similarity=0.476 Sum_probs=204.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++...||.|+|+.|-.+.+..+++.+++|++.... ....+|+.++... .||||+++++++ .+..++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee--cCCcee
Confidence 4678999999999999999999999999999999997652 1223577666555 699999999999 555689
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee-cCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL-NNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL-d~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+|||++.|+++.........+. .++..|+++|+.||.|||.+|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999865544443333344 8899999999999999999999999999999999 58899999999999987543
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
+.+.|-|..|.|||++.. ..|+.++||||||++||+||+|..||...... ..|...++.+..
T Consensus 470 --~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~------------ 531 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF------------ 531 (612)
T ss_pred --hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc------------
Confidence 455688999999999985 67999999999999999999999999876655 222222222211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
...+|+.++|||++||++||.+||++.+|+.||||
T Consensus 532 -----------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -----------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 13499999999999999999999999999999999
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.42 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=205.3
Q ss_pred CeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhc--cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKER--EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~ 487 (776)
.|++.+.||.|+||.||+|.+. .+|..||+|++...... ......+.+|+.+|..+ +|+||+.++++|.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999874 47899999999754321 12234456899999999 59999999998844 45
Q ss_pred eeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.++ |...+. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 789999999964 544444 456799999999999999999999999999999999999999999999999999986643
Q ss_pred CC-CCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PL-KPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~-~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. .......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------- 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC---------
Confidence 21 222346789999999998753 3467899999999999999999999975433222222222110000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
...+..++..+.+||.+||..||.+|+ ++.+++.||||+.+.+
T Consensus 229 ------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 229 ------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 001123678899999999999999997 8999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.83 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=203.0
Q ss_pred eeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.++..++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999999866 8999999997654332 34566789999999999999999999854 5689999999
Q ss_pred hh-hhhhhHHhhc--------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 496 ME-HDLKGLMETM--------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 496 ~~-g~Ll~~l~~~--------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+. ++|...+... ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 96 5666666654 47799999999999999999999999999999999999999999999999999987654
Q ss_pred CC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.. .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 32 22334567889999999987 468999999999999999999 699998887666665553310
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 225 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001122368899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=333.92 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=209.2
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|.....||+|+||.||++..+.++..||||++..... .....+.+|+.+++.+.|+||+++++++.. .+..|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 4444679999999999999999999999998854321 123456789999999999999999999854 458999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
|+.++.+..+.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.............
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 998755444443 3468999999999999999999999999999999999999999999999999987664433333446
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
.+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+......+..+...... .
T Consensus 177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~------------- 235 (292)
T cd06657 177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------K------------- 235 (292)
T ss_pred ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-------c-------------
Confidence 78999999998876 45789999999999999999999999887666555444322110 0
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
+.....++..+.+||.+||..||.+||++.++|.||||.....|
T Consensus 236 --------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 236 --------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred --------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence 00112367888999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.08 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=210.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..|..++.||+|+||.||+|+++.++..||||.+..... .......+.+|+.+++.++|+|++++++++... ...|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 458888999999999999999999999999999864322 112223566899999999999999999998654 57899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++...+.....++++.++..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++..... .
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~ 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence 999999988887776667799999999999999999999999999999999999999999999999999876532 2
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+....+..+..... +
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------------- 232 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------------- 232 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C---------------
Confidence 34578899999999853 24578899999999999999999999977655444443322110 0
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
......++..+.+||.+||..+|.+||++.++++||||...
T Consensus 233 -------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00012367888999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.98 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=201.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..+|.+++.||+|+||.||+|.+.. ++..||||+++..... .....+.+|+++|+.+.||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3579999999999999999998753 4688999998654322 1234677899999999999999999999554
Q ss_pred CeeEEEeeehhh-hhhhHHhhc-------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM-------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~-------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
..+|+||||+.+ +|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 589999999986 455555432 235899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 004049 553 LKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFK 629 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~ 629 (776)
++|+|||++....... .......+++.|+|||++.+ ..++.++|||||||+||+|++ |..||...+....+..+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999997643221 11223456788999999987 568999999999999999998 9999988777666665543
Q ss_pred hcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 630 ~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....+ ....++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~~~~~------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQ------------------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCC------------------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 21110 01236788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.36 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=202.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|++.+.||+|+||+||+|.++.+ ...||||+++.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence 6799999999999999999998654 45799998865432 1223456789999999999999999999854 4578
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|..++......+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999986 5666666555679999999999999999999999999999999999999999999999999998774222
Q ss_pred CCcc--ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 KPYT--HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ~~~~--~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----------- 228 (266)
T ss_pred cceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2222 2344678999999876 568999999999999999997 999997766665555553321111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....++..+.+||.+||+.+|.+||++.+|+++
T Consensus 229 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 -------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.13 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=192.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g 498 (776)
+.||+|+||.||+|+++.+++.||+|.+.... .......+.+|+.+++.+.||||+++++++.. ...+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 36899999999999999999999999875432 11223457789999999999999999999854 4578999999986
Q ss_pred -hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc--cccc
Q 004049 499 -DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY--THLV 575 (776)
Q Consensus 499 -~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~--~~~~ 575 (776)
+|..++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 5555555545569999999999999999999999999999999999999999999999999987643221111 1112
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+......
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 2456999999877 458899999999999999997 89999766654444333221100
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||++|||+.++++
T Consensus 216 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 ---------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ---------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011236788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.69 Aligned_cols=261 Identities=28% Similarity=0.513 Sum_probs=219.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
.+++.+.+..||.|+.|+||+++.+.+|...|||.+......+ ..+.++..+.++...+ +|+||+.++||.... .+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DV 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hH
Confidence 4577888999999999999999999999999999997654332 3456777777766655 899999999998765 67
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
++.||.|.-=+..++...+++++|.-+-++...++.||.||- .+||||||+||+|||||..|++||||||++..+...
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 889999986666777777889999999999999999999998 467999999999999999999999999999877433
Q ss_pred CCccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNG-KSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
...+...|-+.|||||.+.- ...|+..+||||||++|+||.||+.||.+ ..+++.+-+|++... | ..|
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P---~L~----- 316 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-P---LLP----- 316 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-C---CCC-----
Confidence 33455688999999999853 35689999999999999999999999987 567888888877421 1 111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....+|+.+.+|+..||++|+.+||.-.++|+|||+...
T Consensus 317 -------------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 317 -------------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred -------------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 112389999999999999999999999999999999764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=324.77 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=205.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..+|.+++.||.|+||.||+|.++. +..+|+|++...... ....+..|+.+++.++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 4679999999999999999999987 889999998754321 13456789999999999999999999854 457899
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+ +|..++... ...+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999986 666666543 34689999999999999999999999999999999999999999999999999987654333
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 224 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-------------- 224 (261)
T ss_pred cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC--------------
Confidence 3333456778999999876 568899999999999999998 899998877666666554321110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||+.||.+|||+.+|++
T Consensus 225 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ----------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11237889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.13 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=198.2
Q ss_pred eeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC----C
Q 004049 415 FERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----D 487 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----~ 487 (776)
|.+.+.||+|+||.||+|....+ +..||||+++...........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987653 4789999987543332223456789999999999999999998754322 2
Q ss_pred eeEEEeeehhh-hhhhHHhhc-----cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 488 SIFMVMEYMEH-DLKGLMETM-----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~-----~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
..+++|||+.+ +|...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 47999999985 454444322 236899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 562 RQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 562 ~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
......... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR------ 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 865432211 112334678999999876 568999999999999999999 9999988776665555433210
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 234 ------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112367889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.06 Aligned_cols=252 Identities=21% Similarity=0.380 Sum_probs=200.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEE----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
+++|++.+.||+|+||+||+|.+ ..++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 46899999999999999999985 345678999998643221 122356789999999999999999999854 45
Q ss_pred eeEEEeeehhh-hhhhHHhhc----------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETM----------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~----------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
..|+||||+.+ +|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 78999999985 565555321 2348899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 004049 551 GELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI 627 (776)
+.+||+|||++....... .......++..|+|||.+.+ ..++.++|||||||+||+|++ |.+||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998653221 11233455778999999976 458999999999999999998 99999887765555544
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...... ..+..++..+.+||.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLL------------------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcC------------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 322100 0112367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.71 Aligned_cols=279 Identities=19% Similarity=0.264 Sum_probs=197.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhh-hhhH
Q 004049 425 TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGL 503 (776)
Q Consensus 425 sfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~-Ll~~ 503 (776)
+++.||.++.+.+++.||||++............+.+|+.+++.++||||+++++++.. ...+|++|||+.++ +..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 45667777777799999999997653333334567789999999999999999999854 45789999999964 5455
Q ss_pred Hhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-------Cccccc
Q 004049 504 METM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-------PYTHLV 575 (776)
Q Consensus 504 l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-------~~~~~~ 575 (776)
+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 5432 34689999999999999999999999999999999999999999999999998875532111 123345
Q ss_pred cccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-C-CCCCCCCCCCCCcchhh
Q 004049 576 VTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP-N-EKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 576 GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p-~-~~~wp~~~~lp~~~~~~ 652 (776)
++..|+|||++.+. ..++.++|||||||++|+|++|..||........+.......... . ...++............
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 78889999998753 357899999999999999999999998765544332222211100 0 00000000000000000
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
........ .........++..+.+||.+||++||++|||+.++|+||||+.+.
T Consensus 250 --~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 --NEHPNNRD---SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred --ccccchhh---hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000000 001111224677899999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.79 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=197.3
Q ss_pred eeEEeeeecCCceEEEEEEECCCCc--EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCCe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGE--IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLDS 488 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~~ 488 (776)
|.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+++.++||||+++++++... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999999877765 699999876533333345667899999999999999999876432 1235
Q ss_pred eEEEeeehhh-hhhhHHhh-----ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 489 IFMVMEYMEH-DLKGLMET-----MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~-----~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.+++|||+.+ ++...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999985 55554432 22458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 563 QYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 563 ~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 7643221 1122345778999999987 568999999999999999999 8999988766555544432210
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+.....++..+.+||.+||+.||.+|||+.+|+++
T Consensus 233 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00112367789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.30 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=194.6
Q ss_pred eeecCCceEEEEEEE--CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 420 KIDEGTYGVVYRARD--KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~--k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
.||+|+||.||+|.+ +.++..||+|+++...........+.+|+.+++.+.||||+++++++. ....++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 589999999999965 457889999998755433333456778999999999999999999873 246799999999
Q ss_pred hh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc---cc
Q 004049 498 HD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---TH 573 (776)
Q Consensus 498 g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~---~~ 573 (776)
++ |..++. ....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++.......... ..
T Consensus 79 ~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 79 LGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 65 555543 44579999999999999999999999999999999999999999999999999998764432221 22
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~------------------- 217 (257)
T cd05116 158 GKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM------------------- 217 (257)
T ss_pred CCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-------------------
Confidence 234678999999876 568889999999999999998 99999887776666655332110
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||+.||++||++.+|..
T Consensus 218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011237889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.00 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=201.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.+|.+.+.||.|+||.||+|.++.++..||+|++..... ....+.+|+.+++.+.||||+++++++.. ...+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 569999999999999999999999999999999864321 13456789999999999999999999844 4578999
Q ss_pred eeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999975 566665443 346899999999999999999999999999999999999999999999999999876432211
Q ss_pred c-cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 Y-THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 ~-~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------- 223 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------------
Confidence 1 11233567999999876 568899999999999999998 9999988766555444432110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..++..+.+||.+||..||.+|||+.++++.
T Consensus 224 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 224 --------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 01112377899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.35 Aligned_cols=290 Identities=33% Similarity=0.542 Sum_probs=241.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~ 487 (776)
..+|.-+..+|.|.- .|.-|.+.-+++.||+|++..............+|..++..+.|+||+.++.+|.... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888999999998 8889999999999999998766555555677889999999999999999999995322 23
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+|||||.+++...+. -.++-..+.+++.|+++|++|||+.||+||||||+||++..++.+||.|||+|......
T Consensus 95 e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 579999999999888776 34788899999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
-..+..+.|..|+|||++.+.+ |...+||||+||++.||++|...|.|.+..++..+|...+|+|.+.+..++.....
T Consensus 172 -~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3567789999999999999955 99999999999999999999999999999999999999999998877654433221
Q ss_pred c-chhhhhhhhhHhhhcCCCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 648 V-KVNFIKHQYNLLRKKFPATSFTG----SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 648 ~-~~~~~~~~~~~l~~~~p~~~~~~----~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
. ..+..+.+.-.+...+|...|.. ++.-+..+.||+.+||..||++|++++++|+||||+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1 11112222233444566555543 335567889999999999999999999999999997
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.02 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=199.7
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|.+.+.||+|+||+||++.+. .++..||+|.+...... ....+.+|+.+++++.||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 57999999999999999999853 35667999988643321 23456789999999999999999999854 45
Q ss_pred eeEEEeeehhh-hhhhHHhhcc------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEE
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELK 554 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iK 554 (776)
.+|+||||+.+ +|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 88999999985 5555554322 2489999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 004049 555 ICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 555 L~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~l 631 (776)
|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986532211 1223445788999999987 568999999999999999998 999998877766666654431
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+ ....++..+.+||.+||+.||.+|||+.+++.
T Consensus 240 ~~~------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQ------------------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC------------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 100 01136788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=364.90 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=202.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeE-EEec---cC-C
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKE-VVVG---SN-L 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~-~~~~---~~-~ 486 (776)
.++++.+.|.+|+|+.||+|++...|..||+|++... .+.......+||.+|+.|. |+|||.|++ .... .. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 5688999999999999999999888899999998654 3333456679999999998 999999999 3321 22 2
Q ss_pred CeeEEEeeehh-hhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 487 DSIFMVMEYME-HDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
-.++|+||||. |+|.+++.++ ...|++.+++.||.++++|+.+||... |||||||-|||||..+|++||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 35789999999 6898888765 345999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCCc---------cccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004049 563 QYGSPLKPY---------THLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 563 ~~~s~~~~~---------~~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~l 631 (776)
......... ....-|+.|+|||++. .....+.|+|||+|||+||-|+....||.......++ ++.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----ng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----NGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----ecc
Confidence 543222110 1123599999999983 3356899999999999999999999999765332221 111
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
..|...+..+..+++||+.||+.||.+||++.|++.+-+
T Consensus 271 -----------------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 271 -----------------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -----------------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 112222458999999999999999999999999887643
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.79 Aligned_cols=252 Identities=28% Similarity=0.481 Sum_probs=202.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+.+++++.|+||+++++++... ..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 6799999999999999999999999999999998753322 22245677899999999999999999999553 57899
Q ss_pred Eeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|..++.. ....+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999986 56555543 2456899999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE--FDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~--~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
........++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+......+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 227 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP----------- 227 (267)
T ss_pred CcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC-----------
Confidence 333445678999999999987 5588999999999999999999999965431 12222221110000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+ ...++..+.+||.+||..+|.+|||+.+|++
T Consensus 228 ------------------~~------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ------------------LP------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ------------------CC------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 1136778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.75 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=206.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..+.+++.||+|.||.||+|.+.. ...||+|.++.... ....+++|++||++|+|+|||+|++++..+ ..+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEE
Confidence 456778999999999999999964 34799999976432 235677999999999999999999999543 379999
Q ss_pred eeehh-hhhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYME-HDLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~-g~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||. |.|++++.. .+..+...+.+.++.||+.|++||+++++|||||-..||||+++..+||+|||||+...+....
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99998 678888886 5667999999999999999999999999999999999999999999999999999965432211
Q ss_pred -ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 -YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....--...|+|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.++.|-++...|
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------------- 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------------- 424 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------------
Confidence 111122567999999987 558999999999999999998 899999999999999887663322
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
.+..+++.+.+|+..|+..+|++|||.+.+.
T Consensus 425 ----------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ----------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2345899999999999999999999998554
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.45 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=198.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++.+.||+|+||.||+|.++. ++..||||++...... .....+.+|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4689999999999999999998652 4567999988543211 12234678999999999999999999984 44
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK---------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~---------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
..+|+||||+.+ +|..++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 578999999985 5555554322 236788999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999876532211 1122345788999999987 568999999999999999998 78999887766555544322100
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 241 ------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 ------------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012367789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.35 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=197.4
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++++.||.|+||.||+|.+. .+++.||+|++...... .....+.+|+.++.++ .|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 57999999999999999999754 34578999998643321 1223566899999999 799999999988543 3
Q ss_pred CeeEEEeeehhh-hhhhHHhhc----------------------------------------------------------
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---------------------------------------------------------- 507 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---------------------------------------------------------- 507 (776)
..+|++|||+.+ +|..++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578999999986 454444321
Q ss_pred --cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--CccccccccccCCc
Q 004049 508 --KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAP 583 (776)
Q Consensus 508 --~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~AP 583 (776)
..++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 12689999999999999999999999999999999999999999999999999987532211 12234557789999
Q ss_pred hhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhh
Q 004049 584 ELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK 662 (776)
Q Consensus 584 Evl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~ 662 (776)
|++.+ ..++.++|||||||+||+|++ |..||.+....+.+...+.....
T Consensus 245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 294 (337)
T cd05054 245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------------------------- 294 (337)
T ss_pred HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-----------------------------
Confidence 99987 568999999999999999998 99999775444333332221000
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 663 KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 663 ~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+...+..+.+|+.+||+.+|++|||+.+|++|
T Consensus 295 ------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 ------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112367889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.73 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.+++.||.|+||+||+|.+.. +..||||.+..... ....+.+|+.+++.++||||+++++++. ....+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEE
Confidence 3679999999999999999998754 45699998864322 1245778999999999999999999984 3457899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|..++......+++.+++.++.||+.||.|||++||+|+||||.|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999985 566666554557999999999999999999999999999999999999999999999999998765332111
Q ss_pred -ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 -YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+......+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC--------------
Confidence 112234678999999976 458899999999999999998 999998777666655554331110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.....+..+.+||.+||..||.+|||+.+||.+
T Consensus 222 ----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 ----------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 011257889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.51 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=201.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++.+.||.|+||.||+|+++.++..||||.+..... .......+.+|+.+++.+.||||+++++++.. ...+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 579999999999999999999999999999998865332 11223456789999999999999999999854 448899
Q ss_pred Eeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|||+.+ +|..++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999986 45555442 2456899999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF--DQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~--~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... .....+... .
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 224 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D------------- 224 (267)
T ss_pred CcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-C-------------
Confidence 333345678999999999977 45788999999999999999999999754321 112211110 0
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
++. .....++..+.+||.+||..||.+|||+.+|++
T Consensus 225 ------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ------------------YPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------------------CCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 011237788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.05 Aligned_cols=245 Identities=33% Similarity=0.538 Sum_probs=202.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh-h
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-H 498 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~-g 498 (776)
||.|+||.||++.+..++..||+|++....... .....+..|+.+++.+.||||+++++.+. ....+|+||||+. +
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence 699999999999999899999999987654322 12345678999999999999999999884 4568999999996 5
Q ss_pred hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccccc
Q 004049 499 DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL 578 (776)
Q Consensus 499 ~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~ 578 (776)
+|...+.. ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++..............++.
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 56555544 44699999999999999999999999999999999999999999999999999987654323344567899
Q ss_pred ccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhh
Q 004049 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658 (776)
Q Consensus 579 ~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~ 658 (776)
.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------------------- 208 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---------------------------- 208 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----------------------------
Confidence 9999999977 45788999999999999999999999877654444444221
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHHcCcCc
Q 004049 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA---EAALNHDWF 706 (776)
Q Consensus 659 ~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa---~EIL~HPwf 706 (776)
.+..+..++..+.+||.+||..||.+|||+ .++++||||
T Consensus 209 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 ---------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011122357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.23 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=199.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..+|++++.||.|+||+||+|.+..++. .||+|+++.... ......+.+|+.++..+.||||+.+++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 4789999999999999999999877776 489998864322 1123456789999999999999999998853 3
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+++|+|++ |++..++......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 5789999998 567777666566799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .....+++.|+|||.+.+ ..++.++|||||||+||||++ |.+||...........+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC---------
Confidence 2221 112234678999999977 458999999999999999998 99999776554443333211 110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.....++..+.+||.+||..||++||++.+++.
T Consensus 231 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 --------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011236788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.59 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=200.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.+|++.+.||+|+||.||+|.++ ++..+|+|++..... ....+.+|+.+++.++||||+++++++. ....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEE
Confidence 46899999999999999999886 467899999864322 1235678999999999999999999884 44578999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||++| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999975 5666666555679999999999999999999999999999999999999999999999999997654321111
Q ss_pred -cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 -THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 -~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
....++..|+|||.+.+ ..++.++|||||||+||+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 11223457999999987 568999999999999999998 89999877766655554322110
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..+|++|||+.++++.
T Consensus 221 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 --------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1112378899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.34 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=200.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|+++++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++. ....+|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEE
Confidence 478999999999999999999874 567799998864322 1345678999999999999999999884 4457899
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+|||+.+ +|..++... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999974 666666543 35689999999999999999999999999999999999999999999999999987643221
Q ss_pred C-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 P-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1 122345678999999876 558889999999999999998 99999887766666555332111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.....++..+.+||.+||..+|++|||++++++
T Consensus 224 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 ----------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.59 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=200.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC----------------cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG----------------EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV 475 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg----------------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV 475 (776)
..+|++++.||+|+||.||+|.+..++ ..||+|++...... .....+.+|+.++..++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence 367999999999999999999876544 56899998754322 2234567899999999999999
Q ss_pred eeeEEEeccCCCeeEEEeeehhh-hhhhHHhhcc----------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCC
Q 004049 476 DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK----------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544 (776)
Q Consensus 476 ~l~~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~----------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeN 544 (776)
++++++.. ...++++|||+.+ +|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999854 3588999999985 5555554332 268999999999999999999999999999999999
Q ss_pred eeecCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCCh
Q 004049 545 LLLNNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLFNGKSE 620 (776)
Q Consensus 545 ILLd~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt--G~~PF~~~s~ 620 (776)
||++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999997653221 11223456788999999887 468999999999999999998 7889987766
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 621 ~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
...+..+.......... ........++.++.+||.+||+.||.+|||+.+|
T Consensus 240 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 240 QQVIENAGHFFRDDGRQ-----------------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred HHHHHHHHhcccccccc-----------------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 66555543321110000 0011123467899999999999999999999999
Q ss_pred Hc
Q 004049 701 LN 702 (776)
Q Consensus 701 L~ 702 (776)
++
T Consensus 291 ~~ 292 (296)
T cd05051 291 HL 292 (296)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.36 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=203.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+|.+.+.||+|+||.||++.+..++..+++|+++..... ......+..|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 488999999999999999999888877888877643321 1222345578999999999999999998844 45789
Q ss_pred EEeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 491 MVMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+||||+.+ ++...+.. ....+++.+++.++.||+.||.|||++||+|+||||+||+++. +.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999986 44444432 3457999999999999999999999999999999999999975 6799999999987654
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.... ++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~----------- 223 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP----------- 223 (260)
T ss_pred CcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC-----------
Confidence 4333445678899999999876 557889999999999999999999998776655554443210 00
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
..+..++..+.+||.+||..||.+||++.++|+||||
T Consensus 224 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 -----------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.26 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=197.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc--EEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE--IVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l 489 (776)
++|++.+.||+|+||.||+|.++.++. .+++|.++..... .....+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-NDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-HHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999887765 4688887632211 1224567899999999 79999999999844 4578
Q ss_pred EEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcE
Q 004049 490 FMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGEL 553 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~i 553 (776)
|+||||+++ +|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999984 6666654321 358999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004049 554 KICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLG 632 (776)
Q Consensus 554 KL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg 632 (776)
||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+.....
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999864322111 111233567999999876 568999999999999999997 9999988776665555432210
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
. ..+..++..+.+||.+||..||.+|||++++++.
T Consensus 237 ~------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M------------------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0112378899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.15 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=203.4
Q ss_pred CeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhc--cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKER--EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~ 487 (776)
+|++.+.||+|+||.||++.+. .++..||||+++..... ......+..|+.++.++ +||||+.+++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 4889999999999999999864 46789999999754321 22234566899999999 5999999999884 445
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.+ +|...+. ....+++..++.++.||+.||.|||+.|++|+||||.|||++.++.++|+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHh-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 88999999986 4554444 345799999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-ccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PLKP-YTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~~~-~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.... .....|+..|+|||.+.+.. .++.++||||||+++|+|++|..||...........+.+....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 226 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK----------- 226 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-----------
Confidence 2211 22356899999999987632 3678999999999999999999999654322221222111000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcCcCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT---AEAALNHDWFREVPLP 712 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT---a~EIL~HPwf~~i~~p 712 (776)
.....+..++..+.+||.+||+.||.+||| +.++|+||||+.+.++
T Consensus 227 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 ----------------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 001112236788999999999999999998 5788999999988663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=380.95 Aligned_cols=258 Identities=30% Similarity=0.478 Sum_probs=218.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
-+|.....||.|.||.||-|.+..+|...|+|-|+...........+.+|+.+|..|.|||+|++|++=++. +.+||.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IF 1312 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIF 1312 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHHH
Confidence 357778899999999999999999999999999987765555556677999999999999999999987654 478999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC---
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--- 569 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--- 569 (776)
||||.|+.+..+....+-++|...+.|..|++.||.|||++|||||||||+||||+.+|.||++|||.|..+..+..
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999887777777777889999999999999999999999999999999999999999999999999987755432
Q ss_pred -CccccccccccCCchhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLFNG-KSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~--~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
......||+.|||||++.+.+ ...-++|||||||++.||+||+.||.. ++++.++.++-.+- .|
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~P----------- 1460 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KP----------- 1460 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CC-----------
Confidence 234578999999999998743 467799999999999999999999954 55666666653331 11
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+ +..+|.+.+|||.+||..||.+|+++.|||.|.|-+.
T Consensus 1461 -----------------q~-------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 -----------------QI-------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred -----------------CC-------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 01 1238999999999999999999999999999998754
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.69 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=200.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
+.+|++++.||+|+||.||+|.+.. .+..||||+++..... .....+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 3568899999999999999998754 3578999998744321 122346689999999999999999999844 4
Q ss_pred CeeEEEeeehhh-hhhhHHhh---------------ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMET---------------MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~---------------~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
..+++++||+.+ ++..++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 578999999985 45444431 12358899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 004049 551 GELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI 627 (776)
+.+||+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999886532211 1223455789999999976 458999999999999999998 88999887776666665
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
......+ .+..++..+.+||.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~------------------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLP------------------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCC------------------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4431110 012377889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=323.16 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=197.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcE----EEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEI----VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||+||+|.+..++.. |++|.+..... ......+..|+.++..+.||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 46899999999999999999999877764 66666642211 1122345678888999999999999998732 3
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+++++||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 5789999998 577777776667899999999999999999999999999999999999999999999999999986532
Q ss_pred CCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--------- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERL--------- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC---------
Confidence 221 2233456788999999976 568999999999999999998 99999877654443333211 000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.++|.+||..||.+|||+.++++
T Consensus 231 --------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 --------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001125667889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.24 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=199.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||++.++.. ...||+|++....... ....+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 36899999999999999999988644 3789999987543211 224567899999999 79999999999844
Q ss_pred CCeeEEEeeehhh-hhhhHHhh---------------ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC
Q 004049 486 LDSIFMVMEYMEH-DLKGLMET---------------MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~---------------~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~ 549 (776)
...+|++|||+.+ +|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 4578999999985 55555532 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004049 550 RGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDK 626 (776)
Q Consensus 550 ~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~k 626 (776)
++.+||+|||++..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999987643211 1122234577999999876 568999999999999999997 9999987766555544
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+..... +..+...+..+.+||.+||..||.+|||+.++|++
T Consensus 247 ~~~~~~------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR------------------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc------------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 422110 01112367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=323.14 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=199.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+...... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 679999999999999999999987 7789999988643221 112457789999999999999999998854 34
Q ss_pred eeEEEeeehhh-hhhhHHhhcc------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEee
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICD 557 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~D 557 (776)
..|+||||+.| +|..++.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 67999999975 5666654432 2589999999999999999999999999999999999998765 599999
Q ss_pred cccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 004049 558 FGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTP 634 (776)
Q Consensus 558 FGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p 634 (776)
||++........ .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~- 239 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R- 239 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c-
Confidence 999986532111 1112233567999999987 558999999999999999997 999998877665554432210 0
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 635 ~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..++..+.+||.+||+.||.+|||+.++|+|
T Consensus 240 ----------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 ----------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00112367889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.57 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=199.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||+|+||.||+|.+. ++..||||.++.... ....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeee
Confidence 57999999999999999999875 457899999865432 23456789999999999999999998844 4578999
Q ss_pred eeehh-hhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYME-HDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~-g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+. ++|...+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99996 56776665543 46999999999999999999999999999999999999999999999999999876532111
Q ss_pred -ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 -YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 -~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+......+..+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------------- 223 (261)
T ss_pred ccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 111222457999999876 568999999999999999999 99999887766666555332110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.....++..+.+||.+||..+|.+||++.+|++
T Consensus 224 ---------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ---------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011236788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.94 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=207.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..+++.+...||+|.||+||+|.+-.+ ||||+++...........|..|+.++++-+|-||+-+.+|+... .+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLA 463 (678)
T ss_pred CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---cee
Confidence 346778889999999999999999754 99999998876666778889999999999999999999999433 348
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC--CC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG--SP 567 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~--s~ 567 (776)
||+.+|+| +|+.++.....+|...+.+.|++||++|+.|||.++|||||||..||||.+++++||+||||+.... ..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999998 5666666667789999999999999999999999999999999999999999999999999997432 22
Q ss_pred CCCccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
........|...|||||++.- ...|++.+|||||||++|||++|..||...+...++-.+-++...|..
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~--------- 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL--------- 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc---------
Confidence 233445577889999999963 356999999999999999999999999854444433333232222111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
......++.++++|+..|+.+++++||+..+||.
T Consensus 615 -----------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 -----------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 0112246779999999999999999999999886
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.88 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=199.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|.+++.||.|+||.||+|.++.. +..||+|.+...... .....+.+|+.+|+.+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 36899999999999999999988644 478999998643211 112356789999999999999999999854 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhc---------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
..+|+||||+.+ +|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 578999999974 666655432 1247889999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||+++...... .......+|..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 999997653221 12233456789999999876 458999999999999999998 99999887766655544311 00
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+ ..+..++..+.+||.+||+.+|.+|||+.+|++
T Consensus 240 ~-----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L-----------------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011235788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.06 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=196.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcE--EEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEI--VALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~--VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|++.+.||+|+||.||+|.++.++.. +|+|.++... .......+.+|+.++.++ +||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 47899999999999999999999877765 4666664321 112234566899999999 89999999999844 457
Q ss_pred eEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 489 IFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
+|+||||+.+ +|..++.... ..|++.+++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999985 5666654321 25899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 004049 553 LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~l 631 (776)
+||+|||++....... ......++..|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+....+....
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhh-hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999986432111 1112234667999998876 558899999999999999998 999998776655444331110
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..+..++..+.+||.+||..+|.+||++.++|.+
T Consensus 241 ------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 ------------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000112367889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.69 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=193.1
Q ss_pred eeeecCCceEEEEEEECCCC---cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARDKKTG---EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+.||||+++++++. ...+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEe
Confidence 46999999999999876555 78999998755432 22345678999999999999999999874 2367999999
Q ss_pred hhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc-
Q 004049 496 MEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH- 573 (776)
Q Consensus 496 ~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~- 573 (776)
+.+ +|.+++.. ...+++..+..++.||+.||.|||..+|+|+||||+|||++.++.+||+|||++............
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 985 56655554 347999999999999999999999999999999999999999999999999999876433322211
Q ss_pred --cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 574 --LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 574 --~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 216 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------ 216 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------------
Confidence 123467999999976 568999999999999999998 9999987766555444422100
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..++..+.+||.+||..||.+|||+.++++
T Consensus 217 ------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0111236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=319.52 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=200.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCC---cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTG---EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+|++.+.||.|+||.||+|.++.++ ..+|+|.++..... .....+.+|+.+++.++||||+++++++.. .+.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 57999999999999999999986554 37999988653321 123456789999999999999999999854 4578
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+++ +|..++......+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999986 5666666555679999999999999999999999999999999999999999999999999998764322
Q ss_pred CCc---cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 KPY---THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~~~---~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+......|
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP---------- 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC----------
Confidence 211 11223568999999987 568999999999999999886 999998776665555553321110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....++..+.+||.+||+.+|.+|||+.++++
T Consensus 230 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 --------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.59 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=198.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|+++++||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++++. ....|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEE
Confidence 5799999999999999999988765 4599999875332 1235678999999999999999998873 2457999
Q ss_pred eeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 493 MEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||+.+ ++..++... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999985 666666543 345899999999999999999999999999999999999999999999999999866432211
Q ss_pred c-cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 571 Y-THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 571 ~-~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+......+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------- 223 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC--------------
Confidence 1 22345678999998876 558999999999999999999 899998877666655553321100
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....++..+.+||.+||+.||.+|||+.++++
T Consensus 224 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01236788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.91 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=199.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|+++++||.|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++||||+++++++. ...+|++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEE
Confidence 67999999999999999999864 578899999864332 2345778999999999999999999873 2468999
Q ss_pred eeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-C
Q 004049 493 MEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-K 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~ 569 (776)
|||+.+ +|...+... ...+++.++..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999975 666665443 3468999999999999999999999999999999999999999999999999998764221 1
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-------------- 223 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC--------------
Confidence 1223345678999999876 558899999999999999998 999998877666555543221110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....++..+.+||.+||..+|++|||+++++.
T Consensus 224 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 ----------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.32 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=198.9
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+....... ...+.+|+.+++.+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGD--GD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH--HHHHHHHHHHHhcCCCCCcceEEEEEcc--CC
Confidence 57999999999999999999854 345679999886443221 2456789999999999999999999854 45
Q ss_pred eeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG 551 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g 551 (776)
.+++||||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 78999999985 565555432 23489999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 004049 552 ELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIF 628 (776)
Q Consensus 552 ~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~ 628 (776)
.++|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+....++.+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976543221 1233456888999999987 568899999999999999998 999998877666555443
Q ss_pred HhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 629 ~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.... + .....++..+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~-------~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRV-------L-----------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCC-------C-----------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2210 0 001236778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=368.71 Aligned_cols=263 Identities=32% Similarity=0.473 Sum_probs=206.4
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS---- 484 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~---- 484 (776)
.+-+.+|+.+..||+|+||.||+++++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..|+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 356789999999999999999999999999999999998776 444556788999999999999999987653200
Q ss_pred --------------------------------------------------------------------------------
Q 004049 485 -------------------------------------------------------------------------------- 484 (776)
Q Consensus 485 -------------------------------------------------------------------------------- 484 (776)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred ---------------------------------CCCeeEEEeeehhhhhhhHHhhccCCC-CHHHHHHHHHHHHHHhhhh
Q 004049 485 ---------------------------------NLDSIFMVMEYMEHDLKGLMETMKQPF-SQSEVKCLMLQLLEGIKYL 530 (776)
Q Consensus 485 ---------------------------------~~~~l~LVmEy~~g~Ll~~l~~~~~~L-se~~~~~i~~qIl~aL~yL 530 (776)
....+||-||||+..++..+...+..+ ....++.+++||+.||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 001368999999998888887766655 5788999999999999999
Q ss_pred ccCCcccCCCCCCCeeecCCCcEEEeecccccccC------------------CCCCCccccccccccCCchhhccCC--
Q 004049 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG------------------SPLKPYTHLVVTLWYRAPELLLGSK-- 590 (776)
Q Consensus 531 Hs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~------------------s~~~~~~~~~GT~~Y~APEvl~g~~-- 590 (776)
|++|||||||||-||+|+.++.|||+|||+|+... .+....+..+||.-|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998721 1222456789999999999998765
Q ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCC
Q 004049 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFT 670 (776)
Q Consensus 591 ~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~ 670 (776)
.|+.++|||||||||+||+ .||....+ ... ++..+..+.-+.-++|.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsME--Ra~-iL~~LR~g~iP~~~~f~--------------------------- 840 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFGTSME--RAS-ILTNLRKGSIPEPADFF--------------------------- 840 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCCchHH--HHH-HHHhcccCCCCCCcccc---------------------------
Confidence 6999999999999999998 34644322 222 22222222111101110
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 671 GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 671 ~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
..--+....+|++||+.||.+||||.|+|++.||.
T Consensus 841 --~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 841 --DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred --cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 00123345899999999999999999999999995
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=327.60 Aligned_cols=287 Identities=37% Similarity=0.637 Sum_probs=233.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC---CeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL---DSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~---~~l~ 490 (776)
+.+-.+.||.|+||.||-+.+..+|+.||+|++..-...-...+.+.+|+++|..++|.|++..+++...... ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4555688999999999999999999999999987654444445677899999999999999998887743322 2468
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC-CCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-PLK 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s-~~~ 569 (776)
+|+|++..+|..++.. .+.|+.+.++-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+|+.... ...
T Consensus 134 V~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 9999999988877765 56799999999999999999999999999999999999999999999999999986542 223
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.++..+.|-.|+|||+++|...|+.++||||+|||+.|||..+..|...+..++++.|...+|+|..+-..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr--------- 283 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK--------- 283 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH---------
Confidence 45667889999999999999999999999999999999999999999999999999999999999754211
Q ss_pred hhhhhhhhhHhhhcCCCCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSF------TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~------~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..-.......++.......+ ........++.+++.+||.+||.+|++.+++|.|+|+.+..
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11111112223222211111 11224456788999999999999999999999999997754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.89 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=198.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.++++++|+||+++++++. ...+|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEE
Confidence 367999999999999999999875 5667999998754321 245778999999999999999999873 235799
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+|||+.+ +|..++... ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999985 566665543 34589999999999999999999999999999999999999999999999999986543221
Q ss_pred C-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 P-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-------------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1 112345668999999876 568899999999999999999 89999887766666655332110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
..+...+..+.+||.+||..||.+|||+.+++
T Consensus 223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 ----------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ----------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01123678899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.34 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=200.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|+..+.||+|+||.||+|.++.++. .+|+|.+...... .....+..|+.+++.+.||||+++++++. ..+.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCc
Confidence 578999999999999999999876654 7999988654211 11345678999999999999999999984 44578
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|..++......+++.++..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999986 5555555555679999999999999999999999999999999999999999999999999997664322
Q ss_pred CCcc---ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 KPYT---HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~~~~---~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.... ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....|......|
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---------- 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----------
Confidence 1111 1123457999999977 568999999999999999997 999998877666665553321111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....++..+.+||.+||+.+|.+||++.+|++
T Consensus 231 --------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 --------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred --------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01126778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.06 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=200.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.+|++.+.||.|+||.||+|.+. .+..+|+|++...... ...+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 57999999999999999999885 4678999988643321 2356789999999999999999999844 4578999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-C
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-P 570 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-~ 570 (776)
|||+.++ |..++......+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999864 5555555556799999999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||........+..+......
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------- 220 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------
Confidence 122345678999999986 568899999999999999998 99999877766655554322100
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+...+..+.+|+.+||..+|.+|||+.++|++
T Consensus 221 --------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 --------------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0112367889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.98 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=196.0
Q ss_pred CCe-eEEeeeecCCceEEEEEE----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEF-ERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~y-eil~~LG~GsfG~Vyla~----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++| ++++.||+|+||+||++. ...++..||+|+++..... .....+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 445 899999999999998865 3457889999998754321 1234567899999999999999999988665556
Q ss_pred eeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.++ |..++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 789999999864 4444433 3599999999999999999999999999999999999999999999999999986643
Q ss_pred CCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+.... . .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~----~------~ 226 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPK----Q------G 226 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccc----c------c
Confidence 2211 122345677999999876 56889999999999999999999998654321 11111100 0 0
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..... .+ ...+.. ......+..++..+.+||.+||..||.+|||+.+|+.
T Consensus 227 ~~~~~--~~----~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 QMTVV--RL----IELLER---GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccchh--hh----hhhhhc---CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00 000000 0111123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.71 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=192.8
Q ss_pred eeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 420 KIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.++++++||||+++++++. ...+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCC
Confidence 3899999999999775 4456799999865432 222345778999999999999999999873 246899999998
Q ss_pred h-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc---cc
Q 004049 498 H-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---TH 573 (776)
Q Consensus 498 g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~---~~ 573 (776)
+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 5 5555555556679999999999999999999999999999999999999999999999999998654322211 11
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 216 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-------------------- 216 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------------------
Confidence 233578999999876 458999999999999999996 9999988776665554433210
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+...+.++.+||.+||..||.+||++.+|++.
T Consensus 217 ----------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 217 ----------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112468899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.74 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=201.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.+.+.||.|+||.||+|.+. .+..||||.+..... ....+.+|+.+++.+.||||+++++++.. ...+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 478999999999999999999875 457899999875332 23457789999999999999999999843 457899
Q ss_pred Eeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+ +|...+.... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999986 5666665533 4699999999999999999999999999999999999999999999999999987643211
Q ss_pred C-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 P-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 1 112234568999999986 568999999999999999998 999998887777776664432111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+...+..+.++|.+||+.+|.+||++.++++
T Consensus 225 -----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 -----------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11225678899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.62 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=209.6
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc--CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE--GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~--~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
....||+|+|-+||+|.+..+|-.||.-.++...... .....+..|+.+|+.|+|||||++|.+|.+.....+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999999999999977665544332 22367789999999999999999999998887778999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecC-CCcEEEeecccccccCCCCCCc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNN-RGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
++.++.+..+....+.++...++.|++|||.||.|||++. |||||||.+||||+. .|.+||+|+|||+..... ..
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--HA 201 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--cc
Confidence 9996655655566677999999999999999999999987 999999999999986 489999999999987543 34
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
...+|||.|||||++.. .|+..+||||||++|+||+|+..||.--....+ +.++..+.. | ..
T Consensus 202 ksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-P-~s------------- 264 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-P-AA------------- 264 (632)
T ss_pred ceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-H-HH-------------
Confidence 55899999999999974 699999999999999999999999976544444 444444321 1 00
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....-.+++++||.+||.. ...|+||.|+|+||||+..
T Consensus 265 --------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 --------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 0112467899999999999 8999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=344.24 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=200.1
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
...++-||.|+.|.||+|+.. ++.||||+++.-+ ..+|+-|++|+|||||.|.++|. ...++|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeec--CCceeEEeee
Confidence 344678999999999999875 7799999886332 25899999999999999999994 4458999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL 574 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~ 574 (776)
||..+-+..++...++++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... .....+
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSF 271 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSF 271 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhh
Confidence 9996655666666788999999999999999999999999999999999999999999999999999887544 445568
Q ss_pred ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 575 ~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
+||..|||||+|.+ ...+.++|||||||+|||||||..||...+...+ |+ ++|.-
T Consensus 272 aGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw-GVGsN-------------------- 326 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW-GVGSN-------------------- 326 (904)
T ss_pred hhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhee---EE-eccCC--------------------
Confidence 99999999999998 5689999999999999999999999976543222 21 11211
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
...+..+..+++-++=||++||+-.|..||+..+||.|-
T Consensus 327 -----------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 327 -----------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -----------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 112223345888899999999999999999999999995
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.82 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=197.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..+|++.+.||+|+||.||++... +..||+|.++... ....+.+|+.+++.+.|+||+++++++... ...+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 468999999999999999999765 7789999986432 234567899999999999999999876443 357899
Q ss_pred Eeeehhh-hhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+ +|..++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999985 67666655433 48999999999999999999999999999999999999999999999999987653321
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+.+...
T Consensus 157 --~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 217 (256)
T cd05082 157 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------------- 217 (256)
T ss_pred --CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 23345678999999876 568899999999999999997 9999987665554444422100
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
......++..+.+||.+||..+|.+|||+.++++
T Consensus 218 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 --------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011247889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.82 Aligned_cols=268 Identities=25% Similarity=0.427 Sum_probs=199.1
Q ss_pred CCeeEEeeeecCCceEEEEEEE----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARD----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+|++++.||.|+||.||+|.. ..++..||||.+...... ....+.+|+.+|+.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5799999999999999999974 457889999998654321 2345678999999999999999999876555567
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 8999999975 676666655567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCc---cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LKPY---THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~~~---~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++|..++..... .....+ +.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~~~----~--- 228 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM----GNDKQ----G--- 228 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc----ccccc----c---
Confidence 2111 11223456999999977 5689999999999999999998877654321 111111 10000 0
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+.. .......+... ..+.....++..+.+||.+||..+|++|||+.+|++.
T Consensus 229 -~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 229 -QMI----VYHLIELLKNN---GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred -ccc----hHHHHHHHhcC---CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 000 00000111111 1112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.82 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=199.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|.+.+.||+|+||.||+|.+ ..++..||+|+++..... .....+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-SEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-HHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 36899999999999999999975 334568999998654321 1234567899999999 79999999999854
Q ss_pred CCeeEEEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
...+|+||||+.+ +|..++.... ..+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4478999999985 5666665433 3489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 564 YGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 564 ~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||........+.++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR------- 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc-------
Confidence 543221 1122345788999999987 458999999999999999998 99999876655544443321100
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.......+..+.+||.+||..+|++|||+.++++
T Consensus 263 ----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 ----------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011236788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.61 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=198.1
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.+|.+.++||+|+||.||+|... .++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH--HHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 56888999999999999999753 35678999988644322 23457789999999999999999998854 45
Q ss_pred eeEEEeeehhh-hhhhHHhhcc--------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK--------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~--------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
.+|++|||+.+ +|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 78999999985 5555554322 24899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 004049 553 LKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFK 629 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~ 629 (776)
+||+|||++....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999997653221 11222345788999999987 558999999999999999998 9999987776666555533
Q ss_pred hcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 630 ~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.... ..+..++..+.+||.+||+.||.+||++.+|++
T Consensus 240 ~~~~------------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL------------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC------------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2110 011236788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.50 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=197.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
++|.+.+.||+|+||.||+|.+.. +...||+|+++.... ......+..|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 679999999999999999998643 235799999875421 11234567899999999 79999999999854
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN 548 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd 548 (776)
...+|+||||+.+ +|..++.... ..+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4578999999985 6666665432 2489999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 004049 549 NRGELKICDFGLARQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625 (776)
Q Consensus 549 ~~g~iKL~DFGlA~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~ 625 (776)
.++.+||+|||++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999765422111 111234568999999987 568999999999999999998 889997766544444
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+.... ....+..++.++++||.+||..+|.+|||+.+++++
T Consensus 254 ~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCC------------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 332210 001122367899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.53 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=200.6
Q ss_pred eeEEeeeecCCceEEEEEEECCCC----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
|++.+.||.|+||.||++.+...+ ..||+|++....... ....+..|+.++..+.|+||+++++++... ...|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeE
Confidence 456789999999999999998766 899999996543221 234667899999999999999999998544 5899
Q ss_pred EEeeehhh-hhhhHHhhccCC-CCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQP-FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~-Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
++|||+.+ ++...+...... +++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999986 566665544433 9999999999999999999999999999999999999999999999999998764331
Q ss_pred CCcc-ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 KPYT-HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 ~~~~-~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.... ...+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+....++.+......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL------------- 223 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 1111 1236789999999865 568999999999999999998 89999887666666555332110
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.....++..+.++|.+||..||.+|||+.++++
T Consensus 224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 -----------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011226888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=312.69 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=198.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||.|+||.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.+.||||+++++++. ....|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEE
Confidence 5799999999999999999988655 4699998764321 2345678999999999999999998873 2457999
Q ss_pred eeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 493 MEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
|||+.+ +|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999985 677776543 34589999999999999999999999999999999999999999999999999986643221
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-------------- 223 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 1122345678999998876 558999999999999999999 999998877666665553321100
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||..||.+||+++++++
T Consensus 224 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 ----------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01136788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.72 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=195.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++..... .....+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999985 346789999999654321 1234567899999999 689999999987543
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc---------------------------------------------------------
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM--------------------------------------------------------- 507 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~--------------------------------------------------------- 507 (776)
...+|+||||+.+ +|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3468999999985 555554321
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--Ccccccc
Q 004049 508 ---------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVV 576 (776)
Q Consensus 508 ---------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~G 576 (776)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12478889999999999999999999999999999999999999999999999986532211 1122345
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||........+...+.....
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 300 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------------- 300 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC----------------------
Confidence 678999999977 568999999999999999997 99999765433222222111000
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..+++.+.++|..||..||.+|||+.+|++|
T Consensus 301 -------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 -------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112367788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=362.23 Aligned_cols=255 Identities=28% Similarity=0.373 Sum_probs=198.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.. .+.+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEE
Confidence 36899999999999999999999999999999999754321 1223457789999999999999999999844 45899
Q ss_pred EEeeehhh-hhhhHHhhc----------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 491 MVMEYMEH-DLKGLMETM----------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~----------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
+||||++| +|..++... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999986 455544321 1346677889999999999999999999999999999999999999999999
Q ss_pred cccccCCC------------------CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH
Q 004049 560 LARQYGSP------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621 (776)
Q Consensus 560 lA~~~~s~------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~ 621 (776)
++...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99865211 011123579999999999987 56899999999999999999999999775433
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
..... .....|.. ......+++.+.+++.+||..||.+|++..+.|
T Consensus 238 ki~~~--~~i~~P~~--------------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 238 KISYR--DVILSPIE--------------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhh--hhccChhh--------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 22211 01000000 000123778899999999999999999876666
Q ss_pred cC
Q 004049 702 NH 703 (776)
Q Consensus 702 ~H 703 (776)
.+
T Consensus 284 l~ 285 (932)
T PRK13184 284 KQ 285 (932)
T ss_pred HH
Confidence 44
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.19 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=201.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+|++++.||+|+||.||+|.++.++. .||+|.+..... ......+.+|+.++..+.||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 679999999999999999999877665 589998765432 1123456789999999999999999999864 57
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.++||||+.+ +|.+.+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 8999999984 677777666667999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcc--ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LKPYT--HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~~~~--~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
..... ...++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER------------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC------------
Confidence 22221 1223568999999876 568899999999999999998 9999988766555544432210
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+..+...+..+.++|.+||..||.+|||+.++++
T Consensus 230 ------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1112236778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.66 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=200.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
+.+|++.+.||+|+||.||+|.++.++. .||||+++.... ......+..|+.+++.+.||||+++++++. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCc
Confidence 3569999999999999999999887665 699999865321 122345778999999999999999999984 4457
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+++||||+.+ +|..++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 8999999986 455566555567999999999999999999999999999999999999999999999999998765332
Q ss_pred CCC--ccccc---cccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 568 LKP--YTHLV---VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 568 ~~~--~~~~~---GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
... ..... .+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP------- 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC-------
Confidence 111 11111 2457999999976 568999999999999999886 999998877666555553221100
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....++..+.+||.+||..+|.+||++.+|+..
T Consensus 232 -----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 232 -----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred -----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112367788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.25 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=199.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
..+|++.+.||.|+||.||+|... ++.||+|.++.... ....+.+|+.+++.+.|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 468999999999999999999875 78999999975543 24567789999999999999999999854 457899
Q ss_pred Eeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+ +|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999985 6666665433 269999999999999999999999999999999999999999999999999998763221
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+....
T Consensus 157 --~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------- 216 (256)
T cd05039 157 --DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY----------------- 216 (256)
T ss_pred --ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 12344677999999876 568889999999999999997 999998776555444432210
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..+..+++.+.+||.+||..+|.+|||+.++++
T Consensus 217 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 -------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00111236789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=338.27 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=195.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~ 485 (776)
.++|++++.||.|+||.||+|.+... +..||||++..... ......+.+|+.+|..+. ||||+++++++. .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACT--K 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--c
Confidence 36799999999999999999987433 35799999965432 222345778999999996 999999999994 3
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc---------------------------------------------------------
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM--------------------------------------------------------- 507 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~--------------------------------------------------------- 507 (776)
...+|||||||.+ +|..++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4579999999985 555544321
Q ss_pred --------------------------------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC
Q 004049 508 --------------------------------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549 (776)
Q Consensus 508 --------------------------------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~ 549 (776)
...|++.++..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124888999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004049 550 RGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDK 626 (776)
Q Consensus 550 ~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~k 626 (776)
++.+||+|||++........ ......+++.|+|||++.+ ..++.++|||||||+||+|++ |..||........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999986533221 1223456788999999987 568999999999999999997 9999976543333322
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..... +.....++..+.+||.+||..||.+|||+.+|.+
T Consensus 352 ~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYR-----------------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCC-----------------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2221000 0011237788999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.00 Aligned_cols=249 Identities=21% Similarity=0.351 Sum_probs=194.5
Q ss_pred CeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
+|++.+.||+|+||.||+|.+.. ....+|+|.+....... ....+.+|+.+++.+.||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-ELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998753 23578998886443211 12456789999999999999999998843 457
Q ss_pred eEEEeeehhh-hhhhHHhhc-----------------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETM-----------------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~-----------------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeN 544 (776)
.|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999985 454444321 1358899999999999999999999999999999999
Q ss_pred eeecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 004049 545 LLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEF 621 (776)
Q Consensus 545 ILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~ 621 (776)
|||+.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999976532211 1122345778999999876 568999999999999999998 99999877655
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
...+.+..... +..+..++..+.+||.+||+.||.+||++.+|+
T Consensus 237 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 237 RLFNLLKTGYR------------------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred HHHHHHhCCCC------------------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 54443321110 011123678899999999999999999999997
Q ss_pred c
Q 004049 702 N 702 (776)
Q Consensus 702 ~ 702 (776)
+
T Consensus 281 ~ 281 (290)
T cd05045 281 K 281 (290)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.99 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=195.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g 498 (776)
+.||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.+.||||+++++++.. ....|+||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 368999999999999877 999999998654332 223457789999999999999999999854 4578999999975
Q ss_pred -hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc--cccc
Q 004049 499 -DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY--THLV 575 (776)
Q Consensus 499 -~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~--~~~~ 575 (776)
++..++......+++..+..++.+++.||.|||++||+||||||+|||++.++.++|+|||++.......... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 5666665555678999999999999999999999999999999999999999999999999998654221111 1123
Q ss_pred cccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhh
Q 004049 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIK 654 (776)
Q Consensus 576 GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~ 654 (776)
.+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+......
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 3567999999876 568999999999999999999 89999877655544443221100
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..+|.+|||+.++|+
T Consensus 215 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 ---------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ---------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.18 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=196.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCC--------------cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTG--------------EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVK 478 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg--------------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~ 478 (776)
.+|++.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+++|+.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 57999999999999999999875432 3589999865422 11223567899999999999999999
Q ss_pred EEEeccCCCeeEEEeeehhh-hhhhHHhhcc-----------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCee
Q 004049 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMK-----------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLL 546 (776)
Q Consensus 479 ~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~-----------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNIL 546 (776)
+++.. ...+|+||||+.+ +|..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99954 4578999999986 5555543321 23788999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCChHH
Q 004049 547 LNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLFNGKSEFD 622 (776)
Q Consensus 547 Ld~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt--G~~PF~~~s~~~ 622 (776)
++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ +..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999976532211 1122345678999999887 558999999999999999988 678898776666
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 623 QLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 623 ~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..+......... .......+.++..+.+||.+||..||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGR-----------------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccc-----------------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55544322100000 0001122346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.84 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=199.5
Q ss_pred CeeEEeeeecCCceEEEEEEE----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 414 EFERLNKIDEGTYGVVYRARD----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
-|++++.||+|+||.||+|.. +.++..||+|.++..... .....+.+|+.+++.+.||||+++++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 378999999999999999974 467889999998654322 223457789999999999999999999866545678
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
++||||++| +|..++......+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999986 4555554444568999999999999999999999999999999999999999999999999998764322
Q ss_pred CC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 569 KP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. .....++..|+|||++.+ ..++.++|||||||++|+|+++..|+.... ..+. ...+......
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~~---~~~~~~~~~~------- 230 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPM--TLFL---KMIGPTHGQM------- 230 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCcccc--chhh---hhcccccccc-------
Confidence 21 123456778999999887 468899999999999999999887654321 1111 1111110000
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.. ......+... ..+.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 231 -----~~-~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 -----TV-TRLVRVLEEG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -----cH-HHHHHHHHcC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 0000111110 1112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.66 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=197.7
Q ss_pred eeeecCCceEEEEEEECC-CC--cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARDKK-TG--EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~-tg--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
+.||.|+||.||+|.+.. .+ ..||||.+...... .....+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999865 33 36999999765443 334567789999999999999999999855 578999999
Q ss_pred hh-hhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC---
Q 004049 496 ME-HDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP--- 570 (776)
Q Consensus 496 ~~-g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~--- 570 (776)
+. ++|...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 97 56776666544 57899999999999999999999999999999999999999999999999999876442221
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.+..+...... +
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~---------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----L---------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----C----------
Confidence 112456788999999876 558999999999999999998 99999877776666655431100 0
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..+|.+|||+.++++
T Consensus 221 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 --------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011236788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.79 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=202.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc---CCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS---NLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~---~~~~ 488 (776)
-++|.+.+.||+|+|+.||+++...++..||+|++...... .....++|+...++++|||+++++++...+ ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~--~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE--DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH--HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 46899999999999999999999999999999999876522 245678999999999999999999887532 2345
Q ss_pred eEEEeeehh-hhhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 489 IFMVMEYME-HDLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 489 l~LVmEy~~-g~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.||+++|+. |++++.+... +..++|.++..|+.+|+.||++||... .+||||||.|||+...+.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 899999997 6677776544 336999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC---------CccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004049 563 QYGSPLK---------PYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 563 ~~~s~~~---------~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~l 631 (776)
...-... .......|..|+|||++.- ....+.++|||||||+||.|+.|..||... +..-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcC
Confidence 6531111 1122345899999998853 234688999999999999999999999532 1111
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+...... .-+...+.....+|..+.+||++||+.||.+||++.++|.+
T Consensus 249 gSlaLAv------------------------~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAV------------------------QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEee------------------------eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1100000 00111223334489999999999999999999999999865
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.38 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=195.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECC----------------CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcce
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK----------------TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~----------------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~ 476 (776)
++|++.+.||+|+||.||++.+.. +...||+|++..... ......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 345799999864421 122345678999999999999999
Q ss_pred eeEEEeccCCCeeEEEeeehhh-hhhhHHhhcc----------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCe
Q 004049 477 VKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK----------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNL 545 (776)
Q Consensus 477 l~~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~----------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNI 545 (776)
+++++... ..+|+||||+.+ +|..++.... ..+++.++..++.||+.||.|||++||+|+||||+||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99998544 478999999985 5665554422 2477889999999999999999999999999999999
Q ss_pred eecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCChH
Q 004049 546 LLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS--KEPLFNGKSEF 621 (776)
Q Consensus 546 LLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt--G~~PF~~~s~~ 621 (776)
|++.++.++|+|||++..+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999986533211 1122344678999998876 468999999999999999998 77899776655
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
+.+..+..... .......+..+..++..+.+||.+||+.||.+|||+.+|+
T Consensus 241 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 241 QVIENTGEFFR-----------------------------DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred HHHHHHHHHHh-----------------------------hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 54433211100 0000001111234678899999999999999999999987
Q ss_pred c
Q 004049 702 N 702 (776)
Q Consensus 702 ~ 702 (776)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.58 Aligned_cols=239 Identities=23% Similarity=0.269 Sum_probs=185.0
Q ss_pred eeeecCCceEEEEEEECCC------------CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 419 NKIDEGTYGVVYRARDKKT------------GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~t------------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
+.||+|+||.||+|+.... ...||+|++.... ......+..|+.++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 3689999999999985322 2358888875432 22234567889999999999999999998544
Q ss_pred CeeEEEeeehhhhhhhHHh-hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc-------EEEeec
Q 004049 487 DSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-------LKICDF 558 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~-~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~-------iKL~DF 558 (776)
...++||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++. ++|+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 4679999999976555444 34567999999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELL-tG~~PF~~~s~~~~l~kI~~~lg~p~~~ 637 (776)
|++..... .....++..|+|||++.....++.++|||||||+||+|+ .|..||......+.. .+....
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~------ 225 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ------ 225 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC------
Confidence 99876532 234567889999999875567899999999999999998 588888765432221 111110
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+......+..+.+||.+||+.||.+||++.+||++
T Consensus 226 -------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -------------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00011145678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.22 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=187.0
Q ss_pred eeeecCCceEEEEEEECCCCcE-------EEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 419 NKIDEGTYGVVYRARDKKTGEI-------VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~-------VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+.||.|+||.||+|.++.++.. ||+|.+..... .....+..|+.+++.+.||||+++++++... ...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--NYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH--HHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEE
Confidence 3689999999999998665443 88888754321 2234567899999999999999999999653 46899
Q ss_pred Eeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc--------EEEeeccccc
Q 004049 492 VMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--------LKICDFGLAR 562 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~--------iKL~DFGlA~ 562 (776)
||||+.++ |..++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999864 55555555557999999999999999999999999999999999999987765 6999999987
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
.... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||............ ...
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~---------- 221 (258)
T cd05078 157 TVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR---------- 221 (258)
T ss_pred ccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc----------
Confidence 5532 23457889999999998756689999999999999999998 5677655443332211 110
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+ +...+..+.+||.+||+.||++|||+.+|++.
T Consensus 222 --------------------~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 --------------------HQL-------PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------ccC-------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001 11245678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.42 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=200.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC-------CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK-------KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVV 482 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k-------~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~ 482 (776)
..++|.+.+.||+|+||.||+|++. .++..||+|.+..... ......+.+|+.+++.+ .||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3478999999999999999999753 2345799999864321 12234567899999999 7999999999985
Q ss_pred ccCCCeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCee
Q 004049 483 GSNLDSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLL 546 (776)
Q Consensus 483 ~~~~~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNIL 546 (776)
. ...+|+||||+.+ +|..++... ...+++.++..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 4 4578999999985 566565442 134788999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 004049 547 LNNRGELKICDFGLARQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQ 623 (776)
Q Consensus 547 Ld~~g~iKL~DFGlA~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~ 623 (776)
++.++.+||+|||++......... .....+++.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.+..+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999876432211 122345678999999987 568999999999999999998 8899988776666
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 624 LDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 624 l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..... ......++..+++||.+||..+|.+|||+.++|+.
T Consensus 249 ~~~~~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHR------------------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCc------------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 555432210 00112367899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.71 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=198.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++++.||+|+||.||+|.+.. ++..||||++...... .....+.+|+.+++.+.||||+++++++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCA--VG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEc--CC
Confidence 3689999999999999999998753 6789999998643221 11245678999999999999999999884 34
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK---------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~---------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeN 544 (776)
..+|+||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||.|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 578999999985 5666654321 247889999999999999999999999999999999
Q ss_pred eeecCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 004049 545 LLLNNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEF 621 (776)
Q Consensus 545 ILLd~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~ 621 (776)
||++.++.++|+|||++....... ........+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999987653221 11122344677999999877 568999999999999999997 88899877666
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
+.+..+..... + ..+..++..+.+||.+||+.||.+|||+.||+
T Consensus 240 ~~~~~~~~~~~------~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 240 EVIYYVRDGNV------L------------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred HHHHHHhcCCC------C------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 65554432210 0 01123678899999999999999999999987
Q ss_pred c
Q 004049 702 N 702 (776)
Q Consensus 702 ~ 702 (776)
+
T Consensus 284 ~ 284 (288)
T cd05050 284 R 284 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.57 Aligned_cols=288 Identities=28% Similarity=0.460 Sum_probs=224.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC------CCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH------HPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~------HPnIV~l~~~~~~~~~ 486 (776)
.+|.+....|+|-|++|..|.+..-|..||||+|..... ..+.-++|+.||++|. --|+++|+..|. ..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--HK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--hc
Confidence 579999999999999999999999999999999975432 2345578999999995 248999998884 45
Q ss_pred CeeEEEeeehhhhhhhHHhhccC--CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccc
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQ 563 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~--~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~ 563 (776)
+++|||||-+.-+|...+...+. .|....++.|+.||+.||.+|-..||+|.||||+|||++.. ..+||||||.|..
T Consensus 507 nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 59999999999888888877643 58889999999999999999999999999999999999975 4689999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
... +..+.+..+..|.|||++.| ..|+...|+||+||+||||.||+..|.|.+..+++...+..-|..+..+.-.-.
T Consensus 587 ~~e--neitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 587 ASE--NEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccc--ccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 754 33455677889999999999 679999999999999999999999999999999999888888776644321100
Q ss_pred ---CCCCcchhhhhhhhhHh------------------hh-cCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 644 ---KLPGVKVNFIKHQYNLL------------------RK-KFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 644 ---~lp~~~~~~~~~~~~~l------------------~~-~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
+..+...+|+......+ .. .+....+ ...+.+-..+++||.+||..||++|+|+.|+
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 00111222221111100 00 0000000 0112233467899999999999999999999
Q ss_pred HcCcCcCC
Q 004049 701 LNHDWFRE 708 (776)
Q Consensus 701 L~HPwf~~ 708 (776)
|+||||++
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=321.42 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=196.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
++|.+.+.||+|+||.||+|++.. ....||+|+++..... .....+..|+.+++.+ .||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 679999999999999999998642 3457999998643221 1233567899999999 59999999999844
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN 548 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd 548 (776)
...+|+||||+.+ +|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 4578999999985 565555432 13589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 004049 549 NRGELKICDFGLARQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625 (776)
Q Consensus 549 ~~g~iKL~DFGlA~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~ 625 (776)
.++.+||+|||+++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865422111 112234567999999987 568999999999999999999 899998876665555
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..... ...+..++..+++||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHR------------------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCC------------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4432100 0011236788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.08 Aligned_cols=252 Identities=22% Similarity=0.394 Sum_probs=198.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|+++..||.|+||.||+|+.+. +.+.|++|.+..... ......+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 679999999999999999999754 346799998754321 1123457789999999999999999998843 45
Q ss_pred eeEEEeeehhh-hhhhHHhhcc--------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK--------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~--------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
..|+||||+++ +|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 78999999985 5655554432 16999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 559 GLARQYGSP-LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 559 GlA~~~~s~-~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
|++...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~---- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc----
Confidence 998754221 112233466788999999876 457889999999999999998 8889977665554444322100
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+.....++..+.+||.+||..||.+|||+.++|.+
T Consensus 237 -------------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -------------------------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 011112367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=312.87 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=199.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|.+.+.||+|+||.||+|.+... ...||||.+...... .....+.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 5689999999999999999987544 457999988654321 123456789999999999999999998843 357
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|..++......+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999985 6767666555579999999999999999999999999999999999999999999999999998664321
Q ss_pred CC-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 KP-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 ~~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------------- 227 (270)
T ss_pred ceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-------------
Confidence 11 112234567999999876 568999999999999999986 99999887766665554322110
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112367899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.84 Aligned_cols=244 Identities=24% Similarity=0.402 Sum_probs=193.6
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g 498 (776)
+.||+|+||.||+|... ++..||+|++...... .....+.+|+.+++.+.||||+++++++.. ...+++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 36899999999999864 6889999998654321 122356789999999999999999999854 4578999999985
Q ss_pred -hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc-ccccc
Q 004049 499 -DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY-THLVV 576 (776)
Q Consensus 499 -~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~-~~~~G 576 (776)
++..++......+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......... ....+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 5666665555678999999999999999999999999999999999999999999999999997643222111 11234
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 667999999976 568899999999999999998 9999987766555444422110
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..++..+.+||.+||..+|++|||+.++++.
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 -------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00112367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.97 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=194.7
Q ss_pred eEEeeeecCCceEEEEEEEC----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 416 ERLNKIDEGTYGVVYRARDK----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+.+.||.|.||.||+|.+. ..+..|+||+++.... ......+.+|++++++++||||+++++++.. ...+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999987 4567899999954321 1124567899999999999999999999973 345899
Q ss_pred Eeeehh-hhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYME-HDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~-g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+. |+|...+... ...+++.++..|+.||+.||.|||+++|+|++|++.||||+.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999998 5677777765 56799999999999999999999999999999999999999999999999999987632111
Q ss_pred --CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 --PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 --~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
..........|+|||.+.. ..++.++||||||+++|||++ |..||...+..+.+.++......+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~------------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP------------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT------------
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce------------
Confidence 1223456788999999987 458999999999999999999 789998887777666663331110
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||..||..||.+|||+.+|++
T Consensus 226 ------------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 ------------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11237888999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.76 Aligned_cols=213 Identities=27% Similarity=0.434 Sum_probs=176.3
Q ss_pred cccccccccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEE
Q 004049 401 RSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480 (776)
Q Consensus 401 ~~~~~~~~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~ 480 (776)
..+.+.+.....+.|..-..||+|+||.||+|.... +..||||.+....... ...+.+|+.+|.+++|||+|+|++|
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 334444444566899999999999999999998754 4899999876554332 4458999999999999999999999
Q ss_pred EeccCCCeeEEEeeehh-hhhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCC---cccCCCCCCCeeecCCCcEEE
Q 004049 481 VVGSNLDSIFMVMEYME-HDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNW---VLHRDLKTSNLLLNNRGELKI 555 (776)
Q Consensus 481 ~~~~~~~~l~LVmEy~~-g~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~g---IvHrDLKPeNILLd~~g~iKL 555 (776)
|..... ..+||+||+. |+|.+.+..... +|+|..+..|+.+++.||+|||... |||||||++|||||.+.++||
T Consensus 140 C~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 965432 5899999998 567677666555 8999999999999999999999855 999999999999999999999
Q ss_pred eecccccccCCCCCCcccc-ccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 004049 556 CDFGLARQYGSPLKPYTHL-VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK 618 (776)
Q Consensus 556 ~DFGlA~~~~s~~~~~~~~-~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~ 618 (776)
+|||+|+..........+. .||.+|+|||.+.. +..+.++|||||||+|+||++|+.+....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999997654311222222 89999999999986 66899999999999999999999888653
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.63 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=189.8
Q ss_pred eeeecCCceEEEEEEECC---CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeee
Q 004049 419 NKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy 495 (776)
+.||+|+||.||+|.+.. ....||||.+..... ......+.+|+.+++.++||||+++++++... ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998653 346799998753221 11234566899999999999999999977533 3457899999
Q ss_pred hhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC----CC
Q 004049 496 MEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL----KP 570 (776)
Q Consensus 496 ~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~----~~ 570 (776)
+.+ +|..++......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 985 6666665555567888899999999999999999999999999999999999999999999997553211 11
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 220 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----------------- 220 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence 123345778999999876 568899999999999999999 5777876665554444322100
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+.....++..+.+||.+||..+|++||++.++|+.
T Consensus 221 -------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 -------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00012367789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.29 Aligned_cols=228 Identities=26% Similarity=0.374 Sum_probs=183.3
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-hhhh
Q 004049 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG 502 (776)
Q Consensus 424 GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g-~Ll~ 502 (776)
|.||+||+|.++.+++.||+|.+..... ..+|...+....||||+++++++.. ...+|+||||+.| +|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 8999999999999999999999976432 2245555566679999999999854 4589999999996 4555
Q ss_pred HHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccccccCC
Q 004049 503 LMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582 (776)
Q Consensus 503 ~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~A 582 (776)
.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....++..|+|
T Consensus 75 ~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 75 HISK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 5543 456999999999999999999999999999999999999999999999999988765432 233456788999
Q ss_pred chhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhh
Q 004049 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK 662 (776)
Q Consensus 583 PEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~ 662 (776)
||.+.+ ..++.++|||||||++|+|++|..||...... + ..
T Consensus 151 PE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~--------------------- 191 (237)
T cd05576 151 PEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT--------------------- 191 (237)
T ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc---------------------
Confidence 998876 45789999999999999999999887532110 0 00
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCcCc
Q 004049 663 KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWF 706 (776)
Q Consensus 663 ~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-----~EIL~HPwf 706 (776)
...+..+..++..+.+||.+||+.||.+|+|+ .++++||||
T Consensus 192 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 ---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00001123478899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=316.19 Aligned_cols=238 Identities=23% Similarity=0.315 Sum_probs=184.3
Q ss_pred eeecCCceEEEEEEECCC------------------------CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc
Q 004049 420 KIDEGTYGVVYRARDKKT------------------------GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV 475 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~t------------------------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV 475 (776)
.||+|+||.||+|....+ ...||+|++..... .....+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999975322 24588888865432 1234567889999999999999
Q ss_pred eeeEEEeccCCCeeEEEeeehhhhhhhHH-hhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---
Q 004049 476 DVKEVVVGSNLDSIFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG--- 551 (776)
Q Consensus 476 ~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l-~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g--- 551 (776)
++++++... ...||||||+.++.+..+ ......+++..+..++.||+.||+|||++||+||||||.|||++..+
T Consensus 80 ~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999998654 478999999997655444 44456799999999999999999999999999999999999998644
Q ss_pred ----cEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHH
Q 004049 552 ----ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDK 626 (776)
Q Consensus 552 ----~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELL-tG~~PF~~~s~~~~l~k 626 (776)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|.+||..........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~- 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER- 232 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence 4899999998654221 23467888999999976566899999999999999985 6999997765443322
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
++.... .++ ...+..+.+||.+||..+|.+|||+.+||++
T Consensus 233 ~~~~~~------------------------------~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEKKH------------------------------RLP-------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhcc------------------------------CCC-------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111100 000 1145678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.43 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=199.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|.+.+.||+|+||.||+|.+.. ++..|++|++.... .......+.+|+.+|+.+.||||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 3689999999999999999999876 36889999886432 112234567899999999999999999987544 35
Q ss_pred eeEEEeeehh-hhhhhHHhhcc-------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 488 SIFMVMEYME-HDLKGLMETMK-------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~-------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
..+++++|+. +++..++.... ..|++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 6899999998 45656554432 458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 560 LARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 560 lA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
+++.+..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 237 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR---- 237 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC----
Confidence 9986532211 1122345778999999977 558999999999999999998 9999987766554443322110
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+.....+++.+.++|.+||..||.+|||+.++++
T Consensus 238 --------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 --------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0111236788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.58 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=198.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|+.++.||.|+||.||+|.+..++. .||+|.+..... ......+.+|+.+++.+.||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4679999999999999999999887776 468887754322 11123467899999999999999999988532
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+++++|+. |++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999998 567777666566799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+ .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC---------
Confidence 2221 222345778999999876 568999999999999999997 89999776544333222 211000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..++..+..+.+||.+||..+|++||++.++++.
T Consensus 231 --------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 --------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.10 Aligned_cols=236 Identities=24% Similarity=0.318 Sum_probs=185.5
Q ss_pred eeeecCCceEEEEEEECCCC----------cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 419 NKIDEGTYGVVYRARDKKTG----------EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg----------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+|+.+.||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 36899999999999998776 35788876543321 4567789999999999999999998855 45
Q ss_pred eEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-------cEEEeeccc
Q 004049 489 IFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-------ELKICDFGL 560 (776)
Q Consensus 489 l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-------~iKL~DFGl 560 (776)
.|+||||+.++ |..++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 79999999965 4444444444799999999999999999999999999999999999999888 899999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+...........
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-------- 222 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-------- 222 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--------
Confidence 987543 2234667889999999874 368999999999999999999 57888665432222111100
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+ ......+.+||.+||..+|.+|||+.++|+
T Consensus 223 -----------------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -----------------------HRLP-------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------CCCC-------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 012367889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.59 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=198.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 368999999999999999999864 456799998864322 13456789999999999999999998844 46899
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+|||+.+ ++.+++... ...+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999984 677766543 34588999999999999999999999999999999999999999999999999976543221
Q ss_pred C-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 P-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. .....++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+.......+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence 1 122345677999999976 568999999999999999998 99999887766665554332110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
......+..+.+||.+||..||.+||++.++++
T Consensus 223 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 ----------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011236788999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.27 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=188.6
Q ss_pred eeecCCceEEEEEEECCCCc--EEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 420 KIDEGTYGVVYRARDKKTGE--IVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~--~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
.||+|+||.||+|+++.++. .+|+|.++.... ......+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 58999999999999988776 468888764221 11223567899999999 79999999999854 44789999999
Q ss_pred hh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccc
Q 004049 497 EH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560 (776)
Q Consensus 497 ~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGl 560 (776)
.+ +|..++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 84 6666654321 2488999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
+....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------- 228 (270)
T cd05047 159 SRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-------- 228 (270)
T ss_pred ccccchhh-hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC--------
Confidence 86432111 1112234667999999876 568999999999999999997 999998766555544442110
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.......++..+.+||.+||..||.+|||+.++++
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00011236778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.70 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=198.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC-------CcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT-------GEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t-------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
.+|.+++.||+|+||.||+|++... +..||+|+++..... .....+.+|+.+++++ .||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4699999999999999999986432 236899988643211 1234567899999999 79999999999854
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN 548 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd 548 (776)
...+|++|||+.+ +|..++... ...+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4578999999985 566665432 12478899999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 004049 549 NRGELKICDFGLARQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625 (776)
Q Consensus 549 ~~g~iKL~DFGlA~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~ 625 (776)
.++.+||+|||+++........ .....++..|+|||++.+ ..++.++|||||||+||+|++ |..||.+.+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999865432111 122234567999999987 568899999999999999998 899998877666555
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
.+..... ......++..+.+||.+||..+|.+|||+.++|++-
T Consensus 248 ~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 248 LLKEGHR------------------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHcCCC------------------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 5432210 001123677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.06 Aligned_cols=251 Identities=26% Similarity=0.498 Sum_probs=200.6
Q ss_pred CeeEEeeeecCCceEEEEEEECC-CCcEEEEEEeecchhc--------cCCccchHHHHHHHHh-CCCCCcceeeEEEec
Q 004049 414 EFERLNKIDEGTYGVVYRARDKK-TGEIVALKKVKMEKER--------EGFPLTSLREINILLS-FHHPSIVDVKEVVVG 483 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~-tg~~VAIK~i~~~~~~--------~~~~~~~~rEi~iL~~-L~HPnIV~l~~~~~~ 483 (776)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+...... ......+.+|+.++.+ +.||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 6889999998644321 1112335678888865 789999999999854
Q ss_pred cCCCeeEEEeeehhh-hhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeec
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
...+|+||||+.| ++..++. .....+++..++.++.||+.||.|||+ .||+|+||||.|||++.++.++|+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 4589999999986 4555443 234569999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
|++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+......|.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 233 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--- 233 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC---
Confidence 9998764432 3345678999999999987 5589999999999999999999999987766555554433221110
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....++..+.+||.+||+.||.+||++.|+..+
T Consensus 234 --------------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 --------------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 011367889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.03 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=201.1
Q ss_pred CCeeEEeeeecCCceEEEEEEEC----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+|++++.||+|+||.||+|... .++..||||++...... .....+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46888999999999999999864 34889999999755432 23446778999999999999999999886655667
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ ++..++......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 8999999975 666666655556999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCc---cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LKPY---THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~~~---~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ...+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-----~~~~~~~~-------- 228 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-----RMIGIAQG-------- 228 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhc-----cccccccc--------
Confidence 2211 12244567999999977 4688999999999999999999999865432110 00000000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..........+.. ...+.....++..+.+||.+||..+|.+|||+.+|++
T Consensus 229 -----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 229 -----QMIVTRLLELLKE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred -----cccHHHHHHHHHc---CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000111111 1112223346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.78 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=195.4
Q ss_pred eeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC----C
Q 004049 415 FERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----D 487 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----~ 487 (776)
|.+.+.||+|+||.||+|.++ .++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999865 357899999997654333334456789999999999999999998854322 1
Q ss_pred eeEEEeeehhh-hhhhHHhhc-----cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 488 SIFMVMEYMEH-DLKGLMETM-----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~-----~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
..+++++|+.+ ++..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788999985 444443321 124899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 562 RQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 562 ~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
........ ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.........+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~----- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R----- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c-----
Confidence 86543211 1223345678999999876 568899999999999999999 899998776655444443210 0
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+...+..+..+.+|+.+||..+|.+|||+.+++++
T Consensus 234 ------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112367889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=313.05 Aligned_cols=259 Identities=18% Similarity=0.223 Sum_probs=188.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCC---------ccchHHHHHHHHhCCCCCcceeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGF---------PLTSLREINILLSFHHPSIVDVKEV 480 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HPnIV~l~~~ 480 (776)
.+|++.+.||+|+||+||+|.+..+ +..+|+|+.......... ......++..+..+.|+||+.++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999998877 677788865432211000 0111233344566789999999987
Q ss_pred EeccCC--CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 481 VVGSNL--DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 481 ~~~~~~--~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
...... ...|++|+++...+...+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 643322 23478888887666555543 334788999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004049 559 GLARQYGSPL-------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 559 GlA~~~~s~~-------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~l 631 (776)
|+|+.+.... .......||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+......+......
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~- 248 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC- 248 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-
Confidence 9998663221 11223579999999999987 56899999999999999999999999877433222111110
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+... ....++ ..+..+..+.+|+..|+..+|.+||+..+|++
T Consensus 249 -------------------~~~~~---~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 -------------------DFIKR---LHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -------------------HHHHH---hhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000 000000 01235788999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=345.85 Aligned_cols=276 Identities=25% Similarity=0.353 Sum_probs=184.9
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCC----CcEEEEEEeecchhccCCccchHHHHHHH---HhCCCCCcceeeEEEe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKT----GEIVALKKVKMEKEREGFPLTSLREINIL---LSFHHPSIVDVKEVVV 482 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~t----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL---~~L~HPnIV~l~~~~~ 482 (776)
...++|++.+.||+|+||.||+|++..+ +..||||++..... .|+.+. ....+.+++.++..|.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------~e~~~~e~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------VEIWMNERVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------hHHHHHHHHHhhchhhHHHHHHhhh
Confidence 3568999999999999999999999988 99999998754221 122222 2222333333322221
Q ss_pred ----ccCCCeeEEEeeehhhh-hhhHHhhccCC-------------------CCHHHHHHHHHHHHHHhhhhccCCcccC
Q 004049 483 ----GSNLDSIFMVMEYMEHD-LKGLMETMKQP-------------------FSQSEVKCLMLQLLEGIKYLHDNWVLHR 538 (776)
Q Consensus 483 ----~~~~~~l~LVmEy~~g~-Ll~~l~~~~~~-------------------Lse~~~~~i~~qIl~aL~yLHs~gIvHr 538 (776)
......++|||||+.++ |..++...... ..+..+..|+.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 13445789999999864 55555432211 1234577899999999999999999999
Q ss_pred CCCCCCeeecC-CCcEEEeecccccccCCCC-CCccccccccccCCchhhccCC---------------------CCCcc
Q 004049 539 DLKTSNLLLNN-RGELKICDFGLARQYGSPL-KPYTHLVVTLWYRAPELLLGSK---------------------QYSTA 595 (776)
Q Consensus 539 DLKPeNILLd~-~g~iKL~DFGlA~~~~s~~-~~~~~~~GT~~Y~APEvl~g~~---------------------~ys~~ 595 (776)
||||+||||+. ++.+||+|||+|+.+.... ......++|+.|+|||.+.... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5899999999998653221 2234578899999999764321 13456
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCC
Q 004049 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVL 675 (776)
Q Consensus 596 sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~l 675 (776)
+|||||||+||||+++..+ ..+...++..++...+..... |.... . ......+.+.+ ......
T Consensus 360 ~DVwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~-~~~~~--~-------~~~~~~~~~~~-----~~~d~~ 422 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVA-WRKLV--E-------PRASPDLRRGF-----EVLDLD 422 (566)
T ss_pred cccHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHH-HHHhh--c-------cccchhhhhhh-----hhcccc
Confidence 7999999999999986554 344555555555543322111 10000 0 00000001101 111123
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 676 SDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 676 S~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...++|||.+||++||.+|||+.++|+||||+....
T Consensus 423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 423 GGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred chHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 556789999999999999999999999999998654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.46 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=198.1
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~ 486 (776)
++|.+.+.||+|+||.||+|++. .++..||||+++..... .....+.+|+.+|..+. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 57889999999999999999864 35578999999754322 22235678999999997 99999999998543
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------------------------------------------------------
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK--------------------------------------------------------- 508 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~--------------------------------------------------------- 508 (776)
..+||||||+.+ +|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 478999999985 5655553221
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec
Q 004049 509 ----------------------------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN 548 (776)
Q Consensus 509 ----------------------------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd 548 (776)
..|++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 2367888999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 004049 549 NRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625 (776)
Q Consensus 549 ~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~ 625 (776)
.++.+||+|||++..+.... .......+++.|+|||.+.+ ..++.++|||||||+||||++ |..||......+.+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 99999999999998653221 11223467889999999987 558899999999999999998 899997765555443
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..-.. ...+..++..+.+||.+||..+|.+||++.+||+.
T Consensus 353 ~~~~~~~~-----------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYR-----------------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCC-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33221100 00112368899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.09 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=196.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++.+.||+|+||.||++.. +++.||+|++..... ...+.+|+.+++.++||||+++++++.. +.+|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~ 74 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILH---NGLY 74 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcE
Confidence 346899999999999999999864 688899999864321 2456789999999999999999998843 3479
Q ss_pred EEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||+.+ +|..++.... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 99999985 6766665543 35899999999999999999999999999999999999999999999999999764321
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 216 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-------------- 216 (254)
T ss_pred --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------------
Confidence 122344678999999876 568899999999999999997 99999887765555444221100
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.....++..+.+||.+||..+|.+|||+.+++.
T Consensus 217 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 ----------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011236788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.03 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=186.7
Q ss_pred eeeecCCceEEEEEEECC--CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKK--TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~--tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999996532 34568888775432 11223356789999999999999999999854 45789999999
Q ss_pred hh-hhhhHHhhcc----CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--C
Q 004049 497 EH-DLKGLMETMK----QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--K 569 (776)
Q Consensus 497 ~g-~Ll~~l~~~~----~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--~ 569 (776)
.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 85 5656554432 235788899999999999999999999999999999999999999999999986532211 1
Q ss_pred CccccccccccCCchhhcc------CCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG------SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g------~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
......+++.|+|||++.. ...++.++|||||||++|+|++ |.+||......+.+..+......+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL------- 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC-------
Confidence 1123355778999999753 2356889999999999999999 7889987776666555543321110
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+. ......++..+.+++..|+ .||.+|||+.+|++
T Consensus 231 ----------------------~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 ----------------------PK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------------------CC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 0011237788889999988 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.09 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=186.5
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|.+. .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999864 35567999988654321 112356789999999999999999998843 45789999999
Q ss_pred hh-hhhhHHhhcc----CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--
Q 004049 497 EH-DLKGLMETMK----QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-- 569 (776)
Q Consensus 497 ~g-~Ll~~l~~~~----~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-- 569 (776)
.+ +|..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++++||+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 85 5555554322 2467788889999999999999999999999999999999999999999999975432211
Q ss_pred CccccccccccCCchhhccCC------CCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGSK------QYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~------~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
......++..|+|||++.+.. .++.++|||||||++|+|++ |.+||......+.+.........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL--------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------
Confidence 122346788899999986421 35789999999999999996 99999776655443332221000
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.++.. ......+..+.+||..|+ .+|.+|||+.+|+.
T Consensus 229 --------------------~~~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 --------------------KLPKP--RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------------CCCCC--ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000 001136778899999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.42 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=191.5
Q ss_pred eeeecCCceEEEEEEECCCC------cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 419 NKIDEGTYGVVYRARDKKTG------EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.||+|+||.||+|+++... ..||||.+..... ......+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999986544 6899998864321 1223457789999999999999999999854 4578999
Q ss_pred eeehhh-hhhhHHhhc------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-----cEEEeeccc
Q 004049 493 MEYMEH-DLKGLMETM------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-----ELKICDFGL 560 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-----~iKL~DFGl 560 (776)
|||+.+ +|..++... ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999985 566665432 23488999999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 004049 561 ARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 561 A~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~ 637 (776)
+........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------ 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC------
Confidence 976532211 1122345788999999987 568999999999999999998 999998776655544442210
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+.....++..+.+||.+||..+|.+||++.+|++
T Consensus 231 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00111236788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=327.58 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=214.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-----ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-----REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-----~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|-++.+||+|+|+.||+|.+....++||+|+-..... .+...+...+|..|-+.|.||-||++|+||.-+. +
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-d 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-D 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-c
Confidence 678899999999999999999999999999999765442 2334455678999999999999999999996543 5
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecC---CCcEEEeeccccc
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNN---RGELKICDFGLAR 562 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~---~g~iKL~DFGlA~ 562 (776)
.+|-|+|||+|+.+++++...+.+++.+++.|+.||+.||.||.... |||-||||.||||-. -|.|||+||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 78999999999888887777788999999999999999999999765 999999999999964 4789999999999
Q ss_pred ccCCCCC-------CccccccccccCCchhhccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004049 563 QYGSPLK-------PYTHLVVTLWYRAPELLLGS---KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632 (776)
Q Consensus 563 ~~~s~~~-------~~~~~~GT~~Y~APEvl~g~---~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg 632 (776)
.+..... ......||.||++||++.-. +..+.++||||+|||+|.+|.|+.||...... +.|+....
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILqeNT 698 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQENT 698 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHhhhc
Confidence 8754322 23456899999999998642 45788999999999999999999999765322 22222100
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.. +.....|...|.++.++++||++||.+--+.|+.+.++-.||||.-
T Consensus 699 Il----------------------------kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 IL----------------------------KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hh----------------------------cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 00 0011234445679999999999999999999999999999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=337.16 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=217.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEec---cCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVG---SNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~---~~~~~ 488 (776)
+-|++.+.||.|.||+||+++.+.+++.+|+|++...... ...+..|.+||+.+. |||++.++++|.. ...+.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 5699999999999999999999999999999998765433 345667899998874 9999999999963 45678
Q ss_pred eEEEeeehhhhh-hhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 489 IFMVMEYMEHDL-KGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 489 l~LVmEy~~g~L-l~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
++||||||.|+. -+++... +..|.|..+.+|++.++.||.|||.+.+||||||-.||||+.++.+||+|||++.++.+
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 999999999643 3333322 56799999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCccccccccccCCchhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGS----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~----~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
......+++||+.|||||++.-. ..|+..+|+||||++..||.-|.|||........+-+|- ..|+.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPP------ 246 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPP------ 246 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCc------
Confidence 88888899999999999999642 347789999999999999999999998766554443331 11211
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+...+..+.|||..||.+|-.+||+..++|+|||+.+
T Consensus 247 -------------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 -------------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -------------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11223347889999999999999999999999999999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.23 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=186.0
Q ss_pred eeecCCceEEEEEEECCC--CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 420 KIDEGTYGVVYRARDKKT--GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~t--g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
.||+|+||+||++..... ...+++|.+..... ......+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 589999999999975433 23466666654321 1223467789999999999999999999854 457899999999
Q ss_pred h-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--CCc
Q 004049 498 H-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--KPY 571 (776)
Q Consensus 498 g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--~~~ 571 (776)
+ +|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 5 566665543 2346778889999999999999999999999999999999999999999999986432111 122
Q ss_pred cccccccccCCchhhccC------CCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 572 THLVVTLWYRAPELLLGS------KQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~------~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
...+++..|+|||++... ..++.++|||||||++|+|++ |.+||...+..+.+..+....... .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~----- 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---LF----- 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---cC-----
Confidence 345788999999988531 235779999999999999997 578898777766666654431110 00
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.......+++.+.+||..|+ .+|.+|||+.+|++
T Consensus 231 -----------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 -----------------------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00011236788899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.69 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=205.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc---E-EEEEEeecch-hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE---I-VALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~---~-VAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++-.+.++||+|+||.||+|..+..+. . ||+|..+... ........+++|..+|+.|+|||||++|++...+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-- 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-- 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--
Confidence 3556667999999999999999865422 3 8999987532 3444566788999999999999999999998654
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
.-+|||||+|.| +|.+++......++..+...++.+.+.||+|||++++|||||-..|+|+..++.+||+||||++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 478999999996 6777777766679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh-cCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKT-LGTPNEKIWPGFS 643 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~-lg~p~~~~wp~~~ 643 (776)
.........--...|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+...+|... ...+.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-------- 384 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-------- 384 (474)
T ss_pred ceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC--------
Confidence 11111112234678999999987 479999999999999999998 88899999999888888543 11111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+...+..+..++.+|+..||+.|+|+.++.+
T Consensus 385 ----------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ----------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1135677888999999999999999988764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=284.71 Aligned_cols=242 Identities=43% Similarity=0.665 Sum_probs=195.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhh-hhhhH
Q 004049 425 TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGL 503 (776)
Q Consensus 425 sfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g-~Ll~~ 503 (776)
+||.||+|.+..+++.||+|++........ ...+.+|+.+++.++|+||+++++++... ...+++|||+.+ ++...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 589999999998999999999875543221 35677899999999999999999998543 578999999998 66665
Q ss_pred HhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCc
Q 004049 504 METMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583 (776)
Q Consensus 504 l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~AP 583 (776)
+... ..+++..+..++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 5443 348999999999999999999999999999999999999999999999999998765432 33456788999999
Q ss_pred hhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhh
Q 004049 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK 662 (776)
Q Consensus 584 Evl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~ 662 (776)
|.+.+ ..++.++|||+||+++|+|++|..||... .....+..+......+.
T Consensus 156 E~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------- 207 (244)
T smart00220 156 EVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP--------------------------- 207 (244)
T ss_pred HHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------------
Confidence 99986 55788999999999999999999999773 33333332221110000
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 663 KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 663 ~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.....++..+.+||.+||..+|.+||++.++++||||
T Consensus 208 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 -------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0000166788999999999999999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=330.42 Aligned_cols=204 Identities=32% Similarity=0.477 Sum_probs=172.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~~ 488 (776)
.-|..-+.||+|+||.||+++++.+|+.||||.++... .........+|+++|++|+|||||++.++-.+.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34777789999999999999999999999999998755 2223445668999999999999999988764443 345
Q ss_pred eEEEeeehhh-hhhhHHhhc--cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC--CC--cEEEeecccc
Q 004049 489 IFMVMEYMEH-DLKGLMETM--KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--RG--ELKICDFGLA 561 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~--~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--~g--~iKL~DFGlA 561 (776)
.++|||||.| +|...+... ...|++.+++.++..+..||.|||++|||||||||.||++-. +| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 6899999996 455555432 346999999999999999999999999999999999999853 23 4799999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK 618 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~ 618 (776)
+.+..+ ..+.+++||+.|++||++...+.|+..+|.|||||++|+++||..||...
T Consensus 172 rel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 988654 47888999999999999986578999999999999999999999999654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=317.83 Aligned_cols=274 Identities=22% Similarity=0.346 Sum_probs=187.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC----------------CCCcEEEEEEeecchhc------------cCCccchHHH
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK----------------KTGEIVALKKVKMEKER------------EGFPLTSLRE 462 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k----------------~tg~~VAIK~i~~~~~~------------~~~~~~~~rE 462 (776)
..++|++.++||+|+||+||+|.+. ..++.||||.+...... .........|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999752 34567999998653211 1112234457
Q ss_pred HHHHHhCCCCCc-----ceeeEEEecc------CCCeeEEEeeehhh-hhhhHHhhcc----------------------
Q 004049 463 INILLSFHHPSI-----VDVKEVVVGS------NLDSIFMVMEYMEH-DLKGLMETMK---------------------- 508 (776)
Q Consensus 463 i~iL~~L~HPnI-----V~l~~~~~~~------~~~~l~LVmEy~~g-~Ll~~l~~~~---------------------- 508 (776)
+.++.+++|.++ +.++++|... .....+|||||+.+ +|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 788888876654 5666766431 12457999999985 4544443211
Q ss_pred -CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC-ccccccccccCCchhh
Q 004049 509 -QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP-YTHLVVTLWYRAPELL 586 (776)
Q Consensus 509 -~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~-~~~~~GT~~Y~APEvl 586 (776)
..+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 23567789999999999999999999999999999999999999999999999765332111 1112348899999998
Q ss_pred ccCCC-------------------CC--ccchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 587 LGSKQ-------------------YS--TAIDMWSLGCIMAELLSKEP-LFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 587 ~g~~~-------------------ys--~~sDVWSLGvlLyELLtG~~-PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
..... |+ ...||||+|||||+|+++.. ||.....+.... ..... ....|..
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~---~~~~~-~~~~~r~--- 455 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL---RQYDN-DLNRWRM--- 455 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---hhccc-hHHHHHh---
Confidence 64211 12 24799999999999999875 775432221110 00000 0000000
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHcCcCcCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP---DKRITAEAALNHDWFRE 708 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP---~kRpTa~EIL~HPwf~~ 708 (776)
... ....+......++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 456 --------------~~~---~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 --------------YKG---QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --------------hcc---cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 011222234578999999999999876 68999999999999953
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=330.46 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=207.5
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.+.+..+.||+|+||+||+|+.. .....||||.++..... ....+|.+|+.+|..|+|||||+|++++. ..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCR--EGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEc--cCC
Confidence 56778899999999999999763 34578999999765433 24567899999999999999999999994 445
Q ss_pred eeEEEeeehh-hhhhhHHhhcc---------C----CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcE
Q 004049 488 SIFMVMEYME-HDLKGLMETMK---------Q----PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGEL 553 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~---------~----~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~i 553 (776)
-+|||||||. |||..++.... . +|+..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..+
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 7899999998 77877776532 2 38999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 004049 554 KICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKT 630 (776)
Q Consensus 554 KL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~ 630 (776)
||+||||++..-+.. +......-...|||||.|+- ..|+.++||||+||+|||+++ |..||.+-++.+.++.|.++
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 999999998653321 11112234678999999987 569999999999999999998 99999999999999988665
Q ss_pred cCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 631 LGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 631 lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
-- +..+..++.++.+|+..|+..+|.+||+..||
T Consensus 722 ~l------------------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 QL------------------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred Cc------------------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11 12234589999999999999999999999886
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.99 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=207.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHH-hCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL-SFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~-~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++.+-+..||.|+||+|++..++.+|+..|||.|...... ....+++.|..... .-..||||++|+....+. ..+|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceee
Confidence 5566778999999999999999999999999999766542 22345666777644 446999999999886554 5689
Q ss_pred EeeehhhhhhhHHh----hccCCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLME----TMKQPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~----~~~~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.||+|.-++..++. ..+..++|.-+-.|....+.||.||- ...||||||||+||||+..|.+||||||++.++..
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999976554433 23456999999999999999999998 46799999999999999999999999999987743
Q ss_pred CCCCccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKS-EFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s-~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. ...+.-.|-..|||||.+.... .|+.++||||||++|||+.||..||.+-+ .++|+..+..+ .|+.-..+
T Consensus 221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g--dpp~l~~~---- 293 (361)
T KOG1006|consen 221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG--DPPILLFD---- 293 (361)
T ss_pred H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC--CCCeecCc----
Confidence 2 2234457888999999997544 49999999999999999999999997743 45555555443 33211110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...-.++..+..||.-||.+|-..||...+++++||++-.
T Consensus 294 -------------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 -------------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -------------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 0112478899999999999999999999999999999764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=333.58 Aligned_cols=248 Identities=25% Similarity=0.436 Sum_probs=207.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCC-----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTG-----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg-----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..-++++.||+|+||.||.|...... ..||||.++.... ......|++|..+|+.+.|||||++++++... .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--G 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--C
Confidence 45778899999999999999875432 2489998876542 23356789999999999999999999999773 4
Q ss_pred eeEEEeeehh-hhhhhHHhhc------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccc
Q 004049 488 SIFMVMEYME-HDLKGLMETM------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGl 560 (776)
..+|++|||. |+|+.++... ...|+..+...++.+|++|+.||+++++|||||-..|+||+....+||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 6799999998 5788888876 56699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcccc----ccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 004049 561 ARQYGSPLKPYTHL----VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPN 635 (776)
Q Consensus 561 A~~~~s~~~~~~~~----~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~ 635 (776)
|+.+-.. .+... .-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.+.++.+..++.+-
T Consensus 849 ArDiy~~--~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---- 921 (1025)
T KOG1095|consen 849 ARDIYDK--DYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---- 921 (1025)
T ss_pred hHhhhhc--hheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC----
Confidence 9944221 11111 22467999999997 679999999999999999998 899999999998887665541
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
++..+.++++.+.+||.+|++.+|++||+...|++
T Consensus 922 --------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 --------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 12223458899999999999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=306.39 Aligned_cols=289 Identities=34% Similarity=0.558 Sum_probs=215.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC---CCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~ 487 (776)
...|..+++||.|+|++||+|.+.. ..+.||+|.|..... ...+.+|+++|..+. +.||+.+.+++ .+.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCF--RNND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhh--ccCC
Confidence 3679999999999999999999887 789999999875442 345789999999996 99999999999 5667
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccC-
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYG- 565 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~- 565 (776)
++++||||+++.....+. ..++..+++.|++.++.||.|+|.+|||||||||.|+|.+. .+.-.|+|||||....
T Consensus 109 ~v~ivlp~~~H~~f~~l~---~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY---RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHH---hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999985433333 34789999999999999999999999999999999999985 5788999999997221
Q ss_pred --------C-------C----------------------------CCCccccccccccCCchhhccCCCCCccchhhhHH
Q 004049 566 --------S-------P----------------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLG 602 (776)
Q Consensus 566 --------s-------~----------------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLG 602 (776)
. . ........||++|+|||++......+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 00001236899999999999988889999999999
Q ss_pred HHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCC--------CC--CCCC--CCCCCCcchhhhhhhhhHhhh-cCC-CC
Q 004049 603 CIMAELLSKEPLF-NGKSEFDQLDKIFKTLGTPN--------EK--IWPG--FSKLPGVKVNFIKHQYNLLRK-KFP-AT 667 (776)
Q Consensus 603 vlLyELLtG~~PF-~~~s~~~~l~kI~~~lg~p~--------~~--~wp~--~~~lp~~~~~~~~~~~~~l~~-~~p-~~ 667 (776)
+|++.++++..|| ...++.+.+..|...+|.-. .. +|.. +..++.....|.......+.+ ..+ ..
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999998776 55666666666665544321 11 2221 111111112221111111111 000 12
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 668 SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 668 ~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
........+..+.|||.+||..||.+|+||+++|+||||...
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 223345677799999999999999999999999999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=315.00 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=222.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|+++..+|.|+||.||+|+++.+++..|+|+++...... ...+.+||-+++.++|||||.+++.|.. .+.+++.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr--~dklwic 90 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWIC 90 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhh--hcCcEEE
Confidence 78999999999999999999999999999999998875432 3445689999999999999999999854 4578999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+.++.+....++|++.++.+++++.+++|+|||+.|-+|||||-.|||++..|.+||+|||.+.+++.......
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99999988888888889999999999999999999999999999999999999999999999999999999887777778
Q ss_pred ccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 573 HLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.+.||+.|||||+.. ....|...+|||++|++..||---++|.........+..+-+....|+
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp--------------- 235 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP--------------- 235 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---------------
Confidence 899999999999874 235699999999999999999888887655555444444433322221
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
........+..+.+|++.+|.++|.+|||++-+|.|||..+
T Consensus 236 -----------------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 -----------------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -----------------cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11222347888999999999999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=318.46 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=190.1
Q ss_pred eeEEeeeecCCceE-EEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEE
Q 004049 415 FERLNKIDEGTYGV-VYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 415 yeil~~LG~GsfG~-Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LV 492 (776)
|.--+.+|.|+-|+ ||+|.. .|+.||||.+-... ...+.+||.+|+... |||||++++.- .+...+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEE
Confidence 44446789999976 799987 48899999885443 234568999999885 99999987654 667789999
Q ss_pred eeehhhhhhhHHhhc--cCCC-CHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---C--CcEEEeeccccccc
Q 004049 493 MEYMEHDLKGLMETM--KQPF-SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---R--GELKICDFGLARQY 564 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~--~~~L-se~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~--g~iKL~DFGlA~~~ 564 (776)
+|.|..+|.+++... ...+ .....+.++.|++.||+|||+.+||||||||.||||+. + ..++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999998874 1111 11456889999999999999999999999999999986 3 46899999999988
Q ss_pred CCCCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 565 GSPLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 565 ~s~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
...... ..+..||-+|+|||++.... -..++|||||||++|..++| ..||...- +.-..|+.+....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L------ 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTL------ 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccce------
Confidence 644332 34578999999999998744 57799999999999998886 89996542 2223333321110
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.... +....++.|||.+||.+||..||+|.++|.||||
T Consensus 733 --------------------------~~L~--~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 733 --------------------------VHLE--PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred --------------------------eeec--cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 0000 1112288999999999999999999999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=305.51 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=213.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC-C--cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT-G--EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t-g--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++..+.++||+|+||.|++|.|+.. | -.||||++....... ....|++|+.+|.+|+|||+|+||++..++ .+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---p~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc---hh
Confidence 4456678899999999999998753 2 458999998765443 456789999999999999999999999653 57
Q ss_pred EEEeeehh-hhhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 490 FMVMEYME-HDLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 490 ~LVmEy~~-g~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.||||++. |+|++.+.+ .+..|-......|+.||+.|+.||..+++|||||-..||||-....+|||||||.+.++..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999998 677777766 5567899999999999999999999999999999999999999999999999999988765
Q ss_pred CCCccc---cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LKPYTH---LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~~~~~---~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
...+.. .-....|+|||.|.. ..++.++|||++||+||||++ |..||.|....+++++|-++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------------- 331 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------------- 331 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------------
Confidence 554421 123567999999988 568999999999999999998 78999999988888777322
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..+..++.++.++.+++..|+..+|+.|||...|...-++++
T Consensus 332 -----------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 332 -----------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 223345569999999999999999999999999876655554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=301.31 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=202.3
Q ss_pred eeEEeeeecCCceEEEEEEECC----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARDKK----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..+.++||.|.||.||.|.... ..-.||||.-+.+...+. ...|+.|..+|+.+.|||||+|++++... -.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~---P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeecc---cee
Confidence 4456789999999999998643 244689998877554433 56789999999999999999999999543 579
Q ss_pred EEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||++. |.|..++...+..|+......|+.||..||.|||+..+|||||-..|||+....-+||+||||++.+....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~- 545 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA- 545 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc-
Confidence 9999998 77888888888899999999999999999999999999999999999999999999999999999875432
Q ss_pred Ccccccc--ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 PYTHLVV--TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ~~~~~~G--T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
-+....| ..-|||||.+.- ..++.++|||.|||++||+|. |..||.+-.+.+.+-.|-++
T Consensus 546 yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---------------- 608 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---------------- 608 (974)
T ss_pred hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC----------------
Confidence 2222233 567999999875 668999999999999999875 99999988776666555433
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
.++..++.+++.+..|+.+|+.+||.+||...+|
T Consensus 609 --------------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 609 --------------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred --------------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 2233456799999999999999999999987554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=299.80 Aligned_cols=202 Identities=30% Similarity=0.463 Sum_probs=177.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------CCccchHHHHHHHHhCC---CCCcceeeEEE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFPLTSLREINILLSFH---HPSIVDVKEVV 481 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~---HPnIV~l~~~~ 481 (776)
...+|..++.||.|+||.|++|.++.....|+||.|.+++.-. ...-..--||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4567999999999999999999999999999999998876321 11223346999999997 99999999999
Q ss_pred eccCCCeeEEEeeehhh--hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 482 VGSNLDSIFMVMEYMEH--DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 482 ~~~~~~~l~LVmEy~~g--~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
++++++||+||--.. +|.+++ ..+..++|.+++.|++||+.|+++||+.||||||||-+||.++.+|-+||+|||
T Consensus 639 --Eddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 --EDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred --ecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 667799999998763 344444 456679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 004049 560 LARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617 (776)
Q Consensus 560 lA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~ 617 (776)
.|....+ .++..++||..|.|||++.|.++.++..|||+||++||.++....||+.
T Consensus 716 saa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9987643 5778899999999999999988889999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=307.40 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=216.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCC---cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTG---EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
......|.+.||.|.||.|++|+.+..| ..||||.++... .+.....|+.|+.||-++.||||++|.++.. ...
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCc
Confidence 3456778899999999999999998766 469999997543 3445678999999999999999999999984 345
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
-+.||.|||+ |.|..++....+.|+..+..-+++.|+.|++||-++|.|||||-..||||+.+-.+|++||||++.+.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 7899999998 677778888888899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC-cccccc--ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKP-YTHLVV--TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~-~~~~~G--T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... +++.-| ...|.|||.|.. ..++.++||||+||+|||.++ |..||...++++.+..|..+..-|+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------ 856 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------ 856 (996)
T ss_pred CCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC------
Confidence 4433 333333 478999999987 568999999999999999665 99999999999999999887554433
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..++..+.+|+..|+++|-++||...||+.+
T Consensus 857 ------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 ------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3488899999999999999999999988764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=294.82 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=204.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+...+.++||+|-||.|.++... .+..||+|+++..... .....+.+||++|.+|+|||||.|+++|..+ +-+++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHH
Confidence 45678899999999999999764 4689999999765432 2346788999999999999999999999654 478999
Q ss_pred eeehh-hhhhhHHhhccCCC-CHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC--
Q 004049 493 MEYME-HDLKGLMETMKQPF-SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-- 568 (776)
Q Consensus 493 mEy~~-g~Ll~~l~~~~~~L-se~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-- 568 (776)
|||++ |+|.+++.....+. .-.....|+.||+.|++||.+.++|||||.+.|||++.++++||+|||+++.+-+..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99998 67777777654443 455566799999999999999999999999999999999999999999998653321
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHH--HhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAEL--LSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyEL--LtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+-...|||||.+.. +.++.++|+|+||++|||+ +|...||...++.+..+.....+..+...
T Consensus 694 ~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~--------- 763 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ--------- 763 (807)
T ss_pred eeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc---------
Confidence 11222345788999999987 5689999999999999997 46889998887777766654443322211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++.++..+.+||.+|+..|-.+||+.+++-.
T Consensus 764 --------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 --------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 122345568899999999999999999999999753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=292.99 Aligned_cols=244 Identities=22% Similarity=0.370 Sum_probs=201.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+..+..+||.|.||.||.+.|+.-...||||.++.+... ...|+.|..+|+.++|||+|+|+++|..+. -+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEE
Confidence 455668999999999999999999999999999765432 457899999999999999999999995543 689999
Q ss_pred eehh-hhhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYME-HDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~-g~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||. |+|++++...++ -++.-..++++.||..|+.||..+++|||||-..|+|+.++..+|++||||++++... .+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD--TY 420 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD--TY 420 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC--ce
Confidence 9998 889999987754 4677778899999999999999999999999999999999999999999999988543 33
Q ss_pred ccccc---ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 572 THLVV---TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 572 ~~~~G---T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
+...| ..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||.+-+.-..+..+-+
T Consensus 421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk------------------ 481 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK------------------ 481 (1157)
T ss_pred ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc------------------
Confidence 33344 567999999875 458999999999999999988 7888887654433333222
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
.|. ...+..+++....|++.|+++.|..||+..||-
T Consensus 482 ---------------gyR---M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 482 ---------------GYR---MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ---------------ccc---ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 111 123445899999999999999999999987763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=321.78 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=183.1
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|...+.||+|+||.||+|+++.++..||||++..... ....|+.++++++|||||++++++... ..+|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEE
Confidence 45667789999999999999999999999999864321 223578999999999999999999544 4789999
Q ss_pred eehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc---cCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 494 EYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH---DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 494 Ey~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH---s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||+++ +|.+++. .+++.++..|+.||+.||+||| +.+|+||||||+|||++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99985 4555553 3899999999999999999999 6699999999999999998888776 666544321
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCC-CCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTP-NEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~p-~~~~wp~~~~lp~ 647 (776)
.....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+.......... ....|
T Consensus 835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (968)
T PLN00113 835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-------- 904 (968)
T ss_pred -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe--------
Confidence 123478999999999987 56899999999999999999999999543211 1111111110000 00000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....+.. ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 905 ------------~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ------------IDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ------------eCccccC-CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000 000001122356789999999999999999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=243.44 Aligned_cols=213 Identities=43% Similarity=0.687 Sum_probs=180.5
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehh-hh
Q 004049 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-HD 499 (776)
Q Consensus 421 LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~-g~ 499 (776)
||.|.+|.||++....+++.+++|++....... ....+.+|+.+++.+.|++|+++++++... ...+++|||+. ++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999998889999999997554321 234577899999999999999999999543 58899999999 56
Q ss_pred hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCCCCCCcccccccc
Q 004049 500 LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGSPLKPYTHLVVTL 578 (776)
Q Consensus 500 Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~~~~~~~~~GT~ 578 (776)
+..++......++...++.++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||++..............+..
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 66665544357999999999999999999999999999999999999999 89999999999987654322234456788
Q ss_pred ccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhh
Q 004049 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658 (776)
Q Consensus 579 ~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~ 658 (776)
.|++||.+.....++.+.|+|+||+++|+|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------- 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------- 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------
Confidence 999999997743688999999999999999
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 659 ~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..+.++|.+||..||.+||++.++++|+
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1335799999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=252.27 Aligned_cols=214 Identities=26% Similarity=0.459 Sum_probs=175.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++..-+..||+|+||.|-+.++..+|...|+|.+..... .....+.++|+++..+. .+|++|.+|+.+..+ ..+++
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwI 122 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWI 122 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEE
Confidence 456667889999999999999999999999999975543 22345667888886655 699999999988554 47899
Q ss_pred EeeehhhhhhhHH---hhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEHDLKGLM---ETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g~Ll~~l---~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.||.|.-++..+. ...++.++|..+-+|+..++.||.|||++ .|||||+||.||||+..|++|+||||++..+.+.
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9999997665443 44567899999999999999999999965 6999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhcc---CCCCCccchhhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHh
Q 004049 568 LKPYTHLVVTLWYRAPELLLG---SKQYSTAIDMWSLGCIMAELLSKEPLFN-GKSEFDQLDKIFKT 630 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g---~~~ys~~sDVWSLGvlLyELLtG~~PF~-~~s~~~~l~kI~~~ 630 (776)
.. .+.-.|--.|||||.+.. ...|+.++||||||+++.||.+++.||. ..++++++.+++..
T Consensus 203 iA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 203 IA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 22 122467778999999853 3468999999999999999999999995 46778888887653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=286.31 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=198.0
Q ss_pred CeeEEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSN 485 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~ 485 (776)
...+.+.||.|.||.|++|.... ....||||.++..... .....+..|+++|+.+. ||||+.+++++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 34556699999999999997431 2567999999766544 44567789999999995 9999999999955
Q ss_pred CCeeEEEeeehh-hhhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC
Q 004049 486 LDSIFMVMEYME-HDLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549 (776)
Q Consensus 486 ~~~l~LVmEy~~-g~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~ 549 (776)
...+++|+||+. |+|+.++.... ..|+..+...++.||+.|++||++..+|||||-..||||..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 568999999998 67888877765 34999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCc-ccccc--ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC-hHHHH
Q 004049 550 RGELKICDFGLARQYGSPLKPY-THLVV--TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKS-EFDQL 624 (776)
Q Consensus 550 ~g~iKL~DFGlA~~~~s~~~~~-~~~~G--T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s-~~~~l 624 (776)
+..+||+|||+|+......... ....+ ...|||||.+.. ..|+.++||||+||+||||++ |..||.+-. ..+.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999998643221111 11222 344999999998 679999999999999999998 889998744 34444
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+.+..+. +...+..+++++.+|++.|+..+|.+||+..++.+
T Consensus 533 ~~l~~G~------------------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGN------------------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCC------------------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4333221 11223458999999999999999999999988763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=304.62 Aligned_cols=203 Identities=17% Similarity=0.213 Sum_probs=148.8
Q ss_pred hCCC-CCcceeeEEEec-----cCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCC
Q 004049 468 SFHH-PSIVDVKEVVVG-----SNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLK 541 (776)
Q Consensus 468 ~L~H-PnIV~l~~~~~~-----~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLK 541 (776)
.+.| +||+.++++|.. .....++++|||+.++|..++......|++.+++.|++||+.||.|||++||||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 588888887721 1124678899999999998887666679999999999999999999999999999999
Q ss_pred CCCeeecCC-------------------CcEEEeecccccccCCCC----------------CCccccccccccCCchhh
Q 004049 542 TSNLLLNNR-------------------GELKICDFGLARQYGSPL----------------KPYTHLVVTLWYRAPELL 586 (776)
Q Consensus 542 PeNILLd~~-------------------g~iKL~DFGlA~~~~s~~----------------~~~~~~~GT~~Y~APEvl 586 (776)
|+||||+.. +.+||+|||+++...... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 445666666665321000 001124689999999999
Q ss_pred ccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCC
Q 004049 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPA 666 (776)
Q Consensus 587 ~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~ 666 (776)
.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .|+.
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~------------------------------ 233 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ------------------------------ 233 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh------------------------------
Confidence 87 558999999999999999999998875321 1222221110 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 667 TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 667 ~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+ ......+.+++.+||.+||.+|||+.|||+||||...
T Consensus 234 --~---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 --I---LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred --h---hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0 0023455689999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=242.35 Aligned_cols=213 Identities=40% Similarity=0.578 Sum_probs=175.1
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|.+.+.||.|+||.||++.+..++..+|||.+...... .....+.+|+..++.+.|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999988999999999765432 124566789999999999999999998854 357899999
Q ss_pred ehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-CCcc
Q 004049 495 YMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-KPYT 572 (776)
Q Consensus 495 y~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~~~~ 572 (776)
|+.+ +|...+......+++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9997 6666655433338999999999999999999999999999999999999999999999999998765432 1223
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CCh-HHHHHHHHHh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG-KSE-FDQLDKIFKT 630 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~-~~~l~kI~~~ 630 (776)
...++..|++||.+.....++.++|||+||+++|+|++|++||.. .+. ....+.|...
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 457888999999984335677899999999999999999999977 333 3555555444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=281.56 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=204.4
Q ss_pred eeEEeeeecCCceEEEEEEECCCC----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+...+.||.|+||+||+|.+.-.| -+||||++...... .....++.|+-+|.+|.|||+++|++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 445678999999999999986544 46888887644322 23467889999999999999999999996543 78
Q ss_pred EEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||++|++ |.|++++...+..+-.+..+.|..||++||.|||.+.+|||||-..||||..-.++||+|||+|+.+.....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999 679999999889999999999999999999999999999999999999999999999999999998876666
Q ss_pred Ccccccc--ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 PYTHLVV--TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ~~~~~~G--T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.+....| .+-|||-|.+.. ..|+.++|||||||++|||+| |..|+.+....++-+.+-.+
T Consensus 854 ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---------------- 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---------------- 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc----------------
Confidence 6655444 566999998887 679999999999999999987 99999887665543333221
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
.++.-++.++.++.-++.+||..|+..||++.++-
T Consensus 917 --------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 917 --------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred --------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 11233556899999999999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=268.91 Aligned_cols=195 Identities=26% Similarity=0.365 Sum_probs=156.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHH--hCCCCCcceeeEEEeccC--CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL--SFHHPSIVDVKEVVVGSN--LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~--~L~HPnIV~l~~~~~~~~--~~ 487 (776)
+...++++.||+|.||.||+|+.. ++.||||++..... ..+.+|.+|.. .++|+||++++++-.... .-
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 355677889999999999999875 58999999976543 23556666655 468999999988753222 33
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC---------CcccCCCCCCCeeecCCCcEEEee
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN---------WVLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~---------gIvHrDLKPeNILLd~~g~iKL~D 557 (776)
.+.||++|.+ |+|.+++... .+++.....|+..|++||+|||+. .|+|||||..||||..+++..|+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 6899999998 6777777653 589999999999999999999963 499999999999999999999999
Q ss_pred cccccccCC--CCCCccccccccccCCchhhccCCCCC-----ccchhhhHHHHHHHHHhCCCCC
Q 004049 558 FGLARQYGS--PLKPYTHLVVTLWYRAPELLLGSKQYS-----TAIDMWSLGCIMAELLSKEPLF 615 (776)
Q Consensus 558 FGlA~~~~s--~~~~~~~~~GT~~Y~APEvl~g~~~ys-----~~sDVWSLGvlLyELLtG~~PF 615 (776)
||||..+.. ........+||..|||||+|.+.-.+. .+.||||+|.+||||++....+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999987742 222334479999999999998754443 4689999999999999865544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=263.42 Aligned_cols=191 Identities=27% Similarity=0.389 Sum_probs=153.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHH--HHHHHHhCCCCCcceeeEEEec--cCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLR--EINILLSFHHPSIVDVKEVVVG--SNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~r--Ei~iL~~L~HPnIV~l~~~~~~--~~~ 486 (776)
...+..+.+.||+|-||.||+|.++ |..||||++...... ...+ ||.....|+|+||+.+++.-.. ...
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~-----SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER-----SWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccchh-----hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3467889999999999999999997 889999999644322 2334 4555556799999999876532 223
Q ss_pred CeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-----CC---cccCCCCCCCeeecCCCcEEEee
Q 004049 487 DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-----NW---VLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-----~g---IvHrDLKPeNILLd~~g~iKL~D 557 (776)
.+++||.+|.+ |+|.+++.. ..++......++..++.||+|||. +| |+|||||..||||..+|...|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 46899999999 667777665 569999999999999999999995 23 99999999999999999999999
Q ss_pred cccccccCCCC----CCccccccccccCCchhhccCCC-----CCccchhhhHHHHHHHHHh
Q 004049 558 FGLARQYGSPL----KPYTHLVVTLWYRAPELLLGSKQ-----YSTAIDMWSLGCIMAELLS 610 (776)
Q Consensus 558 FGlA~~~~s~~----~~~~~~~GT~~Y~APEvl~g~~~-----ys~~sDVWSLGvlLyELLt 610 (776)
+|||....+.. ...+..+||..|||||+|...-. .-..+||||||.+|||++.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99998765432 23466799999999999964221 1246899999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=275.55 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred eecCCceEEEEEEE---CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 421 IDEGTYGVVYRARD---KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 421 LG~GsfG~Vyla~~---k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+|+|+||.|+++.. ...+..||+|++++.............|..++..++ ||++|.++..|.. ...++++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 79999999998753 345788999999877654444445667999999997 9999999999944 45889999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G 576 (776)
.|+.+.........+.+...+.+...++.+|+++|+.||+|||+|++||+++.+|++++.|||+++..-.... .||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----ccc
Confidence 9876666666667799999999999999999999999999999999999999999999999999987643221 299
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
|..|||||++.+ +..++|+||||+++++|++|..||.+ +....|.+.
T Consensus 156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-------------------------- 202 (612)
T KOG0603|consen 156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-------------------------- 202 (612)
T ss_pred chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--------------------------
Confidence 999999999983 67899999999999999999999987 555555442
Q ss_pred hhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC--CCCCCCCCcc
Q 004049 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP--KSKDFMPTFP 722 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p--k~~~~~~~~~ 722 (776)
.+..+..++..+++++..|+..+|.+|+. +.++++|+||+.+.|. ......+.|.
T Consensus 203 -----------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fk 264 (612)
T KOG0603|consen 203 -----------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFK 264 (612)
T ss_pred -----------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCC
Confidence 11122247889999999999999999985 5899999999999887 3334444443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=246.42 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=190.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..+.|.+.+.||+|.||++.+|.++.++..+++|.+...... ...+.+|..---.|. |.||+.-|++.. +..+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHh-hcCceE
Confidence 457899999999999999999999999999999998754322 345677776655554 899998887643 345588
Q ss_pred EEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC--CCcEEEeecccccccCC
Q 004049 490 FMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGS 566 (776)
Q Consensus 490 ~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~~~s 566 (776)
+++|||++ |+|...+.. ..+-|...+.++.||+.||.|||+++|||||||.+||||-. .-.+||||||+.+..+.
T Consensus 98 vF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999 777776665 35889999999999999999999999999999999999953 34799999999987654
Q ss_pred CCCCccccccccccCCchhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGS----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~----~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~ 641 (776)
.... .--+..|.+||++... -...+.+|+|.||+|+|.+|+|.+||......+. +...++
T Consensus 176 tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~------------ 240 (378)
T KOG1345|consen 176 TVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ------------ 240 (378)
T ss_pred eehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH------------
Confidence 3222 2235569999987531 2246789999999999999999999974322211 000000
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcCcC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR---ITAEAALNHDWFR 707 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kR---pTa~EIL~HPwf~ 707 (776)
|.+.....+.++| ..+|+.+..+.++-|..+|+.| .++.......|..
T Consensus 241 ----------w~~rk~~~~P~~F--------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 241 ----------WLKRKNPALPKKF--------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ----------HhcccCccCchhh--------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 0000000011111 2378999999999999999999 5666666666754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.40 Aligned_cols=166 Identities=25% Similarity=0.349 Sum_probs=129.4
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
|+|.+++...+.+|++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 4677777766678999999999999999999999998 999999999999999 9999876432 23689
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~ 656 (776)
+.|||||++.+ ..|+.++|||||||++|+|++|.+||...... ..+..+........ +....
T Consensus 68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~------------ 130 (176)
T smart00750 68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----PRDRS------------ 130 (176)
T ss_pred ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----ccccc------------
Confidence 99999999987 56899999999999999999999999765443 23333333211100 00000
Q ss_pred hhHhhhcCCCCCCCCCCCCCH--HHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 657 YNLLRKKFPATSFTGSPVLSD--AGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 657 ~~~l~~~~p~~~~~~~~~lS~--~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
....++. .+.+||.+||..||.+|||+.++++|+|+.
T Consensus 131 --------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 --------------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --------------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0001223 688999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-25 Score=226.47 Aligned_cols=263 Identities=37% Similarity=0.558 Sum_probs=205.2
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCCC-CcceeeEEEeccCCCeeEEE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHHP-SIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HP-nIV~l~~~~~~~~~~~l~LV 492 (776)
|.+...||.|+|+.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.++.++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788899999999999999987 7899999976654443 456678999999999988 79999999933 3458999
Q ss_pred eeehhhhhhhHHhhccC---CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCCCC
Q 004049 493 MEYMEHDLKGLMETMKQ---PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPL 568 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~---~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~~ 568 (776)
++|+.+..+..+..... .+.+..+..++.|++.+|.|+|..+++||||||+|||++..+ .++|+|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999755444433332 799999999999999999999999999999999999999988 79999999998654332
Q ss_pred C------CccccccccccCCchhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-CC
Q 004049 569 K------PYTHLVVTLWYRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---FDQLDKIFKTLGTP-NE 636 (776)
Q Consensus 569 ~------~~~~~~GT~~Y~APEvl~g~--~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---~~~l~kI~~~lg~p-~~ 636 (776)
. .....+||..|+|||.+.+. ..+....|+|++|++++++++|..||..... ......++.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2 34667999999999999874 4688999999999999999999999887764 33333333332222 00
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..... ... ......+.+++..|+..+|..|.++.+...++|+....
T Consensus 237 ~~~~~---------------------~~~-------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 237 SPLSP---------------------SNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cccCc---------------------ccc-------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 00000 000 11335778999999999999999999999997776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=273.97 Aligned_cols=264 Identities=30% Similarity=0.444 Sum_probs=196.1
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecc----hhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~----~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
....+|.|+||.|+.+........++.|.+... .........+..|+-+-..|.||||+..+..+.. ....+-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchhh
Confidence 456799999999999988777777777765421 1111111224467777788899999887766633 2344455
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC----
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL---- 568 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~---- 568 (776)
||||+++|..++.. ...|+..++..++.||+.||+|||+.||.||||||+|||+...|.+||+|||.+..+..+.
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999966655554 3579999999999999999999999999999999999999999999999999998664332
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+|+-.|+|||++.+..+....+||||.|++++.|++|+.||......+....-... ..
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------~~------- 542 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------SD------- 542 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------cc-------
Confidence 23456799999999999998666667899999999999999999999765443322100000 00
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..+.......+ ...++...+.+|.+||++||.+|+|+.+||+.+||+.+..
T Consensus 543 ~~~~~~~~~~~------------~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 543 QRNIFEGPNRL------------LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ccccccChHHH------------HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00000011111 1237778899999999999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=261.50 Aligned_cols=225 Identities=29% Similarity=0.485 Sum_probs=172.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
-.+|+.++.|--|+||.||+++++.+.+.+|+| ++++.... + +||.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------R--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------R--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------h--ccccccCCccee----------------
Confidence 378999999999999999999999999999994 43332111 0 022222333332
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC---
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--- 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--- 568 (776)
|+...++.. .++++.+ ++.+++|||+.||+|||+||+|+||..-|++||+|||+++...-..
T Consensus 136 ------gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 443333333 2334433 2889999999999999999999999999999999999987431000
Q ss_pred ------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 569 ------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 569 ------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
-.....|||+.|+|||++.. ..|++.+|||++|+|+|+.+.|..||.+++..+++..++.....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--- 276 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 276 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---
Confidence 01134599999999999987 56999999999999999999999999999999998888765433
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcCCCCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI---TAEAALNHDWFREVPLP 712 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp---Ta~EIL~HPwf~~i~~p 712 (776)
||.- ..-+.++++++|.+||+.+|..|. .+-++.+|+||+..+|.
T Consensus 277 --wpE~-----------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 277 --WPEE-----------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --cccc-----------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 3221 112778999999999999999997 57899999999999886
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=234.34 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=198.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc-----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE-----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~-----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++++...+-+|.||.||.|.+++... .|.+|.++... ..-+...++.|-.+|..+.|||+..+.++.... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 568888899999999999998875433 35555554332 222344567899999999999999999988754 45
Q ss_pred eeEEEeeehh-hhhhhHHhhc-------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 488 SIFMVMEYME-HDLKGLMETM-------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~-------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
..++++.+++ |+|..++... .+.++..+...++.||+.|++|||.+||||.||-..|++||+.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6788888888 6777777633 2358889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 560 LARQYGSPLKPY--THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 560 lA~~~~s~~~~~--~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
|++.+-.....+ ........||+||.+.+ ..|+.++|+||||++||||+| |+.|+..-++++....+.++.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy----- 515 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY----- 515 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-----
Confidence 988653211111 01122567999999998 679999999999999999988 899999888888777665541
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
++.-+.+++++++.++.-|+..+|++||+.+|+..
T Consensus 516 -------------------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -------------------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -------------------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11123358999999999999999999999998763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=235.59 Aligned_cols=165 Identities=21% Similarity=0.190 Sum_probs=127.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-CCcEEEEEEeecchh---ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-TGEIVALKKVKMEKE---REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.+.|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+.+|+.|.|+||+..+..+ .
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----C
Confidence 4789999999999999999999876 678889998753211 111223467999999999999998533222 2
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCC-CCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL-KTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDL-KPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..||||||+.|..+..+. ... ...++.||+.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 479999999986554321 111 1468899999999999999999999 99999999999999999999987643
Q ss_pred CCCC--------ccccccccccCCchhhcc
Q 004049 567 PLKP--------YTHLVVTLWYRAPELLLG 588 (776)
Q Consensus 567 ~~~~--------~~~~~GT~~Y~APEvl~g 588 (776)
.... ....++++.|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3211 134678889999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=219.92 Aligned_cols=208 Identities=26% Similarity=0.318 Sum_probs=168.3
Q ss_pred CeeEEeeeecCCceEEEEEEECCCC-cEEEEEEeecchhccCCccchHHHHHHHHhCCC----CCcceeeEEEeccCCCe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTG-EIVALKKVKMEKEREGFPLTSLREINILLSFHH----PSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg-~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H----PnIV~l~~~~~~~~~~~ 488 (776)
.|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.+|..+.. +++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 7999999999999999999988774 6788888765433221 156679999988873 58888888774 23446
Q ss_pred eEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-----CcEEEeeccccc
Q 004049 489 IFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-----GELKICDFGLAR 562 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-----g~iKL~DFGlA~ 562 (776)
-||||+.+..+|.++..... +.|+...+..|+.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|+
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 79999999999998886655 789999999999999999999999999999999999999865 369999999998
Q ss_pred ccC--CCC-------CC-ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 004049 563 QYG--SPL-------KP-YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625 (776)
Q Consensus 563 ~~~--s~~-------~~-~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~ 625 (776)
.+. ... .. ...+.||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||.+........
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 321 111 11 233569999999999888 568999999999999999999999997765443333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=207.74 Aligned_cols=209 Identities=23% Similarity=0.343 Sum_probs=174.2
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|.+.++||+|+||.+|+|...-++++||||.-..... .-.+..|....+.|. .++|..+|.+- +...+-.||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLV 102 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILV 102 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhh
Confidence 59999999999999999999999999999998755432 234455777777764 78888876544 555566899
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-----CcEEEeecccccccCCC
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-----GELKICDFGLARQYGSP 567 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-----g~iKL~DFGlA~~~~s~ 567 (776)
||++..+|.+++..+.+.|+...+..++.||+.-++|+|++.+|+|||||+|+||..- ..|.|+|||+|+.+.++
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 9999999999999999999999999999999999999999999999999999999753 35999999999988654
Q ss_pred CCC-------ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHH
Q 004049 568 LKP-------YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK---SEFDQLDKIFK 629 (776)
Q Consensus 568 ~~~-------~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~---s~~~~l~kI~~ 629 (776)
.+. .....||..||+=-..+| ...+..-|+-|||-+++..|-|..||.+- +..+.+++|-.
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 432 345689999999777777 56788999999999999999999999774 44556666643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-23 Score=239.93 Aligned_cols=248 Identities=26% Similarity=0.339 Sum_probs=181.7
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER--EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.... -......+.|++ ...++|||++++.-+.+. ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 78889999999999999998864 44 999998654321 111223345666 666789999999877643 346799
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC---
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL--- 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~--- 568 (776)
|-+|+.++|++.+..+ ..|...+.+.|+.||+.||.-||..||+|||||.+||||+.-+.+.|+||-..+..--+.
T Consensus 99 vRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999999999888764 347889999999999999999999999999999999999999999999998765432111
Q ss_pred CCcc----ccccccccCCchhhccCC----------CCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 569 KPYT----HLVVTLWYRAPELLLGSK----------QYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 569 ~~~~----~~~GT~~Y~APEvl~g~~----------~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
..++ +.....+|+|||.+.... ..+++.||||+||+++||++ |.|||.-. |+-....+-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~-- 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN-- 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC--
Confidence 1122 222346799999986421 15678999999999999988 79999521 221111110
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
......+..++ -+..++.||..|++.||.+|++|++.|+.
T Consensus 252 --------------------~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 --------------------ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --------------------ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00001111111 23467899999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-22 Score=200.79 Aligned_cols=142 Identities=25% Similarity=0.281 Sum_probs=109.5
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC-------cc-----------------chHHHHHHHHhCCCCC
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-------PL-----------------TSLREINILLSFHHPS 473 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~-------~~-----------------~~~rEi~iL~~L~HPn 473 (776)
...||+|+||.||+|.+. +|+.||||+++........ .. ...+|+.+|..|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999765321111 01 1124999999998887
Q ss_pred cceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhh-ccCCcccCCCCCCCeeecCCCc
Q 004049 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL-HDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 474 IV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL-Hs~gIvHrDLKPeNILLd~~g~ 552 (776)
+.....+.. . ..+|||||++|+.+........++++.++..++.||+.+|.|| |..||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 754433321 1 2389999999864433322346799999999999999999999 799999999999999998 488
Q ss_pred EEEeecccccccC
Q 004049 553 LKICDFGLARQYG 565 (776)
Q Consensus 553 iKL~DFGlA~~~~ 565 (776)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=196.90 Aligned_cols=205 Identities=24% Similarity=0.329 Sum_probs=168.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC-CCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PnIV~l~~~~~~~~~~~l 489 (776)
....|.++++||.|+||.+|+|....+|..||||+-..... ...+..|..+.+.|++ ..|..++.+. ....+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc--cccccc
Confidence 34789999999999999999999999999999998654332 2345678899988874 5666666555 344567
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccccccCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLARQYGS 566 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA~~~~s 566 (776)
.|||+++..+|.+++.-+...|+..++..++-|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||||+.+.+
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 899999999999999988899999999999999999999999999999999999999864 34699999999997743
Q ss_pred CCC-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 004049 567 PLK-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD 622 (776)
Q Consensus 567 ~~~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~ 622 (776)
... ......||..|.+=-...+ ...+...|+-|+|.+|..+.-|..||.+-....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 221 2234689999988666665 346788999999999999999999998865443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-22 Score=210.56 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=147.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-CccchHHHHHHHHhCCC----------CCcceeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLTSLREINILLSFHH----------PSIVDVKEVVV 482 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~H----------PnIV~l~~~~~ 482 (776)
.+...+.||.|+|+.||.+++..|++.+|+|++........ ....+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999999865442221 12223333322222221 11111111111
Q ss_pred ----------ccCCC-----eeEEEeeehhhhhhhHHhhc---cCC---CCHHHHHHHHHHHHHHhhhhccCCcccCCCC
Q 004049 483 ----------GSNLD-----SIFMVMEYMEHDLKGLMETM---KQP---FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLK 541 (776)
Q Consensus 483 ----------~~~~~-----~l~LVmEy~~g~Ll~~l~~~---~~~---Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLK 541 (776)
..... ..+++|+-+.++|..++... ... +.......+..|++..+++||..||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 01001 24788998888877665432 111 2233335566999999999999999999999
Q ss_pred CCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCchhhccC-------CCCCccchhhhHHHHHHHHHhCCCC
Q 004049 542 TSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS-------KQYSTAIDMWSLGCIMAELLSKEPL 614 (776)
Q Consensus 542 PeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~-------~~ys~~sDVWSLGvlLyELLtG~~P 614 (776)
|+|+|++.+|.++|+||+.....+... .....+..|.+||..... -.++.+.|.|+||++||.|+|+..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999887665321 113446779999977442 2478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 004049 615 FNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694 (776)
Q Consensus 615 F~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kR 694 (776)
|........... .|.....++...++||..||++||.+|
T Consensus 250 f~~~~~~~~~~~-----------------------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW-----------------------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG-----------------------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc-----------------------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 976532110000 111112488899999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=193.01 Aligned_cols=141 Identities=23% Similarity=0.231 Sum_probs=111.1
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC------------------------ccchHHHHHHHHhCCCCC
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF------------------------PLTSLREINILLSFHHPS 473 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~------------------------~~~~~rEi~iL~~L~HPn 473 (776)
.+.||+|+||.||+|.+. +|+.||||++......... ......|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999765311000 001246889999999998
Q ss_pred cceeeEEEeccCCCeeEEEeeehhhhh-hhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCC
Q 004049 474 IVDVKEVVVGSNLDSIFMVMEYMEHDL-KGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRG 551 (776)
Q Consensus 474 IV~l~~~~~~~~~~~l~LVmEy~~g~L-l~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g 551 (776)
|.....+... ..||||||++|.. ..... ....++..++..++.||+.+|.+||. +||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 8655554422 2389999999863 22222 23568899999999999999999999 9999999999999999 79
Q ss_pred cEEEeecccccccC
Q 004049 552 ELKICDFGLARQYG 565 (776)
Q Consensus 552 ~iKL~DFGlA~~~~ 565 (776)
.++|+|||+|....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=199.94 Aligned_cols=191 Identities=25% Similarity=0.381 Sum_probs=140.6
Q ss_pred CCCCcceeeEEEecc-------------------------CCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHH
Q 004049 470 HHPSIVDVKEVVVGS-------------------------NLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLL 524 (776)
Q Consensus 470 ~HPnIV~l~~~~~~~-------------------------~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl 524 (776)
+|||||.+..+|.++ ....+|+||..+..+|..++... ..+....+.|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence 599999998887522 12357999999999999888764 367888999999999
Q ss_pred HHhhhhccCCcccCCCCCCCeeecC--C--CcEEEeecccccccCCC------CCCccccccccccCCchhhccCCC---
Q 004049 525 EGIKYLHDNWVLHRDLKTSNLLLNN--R--GELKICDFGLARQYGSP------LKPYTHLVVTLWYRAPELLLGSKQ--- 591 (776)
Q Consensus 525 ~aL~yLHs~gIvHrDLKPeNILLd~--~--g~iKL~DFGlA~~~~s~------~~~~~~~~GT~~Y~APEvl~g~~~--- 591 (776)
.|+.|||.+||.|||||.+||||.- + -.+.|+|||++-..... .......-|....||||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999843 3 35899999987533221 111223456778999999864221
Q ss_pred --CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCC
Q 004049 592 --YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSF 669 (776)
Q Consensus 592 --ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~ 669 (776)
.-.++|.|+.|.+.||++....||++..+..+--.-.+ +..+|
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-------------------------------e~qLP---- 476 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-------------------------------ESQLP---- 476 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-------------------------------hhhCC----
Confidence 12479999999999999999999988543211000000 00111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 670 TGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 670 ~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
..+.-+++.+++|+..+|+.||.||+++
T Consensus 477 alp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 477 ALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CCcccCChHHHHHHHHHhcCCccccCCc
Confidence 1123488899999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=195.06 Aligned_cols=174 Identities=15% Similarity=0.140 Sum_probs=130.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-Cccc------hHHHHHHHHhCCCCCcceeeEEEecc
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-FPLT------SLREINILLSFHHPSIVDVKEVVVGS 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-~~~~------~~rEi~iL~~L~HPnIV~l~~~~~~~ 484 (776)
-++|++++.||.|+||.||++.. ++..||||++........ .... +.+|+..+.+|.||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 37899999999999999999755 466899999965432211 1111 46899999999999999999887533
Q ss_pred C------CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 485 N------LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 485 ~------~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
. ....+|||||++|..+..+. .+++ ..+.+|+.+|..||..||+||||||.|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 23579999999985433332 2333 3466999999999999999999999999999988 999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHH
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL 609 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELL 609 (776)
|......... .. .-++.. ..|+.++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~-a~-----------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRK-AK-----------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchh-hH-----------HHHHHH-hHhcccccccceeEeehHHH
Confidence 9887552211 00 012333 45778999999999987765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=189.18 Aligned_cols=189 Identities=14% Similarity=0.045 Sum_probs=139.9
Q ss_pred eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC--CccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEE
Q 004049 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG--FPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~--~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.+...|+.|+||+||++.. .+..++.+.+........ ....+.+|+++|++|. |++|++++++. ..|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 3567899999999998855 577788777765443211 1123568999999995 58899998862 46999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCC-CCCCeeecCCCcEEEeecccccccCCCCCC-
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL-KTSNLLLNNRGELKICDFGLARQYGSPLKP- 570 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDL-KPeNILLd~~g~iKL~DFGlA~~~~s~~~~- 570 (776)
|+|+.|..+..... . ....++.|++.+|.+||.+||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999865532211 1 12458899999999999999999999 799999999999999999999865432211
Q ss_pred ---c---------cccccccccCCchhhccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCC
Q 004049 571 ---Y---------THLVVTLWYRAPELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKS 619 (776)
Q Consensus 571 ---~---------~~~~GT~~Y~APEvl~g~~~ys-~~sDVWSLGvlLyELLtG~~PF~~~s 619 (776)
. .-...++.|++|+...-....+ ...+|++.|+-+|.++|+..|+.+++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0012478888888654322233 56799999999999999999887654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=208.77 Aligned_cols=192 Identities=25% Similarity=0.344 Sum_probs=154.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~ 488 (776)
.+.|.|-+.||+|+||+||+|.... |+.||||+-+.....+ +.--.+++.+|+ -+.|..+..+++..+ .
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN--A 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCC--c
Confidence 4679999999999999999999876 9999999987655433 222334445554 345666665554444 5
Q ss_pred eEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-------CCcEEEeeccc
Q 004049 489 IFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-------RGELKICDFGL 560 (776)
Q Consensus 489 l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-------~g~iKL~DFGl 560 (776)
-+||+||.+ |+|++++. ..+.+++..+.+++.|||..|++||..+|||+||||+|+||.. .--++|+|||.
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 689999998 77887777 4567999999999999999999999999999999999999953 23599999999
Q ss_pred ccccC--CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCC
Q 004049 561 ARQYG--SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613 (776)
Q Consensus 561 A~~~~--s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~ 613 (776)
+..+. .....+...++|-.+-.+|+..| +.+++.+|.|.|..++|.||+|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 86542 23345667788999999999998 779999999999999999999873
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=182.00 Aligned_cols=145 Identities=19% Similarity=0.129 Sum_probs=111.7
Q ss_pred CeeEEeeeecCCceEEEEEE-ECCCCcEEEEEEeecchhccCC----------------------ccchHHHHHHHHhCC
Q 004049 414 EFERLNKIDEGTYGVVYRAR-DKKTGEIVALKKVKMEKEREGF----------------------PLTSLREINILLSFH 470 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~-~k~tg~~VAIK~i~~~~~~~~~----------------------~~~~~rEi~iL~~L~ 470 (776)
.|.+.+.||+|+||.||+|. +..+|+.||||++......... ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 6678999999999754311000 012357999999997
Q ss_pred CCC--cceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC-cccCCCCCCCeee
Q 004049 471 HPS--IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW-VLHRDLKTSNLLL 547 (776)
Q Consensus 471 HPn--IV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g-IvHrDLKPeNILL 547 (776)
+.+ +..++.+ . ..||||||+.|..+.........+...++..++.||+.+|.|||.+| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 633 3333332 1 34899999998654433333445777788999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccccccC
Q 004049 548 NNRGELKICDFGLARQYG 565 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~ 565 (776)
+ ++.++|+|||+|....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=175.82 Aligned_cols=137 Identities=18% Similarity=0.222 Sum_probs=104.1
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-----CCCCcceeeEEEeccCC-CeeE
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-----HHPSIVDVKEVVVGSNL-DSIF 490 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HPnIV~l~~~~~~~~~-~~l~ 490 (776)
-...||+|+||.||. +..++.. +||++..... .....+.+|+.+++.| .||||+++++++.+... ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 346899999999995 7667665 6998865422 1234578999999999 57999999999976532 2334
Q ss_pred -EEeeehh---hhhhhHHhhccCCCCHHHHHHHHHHHHHHh-hhhccCCcccCCCCCCCeeecCC----CcEEEeecccc
Q 004049 491 -MVMEYME---HDLKGLMETMKQPFSQSEVKCLMLQLLEGI-KYLHDNWVLHRDLKTSNLLLNNR----GELKICDFGLA 561 (776)
Q Consensus 491 -LVmEy~~---g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL-~yLHs~gIvHrDLKPeNILLd~~----g~iKL~DFGlA 561 (776)
+||||+. ++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 467677644 347666 46688888888 99999999999999999999743 37999995544
Q ss_pred c
Q 004049 562 R 562 (776)
Q Consensus 562 ~ 562 (776)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-19 Score=213.12 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=201.8
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-CCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-KTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~ 490 (776)
..|.+.+.||+|+|+.|-++... .+...+|+|.+............+..|..+-..+. |+|++.+++.. ......+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence 45888888999999999998763 34556777777655433334444556777777777 99999999988 4556789
Q ss_pred EEeeehhhhhhhHHh-hccC-CCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeecCCC-cEEEeecccccccCC
Q 004049 491 MVMEYMEHDLKGLME-TMKQ-PFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~-~~~~-~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s 566 (776)
++++|..|+.+.... .... .++...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998875444333 3333 6888899999999999999999 99999999999999999999 999999999997754
Q ss_pred -CC--CCcccccc-ccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 -PL--KPYTHLVV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 -~~--~~~~~~~G-T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.. ......+| ++.|+|||.+.+..+..+..|+||+|+++.-|++|..|+.......... ..|
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~--- 243 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSW--- 243 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eee---
Confidence 22 23445688 9999999999986677899999999999999999999986543322100 001
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
+... ..........++..+.+++.++|..+|..|.+..++..+||+..
T Consensus 244 ----------~~~~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 244 ----------KSNK--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ----------cccc--------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 00012223347888899999999999999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=178.25 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=185.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+.+..++-+|.....|..|++++. |.-+++|+++...........|..|.-.|+-+.||||+.+++.+ ....++.+
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~ 264 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVI 264 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceE
Confidence 345667778999999999999996 44677788876655555556777888999999999999999999 55568999
Q ss_pred Eeeehh-hhhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEe--ecccccccC
Q 004049 492 VMEYME-HDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKIC--DFGLARQYG 565 (776)
Q Consensus 492 VmEy~~-g~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~--DFGlA~~~~ 565 (776)
|..||+ |+|+..+..... -++..++..++.+|+.|+.|||+.. |.---|....++||++-+.+|. |--++.+.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-
Confidence 999999 667776655432 3678899999999999999999876 5555788999999998776654 43333221
Q ss_pred CCCCCccccccccccCCchhhccCCCC--CccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQY--STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~y--s~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
....-.|.||+||.+...+.. -.++|+|||.++||||.|...||..-+..+.-.+|.
T Consensus 344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------- 402 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------- 402 (448)
T ss_pred ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------
Confidence 122347889999999864332 347999999999999999999998776655443331
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
+...+...++.++..+..|+.-|+..||.+||..+.|+
T Consensus 403 --------------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 --------------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --------------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11112233456899999999999999999999876653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=185.86 Aligned_cols=178 Identities=30% Similarity=0.459 Sum_probs=131.4
Q ss_pred CeeEEEeeehhh-hhhhHHhhc--cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM--KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~--~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
.++||.|++|.- +|.+++... ....+......++.|++.|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 358999999984 566666432 2346788899999999999999 9999999999999999999999999999987
Q ss_pred cCCCC------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 564 YGSPL------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 564 ~~s~~------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
..... ...+..+||.+||+||.|.+ ..|+.++||||||+||+||+. -...|.- ...+..| ..
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~-------r~ 474 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDI-------RD 474 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh-------hc
Confidence 64332 13355789999999999998 679999999999999999996 2222211 1111111 11
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
..||.. +.. --+.-.+||.+||...|.+||++.+.--|+|.+
T Consensus 475 g~ip~~-----------------~~~------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 475 GIIPPE-----------------FLQ------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred CCCChH-----------------Hhh------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 122210 000 112335899999999999999888888888763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.1e-17 Score=164.07 Aligned_cols=138 Identities=21% Similarity=0.211 Sum_probs=105.6
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC--------------------CccchHHHHHHHHhCCCCC-
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG--------------------FPLTSLREINILLSFHHPS- 473 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~--------------------~~~~~~rEi~iL~~L~HPn- 473 (776)
|.+.+.||.|+||.||++... +|+.||||++........ .......|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999875 799999999765321000 0012457888999998774
Q ss_pred -cceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 474 -IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 474 -IV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
++.+++. ...++||||+.|..+..+.. ...+..++.+|+.+|.+||..||+|+||||+||||+.++.
T Consensus 96 ~v~~~~~~------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPIDW------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceeec------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 3333321 24589999999854443322 1346788999999999999999999999999999999999
Q ss_pred EEEeecccccccC
Q 004049 553 LKICDFGLARQYG 565 (776)
Q Consensus 553 iKL~DFGlA~~~~ 565 (776)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.9e-17 Score=164.12 Aligned_cols=136 Identities=24% Similarity=0.258 Sum_probs=106.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.||+|++|.||+|.+ .+..|++|+........ .....+.+|+.++..+.|++|.....++... ...++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999987 67789999865332111 0112456799999999999988777666443 367899
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
|||++|..+..+.... .. +...++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999875443333322 22 7889999999999999999999999999999999 78999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=157.82 Aligned_cols=137 Identities=23% Similarity=0.253 Sum_probs=97.9
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccc----------------------hHHHHHHHHhCCCCC--
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLT----------------------SLREINILLSFHHPS-- 473 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~HPn-- 473 (776)
.+.||+|+||+||+|.+. ++..||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8999999998754321111111 124666666665443
Q ss_pred cceeeEEEeccCCCeeEEEeeehhhhhh--hHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCC
Q 004049 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLK--GLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 474 IV~l~~~~~~~~~~~l~LVmEy~~g~Ll--~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~ 550 (776)
+..++.+ ...+|||||+.|+.. ..+.... . ..+++.++.+++.+|.+||. .||+|+||||+|||++ +
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 3333332 135899999998321 1111111 1 16788999999999999999 9999999999999999 8
Q ss_pred CcEEEeecccccccC
Q 004049 551 GELKICDFGLARQYG 565 (776)
Q Consensus 551 g~iKL~DFGlA~~~~ 565 (776)
+.++|+|||++....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-17 Score=193.57 Aligned_cols=267 Identities=26% Similarity=0.370 Sum_probs=205.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+.+.|.+.+-+-.|+|+.++.+.-..+|...++|+...... .........++-+++-..++|.++....-+ .....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCc
Confidence 56889999999999999999999988998888887755432 222233444555555555667776554433 334578
Q ss_pred EEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC--
Q 004049 490 FMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS-- 566 (776)
Q Consensus 490 ~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s-- 566 (776)
+|+++|++|+ +...+. .-...+..-++.++..+.++++|||...++|+|++|.|+|+..+|+.+++|||+....+-
T Consensus 880 ~L~~~~~~~~~~~Skl~-~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLH-NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred chhhHHhccCCchhhhh-cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999863 444433 344688888999999999999999999999999999999999999999999984432210
Q ss_pred -----------------------------CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 004049 567 -----------------------------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617 (776)
Q Consensus 567 -----------------------------~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~ 617 (776)
.........||+.|.+||++.+ .....++|||++|+++++.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0011233578999999999998 5578899999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 618 KSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 618 ~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
......++.|.+.. .-||. .....+..+++++..+|..+|.+|.++
T Consensus 1038 ~tpq~~f~ni~~~~-----~~~p~-----------------------------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRD-----IPWPE-----------------------------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cchhhhhhccccCC-----CCCCC-----------------------------CccccChhhhhhhhhhhccCchhccCc
Confidence 88877776665442 12332 223478899999999999999999988
Q ss_pred H---HHHcCcCcCCCCCCCCC
Q 004049 698 E---AALNHDWFREVPLPKSK 715 (776)
Q Consensus 698 ~---EIL~HPwf~~i~~pk~~ 715 (776)
. ++..|+||+.++|....
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred ccccccccCCccCCCCccccc
Confidence 7 99999999999886543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.1e-16 Score=158.04 Aligned_cols=133 Identities=22% Similarity=0.240 Sum_probs=99.8
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhccC------CccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG------FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~------~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.||+|+||.||+|.. ++..|++|+......... ....+.+|+.++..+.|+++.....++... ...++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 389999999999985 577899998654321110 113455799999999988765554444333 3568999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
||++|..+..+..... ..++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9998754433322211 17899999999999999999999999999999 799999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=177.02 Aligned_cols=205 Identities=23% Similarity=0.322 Sum_probs=154.9
Q ss_pred HHhCCCCCcceeeEEEeccCCCeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCc-ccCCCCCC
Q 004049 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV-LHRDLKTS 543 (776)
Q Consensus 466 L~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gI-vHrDLKPe 543 (776)
|+.+.|.|+.++++.+... ..+++|.+||. |.|.+.+......+++--...++++|+.||.|||.--| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578899999999999776 57899999998 67778777777789999999999999999999998766 99999999
Q ss_pred CeeecCCCcEEEeecccccccCC--CCCCccccccccccCCchhhccCCC------CCccchhhhHHHHHHHHHhCCCCC
Q 004049 544 NLLLNNRGELKICDFGLARQYGS--PLKPYTHLVVTLWYRAPELLLGSKQ------YSTAIDMWSLGCIMAELLSKEPLF 615 (776)
Q Consensus 544 NILLd~~g~iKL~DFGlA~~~~s--~~~~~~~~~GT~~Y~APEvl~g~~~------ys~~sDVWSLGvlLyELLtG~~PF 615 (776)
|+++|....+||+|||+...... .........-...|.|||++.+... .+.+.||||||+++||+++..-||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999876532 1111122233567999999976311 466799999999999999999999
Q ss_pred CCCCh----HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 004049 616 NGKSE----FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691 (776)
Q Consensus 616 ~~~s~----~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP 691 (776)
..... .+.+..+.+. ....+.|.+... ..+.+++..++..|+..+|
T Consensus 159 ~~~~~~~~~~eii~~~~~~---~~~~~rP~i~~~---------------------------~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKG---GSNPFRPSIELL---------------------------NELPPELLLLVARCWEEIP 208 (484)
T ss_pred ccccccCChHHHHHHHHhc---CCCCcCcchhhh---------------------------hhcchHHHHHHHHhcccCh
Confidence 76322 2344444331 111122221100 0244578899999999999
Q ss_pred CCCCCHHHHHc
Q 004049 692 DKRITAEAALN 702 (776)
Q Consensus 692 ~kRpTa~EIL~ 702 (776)
.+||+++++-.
T Consensus 209 ~~rPs~~~i~~ 219 (484)
T KOG1023|consen 209 EKRPSIEQIRS 219 (484)
T ss_pred hhCccHHHHHh
Confidence 99999988753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.9e-16 Score=176.95 Aligned_cols=254 Identities=22% Similarity=0.225 Sum_probs=199.7
Q ss_pred CCeeEEeeeec--CCceEEEEEEE--CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDE--GTYGVVYRARD--KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~--GsfG~Vyla~~--k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~ 487 (776)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+...........-++|+.-.+.+. |+|.++.+..+ ...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCC
Confidence 34677788999 99999999998 889999999985443332333344557777777775 99999988887 4455
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHH----HhhhhccCCcccCCCCCCCeeecCC-CcEEEeeccccc
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE----GIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLAR 562 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~----aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~ 562 (776)
.+|+-+|+|...+..+.......++...++.++.+... ||.++|+.+|+|-|+||+||++..+ ...+++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 88999999999998888888878999999999999999 9999999999999999999999999 889999999998
Q ss_pred ccCCCCCCccc-----cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCC
Q 004049 563 QYGSPLKPYTH-----LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK--SEFDQLDKIFKTLGTPN 635 (776)
Q Consensus 563 ~~~s~~~~~~~-----~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~--s~~~~l~kI~~~lg~p~ 635 (776)
.+....-.... ..|...|++||++.+ -++...|+|+||.++.+..++..++... +.|.++..++ .|.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----ip~ 345 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----IPL 345 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----Cch
Confidence 88654322222 256788999999986 5799999999999999998887666443 3333322211 000
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
. .-...+.++...+.+||..+|-.|++++.+++|+++..
T Consensus 346 -------------------------------e---~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 -------------------------------E---FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -------------------------------h---hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0 01124556666899999999999999999999999875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=177.77 Aligned_cols=139 Identities=19% Similarity=0.133 Sum_probs=104.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------CCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..|...+.||+|+||+||++.+... .+++|+........ .....+.+|+.++..++|++|+.++.++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 4456789999999999999987533 44444432211110 1123466899999999999998877666443
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...++||||++|..+..+.. ....++.+|+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 35689999998744333222 357799999999999999999999999999999 5789999999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=142.13 Aligned_cols=132 Identities=23% Similarity=0.241 Sum_probs=107.7
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC--CCcceeeEEEeccCCCeeEEEee
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH--PSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PnIV~l~~~~~~~~~~~l~LVmE 494 (776)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| .++++++.++.. .+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 45789999999999998753 6899998865432 3456789999999976 588888887743 357899999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC---CcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN---WVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~---gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
|+.|..+..+ +......++.+++.+|.+||.. +|+|+||+|.|||++..+.++|+|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9987543322 5566778899999999999984 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=150.48 Aligned_cols=137 Identities=19% Similarity=0.223 Sum_probs=100.4
Q ss_pred eeee-cCCceEEEEEEECCCCcEEEEEEeecchh-----c------cCCccchHHHHHHHHhCCCCCc--ceeeEEEecc
Q 004049 419 NKID-EGTYGVVYRARDKKTGEIVALKKVKMEKE-----R------EGFPLTSLREINILLSFHHPSI--VDVKEVVVGS 484 (776)
Q Consensus 419 ~~LG-~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-----~------~~~~~~~~rEi~iL~~L~HPnI--V~l~~~~~~~ 484 (776)
..|| .|+.|+||.+... +..++||.+..... . ......+.+|+.++..|.|++| +.++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8888889888764 67899998854211 1 0112345789999999998875 5666654332
Q ss_pred CCC--eeEEEeeehhh--hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccc
Q 004049 485 NLD--SIFMVMEYMEH--DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560 (776)
Q Consensus 485 ~~~--~l~LVmEy~~g--~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGl 560 (776)
... ..+|||||++| ++..++.. ..+++. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 211 23599999996 44444432 346654 367899999999999999999999999999999999999998
Q ss_pred ccc
Q 004049 561 ARQ 563 (776)
Q Consensus 561 A~~ 563 (776)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-13 Score=155.45 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=188.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC-CCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK-KTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k-~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~ 488 (776)
-+.+|.++..||.|.|+.|+.+..+ .++..|++|.+.............+.|+.+...+. |.+++.+...| ....+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW--SQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc--ccccc
Confidence 3578999999999999999998765 67889999988655444333344567777777764 88888877666 23446
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~~s~ 567 (776)
.|+-.|||.+....+.......+.+...+.+..|++.+|.++|++.++|+|+||+||++..+ +..++.|||+.+.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 78999999876655555556679999999999999999999999999999999999999986 78999999998753211
Q ss_pred CCCccccccccccC-CchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYR-APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~-APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
...+..+-+++ ..|++.....+..++|+++||..+++.+++.+.-.....+. .|+.+
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~---------------- 478 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG---------------- 478 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc----------------
Confidence 12233444556 36777666778999999999999999999876543322111 11111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
.....+.....+..+.+.++..++..|+.+.++..|.=|-
T Consensus 479 ---------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 ---------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0111122446778899999999999999999999887664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.7e-12 Score=145.37 Aligned_cols=184 Identities=20% Similarity=0.346 Sum_probs=134.0
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|.+ ....-++.+..-.|..+.++.+|.|..++.... .......+-++-|+.|+||||+++++.+.. ..++|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEee
Confidence 444 334444444333567788899999998876554 233446678999999999999999999844 458999999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
.+.. +...+.. +....+...+.||+.||.||| ..+++|++|.-..|+|+..|..||++|-++............
T Consensus 90 rV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~ 164 (690)
T KOG1243|consen 90 RVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS 164 (690)
T ss_pred cccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence 9874 1122222 336778889999999999997 677999999999999999999999999998755332211111
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG 611 (776)
..---.|..|+.+... ....|.|-|||++++++.|
T Consensus 165 ~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 2222336777765432 2568999999999999988
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.5e-12 Score=129.96 Aligned_cols=140 Identities=20% Similarity=0.208 Sum_probs=100.4
Q ss_pred eeeecCCceEEEEEEECC------CCcEEEEEEeecchh-----------ccCC---------ccch----HHHHHHHHh
Q 004049 419 NKIDEGTYGVVYRARDKK------TGEIVALKKVKMEKE-----------REGF---------PLTS----LREINILLS 468 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~------tg~~VAIK~i~~~~~-----------~~~~---------~~~~----~rEi~iL~~ 468 (776)
..||.|.-+.||.|.... .+..+|||+.+.... ...+ ...+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997643 357899999864321 0000 0111 268999998
Q ss_pred CCC--CCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhh-ccCCcccCCCCCCCe
Q 004049 469 FHH--PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL-HDNWVLHRDLKTSNL 545 (776)
Q Consensus 469 L~H--PnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL-Hs~gIvHrDLKPeNI 545 (776)
|.. -++..++.+. .-+|||||+.++.+....-....+++.++..++.+++.+|.+| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 863 4555555542 2389999998742211111123466677888899999999999 899999999999999
Q ss_pred eecCCCcEEEeecccccccC
Q 004049 546 LLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 546 LLd~~g~iKL~DFGlA~~~~ 565 (776)
|++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.8e-12 Score=122.25 Aligned_cols=128 Identities=16% Similarity=0.146 Sum_probs=94.7
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCCeeEEEeeeh
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~~l~LVmEy~ 496 (776)
++.|+.|.++.||++... +..|++|+...... ......+|+.+++.+.+.+++ +++.+. . ..-++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEec
Confidence 467899999999999864 77899998754321 123456899999998765554 344433 2 2348999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCc-----ccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWV-----LHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gI-----vHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
+|..+... ......++.+|+.+|..||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98433221 01124567899999999999885 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-12 Score=150.83 Aligned_cols=144 Identities=20% Similarity=0.267 Sum_probs=97.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---------------------c-----------CCc----
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---------------------E-----------GFP---- 456 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---------------------~-----------~~~---- 456 (776)
..|+. +.||.|++|.||+|+.+.+|+.||||++...... . ...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7999999999999999888999999999743210 0 001
Q ss_pred --cchHHHHHHHHhCC----CCCcceeeEEEeccCCCeeEEEeeehhhhhhhHH---hhcc---CCCCHHHHHHHHHHHH
Q 004049 457 --LTSLREINILLSFH----HPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLM---ETMK---QPFSQSEVKCLMLQLL 524 (776)
Q Consensus 457 --~~~~rEi~iL~~L~----HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l---~~~~---~~Lse~~~~~i~~qIl 524 (776)
..+.+|+..+.++. +.+.+.+-.+|.+- ....+|||||+.|.-...+ ...+ ..+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 12334444444442 34444444444221 2345899999998543322 2211 1355666677777776
Q ss_pred HHhhhhccCCcccCCCCCCCeeecCCC----cEEEeecccccccC
Q 004049 525 EGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLARQYG 565 (776)
Q Consensus 525 ~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA~~~~ 565 (776)
..|++|+|+||.|||++.+| .++++|||++..+.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 48999999999999999988 99999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.4e-13 Score=141.04 Aligned_cols=243 Identities=20% Similarity=0.223 Sum_probs=157.8
Q ss_pred eEEEEEEECCCCcEEEEEEeecchhccC--CccchHHHHHHHHhCCCCCcceeeEEEecc---CCCeeEEEeeehh-hhh
Q 004049 427 GVVYRARDKKTGEIVALKKVKMEKEREG--FPLTSLREINILLSFHHPSIVDVKEVVVGS---NLDSIFMVMEYME-HDL 500 (776)
Q Consensus 427 G~Vyla~~k~tg~~VAIK~i~~~~~~~~--~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~---~~~~l~LVmEy~~-g~L 500 (776)
-.||++.+...|..|+.-.+.......- ...+...-...|.++-|.|||+++.|+.+. +...+.++.||+. |.+
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 3578888888887776444432211110 011111234446667799999999998543 2345789999998 555
Q ss_pred hhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeecccccccCC----CCCCc
Q 004049 501 KGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLARQYGS----PLKPY 571 (776)
Q Consensus 501 l~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s----~~~~~ 571 (776)
..++... ...+.....++|+-||+.||.|||+.. |+|+.+...-|++..+|-||+.---......+ .....
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence 5555433 346889999999999999999999876 99999999999999999888753211111000 00001
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL-FNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P-F~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+-++|.+||.=.. ...+.++|||+||+...+|..+..- -.+.+....-..|.+....
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~----------------- 301 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG----------------- 301 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-----------------
Confidence 11234678999996544 3456799999999999999877643 2332222221112111000
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
. -.+.-.++|.+||+-.|+.||++.++|-||.+-+++
T Consensus 302 --------------------l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 302 --------------------L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred --------------------c---cCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 0 111224789999999999999999999999887765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-11 Score=140.38 Aligned_cols=142 Identities=20% Similarity=0.221 Sum_probs=93.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhcc---------------------C-----------------CccchH
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE---------------------G-----------------FPLTSL 460 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~---------------------~-----------------~~~~~~ 460 (776)
+.||.|++|.||+|+.+ +|+.||||+........ . ....+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999875 78999999986431000 0 001233
Q ss_pred HHHHHHHhC----CCCCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhh-ccCCCCHHHHHHHHHHHHH-HhhhhccCC
Q 004049 461 REINILLSF----HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMET-MKQPFSQSEVKCLMLQLLE-GIKYLHDNW 534 (776)
Q Consensus 461 rEi~iL~~L----~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~-~~~~Lse~~~~~i~~qIl~-aL~yLHs~g 534 (776)
+|...+.++ .|.+-+.+-.+|..- ....+|||||+.|..+..+.. ....++ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555554 233333333333221 234589999999854433322 111222 3445566655 478889999
Q ss_pred cccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 535 IvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
++|+|+||.|||++.++.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-09 Score=120.30 Aligned_cols=213 Identities=15% Similarity=0.185 Sum_probs=154.6
Q ss_pred ceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc--CCCeeEEEeeehhh--hhh
Q 004049 426 YGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEH--DLK 501 (776)
Q Consensus 426 fG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~--~~~~l~LVmEy~~g--~Ll 501 (776)
-.+.|++....+|..|++|.+...... .......-+++++++.|+|||++.++|.+. ....++||++|+++ +|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 367899999999999999999443322 122334568899999999999999998632 23468999999985 566
Q ss_pred hHHhhc--------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 502 GLMETM--------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 502 ~~l~~~--------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+++-.. +...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..|+|...|+...+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 654321 234789999999999999999999999999999999999999888998887776655332
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHH-HHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF-NGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF-~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~l 645 (776)
. . +-+.. -.+-|.=.||.+|+.|.||..-- ........ +..|.
T Consensus 447 ~------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~----------------- 491 (655)
T KOG3741|consen 447 P------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT----------------- 491 (655)
T ss_pred C------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------------
Confidence 1 0 22222 23568889999999999996431 11111111 22221
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...|.++.++|.-+...++.. -++.++|.|
T Consensus 492 ---------------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 ---------------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 126788888998888888876 677777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=111.24 Aligned_cols=143 Identities=18% Similarity=0.227 Sum_probs=103.0
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC--CcceeeEEEeccC-CCeeEEEee
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP--SIVDVKEVVVGSN-LDSIFMVME 494 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--nIV~l~~~~~~~~-~~~l~LVmE 494 (776)
++.|+.|.++.||++.... |..|++|+....... .....+.+|+.++..+.+. ++.+++.+..... .+..++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3678999999999998743 678999987543321 1344677899999999763 4566666653211 125689999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc------------------------------------------
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD------------------------------------------ 532 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs------------------------------------------ 532 (776)
|++|..+...... ..+++.+...++.+|+.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998543332211 356777777788888888888873
Q ss_pred --------------CCcccCCCCCCCeeecC--CCcEEEeecccccc
Q 004049 533 --------------NWVLHRDLKTSNLLLNN--RGELKICDFGLARQ 563 (776)
Q Consensus 533 --------------~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~ 563 (776)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=108.61 Aligned_cols=143 Identities=25% Similarity=0.309 Sum_probs=103.9
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecch------hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK------EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~------~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+..|-+|+-+.|+++.+ .|+.+.||.-.... ...-.....++|+.+|.++.--.|.-..-+|.+.. .-+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCe
Confidence 678899999999999976 48888888543221 11112234568999998886545544444554443 337
Q ss_pred EEeeehhh--hhhhHHhhccCCCCHHHH-HHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEeecccccc
Q 004049 491 MVMEYMEH--DLKGLMETMKQPFSQSEV-KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICDFGLARQ 563 (776)
Q Consensus 491 LVmEy~~g--~Ll~~l~~~~~~Lse~~~-~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~~ 563 (776)
|+|||+.| .+.+++......-.+++. ..+++.|-..|.-||..+|||+||..+||||..++ .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 88999998 666666654433333343 78999999999999999999999999999998665 358999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.3e-09 Score=107.29 Aligned_cols=133 Identities=23% Similarity=0.246 Sum_probs=92.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccC-----CccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REG-----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~-----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|++|+-+.+|.+.+. |..+++|.=..... ... ......+|..+|..+.--.|...+-++++. +...|+
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEEE
Confidence 35789999999999764 44566665322211 111 112345799999888654444333333333 356899
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
|||++|.++....... ...++..|-.-+.-||..||||+||.+.||++...+ +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999997766433322 256788888888999999999999999999998754 99999999974
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9e-10 Score=127.29 Aligned_cols=157 Identities=24% Similarity=0.369 Sum_probs=116.0
Q ss_pred HHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC----Cc-----cccccccccCCchhhccCCCC
Q 004049 523 LLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK----PY-----THLVVTLWYRAPELLLGSKQY 592 (776)
Q Consensus 523 Il~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~----~~-----~~~~GT~~Y~APEvl~g~~~y 592 (776)
++.||.|+|. .++||+.|.|++|.++..+..||+.|+++.....+.. .+ ....-...|.|||++.+ ...
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccc
Confidence 3389999995 5799999999999999999999999998865533111 01 11223567999999988 567
Q ss_pred CccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCC
Q 004049 593 STAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTG 671 (776)
Q Consensus 593 s~~sDVWSLGvlLyELL-tG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~ 671 (776)
+.++|+|||||++|.+. .|+..|.+.+.......-. .......+..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------------------------------~~~~~~~~~~ 233 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------------------------------NLLNAGAFGY 233 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------------------------------cccccccccc
Confidence 89999999999999999 5666665543222211111 1111112233
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 672 SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 672 ~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
...++.++++-|.++|..++..||++.+++.-|||+....+.
T Consensus 234 s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 234 SNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA 275 (700)
T ss_pred cccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence 356889999999999999999999999999999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-08 Score=102.92 Aligned_cols=128 Identities=27% Similarity=0.310 Sum_probs=83.5
Q ss_pred EEEEEEECCCCcEEEEEEeecchh-----------ccC--------Cc-----cchHHHHHHHHhCCCC--CcceeeEEE
Q 004049 428 VVYRARDKKTGEIVALKKVKMEKE-----------REG--------FP-----LTSLREINILLSFHHP--SIVDVKEVV 481 (776)
Q Consensus 428 ~Vyla~~k~tg~~VAIK~i~~~~~-----------~~~--------~~-----~~~~rEi~iL~~L~HP--nIV~l~~~~ 481 (776)
.||.|.. ..|..+|||+.+.... ... .. ....+|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899977 4678999999865310 000 00 1124699999999865 455565443
Q ss_pred eccCCCeeEEEeeehh--hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhh-hccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 482 VGSNLDSIFMVMEYME--HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY-LHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 482 ~~~~~~~l~LVmEy~~--g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~y-LHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
.+ +|||||++ |..+..+.... ++..+...++.+++..+.. +|..||||+||.+.|||++.+ .+.|+||
T Consensus 80 --~~----~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --RN----VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --TT----EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred --CC----EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 32 79999999 75554444322 2245667788888886555 579999999999999999987 9999999
Q ss_pred ccccccC
Q 004049 559 GLARQYG 565 (776)
Q Consensus 559 GlA~~~~ 565 (776)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=4e-08 Score=105.13 Aligned_cols=134 Identities=18% Similarity=0.170 Sum_probs=91.6
Q ss_pred EEEEEEECCCCcEEEEEEeecchhcc--------CCc-cchHHHHHHHHhCCCCCcc--eeeEEEeccC---CCeeEEEe
Q 004049 428 VVYRARDKKTGEIVALKKVKMEKERE--------GFP-LTSLREINILLSFHHPSIV--DVKEVVVGSN---LDSIFMVM 493 (776)
Q Consensus 428 ~Vyla~~k~tg~~VAIK~i~~~~~~~--------~~~-~~~~rEi~iL~~L~HPnIV--~l~~~~~~~~---~~~l~LVm 493 (776)
.|+++.. .|+.|.||......... ... ..+.+|...+..|..-+|. .++.+..... ...-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 4556544 46789999764322110 011 1366888888877533333 3333432211 23468999
Q ss_pred eehhh--hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-------CCcEEEeecccccc
Q 004049 494 EYMEH--DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-------RGELKICDFGLARQ 563 (776)
Q Consensus 494 Ey~~g--~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-------~g~iKL~DFGlA~~ 563 (776)
|++++ ++.+++... ....+......++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99998 455555432 345677788899999999999999999999999999999985 46799999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.9e-07 Score=98.13 Aligned_cols=192 Identities=12% Similarity=0.099 Sum_probs=127.9
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcce----eeEEEeccCCCe-eEE
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVD----VKEVVVGSNLDS-IFM 491 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~----l~~~~~~~~~~~-l~L 491 (776)
.+.||+|+-+.+|-.-.- +. .+.|++...... ...+-+..|... .||-+-. ......+.+... +-+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa-----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA-----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCch-----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 367899999999976432 22 345766433211 111222333332 3553322 111122333333 678
Q ss_pred Eeeehhhh--hhhHHhh--c---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 492 VMEYMEHD--LKGLMET--M---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 492 VmEy~~g~--Ll~~l~~--~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
+|..+.|- ...++.- . ...+.++-+..+++.|+.+.+.||..|.+-+|+.++|||+.+++.+.|.|=......
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888862 2222221 1 123788999999999999999999999999999999999999999999986544332
Q ss_pred CCCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhC-CCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSK-EPLFNGK 618 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~ 618 (776)
.+...+...+|...|.+||...- ...-+...|.|.||++|++||.| +.||.+-
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 33445556789999999997651 12235678999999999999886 9999774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-07 Score=95.91 Aligned_cols=107 Identities=21% Similarity=0.256 Sum_probs=79.4
Q ss_pred cchHHHHHHHHhCCCCC--cceeeEEEeccC--CCeeEEEeeehhh--hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhh
Q 004049 457 LTSLREINILLSFHHPS--IVDVKEVVVGSN--LDSIFMVMEYMEH--DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530 (776)
Q Consensus 457 ~~~~rEi~iL~~L~HPn--IV~l~~~~~~~~--~~~l~LVmEy~~g--~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL 530 (776)
....+|...+..|..-. +..++++..... ....+||+|++++ +|..++..... ++......++.+|+..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 34667888877775332 333444432211 1345899999997 45555554322 77788899999999999999
Q ss_pred ccCCcccCCCCCCCeeecCCC---cEEEeeccccccc
Q 004049 531 HDNWVLHRDLKTSNLLLNNRG---ELKICDFGLARQY 564 (776)
Q Consensus 531 Hs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~~~ 564 (776)
|..||+|+||++.|||++.++ .+.|+||+.+...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.9e-07 Score=95.55 Aligned_cols=139 Identities=22% Similarity=0.233 Sum_probs=98.8
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecch----------hc----cC------CccchHHHHHHHHhCCCC--
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK----------ER----EG------FPLTSLREINILLSFHHP-- 472 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~----------~~----~~------~~~~~~rEi~iL~~L~HP-- 472 (776)
+.+...||-|.-+.||.|.+. .|..+|||.-..-. .. .. ......+|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345688999999999999875 78999999754311 00 00 112345799999999754
Q ss_pred CcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 473 nIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
.+...+++- .-.+||||++|-.+..+. ++...+..++..|+.-+..+-..||||+|+.+-|||++.+|.
T Consensus 172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAWN------RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCccccc------cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 566665542 348999999994433222 234445556666666666666889999999999999999999
Q ss_pred EEEeecccccccC
Q 004049 553 LKICDFGLARQYG 565 (776)
Q Consensus 553 iKL~DFGlA~~~~ 565 (776)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998765543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=88.90 Aligned_cols=140 Identities=12% Similarity=0.106 Sum_probs=99.6
Q ss_pred ecCCceEEEEEEECCCCcEEEEEEeecchhc----cCCccchHHHHHHHHhCCCCC--cceeeEEEe--ccCCCeeEEEe
Q 004049 422 DEGTYGVVYRARDKKTGEIVALKKVKMEKER----EGFPLTSLREINILLSFHHPS--IVDVKEVVV--GSNLDSIFMVM 493 (776)
Q Consensus 422 G~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~~--~~~~~~l~LVm 493 (776)
|+|+.+.|+..... |+.|-+|.-...... ..-...+.+|+..|..|..-+ +.++...-. ....-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 67999999998654 346888876422111 223456789999999886433 333331111 11223468999
Q ss_pred eehhh--hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc--EEEeecccccc
Q 004049 494 EYMEH--DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--LKICDFGLARQ 563 (776)
Q Consensus 494 Ey~~g--~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~--iKL~DFGlA~~ 563 (776)
|-+.| +|..++... -.+.+..+...++.+|+.+|.-||..|+.|+|+-+.|||++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98885 566655442 235678888899999999999999999999999999999987777 99999986653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.7e-06 Score=90.68 Aligned_cols=141 Identities=22% Similarity=0.220 Sum_probs=97.6
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC----------------c-cc-----hHHHHHHHHhCC--CCC
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF----------------P-LT-----SLREINILLSFH--HPS 473 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~----------------~-~~-----~~rEi~iL~~L~--HPn 473 (776)
..+|..|.-++||+|.. .++..||+|+++........ . .. ..+|+.-|+++. +=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788899999999965 56889999999754311100 0 00 124666777764 334
Q ss_pred cceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCc
Q 004049 474 IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 474 IV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~ 552 (776)
+.+.+.++ .+ .|||||++....-.-.-..-++...++..+..+++..+.-|-. .++||+||..=|||+. ++.
T Consensus 132 vP~Pi~~~--~n----VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFR--NN----VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeec--CC----eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 45555554 33 8999999854111111112234455788889999999888876 8999999999999999 889
Q ss_pred EEEeecccccccCC
Q 004049 553 LKICDFGLARQYGS 566 (776)
Q Consensus 553 iKL~DFGlA~~~~s 566 (776)
+.|+|||-|....+
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999999876643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.4e-07 Score=106.50 Aligned_cols=245 Identities=19% Similarity=0.167 Sum_probs=167.9
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC-cceeeEEEeccCCCeeEEEe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS-IVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn-IV~l~~~~~~~~~~~l~LVm 493 (776)
|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+ +..+...++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhh
Confidence 444566799999999999887666555 6666433 22335899999999999 54444444 4445788999
Q ss_pred eehhhh--hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 494 EYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 494 Ey~~g~--Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
+|+.++ .........-.|.+-+...+.+.-+.+|+|||+.-=+|+| |||..+ +..++.||+.+..+.... ..
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 999864 2222222222355666777888889999999998778998 887766 789999999998875433 44
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
.+..+|+.++|||+... ..+....|.|++|.--.+|.-|.+|-... +.....++.. ++..
T Consensus 388 ~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P---------------~~~~~~~g~~--p~s~-- 447 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSP---------------PAVLPMIGNG--PNSP-- 447 (829)
T ss_pred ccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCC---------------ccccCCCCCC--CCcc--
Confidence 56789999999999887 45888999999998777887777776541 0000000000 0000
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHH-HHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAG-FDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~-~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.+..+ .. .+... .++...||..-|..|++...++.|.+|..-++
T Consensus 448 -------~L~~~---~a------w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 448 -------MLTDK---SA------WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred -------ccchh---hh------cCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 00000 00 01111 15778899999999999999999999988665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.8e-06 Score=95.90 Aligned_cols=142 Identities=22% Similarity=0.277 Sum_probs=87.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchh--------------------ccC------------------CccchH
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--------------------REG------------------FPLTSL 460 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--------------------~~~------------------~~~~~~ 460 (776)
..|+.++-|.||+|+.+ +|+.||||+...... ... ....+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999986 499999999754210 000 001223
Q ss_pred HHHHHHHhCC-----CCCcceeeEEEeccCCCeeEEEeeehhhhhh-hHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC
Q 004049 461 REINILLSFH-----HPSIVDVKEVVVGSNLDSIFMVMEYMEHDLK-GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534 (776)
Q Consensus 461 rEi~iL~~L~-----HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll-~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g 534 (776)
+|...+.++. .|+| .+=.+|.. -...-+|+|||+.|--. +........++...+.....++.. ..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 4555555542 2333 23233321 11234899999998422 222122244554443333322221 1222378
Q ss_pred cccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 535 IvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
++|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=8.5e-06 Score=82.84 Aligned_cols=139 Identities=21% Similarity=0.272 Sum_probs=77.5
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC--CcceeeEEEec-cCCCeeEEEee
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP--SIVDVKEVVVG-SNLDSIFMVME 494 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--nIV~l~~~~~~-~~~~~l~LVmE 494 (776)
++.|+.|..+.||++.... ..+++|+.... .....+.+|+.+++.|... .+..++.+... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998764 48999987554 1123455788888887533 34556554322 22234689999
Q ss_pred ehhhhhhhH-----------------H---hhcc---CCCCHHH------HHHH---------------HHHHHH-Hhhh
Q 004049 495 YMEHDLKGL-----------------M---ETMK---QPFSQSE------VKCL---------------MLQLLE-GIKY 529 (776)
Q Consensus 495 y~~g~Ll~~-----------------l---~~~~---~~Lse~~------~~~i---------------~~qIl~-aL~y 529 (776)
|++|..... + .... .++.... ...+ ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998742222 0 0110 0111000 0000 111122 2233
Q ss_pred hc-------cCCcccCCCCCCCeeec-CCCcEEEeeccccc
Q 004049 530 LH-------DNWVLHRDLKTSNLLLN-NRGELKICDFGLAR 562 (776)
Q Consensus 530 LH-------s~gIvHrDLKPeNILLd-~~g~iKL~DFGlA~ 562 (776)
++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 34599999999999999 66777899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.3e-05 Score=83.17 Aligned_cols=141 Identities=21% Similarity=0.179 Sum_probs=88.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCcc------chHHHHHHHHhCCC---CCcceeeEEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPL------TSLREINILLSFHH---PSIVDVKEVV 481 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~------~~~rEi~iL~~L~H---PnIV~l~~~~ 481 (776)
-.+|.+++.+-......|.+..- +|..+++|......... .... ...+.+..+..+.. -.++.++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 36788888888888877877754 46789999875432111 0011 12344554444432 2333322222
Q ss_pred e---ccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 482 V---GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 482 ~---~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
. ..-....+|+|||++|-.+..+.. +++ .+...|+.+|.-||..|++|+|+.|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 1 111234568999999943322221 222 244667788999999999999999999999965 5999999
Q ss_pred ccccc
Q 004049 559 GLARQ 563 (776)
Q Consensus 559 GlA~~ 563 (776)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.1e-05 Score=98.31 Aligned_cols=202 Identities=19% Similarity=0.227 Sum_probs=135.9
Q ss_pred HHHHHHHhCCCCCcceeeEEEeccCCCe--eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccC
Q 004049 461 REINILLSFHHPSIVDVKEVVVGSNLDS--IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538 (776)
Q Consensus 461 rEi~iL~~L~HPnIV~l~~~~~~~~~~~--l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHr 538 (776)
.|+..+..+.|+|++.++.|-....... +.+..+||.......+.+.-..++...++.+..+++.||.|+|+....|.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v 310 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV 310 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence 4666778889999999988875433222 23344666654444455556678999999999999999999999865555
Q ss_pred CCCCC---CeeecCCCcEEEe--ecccccccCCCCCCccccccccccCCchhhccCCCCCcc--chhhhHHHHHHHHHhC
Q 004049 539 DLKTS---NLLLNNRGELKIC--DFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA--IDMWSLGCIMAELLSK 611 (776)
Q Consensus 539 DLKPe---NILLd~~g~iKL~--DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~--sDVWSLGvlLyELLtG 611 (776)
-|... +..++..+...++ ||+.+..+........ ...+..+.++|.... ..+..+ .|+|.+|.++..+..|
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcccchh-hcCcccccccccccc-ccchhhhhhHHHHHHHHHhhhhhc
Confidence 44444 3334455666666 9998877654433322 344566778887765 334443 6999999999999887
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 004049 612 EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691 (776)
Q Consensus 612 ~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP 691 (776)
..+-... .....++. . .......+++.+|+.-++
T Consensus 389 ~~i~~~~---~~~~~~l~------------------------------------------~-~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 389 EDISEKS---AVPVSLLD------------------------------------------V-LSTSELLDALPKCLDEDS 422 (1351)
T ss_pred Ccccccc---cchhhhhc------------------------------------------c-ccchhhhhhhhhhcchhh
Confidence 6543111 00000000 0 011156789999999999
Q ss_pred CCCCCHHHHHcCcCcCCCC
Q 004049 692 DKRITAEAALNHDWFREVP 710 (776)
Q Consensus 692 ~kRpTa~EIL~HPwf~~i~ 710 (776)
++|+++.++|.|+|.+.-.
T Consensus 423 ~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhccchhhhhhchhccccc
Confidence 9999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.9e-05 Score=81.10 Aligned_cols=131 Identities=16% Similarity=0.124 Sum_probs=77.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc--ceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI--VDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI--V~l~~~~~~~~~~~l~LVmEy~ 496 (776)
..||.|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+++.+. .......+||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeec
Confidence 57899999999984 24457788875422 12345789999988864333 4455554 3344578899999
Q ss_pred hhhh-----h-----------hHHhh----c-c---CCCCHHH------------------HHHHHHHHHHHhhhhccCC
Q 004049 497 EHDL-----K-----------GLMET----M-K---QPFSQSE------------------VKCLMLQLLEGIKYLHDNW 534 (776)
Q Consensus 497 ~g~L-----l-----------~~l~~----~-~---~~Lse~~------------------~~~i~~qIl~aL~yLHs~g 534 (776)
.|.. . ..+.. . . ....... .+..+...+..+.. ...
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~--~~~ 154 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD--TST 154 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC--CCc
Confidence 9841 0 00000 0 0 0111111 11111111111100 123
Q ss_pred cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 535 VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 535 IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=6e-05 Score=87.52 Aligned_cols=138 Identities=21% Similarity=0.201 Sum_probs=89.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc-----------------------------------cCCccchHHHH
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-----------------------------------EGFPLTSLREI 463 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-----------------------------------~~~~~~~~rEi 463 (776)
+.||.-+.|.||+|+.+. |+.||||+-+..... -.....+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999876 999999986532100 00112233444
Q ss_pred HHH----HhCCCCC------cceeeEEEeccCCCeeEEEeeehhhh---hhhHHhhccCCCCHHHHHHHHHHHHHHhhhh
Q 004049 464 NIL----LSFHHPS------IVDVKEVVVGSNLDSIFMVMEYMEHD---LKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530 (776)
Q Consensus 464 ~iL----~~L~HPn------IV~l~~~~~~~~~~~l~LVmEy~~g~---Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL 530 (776)
+-. +.+.|-+ |.++|..+ ...-+|+||||.|- .++.+.. ..++...+...+.++..-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIF- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHH-
Confidence 433 3334555 44444333 22458999999983 2333333 346766665555554433333
Q ss_pred ccCCcccCCCCCCCeeecC----CCcEEEeecccccccC
Q 004049 531 HDNWVLHRDLKTSNLLLNN----RGELKICDFGLARQYG 565 (776)
Q Consensus 531 Hs~gIvHrDLKPeNILLd~----~g~iKL~DFGlA~~~~ 565 (776)
..|++|+|-+|.|||+.. ++.+.|-|||+...+.
T Consensus 319 -~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 -KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 357999999999999994 5689999999988664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=76.27 Aligned_cols=134 Identities=17% Similarity=0.166 Sum_probs=77.8
Q ss_pred eeecCCc-eEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 420 KIDEGTY-GVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 420 ~LG~Gsf-G~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
.|-.|.+ ..||++... +..+.||+..... .....+|+.+++.+. +--+.+++.+... .+..++||+|++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 3445555 889999653 3678888875432 234568999988885 3334456665532 245789999998
Q ss_pred hhhhhHHh--------------------hcc---CCCCHH------HHHHH-------------------HHHHHHHhhh
Q 004049 498 HDLKGLME--------------------TMK---QPFSQS------EVKCL-------------------MLQLLEGIKY 529 (776)
Q Consensus 498 g~Ll~~l~--------------------~~~---~~Lse~------~~~~i-------------------~~qIl~aL~y 529 (776)
|..+.... ... .++... ..... +.+++..|..
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 84322110 000 011100 00000 1112222211
Q ss_pred h----ccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 530 L----HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 530 L----Hs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
. ....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1 22348999999999999997778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00018 Score=88.63 Aligned_cols=82 Identities=18% Similarity=0.263 Sum_probs=54.5
Q ss_pred EEeeeecCCceEEEEEEECCCC--cEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCc--ceeeEEEecc-CCCeeE
Q 004049 417 RLNKIDEGTYGVVYRARDKKTG--EIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSI--VDVKEVVVGS-NLDSIF 490 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg--~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnI--V~l~~~~~~~-~~~~l~ 490 (776)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+. .....|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3578899999999998765432 46777776432211 11235678999999996 6665 5666665332 123578
Q ss_pred EEeeehhhh
Q 004049 491 MVMEYMEHD 499 (776)
Q Consensus 491 LVmEy~~g~ 499 (776)
+||||+.|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999984
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00012 Score=73.46 Aligned_cols=131 Identities=24% Similarity=0.238 Sum_probs=88.9
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
-+..+.|++|.+|.||++.++ |..+|+|+-..+.. ...+..|.++|..+.--++.+=+..| +. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~y-g~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFY-GE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEe-ch----hhhhhh
Confidence 345678999999999999886 56899998765433 34567899999998865554433222 22 256699
Q ss_pred ehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCC-CCCeeecCCCcEEEeeccccccc
Q 004049 495 YMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLK-TSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 495 y~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLK-PeNILLd~~g~iKL~DFGlA~~~ 564 (776)
|+.| .|....... + +.-+..++.+---|-..||-|..|. |..++|-.++.+.|+||..|+..
T Consensus 93 ~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998 333333211 1 3344555666555667899999886 55555555569999999999854
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0004 Score=71.36 Aligned_cols=129 Identities=23% Similarity=0.321 Sum_probs=88.2
Q ss_pred CCeeEEeeeecCCc-eEEEEEEECCCCcEEEEEEeec---chh-------c--c-------CCccchHHHHHHHHhC---
Q 004049 413 DEFERLNKIDEGTY-GVVYRARDKKTGEIVALKKVKM---EKE-------R--E-------GFPLTSLREINILLSF--- 469 (776)
Q Consensus 413 ~~yeil~~LG~Gsf-G~Vyla~~k~tg~~VAIK~i~~---~~~-------~--~-------~~~~~~~rEi~iL~~L--- 469 (776)
.+++.++.||.|.- |.||++... |+.||||++.. ... . . ....-+..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 999999874 77999999432 110 0 0 1112344565554444
Q ss_pred CCCCc--ceeeEEEeccC----------------CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc
Q 004049 470 HHPSI--VDVKEVVVGSN----------------LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531 (776)
Q Consensus 470 ~HPnI--V~l~~~~~~~~----------------~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH 531 (776)
.+.++ |++++|+.-.. .....||.||+.... .+. ..-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 56666 88888874221 112356788776532 223 234566777788999
Q ss_pred cCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 532 s~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
..||+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 4589999965
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.1e-05 Score=99.94 Aligned_cols=203 Identities=12% Similarity=-0.018 Sum_probs=136.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecch---hccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK---EREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.+.++++.--||-|.++.--.-+.+ -..+.+|+.+... ..+-.....+.|+.-++...|+++.....-.......
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~k--id~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSK--IDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhh--hceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 4566776655665554432221111 1235566554322 1111122334566666778899998877666555555
Q ss_pred eeEEEeeehhh-hhhhHHhhcc---CCCCHHHHHHHHHHHHHHhhhhccCC-----cccCCCCCCCeeecCCCcEEEeec
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK---QPFSQSEVKCLMLQLLEGIKYLHDNW-----VLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~---~~Lse~~~~~i~~qIl~aL~yLHs~g-----IvHrDLKPeNILLd~~g~iKL~DF 558 (776)
..|.+++|+.+ .+...+.+.- .++...-+.....+.+.+..-+|... .+|++||+.|.+|..+.++|+.+|
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 67899999985 4555554432 23444445555555588888877542 799999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFN 616 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~ 616 (776)
|+.+............++++.|+.|++... -.++.++|+|.+|+.+|.+..|.++|.
T Consensus 1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999954444444556778899999998876 457778999999999999999888873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00063 Score=70.49 Aligned_cols=72 Identities=13% Similarity=0.236 Sum_probs=46.5
Q ss_pred EeeeecCCceEEEEEEECC-CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc-ceeeEEEeccCCCeeEEEeee
Q 004049 418 LNKIDEGTYGVVYRARDKK-TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI-VDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI-V~l~~~~~~~~~~~l~LVmEy 495 (776)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+...++ .+++..+ .. .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEEe
Confidence 4678889899999997543 356788997653211 12233579999998864333 3443332 22 479999
Q ss_pred hhh
Q 004049 496 MEH 498 (776)
Q Consensus 496 ~~g 498 (776)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 887
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00036 Score=76.93 Aligned_cols=144 Identities=23% Similarity=0.258 Sum_probs=100.0
Q ss_pred eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-------------------CCcc---ch--HHHHHHHHhCCC
Q 004049 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-------------------GFPL---TS--LREINILLSFHH 471 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-------------------~~~~---~~--~rEi~iL~~L~H 471 (776)
++-.+|..|.-+.||.|.. .+|..+|||+++.....- .... .. ..|+.-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3456889999999999965 578889999987542110 0001 11 247777777765
Q ss_pred CCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhh-ccCCcccCCCCCCCeeecCC
Q 004049 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL-HDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 472 PnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL-Hs~gIvHrDLKPeNILLd~~ 550 (776)
-.|.-..-+..- .-+|||+|+..+-...-.-....|+...+..+-.|++.-+.-| |..++||.||.--|+|+..
T Consensus 226 aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 226 AGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD- 300 (520)
T ss_pred cCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-
Confidence 554333222221 2279999998643333333345688888999888888888777 5678999999999999875
Q ss_pred CcEEEeecccccccC
Q 004049 551 GELKICDFGLARQYG 565 (776)
Q Consensus 551 g~iKL~DFGlA~~~~ 565 (776)
|.+.|+|.+-+....
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 899999998776554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00043 Score=72.24 Aligned_cols=30 Identities=30% Similarity=0.396 Sum_probs=25.6
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999876556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00058 Score=69.49 Aligned_cols=97 Identities=22% Similarity=0.261 Sum_probs=77.5
Q ss_pred HHHHHHHhCCC-CCcceeeEEEeccCCCeeEEEeeehhh-hhhhH---HhhccCCCCHHHHHHHHHHHHHHhhhhcc---
Q 004049 461 REINILLSFHH-PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGL---METMKQPFSQSEVKCLMLQLLEGIKYLHD--- 532 (776)
Q Consensus 461 rEi~iL~~L~H-PnIV~l~~~~~~~~~~~l~LVmEy~~g-~Ll~~---l~~~~~~Lse~~~~~i~~qIl~aL~yLHs--- 532 (776)
.|.-+|+.|.+ +++.++++++ .. ++|.||... .+... +.+ -..-+|..+..|+.+|+..+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--GR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--CC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 58888999986 6999999998 32 778999985 33221 111 1236899999999999999999987
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
..+.-.|++++|+-|+.+|++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 44889999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0012 Score=69.84 Aligned_cols=133 Identities=20% Similarity=0.292 Sum_probs=75.6
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCCeeEEEeeehhh
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~~l~LVmEy~~g 498 (776)
.+..|-...+|+.. .++..+++|+....... ......+|..+++.+..-.++ +++.+. . -++||+|++|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccC
Confidence 35678888999886 34667888876433211 112356799999988643332 333332 2 2689999997
Q ss_pred hhhhH-----------H----h---hc---cCCCCHH-HHHHHHHHH---------HHHhhhhc--------cCCcccCC
Q 004049 499 DLKGL-----------M----E---TM---KQPFSQS-EVKCLMLQL---------LEGIKYLH--------DNWVLHRD 539 (776)
Q Consensus 499 ~Ll~~-----------l----~---~~---~~~Lse~-~~~~i~~qI---------l~aL~yLH--------s~gIvHrD 539 (776)
..... + . .. ..+++.. .+..+..++ ...+..+- ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 32210 0 0 00 1112221 122222111 11111111 12489999
Q ss_pred CCCCCeeecCCCcEEEeecccccc
Q 004049 540 LKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 540 LKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
+.|.|||++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0025 Score=65.50 Aligned_cols=128 Identities=18% Similarity=0.272 Sum_probs=86.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecch--------------hccCCccchHHHHHHHHhCC------CCCcceee
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--------------EREGFPLTSLREINILLSFH------HPSIVDVK 478 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HPnIV~l~ 478 (776)
..||+|+.=.||.-- .....+||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 568999999999853 34457899987655 11112344556777666665 78999999
Q ss_pred EEEeccCCCeeEEEeeehh---h----hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC
Q 004049 479 EVVVGSNLDSIFMVMEYME---H----DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG 551 (776)
Q Consensus 479 ~~~~~~~~~~l~LVmEy~~---g----~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g 551 (776)
++..+. ..+-+|+|.+. | +|..++. ...+++ +....+. .-..||-.++|+.+||+|.||++....
T Consensus 84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecC--CceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999554 46788888875 3 3444442 234665 4444444 445677788899999999999997532
Q ss_pred ----cEEEee
Q 004049 552 ----ELKICD 557 (776)
Q Consensus 552 ----~iKL~D 557 (776)
.+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0022 Score=68.91 Aligned_cols=141 Identities=13% Similarity=0.061 Sum_probs=80.4
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC--cceeeEEE----eccCCCe
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS--IVDVKEVV----VGSNLDS 488 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~----~~~~~~~ 488 (776)
..-++.|..|....+|++.. .+..+++|+.... ....+..|+.++..|.+-+ +.+++... .....+.
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 34467788888889999864 2346888987531 1234556888888775332 33433211 0011235
Q ss_pred eEEEeeehhhhhhh---------------HHhhccCCC----------CHHHH--H--------HHHHHHHHHhhhhcc-
Q 004049 489 IFMVMEYMEHDLKG---------------LMETMKQPF----------SQSEV--K--------CLMLQLLEGIKYLHD- 532 (776)
Q Consensus 489 l~LVmEy~~g~Ll~---------------~l~~~~~~L----------se~~~--~--------~i~~qIl~aL~yLHs- 532 (776)
.++||+|++|.... .+......+ .+... . .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 68999999873211 000000000 10000 0 011112233344332
Q ss_pred ------CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 ------NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ------~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.++||+|+.|.|||++.++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999997778899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0096 Score=67.50 Aligned_cols=77 Identities=19% Similarity=0.135 Sum_probs=51.0
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchh--cc---CCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCee
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--RE---GFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--~~---~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~l 489 (776)
.+.||.|.+..||++.....++.|+||.-..... .. ........|...|..+. -.++.+++.+- .+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 4679999999999999864445899998542211 11 12234556888888763 23566666553 2356
Q ss_pred EEEeeehhh
Q 004049 490 FMVMEYMEH 498 (776)
Q Consensus 490 ~LVmEy~~g 498 (776)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.004 Score=67.66 Aligned_cols=144 Identities=17% Similarity=0.141 Sum_probs=80.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC--cceeeEEE----eccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS--IVDVKEVV----VGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~----~~~~~ 486 (776)
+....++.|+.|....+|++.. .++ .+++|+..... .......|+.++..|.... +.+++... .....
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3445567788888889999864 334 57788765421 1223446777777774322 33333211 11123
Q ss_pred CeeEEEeeehhhhhh---------------hHHhhccCCCC--------HHH-----HH----------HHHHHHHHHhh
Q 004049 487 DSIFMVMEYMEHDLK---------------GLMETMKQPFS--------QSE-----VK----------CLMLQLLEGIK 528 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll---------------~~l~~~~~~Ls--------e~~-----~~----------~i~~qIl~aL~ 528 (776)
+..+++|+|++|... ..+......++ ... .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 457899999887211 00110001110 000 00 01112233444
Q ss_pred hhc-------cCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 529 YLH-------DNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 529 yLH-------s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
+|. ..++||+|+++.||+++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 443 3679999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.005 Score=66.53 Aligned_cols=72 Identities=17% Similarity=0.246 Sum_probs=45.5
Q ss_pred EeeeecCCceEEEEEEECC------CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc-ceeeEEEeccCCCeeE
Q 004049 418 LNKIDEGTYGVVYRARDKK------TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI-VDVKEVVVGSNLDSIF 490 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI-V~l~~~~~~~~~~~l~ 490 (776)
++.|..|-...||++.... .++.|++|+...... ......+|+.++..+....+ .+++.++ .. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIF--PN----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEe--CC----C
Confidence 4567777778899987543 257899998654321 22345688888888863333 3444444 22 3
Q ss_pred EEeeehhh
Q 004049 491 MVMEYMEH 498 (776)
Q Consensus 491 LVmEy~~g 498 (776)
+|++|++|
T Consensus 74 ~v~e~i~G 81 (302)
T cd05156 74 RIEEFIPS 81 (302)
T ss_pred chhheeCC
Confidence 57888876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00047 Score=74.98 Aligned_cols=138 Identities=17% Similarity=0.223 Sum_probs=94.0
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh---------------ccC-----CccchHHHHHHHHhCC-CCC
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE---------------REG-----FPLTSLREINILLSFH-HPS 473 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~---------------~~~-----~~~~~~rEi~iL~~L~-HPn 473 (776)
+.+.+.||-|.-+.||.+-+ ..|++.++|+-..-.. ... ......+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56778999999999999977 4688999996432110 000 0112346888888885 332
Q ss_pred -cceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 474 -IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 474 -IV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
+...+++ +.-|+|||++.|-.+..+.. ...+..+...|..-+--|-.+|+||+|..-=||+|+.++.
T Consensus 173 pVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2233332 24589999998732222211 1223456666667777888999999999999999999999
Q ss_pred EEEeecccccccC
Q 004049 553 LKICDFGLARQYG 565 (776)
Q Consensus 553 iKL~DFGlA~~~~ 565 (776)
++++||--.....
T Consensus 241 i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 241 IVVIDFPQMVSTS 253 (465)
T ss_pred EEEeechHhhccC
Confidence 9999997665443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.014 Score=63.60 Aligned_cols=78 Identities=15% Similarity=0.146 Sum_probs=52.4
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC---CCcceeeEEEecc-CCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH---PSIVDVKEVVVGS-NLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H---PnIV~l~~~~~~~-~~~~l~ 490 (776)
-.-.+.||.|..+.||..... ++ .+++|..+.. .....+..|...|+.|.- -.+.++++++... ..+..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 344578999999999998643 23 4667775321 112356789999998853 3567777765332 234579
Q ss_pred EEeeehhh
Q 004049 491 MVMEYMEH 498 (776)
Q Consensus 491 LVmEy~~g 498 (776)
||||++.|
T Consensus 90 LVmE~i~G 97 (297)
T PRK10593 90 LLLERLRG 97 (297)
T ss_pred EEEeccCC
Confidence 99999886
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.011 Score=64.29 Aligned_cols=30 Identities=30% Similarity=0.324 Sum_probs=26.0
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.++||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999976556899999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0044 Score=71.01 Aligned_cols=173 Identities=24% Similarity=0.330 Sum_probs=110.6
Q ss_pred chHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCccc
Q 004049 458 TSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLH 537 (776)
Q Consensus 458 ~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvH 537 (776)
.++-...+++.+.|+|..+++++-.+. .....+|||++.-++.+...... +-. .+++ .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~-------~s~~-------~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKD-------ESLL-------AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cch-------hhhc-------ccccce
Confidence 455677888999999999999887554 34689999999988887776543 110 0111 112222
Q ss_pred CCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 004049 538 RDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617 (776)
Q Consensus 538 rDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~ 617 (776)
-|| ++++| -++.. | |- ...+++|||++|.++.++..|...+..
T Consensus 91 -----~~~-------~~~td-~~~t~----------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFLTK----------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -----ehh-------hhccc-ccccc----------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 122 23333 11100 0 10 111499999999999999999998888
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 618 KSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 618 ~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
....+++..|.+....+.. ........ .+.. .++....+++.+|+...|..||..
T Consensus 134 ~~~s~~l~~i~k~~~~d~~------------~~~~a~e~--~~~~-----------~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQE------------LLSTAMEH--LIQL-----------LADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred HHHHHHHHHHHHhccCchh------------HHHHHHHH--HHHH-----------hhhHhHHHHhccCCccccccccch
Confidence 7777777777664322211 11111100 1000 155667789999999999999999
Q ss_pred HHHHcCcCcCCC
Q 004049 698 EAALNHDWFREV 709 (776)
Q Consensus 698 ~EIL~HPwf~~i 709 (776)
.++.+|+-|.++
T Consensus 189 ~~~~k~~i~~ev 200 (725)
T KOG1093|consen 189 MELSKRCSFTEV 200 (725)
T ss_pred hHHhcCccHHHH
Confidence 999999999876
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.022 Score=63.65 Aligned_cols=74 Identities=14% Similarity=0.113 Sum_probs=47.3
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecchhc-----cCCccchHHHHHHHHhCC--CC-CcceeeEEEeccCCCeeEE
Q 004049 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-----EGFPLTSLREINILLSFH--HP-SIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 420 ~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-----~~~~~~~~rEi~iL~~L~--HP-nIV~l~~~~~~~~~~~l~L 491 (776)
.||.|....||++.....++.|+||.-...... .-...+..-|...|+.+. -| .+.++|.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 579999999999997544468999976433221 222234456888887764 35 344444432 335579
Q ss_pred Eeeehh
Q 004049 492 VMEYME 497 (776)
Q Consensus 492 VmEy~~ 497 (776)
|||+++
T Consensus 78 vMEdL~ 83 (370)
T TIGR01767 78 VMEDLS 83 (370)
T ss_pred hHhhCc
Confidence 999985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.026 Score=62.78 Aligned_cols=138 Identities=11% Similarity=0.108 Sum_probs=78.9
Q ss_pred EEeeeecCCceEEEEEEECC----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCCeeEE
Q 004049 417 RLNKIDEGTYGVVYRARDKK----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLDSIFM 491 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~~l~L 491 (776)
-+..|-.|-.-.+|++.... .++.|++|+..... .......+|+.+++.+..-++. ++++.+ .+ ..
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~----g~ 110 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRF--PN----GR 110 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEE--CC----ce
Confidence 34566668888999987532 34679999875432 1223346799998888644433 445554 22 15
Q ss_pred EeeehhhhhhhH-----------H-------hhccC-----CCCHHHHHHHHHHHH--------------------HHhh
Q 004049 492 VMEYMEHDLKGL-----------M-------ETMKQ-----PFSQSEVKCLMLQLL--------------------EGIK 528 (776)
Q Consensus 492 VmEy~~g~Ll~~-----------l-------~~~~~-----~Lse~~~~~i~~qIl--------------------~aL~ 528 (776)
|.+|++|..+.. + ..... .....++..++.++. ..|.
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 788887622110 0 00010 111223333322211 1111
Q ss_pred -h----hccCCcccCCCCCCCeeecC-CCcEEEeecccccc
Q 004049 529 -Y----LHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQ 563 (776)
Q Consensus 529 -y----LHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~ 563 (776)
. .+...++|+||++.|||++. ++.+.|+||..|..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 22345899999999999986 46899999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.041 Score=60.81 Aligned_cols=137 Identities=16% Similarity=0.254 Sum_probs=76.7
Q ss_pred EeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCCeeEEEe
Q 004049 418 LNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~~l~LVm 493 (776)
++.|-.|-.-.+|++..... +..|++|+...... ......+|+.+++.+..-++. ++++++ .+ . +|.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~--G--~i~ 89 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF--GN--G--MIQ 89 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe--CC--c--Eee
Confidence 34555587788999865432 23788998754321 233445799999888754443 445444 22 1 478
Q ss_pred eehhhhhhh-----------HH-------hhccCC----C-CHHHHHHHHHHH-------------------------HH
Q 004049 494 EYMEHDLKG-----------LM-------ETMKQP----F-SQSEVKCLMLQL-------------------------LE 525 (776)
Q Consensus 494 Ey~~g~Ll~-----------~l-------~~~~~~----L-se~~~~~i~~qI-------------------------l~ 525 (776)
+|+.|..+. .+ .....+ + -...+..++.++ +.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 887763211 00 000100 1 122233332222 11
Q ss_pred Hhh-hhccCC----cccCCCCCCCeeecC-CCcEEEeecccccc
Q 004049 526 GIK-YLHDNW----VLHRDLKTSNLLLNN-RGELKICDFGLARQ 563 (776)
Q Consensus 526 aL~-yLHs~g----IvHrDLKPeNILLd~-~g~iKL~DFGlA~~ 563 (776)
.+. ++...+ ++|+||.+.|||++. ++.++|+||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 222222 799999999999975 57899999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.039 Score=60.75 Aligned_cols=31 Identities=23% Similarity=0.360 Sum_probs=28.0
Q ss_pred CcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 534 gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
.++|+|+.+.||||+..+-+=+.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999988999999998743
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.029 Score=60.48 Aligned_cols=30 Identities=20% Similarity=0.419 Sum_probs=25.3
Q ss_pred CcccCCCCCCCeeecCCCc-EEEeecccccc
Q 004049 534 WVLHRDLKTSNLLLNNRGE-LKICDFGLARQ 563 (776)
Q Consensus 534 gIvHrDLKPeNILLd~~g~-iKL~DFGlA~~ 563 (776)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.12 Score=58.82 Aligned_cols=76 Identities=14% Similarity=0.164 Sum_probs=50.0
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchh--cc---CCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCe
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--RE---GFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--~~---~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~ 488 (776)
..+.||.|....||+.... +..|+||.-..... .. ........|...|+.+. ..++.+++.+. + +.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CC
Confidence 3578999999999999863 45688997653221 11 12334455777776664 23677777766 3 34
Q ss_pred eEEEeeehhh
Q 004049 489 IFMVMEYMEH 498 (776)
Q Consensus 489 l~LVmEy~~g 498 (776)
-+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5889999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.084 Score=59.81 Aligned_cols=77 Identities=18% Similarity=0.144 Sum_probs=49.5
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccC---CccchHHHHHHHHhCC--CCC-cceeeEEEeccCCCeeE
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REG---FPLTSLREINILLSFH--HPS-IVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~---~~~~~~rEi~iL~~L~--HPn-IV~l~~~~~~~~~~~l~ 490 (776)
++.||.|.-..||++.+...++.|+||.-..... ... ...+..-|..+|+.+. -|. +.++|.+- .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhh
Confidence 6789999999999998854456799997643221 111 2233456888888764 454 44454432 33557
Q ss_pred EEeeehhh
Q 004049 491 MVMEYMEH 498 (776)
Q Consensus 491 LVmEy~~g 498 (776)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89998863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.16 Score=57.47 Aligned_cols=74 Identities=18% Similarity=0.266 Sum_probs=43.8
Q ss_pred EEeeeecCCceEEEEEEECCC-CcE-----EEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCCee
Q 004049 417 RLNKIDEGTYGVVYRARDKKT-GEI-----VALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLDSI 489 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~t-g~~-----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~~l 489 (776)
.++.|..|-...+|++..... +.. |.+++.. ..........+|+.+++.|...++. ++++.+ .+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~~---- 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--GD---- 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEec--CC----
Confidence 345666688899999975432 122 3333321 1112223345799999999755444 455555 22
Q ss_pred EEEeeehhhh
Q 004049 490 FMVMEYMEHD 499 (776)
Q Consensus 490 ~LVmEy~~g~ 499 (776)
++|.||++|.
T Consensus 125 g~l~efIeGr 134 (383)
T PTZ00384 125 FTIQEWVEGN 134 (383)
T ss_pred EEEEEEeccc
Confidence 6889999873
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.29 Score=53.28 Aligned_cols=75 Identities=16% Similarity=0.130 Sum_probs=44.8
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCeeEE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~l~L 491 (776)
-+..+.|+.|....+|+.. .++..+.||+-... ....+..|..-|+.|. --.+.+++.+.... +.-||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceE
Confidence 4456789999999999986 56788999987521 1234567888888884 33466677766433 34599
Q ss_pred Eeeehhh
Q 004049 492 VMEYMEH 498 (776)
Q Consensus 492 VmEy~~g 498 (776)
||||++.
T Consensus 90 lle~l~~ 96 (288)
T PF03881_consen 90 LLEFLEM 96 (288)
T ss_dssp EEE----
T ss_pred EEEeecC
Confidence 9999874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.42 Score=55.15 Aligned_cols=74 Identities=15% Similarity=0.188 Sum_probs=46.3
Q ss_pred EEeeeecCCceEEEEEEECCC--------CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc-eeeEEEeccCCC
Q 004049 417 RLNKIDEGTYGVVYRARDKKT--------GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV-DVKEVVVGSNLD 487 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~t--------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV-~l~~~~~~~~~~ 487 (776)
.++.|..|-.-.+|++..... ++.|.+++.-.... ......+|..+++.+..-+|. ++++.+ .+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYNPISEFEVYKTMSKYRIAPQLLNTF--SG-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeCHHHHHHHHHHHHHCCCCCceEEEe--CC--
Confidence 567788888888999975422 46788888754321 122345688888877644443 344554 22
Q ss_pred eeEEEeeehhhh
Q 004049 488 SIFMVMEYMEHD 499 (776)
Q Consensus 488 ~l~LVmEy~~g~ 499 (776)
..|.+|++|.
T Consensus 182 --g~I~efi~g~ 191 (442)
T PTZ00296 182 --GRIEEWLYGD 191 (442)
T ss_pred --CEEEEeeCCc
Confidence 4568888763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.16 Score=56.56 Aligned_cols=73 Identities=16% Similarity=0.264 Sum_probs=55.3
Q ss_pred CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
..+.|++|++-.+.+.. + ..-...++..++.+-+..|.-|..+ -.-||+|...||||+ +|+|.|+||-+++.-
T Consensus 298 ~~y~yl~~kdhgt~is~-i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-I----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeee-e----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 45678888887654322 1 1235678888888887777666644 478999999999999 899999999999843
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.47 Score=60.26 Aligned_cols=31 Identities=29% Similarity=0.505 Sum_probs=26.4
Q ss_pred CCcccCCCCCCCeeecCCC--cEE-Eeecccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRG--ELK-ICDFGLARQ 563 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g--~iK-L~DFGlA~~ 563 (776)
.+|||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4699999999999999875 565 999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.25 E-value=0.19 Score=54.25 Aligned_cols=29 Identities=28% Similarity=0.461 Sum_probs=25.8
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999998 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.42 E-value=0.46 Score=49.87 Aligned_cols=84 Identities=17% Similarity=0.186 Sum_probs=57.5
Q ss_pred hHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc--CCcc
Q 004049 459 SLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD--NWVL 536 (776)
Q Consensus 459 ~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs--~gIv 536 (776)
+..+..++.+++ .|+++.. .+.-.+-+++|+|-.--. + . .-++..-+.+|.-.|+ .+.+
T Consensus 105 y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~---~-~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------N---F-SNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------c---h-hHHHHHhHHHHHHhhccCCCee
Confidence 356788888775 6777752 344456789999853100 0 0 1122222567788883 4599
Q ss_pred cCCCCCCCeeecCCCcEEEeecccc
Q 004049 537 HRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 537 HrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
|+|..|+||+-|..|.+||.|=+..
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999997754
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.49 E-value=0.23 Score=54.97 Aligned_cols=52 Identities=25% Similarity=0.254 Sum_probs=35.7
Q ss_pred HHHHHHHHHHHHHHhhhh---c-cCCcccCCCCCCCeeecCCC------------------cEEEeeccccccc
Q 004049 513 QSEVKCLMLQLLEGIKYL---H-DNWVLHRDLKTSNLLLNNRG------------------ELKICDFGLARQY 564 (776)
Q Consensus 513 e~~~~~i~~qIl~aL~yL---H-s~gIvHrDLKPeNILLd~~g------------------~iKL~DFGlA~~~ 564 (776)
..-++.++.||+.-.--+ - ..+.+|-||||+||||-... .++|.||.++...
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 345677888886543112 1 34699999999999995332 2688899888654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.26 E-value=0.22 Score=54.88 Aligned_cols=51 Identities=24% Similarity=0.293 Sum_probs=35.7
Q ss_pred HHHHHHHHHHHHHhhhh---c-cCCcccCCCCCCCeeecCCC------------------cEEEeeccccccc
Q 004049 514 SEVKCLMLQLLEGIKYL---H-DNWVLHRDLKTSNLLLNNRG------------------ELKICDFGLARQY 564 (776)
Q Consensus 514 ~~~~~i~~qIl~aL~yL---H-s~gIvHrDLKPeNILLd~~g------------------~iKL~DFGlA~~~ 564 (776)
.-++.++.||+.-.-.+ - ..+.+|-||||+||||-... .++|.||.++...
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 45778888987655333 1 34699999999999995433 2567788777643
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=89.02 E-value=0.33 Score=53.44 Aligned_cols=135 Identities=19% Similarity=0.214 Sum_probs=89.4
Q ss_pred EeeeecCCceEEEEEEE-------CC---CCcEEEEEEeecchhc---------cC----------Ccc---ch--HHHH
Q 004049 418 LNKIDEGTYGVVYRARD-------KK---TGEIVALKKVKMEKER---------EG----------FPL---TS--LREI 463 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~-------k~---tg~~VAIK~i~~~~~~---------~~----------~~~---~~--~rEi 463 (776)
-.+|..|.-+.|+-|+- .. .-..||||+++..... .. ... .+ .+|+
T Consensus 257 ~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkEm 336 (531)
T KOG2269|consen 257 DGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKEM 336 (531)
T ss_pred hhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHHH
Confidence 35788899999998843 11 2356899988653210 00 000 11 1355
Q ss_pred HHHHhC-----CCCCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhh-ccCCccc
Q 004049 464 NILLSF-----HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL-HDNWVLH 537 (776)
Q Consensus 464 ~iL~~L-----~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yL-Hs~gIvH 537 (776)
.-|.++ .+|.+|.+.. -+|||-|+..+-+..-.-..-.|+..+.+..-.|++.++.-| |..-+||
T Consensus 337 hNL~RMq~~GlpcP~vV~lkk---------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVH 407 (531)
T KOG2269|consen 337 HNLSRMQKHGLPCPQVVKLKK---------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVH 407 (531)
T ss_pred HHHHHHHhcCCCCCceeeeec---------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheee
Confidence 545544 3566666532 368999998533333222344599999999999999988877 5677999
Q ss_pred CCCCCCCeeecCCCcEEEeeccccc
Q 004049 538 RDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 538 rDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
-||.--|||.... .+-++|..-+.
T Consensus 408 ADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 408 ADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred cchhhhhheecCC-ceEEEechhcc
Confidence 9999999999874 88899976554
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.21 E-value=0.33 Score=49.56 Aligned_cols=29 Identities=31% Similarity=0.505 Sum_probs=25.6
Q ss_pred CcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 534 gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
-.+|+|+.|.||++..+| ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998877 99999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=87.81 E-value=0.78 Score=49.43 Aligned_cols=49 Identities=24% Similarity=0.367 Sum_probs=38.8
Q ss_pred HHHHHHHHHHHHhhhhccC--CcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 515 EVKCLMLQLLEGIKYLHDN--WVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 515 ~~~~i~~qIl~aL~yLHs~--gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
.....+..+-.+|.-+|.. -++|+|+.|+|+|++..+.++|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444566666666666655 489999999999999999999999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 776 | ||||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-79 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-79 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-79 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-79 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-79 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-79 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-79 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-79 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-79 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-79 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-79 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-79 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-79 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-79 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-79 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-79 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-79 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-79 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-79 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-79 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-79 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-79 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-79 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-79 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-79 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-79 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-79 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-78 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-78 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-78 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-78 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-78 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-78 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-78 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-78 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-76 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-76 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-76 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-75 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-75 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-66 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-65 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-65 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-65 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-64 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-64 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-64 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-63 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-63 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-60 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-59 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-58 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-58 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-56 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-55 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-55 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-55 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-53 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-51 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-50 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-50 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-50 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-50 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-49 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-49 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-49 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-49 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-49 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-49 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-49 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-49 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-49 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-49 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-49 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-49 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-49 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-49 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-49 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-49 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-49 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-49 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-49 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-48 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-48 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-47 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-47 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-46 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-46 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-46 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-46 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-46 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-44 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-44 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-44 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-44 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-44 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-44 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-44 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-44 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-44 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-44 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-44 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-44 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-44 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-44 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-44 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-44 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-44 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-44 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-44 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-44 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-44 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-44 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-44 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-44 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-44 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-44 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-44 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-44 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-44 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-44 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-44 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-44 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-44 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-44 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-44 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-44 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-44 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-44 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-44 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-44 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-44 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-44 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-44 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-44 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-44 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-44 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-44 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-44 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-44 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-44 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-44 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-44 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-43 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-43 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-43 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-43 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-43 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-43 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-43 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-43 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-43 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-43 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-42 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-41 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-40 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-40 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-40 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-38 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-38 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-38 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-38 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-37 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-37 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-37 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-37 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-37 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-37 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-37 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-37 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-37 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-37 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-36 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-36 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-36 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-36 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-36 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-36 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-36 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-36 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-36 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-36 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-36 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-36 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-36 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-36 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-36 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-35 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-35 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-35 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-35 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-35 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-35 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-35 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-35 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-35 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-35 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-35 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-34 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-32 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-27 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-26 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-26 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-26 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-25 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-25 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-25 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-25 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-25 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-25 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-25 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-24 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-13 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 5e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-08 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 5e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 |
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 574 bits (1481), Expect = 0.0
Identities = 132/363 (36%), Positives = 195/363 (53%), Gaps = 28/363 (7%)
Query: 400 QRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS 459
Q C V ++E+L KI +GT+G V++AR +KTG+ VALKKV ME E+EGFP+T+
Sbjct: 4 QYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 63
Query: 460 LREINILLSFHHPSIVDVKEVVV------GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQ 513
LREI IL H ++V++ E+ SI++V ++ EHDL GL+ + F+
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK---- 569
SE+K +M LL G+ Y+H N +LHRD+K +N+L+ G LK+ DFGLAR +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
YT+ VVTLWYR PELLLG + Y ID+W GCIMAE+ ++ P+ G +E QL I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 630 TLGTPNEKIWPGFSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLT 688
G+ ++WP + + +K Q ++ + + V DL++ LL
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLV 297
Query: 689 YDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKE 748
DP +RI ++ ALNHD+F P+P M + + RRK
Sbjct: 298 LDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPP-----------RRKH 346
Query: 749 LQQ 751
Sbjct: 347 HHH 349
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 559 bits (1444), Expect = 0.0
Identities = 133/353 (37%), Positives = 196/353 (55%), Gaps = 17/353 (4%)
Query: 406 LQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME---KEREGFPLTSLRE 462
L +E+L+ + EG + VY+ARDK T +IVA+KK+K+ + ++G T+LRE
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
I +L HP+I+ + + + +I +V ++ME DL+ +++ + S +K ML
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
L+G++YLH +W+LHRDLK +NLLL+ G LK+ DFGLA+ +GSP + YTH VVT WYRA
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PELL G++ Y +DMW++GCI+AELL + P G S+ DQL +IF+TLGTP E+ WP
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
LP F L F A D DL+ L ++P RITA AL
Sbjct: 241 CSLPDYV-TFKSFPGIPLHHIFSA--------AGDDLLDLIQGLFLFNPCARITATQALK 291
Query: 703 HDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
+F P P +P + ++ +R + L+QG L
Sbjct: 292 MKYFSNRPGPTPGCQLPRPNCPVETLKEQSNP---ALAIKRKRTEALEQGGLP 341
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 130/320 (40%), Positives = 196/320 (61%), Gaps = 11/320 (3%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH 470
S +F++L K+ GTY VY+ +K TG VALK+VK++ E EG P T++REI+++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELK 61
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMET-----MKQPFSQSEVKCLMLQLLE 525
H +IV + +V+ N + +V E+M++DLK M++ + + VK QLL+
Sbjct: 62 HENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
G+ + H+N +LHRDLK NLL+N RG+LK+ DFGLAR +G P+ ++ VVTLWYRAP++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
L+GS+ YST+ID+WS GCI+AE+++ +PLF G ++ +QL IF +GTPNE +WP +KL
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
P N + LR+ + L D L+ LL +PD R++A+ AL+H W
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTK---EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 706 FREVPLPKSKDFMPTFPAQH 725
F E S + H
Sbjct: 297 FAEYYHHASMGGSRSHHHHH 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 553 bits (1428), Expect = 0.0
Identities = 134/325 (41%), Positives = 197/325 (60%), Gaps = 15/325 (4%)
Query: 393 PEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER 452
+ GP S++ S+D + R+ K+ EGTYG VY+A D T E VA+K++++E E
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73
Query: 453 EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFS 512
EG P T++RE+++L H +I+++K V+ ++ + ++ EY E+DLK M+ S
Sbjct: 74 EGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDKNP-DVS 130
Query: 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-----NRGELKICDFGLARQYGSP 567
+K + QL+ G+ + H LHRDLK NLLL+ LKI DFGLAR +G P
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
++ +TH ++TLWYR PE+LLGS+ YST++D+WS+ CI AE+L K PLF G SE DQL KI
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250
Query: 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLL 687
F+ LG P++ WPG + LP K +F K + L++ +L D G DLL ++L
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG-------ALLDDEGLDLLTAML 303
Query: 688 TYDPDKRITAEAALNHDWFREVPLP 712
DP KRI+A+ AL H +F
Sbjct: 304 EMDPVKRISAKNALEHPYFSHNDFD 328
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 544 bits (1404), Expect = 0.0
Identities = 134/316 (42%), Positives = 203/316 (64%), Gaps = 12/316 (3%)
Query: 396 AGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF 455
L ++++++L K+ EGTYGVVY+A+D G IVALK+++++ E EG
Sbjct: 4 HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62
Query: 456 PLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSE 515
P T++REI++L HHP+IV + +V+ + +V E+ME DLK +++ K S+
Sbjct: 63 PSTAIREISLLKELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDSQ 120
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLV 575
+K + QLL G+ + H + +LHRDLK NLL+N+ G LK+ DFGLAR +G P++ YTH V
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
VTLWYRAP++L+GSK+YST++D+WS+GCI AE+++ +PLF G ++ DQL KIF LGTPN
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 636 EKIWPGFSKLPGVK-VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
+ WP +LP K F + P G DLL+++L +DP+KR
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPG--------FCQEGIDLLSNMLCFDPNKR 292
Query: 695 ITAEAALNHDWFREVP 710
I+A A+NH +F+++
Sbjct: 293 ISARDAMNHPYFKDLD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 542 bits (1400), Expect = 0.0
Identities = 130/302 (43%), Positives = 186/302 (61%), Gaps = 11/302 (3%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
+ ++E+L KI EGTYG V++A++++T EIVALK+V+++ + EG P ++LREI +L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +V+ + +V E+ + DLK ++ VK + QLL+G+ + H
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
VLHRDLK NLL+N GELK+ +FGLAR +G P++ Y+ VVTLWYR P++L G+K
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 592 YSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
YST+IDMWS GCI AEL + PLF G DQL +IF+ LGTP E+ WP +KLP K
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
+ L P L+ G DLL +LL +P +RI+AE AL H +F +
Sbjct: 239 YPMYPATTSLVNVVPK--------LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
Query: 711 LP 712
P
Sbjct: 291 PP 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 540 bits (1394), Expect = 0.0
Identities = 123/327 (37%), Positives = 193/327 (59%), Gaps = 21/327 (6%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARD-KKTGEIVALKKVKMEKEREGFPLTSLREINIL 466
CR+ ++E + +I EG YG V++ARD K G VALK+V+++ EG PL+++RE+ +L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 467 L---SFHHPSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQPF-SQSEVKCL 519
+F HP++V + +V S D + +V E+++ DL ++ + +P +K +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
M QLL G+ +LH + V+HRDLK N+L+ + G++K+ DFGLAR Y + T +VVTLW
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639
YRAPE+LL S Y+T +D+WS+GCI AE+ ++PLF G S+ DQL KI +G P E+ W
Sbjct: 185 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699
P LP + F + K + + G DLL LT++P KRI+A +
Sbjct: 244 PRDVALP--RQAFHSKSAQPIEKFVTD--------IDELGKDLLLKCLTFNPAKRISAYS 293
Query: 700 ALNHDWFREVPLPKSKDFMPTFPAQHA 726
AL+H +F+++ K ++ P
Sbjct: 294 ALSHPYFQDLERCK-ENLDSHLPPSQN 319
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 537 bits (1386), Expect = 0.0
Identities = 141/298 (47%), Positives = 196/298 (65%), Gaps = 11/298 (3%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++++ L KI EGTYGVVY+A++ GE ALKK+++EKE EG P T++REI+IL H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +V+ + +V E+++ DLK L++ + K +LQLL GI Y H
Sbjct: 60 SNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
D VLHRDLK NLL+N GELKI DFGLAR +G P++ YTH +VTLWYRAP++L+GSK+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YST ID+WS+GCI AE+++ PLF G SE DQL +IF+ LGTPN K WP ++LP N
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
F ++ L ++G DLL+ +L DP++RITA+ AL H +F+E
Sbjct: 238 FTVYEPLPWESFLKG--------LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 128/328 (39%), Positives = 185/328 (56%), Gaps = 17/328 (5%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++ + +L+K+ EGTY VY+ + K T +VALK++++E E EG P T++RE+++L H
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 59
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +++ S+ +V EY++ DLK ++ + VK + QLL G+ Y H
Sbjct: 60 ANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
VLHRDLK NLL+N RGELK+ DFGLAR P K Y + VVTLWYR P++LLGS
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK-V 650
YST IDMW +GCI E+ + PLF G + +QL IF+ LGTP E+ WPG K
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
N+ K++ L P L G DLL LL ++ RI+AE A+ H +F +
Sbjct: 238 NYPKYRAEALLSHAPR--------LDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 711 -----LPKSKDFMPTFPAQHAQDRRMRR 733
LP + Q ++ +R
Sbjct: 290 ERIHKLPDTTSIFALKEIQLQKEASLRS 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 119/317 (37%), Positives = 179/317 (56%), Gaps = 23/317 (7%)
Query: 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG---FPLTSLREIN 464
G + +E + +I G YG VY+ARD +G VALK V++ G P++++RE+
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 465 ILL---SFHHPSIVDVKEVVVGSNLD---SIFMVMEYMEHDLKGLMETMKQP-FSQSEVK 517
+L +F HP++V + +V S D + +V E+++ DL+ ++ P +K
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577
LM Q L G+ +LH N ++HRDLK N+L+ + G +K+ DFGLAR Y + T +VVT
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVT 182
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
LWYRAPE+LL S Y+T +DMWS+GCI AE+ ++PLF G SE DQL KIF +G P E
Sbjct: 183 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
WP LP + F ++ P + ++G LL +LT++P KRI+A
Sbjct: 242 DWPRDVSLP--RGAFPPRGPRPVQSVVPE--------MEESGAQLLLEMLTFNPHKRISA 291
Query: 698 EAALNHDWFREV-PLPK 713
AL H + + P+
Sbjct: 292 FRALQHSYLHKDEGNPE 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 519 bits (1340), Expect = 0.0
Identities = 106/316 (33%), Positives = 167/316 (52%), Gaps = 12/316 (3%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
++++E++ KI EG+YGVV++ R++ TG+IVA+KK ++ +LREI +L H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
P++V++ EV + +V EY +H + ++ ++ + VK + Q L+ + + H
Sbjct: 62 PNLVNLLEVFRRKR--RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+ +HRD+K N+L+ +K+CDFG AR P Y V T WYR+PELL+G Q
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK-V 650
Y +D+W++GC+ AELLS PL+ GKS+ DQL I KTLG + FS V
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 651 NFIKHQ-YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+ L KFP +S LL L DP +R+T E L+H +F +
Sbjct: 240 KIPDPEDMEPLELKFPN--------ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291
Query: 710 PLPKSKDFMPTFPAQH 725
+ PA++
Sbjct: 292 REIEDLAKEHDKPAEN 307
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 519 bits (1340), Expect = 0.0
Identities = 103/341 (30%), Positives = 171/341 (50%), Gaps = 15/341 (4%)
Query: 391 GTPEPAGPPQRSINMLQ-GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME 449
G + +S++++E L + EG+YG+V + R+K TG IVA+KK
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61
Query: 450 KEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ 509
+ + ++REI +L H ++V++ EV ++V E+++H + +E
Sbjct: 62 DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--RWYLVFEFVDHTILDDLELFPN 119
Query: 510 PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569
V+ + Q++ GI + H + ++HRD+K N+L++ G +K+CDFG AR +P +
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK 629
Y V T WYRAPELL+G +Y A+D+W++GC++ E+ EPLF G S+ DQL I
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239
Query: 630 TLGTPNEKIWPGFSKLPGVK-VNFIKHQ-YNLLRKKFPATSFTGSPVLSDAGFDLLNSLL 687
LG + F+K P V + + L +++P LS+ DL L
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK--------LSEVVIDLAKKCL 291
Query: 688 TYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQD 728
DPDKR L+HD+F+ + F + +D
Sbjct: 292 HIDPDKRPFCAELLHHDFFQMDGFA--ERFSQELQLKVQKD 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 498 bits (1283), Expect = e-171
Identities = 135/375 (36%), Positives = 195/375 (52%), Gaps = 35/375 (9%)
Query: 407 QGCRSVDEFERLN-KIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREI 463
+ R D FE K+ GTYG VY+A+ K K + ALK++ E G +++ REI
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREI 69
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--------PFSQSE 515
+L HP+++ +++V + ++++ +Y EHDL +++ + +
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 516 VKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPY 571
VK L+ Q+L+GI YLH NWVLHRDLK +N+L+ RG +KI D G AR + SPLKP
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 572 THL---VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-------- 620
L VVT WYRAPELLLG++ Y+ AID+W++GCI AELL+ EP+F+ + E
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249
Query: 621 -FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSF-TGSPVLSDA 678
DQLD+IF +G P +K W K+P + N
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 679 GFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSP 738
F LL LLT DP KRIT+E A+ +F E PLP S F R + P
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK---REFLTEEEP 366
Query: 739 DPLEEQRRKELQQGE 753
D +++ ++ QQG
Sbjct: 367 DDKGDKKNQQQQQGN 381
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-117
Identities = 108/365 (29%), Positives = 177/365 (48%), Gaps = 40/365 (10%)
Query: 377 GGSDTDSEDENDSCGTPEPAGPPQRSIN-MLQGCRSVDE----FERLNKIDEGTYGVVYR 431
G + N P P + I + ++ ++ + I G++GVV++
Sbjct: 1 GSFTMSNAPLNGV--KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQ 58
Query: 432 ARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS--- 488
A+ ++ E VA+KKV +K + RE+ I+ HP++VD+K +
Sbjct: 59 AKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 489 -IFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544
+ +V+EY+ + +KQ +K M QLL + Y+H + HRD+K N
Sbjct: 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171
Query: 545 LLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGC 603
LLL+ G LK+ DFG A+ +P + + +YRAPEL+ G+ Y+T ID+WS GC
Sbjct: 172 LLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGC 230
Query: 604 IMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKK 663
+MAEL+ +PLF G+S DQL +I K LGTP+ + + N+++H++ +
Sbjct: 231 VMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI------KTMNPNYMEHKF----PQ 280
Query: 664 FPATSFTG--SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP-----LPKSKD 716
F+ P DL++ LL Y P R+TA AL H +F E+ +P ++
Sbjct: 281 IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRE 340
Query: 717 FMPTF 721
P F
Sbjct: 341 LPPLF 345
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-114
Identities = 101/322 (31%), Positives = 159/322 (49%), Gaps = 32/322 (9%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+ I G++GVVY+A+ +GE+VA+KKV +K + RE+ I+ H +I
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNI 109
Query: 475 VDVKEVVVGS----NLDSIFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGI 527
V ++ S + + +V++Y+ + + KQ VK M QL +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 528 KYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
Y+H + HRD+K NLLL+ + LK+CDFG A+Q +P + + +YRAPEL+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELI 228
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
G+ Y+++ID+WS GC++AELL +P+F G S DQL +I K LGTP +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI------R 282
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTG--SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
+ N+ + ++ + A +T P L + LL Y P R+T A H
Sbjct: 283 EMNPNYTEFKF----PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 705 WFRE-----VPLPKSKDFMPTF 721
+F E V LP +D F
Sbjct: 339 FFDELRDPNVKLPNGRDTPALF 360
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-109
Identities = 98/317 (30%), Positives = 155/317 (48%), Gaps = 34/317 (10%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKV---KMEKEREGFPLTSLREINIL 466
+ +D F+ +GT+G V ++K TG VA+KKV + RE L+ + L
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE------LQIMQDL 73
Query: 467 LSFHHPSIVDVKEVVVGSNLDS-----IFMVMEYMEHDLKGLMET---MKQPFSQSEVKC 518
HHP+IV ++ + +VMEY+ L + +K
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 519 LMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLV 575
+ QL+ I LH V HRD+K N+L+N G LK+CDFG A++ SP +P +
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYI 192
Query: 576 VTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
+ +YRAPEL+ G++ Y+TA+D+WS+GCI AE++ EP+F G + QL +I + LG P+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 636 EKIW----PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691
++ P + + I F S + +DLL++LL Y P
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIP-----WSNVFSDH----SLKDAKEAYDLLSALLQYLP 303
Query: 692 DKRITAEAALNHDWFRE 708
++R+ AL H +F E
Sbjct: 304 EERMKPYEALCHPYFDE 320
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-107
Identities = 84/304 (27%), Positives = 154/304 (50%), Gaps = 20/304 (6%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HH 471
D+++ + K+ G Y V+ A + E V +K +K K+++ REI IL +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 90
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEY-MEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P+I+ + ++V + +V E+ D K L Q + +++ M ++L+ + Y
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 146
Query: 531 HDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
H ++HRD+K N++++ +L++ D+GLA + P + Y V + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 590 KQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL--- 645
+ Y ++DMWSLGC++A ++ KEP F+G +DQL +I K LGT + + +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
P +H + + + ++S D L+ LL YD R+TA A+ H +
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQ---HLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 706 FREV 709
F V
Sbjct: 323 FYTV 326
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 324 bits (831), Expect = e-103
Identities = 121/408 (29%), Positives = 177/408 (43%), Gaps = 72/408 (17%)
Query: 368 EDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYG 427
+N + + S+ E + P + D +E + I G+YG
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 428 VVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487
V A DK +VA+KK+ E LREI IL +H +V V ++V+ +++
Sbjct: 68 HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 488 S---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSN 544
+++V+E + D K L T ++ +K L+ LL G+KY+H +LHRDLK +N
Sbjct: 128 KFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 545 LLLNNRGELKICDFGLARQYGSPLKP---------------------------YTHLVVT 577
L+N +K+CDFGLAR P T VVT
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-----------KEPLFNGKS------- 619
WYRAPEL+L + Y+ AID+WS+GCI AELL+ + PLF G S
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPD 306
Query: 620 -------------EFDQLDKIFKTLGTPNEKIWPGFS--KLPGVKVNFIKHQYNLLRKKF 664
DQL+ IF LGTP+E+ F K + L ++F
Sbjct: 307 QKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366
Query: 665 PATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712
PA S LL +L ++P+KRIT L H +F+EV +
Sbjct: 367 PA--------SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-103
Identities = 85/348 (24%), Positives = 156/348 (44%), Gaps = 68/348 (19%)
Query: 408 GCRSVDE-FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL 466
G + + + + G++G+V D ++G+ ALKKV + RE++I+
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIM 54
Query: 467 LSFHHPSIVDVKEVVVGSNLDS------------------------------------IF 490
H +I+ + + + + +
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 491 MVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547
++MEY+ L ++++ + + + + QL + ++H + HRD+K NLL+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 548 N-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMA 606
N LK+CDFG A++ P +P + + +YRAPEL+LG+ +Y+ +ID+WS+GC+
Sbjct: 175 NSKDNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 607 ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS------KLPGVKVNFIKHQYNLL 660
EL+ +PLF+G++ DQL +I + +GTP ++ + + P +K
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK----AKD---W 286
Query: 661 RKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
RK P + DLL +L Y+PD RI A+ H +F
Sbjct: 287 RKILPEGT-------PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-96
Identities = 106/312 (33%), Positives = 157/312 (50%), Gaps = 27/312 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L + G G+V+ A D + VA+KK+ + + +LREI I+ H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHD 68
Query: 473 SIVDVKEVV------------VGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM 520
+IV V E++ + L+S+++V EYME DL ++E P + + M
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFM 126
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPLKPYTHL---VV 576
QLL G+KY+H VLHRDLK +NL +N LKI DFGLAR HL +V
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
T WYR+P LLL Y+ AIDMW+ GCI AE+L+ + LF G E +Q+ I +++ +E
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT 696
+ +L V +I++ K P +S D L +LT+ P R+T
Sbjct: 247 ED---RQELLSVIPVYIRNDMTEPHKPL-TQLL---PGISREAVDFLEQILTFSPMDRLT 299
Query: 697 AEAALNHDWFRE 708
AE AL+H +
Sbjct: 300 AEEALSHPYMSI 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 4e-95
Identities = 97/343 (28%), Positives = 163/343 (47%), Gaps = 31/343 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLT---------SLREI 463
+ I G+YG V D G VA+K+V LREI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLM 520
+L FHHP+I+ ++++ V + +++V E M DL ++ + S ++ M
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
+L G+ LH+ V+HRDL N+LL + ++ ICDF LAR+ + TH V WY
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED-TADANKTHYVTHRWY 199
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
RAPEL++ K ++ +DMWS GC+MAE+ +++ LF G + ++QL+KI + +GTP +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED-- 257
Query: 641 GFSKLPGVKV-NFIKHQYNLLRKKFPATSFTG-SPVLSDAGFDLLNSLLTYDPDKRITAE 698
+++++ PA ++T P DL+ +L ++P +RI+ E
Sbjct: 258 -VVMFSSPSARDYLRNS----LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 699 AALNHDWFR------EVPLPKSKDFMPTFPAQHAQDRRMRRMM 735
AL H +F ++ S+ F F M ++
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERF--HFDESVTDVYDMHKIF 353
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 5e-95
Identities = 111/299 (37%), Positives = 162/299 (54%), Gaps = 18/299 (6%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+ + G YG V A DK++GE VA+KK+ + E F + RE+ +L H ++
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 475 VDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+ + +V N ++VM +M+ DL+ +M FS+ +++ L+ Q+L+G+KY+
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590
H V+HRDLK NL +N ELKI DFGLAR + + Y VVT WYRAPE++L
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWM 199
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
Y+ +D+WS+GCIMAE+L+ + LF GK DQL +I K G P + KL
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAA 256
Query: 651 -NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
++I+ RK F F P S DLL +L D DKR+TA AL H +F
Sbjct: 257 KSYIQSLPQTPRKDF-TQLF---PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 2e-94
Identities = 102/328 (31%), Positives = 166/328 (50%), Gaps = 34/328 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-H 471
++E + K+ +G YG+V+++ D++TGE+VA+KK+ + + REI IL H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV++ V+ N +++V +YME DL ++ + ++ QL++ IKYLH
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH 126
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY-------------------- 571
+LHRD+K SN+LLN +K+ DFGL+R + + +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 572 -THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT 630
T V T WYRAPE+LLGS +Y+ IDMWSLGCI+ E+L +P+F G S +QL++I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 631 LGTP---------NEKIWPGFSKLPG-VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF 680
+ P + L V++ + + K ++
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 681 DLLNSLLTYDPDKRITAEAALNHDWFRE 708
DLL+ LL ++P+KRI+A AL H +
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 4e-94
Identities = 118/322 (36%), Positives = 176/322 (54%), Gaps = 19/322 (5%)
Query: 396 AGPPQRSINMLQGCR-SVDE-FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE 453
A M++G V + L+ I EG YG+V A D VA+KK+ E +
Sbjct: 8 AAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQ 66
Query: 454 GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQP 510
+ +LREI ILL F H +I+ + +++ ++ +++V + ME DL L++T Q
Sbjct: 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QH 124
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570
S + + Q+L G+KY+H VLHRDLK SNLLLN +LKICDFGLAR
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 571 YTHL---VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
L V T WYRAPE++L SK Y+ +ID+WS+GCI+AE+LS P+F GK DQL+ I
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 628 FKTLGTPNEKIWPGFSKLPGVKV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSL 686
LG+P+++ + + +K N++ + + + F P DLL+ +
Sbjct: 245 LGILGSPSQED---LNCIINLKARNYLLSLPHKNKVPW-NRLF---PNADSKALDLLDKM 297
Query: 687 LTYDPDKRITAEAALNHDWFRE 708
LT++P KRI E AL H + +
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQ 319
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 7e-94
Identities = 111/314 (35%), Positives = 164/314 (52%), Gaps = 31/314 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKV-----KMEKEREGFPLTSLREINILL 467
+F+ + + EG YGVV A K TGEIVA+KK+ + R +LREI IL
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR------TLREIKILK 64
Query: 468 SFHHPSIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLL 524
F H +I+ + + + ++ ++++ E M+ DL ++ T Q S ++ + Q L
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTL 122
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY----------THL 574
+K LH + V+HRDLK SNLL+N+ +LK+CDFGLAR
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
V T WYRAPE++L S +YS A+D+WS GCI+AEL + P+F G+ QL IF +GTP
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
+ + P + +IK F P ++ G DLL +L +DP KR
Sbjct: 243 HSDNDLRCIESPRAR-EYIKSLPMYPAAPL-EKMF---PRVNPKGIDLLQRMLVFDPAKR 297
Query: 695 ITAEAALNHDWFRE 708
ITA+ AL H + +
Sbjct: 298 ITAKEALEHPYLQT 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-92
Identities = 103/302 (34%), Positives = 156/302 (51%), Gaps = 19/302 (6%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ++ L+ + G YG V A D KTG VA+KK+ + + RE+ +L H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V + +++V M DL +++ Q + V+ L+ Q+L G+K
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLK 146
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK SNL +N ELKI DFGLAR + Y V T WYRAPE++L
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VATRWYRAPEIMLN 203
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+ +D+WS+GCIMAELL+ LF G DQL I + +GTP ++ K+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL---LKKISSE 260
Query: 649 KV-NFIKHQYNLLRKKFPATSFTG-SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
N+I+ + P +F + DLL +L D DKRITA AL H +F
Sbjct: 261 SARNYIQS-----LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 707 RE 708
+
Sbjct: 316 AQ 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 3e-92
Identities = 104/301 (34%), Positives = 162/301 (53%), Gaps = 17/301 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L + G YG V A D +TG VA+KK+ + E F + RE+ +L H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V + ++VM +M DL LM+ + + ++ L+ Q+L+G++
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 142
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK NL +N ELKI DFGLARQ S + Y VVT WYRAPE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+Y+ +D+WS+GCIMAE+++ + LF G DQL +I K GTP + +L
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF---VQRLQSD 256
Query: 649 KV-NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
+ N++K L +K F A+ S +LL +L D ++R+TA AL H +F
Sbjct: 257 EAKNYMKGLPELEKKDF-ASIL---TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
Query: 708 E 708
Sbjct: 313 S 313
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 3e-90
Identities = 96/327 (29%), Positives = 153/327 (46%), Gaps = 26/327 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ L I G G+V A D VA+KK+ + + + RE+ ++ +H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+I+ + V +++VME M+ +L + ++ + L+ Q+L GIK
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC---QVIQMELDHERMSYLLYQMLCGIK 141
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
+LH ++HRDLK SN+++ + LKI DFGLAR T VVT +YRAPE++LG
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 200
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y +D+WS+GCIM E++ LF G DQ +K+ + LGTP + P V
Sbjct: 201 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ--PTV 257
Query: 649 KVNFI----KHQYNLLRKKFPATSFT----GSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
+ ++ K+ K FP F + + + DLL+ +L D KRI+ + A
Sbjct: 258 R-TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 701 LNHDWFR------EVPLPKSKDFMPTF 721
L H + E P K
Sbjct: 317 LQHPYINVWYDPSEAEAPPPKIPDKQL 343
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 3e-88
Identities = 112/355 (31%), Positives = 168/355 (47%), Gaps = 70/355 (19%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D + + I G+YG VY A DK T + VA+KKV E LREI IL
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 473 SIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
I+ + ++++ +L +++V+E + DLK L +T ++ +K ++ LL G +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENF 144
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY------------------ 571
+H++ ++HRDLK +N LLN +K+CDFGLAR S
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 572 ----THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-----------KEPLFN 616
T VVT WYRAPEL+L + Y+ +ID+WS GCI AELL+ + PLF
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 617 GKSEF-----------------DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY-- 657
G S F DQL+ IF +GTP E + I
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED-----------DLKNINKPEVI 313
Query: 658 NLLRK--KFPATSFTGS-PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
++ + P +SD G +LL S+L ++P+KRIT + AL+H + ++V
Sbjct: 314 KYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-87
Identities = 97/310 (31%), Positives = 159/310 (51%), Gaps = 24/310 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ L I G G+V A D VA+KK+ + + + RE+ ++ +H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+I+ + V +++VME M+ +L ++ + + L+ Q+L GIK
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIK 178
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELL 586
+LH ++HRDLK SN+++ + LKI DFGLAR G+ + PY VVT +YRAPE++
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVI 235
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
LG Y +D+WS+GCIM E++ + LF G+ DQ +K+ + LGTP + P
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ--P 292
Query: 647 GVKVNFI----KHQYNLLRKKFPATSFT----GSPVLSDAGFDLLNSLLTYDPDKRITAE 698
V+ N++ K+ K FP + F + + + DLL+ +L DP KRI+ +
Sbjct: 293 TVR-NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 699 AALNHDWFRE 708
AL H +
Sbjct: 352 DALQHPYINV 361
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-67
Identities = 76/324 (23%), Positives = 122/324 (37%), Gaps = 64/324 (19%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF 469
R +FE + + +G +G V +AR+ A+KK++ +E+ T L E+ +L S
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASL 59
Query: 470 HHPSIVDVKEVVVGSNLDS-----------IFMVMEYME-HDLKGLMETMKQPFSQSEVK 517
+H +V + +F+ MEY E L L+ + + E
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV- 576
L Q+LE + Y+H ++HRDLK N+ ++ +KI DFGLA+ L
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 577 -------------TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
T Y A E+L G+ Y+ IDM+SLG I E++ P G +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 624 LDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLL 683
L K+ K+ ++
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEK---------------------------------KII 264
Query: 684 NSLLTYDPDKRITAEAALNHDWFR 707
L+ +DP+KR A LN W
Sbjct: 265 RLLIDHDPNKRPGARTLLNSGWLP 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-65
Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 54/309 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINILLS 468
+++E L I G+YG + R K G+I+ K++ E E++ + E+N+L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ----MLVSEVNLLRE 61
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQ---PFSQSEVKCLMLQLL 524
HP+IV + ++ ++++VMEY E DL ++ + + V +M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 525 EGIKYLHD-----NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
+K H + VLHRDLK +N+ L+ + +K+ DFGLAR V T +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639
Y +PE + Y+ D+WSLGC++ EL + P F S+ + KI + G +I
Sbjct: 182 YMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF-RRIP 237
Query: 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699
+S L +++ +L R + E
Sbjct: 238 YRYSD--------------ELN-------------------EIITRMLNLKDYHRPSVEE 264
Query: 700 ALNHDWFRE 708
L + E
Sbjct: 265 ILENPLILE 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-64
Identities = 77/347 (22%), Positives = 133/347 (38%), Gaps = 63/347 (18%)
Query: 394 EPAGPPQRSINMLQGCRSVD--EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK- 450
+G + N+ SV + L +I G V++ ++ +I A+K V +E+
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 451 ---EREGFPLTSLREINILLSFHHPS--IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME 505
+ + EI L S I+ + + + I+MVME DL ++
Sbjct: 66 DNQTLDSY----RNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLK 119
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--Q 563
K+ E K +LE + +H + ++H DLK +N L+ + G LK+ DFG+A Q
Sbjct: 120 K-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177
Query: 564 YGSPLKPYTHLVVTLWYRAPELLLGS----------KQYSTAIDMWSLGCIMAELLSKEP 613
+ V T+ Y PE + + S D+WSLGCI+ + +
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 614 LFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSP 673
F +Q+ K+ + PN +I +FP
Sbjct: 238 PFQQII--NQISKLHA-IIDPNHEI------------------------EFP-------D 263
Query: 674 VLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPT 720
+ D+L L DP +RI+ L H + + P ++ T
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-64
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 65/315 (20%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF 469
R +F+ + I G +G V++A+ + G+ +K+VK E+ + RE+ L
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKL 61
Query: 470 HHPSIVDVKEVVVGSNLDS--------------IFMVMEYMEH-DLKGLMETMK-QPFSQ 513
H +IV G + D +F+ ME+ + L+ +E + + +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573
L Q+ +G+ Y+H +++RDLK SN+ L + ++KI DFGL + K T
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTR 180
Query: 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGT 633
TL Y +PE + + Y +D+++LG I+AELL F+
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTA-----FETSKFFTD---- 230
Query: 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693
L + LL LL+ P+
Sbjct: 231 -------------------------LRDGIIS-------DIFDKKEKTLLQKLLSKKPED 258
Query: 694 RITAEAALNHDWFRE 708
R L +
Sbjct: 259 RPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-63
Identities = 78/357 (21%), Positives = 127/357 (35%), Gaps = 50/357 (14%)
Query: 353 YHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSV 412
+H H S D + + + S S P P R
Sbjct: 3 HHHHHSSGVDLGT-ENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSR-----PESFFQ 56
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS-FHH 471
F+RL+++ G+YG V++ R K+ G + A+K+ L E+ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
P V +++ +++ E L+ E +++V + L + +LH
Sbjct: 117 PCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
++H D+K +N+ L RG K+ DFGL + G+ Y APELL G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGDPRYMAPELLQG--S 231
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
Y TA D++SLG + E+ L + ++ + LP
Sbjct: 232 YGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQ-------------GYLPP---- 271
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
+F LS +L +L DP R TAEA L R+
Sbjct: 272 -----------EFT-------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 9e-63
Identities = 76/364 (20%), Positives = 135/364 (37%), Gaps = 61/364 (16%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK----EREGFPLTSLREINIL--L 467
+ L +I G V++ ++ +I A+K V +E+ + + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY----RNEIAYLNKL 64
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
H I+ + + + I+MVME DL ++ K+ E K +LE +
Sbjct: 65 QQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAV 121
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPEL 585
+H + ++H DLK +N L+ + G LK+ DFG+A Q + V T+ Y PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 586 LLGS----------KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
+ + S D+WSLGCI+ + + F +Q+ K+ + PN
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHA-IIDPN 237
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
+I +FP + D+L L DP +RI
Sbjct: 238 HEI------------------------EFP-------DIPEKDLQDVLKCCLKRDPKQRI 266
Query: 696 TAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
+ L H + + P ++ T ++ + L+ +
Sbjct: 267 SIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGE 326
Query: 756 IHSD 759
H+
Sbjct: 327 SHNS 330
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-62
Identities = 83/348 (23%), Positives = 154/348 (44%), Gaps = 55/348 (15%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINI 465
+S++++ RL KI EG++G + + G +K++ + KERE S RE+ +
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE----ESRREVAV 76
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQL 523
L + HP+IV +E + S+++VM+Y E DL + K F + ++ +Q+
Sbjct: 77 LANMKHPNIVQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+K++HD +LHRD+K+ N+ L G +++ DFG+AR S ++ + T +Y +P
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
E+ K Y+ D+W+LGC++ EL + + F S + + KI
Sbjct: 195 EICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---------------- 237
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
+ FP S S L L++ L +P R + + L
Sbjct: 238 ----------------ISGSFPPVSLHYSYDLR----SLVSQLFKRNPRDRPSVNSILEK 277
Query: 704 DWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQ 751
+ + + + F+ P A++ ++ K +R Q
Sbjct: 278 GFIAK----RIEKFLS--PQLIAEEFCLKTFSKFGSQPIPAKRPASGQ 319
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-62
Identities = 82/342 (23%), Positives = 139/342 (40%), Gaps = 51/342 (14%)
Query: 383 SEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVA 442
E G P P PQ+++ G ++ F KI G + VYRA G VA
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 443 LKKVKM-----EKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497
LKKV++ K R ++EI++L +HP+++ + + + +V+E +
Sbjct: 62 LKKVQIFDLMDAKARA----DCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVLELAD 115
Query: 498 H-DLKGLMETMKQ---PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGEL 553
DL +++ K+ + V +QL ++++H V+HRD+K +N+ + G +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV 175
Query: 554 KICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEP 613
K+ D GL R + S LV T +Y +PE + Y+ D+WSLGC++ E+ + +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQS 234
Query: 614 LFNGKSEFDQLDKIFKTLGTPNEKIWPG-FSKLPGVKVNFIKHQYNLLRKKFPATSFTGS 672
F G L + K KI + LP S
Sbjct: 235 PFYGDKM--NLYSLCK-------KIEQCDYPPLP-------------------------S 260
Query: 673 PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
S+ L+N + DP+KR + S
Sbjct: 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-61
Identities = 58/314 (18%), Positives = 121/314 (38%), Gaps = 36/314 (11%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
+ + + +G V+R R KKTG++ A+K + + + +RE +L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQP-----FSQSEVKCLMLQL 523
+H +IV + + + ++ME+ G L +++P +SE ++ +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCP---CGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
+ G+ +L +N ++HR++K N++ + + K+ DFG AR+ + + L T
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEE 180
Query: 580 YRAPELLLG-------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632
Y P++ K+Y +D+WS+G + F + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM---- 236
Query: 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPD 692
KI G V ++ P + + S L +L ++L D +
Sbjct: 237 ---YKIITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQE 292
Query: 693 KRITAEAALNHDWF 706
K +
Sbjct: 293 KCWGFDQFFAETSD 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-61
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 73/334 (21%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINIL 466
R + +FE + + G +GVV+ A++K A+K+++ E RE +RE+ L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKAL 57
Query: 467 LSFHHPSIV----------DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSE 515
HP IV +++ S +++ M+ +LK M +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 516 VKCL--MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ---------- 563
CL LQ+ E +++LH ++HRDLK SN+ +K+ DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 564 --YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621
+T V T Y +PE + G YS +D++SLG I+ ELL F+ + E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLYP---FSTQMER 233
Query: 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK-KFPATSFTGSPVLSDAGF 680
+ +R KFP P
Sbjct: 234 VRT--------------------------------LTDVRNLKFPPLFTQKYPCEY---- 257
Query: 681 DLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
++ +L+ P +R A + + F ++ P
Sbjct: 258 VMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-60
Identities = 54/360 (15%), Positives = 96/360 (26%), Gaps = 64/360 (17%)
Query: 384 EDENDSCGTPEPAGPPQRSINML-QGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVA 442
E P + + + + + + G VV+ RD + E A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 443 LKKVKMEKEREGFPLTSLRE-------------------------INILLSFHHPSIVDV 477
LK M E L L E + + P +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 478 KEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ------PFSQSEVKCLMLQLLEGIKYLH 531
+ + ++M DL+ L T+ + L QL+ L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK- 590
++H NL + G L + D + G+ V + Y E L S
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA---SSVPVTYAPREFLNASTA 268
Query: 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650
++ A++ W LG + + F + + +L P
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA---------- 318
Query: 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
F L D L+ L +D +R+ A+ F ++
Sbjct: 319 ------------------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-60
Identities = 74/364 (20%), Positives = 133/364 (36%), Gaps = 61/364 (16%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK----EREGFPLTSLREINILLSF 469
+ L +I G V++ ++ +I A+K V +E+ + + EI L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY----RNEIAYLNKL 111
Query: 470 HHPS--IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
S I+ + + + I+MVME DL ++ K+ E K +LE +
Sbjct: 112 QQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAV 168
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPEL 585
+H + ++H DLK +N L+ + G LK+ DFG+A Q + V + Y PE
Sbjct: 169 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 586 LLGS----------KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
+ + S D+WSLGCI+ + + F +Q+ K+ + PN
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHA-IIDPN 284
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
+I +FP + D+L L DP +RI
Sbjct: 285 HEI------------------------EFP-------DIPEKDLQDVLKCCLKRDPKQRI 313
Query: 696 TAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGELG 755
+ L H + + P ++ T ++ + L+ +
Sbjct: 314 SIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGE 373
Query: 756 IHSD 759
H+
Sbjct: 374 SHNS 377
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-60
Identities = 102/327 (31%), Positives = 151/327 (46%), Gaps = 44/327 (13%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL--LSFHHP 472
+E L I +G++G V +A D K + VALK V+ EK F + EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDK 155
Query: 473 SIVDVKEVVVGSNLDS------IFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLE 525
+ V+ L++ I M E + +L L++ K Q FS V+ +L+
Sbjct: 156 D--NTMNVI--HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+ LH N ++H DLK N+LL R +K+ DFG + + Y + + +YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY---IQSRFYRAP 268
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI----- 638
E++LG++ Y IDMWSLGCI+AELL+ PL G+ E DQL + + LG P++K+
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 639 -------------WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVL---SDAGF-D 681
+ + L V + + + P S L D F D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 682 LLNSLLTYDPDKRITAEAALNHDWFRE 708
L L +DP R+T AL H W R
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-58
Identities = 93/356 (26%), Positives = 155/356 (43%), Gaps = 60/356 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----KVKMEKEREGFPLTSL-REINIL 466
DE+ + G G V A ++KT + VA+K K + RE P ++ EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQ 522
+HP I+ +K + + ++V+E ME G L + + ++ K Q
Sbjct: 70 KKLNHPCIIKIKNFF---DAEDYYIVLELME----GGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLW 579
+L ++YLH+N ++HRDLK N+LL+++ E +KI DFG ++ G L T
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 181
Query: 580 YRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
Y APE+L+ Y+ A+D WSLG I+ LS P F+ Q + ++
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE--HRTQ-VSLK-------DQ 231
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
I G +YN F + +S+ DL+ LL DP R T
Sbjct: 232 ITSG--------------KYN-----FIPEVW---AEVSEKALDLVKKLLVVDPKARFTT 269
Query: 698 EAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGE 753
E AL H W ++ + + ++ + + +++ P ++R + E
Sbjct: 270 EEALRHPWLQDEDMKRK---FQDLLSEENESTALPQVLAQ--PSTSRKRPREGEAE 320
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-58
Identities = 82/303 (27%), Positives = 143/303 (47%), Gaps = 49/303 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ++R+ K+ G YG V RDK T A+K ++ L E+ +L HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LMETM--KQPFSQSEVKCLMLQLLEGIK 528
+I+ + + + + ++VME + G L + + + F++ + ++ Q+L G+
Sbjct: 97 NIMKLYDFF--EDKRNYYLVMECYK----GGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
YLH + ++HRDLK NLLL ++ + +KI DFGL+ + K + T +Y APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEV 209
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
L K+Y D+WS+G I+ LL+ P F G+++ + L K+ K T + W
Sbjct: 210 L--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN---- 263
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
+S+ DL+ +L +D +RI+A+ AL H W
Sbjct: 264 -----------------------------VSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 706 FRE 708
+E
Sbjct: 295 IKE 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 9e-58
Identities = 81/328 (24%), Positives = 145/328 (44%), Gaps = 51/328 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ + + + +G++G V + +D+ T + A+K + + T LRE+ +L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIK 528
+I+ + E++ + S ++V E G L + ++ FS+ + ++ Q+ GI
Sbjct: 82 NIMKLFEIL--EDSSSFYIVGELYT----GGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
Y+H + ++HRDLK N+LL ++ + +KI DFGL+ + + T +Y APE+
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEV 194
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
L Y D+WS G I+ LLS P F GK+E+D L ++ + W
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT---- 248
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
+SD DL+ +LT+ P RITA L H W
Sbjct: 249 -----------------------------ISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279
Query: 706 FREVPLPKSKDFMPTFPAQHAQDRRMRR 733
++ + P+ + +R+
Sbjct: 280 IQKY--SSETPTISDLPSLESAMTNIRQ 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-57
Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 60/314 (19%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTS--------LR 461
+ + ++ K+ G YG V ++K A+K K + +K R +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LMETM--KQPFSQSEVK 517
EI++L S HP+I+ + +V + ++V E+ E G L E + + F + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVF--EDKKYFYLVTEFYE----GGELFEQIINRHKFDECDAA 149
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHL 574
+M Q+L GI YLH + ++HRD+K N+LL N+ +KI DFGL+ + S
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDR 208
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
+ T +Y APE+L K+Y+ D+WS G IM LL P F G+++ D + K+ K
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
+ W +SD +L+ +LTYD +KR
Sbjct: 267 DFNDWKN---------------------------------ISDEAKELIKLMLTYDYNKR 293
Query: 695 ITAEAALNHDWFRE 708
TAE ALN W ++
Sbjct: 294 CTAEEALNSRWIKK 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 93/366 (25%), Positives = 144/366 (39%), Gaps = 59/366 (16%)
Query: 391 GTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVK 447
G P A P + +L RS + R + +G + + D T E+ A K K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 448 MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM 507
+ K + ++ EI+I S H +V + D +F+V+E + L+E
Sbjct: 79 LLKPHQREKMS--MEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELH 132
Query: 508 KQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565
K+ ++ E + + Q++ G +YLH N V+HRDLK NL LN E+KI DFGLA +
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625
+ L T Y APE+L K +S +D+WS+GCIM LL +P F L
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LK 247
Query: 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNS 685
+ + +I K + P ++ L+
Sbjct: 248 ETYL-------RI---------KKNEY----------SIP-------KHINPVAASLIQK 274
Query: 686 LLTYDPDKRITAEAALNHDWFREVPLPK-----SKDFMPTFPAQHAQDRRMRRMMKSPDP 740
+L DP R T LN ++F +P P F + R P
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNR-----KP 329
Query: 741 LEEQRR 746
L +
Sbjct: 330 LTVLNK 335
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-57
Identities = 93/334 (27%), Positives = 149/334 (44%), Gaps = 51/334 (15%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL--LSFHHP 472
+E + I +G++G V +A D+ E VA+K +K ++ F + E+ +L ++ H
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDT 112
Query: 473 SIVDVKEVVVGSNLDS------IFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQLLE 525
+V + +V E + ++L L+ T + S + + Q+
Sbjct: 113 E--MKYYIV--HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 526 GIKYLHDNW--VLHRDLKTSNLLLNN--RGELKICDFGLARQYGSPLKPYTHLVVTLWYR 581
+ +L ++H DLK N+LL N R +KI DFG + Q G + Y + + +YR
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYR 225
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI--- 638
+PE+LLG Y AIDMWSLGCI+ E+ + EPLF+G +E DQ++KI + LG P I
Sbjct: 226 SPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 639 ---------------WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAG---- 679
W G + L T G ++G
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 680 -----FDLLNSLLTYDPDKRITAEAALNHDWFRE 708
DL+ +L YDP RI AL H +F++
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-57
Identities = 91/331 (27%), Positives = 151/331 (45%), Gaps = 57/331 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
D ++ + +G++G V +DK TG+ A+K K +++++ + L LRE+ +L
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL--LREVQLLKQL 83
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LMETM--KQPFSQSEVKCLMLQLLE 525
HP+I+ + E + ++V E G L + + ++ FS+ + ++ Q+L
Sbjct: 84 DHPNIMKLYEFF--EDKGYFYLVGEVYT----GGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
GI Y+H N ++HRDLK NLLL ++ + ++I DFGL+ + K + T +Y A
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIA 196
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE+L Y D+WS G I+ LLS P FNG +E+D L K+ K T W
Sbjct: 197 PEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
S K DL+ +LTY P RI+A AL+
Sbjct: 255 S--ESAK-------------------------------DLIRKMLTYVPSMRISARDALD 281
Query: 703 HDWFREVPLPKSKDFMPTFPAQHAQDRRMRR 733
H+W + + P+ +R+
Sbjct: 282 HEWIQT---YTKEQISVDVPSLDNAILNIRQ 309
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-57
Identities = 83/310 (26%), Positives = 130/310 (41%), Gaps = 49/310 (15%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINIL 466
RS + R + +G + + D T E+ A K K + K + ++ EI+I
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIH 69
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQLL 524
S H +V + D +F+V+E + L+E K+ ++ E + + Q++
Sbjct: 70 RSLAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELHKRRKALTEPEARYYLRQIV 125
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
G +YLH N V+HRDLK NL LN E+KI DFGLA + + L T Y APE
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+L K +S +D+WS+GCIM LL +P F L + + +I
Sbjct: 186 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYL-------RI------ 227
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
K + P ++ L+ +L DP R T LN +
Sbjct: 228 ---KKNEY----------SIP-------KHINPVAASLIQKMLQTDPTARPTINELLNDE 267
Query: 705 WFREVPLPKS 714
+F +P
Sbjct: 268 FFTSGYIPAR 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-57
Identities = 87/314 (27%), Positives = 142/314 (45%), Gaps = 52/314 (16%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINIL 466
+++F+ N + +G++ VYRA TG VA+K K M K + E+ I
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIH 65
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQ---PFSQSEVKCLMLQ 522
HPSI+++ + + +++V+E G + +K PFS++E + M Q
Sbjct: 66 CQLKHPSILELYNYF--EDSNYVYLVLEMCH---NGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
++ G+ YLH + +LHRDL SNLLL +KI DFGLA Q P + + L T Y +
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE+ + D+WSLGC+ LL P F+ + + L+K+
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
V ++ + P+ LS DL++ LL +P R++ + L+
Sbjct: 225 -----VLADY----------EMPSF-------LSIEAKDLIHQLLRRNPADRLSLSSVLD 262
Query: 703 HDWFREVPLPKSKD 716
H + KSKD
Sbjct: 263 HPFMSRNSSTKSKD 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-56
Identities = 88/332 (26%), Positives = 144/332 (43%), Gaps = 54/332 (16%)
Query: 391 GTPEPAGPPQRSINMLQGCRSV-DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KV 446
G+P +G ++M D +E I +G + VV R +++TG+ A+K
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 447 KMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DL----- 500
K RE +I HP IV++ E S+ ++MV E+M+ DL
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETY--SSDGMLYMVFEFMDGADLCFEIV 118
Query: 501 -KGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKIC 556
+ +S++ M Q+LE ++Y HDN ++HRD+K +LL ++ +K+
Sbjct: 119 KRA---DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 557 DFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFN 616
FG+A Q G V T + APE++ + Y +D+W G I+ LLS F
Sbjct: 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 617 GKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS 676
G E ++F E I G +Y + +++ S
Sbjct: 235 GTKE-----RLF-------EGIIKG--------------KYKMNPRQWSHI--------S 260
Query: 677 DAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
++ DL+ +L DP +RIT ALNH W +E
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 57/307 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKME-KEREGFPLTSLREINILLS 468
+ + + + +G++G V + +D+ T + A+K K + K+ LRE+ +L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREVELLKK 77
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+I+ + E++ + S ++V E G L + ++ FS+ + ++ Q+
Sbjct: 78 LDHPNIMKLFEIL--EDSSSFYIVGELYT----GGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYR 581
GI Y+H + ++HRDLK N+LL ++ + +KI DFGL+ + + T +Y
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYI 190
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
APE+L Y D+WS G I+ LLS P F GK+E+D L ++ + W
Sbjct: 191 APEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
+SD DL+ +LT+ P RITA L
Sbjct: 249 ---------------------------------ISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 702 NHDWFRE 708
H W ++
Sbjct: 276 EHPWIQK 282
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-56
Identities = 97/455 (21%), Positives = 165/455 (36%), Gaps = 66/455 (14%)
Query: 301 MPVSDSLQTRARNKFLSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEYHGHESEK 360
P + S T + L RI +E +S + + GDE
Sbjct: 57 SPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEP--TAPVLIPGDE--RKRRRG 112
Query: 361 GDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNK 420
D E + +V + + + P+P + D ++ +
Sbjct: 113 YDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL--------DHYDIHEE 164
Query: 421 IDEGTYGVVYRARDKKTGEIVALK--KVKMEKEREGFPLTSLREINILLSFHHPSIVDVK 478
+ G +GVV+R ++ TG A K E ++E +EI + HP++V++
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLH 220
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKG--LME---TMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
+ + + + M+ E+M G L E S+ E M Q+ +G+ ++H+N
Sbjct: 221 DAF--EDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 534 WVLHRDLKTSNLLLNNRGE--LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+H DLK N++ + LK+ DFGL P + T + APE+ G K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG-KP 332
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
DMWS+G + LLS F G+++ + L +
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------------------------ 368
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711
+N+ F S + G D + LL DP+ R+T AL H W
Sbjct: 369 -KSCDWNMDDSAFSGIS--------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419
Query: 712 PKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRR 746
P +P+ +D + P+PL R
Sbjct: 420 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR 454
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-56
Identities = 76/336 (22%), Positives = 134/336 (39%), Gaps = 54/336 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSL-REINILLS 468
D ++ ++ G + +V + R+K TG A K K + R G + RE++IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
H +++ + +V N + +++E + G L + K+ S+ E + Q+L
Sbjct: 72 VLHHNVITLHDVY--ENRTDVVLILELVS----GGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWY 580
+G+ YLH + H DLK N++L ++ +K+ DFGLA + + ++ T +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE++ + DMWS+G I LLS F G ++ + L I
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------- 230
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
V++ F F S+ D + LL + KR+T + A
Sbjct: 231 -------TSVSY----------DFDEEFF---SHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 701 LNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMK 736
L H W V + R+ +
Sbjct: 271 LRHPWITPVD-NQQAMVRRESVVNLENFRKQYVRRR 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-56
Identities = 89/317 (28%), Positives = 143/317 (45%), Gaps = 55/317 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----KVKMEKEREGFPLTSL-REINIL 466
DE+ + G G V A ++KT + VA++ K + RE P ++ EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQ 522
+HP I+ +K + ++V+E ME G L + + ++ K Q
Sbjct: 195 KKLNHPCIIKIKNFFDAED---YYIVLELME----GGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLW 579
+L ++YLH+N ++HRDLK N+LL+++ E +KI DFG ++ G T L T
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 306
Query: 580 YRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
Y APE+L+ Y+ A+D WSLG I+ LS P F+ Q + ++
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE--HRTQ-VSLK-------DQ 356
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
I G +YN + + + +S+ DL+ LL DP R T
Sbjct: 357 ITSG--------------KYNFIPEVWAE--------VSEKALDLVKKLLVVDPKARFTT 394
Query: 698 EAALNHDWFREVPLPKS 714
E AL H W ++ + +
Sbjct: 395 EEALRHPWLQDEDMKRK 411
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-56
Identities = 89/344 (25%), Positives = 140/344 (40%), Gaps = 64/344 (18%)
Query: 392 TPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE 451
T + A P S + + +E + G VV R K T + A+K + +
Sbjct: 1 TRDAALPGSHSTHGFY-----ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGG 55
Query: 452 R-------EGFPLTSLREINILLS-FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG- 502
+ +L+E++IL HP+I+ +K+ F+V + M+ KG
Sbjct: 56 GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMK---KGE 110
Query: 503 LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560
L + T K S+ E + +M LLE I LH ++HRDLK N+LL++ +K+ DFG
Sbjct: 111 LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLF 615
+ Q P + + T Y APE++ S Y +DMWS G IM LL+ P F
Sbjct: 171 SCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 616 NGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSP-- 673
+ + L I + + F
Sbjct: 230 WHRKQMLMLRMI--------------------------------MSGNY---QFGSPEWD 254
Query: 674 VLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDF 717
SD DL++ L P KR TAE AL H +F++ + + + F
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-56
Identities = 58/313 (18%), Positives = 121/313 (38%), Gaps = 36/313 (11%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
+ + + +G V+R R KKTG++ A+K + + + +RE +L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQP-----FSQSEVKCLMLQL 523
+H +IV + + + ++ME+ G L +++P +SE ++ +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCP---CGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
+ G+ +L +N ++HR++K N++ + + K+ DFG AR+ + + L T
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-LYGTEE 180
Query: 580 YRAPELLLG-------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632
Y P++ K+Y +D+WS+G + F + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM---- 236
Query: 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPD 692
KI G V ++ P + + S L +L ++L D +
Sbjct: 237 ---YKIITGKPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQE 292
Query: 693 KRITAEAALNHDW 705
K +
Sbjct: 293 KCWGFDQFFAETS 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-56
Identities = 67/320 (20%), Positives = 128/320 (40%), Gaps = 59/320 (18%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM--EKEREGFPLTSLREINILLSFHHP 472
+ + K+ EG + V G ALK++ +++RE + RE ++ F+HP
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE----EAQREADMHRLFNHP 86
Query: 473 SIVDVKEVVV--GSNLDSIFMVMEYMEH-DLKGLMETMKQ---PFSQSEVKCLMLQLLEG 526
+I+ + + ++++ + + L +E +K ++ ++ L+L + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV---------T 577
++ +H HRDLK +N+LL + G+ + D G Q ++ + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 578 LWYRAPELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTP 634
+ YRAPEL D+WSLGC++ ++ E ++ + D +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA------- 259
Query: 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
+++Q P SP S A + LLNS++T DP +R
Sbjct: 260 ------------------VQNQL-----SIPQ-----SPRHSSALWQLLNSMMTVDPHQR 291
Query: 695 ITAEAALNHDWFREVPLPKS 714
L+ + P P
Sbjct: 292 PHIPLLLSQLEALQPPAPGQ 311
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 76/306 (24%), Positives = 126/306 (41%), Gaps = 53/306 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
D F K+ G +G V+ ++ +G +K K + + E EI +L S
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSL 77
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQLLE 525
HP+I+ + EV + ++++VME E + + + S+ V LM Q++
Sbjct: 78 DHPNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
+ Y H V+H+DLK N+L + +KI DFGLA + + T+ T Y A
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMA 194
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE+ + + D+WS G +M LL+ F G S + K + P
Sbjct: 195 PEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-- 250
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
L+ DLL +LT DP++R +A L+
Sbjct: 251 --------------------------------LTPQAVDLLKQMLTKDPERRPSAAQVLH 278
Query: 703 HDWFRE 708
H+WF++
Sbjct: 279 HEWFKQ 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 76/308 (24%), Positives = 133/308 (43%), Gaps = 53/308 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSL-REINILLS 468
D +E ++ G + +V + R K TG+ A K K ++ R G + RE+NIL
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+I+ + ++ N + +++E + G L + K+ ++ E + Q+L
Sbjct: 65 IRHPNIITLHDIF--ENKTDVVLILELVS----GGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWY 580
+G+ YLH + H DLK N++L ++ +K+ DFG+A + + ++ T +
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEF 177
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE++ + DMWS+G I LLS F G+++ + L I
Sbjct: 178 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------- 223
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
VN+ F F S+ D + LL DP +R+T +
Sbjct: 224 -------SAVNY----------DFDEEYF---SNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 701 LNHDWFRE 708
L H W +
Sbjct: 264 LEHSWIKA 271
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-55
Identities = 85/295 (28%), Positives = 124/295 (42%), Gaps = 57/295 (19%)
Query: 424 GTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
G++G V A K T A K K +E + + F +EI I+ S HP+I+ + E
Sbjct: 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRF----KQEIEIMKSLDHPNIIRLYET 74
Query: 481 VVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ I++VME G L E K+ F +S+ +M +L + Y H V
Sbjct: 75 F--EDNTDIYLVMELCT----GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 537 HRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYS 593
HRDLK N L LK+ DFGLA ++ P K V T +Y +P++L Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVL--EGLYG 185
Query: 594 TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653
D WS G +M LL P F+ ++ + + KI + T EK W
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN------------ 233
Query: 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
+S L+ LLT P +RIT+ AL H+WF +
Sbjct: 234 ---------------------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 74/346 (21%), Positives = 129/346 (37%), Gaps = 85/346 (24%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
++ I +G+YGVV A + +T I A+K K K+ + E+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYME-------------------------------- 497
HHP+I + EV + I +VME
Sbjct: 86 HHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 498 --------HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549
+ G E++ + + +M Q+ + YLH+ + HRD+K N L +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 550 RGE--LKICDFGLARQYGSP----LKPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLG 602
+K+ DFGL++++ T T ++ APE+L + + Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 603 CIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK 662
++ LL F G ++ D + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQV-------------------------LNKKLC---- 294
Query: 663 KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
F ++ VLS DLL++LL + D+R A AL H W +
Sbjct: 295 -FENPNY---NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-55
Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 56/307 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKME-KEREGFPLTSLREINILLS 468
D ++ ++ +G + VV R K TG A K K+ ++ + RE I
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREARICRK 61
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+IV + + + ++V + + G L E ++ +S+++ + Q+L
Sbjct: 62 LQHPNIVRLHDSI--QEESFHYLVFDLVT----GGELFEDIVAREFYSEADASHCIQQIL 115
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYR 581
E I Y H N ++HR+LK NLLL ++ + +K+ DFGLA + + + T Y
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 174
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
+PE+L YS +D+W+ G I+ LL P F + + +I
Sbjct: 175 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------- 219
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
Y+ +P+ + ++ L++S+LT +P KRITA+ AL
Sbjct: 220 -----------KAGAYD-----YPSPEW---DTVTPEAKSLIDSMLTVNPKKRITADQAL 260
Query: 702 NHDWFRE 708
W
Sbjct: 261 KVPWICN 267
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-55
Identities = 83/332 (25%), Positives = 139/332 (41%), Gaps = 62/332 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HH 471
D +E I G+Y V R K T A+K + K EI ILL + H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQH 75
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGI 527
P+I+ +K+V + +++V E M+ G L++ ++ FS+ E ++ + + +
Sbjct: 76 PNIITLKDVY--DDGKYVYVVTELMK----GGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
+YLH V+HRDLK SN+L + ++ICDFG A+Q + T + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
E+L Y A D+WSLG ++ +L+ F + ++I +I G
Sbjct: 190 EVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEIL-------ARIGSG-- 238
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSP--VLSDAGFDLLNSLLTYDPDKRITAEAAL 701
++ S +G +SD DL++ +L DP +R+TA L
Sbjct: 239 ------------KF----------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
Query: 702 NHDWFREVPLPKSKDFMPTFPAQHAQDRRMRR 733
H W D +P + + +
Sbjct: 277 RHPWIVH------WDQLPQYQLNRQDAPHLVK 302
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-55
Identities = 90/416 (21%), Positives = 155/416 (37%), Gaps = 57/416 (13%)
Query: 328 SERSRSRSSESDERGDRARSLSGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDEN 387
S + +S+ S + E+ + + + + +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63
Query: 388 DSCGTPEPAGPPQRSINMLQG-CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK-- 444
P PA R + QG S + + G +G V++ + TG +A K
Sbjct: 64 VDIPAP-PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 445 KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-- 502
K + K++E EI+++ H +++ + + N I +VMEY++ G
Sbjct: 123 KTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKN--DIVLVMEYVD----GGE 172
Query: 503 LME---TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--LKICD 557
L + ++ + M Q+ EGI+++H ++LH DLK N+L NR +KI D
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 558 FGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617
FGLAR+Y P + T + APE++ S DMWS+G I LLS F G
Sbjct: 233 FGLARRYK-PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
Query: 618 KSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSD 677
++ + L+ I + + F +S+
Sbjct: 291 DNDAETLNNI--------------------LACRW----------DLEDEEF---QDISE 317
Query: 678 AGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDF-MPTFPAQHAQDRRMR 732
+ ++ LL + RI+A AL H W + L AQD +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQDFVTK 373
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 74/344 (21%), Positives = 129/344 (37%), Gaps = 46/344 (13%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL-----LSFHHP 472
+ K+ G + V+ A+D VA+K V+ + + + EI +L
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 473 SIVDVKEVV--------VGSNLDSIFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQL 523
+ ++ G N + MV E + +L L+ + + VK + QL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 524 LEGIKYLHDNW-VLHRDLKTSNLLLN------NRGELKICDFGLARQYGSPLKPYTHLVV 576
L G+ Y+H ++H D+K N+L+ N ++KI D G A Y +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQ 197
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS------EFDQLDKIFKT 630
T YR+PE+LLG+ + D+WS C++ EL++ + LF + D + +I +
Sbjct: 198 TREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256
Query: 631 LGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATS-------FTGSPVLSDAGF-DL 682
LG + + F K D
Sbjct: 257 LGELPSYL---LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 683 LNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHA 726
L+ +L DP KR A +NH W ++ L + +P +
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDT-LGMEEIRVPDRELYGS 356
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 70/332 (21%), Positives = 135/332 (40%), Gaps = 53/332 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSFHH 471
+++ + G +G+V+R + + + K V ++ +EI+IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNIARH 60
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME---TMKQPFSQSEVKCLMLQLLEG 526
+I+ + E +++ + M+ E++ G + E T ++ E+ + Q+ E
Sbjct: 61 RNILHLHESF--ESMEELVMIFEFIS----GLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGE--LKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
+++LH + + H D++ N++ R +KI +FG ARQ P + L Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPE 173
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+ STA DMWSLG ++ LLS F ++ ++ I
Sbjct: 174 VHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------------- 215
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
+ +Y F +F +S D ++ LL + R+TA AL H
Sbjct: 216 --------MNAEYT-----FDEEAF---KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMRRMMK 736
W ++ S + T + +++ +
Sbjct: 260 WLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN 291
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 77/336 (22%), Positives = 135/336 (40%), Gaps = 54/336 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSL-REINILLS 468
D ++ ++ G + +V + R+K TG A K K + R G + RE++IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+I+ + +V N + +++E + G L + K+ S+ E + Q+L
Sbjct: 72 VLHPNIITLHDVY--ENRTDVVLILELVS----GGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWY 580
+G+ YLH + H DLK N++L ++ +K+ DFGLA + + ++ T +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE++ + DMWS+G I LLS F G ++ + L I
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------- 230
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
V++ F F S+ D + LL + KR+T + A
Sbjct: 231 -------TAVSY----------DFDEEFF---SQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 701 LNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMK 736
L H W V + ++ +
Sbjct: 271 LRHPWITPVD-TQQAMVRRESVVNLENFKKQYVRRR 305
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 79/323 (24%), Positives = 135/323 (41%), Gaps = 53/323 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSL-REINILLS 468
D ++ ++ G + VV + R+K TG A K K + + R G + RE++IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+++ + EV N + +++E + G L + K+ ++ E + Q+L
Sbjct: 71 IQHPNVITLHEVY--ENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWY 580
G+ YLH + H DLK N++L +R +KI DFGLA + + ++ T +
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEF 183
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE++ + DMWS+G I LLS F G ++ + L +
Sbjct: 184 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------- 229
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
VN+ +F F S D + LL DP KR+T + +
Sbjct: 230 -------SAVNY----------EFEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 701 LNHDWFREVPLPKSKDFMPTFPA 723
L H W + ++ +
Sbjct: 270 LQHPWIKPKDTQQALSRKASAVN 292
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-54
Identities = 78/309 (25%), Positives = 132/309 (42%), Gaps = 49/309 (15%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILL 467
++++FE + +G +G VY AR+K++ I+ALK K ++EK L RE+ I
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL--RREVEIQS 64
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
HP+I+ + + +++++EY + + F + + +L
Sbjct: 65 HLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANA 121
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+ Y H V+HRD+K NLLL + GELKI DFG + S + L TL Y PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTD-LCGTLDYLPPEMI 179
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
G + + +D+WSLG + E L +P F + + +I
Sbjct: 180 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------------------- 219
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+V F FP +++ DL++ LL ++P +R L H W
Sbjct: 220 -SRVEF----------TFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
Query: 707 REVPLPKSK 715
S
Sbjct: 262 TANSSKPSN 270
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 84/321 (26%), Positives = 139/321 (43%), Gaps = 47/321 (14%)
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVV 482
G + VV + K TG+ A K +K + + L EI +L P ++++ EV
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 483 GSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
++ I +++EY L + + + S+++V L+ Q+LEG+ YLH N ++H
Sbjct: 100 NTS--EIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 539 DLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
DLK N+LL++ +KI DFG++R+ G ++ T Y APE+L +TA
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILNY-DPITTA 213
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
DMW++G I LL+ F G+ + I +VN
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--------------------SQVNV--- 250
Query: 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSK 715
+ +F +S D + SLL +P+KR TAE L+H W ++
Sbjct: 251 -------DYSEETF---SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
Query: 716 DFMPTFPAQHAQDRRMRRMMK 736
T + QD +R
Sbjct: 301 HPEETSSSSQTQDHSVRSSED 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-54
Identities = 82/397 (20%), Positives = 153/397 (38%), Gaps = 59/397 (14%)
Query: 355 GHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDE 414
H G + D + D ED P+P Q S+ D
Sbjct: 5 HHHHHHGSKVRGKYD---GPKINDYDKFYEDIWKKY-VPQPVEVKQGSVY--------DY 52
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALK--KVKMEKEREGFPLTSLREINILLSFHHP 472
++ L ++ G +GVV+R +K TG + K ++ EI+I+ HHP
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISIMNQLHHP 108
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
++++ + + + +++E++ +L + S++EV M Q EG+K++H
Sbjct: 109 KLINLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 532 DNWVLHRDLKTSNLLLNNRGE--LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
++ ++H D+K N++ + +KI DFGLA + P + T + APE++
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDR- 224
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
+ DMW++G + LLS F G+ + + L +
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---------------------- 262
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+ + F +F +S D + +LL +P KR+T AL H W +
Sbjct: 263 ---KRCDWE-----FDEDAF---SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG- 310
Query: 710 PLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRR 746
+P+ + + + P P R
Sbjct: 311 DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 347
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 65/353 (18%), Positives = 134/353 (37%), Gaps = 68/353 (19%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSL------ 460
+ ++++ + +++G + + K + ALK K +EK+R+ +
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 461 ------REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME--------HDLKGLMET 506
E+ I+ + + + ++ +N D ++++ EYME L +
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 507 MKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQY- 564
+KC++ +L Y+H+ + HRD+K SN+L++ G +K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 565 --------GSPLKPYTHLVVTLWYRAPELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLF 615
G+ + PE Y+ +D+WSLG + + F
Sbjct: 204 DKKIKGSRGTYE-----------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 616 NGKSEFDQL-DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPV 674
+ K +L + I + + + + L S +
Sbjct: 253 SLKISLVELFNNIRT------------------KNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 675 LSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQ 727
LS+ D L L +P +RIT+E AL H+W + + ++F + +
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKK 347
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-53
Identities = 84/302 (27%), Positives = 129/302 (42%), Gaps = 62/302 (20%)
Query: 423 EGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF-HHPSIVDVK 478
EG++ + + KK+ + A+K K + +EI L HP+IV +
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNIVKLH 72
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
EV + F+VME + G L E K+ FS++E +M +L+ + ++HD
Sbjct: 73 EVF--HDQLHTFLVMELLN----GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 535 VLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
V+HRDLK NLL + + +KI DFG AR +P TL Y APELL +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG- 185
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSE---FDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y + D+WSLG I+ +LS + F +I +KI
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-------KKI---------- 228
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSP--VLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ F SF G +S DL+ LLT DP+KR+ ++W
Sbjct: 229 -----------KKGDF---SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274
Query: 707 RE 708
++
Sbjct: 275 QD 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-53
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 57/299 (19%)
Query: 423 EGTYGVVYRARDKKTGEIVALKKV-KMEKEREGFPLTSLREINILLSF-HHPSIVDVKEV 480
G G V ++TG+ ALK + K R +E++ P IV + +V
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPKAR--------QEVDHHWQASGGPHIVCILDV 90
Query: 481 V--VGSNLDSIFMVMEYMEHDLKG------LMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+ + ++ME ME G + E Q F++ E +M + I++LH
Sbjct: 91 YENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 533 NWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ + HRD+K NLL ++ + LK+ DFG A++ T +Y APE+L
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPE 204
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
K Y + DMWSLG IM LL P F + + + +I G
Sbjct: 205 K-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-------RIRLG-------- 248
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
QY FP + +S+ L+ LL DP +R+T +NH W +
Sbjct: 249 ------QYG-----FPNPEW---SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 63/323 (19%), Positives = 113/323 (34%), Gaps = 71/323 (21%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS- 468
R EF L KI G +G V++ + G I A+K+ K +LRE+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQ---PFSQSEVKCLMLQLL 524
H +V D + + EY L + + F ++E+K L+LQ+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGEL-------------------KICDFGLARQYG 565
G++Y+H ++H D+K SN+ ++ KI D G +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 566 SPLKPYTHLVV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624
SP + + A E+L + + D+++L + EPL ++
Sbjct: 186 SP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237
Query: 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLN 684
+ + + + P VLS +LL
Sbjct: 238 --------------------------------HEIRQGRLPRI----PQVLSQEFTELLK 261
Query: 685 SLLTYDPDKRITAEAALNHDWFR 707
++ DP++R +A A + H
Sbjct: 262 VMIHPDPERRPSAMALVKHSVLL 284
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-53
Identities = 68/334 (20%), Positives = 125/334 (37%), Gaps = 53/334 (15%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL--LSFHHP 472
F + K+ +GT+G V + + A+K V+ K+ + ++ E +IL +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAKIEADILKKIQNDDI 93
Query: 473 S---IVDVKEVVVGSNLDSIFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQLLEGIK 528
+ IV + + + ++ E + L ++ F ++K +++L+ +
Sbjct: 94 NNNNIVKYHGKFMYYD--HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 529 YLHDNWVLHRDLKTSNLLLNN-------------------------RGELKICDFGLARQ 563
YL + H DLK N+LL++ +K+ DFG A
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
+ T YRAPE++L + + DMWS GC++AEL + LF +
Sbjct: 212 KSDYHGSI---INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 624 LDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLL----------RKKFPATSFTGSP 673
L + + + + +K G K ++ L K
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGSK--YVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 674 VLSDAGF-DLLNSLLTYDPDKRITAEAALNHDWF 706
++ F D L S+L DP R + L H +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-52
Identities = 88/397 (22%), Positives = 148/397 (37%), Gaps = 60/397 (15%)
Query: 328 SERSRSRSSESDERGDRARSLSGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDEN 387
S + E R L + + N + D++ +
Sbjct: 9 SGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKG 68
Query: 388 DSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK--- 444
+ GP + +++ + I G VV R + TG A+K
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 445 KVKM---EKEREGFPLTSLREINILLS-FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDL 500
++ E + RE +IL HP I+ + + S+ +F+V + M
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS--FMFLVFDLMR--- 183
Query: 501 KG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
L + T K S+ E + +M LLE + +LH N ++HRDLK N+LL++ ++++
Sbjct: 184 -KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242
Query: 557 DFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS-----KQYSTAIDMWSLGCIMAELLSK 611
DFG + P + L T Y APE+L S Y +D+W+ G I+ LL+
Sbjct: 243 DFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
Query: 612 EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTG 671
P F + + L I + ++ F+
Sbjct: 302 SPPFWHRRQILMLRMI--------------------------------MEGQY---QFSS 326
Query: 672 SP--VLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
S DL++ LL DP+ R+TAE AL H +F
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-52
Identities = 72/336 (21%), Positives = 130/336 (38%), Gaps = 55/336 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEK-EREGFPLTSLREINILLS 468
+E++ ++ +G + VV R G+ A K+ + + RE I
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL----EREARICRL 66
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+IV + + + S +++ + + G L E ++ +S+++ + Q+L
Sbjct: 67 LKHPNIVRLHDSI--SEEGHHYLIFDLVT----GGELFEDIVAREYYSEADASHCIQQIL 120
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYR 581
E + + H V+HR+LK NLLL ++ + +K+ DFGLA + + + T Y
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
+PE+L Y +D+W+ G I+ LL P F + + +I W
Sbjct: 181 SPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
++ DL+N +LT +P KRITA AL
Sbjct: 240 ---------------------------------VTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 702 NHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKS 737
H W S + R++ +
Sbjct: 267 KHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 79/369 (21%), Positives = 143/369 (38%), Gaps = 58/369 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEK-EREGFPLTSLREINILLS 468
D ++ ++ +G + VV R K TG A K K+ + + RE I
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREARICRK 84
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLL 524
HP+IV + + + ++V + + G L E ++ +S+++ + Q+L
Sbjct: 85 LQHPNIVRLHDSI--QEESFHYLVFDLVT----GGELFEDIVAREFYSEADASHCIQQIL 138
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYR 581
E I Y H N ++HR+LK NLLL ++ + +K+ DFGLA + + + T Y
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 197
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
+PE+L YS +D+W+ G I+ LL P F + + +I
Sbjct: 198 SPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------- 242
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
Y+ +P+ + ++ L++S+LT +P KRITA+ AL
Sbjct: 243 -----------KAGAYD-----YPSPEW---DTVTPEAKSLIDSMLTVNPKKRITADQAL 283
Query: 702 NHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDP--LEEQRRKELQQGELGIHSD 759
W S + R++ + + + L + L
Sbjct: 284 KVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQ 343
Query: 760 LYGEIVCTI 768
+
Sbjct: 344 GPPSTIKES 352
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-52
Identities = 83/370 (22%), Positives = 145/370 (39%), Gaps = 58/370 (15%)
Query: 381 TDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNK-IDEGTYGVVYRARDKKTGE 439
P + + + + +D+++ ++ + G G V + +K+T E
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKN-AIIDDYKVTSQVLGLGINGKVLQIFNKRTQE 88
Query: 440 IVALKKV-KMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVV--VGSNLDSIFMVMEY 495
ALK + K R RE+ + P IV + +V + + + +VME
Sbjct: 89 KFALKMLQDCPKAR--------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 496 MEHDLKG------LMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549
++ G + + Q F++ E +M + E I+YLH + HRD+K NLL +
Sbjct: 141 LD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196
Query: 550 RGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMA 606
+ LK+ DFG A++ + T T +Y APE +LG ++Y + DMWSLG IM
Sbjct: 197 KRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMY 254
Query: 607 ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPA 666
LL P F + +I G QY FP
Sbjct: 255 ILLCGYPPFYSNHGLAISPGMK-------TRIRMG--------------QYE-----FPN 288
Query: 667 TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHA 726
+ +S+ L+ +LL +P +R+T +NH W + + +
Sbjct: 289 PEW---SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 345
Query: 727 QDRRMRRMMK 736
++R +
Sbjct: 346 KERWEDVKEE 355
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 75/346 (21%), Positives = 128/346 (36%), Gaps = 47/346 (13%)
Query: 415 FERLNKIDEGTYGVVYRARD-KKTGEIVALKKVKMEKEREGFPLTSLREINIL--LSFHH 471
+E + + EGT+G V D + VALK ++ + + + EIN+L +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKD 77
Query: 472 PSIVDVKEVVVGSNLDS------IFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQLL 524
+ V D + + E + + + E QP+ V+ + QL
Sbjct: 78 KE--NKFLCV--LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNN-------------------RGELKICDFGLARQYG 565
+++LH+N + H DLK N+L N +++ DFG A
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625
V T YR PE++L ++ D+WS+GCI+ E LF + L
Sbjct: 194 EHHTTI---VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 626 KIFKTLGTPNEKIWPG-------FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDA 678
+ K LG + + N +Y K + +
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 679 GFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQ 724
FDL+ +L +DP +RIT AL H +F + + P++
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-51
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 36/333 (10%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINIL 466
++ +E ++ G +G V R + TGE VA+K + K RE + EI I+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW----CLEIQIM 66
Query: 467 LSFHHPSIVDVKEVVVGSN----LDSIFMVMEYMEH-DLKGLMETMKQP--FSQSEVKCL 519
+HP++V +EV G D + MEY E DL+ + + + ++ L
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQY--GSPLKPYTHL 574
+ + ++YLH+N ++HRDLK N++L R KI D G A++ G
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--E-F 183
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
V TL Y APELL K+Y+ +D WS G + E ++ F + Q +
Sbjct: 184 VGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR----- 237
Query: 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694
K V + + T S +L+ L +L + +R
Sbjct: 238 --------EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289
Query: 695 ITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQ 727
T N F+ + S + +
Sbjct: 290 GTDPQNPNVGCFQALDSILSLKLLSVMNMVSGR 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-51
Identities = 64/337 (18%), Positives = 116/337 (34%), Gaps = 61/337 (18%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL-LSFHHP 472
F + + G G + R VA+K++ E + RE+ +L S HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHP 78
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+++ ++ +E L+ +E E L+ Q G+ +LH
Sbjct: 79 NVIRYFCTEKDRQ--FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 533 NWVLHRDLKTSNLLLNNRGE-----LKICDFGLARQYGSPLKPYTHL---VVTLWYRAPE 584
++HRDLK N+L++ I DFGL ++ ++ T + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 585 LLLGS--KQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
+L + + +D++S GC+ ++S+ F +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------------------- 235
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
Q N+L +L+ ++ DP KR +A+ L
Sbjct: 236 -------------RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282
Query: 702 NHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSP 738
H +F + K F Q DR + + P
Sbjct: 283 KHPFFWSL--EKQLQFF-----QDVSDRIEKESLDGP 312
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 84/341 (24%), Positives = 132/341 (38%), Gaps = 59/341 (17%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTG-EIVALKKVK-MEKEREGFPLTSLREINIL--LSFH 470
+E ++ + EG +G V D K G VA+K VK +++ E + EI +L L+
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AARSEIQVLEHLNTT 71
Query: 471 HPSIVDVKEVVVGSNLDS------IFMVMEYMEHDLKGLM-ETMKQPFSQSEVKCLMLQL 523
P+ V L+ I +V E + + E PF ++ + Q+
Sbjct: 72 DPN--STFRCV--QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNN-------------------RGELKICDFGLARQY 564
+ + +LH N + H DLK N+L ++K+ DFG A
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624
V T YRAPE++L +S D+WS+GCI+ E +F + L
Sbjct: 188 DEHHSTL---VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLL-----RKKFPATS------FTGSP 673
+ + LG + + K K F + + +
Sbjct: 244 AMMERILGPLPKHM---IQKTRKRK-YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 674 VLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
V + FDL+ +L YDP KRIT AL H +F L KS
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFD--LLKKS 338
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 90/352 (25%), Positives = 142/352 (40%), Gaps = 58/352 (16%)
Query: 370 HNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGC---RSVDEFERLNKIDE--- 423
H+++ S G S + + P + + + D +++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 424 -GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVV 482
G +VYR + K T + ALK +K +++ EI +LL HP+I+ +KE+
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLKEIF- 117
Query: 483 GSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
I +V+E + G L + K +S+ + + Q+LE + YLH+N ++HR
Sbjct: 118 -ETPTEISLVLELVT----GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 539 DLKTSNLLLNNRGE---LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
DLK NLL LKI DFGL++ + T Y APE+L G Y
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILRG-CAYGPE 230
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
+DMWS+G I LL F + DQ +F +I
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERG-DQ--FMF-------RRILNC-------------- 266
Query: 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
+Y F + + +S DL+ L+ DP KR+T AL H W
Sbjct: 267 EYY-----FISPWW---DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 77/326 (23%), Positives = 128/326 (39%), Gaps = 78/326 (23%)
Query: 397 GPPQRSINMLQGCRSVDEFERLNK-IDEGTYGVVYRARDKKTGEIVALKKV-KMEKEREG 454
GP +S ++ +D+++ ++ + G G V + +K+T E ALK + K R
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-- 58
Query: 455 FPLTSLREINILLSF-HHPSIVDVKEVV--VGSNLDSIFMVMEYMEHDLKG------LME 505
RE+ + P IV + +V + + + +VME ++ G + +
Sbjct: 59 ------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQD 108
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLAR 562
Q F++ E +M + E I+YLH + HRD+K NLL ++ LK+ DFG
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166
Query: 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD 622
A E ++Y + DMWSLG IM LL P F
Sbjct: 167 -------------------AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
Query: 623 QLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDL 682
+ +I G QY FP + +S+ L
Sbjct: 206 ISPGMK-------TRIRMG--------------QYE-----FPNPEW---SEVSEEVKML 236
Query: 683 LNSLLTYDPDKRITAEAALNHDWFRE 708
+ +LL +P +R+T +NH W +
Sbjct: 237 IRNLLKTEPTQRMTITEFMNHPWIMQ 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-50
Identities = 71/340 (20%), Positives = 130/340 (38%), Gaps = 72/340 (21%)
Query: 401 RSINMLQGCRSVDEFERLNK-IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS 459
R N+ +S+ K + G+ G V + G VA+K++ ++ +
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IA 55
Query: 460 LREINILL-SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDL------KGLMETMKQPFS 512
L EI +L S HP+++ + +++ +E +L K + + +
Sbjct: 56 LMEIKLLTESDDHPNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-------------LKICDFG 559
+ L+ Q+ G+ +LH ++HRDLK N+L++ + I DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 560 LARQYG----SPLKPYTHLVVTLWYRAPELLLGS------KQYSTAIDMWSLGCIMAELL 609
L ++ S + T +RAPELL S ++ + +ID++S+GC+ +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 610 SK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATS 668
SK + F K + N I+ ++
Sbjct: 234 SKGKHPFGDKYSRES---------------------------NIIRGIFS-----LDEMK 261
Query: 669 FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
L DL++ ++ +DP KR TA L H F
Sbjct: 262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-50
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 49/302 (16%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILL 467
++D+F+ + +G +G VY AR+K+ I+ALK K ++EKE L REI I
Sbjct: 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
HP+I+ + I++++E+ +L ++ F + M +L +
Sbjct: 70 HLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADA 126
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
+ Y H+ V+HRD+K NLL+ +GELKI DFG + +P + TL Y PE++
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLDYLPPEMI 184
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
G K + +D+W G + E L P F+ S + +I
Sbjct: 185 EG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------------------- 224
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
V V+ KFP P LSD DL++ LL Y P +R+ + + H W
Sbjct: 225 -VNVDL----------KFP-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
Query: 707 RE 708
+
Sbjct: 267 KA 268
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 72/318 (22%), Positives = 121/318 (38%), Gaps = 59/318 (18%)
Query: 423 EGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLS-FHHPSIVDVK 478
EG + V + T + A+K K F RE+ +L H +++++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-----REVEMLYQCQGHRNVLELI 77
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
E D ++V E M G ++ ++ F++ E ++ + + +LH+
Sbjct: 78 EFF--EEEDRFYLVFEKMR----GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 535 VLHRDLKTSNLLLNNRGE---LKICDFGLARQY--GSPLKPYTH-----LVVTLWYRAPE 584
+ HRDLK N+L + + +KICDF L P + + Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 585 LLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
++ + Y D+WSLG I+ LLS P F G+ D + +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML-- 249
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSP--VLSDAGFDLLNSLLTYDPDKRITAE 698
F + K+ F +S A DL++ LL D +R++A
Sbjct: 250 -FES--------------IQEGKY---EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 699 AALNHDWFR----EVPLP 712
L H W + E LP
Sbjct: 292 QVLQHPWVQGCAPENTLP 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 42/339 (12%), Positives = 97/339 (28%), Gaps = 87/339 (25%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE----------- 462
R + + A D++TGE + + + ++E
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 463 ---------------INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETM 507
+++ ++ V+ + S F + M+ +L+ E +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 508 KQ------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
L LQ++ + LH ++H L+ +++L+ RG + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 562 RQYGSPLKPYTHLVVTLWYRAPELL----------LGSKQYSTAIDMWSLGCIMAELLSK 611
+ G+ V+ + PEL + + D W+LG ++ +
Sbjct: 254 VRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 612 EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTG 671
+ + + IF++ V+
Sbjct: 310 DLPITKDAALGGSEWIFRS--------CKNIP--QPVR---------------------- 337
Query: 672 SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
LL L Y + R+ A+ + ++
Sbjct: 338 ---------ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-48
Identities = 79/339 (23%), Positives = 132/339 (38%), Gaps = 70/339 (20%)
Query: 423 EGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
EG+YG V D +T A+K K K+ + G +EI +L H +++ + +
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRRLRHKNVIQLVD 73
Query: 480 VVVGSNLDSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
V+ ++MVMEY ++ +++ ++ F + QL++G++YLH ++H+
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK 133
Query: 539 DLKTSNLLLNNRGELKICDFGLARQY-------------GSPLKPYTHLVVTLWYRAPEL 585
D+K NLLL G LKI G+A GSP ++ PE+
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA-----------FQPPEI 182
Query: 586 LLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
G +S +D+WS G + + + G
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITT------------------------------GL-- 210
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
P F L + S+ DLL +L Y+P KR + H
Sbjct: 211 YP-----FEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265
Query: 705 WFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEE 743
WFR+ P ++ +P P+ +DR R M LE+
Sbjct: 266 WFRK-KHPPAEAPVPIPPSPDTKDR--WRSMTVVPYLED 301
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 78/346 (22%), Positives = 136/346 (39%), Gaps = 90/346 (26%)
Query: 402 SINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLT 458
S C ++++ ++I +G+YGVV A ++ A+K K K+ ++
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 459 SL---------------------REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME 497
+EI IL HP++V + EV+ N D ++MV E +
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 498 HDLKG-LMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKI 555
+G +ME +P S+ + + L++GI+YLH ++HRD+K SNLL+ G +KI
Sbjct: 122 ---QGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178
Query: 556 CDFGLARQY-----------GSPLKPYTHLVVTLWYRAPELLLGS-KQYS-TAIDMWSLG 602
DFG++ ++ G+P + APE L + K +S A+D+W++G
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPA-----------FMAPESLSETRKIFSGKALDVWAMG 227
Query: 603 CIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLR 661
+ + + P F + KI P + +K
Sbjct: 228 VTLYCFVFGQCP-FMDERIMCLHSKIKS--QALEFPDQPDIA--EDLK------------ 270
Query: 662 KKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
DL+ +L +P+ RI H W
Sbjct: 271 -------------------DLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 80/302 (26%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
DE + +GTYG+VY RD +A+K++ R PL EI + H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL--HEEIALHKHLKHK 79
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHD-LKGLMETMKQPFSQSE--VKCLMLQLLEGIKY 529
+IV + IFM E + L L+ + P +E + Q+LEG+KY
Sbjct: 80 NIVQYLGSFSENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 530 LHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
LHDN ++HRD+K N+L+N G LKI DFG +++ TL Y APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 589 SKQ-YSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
+ Y A D+WSLGC + E+ + K P + + K+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP------------ 245
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ P + +S + DPDKR A L ++
Sbjct: 246 ----------------EIPES-------MSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282
Query: 707 RE 708
+
Sbjct: 283 KV 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 92/402 (22%), Positives = 162/402 (40%), Gaps = 77/402 (19%)
Query: 370 HNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSIN---MLQGCRSVD---EFERLNKIDE 423
H+++ T P PAG S+ + + D F L +I
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 424 GTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-REINILLSFHHPSIVDVKEVVV 482
G++G VY ARD + E+VA+KK+ ++ + +E+ L HP+ + +
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR---- 120
Query: 483 GSNL--DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL 540
G L + ++VMEY L+E K+P + E+ + L+G+ YLH + ++HRD+
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 180
Query: 541 KTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ--YSTAIDM 598
K N+LL+ G +K+ DFG A + P V T ++ APE++L + Y +D+
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 599 WSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQY 657
WSLG I EL ++P P + + +
Sbjct: 237 WSLG-ITCIELAERKP--------------------PLFNMNA-------MSALY----- 263
Query: 658 NLLRKKFPATSFTGSPVLSDAGF-----DLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712
+ + SP L + + ++S L P R T+E L H + P
Sbjct: 264 -HIAQN-------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315
Query: 713 KS-KDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGE 753
D + +R + ++ D L+ ++ K++ E
Sbjct: 316 TVIMDLI----------QRTKDAVRELDNLQYRKMKKILFQE 347
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 68/349 (19%), Positives = 125/349 (35%), Gaps = 63/349 (18%)
Query: 378 GSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKT 437
+ S P + + +++ + G +G VY
Sbjct: 8 HHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 67
Query: 438 GEIVALKKVKMEKEREGFPLTSL----REINILLSFHH--PSIVDVKEVVVGSNLDSIFM 491
VA+K V+ ++ + L + E+ +L ++ + + DS +
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--ERPDSFVL 125
Query: 492 VMEYMEHDLKGLME-----TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLL 546
++E E + + T + + + Q+LE +++ H+ VLHRD+K N+L
Sbjct: 126 ILERPE----PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 181
Query: 547 LN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIM 605
++ NRGELK+ DFG YT T Y PE + + + + +WSLG ++
Sbjct: 182 IDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 606 AELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFP 665
+++ G F+ ++I I+ Q F
Sbjct: 240 YDMVC------GDIPFEHDEEI-------------------------IRGQV-----FFR 263
Query: 666 ATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
+S L+ L P R T E NH W ++V LP+
Sbjct: 264 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 70/357 (19%), Positives = 124/357 (34%), Gaps = 71/357 (19%)
Query: 372 NNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYR 431
+G D+E + + ++ + ++ G++G V+R
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH---------QPRVGRGSFGEVHR 76
Query: 432 ARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491
+DK+TG A+KKV++E R E+ P IV + V +IFM
Sbjct: 77 MKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 492 VMEYME----HDLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNL 545
E +E L +KQ + + Q LEG++YLH +LH D+K N+
Sbjct: 130 --ELLEGGSLGQL------IKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 546 LLNNRG-ELKICDFGLARQYGSPLKPYTH-----LVVTLWYRAPELLLGSKQYSTAIDMW 599
LL++ G +CDFG A + + T + APE+++G K +D+W
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIW 240
Query: 600 SLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNL 659
S C+M +L NG +++ +
Sbjct: 241 SSCCMMLHML------NGC---------------------HPWTQYFRGPLCLKIASEPP 273
Query: 660 LRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716
++ P + + + L +P R +A + K
Sbjct: 274 PIREIPPS-------CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 65/332 (19%), Positives = 118/332 (35%), Gaps = 61/332 (18%)
Query: 389 SCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM 448
G P P G P E+ + +G +G V+ VA+K +
Sbjct: 7 LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66
Query: 449 EKEREGFPLTSL----REINIL----LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-- 498
+ PL+ E+ +L HP ++ + + + +V+E
Sbjct: 67 NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPAQ 124
Query: 499 DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICD 557
DL + K P + +C Q++ I++ H V+HRD+K N+L++ RG K+ D
Sbjct: 125 DLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183
Query: 558 FGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKE-PLFN 616
FG +PYT T Y PE + + ++ +WSLG ++ +++ + P
Sbjct: 184 FGSGALL--HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP--- 238
Query: 617 GKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS 676
F++ +I ++ + FP +S
Sbjct: 239 ----FERDQEI-------------------------LEAEL-----HFP-------AHVS 257
Query: 677 DAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
L+ L P R + E L W +
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 47/310 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D++E I G VV A E VA+K++ +EK + L+EI + HHP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL-LKEIQAMSQCHHP 73
Query: 473 SIVDVKE-VVVGSNLDSIFMVMEYME----HDL----KGLMETMKQPFSQSEVKCLMLQL 523
+IV VV L ++VM+ + D+ E +S + ++ ++
Sbjct: 74 NIVSYYTSFVVKDEL---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL-----VVTL 578
LEG++YLH N +HRD+K N+LL G ++I DFG++ + + V T
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
+ APE++ + Y D+WS G I A EL + P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAA--------------------P--- 226
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
+ K P +KV + Q + + + +++ L DP+KR TA
Sbjct: 227 ----YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282
Query: 698 EAALNHDWFR 707
L H +F+
Sbjct: 283 AELLRHKFFQ 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 74/318 (23%), Positives = 131/318 (41%), Gaps = 66/318 (20%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL-SF 469
+ ++ + L +I G YG V + K +G+I+A+K+++ + + L ++++++ S
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL-LMDLDVVMRSS 78
Query: 470 HHPSIVD-----VKEVVVGSNLDSIFMVMEYM----EHDLKGLMETMKQPFSQSEVKCLM 520
P IV +E ++ ME M + K + + + + +
Sbjct: 79 DCPYIVQFYGALFRE-------GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 521 LQLLEGIKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
L ++ + +L +N ++HRD+K SN+LL+ G +K+CDFG++ Q + T
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRP 190
Query: 580 YRAPELLLGSKQ---YSTAIDMWSLGCIMAEL-LSKEPLFNGKSEFDQLDKIFK----TL 631
Y APE + S Y D+WSLG + EL + P S FDQL ++ K L
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 632 GTPNEKIW-PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYD 690
E+ + P F +NF+ N LT D
Sbjct: 251 SNSEEREFSPSF-------INFV------------------------------NLCLTKD 273
Query: 691 PDKRITAEAALNHDWFRE 708
KR + L H +
Sbjct: 274 ESKRPKYKELLKHPFILM 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 72/313 (23%), Positives = 134/313 (42%), Gaps = 28/313 (8%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH 470
D+FE+++++ G GVV++ K +G ++A K + +E + +RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-IRELQVLHECN 89
Query: 471 HPSIVD-----VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQ--PFSQSEVKCLMLQL 523
P IV + I + ME+M D L + +K+ + + + + +
Sbjct: 90 SPYIVGFYGAFYSD-------GEISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 524 LEGIKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
++G+ YL + ++HRD+K SN+L+N+RGE+K+CDFG++ Q + + V T Y +
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSF-VGTRSYMS 198
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEP--LFNGKSEFDQLDKIFKTLGTPNEKIWP 640
PE L G+ YS D+WS+G + E+ E + + P
Sbjct: 199 PERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF-----DLLNSLLTYDPDKRI 695
P K + + P L F D +N L +P +R
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 696 TAEAALNHDWFRE 708
+ + H + +
Sbjct: 318 DLKQLMVHAFIKR 330
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 64/371 (17%), Positives = 132/371 (35%), Gaps = 38/371 (10%)
Query: 413 DEFERLNKIDEG--TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH 470
+E L I +G V AR K TGE V ++++ +E E+++ F+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 471 HPSIVDVKEV-VVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQLLE 525
HP+IV + + + L ++V +M DL + ++ + ++ +L+
Sbjct: 85 HPNIVPYRATFIADNEL---WVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLK 139
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-------PYTHLVVTL 578
+ Y+H +HR +K S++L++ G++ + S + + V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 579 WYRAPELLL-GSKQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTL----- 631
+ +PE+L + Y D++S+G I A EL + F + + + L
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPF---KDMPATQMLLEKLNGTVP 255
Query: 632 -------GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLN 684
E + ++ + S S +
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 685 SLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQ 744
L +PD R +A LNH +F+++ ++ + +P
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIK-RRASEALPELLRPVTPITNFEGSQSQDHSGIFG 374
Query: 745 RRKELQQGELG 755
L++ E+
Sbjct: 375 LVTNLEELEVD 385
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 74/378 (19%), Positives = 135/378 (35%), Gaps = 70/378 (18%)
Query: 393 PEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----KVK 447
EP + ++ ++ + G +G V+ A DK+ + V +K KV
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 448 MEKEREGFPLTSL-REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME- 505
+ E L + EI IL H +I+ V ++ N +VME G ++
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHG---SG-LDL 117
Query: 506 ----TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+ + QL+ + YL ++HRD+K N+++ +K+ DFG A
Sbjct: 118 FAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
Query: 562 RQY--GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKE-PLFNGK 618
G + T+ Y APE+L+G+ ++MWSLG + L+ +E P
Sbjct: 178 AYLERGKLFYTF---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP----- 229
Query: 619 SEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDA 678
F +L++ ++ P ++S
Sbjct: 230 --FCELEET-------------------------VEAAI-----HPP-------YLVSKE 250
Query: 679 GFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQD---RRMRRMM 735
L++ LL P++R T E + W + + F + M
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEM 310
Query: 736 KSPDPLEEQRRKELQQGE 753
+ + + +EL GE
Sbjct: 311 GNRSLSDVAQAQELCGGE 328
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 89/334 (26%), Positives = 149/334 (44%), Gaps = 52/334 (15%)
Query: 389 SCGTPEPAGPPQRSINMLQGCRSV----DEFERLNKIDEGTYGVVYRARDKKTGEIVALK 444
S T + PP+R + L + F+ L K+ EG+YG VY+A K+TG+IVA+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 445 KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--DSIFMVMEYMEH-DLK 501
+V +E + + ++EI+I+ P +V GS +++VMEY +
Sbjct: 61 QVPVESDLQEI----IKEISIMQQCDSPHVVKYY----GSYFKNTDLWIVMEYCGAGSVS 112
Query: 502 GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
++ + ++ E+ ++ L+G++YLH +HRD+K N+LLN G K+ DFG+A
Sbjct: 113 DIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSE 620
Q + ++ T ++ APE++ Y+ D+WSLG I A E+ +P
Sbjct: 173 GQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLG-ITAIEMAEGKP------- 223
Query: 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF 680
P I P ++ F ++ P T F + SD
Sbjct: 224 -------------PYADIHP-------MRAIF------MIPTNPPPT-FRKPELWSDNFT 256
Query: 681 DLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714
D + L P++R TA L H + R
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 72/315 (22%), Positives = 140/315 (44%), Gaps = 59/315 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ +E + ++ +G +G VY+A++K+TG + A K ++ + E E + EI IL + HP
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHP 76
Query: 473 SIVDVKEV-VVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
IV + L ++++E+ + +M + + ++ +++ + Q+LE + +L
Sbjct: 77 YIVKLLGAYYHDGKL---WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS- 589
H ++HRDLK N+L+ G++++ DFG++ + L+ + T ++ APE+++
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 590 ---KQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
Y D+WSLG I E+ EP P+ ++ P
Sbjct: 194 MKDTPYDYKADIWSLG-ITLIEMAQIEP--------------------PHHELNP----- 227
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAG-----F-DLLNSLLTYDPDKRITAEA 699
++V + K P P L F D L L +P+ R +A
Sbjct: 228 --MRVLL------KIAKSDP-------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
Query: 700 ALNHDWFREVPLPKS 714
L H + + K+
Sbjct: 273 LLEHPFVSSITSNKA 287
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 67/317 (21%), Positives = 124/317 (39%), Gaps = 68/317 (21%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL-SF 469
D+ E + ++ G YGVV + R +G+I+A+K+++ + L +++I + +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL-LMDLDISMRTV 63
Query: 470 HHPSIVD-----VKEVVVGSNLDSIFMVMEYME---HDLKGLMETMKQPFSQSEVKCLML 521
P V +E +++ ME M+ + Q + + + +
Sbjct: 64 DCPFTVTFYGALFRE-------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 522 QLLEGIKYLHDNW-VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
+++ +++LH V+HRD+K SN+L+N G++K+CDFG++ + Y
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKPY 175
Query: 581 RAPELLLGSKQ---YSTAIDMWSLGCIMAEL-LSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
APE + YS D+WSLG M EL + + P + + F QL ++ E
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------VEE 229
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF-----DLLNSLLTYDP 691
SP L F D + L +
Sbjct: 230 P----------------------------------SPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 692 DKRITAEAALNHDWFRE 708
+R T + H +F
Sbjct: 256 KERPTYPELMQHPFFTL 272
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 82/307 (26%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ KI EG+ G+V AR+K +G VA+K + + K++ L E+ I+ + H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102
Query: 473 SIVDVKE-VVVGSNLDSIFMVMEYMEHDLKG--LMETMKQ-PFSQSEVKCLMLQLLEGIK 528
++V++ + +VG L +++ME+++ G L + + Q ++ ++ + +L+ +
Sbjct: 103 NVVEMYKSYLVGEEL---WVLMEFLQ----GGALTDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YLH V+HRD+K+ ++LL G +K+ DFG Q + LV T ++ APE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 589 SKQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
Y+T +D+WSLG IM E++ EP P P
Sbjct: 216 -SLYATEVDIWSLG-IMVIEMVDGEP--------------------PYFSDSP------- 246
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
V+ LR P S +S D L +L DP +R TA+ L+H +
Sbjct: 247 VQAMK------RLRDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
Query: 708 EVPLPKS 714
+ LP+
Sbjct: 300 QTGLPEC 306
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 78/301 (25%), Positives = 139/301 (46%), Gaps = 52/301 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ R KI +G G VY A D TG+ VA++++ ++++ + + + EI ++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 473 SIVDVKEVVVGSNL--DSIFMVMEYMEHDLKG--LMETMKQ-PFSQSEVKCLMLQLLEGI 527
+IV+ S L D +++VMEY+ G L + + + + ++ + + L+ +
Sbjct: 78 NIVNYL----DSYLVGDELWVVMEYLA----GGSLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
++LH N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 588 GSKQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
K Y +D+WSLG IMA E++ EP P P
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEP--------------------PYLNENP------ 221
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
++ + L+ LS D LN L D +KR +A+ L H +
Sbjct: 222 -LRALY------LIATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
Query: 707 R 707
+
Sbjct: 274 K 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 50/303 (16%)
Query: 415 FERLNK-IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
F + + I G++ VY+ D +T VA +++ K + E +L HP+
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 474 IVDVK--EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
IV I +V E M LK ++ K ++ Q+L+G+++L
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL 145
Query: 531 HDN--WVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
H ++HRDLK N+ + G +KI D GLA + ++ T + APE +
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPE--M 201
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFK--TLGTPNEKIWPGFSKL 645
++Y ++D+++ G M E+ + E + SE +I++ T G
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASF------- 251
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
V +++ + + D+R + + LNH +
Sbjct: 252 --------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285
Query: 706 FRE 708
F+E
Sbjct: 286 FQE 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 73/382 (19%), Positives = 136/382 (35%), Gaps = 79/382 (20%)
Query: 391 GTPEPAGPPQRSINMLQGCRSVD----EFERLNKIDEGTYGVVYRARDKKTGEIVALKKV 446
G G R + G ++V+ + EG + VY A+D +G ALK++
Sbjct: 3 GPGSLGGASGRDQSDFVG-QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61
Query: 447 ---KMEKEREGFPLTSLREINILLS-FHHPSIV------DVKEVVVGSNLDSIFMVMEYM 496
+ EK R ++E+ + HP+IV + + + ++ E
Sbjct: 62 LSNEEEKNRA-----IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 497 EHDLKGLMETM--KQPFSQSEVKCLMLQLLEGIKYLHDN--WVLHRDLKTSNLLLNNRGE 552
+ L ++ M + P S V + Q ++++H ++HRDLK NLLL+N+G
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 553 LKICDFGLARQYGSPLKPYTHLVV------------TLWYRAPEL--LLGSKQYSTAIDM 598
+K+CDFG A T YR PE+ L + D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658
W+LGCI+ L ++ F ++ +I + +Y
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKL----RI-------------------------VNGKY- 266
Query: 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFM 718
P L+ ++L +P++R++ ++ E+ ++ +
Sbjct: 267 ----SIPP-----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ--EIAAARNVNPK 315
Query: 719 PTFPAQHAQDRRMRRMMKSPDP 740
Q+ S P
Sbjct: 316 SPITELLEQNGGYGSATLSRGP 337
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 82/308 (26%), Positives = 141/308 (45%), Gaps = 53/308 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ F +L KI +G++G V++ D +T ++VA+K + +E+ + +EI +L P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSP 80
Query: 473 SIVDVKEVVVGSNL--DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+ GS L ++++MEY+ L+E P ++++ ++ ++L+G+ Y
Sbjct: 81 YVTKYY----GSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY 134
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH +HRD+K +N+LL+ GE+K+ DFG+A Q V T ++ APE++ S
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 590 KQYSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y + D+WSLG I A EL EP P S+L +
Sbjct: 195 -AYDSKADIWSLG-ITAIELARGEP--------------------P-------HSELHPM 225
Query: 649 KVNFI--KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
KV F+ K+ L + S L + + + L +P R TA+ L H +
Sbjct: 226 KVLFLIPKNNPPTLEGNY-------SKPLK----EFVEACLNKEPSFRPTAKELLKHKFI 274
Query: 707 REVPLPKS 714
S
Sbjct: 275 LRNAKKTS 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 88/361 (24%), Positives = 149/361 (41%), Gaps = 65/361 (18%)
Query: 405 MLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREI 463
M R + + + EG++G V A KT + VALK + + ++ + REI
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQL 523
+ L HP I+ + +V+ + I MV+EY +L + K+ ++ E + Q+
Sbjct: 61 SYLKLLRHPHIIKLYDVI--TTPTDIVMVIEYAGGELFDYI-VEKKRMTEDEGRRFFQQI 117
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY----------GSPLKPYTH 573
+ I+Y H + ++HRDLK NLLL++ +KI DFGL+ GSP
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN----- 172
Query: 574 LVVTLWYRAPELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632
Y APE++ G K Y+ +D+WS G ++ +L G+ FD D+ L
Sbjct: 173 ------YAAPEVING-KLYAGPEVDVWSCGIVLYVMLV------GRLPFD--DEFIPNL- 216
Query: 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPD 692
+K+ +P LS L+ ++ DP
Sbjct: 217 --FKKVNSCVYVMP--------------------------DFLSPGAQSLIRRMIVADPM 248
Query: 693 KRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQG 752
+RIT + WF LP M +A R + ++ ++ E+ + L+
Sbjct: 249 QRITIQEIRRDPWFNV-NLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSD 307
Query: 753 E 753
E
Sbjct: 308 E 308
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 68/372 (18%), Positives = 118/372 (31%), Gaps = 114/372 (30%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVAL--------KKVKMEKEREGFPLTSLR 461
R + +FE + + G +GVV+ A++K A+ + + + RE L L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 462 ------------------------------------------------EINILLSFHHPS 473
+I + F +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCL--MLQLLEGIKYL 530
V + +++ M+ +LK M + CL +Q+ E +++L
Sbjct: 123 TVGQLQPSSPKV--YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR------------QYGSPLKPYTHLVVTL 578
H ++HRDLK SN+ +K+ DFGL +T V T
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
Y +PE + G YS +D++SLG I+ ELL T E++
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS-------------------FSTQMERV 280
Query: 639 WPGFSKLPGVKVNFIKHQYNLLRK-KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
+R KFP P ++ +L+ P +R A
Sbjct: 281 ----------------RIITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTERPEA 320
Query: 698 EAALNHDWFREV 709
+ + F +
Sbjct: 321 TDIIENAIFENL 332
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 91/376 (24%), Positives = 138/376 (36%), Gaps = 57/376 (15%)
Query: 397 GPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKERE 453
P + D ++ + I G +GV RDK T E+VA+K + E
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN- 62
Query: 454 GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LME--TMKQP 510
REI S HP+IV KEV+ + ++MEY G L E
Sbjct: 63 -----VQREIINHRSLRHPNIVRFKEVI--LTPTHLAIIMEYASG---GELYERICNAGR 112
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL--NNRGELKICDFGLARQYGSPL 568
FS+ E + QLL G+ Y H + HRDLK N LL + LKICDFG ++
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 569 KPYTHLVVTLWYRAPELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
+P + V T Y APE+LL ++Y D+WS G + +L G F+
Sbjct: 173 QPKS-TVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLV------GAYPFED---- 220
Query: 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKF--PATSFTGSPVLSDAGFDLLNS 685
P ++ K +L K+ P +S L++
Sbjct: 221 ------------------PEEPRDYRKTIQRILSVKYSIPDDIR-----ISPECCHLISR 257
Query: 686 LLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQR 745
+ DP RI+ H WF + + T ++ M+ + + E
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEAT 317
Query: 746 RKELQQGELGIHSDLY 761
++ L
Sbjct: 318 IPAVRNRCLDDFMTDN 333
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 75/344 (21%), Positives = 130/344 (37%), Gaps = 69/344 (20%)
Query: 377 GGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKK 436
GS G A ++ E L ++ GT G V++ R +K
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEI--------------NDLENLGEMGSGTCGQVWKMRFRK 48
Query: 437 TGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVD-----VKEVVVGSNLDSIF 490
TG ++A+K+++ +E L +++++L H P IV + +F
Sbjct: 49 TGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHDCPYIVQCFGTFITN-------TDVF 100
Query: 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW-VLHRDLKTSNLLLNN 549
+ ME M + L + M+ P + + + + +++ + YL + V+HRD+K SN+LL+
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 550 RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPE----LLLGSKQYSTAIDMWSLGCIM 605
RG++K+CDFG++ + Y APE Y D+WSLG +
Sbjct: 161 RGQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 606 AEL-LSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKF 664
EL + P N K++F+ L K+ +
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVL----------------------------------QE 245
Query: 665 PATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
G S + LT D KR L H + +
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 85/340 (25%), Positives = 134/340 (39%), Gaps = 61/340 (17%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEV 480
I +G + V AR TG VA+K + + RE+ I+ +HP+IV + EV
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 481 VVGSNLDSIFMVMEYMEHDLKG------LMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ +++++MEY G L+ + E + Q++ ++Y H
Sbjct: 83 I--ETEKTLYLIMEYA----SGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLGSKQY 592
++HRDLK NLLL+ +KI DFG + ++ G L Y APEL G K+Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD--AF-CGAPPYAAPELFQG-KKY 190
Query: 593 S-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
+D+WSLG I+ L+S G FD + K L E++ G ++P
Sbjct: 191 DGPEVDVWSLGVILYTLVS------GSLPFD--GQNLKEL---RERVLRGKYRIP----- 234
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR---E 708
+S +LL L +P KR T E + W E
Sbjct: 235 ---------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273
Query: 709 VPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKE 748
K + + M M S + ++E K
Sbjct: 274 EDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKM 313
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSL-----REINILL 467
+E E +I +G +G+V++ R K +VA+K + + + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
+ +HP+IV + G + MVME++ DL + P S LML + G
Sbjct: 79 NLNHPNIVK----LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 527 IKYLHDN--WVLHRDLKTSNLLLNNRGE-----LKICDFGLARQYGSPLKPYTHLVVTLW 579
I+Y+ + ++HRDL++ N+ L + E K+ DFGL++Q + + L+
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQ 191
Query: 580 YRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
+ APE + + Y+ D +S I+ +L+ E F+ S
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-42
Identities = 44/333 (13%), Positives = 94/333 (28%), Gaps = 78/333 (23%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK----------EREGFPLTSLREI- 463
R + + A D++TGE + + + E L LR I
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 464 ---------------NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMK 508
+++ ++ V+ + S F + M+ +L+ E +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 509 Q------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562
L LQ++ + LH ++H L+ +++L+ RG + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 563 QYGSPLKPYTHLVV-TLWYRAPELLLGSKQ----YSTAIDMWSLGCIMAELLSKEPLFNG 617
+ G+ A +L + + A D W+LG + + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 618 KSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSD 677
+ + IF+ +
Sbjct: 320 DAALGGSEWIFR-----------------------------------------SCKNIPQ 338
Query: 678 AGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710
LL L Y + R+ A+ + ++
Sbjct: 339 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 73/313 (23%), Positives = 117/313 (37%), Gaps = 78/313 (24%)
Query: 423 EGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
EG YG V A ++ T E VA+K + E +EI I +H ++V
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKMLNHENVVKFYG 72
Query: 480 VVVGSNLDSIFMVMEYMEHDLKG--LMETM--KQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ ++ +EY G L + + + + + QL+ G+ YLH +
Sbjct: 73 HR--REGNIQYLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQY-------------GSPLKPYTHLVVTLWYRA 582
HRD+K NLLL+ R LKI DFGLA + G+ Y A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-----------YVA 175
Query: 583 PELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
PELL +++ +D+WS G ++ +L+ G+ +DQ + ++
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQEY---SDWKEKK 225
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
P K + A LL+ +L +P RIT
Sbjct: 226 TYLNPWKK-------------------------IDSAPLALLHKILVENPSARITIPDIK 260
Query: 702 NHDWFREVPLPKS 714
W+ + PL K
Sbjct: 261 KDRWYNK-PLKKG 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 75/345 (21%), Positives = 135/345 (39%), Gaps = 66/345 (19%)
Query: 380 DTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGE 439
D + + G+ + A PP + ++F+ + EG++ V AR+ T
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKK-----RPEDFKFGKILGEGSFSTVVLARELATSR 56
Query: 440 IVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSIFMVME 494
A+K K + KE + RE +++ HP V + + + + ++ +
Sbjct: 57 EYAIKILEKRHIIKENKV--PYVTRERDVMSRLDHPFFVKLY----FTFQDDEKLYFGLS 110
Query: 495 YMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGEL 553
Y ++ +L + + F ++ + +++ ++YLH ++HRDLK N+LLN +
Sbjct: 111 YAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 169
Query: 554 KICDFGLARQ---YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+I DFG A+ + + V T Y +PELL K + D+W+LGCI+ +L++
Sbjct: 170 QITDFGTAKVLSPESKQARANS-FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVA 227
Query: 611 KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFT 670
P F +E+ KI K + FP
Sbjct: 228 GLPPFRAGNEYLIFQKIIK------LEY------------------------DFP----- 252
Query: 671 GSPVLSDAGFDLLNSLLTYDPDKRIT------AEAALNHDWFREV 709
DL+ LL D KR+ H +F V
Sbjct: 253 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 75/322 (23%), Positives = 133/322 (41%), Gaps = 67/322 (20%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HH 471
FE + + GTYG VY+ R KTG++ A+K + + + E +EIN+L + HH
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHH 80
Query: 472 PSIVD-----VKEVVVGSNLDSIFMVMEYME----HDLKGLMETMKQPFSQSEVKCLMLQ 522
+I +K+ G + D +++VME+ DL + T + + + +
Sbjct: 81 RNIATYYGAFIKKNPPGMD-DQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
+L G+ +LH + V+HRD+K N+LL E+K+ DFG++ Q + + T ++ A
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 583 PELLLGSKQ----YSTAIDMWSLGCIMA-ELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
PE++ + Y D+WSLG I A E+ P P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP--------------------P--- 233
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF-----DLLNSLLTYDPD 692
+ ++ F L+ + P L + + S L +
Sbjct: 234 ----LCDMHPMRALF------LIPRNPA-------PRLKSKKWSKKFQSFIESCLVKNHS 276
Query: 693 KRITAEAALNHDWFREVPLPKS 714
+R E + H + R+ P +
Sbjct: 277 QRPATEQLMKHPFIRDQPNERQ 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
E E + G +GVV +A+ + + VA+K+++ E ER+ F + E+ L +HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAF----IVELRQLSRVNHP 61
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP--FSQSEVKCLMLQLLEGIKY 529
+IV + G+ L+ + +VMEY E L ++ + ++ + LQ +G+ Y
Sbjct: 62 NIVKL----YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 530 LHD---NWVLHRDLKTSNLLLNNRGE-LKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
LH ++HRDLK NLLL G LKICDFG A + + T+ + + APE+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEV 174
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
GS YS D++S G I+ E++++ F+
Sbjct: 175 FEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 71/348 (20%), Positives = 119/348 (34%), Gaps = 81/348 (23%)
Query: 423 EGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
EG YG V A ++ T E VA+K + E +EI I +H ++V
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKMLNHENVVKFYG 72
Query: 480 VVVGSNLDSIFMVMEYMEHDLKG--LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWV 535
+ ++ +EY G L + + + + QL+ G+ YLH +
Sbjct: 73 HR--REGNIQYLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQY-------------GSPLKPYTHLVVTLWYRA 582
HRD+K NLLL+ R LKI DFGLA + G+ Y A
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-----------YVA 175
Query: 583 PELLLGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
PELL +++ +D+WS G ++ +L+ G+ +DQ + ++
Sbjct: 176 PELLKR-REFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQEY---SDWKEKK 225
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701
P K + A LL+ +L +P RIT
Sbjct: 226 TYLNPWKK-------------------------IDSAPLALLHKILVENPSARITIPDIK 260
Query: 702 NHDWFR----EVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQR 745
W+ + + + ++ + R
Sbjct: 261 KDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASR 308
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 49/350 (14%), Positives = 103/350 (29%), Gaps = 78/350 (22%)
Query: 413 DEFERLNKIDEGTYGVVYRAR-----DKKTGEIVALKKVKMEKEREGFPLTSLREINILL 467
+ + EG + VY A D K + LK K E + T + + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--QLMERLK 122
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK----QPFSQSEVKCLMLQ 522
+ + + +V E + L + K + Q V ++
Sbjct: 123 PSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNR-----------GELKICDFGLARQYGSPLKPY 571
+L I+ +HD ++H D+K N +L N L + D G + L P
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK--LFPK 238
Query: 572 THLVVTLW----YRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD-QLDK 626
+ ++ E+L K ++ ID + + + +L + + + +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSL 686
+F+ P+ +W + + +
Sbjct: 298 LFR--RLPHLDMWN----------------------------------------EFFHVM 315
Query: 687 LTYDPDKRITAEAALNH---DWFREVPLPKSKDFMPTFPAQHAQDRRMRR 733
L + + L F++ K + + +R R+
Sbjct: 316 LNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 85/303 (28%), Positives = 120/303 (39%), Gaps = 69/303 (22%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKE 479
+ GT+G V + TG VA+K + +K REI L F HP I+ + +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 480 VVVGSNLDSIFMVMEYMEHDLKG-LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
V+ S FMVMEY+ G L + + E + L Q+L + Y H + V+
Sbjct: 79 VI--STPTDFFMVMEYVS---GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQY----------GSPLKPYTHLVVTLWYRAPELL 586
HRDLK N+LL+ KI DFGL+ GSP Y APE++
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVI 182
Query: 587 LGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
G + Y+ +D+WS G I+ LL G L
Sbjct: 183 SG-RLYAGPEVDIWSCGVILYALLC------------------------------GT--L 209
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
P F L KK F L+ + LL +L DP KR T + H+W
Sbjct: 210 P-----FDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 706 FRE 708
F++
Sbjct: 265 FKQ 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 7e-40
Identities = 94/348 (27%), Positives = 140/348 (40%), Gaps = 69/348 (19%)
Query: 421 IDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHHPSIVDVKE 479
+ GT+G V + + TG VA+K + +K REI L F HP I+ + +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 480 VVVGSNLDSIFMVMEYMEHDLKG-LME--TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
V+ S IFMVMEY+ G L + + E + L Q+L G+ Y H + V+
Sbjct: 84 VI--STPSDIFMVMEYVS---GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQY----------GSPLKPYTHLVVTLWYRAPELL 586
HRDLK N+LL+ KI DFGL+ GSP Y APE++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVI 187
Query: 587 LGSKQYS-TAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
G + Y+ +D+WS G I+ LL G FD D TL +KI G
Sbjct: 188 SG-RLYAGPEVDIWSSGVILYALLC------GTLPFD--DDHVPTL---FKKICDGIFYT 235
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
P L+ + LL +L DP KR T + H+W
Sbjct: 236 P--------------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 706 FREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGE 753
F++ P++ + D ++ + + + EE+ L
Sbjct: 270 FKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRN 317
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 39/213 (18%), Positives = 82/213 (38%), Gaps = 13/213 (6%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L K++E G +++ R + G + +K +K+ E L F HP
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM-ETMKQPFSQSEVKCLMLQLLEGIKYL 530
+++ V ++ +M + L ++ E QS+ L + G+ +L
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 531 H--DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
H + + L + +++++ +I + + S + + APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQK 182
Query: 589 --SKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
+ DMWS ++ EL+++E F S
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-36
Identities = 80/374 (21%), Positives = 137/374 (36%), Gaps = 88/374 (23%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----KVKMEKEREGFPLTSLREINI 465
+ D FE L I +G++G V + T ++ A+K K E +E+ I
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN----VFKELQI 68
Query: 466 LLSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVK 517
+ HP +V NL + +FMV++ + DL+ ++ F + VK
Sbjct: 69 MQGLEHPFLV---------NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVK 118
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577
+ +L+ + YL + ++HRD+K N+LL+ G + I DF +A + T + T
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGT 177
Query: 578 LWYRAPELLLGSKQ--YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635
Y APE+ K YS A+D WSLG ELL ++ +S +I
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIV------- 229
Query: 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
P S LL LL +PD+R
Sbjct: 230 HTFETTVVTYP--------------------------SAWSQEMVSLLKKLLEPNPDQRF 263
Query: 696 -TAEAALNHDWFREV---------------PLPKSKDFMPTFPAQHAQDRRMRRMMKSPD 739
N + ++ P + PTF + M+
Sbjct: 264 SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELE--------EMILESK 315
Query: 740 PLEEQRRKELQQGE 753
PL +++++ ++ +
Sbjct: 316 PLHKKKKRLAKKEK 329
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 48/222 (21%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM--EKEREGFPLTSLREINILLSFH 470
+ + +G +G + ++TGE++ +K++ E+ + F L+E+ ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF----LKEVKVMRCLE 65
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+++ K + V + + EY++ L+G++++M + S+ + G+ Y
Sbjct: 66 HPNVL--KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-------------QYGSPLKPYTHLVV 576
LH ++HRDL + N L+ + + DFGLAR P + + VV
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 577 -TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617
++ APE++ G + Y +D++S G ++ E++ +
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 70/313 (22%), Positives = 122/313 (38%), Gaps = 57/313 (18%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINIL 466
+++E + I G +G V R K T ++ A+K + +++ F E +I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIM 123
Query: 467 LSFHHPSIVDVKEVVVGS--NLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQL 523
+ P +V + + + ++MVMEYM DL LM + + ++
Sbjct: 124 AFANSPWVVQLF----YAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEV 177
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRA 582
+ + +H +HRD+K N+LL+ G LK+ DFG + V T Y +
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 583 PELLL---GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639
PE+L G Y D WS+G + E+L + F D L + KI
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTY-------SKI- 285
Query: 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699
+ H+ +L FP +S +L+ + LT D + R+
Sbjct: 286 -------------MNHKNSL---TFP-----DDNDISKEAKNLICAFLT-DREVRLGRNG 323
Query: 700 AL---NHDWFREV 709
H +F+
Sbjct: 324 VEEIKRHLFFKND 336
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 11/216 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ +I G++G VY+ + VA+K + + E+ +L H
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+I+ L +V ++ E L + + F ++ + Q G+ YLH
Sbjct: 81 NILLFMGYSTAPQL---AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTLWYRAPELLLG- 588
++HRDLK++N+ L+ +KI DFGLA S + L ++ + APE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 589 -SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
S YS D+++ G ++ EL++ + ++ + DQ
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 88/364 (24%), Positives = 136/364 (37%), Gaps = 83/364 (22%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVK-MEKEREGFPLTSLREINILLSFHHPSIVD 476
+ K+ G + V+ + D + + VA+K VK E E T+L EI +L S + D
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE----TALDEIRLLKSVRNSDPND 97
Query: 477 VKEVVVGSNLDS----------IFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLE 525
+V LD I MV E + H L + Q VK ++ Q+L+
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 526 GIKYLH-DNWVLHRDLKTSNLLLN------------------------------------ 548
G+ YLH ++H D+K N+LL+
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 549 -------------NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
+ ++KI D G A K +T + T YR+ E+L+GS Y+T
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGSG-YNTP 273
Query: 596 IDMWSLGCIMAELLSKEPLFNGKS------EFDQLDKIFKTLGTPNEKIWPG------FS 643
D+WS C+ EL + + LF S + D + I + LG K+ F
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
G + K + L + + S + D L +L P+KR TA L H
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLV-EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 704 DWFR 707
W
Sbjct: 393 PWLN 396
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 10/215 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ KI G++G V+RA G VA+K + + LRE+ I+ HP
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM--ETMKQPFSQSEVKCLMLQLLEGIKY 529
+IV V ++ +V EY+ L L+ ++ + + + +G+ Y
Sbjct: 95 NIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 530 LHDN--WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
LH+ ++HR+LK+ NLL++ + +K+CDFGL+R S T + APE+L
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 588 GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD 622
+ + D++S G I+ EL + + + +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-35
Identities = 62/321 (19%), Positives = 119/321 (37%), Gaps = 67/321 (20%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINIL 466
D+FE L I G + V + K+TG++ A+K + +++ E ++L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE---ERDVL 115
Query: 467 LSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKC 518
++ I L + +++VMEY DL L+ + +
Sbjct: 116 VNGDRRWIT---------QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 519 LMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-T 577
+ +++ I +H +HRD+K N+LL+ G +++ DFG + + + + V T
Sbjct: 167 YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 578 LWYRAPELLLG------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631
Y +PE+L + Y D W+LG E+ + F D + +
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETY--- 279
Query: 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691
KI + ++ +L P + + D + LL P
Sbjct: 280 ----GKI--------------VHYKEHL---SLPL----VDEGVPEEARDFIQRLLC-PP 313
Query: 692 DKRITAEAAL---NHDWFREV 709
+ R+ A H +F +
Sbjct: 314 ETRLGRGGAGDFRTHPFFFGL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 63/327 (19%), Positives = 123/327 (37%), Gaps = 57/327 (17%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK-----MEKEREGFPLTSLREINI 465
++FE L I G +G V + K ++ A+K + E F E ++
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF----REERDV 127
Query: 466 LLSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
L++ I + + + +++++VM+Y DL L+ + + + + +
Sbjct: 128 LVNGDSKWITTLH----YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYR 581
++ I +H +HRD+K N+L++ G +++ DFG + + + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 582 APELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
+PE+L G +Y D WSLG M E+L E F + L + + K
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETY-------GK 292
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
I + FP +S+ DL+ L+ + R+
Sbjct: 293 IMNHKERFQ-----------------FPT----QVTDVSENAKDLIRRLIC-SREHRLGQ 330
Query: 698 EAAL---NHDWFREVPLPKSKDFMPTF 721
H +F + ++ +
Sbjct: 331 NGIEDFKKHPFFSGIDWDNIRNCEAPY 357
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 71/317 (22%), Positives = 132/317 (41%), Gaps = 62/317 (19%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLS 468
D F + G +G V+ + K TG++ A KK+ + K+R+G+ + E IL
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAK 241
Query: 469 FHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEH-DLK---GLMETMKQPFSQSEVK 517
H IV +L + +VM M D++ ++ F +
Sbjct: 242 VHSRFIV---------SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 518 CLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577
Q++ G+++LH +++RDLK N+LL++ G ++I D GLA + + T
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
+ APELLLG ++Y ++D ++LG + E+++ F + E + ++ + +
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VLEQA 409
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-- 695
+ +P S A D +LL DP+KR+
Sbjct: 410 V------------------------TYP-------DKFSPASKDFCEALLQKDPEKRLGF 438
Query: 696 ---TAEAALNHDWFREV 709
+ + H FR++
Sbjct: 439 RDGSCDGLRTHPLFRDI 455
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 91/356 (25%), Positives = 154/356 (43%), Gaps = 74/356 (20%)
Query: 371 NNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVY 430
N + GS+ +S E + + ++ Q +D+F+R+ + G++G V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFL---KKWETPSQNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 431 RARDKKTGEIVALKKVKME-----KEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS- 484
+ K++G A+K + + K+ E +L E IL + + P +V ++ S
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLE----FSF 110
Query: 485 -NLDSIFMVMEYME-----HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
+ +++MVMEY+ L+ FS+ + Q++ +YLH +++R
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDM 598
DLK NLL++ +G +++ DFG A++ + +T L T APE++L SK Y+ A+D
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWT-LCGTPEALAPEIIL-SKGYNKAVDW 221
Query: 599 WSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYN 658
W+LG ++ E+ + P F DQ +I+ EKI G KV F H
Sbjct: 222 WALGVLIYEMAAGYPPFFA----DQPIQIY-------EKIVSG-------KVRFPSH--- 260
Query: 659 LLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREV 709
S DLL +LL D KR NH WF
Sbjct: 261 ----------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 84/315 (26%), Positives = 137/315 (43%), Gaps = 69/315 (21%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALK-----KVKMEKEREGFPLTSLREINI 465
S+ +F+ L + G++G V+ R + G A+K V K+ E + E +
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE----HTNDERLM 59
Query: 466 LLSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEHDLKG--LMETMK--QPFSQSEVKCL 519
L HP I+ + G+ + IFM+M+Y+E G L ++ Q F K
Sbjct: 60 LSIVTHPFIIRMW----GTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFY 111
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLW 579
++ ++YLH +++RDLK N+LL+ G +KI DFG A+ YT L T
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYT-LCGTPD 168
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639
Y APE++ +K Y+ +ID WS G ++ E+L+ F + +KI ++
Sbjct: 169 YIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------AEL- 220
Query: 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI---- 695
+FP P ++ DLL+ L+T D +R+
Sbjct: 221 -----------------------RFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 696 -TAEAALNHDWFREV 709
E NH WF+EV
Sbjct: 251 NGTEDVKNHPWFKEV 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-33
Identities = 64/308 (20%), Positives = 133/308 (43%), Gaps = 47/308 (15%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLS 468
+ + F + + +G +G V + + TG++ A KK++ + K+R+G + L E IL
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEK 240
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEG 526
+ +V + D++ +V+ M DLK + + F ++ ++ G
Sbjct: 241 VNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
++ LH +++RDLK N+LL++ G ++I D GLA V T+ Y APE++
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV 357
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
++Y+ + D W+LGC++ E+++ + F + + + +++ +
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKEVPE-------- 406
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAAL 701
++ S L + LL DP +R+ +A
Sbjct: 407 ----------------EYS-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443
Query: 702 NHDWFREV 709
H F+++
Sbjct: 444 EHPLFKKL 451
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 22/240 (9%)
Query: 387 NDSCGTPEPAGPPQRSINMLQGCRSVDEFER-----LNKIDEGTYGVVYRAR----DKKT 437
+D Q ++ R +FE L ++ +G +G V R T
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNT 69
Query: 438 GEIVALKKVK--MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEY 495
GE+VA+KK++ E+ F REI IL S H +IV K V + ++ ++MEY
Sbjct: 70 GEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 496 MEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELK 554
+ + L+ ++ K+ ++ Q+ +G++YL +HRDL T N+L+ N +K
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 555 ICDFGLARQYGSPLKPYTHLVVTL----WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
I DFGL + + Y WY APE L SK +S A D+WS G ++ EL +
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 243
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS--LREINILLSFH 470
E I G +G VYRA G+ VA+K + + + + +E +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+I+ ++ V + ++ +VME+ L ++ + P + +Q+ G+ Y
Sbjct: 65 HPNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQIARGMNY 120
Query: 530 LHDN---WVLHRDLKTSNLLLNNRGE--------LKICDFGLARQYGSPLKPYTHLVVTL 578
LHD ++HRDLK+SN+L+ + E LKI DFGLAR++
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAGAY 178
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
+ APE++ S +S D+WS G ++ ELL+ E F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGID 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ E I +G +G VY R VA++ + +E++ E RE+ H
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
++V + + ++ + L ++ K ++ + + ++++G+ YLH
Sbjct: 90 NVVLFMGACMSP--PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGSPLKPYTHLVVTLWYRAPELL 586
+LH+DLK+ N+ +N G++ I DFGL Q G L + APE++
Sbjct: 148 AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 587 --------LGSKQYSTAIDMWSLGCIMAELLSKEPLFNG 617
+S D+++LG I EL ++E F
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 40/222 (18%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK--MEKEREGFPLTSLRE 462
+FE L ++ +G +G V R TGE+VA+KK++ E+ F RE
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----ERE 61
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLML 521
I IL S H +IV K V + ++ ++MEY+ + L+ ++ K+ ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG-------------SPL 568
Q+ +G++YL +HRDL T N+L+ N +KI DFGL + SP+
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
WY APE L SK +S A D+WS G ++ EL +
Sbjct: 182 F---------WY-APESLTESK-FSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 28/238 (11%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK---MEKEREGFPLTSLR 461
FE+ + + EG +G V R TGE VA+K +K +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KK 72
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLM 520
EI IL + +H +IV K + + I ++ME++ LK + K + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL-- 578
+Q+ +G+ YL +HRDL N+L+ + ++KI DFGL + + + YT
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 579 --WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634
WY APE L+ SK + A D+WS G + ELL+ S+ + K +G
Sbjct: 193 VFWY-APECLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE----REGFPLTSLREINILLS 468
+ + + +I +G YG V+ + + GE VA+K +E RE EI +
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRE-------TEIYQTVL 87
Query: 469 FHHPSIV-----DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
H +I+ D+K + L +++ +Y E+ L ++ + L
Sbjct: 88 MRHENILGFIAADIKGTGSWTQL---YLITDYHENGSLYDYLK--STTLDAKSMLKLAYS 142
Query: 523 LLEGIKYLHDNW--------VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK----P 570
+ G+ +LH + HRDLK+ N+L+ G I D GLA ++ S P
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 571 YTHLVVTLWYRAPELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
V T Y PE+L S Q DM+S G I+ E+ + E+
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 50/235 (21%), Positives = 87/235 (37%), Gaps = 41/235 (17%)
Query: 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE----REGFPLTSLREINILLSF 469
+ L + +G YG V+R + GE VA+K E RE E+ +
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRE-------TELYNTVML 59
Query: 470 HHPSIV-----DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQL 523
H +I+ D+ + L +++ Y E L + ++L +
Sbjct: 60 RHENILGFIASDMTSRHSSTQL---WLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSI 114
Query: 524 LEGIKYLHDNW--------VLHRDLKTSNLLLNNRGELKICDFGLAR----QYGSPLKPY 571
G+ +LH + HRDLK+ N+L+ G+ I D GLA
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 572 THLVVTLWYRAPELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF 621
V T Y APE+L + +D+W+ G ++ E+ + ++
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 74/312 (23%), Positives = 134/312 (42%), Gaps = 55/312 (17%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILL- 467
++++F I G +G VY R TG++ A+K + + K ++G L L E +L
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSL 245
Query: 468 --SFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
+ P IV + + D + +++ M DL + FS+++++ +
Sbjct: 246 VSTGDCPFIVCMS----YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAE 300
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
++ G++++H+ +V++RDLK +N+LL+ G ++I D GLA S KP+ V T Y A
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHA-SVGTHGYMA 358
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE+L Y ++ D +SLGC++ +LL F D+ +I +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM------------ 405
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TA 697
+ P S LL LL D ++R+ A
Sbjct: 406 ----------TLTM----AVELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 698 EAALNHDWFREV 709
+ +FR +
Sbjct: 445 QEVKESPFFRSL 456
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 59/263 (22%), Positives = 99/263 (37%), Gaps = 36/263 (13%)
Query: 379 SDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTG 438
D + G+ P QR+I I +G +G V+R + + G
Sbjct: 17 KDLIYDMTTSGSGSGLPL-LVQRTI--------ARTIVLQESIGKGRFGEVWRGKWR--G 65
Query: 439 EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI--FMVMEYM 496
E VA+K +ER EI + H +I+ N ++V +Y
Sbjct: 66 EEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 497 EH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--------VLHRDLKTSNLLL 547
EH L + + + + L L G+ +LH + HRDLK+ N+L+
Sbjct: 123 EHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 548 NNRGELKICDFGLARQYGSPLK----PYTHLVVTLWYRAPELLLGS-----KQYSTAIDM 598
G I D GLA ++ S H V T Y APE+L S + D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 599 WSLGCIMAELLSKEPLFNGKSEF 621
+++G + E+ + + ++
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDY 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 78/379 (20%), Positives = 153/379 (40%), Gaps = 75/379 (19%)
Query: 353 YHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSV 412
+H H E+ + D G + +++ + I
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI--------- 53
Query: 413 DEFERLNKIDEGTYGVVYRAR---DKKTGEIVA---LKKVKMEKEREGFPLTSLREINIL 466
+ FE L + G YG V+ R TG++ A LKK + ++ + T E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVL 112
Query: 467 -LSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEVKCL 519
P +V + + + ++++Y+ G L + Q F++ EV+
Sbjct: 113 EHIRQSPFLVTLH----YAFQTETKLHLILDYI----NGGELFTHLSQRERFTEHEVQIY 164
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-LVVTL 578
+ +++ +++LH +++RD+K N+LL++ G + + DFGL++++ + + T+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 579 WYRAPELLLGSKQ-YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
Y AP+++ G + A+D WSLG +M ELL+ F E + +I +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-------RR 277
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKK--FPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695
I L+ + +P +S DL+ LL DP KR+
Sbjct: 278 I---------------------LKSEPPYP-------QEMSALAKDLIQRLLMKDPKKRL 309
Query: 696 -----TAEAALNHDWFREV 709
A+ H +F+++
Sbjct: 310 GCGPRDADEIKEHLFFQKI 328
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 48/247 (19%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK---MEKEREGFPLTSLR 461
F + + + EG +G V + TGE+VA+K +K + R G+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQ 82
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLM 520
EI+IL + +H I+ K + S+ +VMEY+ L+ + + +++
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFA 140
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG-------------SP 567
Q+ EG+ YLH +HRDL N+LL+N +KI DFGLA+ SP
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627
+ WY APE L K + A D+WS G + ELL+ S K
Sbjct: 201 VF---------WY-APECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKF 244
Query: 628 FKTLGTP 634
+ +G
Sbjct: 245 LELIGIA 251
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 42/240 (17%)
Query: 397 GPPQRSINMLQGCRSVDEFER-----LNKIDEGTYGVVYRAR----DKKTGEIVALKKVK 447
G L C+ FE ++++ +G +G V R TG +VA+K+++
Sbjct: 2 GHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ 61
Query: 448 ---MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGL 503
+++R+ F REI IL + H IV + V G S+ +VMEY+ L+
Sbjct: 62 HSGPDQQRD-F----QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 504 METMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563
++ + S + Q+ +G++YL +HRDL N+L+ + +KI DFGLA+
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176
Query: 564 YG-------------SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
SP+ WY APE L + +S D+WS G ++ EL +
Sbjct: 177 LPLDKDYYVVREPGQSPIF---------WY-APESLSDNI-FSRQSDVWSFGVVLYELFT 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 71/374 (18%), Positives = 141/374 (37%), Gaps = 65/374 (17%)
Query: 349 SGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQG 408
G+ ++ +G + + G T + +E + + R
Sbjct: 283 EGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDR----- 337
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINIL 466
+ +F L + +G++G V + K T E+ A+K +K + + + T + E +L
Sbjct: 338 -MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVL 395
Query: 467 -LSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEHDLKG-LMETMKQP--FSQSEVKCLM 520
L P + + +D ++ VMEY+ G LM ++Q F +
Sbjct: 396 ALPGKPPFLTQLH----SCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYA 448
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
++ G+ +L +++RDLK N++L++ G +KI DFG+ ++ T Y
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE++ + Y ++D W+ G ++ E+L+ + F G+ E + I +
Sbjct: 509 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNV-- 559
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI----- 695
+P +S + L+T P KR+
Sbjct: 560 ----------------------AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPE 590
Query: 696 TAEAALNHDWFREV 709
H +FR +
Sbjct: 591 GERDIKEHAFFRYI 604
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 64/314 (20%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK----MEKEREGFPLTSLREINIL 466
++++F+ L + +GT+G V R+K TG A+K ++ + K+ +T E +L
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVL 59
Query: 467 LSFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEVKCLM 520
+ HP + +K + D + VMEY G L + + F++ +
Sbjct: 60 QNTRHPFLTALK----YAFQTHDRLCFVMEYA----NGGELFFHLSRERVFTEERARFYG 111
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
+++ ++YLH V++RD+K NL+L+ G +KI DFGL ++ S T Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE+L Y A+D W LG +M E++ F + + I E+I
Sbjct: 172 LAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEEI-- 222
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI----- 695
+FP LS LL LL DP +R+
Sbjct: 223 ----------------------RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
Query: 696 TAEAALNHDWFREV 709
A+ + H +F +
Sbjct: 254 DAKEVMEHRFFLSI 267
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 75/353 (21%), Positives = 137/353 (38%), Gaps = 79/353 (22%)
Query: 381 TDSEDENDSCGTPEPAGPPQRSINMLQGCR---SVDEFERLNKIDEGTYGVVYRARDKKT 437
+ ++ P P P + IN+ +F L I +G++G V AR K
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 438 GEIVALK-----KVKMEKEREGFPLTSLREINILL-SFHHPSIVDVKEVVVGSNL----- 486
A+K + +KE + + E N+LL + HP +V L
Sbjct: 63 EVFYAVKVLQKKAILKKKEEK----HIMSERNVLLKNVKHPFLV---------GLHFSFQ 109
Query: 487 --DSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL 540
D ++ V++Y+ G L +++ F + + ++ + YLH +++RDL
Sbjct: 110 TADKLYFVLDYI----NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 541 KTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWS 600
K N+LL+++G + + DFGL ++ + T Y APE+L + Y +D W
Sbjct: 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWC 224
Query: 601 LGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLL 660
LG ++ E+L P F ++ + D I N+ +
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKPL---------------------- 256
Query: 661 RKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI----TAEAALNHDWFREV 709
+ P ++++ LL LL D KR+ +H +F +
Sbjct: 257 --QLK-------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 21/236 (8%)
Query: 389 SCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKK-TGEIVALKKVK 447
CG+P P + G ++E I G G +Y A D+ G V LK +
Sbjct: 61 YCGSPYSFLPQ-----LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV 115
Query: 448 MEKEREGFPLTSLREINILLSFHHPSIV---DVKEVVVGSNLDSIFMVMEYME-HDLKGL 503
+ E ++ E L HPSIV + E ++VMEY+ LK
Sbjct: 116 HSGDAE-AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK-- 172
Query: 504 METMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563
+ Q +E +L++L + YLH +++ DLK N++L LK+ D G +
Sbjct: 173 -RSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR 230
Query: 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
S + +L T ++APE++ + A D++++G +A L P NG+
Sbjct: 231 INS----FGYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 78/317 (24%), Positives = 138/317 (43%), Gaps = 73/317 (23%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVA---LKK--VKMEKEREGFPLTSLREINI 465
+++F + +G++G V+ A KKT + A LKK V M+ + E ++ E +
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE----CTMVEKRV 70
Query: 466 L-LSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEHDLKG--LMETMKQ--PFSQ 513
L L++ HP + ++ +++F VMEY+ G LM ++ F
Sbjct: 71 LSLAWEHPFLT---------HMFCTFQTKENLFFVMEYLN----GGDLMYHIQSCHKFDL 117
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573
S +++ G+++LH +++RDLK N+LL+ G +KI DFG+ ++
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
Query: 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGT 633
T Y APE+LLG ++Y+ ++D WS G ++ E+L + F+G+ E + I
Sbjct: 178 FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----- 231
Query: 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693
+ +P L DLL L +P+K
Sbjct: 232 -MDNP------------------------FYP-------RWLEKEAKDLLVKLFVREPEK 259
Query: 694 RITAEAAL-NHDWFREV 709
R+ + H FRE+
Sbjct: 260 RLGVRGDIRQHPLFREI 276
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 8e-30
Identities = 51/354 (14%), Positives = 105/354 (29%), Gaps = 73/354 (20%)
Query: 400 QRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-------- 451
Q+ C ++ +R KI EG +G V++ VA+K + +E
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQ 64
Query: 452 -------REGFPLTSLREINILLSFHHPSIVDVKEVVV---------------------- 482
E L ++ + + + V
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 483 ------GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW-V 535
D +F+V+E E L + + S + K ++ QL + +
Sbjct: 125 ANDRPDFFKDDQLFIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRF 183
Query: 536 LHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTA 595
HRDL N+LL K+ + P ++ Y+ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID--------------YTLS 229
Query: 596 IDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655
+ ++ E LF G + D I++ + N W + P V ++ +
Sbjct: 230 RLERDGIVVFCDVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYH--PYSNVLWLHY 285
Query: 656 QYNLLRKKFPATSFTGSPVLSDA---GFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ + K+ + +P + + ++L + +A L
Sbjct: 286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 7/208 (3%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHHPS 473
++ ++K+ G VY A D VA+K + + +E+E RE++ H +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 474 IVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
IV + +V D ++VMEY+E L +E+ P S Q+L+GIK+ HD
Sbjct: 73 IVSMIDV--DEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD 129
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLLGSKQ 591
++HRD+K N+L+++ LKI DFG+A+ T+ V+ T+ Y +PE G +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EA 188
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKS 619
D++S+G ++ E+L EP FNG++
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L G +G V++A+ E VA+K ++ ++ + E+ L H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHE 78
Query: 473 SIV-----DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
+I+ + + V +L +++ + E L ++ S +E+ + + G
Sbjct: 79 NILQFIGAEKRGTSVDVDL---WLITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARG 133
Query: 527 IKYLHDNW----------VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY-THLV 575
+ YLH++ + HRD+K+ N+LL N I DFGLA ++ + TH
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 576 V-TLWYRAPELLLGS----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624
V T Y APE+L G+ + IDM+++G ++ EL S+ +G + L
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 80/338 (23%)
Query: 397 GPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRAR---DKKTGEIVA---LKK---VK 447
G + S+N + FE L + +G YG V++ R TG+I A LKK V+
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 448 MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEHDL 500
K+ + E NIL HP IV +L +++++EY+
Sbjct: 61 NAKDTA----HTKAERNILEEVKHPFIV---------DLIYAFQTGGKLYLILEYL---- 103
Query: 501 KG--LMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
G L +++ F + + ++ + +LH +++RDLK N++LN++G +K+
Sbjct: 104 SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163
Query: 557 DFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFN 616
DFGL ++ T+ Y APE+L+ ++ A+D WSLG +M ++L+ P F
Sbjct: 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT 222
Query: 617 GKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS 676
G++ +DKI K+ P P L+
Sbjct: 223 GENRKKTIDKIL------KCKL------------------------NLP-------PYLT 245
Query: 677 DAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREV 709
DLL LL + R+ A H +FR +
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 38/227 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D + L I G YG VY+ VA+K + + + I + H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHD 67
Query: 473 SIV-----DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEG 526
+I D + G +VMEY + L + L + G
Sbjct: 68 NIARFIVGDERVTADGRM--EYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRG 123
Query: 527 IKYLHDNW---------VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY------ 571
+ YLH + HRDL + N+L+ N G I DFGL+ +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 572 --THLVVTLWYRAPELLLGS------KQYSTAIDMWSLGCIMAELLS 610
V T+ Y APE+L G+ + +DM++LG I E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/322 (21%), Positives = 130/322 (40%), Gaps = 78/322 (24%)
Query: 411 SVDEFERLNKIDEGTYGVVYRAR---DKKTGEIVALKKVK----MEKEREGFPLTSLREI 463
+FE L + +G++G V+ + ++ A+K +K ++R + E
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV----RTKMER 77
Query: 464 NILLSFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEHDLKG--LMETMKQ--PFS 512
+IL+ +HP IV L ++++++++ +G L + + F+
Sbjct: 78 DILVEVNHPFIV---------KLHYAFQTEGKLYLILDFL----RGGDLFTRLSKEVMFT 124
Query: 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572
+ +VK + +L + +LH +++RDLK N+LL+ G +K+ DFGL+++ K
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632
T+ Y APE++ + ++ + D WS G +M E+L+ F GK + + I
Sbjct: 185 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL---- 239
Query: 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPD 692
K+ P LS LL L +P
Sbjct: 240 --KAKL------------------------GMP-------QFLSPEAQSLLRMLFKRNPA 266
Query: 693 KRI-----TAEAALNHDWFREV 709
R+ E H +F +
Sbjct: 267 NRLGAGPDGVEEIKRHSFFSTI 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 86/358 (24%), Positives = 143/358 (39%), Gaps = 61/358 (17%)
Query: 364 MEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDE 423
++ D + D S +D+ G E + + + +++EFE L + +
Sbjct: 103 IQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV----TMNEFEYLKLLGK 158
Query: 424 GTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINILLSFHHPSIVDVKEVV 481
GT+G V ++K TG A+K +K E ++ T L E +L + HP + +K
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTALKYSF 217
Query: 482 VGSNLDSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEVKCLMLQLLEGIKYLH-DNWVL 536
D + VMEY G L + + FS+ + +++ + YLH + V+
Sbjct: 218 --QTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 271
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAI 596
+RDLK NL+L+ G +KI DFGL ++ T Y APE+L Y A+
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAV 330
Query: 597 DMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQ 656
D W LG +M E++ F + + I E+I
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEEI------------------ 366
Query: 657 YNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREV 709
+FP L LL+ LL DP +R+ A+ + H +F +
Sbjct: 367 ------RFP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 85/379 (22%), Positives = 147/379 (38%), Gaps = 75/379 (19%)
Query: 351 DEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCR 410
YH H + D N G+ +E +G S+ +
Sbjct: 2 SYYHHHHHH-----DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----- 51
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINIL-L 467
+F+ L I G+Y V R KKT I A++ VK E + E E ++
Sbjct: 52 --QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQ 108
Query: 468 SFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEV 516
+ +HP +V L +F V+EY+ G LM M++ +
Sbjct: 109 ASNHPFLV---------GLHSCFQTESRLFFVIEYV----NGGDLMFHMQRQRKLPEEHA 155
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
+ ++ + YLH+ +++RDLK N+LL++ G +K+ D+G+ ++ P +
Sbjct: 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
T Y APE+L G + Y ++D W+LG +M E+++ G+S FD + +
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMA------GRSPFDIVGSSDNPDQNTED 268
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI- 695
+ F + ++ + P LS +L S L DP +R+
Sbjct: 269 YL---FQVILEKQI------------RIP-------RSLSVKAASVLKSFLNKDPKERLG 306
Query: 696 -----TAEAALNHDWFREV 709
H +FR V
Sbjct: 307 CHPQTGFADIQGHPFFRNV 325
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 65/313 (20%), Positives = 125/313 (39%), Gaps = 61/313 (19%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME--KEREGFPLTSLREINIL-L 467
+ +F L + +G++G V + K T E+ A+K +K + + + T + E +L L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLAL 76
Query: 468 SFHHPSIVDVKEVVVGS--NLDSIFMVMEYMEHDLKG--LMETMKQP--FSQSEVKCLML 521
P + + +D ++ VMEY+ G LM ++Q F +
Sbjct: 77 PGKPPFLTQLH----SCFQTMDRLYFVMEYV----NGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 522 QLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYR 581
++ G+ +L +++RDLK N++L++ G +KI DFG+ ++ T Y
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641
APE++ + Y ++D W+ G ++ E+L+ + F G+ E + I +
Sbjct: 189 APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHNV--- 238
Query: 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----T 696
+P +S + L+T P KR+
Sbjct: 239 ---------------------AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 697 AEAALNHDWFREV 709
H +FR +
Sbjct: 271 ERDIKEHAFFRYI 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 78/348 (22%), Positives = 145/348 (41%), Gaps = 76/348 (21%)
Query: 377 GGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKK 436
G ++ E + G D FE + + +G++G V AR K+
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGI--------------DNFEFIRVLGKGSFGKVMLARVKE 46
Query: 437 TGEIVALKKVKMEK--EREGFPLTSLREINIL-LSFHHPSIVDVKEVVVGS--NLDSIFM 491
TG++ A+K +K + + + T + E IL L+ +HP + + D +F
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQLF----CCFQTPDRLFF 101
Query: 492 VMEYMEHDLKG--LMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547
VME++ G LM +++ F ++ + +++ + +LHD +++RDLK N+LL
Sbjct: 102 VMEFV----NGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 548 NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAE 607
++ G K+ DFG+ ++ T Y APE+L Y A+D W++G ++ E
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYE 216
Query: 608 LLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPAT 667
+L F ++E D + I N+++ +P
Sbjct: 217 MLCGHAPFEAENEDDLFEAIL------NDEV------------------------VYP-- 244
Query: 668 SFTGSPVLSDAGFDLLNSLLTYDPDKRI------TAEAALNHDWFREV 709
L + +L S +T +P R+ A L H +F+E+
Sbjct: 245 -----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 78/319 (24%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINIL-L 467
+ +F+ L I G+Y V R KKT I A+K VK E + E E ++
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQ 65
Query: 468 SFHHPSIVDVKEVVVGSNL-------DSIFMVMEYMEHDLKG--LMETMKQ--PFSQSEV 516
+ +HP +V L +F V+EY+ G LM M++ +
Sbjct: 66 ASNHPFLV---------GLHSCFQTESRLFFVIEYV----NGGDLMFHMQRQRKLPEEHA 112
Query: 517 KCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV 576
+ ++ + YLH+ +++RDLK N+LL++ G +K+ D+G+ ++ P +
Sbjct: 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636
T Y APE+L G + Y ++D W+LG +M E+++ G+S FD + +
Sbjct: 173 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMA------GRSPFDIVGSSDNPDQNTED 225
Query: 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI- 695
+ F I + + + P LS +L S L DP +R+
Sbjct: 226 YL---FQV--------ILEK----QIRIP-------RSLSVKAASVLKSFLNKDPKERLG 263
Query: 696 -----TAEAALNHDWFREV 709
H +FR V
Sbjct: 264 CHPQTGFADIQGHPFFRNV 282
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSF 469
++ +I G +G V+ R + +VA+K + + F L+E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY 169
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+IV + V I++VME ++ D + T + ++ G++
Sbjct: 170 SHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS-------PLKPYTHLVV 576
YL +HRDL N L+ + LKI DFG++R Y + P+K
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------- 280
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W APE L + YS+ D+WS G ++ E S
Sbjct: 281 --WT-APEALNYGR-YSSESDVWSFGILLWETFS 310
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVK---MEKEREGFPLTSLREINIL 466
I G G V R + G+ VA+K +K E++R F L E +I+
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIM 104
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
F HP+I+ ++ VV +V EYME+ L + T F+ ++ ++ +
Sbjct: 105 GQFDHPNIIRLEGVVTRG--RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYR 581
G++YL D +HRDL N+L+++ K+ DFGL+R W
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSK 611
APE + +S+A D+WS G +M E+L+
Sbjct: 222 APEAIAFRT-FSSASDVWSFGVVMWEVLAY 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 19/230 (8%)
Query: 393 PEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVK-- 447
P P ++++ + G +G V R K + VA+K +K
Sbjct: 25 PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 448 -MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLME 505
EK+R F L E +I+ F HP+I+ ++ VV S + +V EYME+ L +
Sbjct: 85 YTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLR 138
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565
F+ ++ ++ + G+KYL D +HRDL N+L+N+ K+ DFGL R
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 566 SPLKPYTHLVVTL----WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611
+ W +PE + K +++A D+WS G ++ E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVMSY 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 10/235 (4%)
Query: 391 GTPEPAGPPQRSINMLQGCRSVDEFER---LNKIDEGTYGVVYRARDKKTGEIVALKKVK 447
P ++ R +F + G G VY A D IVALK +
Sbjct: 9 HHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS 68
Query: 448 MEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLME 505
F RE P +V + + G +++ M + DL ++
Sbjct: 69 ETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF--GEIDGQLYVDMRLINGVDLAAMLR 126
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565
+ P + ++ Q+ + H HRD+K N+L++ + DFG+A
Sbjct: 127 R-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185
Query: 566 SPLKPYTHLVV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
V TL+Y APE + D+++L C++ E L+ P + G
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 9/223 (4%)
Query: 404 NMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLRE 462
+M D +E + G V+ ARD + VA+K ++ + R F L RE
Sbjct: 3 HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 463 INILLSFHHPSIVDVKEV--VVGSNLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCL 519
+ +HP+IV V + ++VMEY++ L+ ++ T + P + +
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEV 121
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH---LVV 576
+ + + + H N ++HRD+K +N++++ +K+ DFG+AR T ++
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619
T Y +PE G D++SLGC++ E+L+ EP F G S
Sbjct: 182 TAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEI----VALKKVK---MEKEREGFPLTSLREINI 465
R I G +G VY+ K + VA+K +K EK+R F L E I
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGI 99
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLL 524
+ F H +I+ ++ V+ S + ++ EYME+ L + FS ++ ++ +
Sbjct: 100 MGQFSHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WY 580
G+KYL + +HRDL N+L+N+ K+ DFGL+R + W
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611
APE + K +++A D+WS G +M E+++
Sbjct: 218 -APEAISYRK-FTSASDVWSFGIVMWEVMTY 246
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRAR---DKKTGEI-VALKKVK---MEKEREGFPLTSLREINI 465
EF+++ + G +G VY+ + + +I VA+K+++ K + L E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLL 524
+ S +P + + + + ++ ++ + M L + K + +Q+
Sbjct: 71 MASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS------------PLKPYT 572
+G+ YL D ++HRDL N+L+ +KI DFGLA+ G+ P+K
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E +L + Y+ D+WS G + EL++
Sbjct: 185 ------WM-ALESIL-HRIYTHQSDVWSYGVTVWELMT 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-27
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ K+ +G +G V+ T VA +K K P L+E ++ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VA---IKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + VV + I++V EYM L L + ++ + Q+ G+ Y+
Sbjct: 240 KLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELL 586
+HRDL+ +N+L+ K+ DFGLAR YT W APE
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWT-APEAA 353
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSK 611
L +++ D+WS G ++ EL +K
Sbjct: 354 L-YGRFTIKSDVWSFGILLTELTTK 377
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 39/222 (17%), Positives = 80/222 (36%), Gaps = 40/222 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEI-------VALKKVKM--EKEREGFPLTSLREI 463
++ + +GT+ +++ ++ G+ V LK + E F
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAA 63
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
+++ H +V V V D +V E+++ L ++ K + + Q
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCG--DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGEL--------KICDFGLARQ------YGSPL 568
L + +L +N ++H ++ N+LL + K+ D G++ +
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W PE + K + A D WS G + E+ S
Sbjct: 182 P---------WV-PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
E + L I +G +G V + VA+K +K + + F L E +++ H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF----LAEASVMTQLRHS 74
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYL 530
++V + V+ +++V EYM L L + + L + E ++YL
Sbjct: 75 NLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS--PLKPYTHLVVTLWYRAP 583
N +HRDL N+L++ K+ DFGL + Q P+K W AP
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WT-AP 183
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLS 610
E L K +ST D+WS G ++ E+ S
Sbjct: 184 EALREKK-FSTKSDVWSFGILLWEIYS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRA--RDKKTGEI-VALKKVK---MEKEREGFPLTSLREINIL 466
+ E I EG +G V++ + + VA+K K + RE F L+E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTM 70
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
F HP IV + V+ + ++++ME +L+ ++ K + + QL
Sbjct: 71 RQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ------YGS-----PLKPYTHL 574
+ YL +HRD+ N+L+++ +K+ DFGL+R Y + P+K
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----- 182
Query: 575 VVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611
W APE + + +++A D+W G M E+L
Sbjct: 183 ----WM-APESINFRR-FTSASDVWMFGVCMWEILMH 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRA--RDKKTGEI-VALKKVK---MEKEREGFPLTSLREINIL 466
++ + EG +G VY + K +I VA+K K +E F + E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIM 67
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
+ HP IV + ++ + +++ME + +L +E K + LQ+ +
Sbjct: 68 KNLDHPHIVKLIGIIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYR 581
+ YL +HRD+ N+L+ + +K+ DFGL+R + Y VT W
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWM- 181
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLSK 611
+PE + + ++TA D+W M E+LS
Sbjct: 182 SPESINFRR-FTTASDVWMFAVCMWEILSF 210
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHH 471
E + +I G +G+V+ + VA+K ++ E F + E +++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 62
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P +V + V + I +V E+MEH L + T + F+ + + L + EG+ YL
Sbjct: 63 PKLVQLYGVCLEQ--APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLW 579
+ V+HRDL N L+ +K+ DFG+ R QY S P+K W
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK---------W 171
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+PE+ S+ YS+ D+WS G +M E+ S
Sbjct: 172 A-SPEVFSFSR-YSSKSDVWSFGVLMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
+ +K+ G YG VY KK VA+K +K + E E F L+E ++ H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 275
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKY 529
P++V + V +++ E+M + +L L E +Q S + + Q+ ++Y
Sbjct: 276 PNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPEL 585
L +HR+L N L+ +K+ DFGL+R YT W APE
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT-APES 390
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSK 611
L ++S D+W+ G ++ E+ +
Sbjct: 391 LA-YNKFSIKSDVWAFGVLLWEIATY 415
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHH 471
+ +K+ G YG VY KK VA+K +K + E E F L+E ++ H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 68
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKY 529
P++V + V + +++ E+M + +L L E +Q S + + Q+ ++Y
Sbjct: 69 PNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPEL 585
L +HRDL N L+ +K+ DFGL+R YT W APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT-APES 183
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLS 610
L +K +S D+W+ G ++ E+ +
Sbjct: 184 LAYNK-FSIKSDVWAFGVLLWEIAT 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 420 KIDEGTYGVVYRARDKKTGEI--VALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
++ G +G V + + + VA+K +K + + E +RE I+ +P I
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYI 72
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + V +++ +VME L + ++ S V L+ Q+ G+KYL +
Sbjct: 73 VRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELLLGS 589
+HRDL N+LL NR KI DFGL++ G+ YT WY APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 188
Query: 590 KQYSTAIDMWSLGCIMAELLS 610
K +S+ D+WS G M E LS
Sbjct: 189 K-FSSRSDVWSYGVTMWEALS 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
E + L I +G +G V + G VA+K +K + + F L E +++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLRHS 246
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYL 530
++V + V+V +++V EYM L L + + L + E ++YL
Sbjct: 247 NLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS--PLKPYTHLVVTLWYRAP 583
N +HRDL N+L++ K+ DFGL + Q P+K W AP
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WT-AP 355
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSK 611
E L K +ST D+WS G ++ E+ S
Sbjct: 356 EALREKK-FSTKSDVWSFGILLWEIYSF 382
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ + K+ G +G V+ A K + VA VK K L E N++ + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VA---VKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + VV + I+++ E+M L L ++ Q+ EG+ ++
Sbjct: 244 KLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELL 586
+HRDL+ +N+L++ KI DFGLAR YT W APE +
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWT-APEAI 357
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSK 611
++ D+WS G ++ E+++
Sbjct: 358 NFGS-FTIKSDVWSFGILLMEIVTY 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHH 471
+ L ++ G +GVV + + + VA+K +K + F + E ++++ H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEF----IEEAKVMMNLSH 78
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + V + IF++ EYM + L + M+ F ++ + + E ++YL
Sbjct: 79 EKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVTLW 579
LHRDL N L+N++G +K+ DFGL+R +Y S P++ W
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---------W 187
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
PE+L+ SK +S+ D+W+ G +M E+ S
Sbjct: 188 S-PPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSLREINILLSF 469
+E L ++ G +GVV + K + VA+K +K M ++ F +E ++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDE--F----FQEAQTMMKL 60
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP +V V S I++V EY+ + L + + + S++ + + EG+
Sbjct: 61 SHPKLVKFYGVC--SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR-----QYGS------PLKPYTHLVVT 577
+L + +HRDL N L++ +K+ DFG+ R QY S P+K
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK-------- 170
Query: 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W APE+ K YS+ D+W+ G +M E+ S
Sbjct: 171 -WS-APEVFHYFK-YSSKSDVWAFGILMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-KEREGFPLTSLREINILLSFHH 471
+ + + ++ G +G V+ + VA+K +K + F L E N++ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQH 67
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKY 529
+V + VV + I+++ EYME+ L L + +++ + Q+ EG+ +
Sbjct: 68 QRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPEL 585
+ + +HRDL+ +N+L+++ KI DFGLAR YT W APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWT-APEA 181
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSK 611
+ ++ D+WS G ++ E+++
Sbjct: 182 INYGT-FTIKSDVWSFGILLTEIVTH 206
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ K+ +G +G V+ T VA +K K P L+E ++ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VA---IKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKG-LMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + VV + I++V EYM L L + ++ + Q+ G+ Y+
Sbjct: 323 KLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELL 586
+HRDL+ +N+L+ K+ DFGLAR YT W APE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWT-APEAA 436
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSK 611
L +++ D+WS G ++ EL +K
Sbjct: 437 L-YGRFTIKSDVWSFGILLTELTTK 460
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 22/211 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRA--RDKKTGEI-VALKKVKM-----EKEREGFPLTSLREIN 464
+ L K+ +G++GVV R + VA+K +K + + F +RE+N
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVN 73
Query: 465 ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQL 523
+ S H +++ + VV+ + MV E L + + F + +Q+
Sbjct: 74 AMHSLDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----W 579
EG+ YL +HRDL NLLL R +KI DFGL R Y W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 580 YRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
APE L +S A D W G + E+ +
Sbjct: 191 C-APESLKTRT-FSHASDTWMFGVTLWEMFT 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEI---VALKKVK---MEKEREGFPLTSLREI 463
S I G +G VY A+K + E F L E
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF----LTEG 77
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
I+ F HP+++ + + + S S +V+ YM+H DL+ + + ++ LQ
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTL-- 578
+ +G+KYL +HRDL N +L+ + +K+ DFGLAR + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 579 -WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E L K ++T D+WS G ++ EL++
Sbjct: 197 KWM-ALESLQTQK-FTTKSDVWSFGVLLWELMT 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 420 KIDEGTYGVVYRAR-DKKTGEI-VALKKVK---MEKEREGFPLTSLREINILLSFHHPSI 474
++ G +G V + + +I VA+K +K + + E +RE I+ +P I
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYI 398
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN 533
V + V +++ +VME L + ++ S V L+ Q+ G+KYL +
Sbjct: 399 VRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 534 WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELLLGS 589
+HR+L N+LL NR KI DFGL++ G+ YT WY APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 514
Query: 590 KQYSTAIDMWSLGCIMAELLS 610
K +S+ D+WS G M E LS
Sbjct: 515 K-FSSRSDVWSYGVTMWEALS 534
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRAR---DKKTGEI-VALKKVK---MEKEREGFPLTSLREINI 465
EF+++ + G +G VY+ + + +I VA+K+++ K + L E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLL 524
+ S +P + + + + ++ ++ + M L + K + +Q+
Sbjct: 71 MASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS------------PLKPYT 572
+G+ YL D ++HRDL N+L+ +KI DFGLA+ G+ P+K
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E +L Y+ D+WS G + EL++
Sbjct: 185 ------WM-ALESILHRI-YTHQSDVWSYGVTVWELMT 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEI---VALKKVK---MEKEREGFPLTSLREINIL 466
+ E I EG +G V++ VA+K K + RE F L+E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTM 445
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLE 525
F HP IV + V+ + ++++ME +L+ ++ K + + QL
Sbjct: 446 RQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYR 581
+ YL +HRD+ N+L+++ +K+ DFGL+R Y W
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKGKLPIKWM- 559
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLS 610
APE + +++++A D+W G M E+L
Sbjct: 560 APESIN-FRRFTSASDVWMFGVCMWEILM 587
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 420 KIDEGTYGVVYRA--RDKKTGEIVALKKVK---MEKE-REGFPLTSLREINILLSFHHPS 473
++ G +G V + + KK + VA+K +K + ++ L E N++ +P
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL----LAEANVMQQLDNPY 79
Query: 474 IVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
IV + + +S +VME E L ++ + + L+ Q+ G+KYL +
Sbjct: 80 IVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE 135
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTL----WYRAPELLLG 588
+ +HRDL N+LL + KI DFGL++ + Y WY APE +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINY 194
Query: 589 SKQYSTAIDMWSLGCIMAELLSK 611
K +S+ D+WS G +M E S
Sbjct: 195 YK-FSSKSDVWSFGVLMWEAFSY 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 66/310 (21%), Positives = 111/310 (35%), Gaps = 34/310 (10%)
Query: 316 LSPELSEVKRIGSERSRSRSSESDERGDRARSLSGDEYHGHESEKGDYMEIDEDHN---N 372
+SP + + R R+S + S D E + N
Sbjct: 1 MSP-IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 373 NDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRA 432
+ D + + P I I G +G VY
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFN-----------EVIGRGHFGCVYHG 108
Query: 433 RDKKTGEI---VALKKVK---MEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486
A+K + E F L E I+ F HP+++ + + + S
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSE- 163
Query: 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNL 545
S +V+ YM+H DL+ + + ++ LQ+ +G+K+L +HRDL N
Sbjct: 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 223
Query: 546 LLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTL---WYRAPELLLGSKQYSTAIDMWS 600
+L+ + +K+ DFGLAR + L W A E L K ++T D+WS
Sbjct: 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWS 281
Query: 601 LGCIMAELLS 610
G ++ EL++
Sbjct: 282 FGVLLWELMT 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 45/218 (20%), Positives = 93/218 (42%), Gaps = 38/218 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRAR---DKKTGEI-VALKKVK---MEKEREGFPLTSLREINI 465
E +L + G +G V++ + ++ +I V +K ++ + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLA 68
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLL 524
+ S H IV + + GS S+ +V +Y+ L + + + +Q+
Sbjct: 69 IGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS------------PLKPYT 572
+G+ YL ++ ++HR+L N+LL + ++++ DFG+A P+K
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK--- 182
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E + K Y+ D+WS G + EL++
Sbjct: 183 ------WM-ALESIHFGK-YTHQSDVWSYGVTVWELMT 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 58/238 (24%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK---MEKEREGFPLTSL 460
E + ++ E +G VY+ + + VA+K +K RE F
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----R 60
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK---------------GLM 504
E + HP++V + VV + + M+ Y H DL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVV--TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 505 ETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ- 563
T+K + L+ Q+ G++YL + V+H+DL T N+L+ ++ +KI D GL R+
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 564 YGS-----------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y + P++ W APE ++ K +S D+WS G ++ E+ S
Sbjct: 179 YAADYYKLLGNSLLPIR---------WM-APEAIMYGK-FSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 52/232 (22%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVK---MEKEREGFPLTSL 460
E R ++ +G++G+VY K E VA+K V +ER F L
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----L 76
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK---------GLMETMKQP 510
E +++ F+ +V + VV S ++ME M DLK + P
Sbjct: 77 NEASVMKEFNCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGS--- 566
S S++ + ++ +G+ YL+ N +HRDL N ++ +KI DFG+ R Y +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 567 --------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P++ W +PE L ++T D+WS G ++ E+ +
Sbjct: 195 RKGGKGLLPVR---------WM-SPESLKDGV-FTTYSDVWSFGVVLWEIAT 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 52/232 (22%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK---MEKEREGFPLTSL 460
E R + + G +G VY + + + VA+K + E++ F L
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----L 81
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK------GLMETMKQPFSQ 513
E I+ F+H +IV V F++ME M DLK + +
Sbjct: 82 MEALIISKFNHQNIVRCIGVS--LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKP 570
++ + + G +YL +N +HRD+ N LL G KI DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 571 YTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ +YR PE + +++ D WS G ++ E+ S
Sbjct: 193 ---IYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFS 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 59/238 (24%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK--MEKEREGFPLTSLR 461
+R ++ EG +G V+ A K +VA+K +K R+ F R
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QR 66
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK---------------GLME 505
E +L + H IV V + D + MV EYM+H DL G
Sbjct: 67 EAELLTNLQHEHIVKFYGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-Y 564
K S++ + Q+ G+ YL +HRDL T N L+ +KI DFG++R Y
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 565 GSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ Y YR PE ++ K ++T D+WS G I+ E+ +
Sbjct: 185 ST---DY--------YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFT 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 48/230 (20%)
Query: 414 EFER-----LNKIDEGTYGVVYRARDKKTGEI---VALKKVKME----KEREGFPLTSLR 461
+R + EG +G V K+ VA+K +K++ +E E F L
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LS 85
Query: 462 EINILLSFHHPSIVDVKEVVVGS---NLDSIFMVMEYMEH-DLKG-----LMETMKQPFS 512
E + F HP+++ + V + + +++ +M++ DL +ET +
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGS----- 566
+ M+ + G++YL + LHRDL N +L + + + DFGL+++ Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 567 ------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P+K W A E L Y++ D+W+ G M E+ +
Sbjct: 206 GRIAKMPVK---------WI-AIESLADRV-YTSKSDVWAFGVTMWEIAT 244
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 56/236 (23%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK--MEKEREGFPLTSLR 461
+R ++ EG +G V+ A ++ +VA+K +K E R+ F R
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QR 92
Query: 462 EINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK--------------GLMET 506
E +L H IV V + MV EYM H DL G +
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 507 MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YG 565
P ++ + Q+ G+ YL +HRDL T N L+ +KI DFG++R Y
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 566 S-----------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ P++ W PE +L K ++T D+WS G ++ E+ +
Sbjct: 211 TDYYRVGGRTMLPIR---------WM-PPESILYRK-FTTESDVWSFGVVLWEIFT 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 52/232 (22%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVK---MEKEREGFPLTSL 460
E R + + G +G VY + + VA+K + E++ F L
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----L 122
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK------GLMETMKQPFSQ 513
E I+ F+H +IV V + S F+++E M DLK + +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQS--LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 514 SEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSPLKP 570
++ + + G +YL +N +HRD+ N LL G KI DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 571 YTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ +YR PE + +++ D WS G ++ E+ S
Sbjct: 234 ---IYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFS 281
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVK 478
KI G +G + ++ T E VA +K+E + P E I V
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAP-QLHLEYRFYKQLGSGDGIPQVY 71
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
G MV+E + L+ L + + FS V + +QL+ ++Y+H +++R
Sbjct: 72 YF--GPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129
Query: 539 DLKTSNLLL-----NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY- 592
D+K N L+ + + I DF LA++Y + P T + YR + L G+ +Y
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEY---IDPETKKHIP--YREHKSLTGTARYM 184
Query: 593 STAI----------DMWSLGCIMAELL 609
S D+ +LG + L
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFL 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 49/231 (21%)
Query: 414 EFER-----LNKIDEGTYGVVYRA--RDKKTGEI-VALKKVK----MEKEREGFPLTSLR 461
+ +G +G V A + + + VA+K +K + E F LR
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LR 74
Query: 462 EINILLSFHHPSIVDVKEVVV----GSNLDSIFMVMEYMEH-DLK-----GLMETMKQPF 511
E + F HP + + V + L +++ +M+H DL +
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 512 SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGS---- 566
+ M+ + G++YL +HRDL N +L + + DFGL+R+ Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 567 -------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
P+K W A E L + Y+ D+W+ G M E+++
Sbjct: 195 QGCASKLPVK---------WL-ALESLADNL-YTVHSDVWAFGVTMWEIMT 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRA--RDKKTGEI-VALKKVK---MEKEREGFPLTSLREI 463
I +G +GVVY D+ I A+K + ++ E F LRE
Sbjct: 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF----LREG 73
Query: 464 NILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQ 522
++ +HP+++ + +++ +++ YM H DL + + ++ + ++ LQ
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ------YGSPLKPYTHLVV 576
+ G++YL + +HRDL N +L+ +K+ DFGLAR Y + L V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
W A E L + ++T D+WS G ++ ELL+
Sbjct: 193 K-WT-ALESLQTYR-FTTKSDVWSFGVLLWELLT 223
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 45/275 (16%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVK 478
KI G++G +Y D GE VA +K+E + P E I I ++
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHP-QLHIESKIYKMMQGGVGIPTIR 71
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
G+ D MVME + L+ L + FS V L Q++ I+Y+H +HR
Sbjct: 72 WC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 129
Query: 539 DLKTSNLLL---NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY-ST 594
D+K N L+ + I DFGLA++Y TH + YR + L G+ +Y S
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKY---RDARTHQHIP--YRENKNLTGTARYASI 184
Query: 595 AI----------DMWSLGCIMAELLSKEPL----FNGKSEFDQLDKIFKT-LGTPNEKIW 639
D+ SLG ++ L ++ + ++I + + TP E +
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQKYERISEKKMSTPIEVL- 242
Query: 640 PGFSKLPGVKVNFIKH----------QYNLLRKKF 664
P ++ Y+ LR+ F
Sbjct: 243 --CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 35/251 (13%), Positives = 65/251 (25%), Gaps = 37/251 (14%)
Query: 388 DSCGTPEPAGP-PQRSINMLQGCRSVDE-FERLNKIDEGTYGVVYRARDKKTGEIVALKK 445
D+ P+ P + ++ G R + + L ++A D VAL
Sbjct: 4 DALREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF 63
Query: 446 VKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGL 503
V + + +L L P + V +VV +V E++ L+ +
Sbjct: 64 VDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG--GLVVAEWIRGGSLQEV 121
Query: 504 METMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563
+T P M L H V S + ++ G++ +
Sbjct: 122 ADTSPSP---VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174
Query: 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623
P D+ +G + LL
Sbjct: 175 TMPDANPQD------------------------DIRGIGASLYALLVNRWPLPEAGVRSG 210
Query: 624 LDKIFKTLGTP 634
L +
Sbjct: 211 LAPAERDTAGQ 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 54/277 (19%), Positives = 106/277 (38%), Gaps = 47/277 (16%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVK 478
+I EG++GV++ + + VA +K E R P E I +V
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNVY 72
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
G +V++ + L+ L++ + FS V Q+L ++ +H+ +++R
Sbjct: 73 YF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130
Query: 539 DLKTSNLLL-----NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY- 592
D+K N L+ N + + DFG+ + Y P H+ YR + L G+ +Y
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP-VTKQHIP----YREKKNLSGTARYM 185
Query: 593 STAI----------DMWSLGCIMAELLSKEPL----FNGKSEFDQLDKIFKT-LGTPNEK 637
S D+ +LG + L + L + + ++I + TP +
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244
Query: 638 IWPGFSKLPGVKVNFIKH----------QYNLLRKKF 664
+ + P ++ + Y+ L+ F
Sbjct: 245 L---CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 31/216 (14%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKE 479
KI G +G++Y A E A VK+E + G PL E+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG-PL--FSELKFYQRVAKKDCIKKWI 100
Query: 480 VVVGSNLDSI-----------------FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
+ I FMVME + DL+ + F +S V L ++
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-FKKSTVLQLGIR 159
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLL--NNRGELKICDFGLARQYGS-------PLKPYTH 573
+L+ ++Y+H+N +H D+K +NLLL N ++ + D+GL+ +Y P
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL 609
T+ + + + G S D+ LG M L
Sbjct: 220 HNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWL 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 53/233 (22%)
Query: 414 EFER-----LNKIDEGTYGVVYRARDKKTGE--IVALKKVK---MEKEREGFPLTSLREI 463
+ + I EG +G V +AR KK G A+K++K + + F E+
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGEL 76
Query: 464 NILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK---------------GLMET 506
+L HHP+I+++ + +++ +EY H +L + +
Sbjct: 77 EVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 507 MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ--- 563
S ++ + G+ YL +HRDL N+L+ KI DFGL+R
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 564 YGS------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y P++ W A E L S Y+T D+WS G ++ E++S
Sbjct: 195 YVKKTMGRLPVR---------WM-AIESLNYSV-YTTNSDVWSYGVLLWEIVS 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 66/246 (26%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK---MEKEREGFPLTSL 460
E+ R + I EG +G V++AR + +VA+K +K + F
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----Q 98
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK------------------ 501
RE ++ F +P+IV + V + ++ EYM + DL
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 502 -----GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
+ P S +E C+ Q+ G+ YL + +HRDL T N L+ +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 557 DFGLARQ-YGS-----------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCI 604
DFGL+R Y + P++ W PE + ++ Y+T D+W+ G +
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIR---------WM-PPESIFYNR-YTTESDVWAYGVV 265
Query: 605 MAELLS 610
+ E+ S
Sbjct: 266 LWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 55/259 (21%), Positives = 96/259 (37%), Gaps = 62/259 (23%)
Query: 398 PPQRSINMLQGCRSVD----EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVAL 443
P + ++ D EF R + G +G V A T VA+
Sbjct: 3 PDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 444 KKVK---MEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH- 498
K +K E + E+ IL+ HH ++V++ + +++E+ +
Sbjct: 63 KMLKEGATHSEHRAL----MSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFG 117
Query: 499 DLK---------------GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTS 543
+L + K + + C Q+ +G+++L +HRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 544 NLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYR------------APELLLGSKQ 591
N+LL+ + +KICDFGLAR + Y APE +
Sbjct: 178 NILLSEKNVVKICDFGLARD----------IYKDPDYVRKGDARLPLKWMAPETIFDRV- 226
Query: 592 YSTAIDMWSLGCIMAELLS 610
Y+ D+WS G ++ E+ S
Sbjct: 227 YTIQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 66/246 (26%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVK---MEKEREGFPLTSL 460
EF R + EG +G V +A + G VA+K +K E L
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----L 74
Query: 461 REINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK------------------ 501
E N+L +HP ++ + S + +++EY ++ L+
Sbjct: 75 SEFNVLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 502 -----GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
L ++ + ++ Q+ +G++YL + ++HRDL N+L+ ++KI
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 557 DFGLARQ-YGS-----------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCI 604
DFGL+R Y P+K W A E L Y+T D+WS G +
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVK---------WM-AIESLFDHI-YTTQSDVWSFGVL 241
Query: 605 MAELLS 610
+ E+++
Sbjct: 242 LWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 57/241 (23%), Positives = 89/241 (36%), Gaps = 61/241 (25%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVK---MEKEREGFPLTSL 460
EF R + G +G V A K + VA+K +K ERE +
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----M 74
Query: 461 REINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK----------------- 501
E+ +L +H +IV++ + ++ EY + DL
Sbjct: 75 SELKVLSYLGNHMNIVNLLGAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 502 GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+ME + ++ Q+ +G+ +L +HRDL N+LL + KICDFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 562 RQYGSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELL 609
R + Y APE + Y+ D+WS G + EL
Sbjct: 193 RD----------IKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 241
Query: 610 S 610
S
Sbjct: 242 S 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 61/241 (25%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-------DKKTGEIVALKKVK---MEKEREGFPLT 458
EF R + EG +G V A K VA+K +K EK+
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--- 87
Query: 459 SLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK--------------- 501
+ E+ ++ H +I+++ + +++++EY +L+
Sbjct: 88 -VSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 502 GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+ ++ + ++ QL G++YL +HRDL N+L+ +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 562 RQYGSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELL 609
R + +Y+ APE L Y+ D+WS G +M E+
Sbjct: 205 RD----------INNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 253
Query: 610 S 610
+
Sbjct: 254 T 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 60/289 (20%), Positives = 104/289 (35%), Gaps = 50/289 (17%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKK---VKMEKEREGFPLTSLREINILLSFHHPSIVD 476
I +G +G +Y A + E V VK+E G PL E+ P +
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNG-PL--FTELKFYQRAAKPEQIQ 97
Query: 477 VKEVVVGSNLDSI-----------------FMVMEYMEHDLKGLMETMKQPFSQSEVKCL 519
+ FM+M+ DL+ + E + FS+ V L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL 157
Query: 520 MLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKI--CDFGLARQYGS-------PLKP 570
L++L+ ++Y+H++ +H D+K SNLLLN + ++ D+GLA +Y P
Sbjct: 158 SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL----FNGKSEFDQLDK 626
T+ + + + G S D+ LG M + L L ++ + K
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWL-TGHLPWEDNLKDPKYVRDSK 275
Query: 627 I-FKTLGTPNEKIWPGFSKLPGVKVNFIKH----------QYNLLRKKF 664
I ++ + PG +++ Y LR
Sbjct: 276 IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 53/238 (22%), Positives = 87/238 (36%), Gaps = 59/238 (24%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR----DKKTGEI-VALKKVK---MEKEREGFPLTSL 460
EF R + G +G V A K+ + VA+K +K E+E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----M 97
Query: 461 REINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK-------------GLME 505
E+ I+ H +IV++ ++ + ++ EY + DL
Sbjct: 98 SELKIMSHLGQHENIVNLLGAC--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-Y 564
S ++ Q+ +G+ +L +HRD+ N+LL N KI DFGLAR
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 565 GSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELLS 610
Y APE + Y+ D+WS G ++ E+ S
Sbjct: 216 NDS-----------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 261
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 49/290 (16%), Positives = 101/290 (34%), Gaps = 50/290 (17%)
Query: 419 NKIDEGTYGVVYRARDKKTGEIVALKK-----VKMEKEREGFPLTSLREINILLSFHHPS 473
+ G++Y A T + + +K++ + L E N P
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG--RL--FNEQNFFQRAAKPL 103
Query: 474 IVDVKEVVVGSNLDSI--------------FMVMEYMEHDLKGLMETM-KQPFSQSEVKC 518
V+ + + + L +I F+V+ + L+ ++ K S+ V
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163
Query: 519 LMLQLLEGIKYLHDNWVLHRDLKTSNLLL--NNRGELKICDFGLARQYGSPLK--PY--- 571
+ +LL+ +++LH+N +H ++ N+ + ++ ++ + +G A +Y K Y
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 572 --THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL----FNGKSEFDQLD 625
+ L + + +L G S D+ SLG M + L L +E
Sbjct: 224 SRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWL-YGFLPWTNCLPNTEDIMKQ 281
Query: 626 KI-FKTLGTPNEKIWPGFSKLPGVKVNFIKH----------QYNLLRKKF 664
K F P + + ++K Y +LR
Sbjct: 282 KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 61/241 (25%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-------DKKTGEIVALKKVK---MEKEREGFPLT 458
EF R + EG +G V A K VA+K +K EK+
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--- 133
Query: 459 SLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK--------------- 501
+ E+ ++ H +I+++ + +++++EY +L+
Sbjct: 134 -VSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 502 GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
+ ++ + ++ QL G++YL +HRDL N+L+ +KI DFGLA
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 562 RQ-YGS-----------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELL 609
R P+K W APE L Y+ D+WS G +M E+
Sbjct: 251 RDINNIDYYKKTTNGRLPVK---------WM-APEALFDRV-YTHQSDVWSFGVLMWEIF 299
Query: 610 S 610
+
Sbjct: 300 T 300
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 1e-18
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVK 478
KI G++G +Y + +T E VA+K +E + P L E I I +V+
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKIYRILQGGTGIPNVR 69
Query: 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHR 538
G D +VM+ + L+ L + S V L Q++ ++++H LHR
Sbjct: 70 WF--GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
Query: 539 DLKTSNLLL---NNRGELKICDFGLARQYGS-------PLKPYTHLVVTLWYRAPELLLG 588
D+K N L+ ++ I DFGLA++Y P + +L T Y + LG
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187
Query: 589 SKQYSTAIDMWSLGCIMAELL 609
+Q S D+ SLG ++ L
Sbjct: 188 IEQ-SRRDDLESLGYVLMYFL 207
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 61/241 (25%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-------DKKTGEIVALKKVK---MEKEREGFPLT 458
E R + EG +G V A VA+K +K EK+
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--- 121
Query: 459 SLREINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK--------------- 501
+ E+ ++ H +I+++ + +++++EY +L+
Sbjct: 122 -ISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 502 GLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561
++ S ++ Q+ G++YL +HRDL N+L+ +KI DFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 562 RQYGSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCIMAELL 609
R + +Y+ APE L Y+ D+WS G ++ E+
Sbjct: 239 RD----------IHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIF 287
Query: 610 S 610
+
Sbjct: 288 T 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 57/246 (23%), Positives = 93/246 (37%), Gaps = 66/246 (26%)
Query: 414 EFER-----LNKIDEGTYGVVYRAR-----DKKTGEIVALKKVK---MEKEREGFPLTSL 460
EF R + G +G V A VA+K +K ERE +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----M 96
Query: 461 REINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLK--------------GLM 504
E+ ++ H +IV++ + I+++ EY + DL
Sbjct: 97 SELKMMTQLGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 505 ETMKQPFSQSEVKCL-MLQLL-------EGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556
E K+ + ++ L LL +G+++L +HRDL N+L+ + +KIC
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 557 DFGLARQYGSPLKPYTHLVVTLWYR------------APELLLGSKQYSTAIDMWSLGCI 604
DFGLAR ++ Y APE L Y+ D+WS G +
Sbjct: 215 DFGLARD----------IMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGIL 263
Query: 605 MAELLS 610
+ E+ S
Sbjct: 264 LWEIFS 269
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS--LREINILL 467
NK+ EG +GVVY+ VA+KK+ + L +EI ++
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85
Query: 468 SFHHPSIVDVKEVVVGSNL-------DSIFMVMEYME--------HDLKGLMETMKQPFS 512
H ++V L D + +V YM L G P S
Sbjct: 86 KCQHENLV---------ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-----TPPLS 131
Query: 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572
+ GI +LH+N +HRD+K++N+LL+ KI DFGLAR T
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQT 189
Query: 573 HL---VV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
+ +V T Y APE L G + + D++S G ++ E+++
Sbjct: 190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK---EREGFPLTSLREINILLSFHH 471
F+ I G +G VY+ + G VALK+ E E F EI L H
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE-F----ETEIETLSFCRH 94
Query: 472 PSIVDVKEVVVGSNLDSIFM--VMEYMEHDLKGLMETMKQPFSQSEVKCLML---QLLE- 525
P +V + +G + M + +YME+ +K+ S++ + + Q LE
Sbjct: 95 PHLVSL----IGFCDERNEMILIYKYMENG------NLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 526 ------GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHL--VV- 576
G+ YLH ++HRD+K+ N+LL+ KI DFG++++ THL VV
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQTHLSTVVK 202
Query: 577 -TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610
TL Y PE + + + D++S G ++ E+L
Sbjct: 203 GTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLC 236
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK----EREGFPLTSLREINILLS 468
D F N + G +G VY+ R G +VA+K++K E+ E + F E+ ++
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQ-F----QTEVEMISM 83
Query: 469 FHHPSIVDVKEVVVG--SNLDSIFMVMEYM-----EHDLKGLMETMKQPFSQSEVKCLML 521
H +++ + G +V YM L+ E+ + P + + + L
Sbjct: 84 AVHRNLLRL----RGFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIAL 138
Query: 522 QLLEGIKYLHDNW---VLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY--THL-- 574
G+ YLHD+ ++HRD+K +N+LL+ E + DFGLA+ L Y TH+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTT 193
Query: 575 -VV-TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD 622
V T+ + APE L + + S D++ G ++ EL++ G+ FD
Sbjct: 194 AVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELIT------GQRAFD 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 23/128 (17%)
Query: 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELK 554
+ + + K + + C Q+ +G+++L +HRDL N+LL+ + +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 555 ICDFGLARQYGS------------PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLG 602
ICDFGLAR PLK W APE + + Y+ D+WS G
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLK---------WM-APETIF-DRVYTIQSDVWSFG 282
Query: 603 CIMAELLS 610
++ E+ S
Sbjct: 283 VLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 25/166 (15%)
Query: 414 EFERLN-----KIDEGTYGVVYRARDK-----KTGEIVALKKVK---MEKEREGFPLTSL 460
EF R + G +G V A T VA+K +K E +
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----M 73
Query: 461 REINILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKC 518
E+ IL+ HH ++V++ + +++E+ + +L + + + F K
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPY--KT 130
Query: 519 LMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564
+ +G Y+ + DLK + + F +
Sbjct: 131 KGARFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-05
Identities = 83/593 (13%), Positives = 170/593 (28%), Gaps = 177/593 (29%)
Query: 253 EQEVEHVDDEDYAPTRNISSSRWAAGNSSPADEGE--ISEDEEL---PKRRKKMPVS-DS 306
++ VE V +Y S P+ I + + L + K VS
Sbjct: 80 QKFVEEVLRINY----KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135
Query: 307 LQTRARNKFLSPELSEVKRI------GSERSRSRSSESDERGDRARSLSGDEYH----GH 356
+ R L EL K + GS ++ + + + + + +
Sbjct: 136 PYLKLRQALL--ELRPAKNVLIDGVLGSGKT-WVALDV-CLSYKVQCKMDFKIFWLNLKN 191
Query: 357 ESEKGDYMEIDED-HNNNDSVGGSDTDSEDENDSCGTPEPAGPPQRSINMLQGCRSVDEF 415
+ +E+ + D + + + + I+ +Q E
Sbjct: 192 CNSPETVLEMLQKLLYQIDP------------NWTSRSDHSSNIKLRIHSIQ-----AEL 234
Query: 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV 475
RL +++ + +V L V+ K F L+ ILL+ +
Sbjct: 235 RRL-----------LKSKPYENCLLV-LLNVQNAKAWNAFNLSC----KILLTTRFKQVT 278
Query: 476 DVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE---------- 525
D L + ++H + EVK L+L+ L+
Sbjct: 279 DF--------LSAATTTHISLDHHSMT--------LTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 526 -GIKYLH---------------DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569
DNW + + L L + + R+
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNW---KHVNCDKLTTIIESSLNVLEPAEYRKM----- 374
Query: 570 PYTHLVV-------------TLW----YRAPELLLGSKQYSTAIDMW------SLGCIMA 606
+ L V +W +++ + ++ S+ I
Sbjct: 375 -FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 607 ELLSKEPL-----------FNGKSEFDQ-------LDK-IFKTLG-----TPNEKIWPGF 642
EL K +N FD LD+ + +G + + F
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF 493
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
+ + F++ + +R A + +GS + + L L Y I +
Sbjct: 494 RMVF-LDFRFLEQK---IRHDSTAWNASGSIL------NTLQQLKFY--KPYIC-----D 536
Query: 703 HDWFREVPLPKSKDFMPTFPAQ--HAQDRRMRR--MMKSPDPLEEQRRKELQQ 751
+D E + DF+P ++ + R +M + + E+ K++Q+
Sbjct: 537 NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 7e-04
Identities = 89/634 (14%), Positives = 182/634 (28%), Gaps = 181/634 (28%)
Query: 10 RDNEFRDRESELDVSRREYAYSKDEFAYERIRNSNHESNGQGHVPYARDRVRVRQKDVKE 69
+ + +D + D+ + SK+E + I S +G + +Q+++ +
Sbjct: 31 DNFDCKDVQ---DMPKS--ILSKEE--IDHIIMSKDAVSG---TLRLFWTLLSKQEEMVQ 80
Query: 70 REVIINGGFCSSSSRSDSGSSGGGGSGSCGLREPELSLKAVDKEPGELSSESGSDDAAEI 129
+ F R + L P +K ++P
Sbjct: 81 K-------FVEEVLRINYKF----------LMSP---IKTEQRQP--------------- 105
Query: 130 ESVSKVKDNEVSKVVENGNQS----PLERKRKFSPI----VWDRDDSD-----M---GKS 173
S+ E + N NQ + R + + + + R + + GK+
Sbjct: 106 -SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 174 RLVATAL---PPPPSLP-KAYWKSPTVVPEGGVCISPIKSSLNNNLQSVSPLI-PPVAAR 228
+ + K +W + C SP ++ LQ + I P +R
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWL--NL----KNCNSP--ETVLEMLQKLLYQIDPNWTSR 216
Query: 229 SVEYAAPESPVGLASSPPREQWHNEQ---------EV---EHVDDEDY-----APTRNIS 271
S + + + + R ++ V + + + TR
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 272 SSRWAAGNSSPADEGEISEDEELPKRRKKMPVSDSLQTRARNKFLSPELSEVKRIGSERS 331
+ + S A IS D + + K+L ++ R
Sbjct: 277 VTDFL----SAATTTHISLDHH----SMTLTPDEVKSLLL--KYLDCRPQDLPR------ 320
Query: 332 RSRSSESDERGDRARSLSGDEYHGHESEKGDYMEIDEDHNNNDSVGGSDTDSEDENDSCG 391
E R S+ + + ++ H N D + +
Sbjct: 321 -----EVLTTNPRRLSIIAESIRDGLATWDNW-----KHVNCDKL--TTI---------- 358
Query: 392 TPEPAGPPQRSINMLQGCRSVDEFERLN------KIDEGTYGVVYRARDKKTGEIVALKK 445
+ S+N+L+ F+RL+ I +++ K +V
Sbjct: 359 -------IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV--- 408
Query: 446 VKMEK----EREGFPLT-SLREINILLSFH-------HPSIVDVKEVVVGSNLDSIFMVM 493
K+ K E++ T S+ I + L H SIVD + + D +
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 494 E------YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547
++ H LK + E L + +L + L + ++ +
Sbjct: 469 LDQYFYSHIGHHLKNI--------EHPERMTLFRMV-----FLDFRF-LEQKIRHDSTAW 514
Query: 548 NNRGELK--ICDFGLARQYGSPLKP-YTHLVVTL 578
N G + + + Y P Y LV +
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 776 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.45 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-60 Score=510.50 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=229.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|+.|+|||||+++++|.+ .+.+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 35789999999999999999999999999999999986653 33344567899999999999999999999954 5689
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC-
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~- 567 (776)
|||||||.| +|.+++. ..+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 108 yivmEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999996 5655554 4567999999999999999999999999999999999999999999999999999977432
Q ss_pred -CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 568 -LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 568 -~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.....+.|||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++.+|.+.....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~------------ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF------------ 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------------
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 234566899999999999988 568999999999999999999999999999999988887652111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HHcCcCcCCCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA------ALNHDWFREVPLPKSK 715 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E------IL~HPwf~~i~~pk~~ 715 (776)
+..+|+++++||.+||++||.+|||+.| |++||||+.++|.+..
T Consensus 254 -------------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 254 -------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp -------------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred -------------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 1237899999999999999999999987 6899999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=524.77 Aligned_cols=291 Identities=38% Similarity=0.656 Sum_probs=241.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~~ 488 (776)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+++|+.+|+.|+|||||++++++... ....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 679999999999999999999999999999999976543333345677999999999999999999998532 3467
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC-
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~- 567 (776)
+|||||||+|+|..++.. .++|++.+++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 134 ~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 999999999998877765 568999999999999999999999999999999999999999999999999999876322
Q ss_pred ---CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 ---LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ---~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.....+.+||+.|||||++.+..+|+.++||||||||||||++|.+||.+.+..+++..|+...+.|+...|.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 23345689999999999999877789999999999999999999999999999999999999999998887765432
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
... . .....++.... ...+.++++++|||.+||++||.+||||.|||+||||++...|..
T Consensus 293 ~~~------~----~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 293 ERV------R----AYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp -CH------H----HHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhh------h----hhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 211 0 01111111100 012357999999999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=509.68 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=225.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
..|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.|+|||||+++++|.. .+.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 569999999999999999999999999999999976542 234567899999999999999999999955 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+.+..+... ..|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999997544444433 5699999999999999999999999999999999999999999999999999998866656667
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
+.+||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..|...... ...
T Consensus 229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~--------------- 291 (346)
T 4fih_A 229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLK--------------- 291 (346)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCS---------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------
Confidence 8899999999999987 56899999999999999999999999999998888888664211 111
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
....+|+++++||.+||++||.+|||+.|||+||||++...
T Consensus 292 ------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 292 ------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp ------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 11238999999999999999999999999999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-59 Score=493.61 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=209.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.|+|||||+++++|.+ .+.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 88 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEI 88 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 468999999999999999999999999999999999765433 2333457899999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||||+|+|.+.+.. .++|++.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.... ..
T Consensus 89 ~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~ 166 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-GN 166 (275)
T ss_dssp EEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-CC
Confidence 99999999988888765 45799999999999999999999999999999999999999999999999999987643 23
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...+.+||+.|||||++.+..+++.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---------------- 230 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---------------- 230 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 4456899999999999998666678999999999999999999999998888888777654211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+|+++++||.+||++||.+|||+.|||+||||+.
T Consensus 231 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 ---------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11237899999999999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-59 Score=511.45 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=220.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.|+|||||+++++|.+ .+.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999998665443334567899999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||.| +|.+++... ...+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999985 677777554 3468999999999999999999999999999999999999999999999999998775433
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+.+||+.|||||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++.+|......+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------
T ss_pred ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--------------
Confidence 33456799999999999988 569999999999999999999999999999999988887752211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+|.++++||.+||++||.+|||+.|||+||||++
T Consensus 245 ----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 245 ----------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 01237899999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=501.37 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=218.1
Q ss_pred CCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|++++.||+|+||+||+|++. .+++.||||++++..........+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 68999999999999999999874 468899999998765444444567789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||||.| +|.+++. ..+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999996 5555554 45689999999999999999999999999999999999999999999999999998765555
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+.+||+.|||||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+++..|.+....
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------- 244 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--------------- 244 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 55667899999999999987 56899999999999999999999999999999988888764211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
.+..+|+++++||.+||++||.+||| ++|||+||||+.++|.
T Consensus 245 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 245 ----------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 11238999999999999999999998 5899999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=510.71 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=225.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.|+|||||+++++|.. .+.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 569999999999999999999999999999999976532 234567899999999999999999999965 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+.+..+.. ...|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 227 mEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999754444443 35699999999999999999999999999999999999999999999999999998866666677
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
+.+||+.|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..|..... +..
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~---------------- 367 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL---------------- 367 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCC----------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC----------------
Confidence 8899999999999987 5699999999999999999999999999999888888866421 111
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.....+|+++++||.+||++||.+|||+.|||+||||++...
T Consensus 368 -----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 368 -----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp -----------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 112248999999999999999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=478.02 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=211.6
Q ss_pred CCe-eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc--CCCee
Q 004049 413 DEF-ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSI 489 (776)
Q Consensus 413 ~~y-eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~--~~~~l 489 (776)
.+| ++.++||+|+||+||+|.++.++..||||++............+.+|+.+|+.|+|||||+++++|... ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 677889999999999999999999999999976554333345678999999999999999999998642 34568
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecC-CCcEEEeecccccccCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNN-RGELKICDFGLARQYGS 566 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s 566 (776)
|||||||.|+.+..+......|++.+++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999996444444444678999999999999999999999999 999999999999984 79999999999986533
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
....+.+||+.|||||++.+ .|+.++|||||||+||||+||.+||.+.+....+...+.....| .
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~---------- 249 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-A---------- 249 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-G----------
T ss_pred --CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-C----------
Confidence 34566899999999999875 48999999999999999999999998766554443332211110 0
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..+..+++++++||.+||++||.+|||+.|||+||||++
T Consensus 250 -----------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 -----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 001237889999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=487.20 Aligned_cols=259 Identities=26% Similarity=0.353 Sum_probs=218.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.|+|||||+++++|.+ ...+|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ 126 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVRE--GPWVN 126 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 3467999999999999999999999999999999997542 22479999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~~ 568 (776)
||||||+| +|.+++. ..+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+....
T Consensus 127 ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999996 5555554 456899999999999999999999999999999999999999988 69999999998764321
Q ss_pred C-----CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 569 K-----PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 569 ~-----~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
. .....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+....+.+|..... +..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~~------- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-PIR------- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-GGG-------
T ss_pred cccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-Cch-------
Confidence 1 2234689999999999988 5699999999999999999999999998887777777765411 000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------HcCcCcCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA-------------LNHDWFREVP 710 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI-------------L~HPwf~~i~ 710 (776)
..++.+++.+.+||.+||++||.+|||+.|| |+|||+++..
T Consensus 277 --------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 277 --------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp --------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred --------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 1123489999999999999999999999997 6799999887
Q ss_pred CCCC
Q 004049 711 LPKS 714 (776)
Q Consensus 711 ~pk~ 714 (776)
.|+.
T Consensus 331 ~Pr~ 334 (336)
T 4g3f_A 331 EPRG 334 (336)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 7654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=483.67 Aligned_cols=288 Identities=31% Similarity=0.471 Sum_probs=217.8
Q ss_pred CCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
+.|++++.||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+ .|||||+++++|.. .++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCE
Confidence 67999999999999999999875 467899999986432 234567899999998 59999999999954 558
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeecccccccCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQYGS 566 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~~s 566 (776)
+|||||||+| +|.+++ +.|++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+....
T Consensus 95 ~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999985 555555 359999999999999999999999999999999999999876 8999999999976532
Q ss_pred CC----------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CC
Q 004049 567 PL----------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF-NG 617 (776)
Q Consensus 567 ~~----------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF-~~ 617 (776)
.. ...++.+||++|||||++.+...|+.++||||||||||+|++|++|| .+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 12345689999999999988777999999999999999999999888 56
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCC--------CCCCCCcchhhhhhhhhHhhhcCC---------CCCCCCCCCCCHHHH
Q 004049 618 KSEFDQLDKIFKTLGTPNEKIWPG--------FSKLPGVKVNFIKHQYNLLRKKFP---------ATSFTGSPVLSDAGF 680 (776)
Q Consensus 618 ~s~~~~l~kI~~~lg~p~~~~wp~--------~~~lp~~~~~~~~~~~~~l~~~~p---------~~~~~~~~~lS~~~~ 680 (776)
.++.+++..|+..+|.+....+.. ....+..................| .........+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 778889999998877543211100 000111100000000000000000 011123456899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 681 DLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 681 DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
|||.+||++||.+||||+|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=501.04 Aligned_cols=271 Identities=27% Similarity=0.448 Sum_probs=235.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+|+.+|+.|+|||||+|+++|.. ...+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~--~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 230 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMV 230 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh--HHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999997644322 3456789999999999999999999954 56899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC--CcEEEeecccccccCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR--GELKICDFGLARQYGSP 567 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~--g~iKL~DFGlA~~~~s~ 567 (776)
||||||.| +|..++......|++.+++.|++||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999985 6777776666789999999999999999999999999999999999999854 8999999999998753
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+||+.|||||++.+ ..|+.++||||||||||+|++|.+||.+.+..+++..|......++...|+
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 381 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------- 381 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGT-------
T ss_pred CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccccc-------
Confidence 344566799999999999988 568999999999999999999999999999999999887764443333222
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPT 720 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~ 720 (776)
.+|++++|||.+||++||.+|||+.|||+||||+...++.....+|.
T Consensus 382 --------------------------~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~p~ 428 (573)
T 3uto_A 382 --------------------------GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 428 (573)
T ss_dssp --------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEECG
T ss_pred --------------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhCCC
Confidence 37999999999999999999999999999999999888765554443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=466.50 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=195.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC-----
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----- 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----- 486 (776)
+++|++++.||+|+||+||+|+++.+|+.||||+++..... .....+.+|+.+|+.|+|||||+++++|...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46799999999999999999999999999999999754321 123457799999999999999999999865432
Q ss_pred -----CeeEEEeeehhh-hhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 487 -----DSIFMVMEYMEH-DLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 487 -----~~l~LVmEy~~g-~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
.++|||||||.| +|.+++.... ..+.+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 247999999986 5555554432 13566779999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC------------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 004049 559 GLARQYGSPLK------------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDK 626 (776)
Q Consensus 559 GlA~~~~s~~~------------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~k 626 (776)
|+|+.+..... ..++.+||+.|||||++.+ ..|+.++|||||||+||||++ ||.+.. +....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 99987643221 2244689999999999987 569999999999999999996 776432 22222
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
+.........+. ....++.+.+||.+||+.||.+|||+.|||+||||
T Consensus 237 ~~~~~~~~~p~~---------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 237 LTDVRNLKFPPL---------------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHHTTCCCHH---------------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhcCCCCCC---------------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 222111000000 00146678899999999999999999999999999
Q ss_pred CCCCCCC
Q 004049 707 REVPLPK 713 (776)
Q Consensus 707 ~~i~~pk 713 (776)
+.+.+|.
T Consensus 284 ~~~~~p~ 290 (299)
T 4g31_A 284 EDLDFPG 290 (299)
T ss_dssp CCC----
T ss_pred CCCCCCC
Confidence 9987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=496.90 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=216.2
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC-ccchHHH---HHHHHhCCCCCcceeeEEEecc
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF-PLTSLRE---INILLSFHHPSIVDVKEVVVGS 484 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~-~~~~~rE---i~iL~~L~HPnIV~l~~~~~~~ 484 (776)
..++++|++++.||+|+||+||+|+++.+|+.||||++.+....... .....+| +.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 44689999999999999999999999999999999999866533222 2223334 566677899999999999954
Q ss_pred CCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 485 NLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
.+.+|||||||.|+.+..+....+.|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 5689999999996544444444578999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---DQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---~~l~kI~~~lg~p~~~~wp~ 641 (776)
... ...+.|||+.|||||++.+...|+.++||||||||||||++|.+||.+.+.. .....+....
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~---------- 410 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------- 410 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC----------
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC----------
Confidence 532 3456799999999999976567999999999999999999999999765332 2222332210
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
...+..+|+++++||.+||++||.+|++ +.||++||||+.++|.
T Consensus 411 ---------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 411 ---------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred ---------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 0112348999999999999999999998 7999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=438.86 Aligned_cols=289 Identities=44% Similarity=0.786 Sum_probs=247.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEE
Confidence 468999999999999999999999999999999998665444444567799999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 99999999999988878889999999999999999999999999999999999999999999999999999876555556
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL-FNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P-F~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
...+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+++..++..++.|....|+.+...+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 6678999999999998866689999999999999999976555 788888899999999999999999988776554321
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..... .........+.++..+++||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 239 ~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYP--------ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCC--------TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccc--------CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11000 00011122345899999999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=441.69 Aligned_cols=289 Identities=46% Similarity=0.880 Sum_probs=240.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|++. +++.||||++............+.+|+.+|+.++||||+++++++. ....+|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SERCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSSCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCCEEE
Confidence 4588999999999999999999985 5899999999766544444456779999999999999999999994 455899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 99999999999998887778999999999999999999999999999999999999999999999999999987655555
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..++..++.+....|+.+..++....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 66678999999999998767789999999999999999999999999999999999999999999888887654432110
Q ss_pred hhhhhhhhHhhhcCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATS-FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~-~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
... ..+.... ....+.++.++++||.+||++||.+|||+.|||+||||+.++
T Consensus 256 ~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 256 RTF--------QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCC--------CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccc--------ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 000 0000000 001234789999999999999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=432.81 Aligned_cols=287 Identities=49% Similarity=0.868 Sum_probs=239.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|.+ .+++.||||++............+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEE
Confidence 36899999999999999999998 678999999997665555555667899999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.+++..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 99999999988888777889999999999999999999999999999999999999999999999999998876544455
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+.+...+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 56789999999999987667899999999999999999999999999999999999999999998888876655443221
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+... .+.........++..+++||.+||+.||.+|||+.|+|+||||++.
T Consensus 238 ~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 FTVY--------EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCC--------CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccc--------cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1100 0000001123589999999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=447.26 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=205.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.++||+|+||+||+|+++. .||||+++...........+.+|+.+|++|+|||||++++++. .+.+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---~~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT---KDNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE---CCeEEE
Confidence 4789999999999999999998753 5999999755433333456789999999999999999999873 246899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--C
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--L 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~ 568 (776)
|||||+| +|.+++.....+|++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+..... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999985 677777666778999999999999999999999999999999999999999999999999999865422 2
Q ss_pred CCccccccccccCCchhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL-GTPNEKIWPGFSKL 645 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~--~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~l-g~p~~~~wp~~~~l 645 (776)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..++... ..|...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~-------- 260 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS-------- 260 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST--------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc--------
Confidence 234567999999999999752 358999999999999999999999999877766665554432 111110
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..+..++..+.+||.+||+.||.+|||+.||+++-
T Consensus 261 ------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 261 ------------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp ------------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ------------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 01224789999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=442.57 Aligned_cols=294 Identities=45% Similarity=0.831 Sum_probs=235.8
Q ss_pred ccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 408 ~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
....+++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.. ..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TT
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CC
Confidence 3446789999999999999999999999999999999997665555555677899999999999999999999954 45
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-----CCCcEEEeeccccc
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-----NRGELKICDFGLAR 562 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-----~~g~iKL~DFGlA~ 562 (776)
.+||||||+.|+|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||++.
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 89999999999888877654 4699999999999999999999999999999999999994 45569999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.+..........+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+.+..++..++.|....|+.+
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 87655555566789999999999988667899999999999999999999999999999999999999999999988877
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...+.....+.......+...+ ...++..+++||.+||++||.+|||+.|||+||||+.+.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVL-------GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHH-------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhccccHhhhc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 6655443222211111111111 1237899999999999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=439.45 Aligned_cols=295 Identities=43% Similarity=0.786 Sum_probs=233.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|.++.+++.||||+++.... ......+.+|+.+|+.++||||+++++++. ....+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEE
Confidence 4689999999999999999999999999999999976542 233456779999999999999999999994 4558999
Q ss_pred EeeehhhhhhhHHhhcc-----CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLMETMK-----QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~-----~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
||||+.|+|..++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99999998888776543 4699999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..|+..++.+....|+.+..++
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 54555667899999999999876678999999999999999999999999999999999999999999999998877665
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+...+.......+.+.+. ......++..+++||.+||+.||.+|||+.|+|+||||++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQ---PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHG---GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hcccccccccchhHHHhhc---ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 4432221110000000000 01123478999999999999999999999999999999987554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=440.50 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=203.3
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|.+.++||+|+||+||+|+++ .++..||||+++..... ....+.+|+.+|++|+|||||++++++.. ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAELLTMLQHQHIVRFFGVCTE--GR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence 67999999999999999999875 36889999999754322 23567899999999999999999999954 45
Q ss_pred eeEEEeeehhh-hhhhHHhhc--------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 488 SIFMVMEYMEH-DLKGLMETM--------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~--------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
.+|||||||++ +|.+++... ..+|++.++..|+.||+.||.|||+++||||||||+||||+.+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 79999999995 566665432 246999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 004049 553 LKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFK 629 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~ 629 (776)
+||+|||+|+...... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999998764322 22345689999999999987 569999999999999999998 8999999988888887766
Q ss_pred hcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 630 TLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 630 ~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+...+ .+..+++++.+||.+||+.||.+|||+.||+++
T Consensus 276 g~~~~------------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELE------------------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCC------------------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCC------------------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 42111 122478999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=437.82 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=210.5
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|.+.+.||+|+||+||+|++. .++..||||+++..... ....+.+|+.+|++|+|||||++++++.. .+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH--HHHHHHHHHHHHHhCCCCCCccEEEEEee--CC
Confidence 68999999999999999999875 36889999999754322 23567899999999999999999999954 45
Q ss_pred eeEEEeeehhh-hhhhHHhhc------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEE
Q 004049 488 SIFMVMEYMEH-DLKGLMETM------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELK 554 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iK 554 (776)
.+|||||||++ +|.+++... ...|++.++..|+.||+.||.|||+++||||||||+||||+.++++|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 89999999985 666666543 24699999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 004049 555 ICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 555 L~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~l 631 (776)
|+|||+|+....... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986643221 2233579999999999987 569999999999999999998 899999999888888876642
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..+ .+..+++++.+||.+||+.||.+|||+.+| |+||+.+
T Consensus 248 ~~~------------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 248 VLQ------------------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp CCC------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CCC------------------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 111 122478999999999999999999999999 5677643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=435.01 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=210.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..+++++++||+|+||+||+|.+. .+++.||||+++... .......+.+|+.+|++|+|||||++++++.. .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--C
Confidence 467999999999999999999864 467899999997543 22234567899999999999999999999954 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
..+|||||||++ +|.+++... ...|++.++..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 578999999985 676666432 2469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCC--CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 004049 551 GELKICDFGLARQYGSP--LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~--~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI 627 (776)
+++||+|||+|+..... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..|
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999865322 223445789999999999987 569999999999999999998 89999999988888777
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
......| .+..++..+.+||.+||+.||.+|||+.||+++
T Consensus 261 ~~~~~~~------------------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLP------------------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCC------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC------------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5542111 122478899999999999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=432.34 Aligned_cols=286 Identities=42% Similarity=0.785 Sum_probs=234.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|.++.+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 77 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 77 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEE
Confidence 46899999999999999999999999999999999755422 223345579999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 78 VFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred EecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 99999999999988877789999999999999999999999999999999999999999999999999998765555555
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+++..++..++.|....|+.+.......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 235 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-- 235 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH--
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc--
Confidence 667899999999999876778999999999999999999999999999999999999999999999888753321100
Q ss_pred hhhhhhhHhhhcCCCC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 652 FIKHQYNLLRKKFPAT----SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~----~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...++.. .....+.++..+.+||.+||++||.+|||+.|||+||||..+..
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 ---------TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp ---------HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ---------ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0001110 01113458999999999999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=443.26 Aligned_cols=298 Identities=34% Similarity=0.615 Sum_probs=229.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.+|+.+. ||||+++++++...+...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357899999999999999999999999999999998654333333455678999999997 9999999999977666689
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP-- 567 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~-- 567 (776)
||||||+.++|...+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 87 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999999988887765 47999999999999999999999999999999999999999999999999999865321
Q ss_pred -------------------CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004049 568 -------------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628 (776)
Q Consensus 568 -------------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~ 628 (776)
....+..+||++|+|||++.+...|+.++||||||||||+|++|.+||.+.+..+++..|+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1223456899999999999876779999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCCcchhhhhhhhhHh---hhcCCC---------CCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 004049 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLL---RKKFPA---------TSFTGSPVLSDAGFDLLNSLLTYDPDKRIT 696 (776)
Q Consensus 629 ~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l---~~~~p~---------~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT 696 (776)
..++.|....+..+.... ...+........ ...+.. ........+++.+++||.+||++||.+|||
T Consensus 245 ~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPF--AKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHCCCCHHHHHTSCCSS--HHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhcCCCCHHHHHhccCHH--HHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 999988765443322110 000100000000 000000 000112357899999999999999999999
Q ss_pred HHHHHcCcCcCCCCCC
Q 004049 697 AEAALNHDWFREVPLP 712 (776)
Q Consensus 697 a~EIL~HPwf~~i~~p 712 (776)
+.|||+||||+.+..+
T Consensus 323 ~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNP 338 (388)
T ss_dssp HHHHTTSTTTTTTCCG
T ss_pred HHHHhCCHHHHHhcCC
Confidence 9999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=453.30 Aligned_cols=296 Identities=39% Similarity=0.628 Sum_probs=222.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~ 488 (776)
.++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+|+.|+|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999999654333333456779999999999999999999985432 357
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.++|..++.. ...|++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 899999999988887765 4579999999999999999999999999999999999999999999999999998764221
Q ss_pred ---------------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-----------
Q 004049 569 ---------------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS----------- 610 (776)
Q Consensus 569 ---------------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt----------- 610 (776)
...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 123456889999999988665779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCC
Q 004049 611 KEPLFNGKS--------------------EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFT 670 (776)
Q Consensus 611 G~~PF~~~s--------------------~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~ 670 (776)
|.++|.+.+ ..+++..|+..++.|....+..+... ........+..........
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE------DAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH------HHHHHHTTSCCCCCCCGGG
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH------HHHHHHHhcCCCCCCCHHH
Confidence 788887765 36788899999998876654432210 0000000000000011111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 671 GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 671 ~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
..+.++..+++||.+||++||.+|||+.|||+||||+.+.++..
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 22457999999999999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=427.79 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=224.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 4578999999999999999999999999999999997655433334567799999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.| +|..++.. .+.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G 168 (328)
T ss_dssp EEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred EEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence 99999986 55555544 467999999999999999999999999999999999999999999999999999876433 3
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+.......+......
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------- 232 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---------------- 232 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 4566789999999999998655568999999999999999999999999888887777654211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.+..+++.+.+||.+||..||.+|||+.|||+||||+....
T Consensus 233 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 233 ---------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 11237899999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=429.38 Aligned_cols=298 Identities=42% Similarity=0.779 Sum_probs=245.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC-----
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----- 485 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----- 485 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 457899999999999999999999999999999999776555555566789999999999999999999986543
Q ss_pred -CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 486 -LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 486 -~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...+||||||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3468999999999999988887788999999999999999999999999999999999999999999999999999876
Q ss_pred CC----CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 565 GS----PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 565 ~s----~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
.. ........+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+...++..|....+.+....|+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 42 22233556889999999999876778999999999999999999999999999999999999999999888888
Q ss_pred CCCCCCCcchh-hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 641 GFSKLPGVKVN-FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 641 ~~~~lp~~~~~-~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
.+......... ........+...+. ....++.+++||.+||++||.+|||+.|+|+||||+..+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHH------HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred ccccchhhcccccccccccCHHHHhh------hccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 75432211000 00000000000000 0014788999999999999999999999999999998776653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=430.06 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=225.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 45789999999999999999999999999999999976542 23334567789999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999754444444556899999999999999999999999999999999999999999999999999987554445
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 223 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 5667899999999999987 56899999999999999999999999998887777777553110
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
+ +..+++.+.+||.+||+.||.+|| ++.+|++||||+.+.|.
T Consensus 224 --------------~-------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 224 --------------F-------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp --------------C-------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------------C-------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 1 123789999999999999999999 99999999999988754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=428.97 Aligned_cols=294 Identities=43% Similarity=0.807 Sum_probs=243.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++|++++.||+|+||+||+|.++.+++.||||++...... ......+.+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eCC
Confidence 357899999999999999999999999999999999754322 222345779999999999999999999994 455
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 88999999999988888877778999999999999999999999999999999999999999999999999999887655
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+++..|+...+.|....|+.+..++.
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 55566678999999999998766789999999999999999999999999999999999999999999999988766554
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~ 716 (776)
.... ..++...+ .....++..+++||.+||..||.+|||+.|+|+||||+..+.+....
T Consensus 246 ~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~ 305 (346)
T 1ua2_A 246 YVTF----------KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305 (346)
T ss_dssp CCCC----------CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred cccc----------cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcc
Confidence 2110 00000000 00134789999999999999999999999999999999887765443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=437.06 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=219.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|..+ .||||++++++|.. ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 45899999999999999999999999999999999986542 233345567899999988 69999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|+.+..+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999975444444445679999999999999999999999999999999999999999999999999998755444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++..|......
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 242 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------------- 242 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 55667899999999999987 56899999999999999999999999999998888888764211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA------EAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa------~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||++||.+||++ .+||+||||+.+.|.
T Consensus 243 ----------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 243 ----------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 112378999999999999999999998 999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=418.64 Aligned_cols=287 Identities=40% Similarity=0.741 Sum_probs=234.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh---ccCCccchHHHHHHHHhCC---CCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE---REGFPLTSLREINILLSFH---HPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~ 484 (776)
..++|++++.||+|+||+||+|+++.+++.||||++..... .........+|+.+++.+. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 34789999999999999999999999999999999975442 1222345667888887775 99999999999654
Q ss_pred CCC---eeEEEeeehhhhhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccc
Q 004049 485 NLD---SIFMVMEYMEHDLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560 (776)
Q Consensus 485 ~~~---~l~LVmEy~~g~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGl 560 (776)
... .+|+||||+.++|..++..... .+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 322 5899999999988888776543 499999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
+...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+++.+|+..++.+....|+
T Consensus 167 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 167 ARIYSYQ-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTTSTTC-CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccCCC-cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 9876433 34456789999999999987 568999999999999999999999999999999999999999999999888
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++..... . ..+.......+.++..+.+||.+||++||.+|||+.|+|+||||++.
T Consensus 245 ~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFP--P--------RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSC--C--------CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccC--C--------CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 76554421110 0 00000001123588999999999999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=444.13 Aligned_cols=299 Identities=39% Similarity=0.629 Sum_probs=235.6
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC---
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--- 486 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~--- 486 (776)
...++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 34578999999999999999999999999999999997544333334567899999999999999999999865432
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+||||||+.++|...+.. ...|++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57899999999988887764 45799999999999999999999999999999999999999999999999999987643
Q ss_pred CC----------------------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-----------CCC
Q 004049 567 PL----------------------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-----------KEP 613 (776)
Q Consensus 567 ~~----------------------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-----------G~~ 613 (776)
.. ...+..+||++|+|||++.....|+.++||||||||||+|++ |.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 22 123567899999999998666779999999999999999998 667
Q ss_pred CCCCCC-----------------hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCC
Q 004049 614 LFNGKS-----------------EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLS 676 (776)
Q Consensus 614 PF~~~s-----------------~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS 676 (776)
+|.+.+ ..+++..|+..+|.|....+..+... ........+....+.......+.++
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP------EVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCH------HHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCH------HHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 776655 46889999999999877654432210 0000000000000100001124589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCC
Q 004049 677 DAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSK 715 (776)
Q Consensus 677 ~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~ 715 (776)
+.+++||.+||++||.+|||+.|||+||||+.+.++...
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence 999999999999999999999999999999998876554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=430.74 Aligned_cols=262 Identities=27% Similarity=0.463 Sum_probs=223.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----CccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----FPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..+.|++++.||+|+||+||+|.++.+|+.||||+++....... ....+.+|+.+|+.+.||||++++++|.. .
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--R 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--C
Confidence 34679999999999999999999999999999999976543221 12456789999999999999999999954 5
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC----cEEEeecccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLA 561 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA 561 (776)
..+||||||+.| +|..++ .....|++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHH-TTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CEEEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 589999999975 555554 4456799999999999999999999999999999999999998877 7999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++...|
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-- 242 (361)
T 2yab_A 167 HEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF-- 242 (361)
T ss_dssp EECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH--
T ss_pred eEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc--
Confidence 877543 34456789999999999987 56899999999999999999999999999988888888765333222111
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..++..+++||.+||..||.+|||+.|+|+||||+.+.
T Consensus 243 -------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 243 -------------------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -------------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -------------------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 13789999999999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=447.81 Aligned_cols=292 Identities=32% Similarity=0.566 Sum_probs=228.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~ 486 (776)
..++|++++.||+|+||+||+|+++.+++.||||++............+.+|+.+|+.++||||++++++|.... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999765433333456779999999999999999999996432 2
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+||||||+.+++...+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 4689999999998877764 3599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|+..++.|....|..+..
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~-- 292 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-- 292 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH--
T ss_pred C-cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch--
Confidence 2 34456799999999999988 5689999999999999999999999999999999999999999987766544321
Q ss_pred Ccchhhhhhhh----hHhhhcCCCCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 647 GVKVNFIKHQY----NLLRKKFPATSFTGS----PVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 647 ~~~~~~~~~~~----~~l~~~~p~~~~~~~----~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
....+..... ..+...++...+... ...++.+++||.+||++||.+|||+.|||+||||+.+.
T Consensus 293 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 293 -TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp -HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred -hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000000000 000011111100000 01256799999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=430.59 Aligned_cols=291 Identities=34% Similarity=0.601 Sum_probs=230.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~ 487 (776)
.++|++++.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999999999999999999654333333456679999999999999999999996432 14
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5799999997777777664 5699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....++|++|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..|+...+.|+..++..+...
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~-- 256 (367)
T 1cm8_A 181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD-- 256 (367)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH--
T ss_pred --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH--
Confidence 2345689999999999987667999999999999999999999999999999999999999999877655433210
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
........+ ...+...+ ...+.+++.+.+||.+||++||.+|||+.++|+||||+.+..+..
T Consensus 257 ----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 257 ----EAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp ----HHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred ----HHHHHHHhC-CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 000000000 00111111 112457999999999999999999999999999999998765543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=433.17 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=217.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++++.... ......+.+|+.+|..+ +||||++++++|.. ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 468899999999999999999999999999999999876433 22334567899999887 89999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999975444444455679999999999999999999999999999999999999999999999999998754455
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---------~~~l~kI~~~lg~p~~~~w 639 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||..... ......|...
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 277 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 277 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---------
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---------
Confidence 55667899999999999988 5689999999999999999999999965321 1122222221
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCcCcCCCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA------EAALNHDWFREVPLP 712 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa------~EIL~HPwf~~i~~p 712 (776)
....+..++..+++||.+||+.||.+||++ .+|++||||+.++|.
T Consensus 278 ----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 278 ----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp ----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 011123489999999999999999999985 899999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=432.23 Aligned_cols=254 Identities=21% Similarity=0.366 Sum_probs=207.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhccCCccchHHHHHHHHhCCC-CCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PnIV~l~~~~~~~~ 485 (776)
.++|++++.||+|+||+||+|.+..+ ++.||||+++..... .....+.+|+.+|.++.| ||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 37899999999999999999997654 468999999754322 123457899999999965 9999999998543
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~ 549 (776)
...+|||||||.+ +|..++... ...|++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 3468999999985 666666542 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004049 550 RGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDK 626 (776)
Q Consensus 550 ~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~k 626 (776)
++++||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987643322 2345689999999999987 569999999999999999998 9999988765554444
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
++..-..+ ..+..+++++.+||.+||+.||.+|||+.||++|
T Consensus 300 ~i~~g~~~-----------------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM-----------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC-----------------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43321111 1123478999999999999999999999999988
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=427.23 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=223.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||+++.... ..........|+.+|..+ +||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 56899999999999999999999999999999999986542 223344567899999876 89999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+||||||+.| +|..++ .....|++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999986 454444 44567999999999999999999999999999999999999999999999999999865444
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|...... +
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----~-------- 237 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-----Y-------- 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----C--------
T ss_pred CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC-----C--------
Confidence 445567899999999999987 56899999999999999999999999999888888777553110 0
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE-AALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~-EIL~HPwf~~i~~p 712 (776)
+..++..+++||.+||+.||.+||++. +|++||||+.+.|.
T Consensus 238 ------------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 238 ------------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ------------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ------------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 123789999999999999999999998 99999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=427.73 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=224.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||+++.... .......+..|+.+|..+ +||||++++++|.. ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 45889999999999999999999999999999999986543 223344567899999888 79999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+||||||+.| +|..++. ....|++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999986 5555554 4467999999999999999999999999999999999999999999999999999875444
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 239 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------- 239 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 445567899999999999987 56899999999999999999999999999888888888664111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLPK 713 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~pk 713 (776)
.+..++..+.+||.+||+.||.+|| ++.+|++||||+.++|.+
T Consensus 240 -----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 240 -----------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred -----------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 0123789999999999999999999 479999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=417.75 Aligned_cols=258 Identities=30% Similarity=0.466 Sum_probs=223.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.+.||||+++++++.. ...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence 458899999999999999999999999999999999765432 2334456789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.| +|..++. ....+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999986 5555544 456799999999999999999999999999999999999999999999999999987643
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+.+|......
T Consensus 159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------- 221 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------------- 221 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------------
T ss_pred -ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 2345789999999999987 56899999999999999999999999998888888887664211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.+..++..+++||.+||+.||.+|| ++.+|++||||+.+.|.
T Consensus 222 ----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 222 ----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 1123789999999999999999999 99999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=433.35 Aligned_cols=296 Identities=42% Similarity=0.763 Sum_probs=227.0
Q ss_pred CCeeEE-eeeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERL-NKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil-~~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+.|++. ++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.|+||||++++++|.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 557774 57999999999999976 568899999996432 23457799999999999999999999977667789
Q ss_pred EEEeeehhhhhhhHHhhcc--------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----cCCCcEEEee
Q 004049 490 FMVMEYMEHDLKGLMETMK--------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICD 557 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~--------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL----d~~g~iKL~D 557 (776)
||||||+.++|..++.... ..|++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999998887775322 249999999999999999999999999999999999999 6778999999
Q ss_pred cccccccCCCC---CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 004049 558 FGLARQYGSPL---KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---------FDQLD 625 (776)
Q Consensus 558 FGlA~~~~s~~---~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---------~~~l~ 625 (776)
||+|..+.... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765322 2234578999999999998866799999999999999999999999987665 48899
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATS-----FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~-----~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
.|+..++.|....|+.+..++......... ....+.... .......+..+++||.+||++||.+|||+.||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDF----RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHC----CGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhc----cccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999999999999998877666432211110 000000000 00112247889999999999999999999999
Q ss_pred HcCcCcCCCCCCCCCC
Q 004049 701 LNHDWFREVPLPKSKD 716 (776)
Q Consensus 701 L~HPwf~~i~~pk~~~ 716 (776)
|+||||++.+++....
T Consensus 332 L~hp~f~~~~~~~~~~ 347 (405)
T 3rgf_A 332 MQDPYFLEDPLPTSDV 347 (405)
T ss_dssp HTSGGGTSSSCCCSST
T ss_pred hcChhhccCCCCcccc
Confidence 9999999988876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=409.62 Aligned_cols=287 Identities=36% Similarity=0.659 Sum_probs=224.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 478999999999999999999999999999999986554333333456789999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 99999988777777767789999999999999999999999999999999999999999999999999998876555555
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++......+..+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 232 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST------- 232 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT-------
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc-------
Confidence 6678999999999998767789999999999999999999999999999998888887766543211000000
Q ss_pred hhhhhhhHhhhcCCCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 652 FIKHQYNLLRKKFPATSF-----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~-----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..+ .....++.... ...+.++..+.+||.+||..||.+|||+.|||+||||+.+..
T Consensus 233 ---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 233 ---NQY-FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp ---CGG-GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ---ccc-cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 000 00000000000 001358899999999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=437.81 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=224.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+|+.|+||||+++++++. ....+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEE
Confidence 347899999999999999999999999999999999765533333456779999999999999999999995 455899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec---CCCcEEEeecccccccCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN---NRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd---~~g~iKL~DFGlA~~~~s 566 (776)
|||||+.| +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999986 45555544 56799999999999999999999999999999999999998 467899999999988766
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
........+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+..|......++...|+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------ 238 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD------ 238 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT------
T ss_pred CCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc------
Confidence 5555567899999999999987 568999999999999999999999999999988888887765444333332
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+++.+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 239 ---------------------------~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 ---------------------------TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---------------------------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---------------------------cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 37899999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=437.08 Aligned_cols=277 Identities=22% Similarity=0.359 Sum_probs=231.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..++||||++++++|.. ...+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEE
Confidence 45899999999999999999999999999999999976442 23334557889999999999999999999954 5589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.| +|..++......|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999975 6666666656789999999999999999999999999999999999999999999999999998764332
Q ss_pred C-CccccccccccCCchhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 569 K-PYTHLVVTLWYRAPELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 569 ~-~~~~~~GT~~Y~APEvl~----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
. .....+||+.|+|||++. +...|+.++|||||||+||||++|.+||.+.+..+.+.+|+.....+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 300 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------- 300 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc---------
Confidence 2 234468999999999997 23568999999999999999999999999999988888886532111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCCCCCCCCCCCc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPLPKSKDFMPTF 721 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~pk~~~~~~~~ 721 (776)
.+|. ....+++.+++||++||+.+|.+ |+++.|||+||||+.+.|.......|.+
T Consensus 301 -------------------~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~ 357 (437)
T 4aw2_A 301 -------------------QFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPY 357 (437)
T ss_dssp -------------------CCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSC
T ss_pred -------------------cCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCC
Confidence 0110 01238999999999999999988 9999999999999999887654444433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=419.84 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=224.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|.++.+++.||+|++...... ...+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc---HHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 47899999999999999999999999999999999754322 2346789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC--CCcEEEeecccccccCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGSPL 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~~~s~~ 568 (776)
||||+.| +|...+......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999986 677777665567999999999999999999999999999999999999997 789999999999877432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..+......+....|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 227 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH---------
T ss_pred CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh---------
Confidence 34456789999999999987 56899999999999999999999999999998888888776433222111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
+.++..+++||.+||..||.+|||+.|+|+||||++...
T Consensus 228 ------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 228 ------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp ------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 137899999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=432.10 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=225.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|..++||||++++++|.. ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 46899999999999999999999999999999999976442 33344567799999999999999999999954 5589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.| +|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999975 55555543 469999999999999999999999999999999999999999999999999998764332
Q ss_pred C-CccccccccccCCchhhccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K-PYTHLVVTLWYRAPELLLGSK---QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~-~~~~~~GT~~Y~APEvl~g~~---~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. ...+.+||+.|+|||++.+.. .|+.++|||||||+||+|++|.+||.+.+....+.+|+.....+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 293 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------- 293 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc---------
Confidence 1 234678999999999998633 278999999999999999999999999998888888865421110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcCcCCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK--RITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k--RpTa~EIL~HPwf~~i~~pk 713 (776)
+.....++..+++||.+||+.+|.+ |+++.||++||||+.+.|..
T Consensus 294 ------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 294 ------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ------------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 1112248999999999999999998 99999999999999987653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=420.85 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=215.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++.+..... .....+.+|+.+|..+ +||||++++++|.. ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 4578999999999999999999999999999999998654221 1223456899999988 89999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999864444444445679999999999999999999999999999999999999999999999999998754444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS---------EFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s---------~~~~l~kI~~~lg~p~~~~w 639 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.... .......|...
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 234 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 234 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------
Confidence 45567899999999999987 568999999999999999999999996521 11122222211
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCcCcCCCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA------EAALNHDWFREVPLP 712 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa------~EIL~HPwf~~i~~p 712 (776)
....+..++..+.+||.+||+.||.+||++ .+|++||||+.+.|.
T Consensus 235 ----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 235 ----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp ----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 011123489999999999999999999995 899999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=432.82 Aligned_cols=280 Identities=23% Similarity=0.350 Sum_probs=232.6
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
...++|++++.||+|+||+||+|+++.+++.||||++++... .......+.+|+.+|..++||||++++++|.+ ...
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 346899999999999999999999999999999999976432 22334567789999999999999999999954 458
Q ss_pred eEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+||||||+. |+|..++......|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999997 4677777665568999999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccccccccccCCchhhcc------CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 568 LK-PYTHLVVTLWYRAPELLLG------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 568 ~~-~~~~~~GT~~Y~APEvl~g------~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
.. .....+||+.|+|||++.+ ...|+.++|||||||+||||++|.+||.+.+..+.+.+|+.......
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----- 290 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS----- 290 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-----
Confidence 22 2334689999999999973 24689999999999999999999999999998888888865311000
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcCcCCCCCCCCCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI---TAEAALNHDWFREVPLPKSKDF 717 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp---Ta~EIL~HPwf~~i~~pk~~~~ 717 (776)
+|. ....++.++++||.+||+ +|.+|+ ++.+|++||||+.+.|......
T Consensus 291 -----------------------~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~ 342 (412)
T 2vd5_A 291 -----------------------LPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDS 342 (412)
T ss_dssp -----------------------CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTS
T ss_pred -----------------------CCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhc
Confidence 000 012489999999999999 999985 9999999999999999877665
Q ss_pred CCCcchh
Q 004049 718 MPTFPAQ 724 (776)
Q Consensus 718 ~~~~~~~ 724 (776)
.|.|.+.
T Consensus 343 ~~p~~p~ 349 (412)
T 2vd5_A 343 VPPFTPD 349 (412)
T ss_dssp CCSCCCC
T ss_pred CCCCCCc
Confidence 5655443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=407.79 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=215.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------------------------CCccchHHHHHHH
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------------------------GFPLTSLREINIL 466 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------------------------~~~~~~~rEi~iL 466 (776)
.+++|++++.||+|+||.||+|+++.+++.||||++....... .....+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999999999999999997543211 1234577899999
Q ss_pred HhCCCCCcceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCee
Q 004049 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLL 546 (776)
Q Consensus 467 ~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNIL 546 (776)
+.++||||+++++++.......+||||||+.++.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999997655678999999998754443332 357999999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCCccccccccccCCchhhccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 004049 547 LNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ--YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624 (776)
Q Consensus 547 Ld~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~--ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l 624 (776)
|+.++.+||+|||++.............+||+.|+|||++.+... ++.++|||||||+||+|++|..||.........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999999877554444456789999999999976432 478899999999999999999999888766666
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..+...... +...+.++..+.+||.+||..||.+|||+.|||+||
T Consensus 250 ~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 250 SKIKSQALE-----------------------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHHCCCC-----------------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHhcccCC-----------------------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 555442111 011234789999999999999999999999999999
Q ss_pred CcCC
Q 004049 705 WFRE 708 (776)
Q Consensus 705 wf~~ 708 (776)
||++
T Consensus 295 ~~~~ 298 (298)
T 2zv2_A 295 WVTR 298 (298)
T ss_dssp HHHC
T ss_pred cccC
Confidence 9963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=427.41 Aligned_cols=292 Identities=35% Similarity=0.607 Sum_probs=221.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~ 487 (776)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999965433222344567899999999999999999998543 225
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.++|..++.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999998888777654 5799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||++|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++..|+..++.|....++.+...
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~-- 260 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE-- 260 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH--
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH--
Confidence 2345789999999999987667999999999999999999999999999999999999999999887666543221
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSK 715 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~ 715 (776)
........+ ...+...+ ...+.+++.+.+||.+||++||.+|||+.++|+||||+....+...
T Consensus 261 ----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 324 (367)
T 2fst_X 261 ----SARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324 (367)
T ss_dssp ----HHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC
T ss_pred ----HHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC
Confidence 000000000 00111110 0113478999999999999999999999999999999987665443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=407.23 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=220.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+++.++||||++++++|.. ...+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEE
Confidence 447899999999999999999999999999999999755322 23456789999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.| +|..++.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999976 55555543 3699999999999999999999999999999999999999999999999999988765555
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+....+..+.......
T Consensus 172 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE--------------- 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------------
T ss_pred ccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 5666789999999999987 568999999999999999999999999888877776665442110
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+..+..++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 236 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 -------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 01122478899999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=419.50 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=223.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|+.+.||||+++++++.. ...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 45899999999999999999999999999999999976543 22334567789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.| +|..++.. ...|++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999986 55555544 467999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......
T Consensus 195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 256 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------------- 256 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 345789999999999987 56899999999999999999999999999888888887664111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
.+..++..+.+||.+||+.||.+||+ +.+|++||||+.+.|.
T Consensus 257 ----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 257 ----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 01237899999999999999999998 9999999999988753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=422.97 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=220.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.|+||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 368999999999999999999999999999999997654333233456789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~~~~s~ 567 (776)
||||+.| +|...+. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999987 4555554 456799999999999999999999999999999999999998654 5999999999877533
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|.......+...|
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 254 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-------- 254 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG--------
T ss_pred -cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc--------
Confidence 33456789999999999987 56899999999999999999999999999888888888765433322222
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..+++.+++||.+||..||.+|||+.++|+||||+.
T Consensus 255 -------------------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 -------------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -------------------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -------------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 137889999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=424.66 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=217.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHH-HHhCCCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINI-LLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~i-L~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..++|++++.||+|+||+||+|+++.++..||||++.+.... ......+.+|..+ ++.++||||++++++|.. ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 568999999999999999999999999999999999765432 2223445667776 567899999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999875444444445679999999999999999999999999999999999999999999999999998754444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|+.....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 257 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--------------- 257 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC---------------
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence 45567899999999999987 56899999999999999999999999999888888887654110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCcCcCCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA----EAALNHDWFREVPLPK 713 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa----~EIL~HPwf~~i~~pk 713 (776)
.++.++..+++||.+||+.||.+||++ .+|++||||+.+.|..
T Consensus 258 ----------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 258 ----------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp ----------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 112478999999999999999999986 6999999999987643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=425.30 Aligned_cols=280 Identities=35% Similarity=0.592 Sum_probs=227.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~~ 488 (776)
.+|++++.||+|+||+||+|+++.+++.||||++.... ....+|+.+|+.|+|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46999999999999999999999999999999986532 1234799999999999999999988542 2234
Q ss_pred eEEEeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-CcEEEeeccccccc
Q 004049 489 IFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-GELKICDFGLARQY 564 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-g~iKL~DFGlA~~~ 564 (776)
++|||||+.+++...+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999999987766543 35679999999999999999999999999999999999999965 67899999999876
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.+.+..+++.+|++.++.|....|.....
T Consensus 208 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 208 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred ccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 433 3344578999999999998766799999999999999999999999999999999999999988876443211100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCC---CC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPAT---SF--TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~---~~--~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+ ..-.++.. .| ...+.++..+++||.+||++||.+|||+.|+|+||||+.+..+
T Consensus 287 --~~-----------~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 287 --NY-----------TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp --CC-----------CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred --hh-----------hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 00 00000000 00 0123478999999999999999999999999999999887554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=411.27 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=211.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCCCCCcceeeEEEeccC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKER--EGFPLTSLREINILLSFHHPSIVDVKEVVVGSN 485 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~ 485 (776)
..++|++++.||+|+||.||+|++. .+++.||||+++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3478999999999999999999985 68999999999765321 2223456789999999999999999999954
Q ss_pred CCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...+||||||+.| +|...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 4589999999986 4545444 4567999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
..........+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----------- 239 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----------- 239 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----------
T ss_pred ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 444444556789999999999987 56899999999999999999999999999888888877664211
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
.++.++..+.+||.+||..||.+|| ++.++|+||||+.+.|
T Consensus 240 --------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 240 --------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp --------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred --------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 1123789999999999999999999 8999999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=411.72 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=219.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----CccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
+.|++.+.||+|+||.||+|.++.++..||||++........ ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 679999999999999999999999999999999976543221 23456789999999999999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC----cEEEeecccccc
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLARQ 563 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA~~ 563 (776)
+|+||||+.| +|..++ .....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 89 VILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEECCCSCBHHHHH-TTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHH-HhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999986 555555 4456799999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+...........
T Consensus 168 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 240 (326)
T 2y0a_A 168 IDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY----- 240 (326)
T ss_dssp CCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH-----
T ss_pred CCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc-----
Confidence 7432 33455789999999999976 5689999999999999999999999999888888777765422211110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 ----------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 ----------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp ----------------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ----------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 01378899999999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=419.97 Aligned_cols=260 Identities=32% Similarity=0.471 Sum_probs=216.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC---CccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG---FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~---~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+.|++++.||+|+||+||+|.++.+++.||||++........ ....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 679999999999999999999999999999999976543221 23456799999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc---EEEeeccccc
Q 004049 490 FMVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLAR 562 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~---iKL~DFGlA~ 562 (776)
||||||+.| +|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 999999985 565555433 345999999999999999999999999999999999999987655 9999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
............+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+. ....+..+...........|
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~--- 256 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW--- 256 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH---
T ss_pred EecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc---
Confidence 87655444556789999999999987 56899999999999999999999999875 34455555543221111100
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 257 ------------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 ------------------------------SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1378999999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=419.94 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=218.1
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..+++|.+++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 4568999999999999999999999999999999999765432 3334567799999999999999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|++.+.+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999999998888887664 56999999999999999999999999999999999999999999999999999876433
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||.+......+..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------------- 219 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------------- 219 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------------
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------------
Confidence 3345678999999999998855457899999999999999999999976532211110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+....+..+..+++.+.+||.+||..||.+|||+.|||+||||+..
T Consensus 220 ---------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 220 ---------------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 1111122234589999999999999999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=430.81 Aligned_cols=262 Identities=28% Similarity=0.416 Sum_probs=214.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEE
Confidence 35789999999999999999999999999999999976542 22334456789999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.|+.+..+......|++..++.|+.||+.||+|||+ +|||||||||+||||+.++.+||+|||+|.......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999975544444555689999999999999999999998 999999999999999999999999999998755444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+..|......
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 367 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------- 367 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 55567899999999999987 56899999999999999999999999998888877777553111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.+..+++.+.+||.+||.+||.+|| |+.|||+||||+.+.+.
T Consensus 368 ----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 368 ----------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 1123789999999999999999999 99999999999988653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=420.26 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=218.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|.++.+++.||||++..... .......+.+|+.+|+.++|||||+++++|.. ...+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 90 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDM 90 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 46899999999999999999999999999999999976542 33334567789999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+||||+.|+.+..+......|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+... .
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-T 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-C
Confidence 999999987655555555678999999999999999999999999999999999999999999999999999876433 4
Q ss_pred CccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---DQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.....+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||...+.. ..+..+....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------- 236 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------- 236 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-------------
Confidence 4566899999999999974 245899999999999999999999999754332 2222222110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-AEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-a~EIL~HPwf~~i~~ 711 (776)
...+..++..+.+||.+||..||.+||+ +.+|++||||+.+.|
T Consensus 237 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 237 ------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1112347899999999999999999998 999999999998865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=416.32 Aligned_cols=278 Identities=29% Similarity=0.578 Sum_probs=226.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc-------
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS------- 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~------- 484 (776)
.++|++++.||+|+||+||+|++..+++.||||++..... ...+|+.+|+.++||||++++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4689999999999999999999999999999999864422 233799999999999999999998542
Q ss_pred -----------------------------CCCeeEEEeeehhhhhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhcc
Q 004049 485 -----------------------------NLDSIFMVMEYMEHDLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHD 532 (776)
Q Consensus 485 -----------------------------~~~~l~LVmEy~~g~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs 532 (776)
....+|+||||+.++|...+. .....+++..++.|+.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 233589999999998766654 345679999999999999999999999
Q ss_pred CCcccCCCCCCCeeec-CCCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC
Q 004049 533 NWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK 611 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd-~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG 611 (776)
+||+||||||+||||+ .++.+||+|||+|..+... ......+||+.|+|||++.+...|+.++|||||||++|+|++|
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 9999999999999998 6889999999999876433 3345568899999999998866799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCC-----CCCCCCCCHHHHHHHHHh
Q 004049 612 EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATS-----FTGSPVLSDAGFDLLNSL 686 (776)
Q Consensus 612 ~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~-----~~~~~~lS~~~~DLL~kL 686 (776)
.+||.+.+..+++..|++.++.|....+..... ......++... ...+..++..+++||.+|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-------------HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT-------------TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc-------------ccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 999999999999999999998876432211000 00000000000 001234889999999999
Q ss_pred cccCCCCCCCHHHHHcCcCcCCC
Q 004049 687 LTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 687 L~~DP~kRpTa~EIL~HPwf~~i 709 (776)
|++||.+|||+.|+|+||||+.+
T Consensus 306 L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCSSGGGSCCHHHHHTSGGGHHH
T ss_pred ccCChhhCCCHHHHhcCHHHHHH
Confidence 99999999999999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=413.65 Aligned_cols=256 Identities=30% Similarity=0.496 Sum_probs=213.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||+||+|.++.+++.||||++.... ....+|+.+|.++ .||||++++++|. ....+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYD--DGKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEE
Confidence 468999999999999999999999999999999997543 2346799999888 7999999999994 456899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC----CcEEEeecccccccC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR----GELKICDFGLARQYG 565 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~----g~iKL~DFGlA~~~~ 565 (776)
|||||+.| +|...+. ....|++.+++.++.||+.||.|||++||+||||||+||||... +.+||+|||++....
T Consensus 93 lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 93 VVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999986 5555554 45679999999999999999999999999999999999998543 359999999998775
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK---SEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~---s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.........+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+. ...+.+..|......+....|
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~--- 247 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW--- 247 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT---
T ss_pred CCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc---
Confidence 55455566789999999999987 45899999999999999999999999763 344555555443222222111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..++..+++||.+||..||.+|||+.++|+||||..+.
T Consensus 248 ------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 248 ------------------------------NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp ------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred ------------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 23889999999999999999999999999999997754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=418.24 Aligned_cols=281 Identities=36% Similarity=0.601 Sum_probs=227.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~ 487 (776)
..+|.+++.||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++||||++++++|.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999987766 88888754321 2237999999999999999999986432 22
Q ss_pred eeEEEeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-CCCcEEEeecccccc
Q 004049 488 SIFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQ 563 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-~~g~iKL~DFGlA~~ 563 (776)
.+||||||+.++++..+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 4789999999887665543 356799999999999999999999999999999999999999 789999999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++..|++.++.|....+....
T Consensus 192 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 192 LIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 6433 334557889999999999886679999999999999999999999999999999999999999887654221100
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATS-----FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~-----~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
.......++... ....+.+++++++||.+||++||.+|||+.|+|+||||+++..+.
T Consensus 271 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 271 -------------PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp -------------GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred -------------hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 000001111100 011234889999999999999999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=410.46 Aligned_cols=286 Identities=35% Similarity=0.644 Sum_probs=225.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEE
Confidence 4689999999999999999999999999999999986554333233446789999999999999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99999999888877776778999999999999999999999999999999999999999999999999999876554455
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....+..+...+
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 256 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP---- 256 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG----
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc----
Confidence 5667899999999999876678999999999999999999999999999999988888776654321110000000
Q ss_pred hhhhhhhhHhhhcCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 651 NFIKHQYNLLRKKFPATS-----FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~-----~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
......++... ....+.++..+.+||.+||+.||.+|||+.|||+||||+..
T Consensus 257 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 257 -------VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp -------GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred -------ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00000000000 00113479999999999999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=405.01 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=212.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 458899999999999999999999999999999999754432 223567899999999999999999999954 45889
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--C
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--L 568 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~ 568 (776)
|||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... .
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999987444444444567999999999999999999999999999999999999999999999999999865321 2
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||...................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence 233457899999999999886556889999999999999999999998766543332222211100
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
......++..+.+||.+||..||.+|||+.|||+||||+...
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 001123788999999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=415.05 Aligned_cols=286 Identities=37% Similarity=0.629 Sum_probs=230.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC----
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD---- 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~---- 487 (776)
.++|.+++.||+|+||+||+|.++.+++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3689999999999999999999999999999999976543333345677899999999999999999999544321
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.++|...+ ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 24999999999877666 34599999999999999999999999999999999999999999999999999986643
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+.+..++...+.|...++..+..
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 271 (371)
T 4exu_A 197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND--- 271 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC---
T ss_pred --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh---
Confidence 234568899999999998766789999999999999999999999999999999999999988887665544321
Q ss_pred cchhhhhhhhhHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
.... .....++.... ...+.+++.+.+||.+||++||.+|||+.|+|+||||+.+..+.
T Consensus 272 ---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 272 ---KAAK----SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp ---HHHH----HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred ---hhhh----hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 0000 01111111100 01235799999999999999999999999999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=397.72 Aligned_cols=290 Identities=39% Similarity=0.718 Sum_probs=239.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC-CCCcEEEEEEeecchhccCCccchHHHHHHHHhC---CCCCcceeeEEEec---
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK-KTGEIVALKKVKMEKEREGFPLTSLREINILLSF---HHPSIVDVKEVVVG--- 483 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k-~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~--- 483 (776)
..++|++++.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.+ .||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999986654444455677888888776 89999999999852
Q ss_pred cCCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 484 SNLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.....+|+||||+.|+|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 2445789999999998888877654 359999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|+..++.|....|+..
T Consensus 169 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 169 IYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 66422 23345688999999999987 56899999999999999999999999999999999999999998888888764
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
...+...... ............++..+.+||.+||..||.+|||+.++|+||||+.+...
T Consensus 247 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 247 VALPRQAFHS----------KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CSSCGGGSCC----------CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccchhhhcc----------cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 4433211100 00000011234589999999999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=413.77 Aligned_cols=287 Identities=39% Similarity=0.675 Sum_probs=234.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l 489 (776)
++|++++.||+|+||.||+|.+..++..||||++..... ......+.+|+.+|+.++||||+++++++.... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 689999999999999999999999999999999974321 112345678999999999999999999985432 2468
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
|+||||+.|+|..++.. ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 99999999988887764 469999999999999999999999999999999999999999999999999998764321
Q ss_pred --CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 --KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 --~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+++..|+..++.|....+..+....
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123456899999999998776778999999999999999999999999999999999999998888765443321100
Q ss_pred CcchhhhhhhhhHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.......++.... ...+.++..+.+||.+||++||.+|||+.|||+||||++...+
T Consensus 264 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 264 ----------ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp ----------HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ----------HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 0000011111000 0123578999999999999999999999999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=419.30 Aligned_cols=293 Identities=31% Similarity=0.545 Sum_probs=221.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----L 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~ 486 (776)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999999999999999999764333333345678999999999999999999995432 2
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 3789999999998887774 4599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++..|+..++.|...++..+...
T Consensus 180 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 256 (371)
T 2xrw_A 180 S-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT- 256 (371)
T ss_dssp -----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH-
T ss_pred c-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH-
Confidence 2 23345789999999999987 56899999999999999999999999999999999999998888765554432110
Q ss_pred Ccchhhhhhhh----hHhhhcCCCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQY----NLLRKKFPATSFTG----SPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~----~~l~~~~p~~~~~~----~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...+..... ..+...++...+.. ....+..+++||.+||++||.+|||+.|||+||||+....
T Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 257 --VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp --HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred --HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 000000000 00000111110100 0112678999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=449.21 Aligned_cols=263 Identities=22% Similarity=0.380 Sum_probs=227.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++++... .......+..|+.+|..+ +||||+.++++| .....
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCCE
Confidence 56899999999999999999999999999999999986542 333445667899999987 699999999999 44568
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||+.|+.+..+......|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999865444444445679999999999999999999999999999999999999999999999999998755444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..|+.++||||||||||||++|.+||.+.+..+++..|+.....
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 560 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------- 560 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC---------------
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 55667899999999999987 56899999999999999999999999999998888888654211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCcCcCCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA-----EAALNHDWFREVPLPK 713 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa-----~EIL~HPwf~~i~~pk 713 (776)
.+..++.++++||.+||++||.+||++ .+|++||||+.+.|.+
T Consensus 561 ----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 561 ----------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred ----------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 112489999999999999999999997 9999999999988653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=392.40 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=221.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++. .....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEEE
Confidence 47899999999999999999999999999999999765543333455678999999999999999999994 4457899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc---EEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~---iKL~DFGlA~~~~s~ 567 (776)
||||+.| ++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999986 45455544 467999999999999999999999999999999999999987655 999999999876533
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+...|
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-------- 231 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT--------
T ss_pred -ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh--------
Confidence 33445789999999999987 56899999999999999999999999998888888777665433222211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 232 -------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 232 -------------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp -------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred -------------------------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 237889999999999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=428.71 Aligned_cols=261 Identities=30% Similarity=0.550 Sum_probs=222.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 478999999999999999999999999999999998765554455677899999999999999999999954 558999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec---CCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN---NRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd---~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.| +|...+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999986 55555544 46799999999999999999999999999999999999995 4567999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ .|+.++|||||||+||+|++|.+||.+.+..+.+..+......+..+.|
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 246 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-------- 246 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG--------
T ss_pred -CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc--------
Confidence 33455789999999999976 4899999999999999999999999999999888888776433322222
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..+++.+++||.+||+.||.+|||+.++|+||||+....
T Consensus 247 -------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 247 -------------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -------------------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 137899999999999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=414.61 Aligned_cols=298 Identities=20% Similarity=0.271 Sum_probs=216.0
Q ss_pred CCCeeEEeeeecC--CceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 412 VDEFERLNKIDEG--TYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~G--sfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.++|++++.||+| +||+||+|+++.+++.||||++............+.+|+.+|+.++|||||+++++|.. ...+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 4789999999999 99999999999999999999998765433334556789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 490 FMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||||+.+ +|..++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999985 555555443 356999999999999999999999999999999999999999999999999988644211
Q ss_pred -------CCCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-----
Q 004049 568 -------LKPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP----- 634 (776)
Q Consensus 568 -------~~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p----- 634 (776)
.......+||+.|+|||++.+. ..|+.++|||||||+||+|++|.+||.+.+....+..++......
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1122335889999999999874 468999999999999999999999999887776665554432110
Q ss_pred ---CCCCCCCCCCCC---CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 635 ---NEKIWPGFSKLP---GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 635 ---~~~~wp~~~~lp---~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
............ .....+..... ...............+++.+++||.+||++||.+|||+.|||+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTP--RPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccCcc--ccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000000000000 00000000000 0000000011123458999999999999999999999999999999998
Q ss_pred CCCCC
Q 004049 709 VPLPK 713 (776)
Q Consensus 709 i~~pk 713 (776)
+....
T Consensus 340 ~~~~~ 344 (389)
T 3gni_B 340 IKRRA 344 (389)
T ss_dssp C---C
T ss_pred Hhhcc
Confidence 76543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=410.33 Aligned_cols=291 Identities=33% Similarity=0.616 Sum_probs=226.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCC---------ccchHHHHHHHHhCCCCCcceeeEEE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGF---------PLTSLREINILLSFHHPSIVDVKEVV 481 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HPnIV~l~~~~ 481 (776)
..++|.+++.||+|+||.||+|.+.. +..||||++......... ...+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999998865 999999999654332211 14567899999999999999999998
Q ss_pred ec---cCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 482 VG---SNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 482 ~~---~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
.. .....+|+||||+.|++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 64 233478999999999999999877778999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
|++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.|....
T Consensus 179 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 179 NLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred Ccccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 999865332 3344568999999999998766789999999999999999999999999999999999999888765432
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcC---CCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKF---PATS-FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~---p~~~-~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
+..+.. ......+...+ +... ....+.+++.+.+||.+||+.||.+|||+.|||+||||+.+..+
T Consensus 258 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 258 VVMFSS---------PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHTSC---------HHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hhhccc---------hhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 211100 00000000000 0000 01123578999999999999999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.00 Aligned_cols=296 Identities=32% Similarity=0.564 Sum_probs=223.9
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---- 485 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---- 485 (776)
..+++|++++.||+|+||+||+|+++.+++.||||++.... .......+++..+..++||||++++++|....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 35689999999999999999999999999999999986532 22345667888889999999999999986432
Q ss_pred -CCeeEEEeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhc--cCCcccCCCCCCCeeecC-CCcEEEeec
Q 004049 486 -LDSIFMVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLH--DNWVLHRDLKTSNLLLNN-RGELKICDF 558 (776)
Q Consensus 486 -~~~l~LVmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLH--s~gIvHrDLKPeNILLd~-~g~iKL~DF 558 (776)
...+|+||||+.+++...+.. ....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 223789999999987765543 4567999999999999999999999 999999999999999997 899999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
|++...... ......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+...++..++..++.|....
T Consensus 177 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 177 GSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 999876533 3344568899999999998766789999999999999999999999999999999999999888876554
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
|..+..... ...+...........++ ......+..+++||.+||++||.+|||+.|||+||||+++..+..
T Consensus 256 ~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 256 LRKLNPSHT-DVDLYNSKGIPWSNVFS----DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHCTTCC-CGGGGCCCCCCHHHHTT----TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHhcccchh-hccccccccCCcccccc----hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 332211000 00000000000000111 112236789999999999999999999999999999999866543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=427.90 Aligned_cols=261 Identities=33% Similarity=0.562 Sum_probs=223.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 36899999999999999999999999999999999765432 2334557799999999999999999999954 55899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s 566 (776)
+||||+.| +|...+. ....+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+..
T Consensus 103 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999986 4555554 45679999999999999999999999999999999999999 4678999999999987754
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|......+..+.|
T Consensus 182 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------- 251 (484)
T 3nyv_A 182 S-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW------- 251 (484)
T ss_dssp C-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG-------
T ss_pred c-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc-------
Confidence 3 34456789999999999976 5899999999999999999999999999999988888776433322222
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..++..+++||.+||++||.+|||+.|+|+||||+....
T Consensus 252 --------------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 252 --------------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------------------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 137899999999999999999999999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=405.92 Aligned_cols=289 Identities=37% Similarity=0.628 Sum_probs=230.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC----C
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL----D 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~----~ 487 (776)
.++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999999999999999997644333334456789999999999999999999964432 2
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|+||||+.++|...+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 459999999987776653 3599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+++..++...+.|...++..+...
T Consensus 179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 254 (353)
T 3coi_A 179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK-- 254 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH--
T ss_pred --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH--
Confidence 2345688999999999987667899999999999999999999999999999999999998888766554432210
Q ss_pred cchhhhhhhhhHhhhcCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSF-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
........+. ..+...+ ...+.++..+.+||.+||..||.+|||+.++|+||||+.+..+.
T Consensus 255 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 255 ----AAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp ----HHHHHHHTSC-BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred ----HHHHHHHhCc-CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence 0000000000 0011111 12345799999999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=413.27 Aligned_cols=261 Identities=26% Similarity=0.450 Sum_probs=222.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..+.|++++.||+|+||.||+|.++.+++.||+|++....... ...+.+|+.+|+.|+||||+++++++.. ...+|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 124 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED--KYEMV 124 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh--HHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEE
Confidence 3578999999999999999999999999999999997543221 2356789999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC--CCcEEEeecccccccCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGSP 567 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~~~s~ 567 (776)
|||||+.| +|...+......|++.+++.++.||+.||.|||++||+||||||+||||+. .+.+||+|||++......
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999985 666666655567999999999999999999999999999999999999974 478999999999877533
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+......+....|
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 274 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF-------- 274 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT--------
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc--------
Confidence 33445689999999999987 56899999999999999999999999999888888877664322222111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..++..+++||.+||+.||.+|||+.+||+||||+...
T Consensus 275 -------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 275 -------------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 23789999999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=424.55 Aligned_cols=259 Identities=30% Similarity=0.448 Sum_probs=222.3
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..+++|.+++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 3568999999999999999999999999999999999765432 2334467799999999999999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+||||||+.| +|.+++ ...+.|++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 ~~lv~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEECCSSEEHHHHT-TSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999976 555554 44567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+....+.+|......
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 234 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY-------------- 234 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--------------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--------------
Confidence 33456789999999999988555688999999999999999999999988887777777554211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+..+++.+.+||.+||+.||.+|||+.+||+||||+..
T Consensus 235 -----------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -----------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 112378899999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=401.72 Aligned_cols=298 Identities=38% Similarity=0.623 Sum_probs=234.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc---CCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS---NLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~---~~~~ 488 (776)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4789999999999999999999999999999999964321 11233566899999999999999999987543 2357
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|+||||+.++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999988887765 469999999999999999999999999999999999999999999999999998764221
Q ss_pred C----------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 569 K----------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 569 ~----------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
. .....+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+...++..++...+.|....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 1 123357899999999987666789999999999999999999999999999999999998888775432
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCC---C-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATS---F-TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~---~-~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
...... . .. .......++... + ...+.++..+.+||.+||..||.+|||+.+||+||||+.+..+..
T Consensus 247 ~~~~~~--~---~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 247 DLRCIE--S---PR----AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTCC--C---HH----HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred cccccc--c---ch----hhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 211100 0 00 000001111100 0 012358999999999999999999999999999999999887665
Q ss_pred CCCCCCc
Q 004049 715 KDFMPTF 721 (776)
Q Consensus 715 ~~~~~~~ 721 (776)
......+
T Consensus 318 ~~~~~~~ 324 (353)
T 2b9h_A 318 EPEGEPI 324 (353)
T ss_dssp SCCCCCC
T ss_pred ccccCCC
Confidence 4433333
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=411.65 Aligned_cols=261 Identities=30% Similarity=0.437 Sum_probs=201.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|+++.+++.||||++..... ....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEE
Confidence 45789999999999999999999999999999999975432 23456799999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc--EEEeecccccccCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--LKICDFGLARQYGSP 567 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~--iKL~DFGlA~~~~s~ 567 (776)
|||||+.| +|...+.. .+.|++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999976 55555543 567999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+......+..++.......
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------------ 238 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK------------ 238 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC------------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC------------
Confidence 2334568999999999998855455669999999999999999999987655433333332211100
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..+.....+++.+.+||.+||..||.+|||+.|||+||||...
T Consensus 239 -------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 239 -------------------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0111122478999999999999999999999999999999653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=427.12 Aligned_cols=259 Identities=31% Similarity=0.553 Sum_probs=217.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||++++++|.. ...+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 357999999999999999999999999999999998765544445677899999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~DFGlA~~~~s~ 567 (776)
|||||.| +|...+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999986 55555544 4679999999999999999999999999999999999999764 45999999999876533
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|......+..+.|+
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 262 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK------- 262 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT-------
T ss_pred -ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc-------
Confidence 33455789999999999864 58999999999999999999999999999998888887765444333222
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.++..+++||.+||++||.+|||+.++|+||||+..
T Consensus 263 --------------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 263 --------------------------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --------------------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --------------------------cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 378999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=399.95 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=220.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----CccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||.||+|.++.+++.||||++........ ....+.+|+.+|+.+.||||+++++++.. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 4679999999999999999999999999999999976543221 12346789999999999999999999954 45
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC----cEEEeeccccc
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLAR 562 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA~ 562 (776)
.+|+||||+.| +|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 89999999975 5555554 456799999999999999999999999999999999999999888 79999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
..... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+.......+...
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (321)
T 2a2a_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF---- 241 (321)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred ecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh----
Confidence 77543 33455689999999999987 5689999999999999999999999999888888777755422211100
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
...++..+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 242 -----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 242 -----------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -----------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -----------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 013788999999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=404.66 Aligned_cols=284 Identities=24% Similarity=0.395 Sum_probs=222.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-----CCCcceeeEEEeccC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-----HPSIVDVKEVVVGSN 485 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HPnIV~l~~~~~~~~ 485 (776)
..++|++++.||+|+||+||+|++..+++.||||++...... ......|+.+|+.+. ||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-- 107 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY---TRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-- 107 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH---HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh---hhhhHHHHHHHHHhcccCCCCCCeecccceeeE--
Confidence 447899999999999999999999999999999999743221 234567999999997 9999999999955
Q ss_pred CCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---------------
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--------------- 549 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--------------- 549 (776)
.+.+||||||+.++|..++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 108 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 45899999999888888877654 45999999999999999999999999999999999999975
Q ss_pred ----------CCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 004049 550 ----------RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS 619 (776)
Q Consensus 550 ----------~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s 619 (776)
++.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78999999999987543 2345689999999999987 568999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCC--------cchhhh-----hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 004049 620 EFDQLDKIFKTLGTPNEKIWPGFSKLPG--------VKVNFI-----KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSL 686 (776)
Q Consensus 620 ~~~~l~kI~~~lg~p~~~~wp~~~~lp~--------~~~~~~-----~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kL 686 (776)
..+.+..+....+.++...+........ ....+. ......+....+. .....++.+.+||.+|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL----YKIIKHELFCDFLYSI 339 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH----HHHCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc----cccchHHHHHHHHHHH
Confidence 9999988888776554322111000000 000000 0000000111110 0112457888999999
Q ss_pred cccCCCCCCCHHHHHcCcCcC
Q 004049 687 LTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 687 L~~DP~kRpTa~EIL~HPwf~ 707 (776)
|++||.+|||+.|||+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=418.28 Aligned_cols=286 Identities=34% Similarity=0.530 Sum_probs=226.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC------CCCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF------HHPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L------~HPnIV~l~~~~~~~ 484 (776)
...+|++++.||+|+||+||+|.+..+++.||||++...... ...+.+|+.+++.+ .|+||+.+++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch---HHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 346899999999999999999999999999999999754321 23456788888777 57799999999954
Q ss_pred CCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc--EEEeecccc
Q 004049 485 NLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--LKICDFGLA 561 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~--iKL~DFGlA 561 (776)
...+||||||+.++|..++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||+|||++
T Consensus 171 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 -RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred -CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 45899999999999888887654 45999999999999999999999999999999999999999887 999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
..... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++..|+..++.|+..++..
T Consensus 250 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 250 CYEHQ---RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp EETTC---CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eecCC---cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 86543 2345689999999999988 5689999999999999999999999999999999999999998887654332
Q ss_pred CCCCCCcchhhhhh-hhhH-------------------hhhc--CCC--CCC--CCCCCCCHHHHHHHHHhcccCCCCCC
Q 004049 642 FSKLPGVKVNFIKH-QYNL-------------------LRKK--FPA--TSF--TGSPVLSDAGFDLLNSLLTYDPDKRI 695 (776)
Q Consensus 642 ~~~lp~~~~~~~~~-~~~~-------------------l~~~--~p~--~~~--~~~~~lS~~~~DLL~kLL~~DP~kRp 695 (776)
..... .+... .+.. .+.. .+. ..+ ......++.+++||.+||++||.+||
T Consensus 326 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 326 SKRAK----NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp BTTHH----HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred hhhhh----hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 11100 00000 0000 0000 000 000 00123578899999999999999999
Q ss_pred CHHHHHcCcCcCCC
Q 004049 696 TAEAALNHDWFREV 709 (776)
Q Consensus 696 Ta~EIL~HPwf~~i 709 (776)
|+.|||+||||+..
T Consensus 402 ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 402 TPGQALRHPWLRRR 415 (429)
T ss_dssp CHHHHHTSTTTC--
T ss_pred CHHHHhCChhhccC
Confidence 99999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=399.57 Aligned_cols=264 Identities=30% Similarity=0.486 Sum_probs=219.5
Q ss_pred CCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeE
Q 004049 413 DEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~ 490 (776)
+.|.+. +.||+|+||+||+|.++.+++.||||++............+.+|+.++..+. ||||+++++++. ....+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NTSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eCCeEE
Confidence 567887 8999999999999999999999999999876544444556789999999995 699999999994 455899
Q ss_pred EEeeehhh-hhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccccccC
Q 004049 491 MVMEYMEH-DLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLARQYG 565 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA~~~~ 565 (776)
+||||+.| +|..++.. ....+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 99999987 55555543 2467999999999999999999999999999999999999998 7899999999998774
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......+....+
T Consensus 186 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------ 257 (327)
T 3lm5_A 186 HA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF------ 257 (327)
T ss_dssp ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT------
T ss_pred Cc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh------
Confidence 33 23345689999999999987 56899999999999999999999999999888887777665433322221
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
..++..+.+||.+||+.||.+|||+.+||+||||+.+.+..
T Consensus 258 ---------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 258 ---------------------------SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp ---------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ---------------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 23788999999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=390.53 Aligned_cols=257 Identities=32% Similarity=0.430 Sum_probs=218.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 3679999999999999999999999999999999976432 224567789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|...+. ....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 84 VMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999986 4545544 35679999999999999999999999999999999999999 78899999999999876533
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++...|
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 33455689999999999876 3899999999999999999999999999888888877665332221111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 232 -------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 232 -------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1378899999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=402.80 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=206.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|+++++||+|+||+||+|.++.+++.||||++.............+.|+..+..+ .||||+++++++.. ...+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 679999999999999999999999999999999865432222223445566665555 89999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.++|...+......|++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 213 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG 213 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCC
Confidence 9999999999988887788999999999999999999999999999999999999999999999999999876433 334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ .++.++|||||||+||+|++|..||.+..... .+..... + .
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~-------------~---~- 271 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYL-------------P---P- 271 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCC-------------C---H-
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCC-------------C---c-
Confidence 45679999999999876 58999999999999999999977776543322 2211100 0 0
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
. ....++..+.+||.+||+.||.+|||+.|||+||||++
T Consensus 272 -----------~-------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -----------E-------FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------H-------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------c-------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0 01237899999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=404.57 Aligned_cols=257 Identities=32% Similarity=0.459 Sum_probs=199.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+.|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 4679999999999999999999999999999999975432 2456689999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.| +|.+.+. ....+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999986 5555554 4567999999999999999999999999999999999999975 889999999999876432
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD-QLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~-~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||....... .+..+...........|
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------- 275 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW------- 275 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT-------
T ss_pred -cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh-------
Confidence 23345789999999999987 568999999999999999999999997765544 45555443222211111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 276 --------------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 276 --------------------------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp --------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred --------------------------hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 23788999999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=424.58 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=219.0
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-----------CCccchHHHHHHHHhCCCCCcceee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-----------GFPLTSLREINILLSFHHPSIVDVK 478 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-----------~~~~~~~rEi~iL~~L~HPnIV~l~ 478 (776)
...++|++++.||+|+||+||+|.++.++..||||++....... .....+.+|+.+|+.|+||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34578999999999999999999999999999999997654221 2234567899999999999999999
Q ss_pred EEEeccCCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEE
Q 004049 479 EVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELK 554 (776)
Q Consensus 479 ~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iK 554 (776)
+++. ....+|||||||.| +|...+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 113 ~~~~--~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFE--DKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEE--CSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEE--cCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9995 45589999999986 55555544 46799999999999999999999999999999999999999876 699
Q ss_pred EeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 004049 555 ICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634 (776)
Q Consensus 555 L~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p 634 (776)
|+|||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|......+
T Consensus 190 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 190 IVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp ECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999999877543 34455789999999999875 58999999999999999999999999999988888887653322
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 635 ~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
....| ..++..+++||.+||++||.+|||+.|+|+||||+...
T Consensus 267 ~~~~~---------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 267 DFNDW---------------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CHHHH---------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred Ccccc---------------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 11111 23789999999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=405.77 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=189.2
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC--CeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--DSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~--~~l~ 490 (776)
.+|.+.+.||+|+||+||+|++ +|+.||||+++...... .....|+.++..|+|||||++++++...+. ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999987 58899999997543221 122346666678899999999999975432 3689
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC--------CcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN--------WVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~--------gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
||||||+| +|.+++.. .++++.++..|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999995 56665543 4699999999999999999999987 8999999999999999999999999999
Q ss_pred cccCCCCC----CccccccccccCCchhhccCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004049 562 RQYGSPLK----PYTHLVVTLWYRAPELLLGSK-----QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632 (776)
Q Consensus 562 ~~~~s~~~----~~~~~~GT~~Y~APEvl~g~~-----~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg 632 (776)
+....... .....+||+.|||||++.+.. .|+.++|||||||+||||+||.+||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~--------- 226 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL--------- 226 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC---------
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc---------
Confidence 87643322 223468999999999997632 367899999999999999999988854332110
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhhhhHhhh----cCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRK----KFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~----~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
| -....+.. ............. .+|.. .........+.+||.+||..||.+|||+.||+++
T Consensus 227 -p------~~~~~~~~-~~~~~~~~~~~~~~~rp~~p~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 -P------YYDLVPSD-PSVEEMRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp -T------TTTTSCSS-CCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred -c------chhccccc-chHHHHHHHHhcccCCCCCCcc--ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 00000000 0000000000000 11100 0011133567899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=410.19 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=213.6
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmE 494 (776)
|...+.||+|+||.||+|.+..++..||||+++..... ....+.+|+.+|+.|+||||+++++++.. ...+|||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 34467899999999999999999999999999764322 13456789999999999999999999954 458999999
Q ss_pred ehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee--cCCCcEEEeecccccccCCCCCCc
Q 004049 495 YMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL--NNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 495 y~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL--d~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+... ...
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~ 245 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKL 245 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-ccc
Confidence 9985 6667776666679999999999999999999999999999999999999 56789999999999877533 334
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..|+.....+....|
T Consensus 246 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF------------ 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG------------
T ss_pred ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh------------
Confidence 45689999999999976 56899999999999999999999999999998888888775332221111
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..++..+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 313 ---------------------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 313 ---------------------QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1378999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=400.54 Aligned_cols=285 Identities=27% Similarity=0.507 Sum_probs=220.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+|+.|. ||||+++++++.......+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3478999999999999999999999999999999986432 345779999999997 9999999999977556789
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~~ 568 (776)
++||||+.++.+..+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 109 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEEECCCCCCHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred EEEEeccCchhHHHHH---HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 9999999965444333 2499999999999999999999999999999999999999777 8999999999876433
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF-NGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF-~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+...++.++|||||||+||+|++|..|| .+....+++..+...++.+....+...... .
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~ 263 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI-E 263 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC-C
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc-c
Confidence 33455689999999999987677999999999999999999999888 455666677766665543211000000000 0
Q ss_pred cchhhhhhhhhHhhhcCCC------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPA------TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~------~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.... ...+...... ........++..+++||.+||++||.+|||+.|||+||||+.+.
T Consensus 264 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPR-----FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTH-----HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccc-----hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0000 0000000000 01112234799999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=405.20 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=190.2
Q ss_pred CCeeEE---eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCe
Q 004049 413 DEFERL---NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil---~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~ 488 (776)
++|++. +.||+|+||+||+|.++.+++.||||++.... .....+|+.+|+.+. ||||+++++++.. ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 457775 78999999999999999999999999996542 234568999999997 9999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEeeccccccc
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICDFGLARQY 564 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~~~ 564 (776)
+||||||+.| +|...+. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEECCCCSCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999987 5555554 456899999999999999999999999999999999999998766 8999999999877
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-------FDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-------~~~l~kI~~~lg~p~~~ 637 (776)
..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+. .+.+..|......+...
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 655555566789999999999987 5689999999999999999999999987543 23333332221111110
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
. ...+++.+++||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~---------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 239 A---------------------------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp H---------------------------------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred c---------------------------------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 0 113789999999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=388.61 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=216.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 56899999999999999999999999999999999976542 22334557789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999996 45555543 467999999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 225 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------- 225 (279)
T ss_dssp ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------
T ss_pred -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC---------------
Confidence 2345689999999999987 56889999999999999999999999988877777666543111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.+..++..+.+||.+||..||.+|||+.|||+||||+....
T Consensus 226 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 226 ----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ----------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 11237889999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=397.51 Aligned_cols=290 Identities=35% Similarity=0.590 Sum_probs=221.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec-------
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG------- 483 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~------- 483 (776)
..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 44789999999999999999999999999999999875432 123456789999999999999999998742
Q ss_pred -----cCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-CCCcEEEee
Q 004049 484 -----SNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICD 557 (776)
Q Consensus 484 -----~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-~~g~iKL~D 557 (776)
.....+|+||||+.|+|..++.. .++++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 22357899999999988877753 5799999999999999999999999999999999999997 567999999
Q ss_pred cccccccCCC---CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 004049 558 FGLARQYGSP---LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTP 634 (776)
Q Consensus 558 FGlA~~~~s~---~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p 634 (776)
||++...... ........+|+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+.+..++.....+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999876422 1223445779999999999876678999999999999999999999999999999998888875543
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCC--C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPAT--S-FTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 635 ~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~--~-~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
....+..+.... ...+....... . ....+.++..+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 245 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 245 HEEDRQELLSVI----------PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHHHHTTS----------CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred chhhhhhhhhcC----------cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 322111100000 00000000000 0 0012358999999999999999999999999999999999887
Q ss_pred CCC
Q 004049 712 PKS 714 (776)
Q Consensus 712 pk~ 714 (776)
|..
T Consensus 315 p~~ 317 (320)
T 2i6l_A 315 PMD 317 (320)
T ss_dssp ---
T ss_pred ccC
Confidence 654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=396.16 Aligned_cols=258 Identities=26% Similarity=0.470 Sum_probs=217.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
.|...+.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48888999999999999999999999999999975432 223456789999999999999999999955 45799999
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccc
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH 573 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~ 573 (776)
||+.|+.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 122 e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 122 EFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp CCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred ecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 9998654444433 346999999999999999999999999999999999999999999999999999877654444556
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFI 653 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~ 653 (776)
.+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+....+..+.......
T Consensus 201 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 260 (321)
T 2c30_A 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------------------- 260 (321)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-------------------
T ss_pred ccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 789999999999987 568999999999999999999999999888777776665431100
Q ss_pred hhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 654 KHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 654 ~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
+.....++..+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus 261 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 261 ---------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp ---------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred ---------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 0111237889999999999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=408.06 Aligned_cols=285 Identities=29% Similarity=0.417 Sum_probs=221.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC--------CCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH--------HPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HPnIV~l~~~~~~ 483 (776)
.++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+|+.+. ||||++++++|..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH---YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc---chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999999999999999999975432 1345678999999985 7889999999863
Q ss_pred c--CCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCC--------
Q 004049 484 S--NLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRG-------- 551 (776)
Q Consensus 484 ~--~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g-------- 551 (776)
. ....+||||||+.++++..+.... ..+++.+++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 445799999999998888877654 6799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeecccccccCCCCCCccccccccccCCchhhccCC
Q 004049 552 -----------------------------------------ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSK 590 (776)
Q Consensus 552 -----------------------------------------~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~ 590 (776)
.+||+|||++..... .....+||+.|+|||++.+ .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVLIG-S 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHHHT-S
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCChhhcC-C
Confidence 799999999987643 2345689999999999988 4
Q ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCCC----------CCCCCCCcchhhhh
Q 004049 591 QYSTAIDMWSLGCIMAELLSKEPLFNGKS------EFDQLDKIFKTLGTPNEKIWP----------GFSKLPGVKVNFIK 654 (776)
Q Consensus 591 ~ys~~sDVWSLGvlLyELLtG~~PF~~~s------~~~~l~kI~~~lg~p~~~~wp----------~~~~lp~~~~~~~~ 654 (776)
.|+.++|||||||+||+|++|.+||.+.+ ....+..++..++.++...+. ....+.........
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 58999999999999999999999998765 456777777777766533210 00000000000000
Q ss_pred hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 655 HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 655 ~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.....+... +......+..+.+||.+||+.||.+|||+.|||+||||+.
T Consensus 349 ~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEK-----YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHT-----SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhh-----cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000111111 1112235677899999999999999999999999999963
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=427.15 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=219.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 260 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDL 260 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEE
Confidence 458899999999999999999999999999999999765432 2334567789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 490 FMVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
||||||+.| +|...+... ...|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999986 555555433 3469999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE----FDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~----~~~l~kI~~~lg~p~~~~wp~ 641 (776)
.........+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+. ......|.....
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------- 410 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------- 410 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC---------
T ss_pred CCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc---------
Confidence 54444455799999999999987 5689999999999999999999999987643 333333332210
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPLP 712 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~p 712 (776)
..+..++..+++||.+||+.||.+||+ +.+|++||||+.+.|.
T Consensus 411 ----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 411 ----------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ----------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 112348999999999999999999995 5899999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=386.81 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=210.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.+.+.||+|+||+||+|.++.++..||+|++..... ......+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhee--cCCeEEE
Confidence 3789999999999999999999999999999999976542 222356778999999999999999999995 4458999
Q ss_pred Eeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeeccccccc
Q 004049 492 VMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQY 564 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~ 564 (776)
||||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999986 666666432 4679999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... ......+||+.|+|||++.+ .++.++|||||||+||+|++|..||.+.+.......+........
T Consensus 178 ~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 245 (285)
T 3is5_A 178 KSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA--------- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred CCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc---------
Confidence 433 33455689999999999864 578999999999999999999999998877666655543211100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.....+++.+.+||.+||+.||.+|||+.|||+||||++
T Consensus 246 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 -------------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 001126889999999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=432.85 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=217.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.||+|+++.+|+.||||++...... ......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 457899999999999999999999999999999999765432 2334456789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
||||||+.| +|..++.... ..|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999986 5555554432 34999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.........+...+.....
T Consensus 340 -~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----------- 406 (576)
T 2acx_A 340 -QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----------- 406 (576)
T ss_dssp -CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-----------
T ss_pred -ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-----------
Confidence 33455799999999999987 56899999999999999999999999876432221222111100000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
..+..++..+++||.+||+.||.+|| ++.|||+||||+.+.|.
T Consensus 407 ----------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 407 ----------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred ----------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 01124899999999999999999999 89999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=387.30 Aligned_cols=260 Identities=30% Similarity=0.513 Sum_probs=193.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 467899999999999999999999999999999999765432 2233567789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999975 6666666656789999999999999999999999999999999999999999999999999998775444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------- 226 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------------- 226 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------------
T ss_pred CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------------
Confidence 44455789999999999987 5689999999999999999999999987654333322110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..+..+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 227 ------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 ------------------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00111234789999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=400.56 Aligned_cols=263 Identities=28% Similarity=0.423 Sum_probs=214.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|++++.||+|+||+||+|.++.++..||||++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 103 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYI 103 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeE
Confidence 6899999999999999999999999999999999765422 2333467789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhc---------------------------------------cCCCCHHHHHHHHHHHHHHhhh
Q 004049 490 FMVMEYMEH-DLKGLMETM---------------------------------------KQPFSQSEVKCLMLQLLEGIKY 529 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~---------------------------------------~~~Lse~~~~~i~~qIl~aL~y 529 (776)
||||||+.| +|..++... ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999975 555554310 1124688899999999999999
Q ss_pred hccCCcccCCCCCCCeeecCCC--cEEEeecccccccCCCC----CCccccccccccCCchhhccC-CCCCccchhhhHH
Q 004049 530 LHDNWVLHRDLKTSNLLLNNRG--ELKICDFGLARQYGSPL----KPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLG 602 (776)
Q Consensus 530 LHs~gIvHrDLKPeNILLd~~g--~iKL~DFGlA~~~~s~~----~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLG 602 (776)
||++||+||||||+||||+.++ .+||+|||++..+.... ......+||+.|+|||++.+. ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998653211 123456899999999999752 5688999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHH
Q 004049 603 CIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDL 682 (776)
Q Consensus 603 vlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DL 682 (776)
|+||+|++|..||.+.+..+.+..++.....+.... ...+++.+.+|
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~l 310 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN---------------------------------YNVLSPLARDL 310 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG---------------------------------GGGSCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc---------------------------------cccCCHHHHHH
Confidence 999999999999999998888888776532221111 11378899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 683 LNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 683 L~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
|.+||..||.+|||+.++|+||||+++.
T Consensus 311 i~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 311 LSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.01 Aligned_cols=265 Identities=30% Similarity=0.446 Sum_probs=220.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-------cCCccchHHHHHHHHhCC-CCCcceeeEEEe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-------EGFPLTSLREINILLSFH-HPSIVDVKEVVV 482 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-------~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~ 482 (776)
..++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999999999999999999754311 111234568999999996 999999999994
Q ss_pred ccCCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 483 GSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 483 ~~~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
. ...+|+||||+.+ +|..++.. ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 4 4589999999986 56555544 567999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCccccccccccCCchhhc-----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLL-----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~-----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
...... ......+||+.|+|||++. ....++.++|||||||+||+|++|..||...+.......+......+..
T Consensus 172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 876433 3345568999999999986 2345889999999999999999999999998888777777665322211
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
..| ..++..+.+||.+||..||.+|||+.++|+||||++....
T Consensus 251 ~~~---------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 251 PEW---------------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp TTG---------------------------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred ccc---------------------------------cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 111 1378899999999999999999999999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=402.07 Aligned_cols=257 Identities=29% Similarity=0.478 Sum_probs=220.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+.|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++... ..+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEE
Confidence 569999999999999999999999999999999975432 111234567899999999999999999999654 58999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||+.|++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~ 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence 999999999888877778899999999999999999999999999999999999999999999999999987642 2
Q ss_pred cccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 572 THLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+.+....+..+......+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 272 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------- 272 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 45689999999999863 3568999999999999999999999999888777776665431110
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.....++..+.+||.+||+.||.+|||+.+||+||||....
T Consensus 273 --------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 273 --------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred --------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 01123788999999999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=397.89 Aligned_cols=266 Identities=29% Similarity=0.369 Sum_probs=223.2
Q ss_pred ccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 408 ~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
......+|.+++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+.||||+++++++.. .
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 113 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--N 113 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 344568899999999999999999999999999999999765321 1223456789999999999999999999954 4
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 58999999999644444444456799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
........+||+.|+|||++.+ ..++.++|||||||+||+|++|..||......+.+..+......
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 259 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------------- 259 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------
T ss_pred CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 4444556789999999999987 56899999999999999999999999988776666655443110
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
.+..++..+.+||.+||..||.+|||+.+||+||||+....+.
T Consensus 260 ------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 260 ------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 1123788999999999999999999999999999998866543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=388.06 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=200.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|.+..+++.||||++............+..+..+++.+.||||+++++++.. ...+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 3478999999999999999999999999999999997553322222233345555788899999999999954 45789
Q ss_pred EEeeehhhhhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 491 MVMEYMEHDLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+||||+.|++..++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999999987666544 456799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCchhh---ccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELL---LGSKQYSTAIDMWSLGCIMAELLSKEPLFNG-KSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl---~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
. .......||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+.......
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 233 (290)
T 3fme_A 163 D-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-------- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------
T ss_pred c-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--------
Confidence 3 223345799999999997 3345689999999999999999999999976 34444444443321100
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 234 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 ---------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ---------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0112378899999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=393.56 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=202.0
Q ss_pred CCCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCee
Q 004049 412 VDEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l 489 (776)
.+.|++. +.||+|+||+||+|.++.+++.||||++.... ......+.+|+.+|.++ .||||+++++++.. ...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 3679986 78999999999999999999999999997543 22344677899999985 79999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc---EEEeecccccccC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLARQYG 565 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~---iKL~DFGlA~~~~ 565 (776)
||||||+.| +|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999985 55555544 467999999999999999999999999999999999999998776 9999999997653
Q ss_pred CCC-------CCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHH------------
Q 004049 566 SPL-------KPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD------------ 622 (776)
Q Consensus 566 s~~-------~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~------------ 622 (776)
... ......+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||.+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 12234579999999999974 1347899999999999999999999998764311
Q ss_pred ---HHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004049 623 ---QLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699 (776)
Q Consensus 623 ---~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E 699 (776)
.+..+...... ++. .....++..+++||.+||..||.+|||+.|
T Consensus 246 ~~~~~~~i~~~~~~------------------------------~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 246 QNMLFESIQEGKYE------------------------------FPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHHHHHHHCCCC------------------------------CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHhccCcc------------------------------cCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 12222211100 000 001237899999999999999999999999
Q ss_pred HHcCcCcCCCC
Q 004049 700 ALNHDWFREVP 710 (776)
Q Consensus 700 IL~HPwf~~i~ 710 (776)
+|+||||+...
T Consensus 293 ~l~hp~~~~~~ 303 (316)
T 2ac3_A 293 VLQHPWVQGCA 303 (316)
T ss_dssp HHHSTTCC---
T ss_pred HhcChhhcCCC
Confidence 99999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=395.56 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=202.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC----
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL---- 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~---- 486 (776)
.+++|++++.||+|+||.||+|+++.+++.||||++.... .......+.+|+.+|+.|+||||++++++|.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4578999999999999999999999999999999997543 22233567799999999999999999999864332
Q ss_pred ---------------------------------------------------CeeEEEeeehhh-hhhhHHhhcc--CCCC
Q 004049 487 ---------------------------------------------------DSIFMVMEYMEH-DLKGLMETMK--QPFS 512 (776)
Q Consensus 487 ---------------------------------------------------~~l~LVmEy~~g-~Ll~~l~~~~--~~Ls 512 (776)
..+|+||||+.| +|..++.... ..++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 238999999987 5555554432 2356
Q ss_pred HHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC------------CCcccccccccc
Q 004049 513 QSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL------------KPYTHLVVTLWY 580 (776)
Q Consensus 513 e~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~------------~~~~~~~GT~~Y 580 (776)
+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 77899999999999999999999999999999999999999999999998775432 223446799999
Q ss_pred CCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHh
Q 004049 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLL 660 (776)
Q Consensus 581 ~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l 660 (776)
+|||++.+ ..++.++|||||||+||+|++|..|+... ...+..+... . +|. .
T Consensus 243 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~---~----~~~---------~--------- 294 (332)
T 3qd2_B 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL---K----FPL---------L--------- 294 (332)
T ss_dssp SCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT---C----CCH---------H---------
T ss_pred cChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc---C----CCc---------c---------
Confidence 99999987 56899999999999999999987765211 1111111111 0 000 0
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 661 RKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 661 ~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++.+.+||.+||+.||.+|||+.|||+||||+++
T Consensus 295 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 295 -----------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -----------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -----------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 01146778899999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=401.17 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=211.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------CCccchHHHHHHHHhCCCCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFPLTSLREINILLSFHHPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~ 484 (776)
..++|++++.||+|+||+||+|.++.+++.||||++....... .....+.+|+.+|+.++||||++++++|.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3478999999999999999999999999999999998654322 13446678999999999999999999994
Q ss_pred CCCeeEEEeeehhh--hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 485 NLDSIFMVMEYMEH--DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 485 ~~~~l~LVmEy~~g--~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
....+|+||||+.+ +|..++ .....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHH-HTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEEeCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 45589999999864 454444 445679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||..... +...
T Consensus 179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~------------ 239 (335)
T 3dls_A 179 YLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA------------ 239 (335)
T ss_dssp ECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT------------
T ss_pred ECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh------------
Confidence 77543 3345578999999999998865558899999999999999999999965211 0000
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....+..++..+.+||.+||..||.+|||+.+||+||||++.
T Consensus 240 -------------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 -------------------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -------------------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 011122478999999999999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=383.60 Aligned_cols=258 Identities=29% Similarity=0.510 Sum_probs=219.4
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..+++|++++.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCE
Confidence 3568899999999999999999999999999999999765432 2233467789999999999999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999986 66665554 457999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------- 229 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------------- 229 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------------
T ss_pred --ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------------
Confidence 2345689999999999987 5689999999999999999999999998887776666644211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
..+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 230 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 230 ----------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ----------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 01124788999999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=409.10 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=203.1
Q ss_pred ccCCCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHH-HhCCCCCcceeeEEEec--cC
Q 004049 410 RSVDEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL-LSFHHPSIVDVKEVVVG--SN 485 (776)
Q Consensus 410 ~~~~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL-~~L~HPnIV~l~~~~~~--~~ 485 (776)
..+++|.++ +.||+|+||+||+|.++.+++.||||++... ..+.+|+.++ +.++||||++++++|.. ..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 356789988 7899999999999999999999999999632 3456888887 45589999999998853 23
Q ss_pred CCeeEEEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeeccc
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGL 560 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGl 560 (776)
..++||||||+.| +|..++.... ..|++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 4578999999985 6766666543 46999999999999999999999999999999999999998 78999999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFD----QLDKIFKTLGTPNE 636 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~----~l~kI~~~lg~p~~ 636 (776)
++..... ......+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+..... ....|.......+.
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 211 AKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9876432 33456789999999999976 568999999999999999999999998765332 22333222111111
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
. ....++..+++||.+||+.||.+|||+.+||+||||...
T Consensus 289 ~---------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 P---------------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp T---------------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred c---------------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1 113488999999999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=387.92 Aligned_cols=266 Identities=25% Similarity=0.414 Sum_probs=220.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER--EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.+++|++++.||+|+||.||+|.+..++..||||+++..... ......+.+|+.+++.++||||+++++++.......
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999999999999999999765432 223356778999999999999999999987666678
Q ss_pred eEEEeeehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+++..++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999998877776653 456999999999999999999999999999999999999999999999999999876422
Q ss_pred --CCCccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 --LKPYTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 --~~~~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----------- 231 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA----------- 231 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC-----------
Confidence 12234567899999999997632 3478999999999999999999999988877777666543110
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
.+..++..+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 232 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 232 --------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp --------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred --------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 1123788999999999999999999999999999999865543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=406.58 Aligned_cols=290 Identities=33% Similarity=0.512 Sum_probs=223.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CC-----CcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HP-----SIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HP-----nIV~l~~~~~~~ 484 (776)
..++|++++.||+|+||+||+|+++.+++.||||+++.... ....+.+|+.+++.+. |+ +|+.+++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH---HHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 45899999999999999999999999999999999975432 1234567888888875 55 49999999854
Q ss_pred CCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhc--cCCcccCCCCCCCeeec--CCCcEEEeecc
Q 004049 485 NLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLH--DNWVLHRDLKTSNLLLN--NRGELKICDFG 559 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLH--s~gIvHrDLKPeNILLd--~~g~iKL~DFG 559 (776)
...+||||||+.++|..++.... ..+++..++.++.||+.||.||| ..|||||||||+||||+ .++.+||+|||
T Consensus 128 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 -RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred -CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 45899999999999988887654 56999999999999999999999 57899999999999995 47889999999
Q ss_pred cccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 560 LARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 560 lA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
++...... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+++..|+..++.|+...+
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred Cceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99877432 345789999999999988 46899999999999999999999999999999999999999888876554
Q ss_pred CCCCC-------CCCcchhh----------hhhhhhHhhhcC------CCCCCCCCCC----CCHHHHHHHHHhcccCCC
Q 004049 640 PGFSK-------LPGVKVNF----------IKHQYNLLRKKF------PATSFTGSPV----LSDAGFDLLNSLLTYDPD 692 (776)
Q Consensus 640 p~~~~-------lp~~~~~~----------~~~~~~~l~~~~------p~~~~~~~~~----lS~~~~DLL~kLL~~DP~ 692 (776)
+.... ++...... .......+...+ +......... .+..+++||.+||++||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 43211 00000000 000000000000 0000000000 114789999999999999
Q ss_pred CCCCHHHHHcCcCcCCC
Q 004049 693 KRITAEAALNHDWFREV 709 (776)
Q Consensus 693 kRpTa~EIL~HPwf~~i 709 (776)
+|||+.|||+||||++.
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=388.32 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=217.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.+++.||+|+||.||+|.++.+++.||||++...... ....+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 46899999999999999999999999999999999754322 23456789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999985 56565544 4579999999999999999999999999999999999999 7789999999999976532
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........+..+...........|
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 231 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW-------- 231 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT--------
T ss_pred -CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc--------
Confidence 23345679999999999987 56899999999999999999999999998888888877665333222111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 232 -------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 232 -------------------------DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -------------------------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 2378899999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=410.74 Aligned_cols=261 Identities=31% Similarity=0.454 Sum_probs=202.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc------cCCccchHHHHHHHHhCCCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER------EGFPLTSLREINILLSFHHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~------~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~ 485 (776)
.++|.+++.||+|+||+||+|.++.+++.||||++...... ......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 47899999999999999999999999999999999765421 1223356799999999999999999999842
Q ss_pred CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEeeccccc
Q 004049 486 LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKICDFGLAR 562 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~DFGlA~ 562 (776)
..+||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 35899999998744433334456799999999999999999999999999999999999997654 59999999998
Q ss_pred ccCCCCCCccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD-KIFKTLGTPNEKIW 639 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~-kI~~~lg~p~~~~w 639 (776)
..... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||........+. .+...........
T Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~- 368 (419)
T 3i6u_A 291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV- 368 (419)
T ss_dssp SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH-
T ss_pred ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh-
Confidence 76532 33456789999999999863 3568899999999999999999999998755433332 3322211110000
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 369 --------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 369 --------------------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp --------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred --------------------------------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 12378999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=400.87 Aligned_cols=260 Identities=30% Similarity=0.494 Sum_probs=217.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc------cCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER------EGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~------~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
.++|++.+.||.|+||.||+|.++.+|+.||||++...... ......+.+|+.+++.+ .||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 36799999999999999999999999999999999754311 11123456899999999 79999999999854
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
...+||||||+.| +|..++. ....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++..
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred -CCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 4589999999997 4555554 456799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCchhhccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~-----~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
+... ......+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||...+....+..+......+..+.
T Consensus 250 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 250 LEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred cCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 7533 334557899999999998642 3588999999999999999999999999888877777766432221111
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
| ..++..+.+||.+||..||.+|||+.++|+||||++
T Consensus 329 ~---------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 W---------------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp H---------------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred c---------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1 137889999999999999999999999999999973
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=385.27 Aligned_cols=264 Identities=29% Similarity=0.376 Sum_probs=221.9
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+.||||+++++++.. ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence 3457899999999999999999999999999999999765322 1223456789999999999999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999964444444445679999999999999999999999999999999999999999999999999998775444
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+.....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------------- 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------------
Confidence 44556789999999999987 5689999999999999999999999998877666655533210
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
..+..++..+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 233 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 233 ---------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ---------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 01123788999999999999999999999999999999876554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=384.33 Aligned_cols=259 Identities=27% Similarity=0.482 Sum_probs=213.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----CccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
++|++++.||+|+||.||+|.++.+++.||+|+++....... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 579999999999999999999999999999999976543221 23456789999999999999999999954 458
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC----cEEEeecccccc
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLARQ 563 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA~~ 563 (776)
+|+||||+.+ +|..++. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999975 5555554 356799999999999999999999999999999999999999877 899999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 162 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (283)
T 3bhy_A 162 IEAG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY----- 234 (283)
T ss_dssp CC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH-----
T ss_pred ccCC-CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh-----
Confidence 6433 23345679999999999987 5689999999999999999999999999888777776654321111000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...++..+.+||.+||..||.+|||+.++|+||||+.+
T Consensus 235 ----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 235 ----------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ----------------------------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----------------------------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 01378899999999999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=379.92 Aligned_cols=258 Identities=29% Similarity=0.408 Sum_probs=209.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|.+++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeE
Confidence 45889999999999999999999999999999999976543 22334467789999999999999999999854 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 999999985 56665544 457999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||........+..+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 229 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--------------- 229 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---------------
Confidence 23345688999999999987554578999999999999999999999888776666665443111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+..++..+.+||.+||+.||.+|||+.+||+||||++.
T Consensus 230 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 ----------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 112378899999999999999999999999999999763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=381.27 Aligned_cols=262 Identities=29% Similarity=0.423 Sum_probs=219.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++.......+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 35789999999999999999999999999999999976543333345677899999999999999999998766667899
Q ss_pred EEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCC-----cccCCCCCCCeeecCCCcEEEeecccc
Q 004049 491 MVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNW-----VLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~g-----IvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
+||||+.+ +|..++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999986 676666543 345999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 235 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR------- 235 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred eeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-------
Confidence 876543333344678999999999987 568999999999999999999999999888777766665542110
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+..++..+.+||.+||..||.+|||+.+||+|+|+.+-
T Consensus 236 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 -----------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 012378899999999999999999999999999999763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.93 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=212.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||.||+|.++.+++.||||++...... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 47899999999999999999999999999999999754422 223456789999999999999999999854 458899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--C
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--L 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~ 568 (776)
||||+.+ +|...+ .....+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .
T Consensus 83 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 83 FLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999986 555544 34557999999999999999999999999999999999999999999999999999765321 1
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||........ +..+......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------------
Confidence 2234568999999999998755558899999999999999999999987654332 2222111000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
......++..+.+||.+||..||.+|||+.+||+||||+...
T Consensus 228 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 228 ---------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ---------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 001123788999999999999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=400.50 Aligned_cols=265 Identities=25% Similarity=0.432 Sum_probs=210.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchh--ccCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKE--REGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
.+++|++++.||+|+||+||+|++. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 3578999999999999999999984 5899999999975432 222334566899999999 69999999999854
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
...+||||||+.+ +|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -CceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 4589999999986 55555544 46799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCC-CCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 564 YGSPL-KPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 564 ~~s~~-~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
+.... ......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...........+.......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-------
Confidence 53221 223446899999999999863 357899999999999999999999997654332222222211000
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
....+..++..+.+||.+||..||.+|| |+.++|+||||+.+.+
T Consensus 282 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 282 --------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred --------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 0011234788999999999999999999 9999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=383.52 Aligned_cols=261 Identities=25% Similarity=0.460 Sum_probs=212.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+.|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 4689999999999999999999999999999999865432 234567789999999999999999999954 458899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999986 455555555678999999999999999999999999999999999999999999999999998643221122
Q ss_pred ccccccccccCCchhhc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 571 YTHLVVTLWYRAPELLL----GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~----g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.....||+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------------ 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------------
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc------------
Confidence 33467999999999984 33568899999999999999999999999888777766665431110
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
...+..++..+.+||.+||..||.+|||+.+||+||||+.+.
T Consensus 242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 001123788999999999999999999999999999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=381.98 Aligned_cols=260 Identities=30% Similarity=0.536 Sum_probs=219.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 478999999999999999999999999999999997665444445567899999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999985 55555544 4579999999999999999999999999999999999999764 46999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......||+.|+|||++.+ .++.++|||||||+||+|++|.+||.+.+..+.+..+......+....
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 245 (287)
T 2wei_A 178 -TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ--------- 245 (287)
T ss_dssp -SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG---------
T ss_pred -CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh---------
Confidence 23345678999999999976 389999999999999999999999999888877777765432211111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
...++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 246 ------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 246 ------------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ------------------------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ------------------------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 123788999999999999999999999999999998653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=379.80 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=210.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc--CCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~--~~~~l~ 490 (776)
..|.+.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++... ....+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458999999999999999999999999999999976554333345677899999999999999999998542 345689
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeec-CCCcEEEeecccccccCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLN-NRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd-~~g~iKL~DFGlA~~~~s 566 (776)
+||||+.+ +|..++. ....+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHH-HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999986 5555554 4467999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....+.
T Consensus 185 --~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 249 (290)
T 1t4h_A 185 --SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------- 249 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----------
T ss_pred --cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc-----------
Confidence 23445689999999998875 489999999999999999999999987655544433322111000
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
......++.+.+||.+||..||.+|||+.+||+||||++
T Consensus 250 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 250 -----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 001236788999999999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=378.27 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=207.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.++..+ .||||+++++++.. ...+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 4789999999999999999999999999999999986544333345677899999999 89999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhc---cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC----------------
Q 004049 491 MVMEYMEH-DLKGLMETM---KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---------------- 550 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~---~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---------------- 550 (776)
+||||+.| +|..++... ...+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999986 677666543 2679999999999999999999999999999999999999844
Q ss_pred ---CcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004049 551 ---GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 ---g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI 627 (776)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ...+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 47999999999876532 2346999999999998765678899999999999999999988865432 2222
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
..... + ..+..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 241 ~~~~~--------------------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 241 RQGRL--------------------------------P----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HTTCC--------------------------------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HcCCC--------------------------------C----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 22100 0 01124789999999999999999999999999999998
Q ss_pred CC
Q 004049 708 EV 709 (776)
Q Consensus 708 ~i 709 (776)
..
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 64
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=393.44 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=205.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC--CCcceeeEEEeccCCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH--PSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PnIV~l~~~~~~~~~~~l~ 490 (776)
..|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|..|.| |||+++++++.. ...+|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~ 85 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIY 85 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEE
Confidence 5799999999999999999988 468999999997654333333556789999999986 999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
|||||..++|..++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 86 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9999888888887765 46799999999999999999999999999999999999997 68999999999987643322
Q ss_pred -CccccccccccCCchhhcc----------CCCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLG----------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTPNEK 637 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g----------~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~p~~~ 637 (776)
.....+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||...... ..+..++.. ..
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-- 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NH-- 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---TS--
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC---Cc--
Confidence 2345689999999999964 246889999999999999999999999764332 223222211 10
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
....+...+..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 239 ------------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 239 ------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp ------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ------------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 01112236788999999999999999999999999999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=382.09 Aligned_cols=258 Identities=29% Similarity=0.507 Sum_probs=214.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 467999999999999999999999999999999997532 24567899999999999999999999954 458899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.+ +|..++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 9999986 666666656678999999999999999999999999999999999999999999999999999876544444
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
.....||+.|+|||++.+ ..++.++|||||||+||+|++|..||........+..+..... +
T Consensus 182 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------------- 243 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P---------------- 243 (314)
T ss_dssp BCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C----------------
T ss_pred cCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c----------------
Confidence 455689999999999987 5689999999999999999999999988776665544433210 0
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.+.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 -----------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0111223788999999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=402.08 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=207.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC--CCCcceeeEEEeccCCCeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH--HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--HPnIV~l~~~~~~~~~~~l~ 490 (776)
..|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.|. ||||+++++++... ..+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 469999999999999999998865 899999999765433333456779999999996 59999999998554 4799
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
|||||..++|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 133 lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 99998778887777654 5799999999999999999999999999999999999996 58999999999987643221
Q ss_pred -CccccccccccCCchhhccC----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGS----------KQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~----------~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-~~~l~kI~~~lg~p~~~ 637 (776)
.....+||+.|+|||++.+. ..|+.++||||||||||+|++|.+||..... ...+..++....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~----- 285 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH----- 285 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS-----
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc-----
Confidence 23456899999999999751 3588999999999999999999999976543 233333322110
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.+..+...+..+.+||.+||..||.+|||+.|||+||||+....
T Consensus 286 ------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 286 ------------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp ------------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred ------------------------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 01112235788999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=384.12 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=211.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC----
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN---- 485 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~---- 485 (776)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 4578999999999999999999999999999999997543 2235677899999999 7999999999997543
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
...+||||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 4578999999986 676666553 35799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
...........+||+.|+|||++.+ ...++.++|||||||+||+|++|.+||...+....+..+...... .
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~-- 253 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP---R-- 253 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---C--
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---c--
Confidence 6544334455689999999999973 245889999999999999999999999888776666555432110 0
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.....++..+.+||.+||..||.+|||+.+||+||||+..+
T Consensus 254 ------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 ------------------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp ------------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ------------------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 01224788999999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=388.48 Aligned_cols=259 Identities=32% Similarity=0.488 Sum_probs=206.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh------ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE------REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~------~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.+.||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 689999999999999999999999999999999975432 112234567899999999999999999998433
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc---EEEeeccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~---iKL~DFGlA~ 562 (776)
.+|+||||+.+ +|...+. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 88 -~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -SEEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -ceEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 48999999986 5555554 4567999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCCCCCccccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIW 639 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~w 639 (776)
..... ......+||+.|+|||++. +...++.++|||||||+||+|++|.+||........ ...+..........
T Consensus 166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 242 (322)
T 2ycf_A 166 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE-- 242 (322)
T ss_dssp ECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH--
T ss_pred ecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch--
Confidence 76432 2234467999999999984 235688999999999999999999999976554332 23332221110000
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 243 -------------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 243 -------------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp -------------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred -------------------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 011378899999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=393.13 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=210.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCC--C
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--D 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~--~ 487 (776)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3478999999999999999999999999999999997643221 122356789999999999999999999865432 2
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.| +|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 45999999986 5555554 456799999999999999999999999999999999999999999999999999986643
Q ss_pred CC---CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PL---KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~---~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+.......+......+...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 241 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------ 241 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH------
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc------
Confidence 22 12234679999999999987 568999999999999999999999999988877776665542221110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
....++..+.+||.+||..||.+||++.++|.|+|++..
T Consensus 242 ---------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 242 ---------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 012378999999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=387.67 Aligned_cols=290 Identities=24% Similarity=0.402 Sum_probs=223.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC-cEEEEEEeecchhccCCccchHHHHHHHHhCCCCC------cceeeEEEecc
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG-EIVALKKVKMEKEREGFPLTSLREINILLSFHHPS------IVDVKEVVVGS 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg-~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn------IV~l~~~~~~~ 484 (776)
.++|++++.||+|+||+||+|.+..++ ..||||+++.... ....+.+|+.+++.+.|++ |+.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc---chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 478999999999999999999998777 7899999975332 1235567999999987665 8888888844
Q ss_pred CCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----------------
Q 004049 485 NLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---------------- 547 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---------------- 547 (776)
...+||||||+.++++..+.... ..+++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 45899999999998888877654 579999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 004049 548 ---NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL 624 (776)
Q Consensus 548 ---d~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l 624 (776)
+.++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999999987543 2345689999999999987 56899999999999999999999999999988888
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCc---chhhh--hhhhhHhhhcCCC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGV---KVNFI--KHQYNLLRKKFPA--TSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~---~~~~~--~~~~~~l~~~~p~--~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
..+...++.++..++......... ...+. ...........+. .........+..+.+||.+||..||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 888887776654332111100000 00000 0000000000000 0011222346688999999999999999999
Q ss_pred HHHHcCcCcCCCC
Q 004049 698 EAALNHDWFREVP 710 (776)
Q Consensus 698 ~EIL~HPwf~~i~ 710 (776)
.|||+||||+.+.
T Consensus 329 ~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 329 AEALLHPFFAGLT 341 (355)
T ss_dssp HHHTTSGGGGGCC
T ss_pred HHHhcChhhcCCC
Confidence 9999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=385.27 Aligned_cols=290 Identities=27% Similarity=0.415 Sum_probs=222.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEE-CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC------CcceeeEEEec
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARD-KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP------SIVDVKEVVVG 483 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~-k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP------nIV~l~~~~~~ 483 (776)
..++|++++.||+|+||+||+|.+ +.+++.||||+++.... ....+.+|+.+++.+.|+ +|+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH---HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc---hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 347899999999999999999998 56889999999965322 124566899999888765 49999999854
Q ss_pred cCCCeeEEEeeehhhhhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-------------
Q 004049 484 SNLDSIFMVMEYMEHDLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN------------- 549 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~------------- 549 (776)
...+||||||+.++|..++.... .++++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 --~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 89 --HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 45899999999888888877654 36999999999999999999999999999999999999987
Q ss_pred ------CCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 004049 550 ------RGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ 623 (776)
Q Consensus 550 ------~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~ 623 (776)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999987543 2345689999999999987 5689999999999999999999999999998888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCC---cchhhh---hhhhhHhhhcCCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 004049 624 LDKIFKTLGTPNEKIWPGFSKLPG---VKVNFI---KHQYNLLRKKFPAT-SFTGSPVLSDAGFDLLNSLLTYDPDKRIT 696 (776)
Q Consensus 624 l~kI~~~lg~p~~~~wp~~~~lp~---~~~~~~---~~~~~~l~~~~p~~-~~~~~~~lS~~~~DLL~kLL~~DP~kRpT 696 (776)
+..+....+.++..++........ ....|. ...........+.. ........+..+.+||.+||..||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 888877776655433221110000 000000 00000000000000 01122335678999999999999999999
Q ss_pred HHHHHcCcCcCCC
Q 004049 697 AEAALNHDWFREV 709 (776)
Q Consensus 697 a~EIL~HPwf~~i 709 (776)
+.|||+||||+.+
T Consensus 323 ~~ell~hp~f~~~ 335 (339)
T 1z57_A 323 LREALKHPFFDLL 335 (339)
T ss_dssp HHHHTTSGGGGGG
T ss_pred HHHHhcCHHHHHH
Confidence 9999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.76 Aligned_cols=279 Identities=21% Similarity=0.311 Sum_probs=216.8
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
-++|++.+.||+|+||+||+|.++.+++.||||++...... .....+.+|+.+|+.++||||+++++++.......+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 46899999999999999999999999999999999754432 22445678999999999999999999997766668899
Q ss_pred Eeeehhh-hhhhHHhhccC--CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----cCCCcEEEeeccccccc
Q 004049 492 VMEYMEH-DLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQY 564 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~--~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL----d~~g~iKL~DFGlA~~~ 564 (776)
||||+.| +|..++..... .+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999985 66666655432 39999999999999999999999999999999999999 78888999999999877
Q ss_pred CCCCCCccccccccccCCchhhcc-------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLG-------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE----FDQLDKIFKTLGT 633 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g-------~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~----~~~l~kI~~~lg~ 633 (776)
... ......+||+.|+|||++.. ...++.++|||||||+||+|++|..||..... .+.+..++..
T Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 242 (319)
T 4euu_A 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--- 242 (319)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---
T ss_pred CCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---
Confidence 543 33445689999999999862 25689999999999999999999999975433 3445555444
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
.+...|..+.........|. ..++. .......++..+.+||.+||+.||.+|||+.|+|+||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWS--------GDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEE--------SSCCT-TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCcccchhhhcccCCccccC--------ccCCc-ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 22233333222221111110 01110 1111234667889999999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=377.01 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=203.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc-------
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS------- 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~------- 484 (776)
.++|++++.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH---HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3689999999999999999999999999999999965332 234567899999999999999999988542
Q ss_pred ----CCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 485 ----NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 485 ----~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
....+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 24578999999975 7777777666678999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--------------CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHH
Q 004049 560 LARQYGSP--------------LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQL 624 (776)
Q Consensus 560 lA~~~~s~--------------~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-s~~~~l 624 (776)
++...... .......+||+.|+|||++.+...++.++|||||||++|+|++ ||... .....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 99865421 1223456789999999999876678999999999999999998 55432 222333
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..+.......+. ......+..+.+||.+||..||.+|||+.++|+||
T Consensus 239 ~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 239 KKLRSVSIEFPP---------------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHSTTCCCCT---------------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred HhccccccccCc---------------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 333221111000 01123677899999999999999999999999999
Q ss_pred CcCC
Q 004049 705 WFRE 708 (776)
Q Consensus 705 wf~~ 708 (776)
||+.
T Consensus 286 ~~~~ 289 (303)
T 1zy4_A 286 WLPV 289 (303)
T ss_dssp CSCC
T ss_pred CcCC
Confidence 9975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=381.06 Aligned_cols=270 Identities=26% Similarity=0.380 Sum_probs=195.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++... ..+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS--SCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCcE
Confidence 347899999999999999999999999999999998654322 2344567899999999999999999999554 4789
Q ss_pred EEeeehhh-hhhhHHhh-------ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 491 MVMEYMEH-DLKGLMET-------MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~-------~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
+||||+.| +|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999975 56665543 24569999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-----CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 004049 563 QYGSPL-----KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 563 ~~~s~~-----~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~ 637 (776)
...... .......||+.|+|||++.+...++.++|||||||+||+|++|..||........+.............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 664321 122346799999999999764568999999999999999999999998887766655443321110000
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.. ........++..+.+||.+||..||.+|||+.+||+||||+...
T Consensus 250 ~~---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 250 GV---------------------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp --------------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred cc---------------------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00 00011234788999999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=408.31 Aligned_cols=252 Identities=17% Similarity=0.248 Sum_probs=199.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHH---HHHHhCCCCCcceee-------EE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREI---NILLSFHHPSIVDVK-------EV 480 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi---~iL~~L~HPnIV~l~-------~~ 480 (776)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+ .+|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3689999999999999999999999999999999975432 222334567899 455556899999998 65
Q ss_pred EeccCC----------C-----eeEEEeeehhhhhhhHHhhccCCCC-------HHHHHHHHHHHHHHhhhhccCCcccC
Q 004049 481 VVGSNL----------D-----SIFMVMEYMEHDLKGLMETMKQPFS-------QSEVKCLMLQLLEGIKYLHDNWVLHR 538 (776)
Q Consensus 481 ~~~~~~----------~-----~l~LVmEy~~g~Ll~~l~~~~~~Ls-------e~~~~~i~~qIl~aL~yLHs~gIvHr 538 (776)
+...+. . ..||||||+.|+|..++.... .++ +..++.|+.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 543311 1 378999999988888877542 244 48888999999999999999999999
Q ss_pred CCCCCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCchhhccC----------CCCCccchhhhHHHHHHHH
Q 004049 539 DLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS----------KQYSTAIDMWSLGCIMAEL 608 (776)
Q Consensus 539 DLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~----------~~ys~~sDVWSLGvlLyEL 608 (776)
||||+||||+.++.+||+|||+|..... .....+| +.|+|||++.+. ..|+.++|||||||+||+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999999999999999986532 3445678 999999999874 2689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcc
Q 004049 609 LSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLT 688 (776)
Q Consensus 609 LtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~ 688 (776)
++|.+||.+.+....+..++ .....+++.+.+||.+||+
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~li~~~L~ 345 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIF-----------------------------------------RSCKNIPQPVRALLEGFLR 345 (377)
T ss_dssp HHSSCCC------CCSGGGG-----------------------------------------SSCCCCCHHHHHHHHHHTC
T ss_pred HHCCCCCcccccccchhhhh-----------------------------------------hhccCCCHHHHHHHHHHcC
Confidence 99999997654322211110 0113478999999999999
Q ss_pred cCCCCCCCHHHHHcCcCcCCC
Q 004049 689 YDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 689 ~DP~kRpTa~EIL~HPwf~~i 709 (776)
.||.+|||+.++|+||||+.+
T Consensus 346 ~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 346 YPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp SSGGGCCCHHHHHTSHHHHHH
T ss_pred CCchhCCCHHHHhhChHHHHH
Confidence 999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=402.53 Aligned_cols=266 Identities=18% Similarity=0.205 Sum_probs=195.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhC--CCCCcceee-------EEEe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSF--HHPSIVDVK-------EVVV 482 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L--~HPnIV~l~-------~~~~ 482 (776)
..|.+++.||+|+||+||+|+++.+++.||||++...... ......+.+|+.++..| .||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999875421 12223445675444444 699988755 4443
Q ss_pred ccCC---------------CeeEEEeeehhhhhhhHHhhccCCCCHHHH------HHHHHHHHHHhhhhccCCcccCCCC
Q 004049 483 GSNL---------------DSIFMVMEYMEHDLKGLMETMKQPFSQSEV------KCLMLQLLEGIKYLHDNWVLHRDLK 541 (776)
Q Consensus 483 ~~~~---------------~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~------~~i~~qIl~aL~yLHs~gIvHrDLK 541 (776)
.... ..+||||||+.|+|..++......+.+..+ ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 2221 458999999999999998876666666666 6778999999999999999999999
Q ss_pred CCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCchhhcc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCh
Q 004049 542 TSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE 620 (776)
Q Consensus 542 PeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g-~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~ 620 (776)
|+||||+.++.+||+|||+|...... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+...
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred HHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 99999999999999999999876432 224567899999999975 24589999999999999999999999977532
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 621 ~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
... ..|..... .........+.....++..+.+||.+||+.||.+|||+.++
T Consensus 299 ~~~-------------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 299 GIK-------------GSWKRPSL---------------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp TCT-------------TCCCBCCT---------------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred ccc-------------cchhhhhh---------------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 110 00000000 00000111122234689999999999999999999999999
Q ss_pred HcCcCcCCC
Q 004049 701 LNHDWFREV 709 (776)
Q Consensus 701 L~HPwf~~i 709 (776)
|+||||+++
T Consensus 351 l~hp~f~~~ 359 (371)
T 3q60_A 351 METPEFLQL 359 (371)
T ss_dssp TTSHHHHHH
T ss_pred hcCHHHHHH
Confidence 999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=390.95 Aligned_cols=289 Identities=24% Similarity=0.389 Sum_probs=213.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEE
Confidence 34789999999999999999999999999999999976431 1123456789999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||+.| +|..++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999987 55555544 45799999999999999999999986 9999999999999999999999999999765321
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+............+. ......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 262 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR-PRTPGR 262 (360)
T ss_dssp -C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC-cccCCC
Confidence 2344689999999999987 5689999999999999999999999988776554333211111110000000 000000
Q ss_pred -----------chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 -----------KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 -----------~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
................+ ......++..+.+||.+||+.||.+|||+.+||+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00000000011111111 112234789999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=375.16 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=216.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.+.||||+++++++.. ...+|+|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence 6799999999999999999999999999999999765422 234567789999999999999999999955 4589999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
|||+.+ +|..++. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999986 5555543 3579999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....||+.|+|||++.+ ..++.++|||||||+||+|++|.+||........+..+......
T Consensus 177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 237 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP------------------ 237 (303)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC------------------
T ss_pred CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC------------------
Confidence 56789999999999987 56889999999999999999999999887776665555332100
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.....++..+.+||.+||..||.+|||+.+||+||||...
T Consensus 238 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 ------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ------------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0112478899999999999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=377.69 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=197.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.+++|++++.||+|+||.||+|.++.+++.||||++............+..+..+++.+.||||+++++++.. ...+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEE
Confidence 4689999999999999999999999999999999997654322222223345557888899999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.+.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...... .
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~ 179 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-K 179 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-c
Confidence 9999996655555555567899999999999999999999995 9999999999999999999999999999766432 2
Q ss_pred CccccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNG-KSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
......||+.|+|||++.+ ...++.++|||||||+||+|++|..||.. ......+..+...... .
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~------ 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----L------ 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC----C------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC----C------
Confidence 3345689999999999952 35688999999999999999999999987 3445555555443110 0
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+.....++..+.+||.+||..||.+|||+.+||+||||+..
T Consensus 250 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 250 ------------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 01112378899999999999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=385.57 Aligned_cols=276 Identities=21% Similarity=0.383 Sum_probs=217.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCc---------------cchHHHHHHHHhCCCCCcc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFP---------------LTSLREINILLSFHHPSIV 475 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~---------------~~~~rEi~iL~~L~HPnIV 475 (776)
.+++|++++.||+|+||.||+|.+ +++.||||++.......... ..+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 457999999999999999999998 89999999997654332211 5677999999999999999
Q ss_pred eeeEEEeccCCCeeEEEeeehhh-hhhhH------Hhhc-cCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCee
Q 004049 476 DVKEVVVGSNLDSIFMVMEYMEH-DLKGL------METM-KQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLL 546 (776)
Q Consensus 476 ~l~~~~~~~~~~~l~LVmEy~~g-~Ll~~------l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNIL 546 (776)
++++++.. ...+|+||||+.+ +|..+ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999954 4589999999997 66555 3322 5679999999999999999999999 99999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCh-HHHH
Q 004049 547 LNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYST-AIDMWSLGCIMAELLSKEPLFNGKSE-FDQL 624 (776)
Q Consensus 547 Ld~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~-~sDVWSLGvlLyELLtG~~PF~~~s~-~~~l 624 (776)
|+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||..... .+.+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876432 3445689999999999988545666 99999999999999999999988777 5555
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..+.......+.. +..+.. ...+.........++..+.+||.+||+.||.+|||+.++|+||
T Consensus 263 ~~i~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 263 NNIRTKNIEYPLD-RNHFLY-----------------PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHTSCCCCCCCS-SSSSTT-----------------TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHhccCcCCccc-hhhhhc-----------------cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5554332111110 000000 0000000111245899999999999999999999999999999
Q ss_pred CcCCCC
Q 004049 705 WFREVP 710 (776)
Q Consensus 705 wf~~i~ 710 (776)
||+..+
T Consensus 325 ~f~~~~ 330 (348)
T 2pml_X 325 WLADTN 330 (348)
T ss_dssp GGTTCC
T ss_pred cccCCC
Confidence 998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=387.28 Aligned_cols=284 Identities=27% Similarity=0.426 Sum_probs=218.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-----------CCCcceeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-----------HPSIVDVKEV 480 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HPnIV~l~~~ 480 (776)
.++|++++.||+|+||+||+|++..+++.||||++...... ...+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc---hhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 47899999999999999999999999999999999754322 234568999998886 8999999999
Q ss_pred Eecc--CCCeeEEEeeehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeec------CC
Q 004049 481 VVGS--NLDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLN------NR 550 (776)
Q Consensus 481 ~~~~--~~~~l~LVmEy~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd------~~ 550 (776)
+... +...+++||||+.++|..++... ...+++..++.++.||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 8643 23378999999988888887764 35699999999999999999999998 999999999999994 44
Q ss_pred CcEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHH
Q 004049 551 GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS------EFDQL 624 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s------~~~~l 624 (776)
+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+ ....+
T Consensus 175 ~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999876432 344689999999999987 568999999999999999999999998764 55677
Q ss_pred HHHHHhcCCCCCCCCCCC-------------CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 004049 625 DKIFKTLGTPNEKIWPGF-------------SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~-------------~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP 691 (776)
..++..++.++..++... ..+........ ...+... +..+..++..+.+||.+||+.||
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL---EDVLTEK-----YKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCH---HHHHHHT-----TCCCHHHHHHHHHHHGGGGCSST
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccch---hhhhhhc-----ccCCcchHHHHHHHHHHHhccCc
Confidence 778877776554321110 00000000000 0001111 11123467789999999999999
Q ss_pred CCCCCHHHHHcCcCcCCCC
Q 004049 692 DKRITAEAALNHDWFREVP 710 (776)
Q Consensus 692 ~kRpTa~EIL~HPwf~~i~ 710 (776)
.+|||+.|||+||||++..
T Consensus 323 ~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred cccCCHHHHhhChhhhccc
Confidence 9999999999999999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=377.56 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=202.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|.+ ++..||||++............+.+|+.+|++++||||+++++++. ....+|+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--STTCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCceEE
Confidence 47899999999999999999987 5889999999765433333345778999999999999999999994 4457899
Q ss_pred Eeeehhh-hhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 492 VMEYMEH-DLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
||||+.+ +|..++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999986 5656555432 23999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
........+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+.+..+......
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------- 257 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------------- 257 (309)
T ss_dssp ----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------------
T ss_pred cccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence 4444456789999999999987 56899999999999999999999999988877766655332111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CcCcCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDWFREV 709 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~--HPwf~~i 709 (776)
...+..+++.+.+||.+||..||.+|||+.+|++ ++|++..
T Consensus 258 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 ----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1112348899999999999999999999999997 5666543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.35 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=208.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||.||+|.+..++..||||++...... ......+.+|+.++..++||||+++++++. ....+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEE
Confidence 47899999999999999999999999999999998654322 122345678999999999999999999984 455899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
+||||+.| +|..++. ...++++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999987 5555554 45679999999999999999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+......+++......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 231 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-------------- 231 (294)
T ss_dssp --------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC--------------
T ss_pred cccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC--------------
Confidence 22344679999999999987 568999999999999999999999999888766655443321000
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
......+.+++.+.+||.+||..||.+||+..+.|.+.|..-..
T Consensus 232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011234789999999999999999999777777787765443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=368.17 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=205.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 96 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKI 96 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEE
Confidence 455666679999999999999999999999999997543 2234557789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeecccccccCCC
Q 004049 492 VMEYMEH-DLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQYGSP 567 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~~s~ 567 (776)
||||+.+ +|..++.... ..+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999975 5666665543 35679999999999999999999999999999999999987 899999999999876543
Q ss_pred CCCccccccccccCCchhhccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGS-KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~-~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~l 645 (776)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||........ +...... ..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~------------ 243 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-KV------------ 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-CC------------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-cc------------
Confidence 3334556899999999999763 2378999999999999999999999975433222 1111110 00
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
....+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 244 ----------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0011234789999999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=376.92 Aligned_cols=261 Identities=22% Similarity=0.330 Sum_probs=194.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC-
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD- 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~- 487 (776)
.++|++++.||+|+||.||+|.++.++. .||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3689999999999999999999887765 899999976543333345678999999999999999999998654321
Q ss_pred ---eeEEEeeehhh-hhhhHHhhcc-----CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 488 ---SIFMVMEYMEH-DLKGLMETMK-----QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 488 ---~l~LVmEy~~g-~Ll~~l~~~~-----~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
.+|+||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 24899999986 5666554332 25999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 004049 559 GLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPN 635 (776)
Q Consensus 559 GlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~ 635 (776)
|++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 258 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-- 258 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC--
Confidence 9998764322 12223456889999999987 568999999999999999999 99999998887777766543211
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHcCcCcCC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-------AEAALNHDWFRE 708 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-------a~EIL~HPwf~~ 708 (776)
...+.++..+.+||.+||..||.+||| +.++|.|||+..
T Consensus 259 ----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 259 ----------------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ----------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ----------------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 112247889999999999999999999 789999999976
Q ss_pred C
Q 004049 709 V 709 (776)
Q Consensus 709 i 709 (776)
.
T Consensus 305 ~ 305 (323)
T 3qup_A 305 T 305 (323)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=375.77 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=211.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc----CCccchHHHHHHHHhCC--CCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE----GFPLTSLREINILLSFH--HPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HPnIV~l~~~~~~~ 484 (776)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+. ||||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 3478999999999999999999999999999999997654322 22345678999999996 5999999999954
Q ss_pred CCCeeEEEeeehh--hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-CCCcEEEeecccc
Q 004049 485 NLDSIFMVMEYME--HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLA 561 (776)
Q Consensus 485 ~~~~l~LVmEy~~--g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-~~g~iKL~DFGlA 561 (776)
...+|+||||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 120 -~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 -PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred -CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 458999999997 566666654 46799999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
...... ......||+.|+|||++.+...++.++|||||||+||+|++|..||.... .+....
T Consensus 198 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~---------- 259 (320)
T 3a99_A 198 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---------- 259 (320)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC----------
T ss_pred cccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccc----------
Confidence 876532 33456899999999999875656889999999999999999999996532 121110
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
......++..+.+||.+||..||.+|||+.+||+||||+.+..
T Consensus 260 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 ---------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ---------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ---------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0011247899999999999999999999999999999998643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.24 Aligned_cols=249 Identities=23% Similarity=0.398 Sum_probs=209.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. ....+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCceEE
Confidence 368999999999999999999986 5778999999754322 245779999999999999999999994 4457999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-C
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-K 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~ 569 (776)
||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999986 5666776666779999999999999999999999999999999999999999999999999998664321 1
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------
Confidence 2233466888999999987 568999999999999999999 99999998887777776543211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.++|+|
T Consensus 227 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ---------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1112378899999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=375.22 Aligned_cols=250 Identities=23% Similarity=0.256 Sum_probs=205.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.| .||||+++++++.. ...+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 82 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAM 82 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEE
Confidence 67999999999999999999999999999999987543 234678999999999 89999999999855 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc-----EEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-----LKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~-----iKL~DFGlA~~~~s 566 (776)
||||+.++|.+++......|++.+++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++..+..
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 83 VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999977888888776778999999999999999999999999999999999999999887 99999999987643
Q ss_pred CCC-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCC
Q 004049 567 PLK-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---DQLDKIFKTLGTPNE 636 (776)
Q Consensus 567 ~~~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---~~l~kI~~~lg~p~~ 636 (776)
... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+.. +.+..|.......+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred CCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 322 1245789999999999988 56899999999999999999999999875433 33333322210000
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+ ...++ .+.+||..||..||.+||++.+|++
T Consensus 241 --------------------~~~~-----------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 --------------------IEVL-----------CENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------------------HHHH-----------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------HHHH-----------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000 01133 8899999999999999999988776
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=371.83 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=201.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc----CCccchHHHHHHHHhC----CCCCcceeeEEEe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE----GFPLTSLREINILLSF----HHPSIVDVKEVVV 482 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L----~HPnIV~l~~~~~ 482 (776)
..++|++++.||+|+||.||+|.++.+++.||||++....... .....+.+|+.++..+ .||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3478999999999999999999999999999999997654221 1234556899999998 8999999999984
Q ss_pred ccCCCeeEEEeee-hh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec-CCCcEEEeecc
Q 004049 483 GSNLDSIFMVMEY-ME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFG 559 (776)
Q Consensus 483 ~~~~~~l~LVmEy-~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd-~~g~iKL~DFG 559 (776)
. ...+|+|||| +. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 4 4578999999 55 466666654 45799999999999999999999999999999999999999 78999999999
Q ss_pred cccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 004049 560 LARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIW 639 (776)
Q Consensus 560 lA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~w 639 (776)
++...... ......||+.|+|||++.+...++.++|||||||+||+|++|..||.... .+....
T Consensus 186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~-------- 249 (312)
T 2iwi_A 186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE-------- 249 (312)
T ss_dssp SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC--------
T ss_pred hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc--------
Confidence 99876532 34556899999999999875555679999999999999999999996531 121110
Q ss_pred CCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 640 PGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 640 p~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 250 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 250 -----------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 001124788999999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=375.48 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=208.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++|++.+.||+|+||+||+|.++.++. .||||+++.... ......+.+|+.+|+.++||||+++++++. ...
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVT--RGR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--GGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence 45789999999999999999999986554 599999975421 112345778999999999999999999994 445
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.| +|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 78999999976 67777766667899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+....+.+..+......+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 274 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------- 274 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--------
Confidence 3222 222355788999999987 568999999999999999999 999999988888777765542111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.+|++.
T Consensus 275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 122478899999999999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.07 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=207.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEEC-------CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDK-------KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k-------~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~ 483 (776)
.++|++++.||+|+||+||+|.+. .++..||||+++.... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-
Confidence 478999999999999999999874 3456899999975432 12234577999999999 8999999999994
Q ss_pred cCCCeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
....+||||||+.| +|..++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 158 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 158 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred -cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 44579999999986 6766665532 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 004049 548 NNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQL 624 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l 624 (776)
+.++.+||+|||++........ ......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+....+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987643221 2234567889999999987 568999999999999999999 99999988776666
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+...... ..+..++..+.+||.+||..||.+|||+.|++++
T Consensus 316 ~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRM------------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCC------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555433110 1122478899999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.48 Aligned_cols=253 Identities=17% Similarity=0.229 Sum_probs=208.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+||+++++++. ....+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeE
Confidence 467999999999999999999999999999999986433 234678899999999 7999999999984 445889
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc-----EEEeecccccccC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE-----LKICDFGLARQYG 565 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~-----iKL~DFGlA~~~~ 565 (776)
+||||+.++|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999977888888777778999999999999999999999999999999999999988776 9999999998764
Q ss_pred CCCC-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Q 004049 566 SPLK-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS---EFDQLDKIFKTLGTPN 635 (776)
Q Consensus 566 s~~~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s---~~~~l~kI~~~lg~p~ 635 (776)
.... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.. ....+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 3322 2345689999999999987 568999999999999999999999998743 3333444433211000
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
. .. ....++..+.+||.+||..||.+|||+.+|++.
T Consensus 242 ---------------------~---~~--------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 242 ---------------------L---RE--------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp ---------------------H---HH--------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ---------------------H---HH--------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 00 012378999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=383.96 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=209.4
Q ss_pred CCCeeEEeeeecCCceEEEEEE-----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRAR-----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~-----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++++.||+|+||+||+|+ +..++..||||+++..... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-hhHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 3689999999999999999999 4457889999998643211 123356789999999999999999999944 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---cEEEe
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG---ELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g---~iKL~ 556 (776)
..+||||||+.| +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 578999999975 6777766543 3599999999999999999999999999999999999999655 49999
Q ss_pred ecccccccCC--CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGS--PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s--~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||+++.... .........||+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999975421 1123344678999999999987 568999999999999999998 99999998888777776543211
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
+ .+..++..+.+||.+||+.||.+|||+.+||+|.|+.
T Consensus 306 ~------------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 D------------------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp C------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------------------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1123788999999999999999999999999998874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.45 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=205.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcE----EEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEI----VALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~----VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..++|++++.||+|+||+||+|.+..++.. ||+|++.... .......+.+|+.++..++||||+++++++. .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~ 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---G 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---B
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---C
Confidence 457899999999999999999999888876 6666664332 2233456678999999999999999999883 3
Q ss_pred CeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 487 DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
..+|+||||+. |+|...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 46899999998 46777776666789999999999999999999999999999999999999999999999999998774
Q ss_pred CCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 566 SPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 566 s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.........+......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL--------- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC---------
T ss_pred cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------
Confidence 3322 2345677889999999987 568999999999999999999 99999987766665555432111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.++++|
T Consensus 237 ---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 237 ---------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112356677899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.03 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=203.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC--CCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH--HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--HPnIV~l~~~~~~~~~~~ 488 (776)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|..+. ||||+++++++.. ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence 3467999999999999999999885 5899999999765433333456678999999997 5999999999954 458
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+|||||+..++|..++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 103 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999999888888888765 457999999999999999999999999999999999999975 899999999998764322
Q ss_pred C--CccccccccccCCchhhccC----------CCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCC
Q 004049 569 K--PYTHLVVTLWYRAPELLLGS----------KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTPN 635 (776)
Q Consensus 569 ~--~~~~~~GT~~Y~APEvl~g~----------~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~p~ 635 (776)
. .....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...... ..+..++...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---- 256 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN---- 256 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT----
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc----
Confidence 1 22345799999999999752 35788999999999999999999999765332 2222222110
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
.....+...+..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 257 -------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 257 -------------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp -------------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred -------------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 001112236788999999999999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.76 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=207.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.+++.++||||+++++++. ....+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeE
Confidence 3478999999999999999999886 6778999999754322 245779999999999999999999994 455799
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999975 6777776656789999999999999999999999999999999999999999999999999998664321
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+......+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 241 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------- 241 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC-------------
Confidence 11233456788999999987 458999999999999999998 999999988877777765542111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..+++.+.+||.+||..||.+|||+.++|+|
T Consensus 242 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 -----------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 112368899999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.57 Aligned_cols=257 Identities=21% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|.+.+.||+|+||+||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 83 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLN 83 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeE
Confidence 35789999999999999999999999999999998854321 223457789999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999986 67777776677899999999999999999999999999999999999999999999999999987643222
Q ss_pred C--------------ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004049 570 P--------------YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPN 635 (776)
Q Consensus 570 ~--------------~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~ 635 (776)
. ....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~------------ 230 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------------ 230 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT------------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH------------
Confidence 1 125689999999999987 5689999999999999999999999865321100
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
. ... .....+...+ ++.+++.+.+||.+||..||.+|||+.+|++ ||+.
T Consensus 231 --------~---~~~----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 231 --------D---FGL----NVRGFLDRYC-------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp --------T---SSB----CHHHHHHHTC-------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred --------H---Hhh----hhhccccccC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 0 000 0001111111 2347888999999999999999999999986 5543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=377.17 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=181.6
Q ss_pred cCCCeeEEe-eeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHH-HHHHHhCCCCCcceeeEEEecc--CC
Q 004049 411 SVDEFERLN-KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLRE-INILLSFHHPSIVDVKEVVVGS--NL 486 (776)
Q Consensus 411 ~~~~yeil~-~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rE-i~iL~~L~HPnIV~l~~~~~~~--~~ 486 (776)
..++|.+++ .||+|+||+||+|.++.+++.||||++.... ...+| ...++.+.||||+++++++... ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 347899976 5999999999999999999999999986532 12233 3446778999999999998542 23
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLA 561 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA 561 (776)
..+||||||+.| +|..++.... ..|++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 468999999986 6767766543 46999999999999999999999999999999999999986 455999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
..... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||...........+.......
T Consensus 179 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 248 (336)
T 3fhr_A 179 KETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------- 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eeccc--cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-------
Confidence 87643 23345688999999999976 568999999999999999999999997765433321111110000
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...++. .....++..+.+||.+||..||.+|||+.++|+||||++.
T Consensus 249 -------------------~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 -------------------QYGFPN---PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------------CCCT---TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -------------------ccccCc---hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000011 1123488999999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.16 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=208.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.++ ++..||+|+++..... ...+.+|+.+++.++||||+++++++ .....+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCceEE
Confidence 478999999999999999999876 5778999999754322 24577999999999999999999999 44557999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK- 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~- 569 (776)
||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999975 57777766666799999999999999999999999999999999999999999999999999987643321
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY-------------- 225 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC--------------
Confidence 1223456778999999987 568999999999999999999 999999888777766664432111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 226 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 ----------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112368899999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.79 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=206.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEE-----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRAR-----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~-----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~ 484 (776)
..++|++++.||+|+||.||+|. +..+++.||||+++..... .....+.+|+.+|..+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 34789999999999999999998 5567799999999754321 1234577899999999 799999999998553
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhccC------------------------------------------------------
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMKQ------------------------------------------------------ 509 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~~------------------------------------------------------ 509 (776)
...+|+||||+.| +|..++.....
T Consensus 99 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred -CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 3458999999986 66666654321
Q ss_pred -----------CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC--Ccccccc
Q 004049 510 -----------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVV 576 (776)
Q Consensus 510 -----------~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~G 576 (776)
.|++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 289999999999999999999999999999999999999999999999999986633222 2344678
Q ss_pred ccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhh
Q 004049 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKH 655 (776)
Q Consensus 577 T~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~ 655 (776)
|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+......+...+.....+
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 315 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 315 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---------------------
Confidence 999999999987 568999999999999999998 999998876555544443331111
Q ss_pred hhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 656 QYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 656 ~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..+++.+.+||.+||..||.+|||+.+|++|
T Consensus 316 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 --------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1122478899999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=374.09 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=188.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHH-HHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREIN-ILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~-iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||.||+|.++.+++.||||++....... ....+..|+. +++.+.||||+++++++.. ...+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCce
Confidence 4578999999999999999999999999999999997543221 1233445665 6677899999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhh----ccCCCCHHHHHHHHHHHHHHhhhhccC-CcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 490 FMVMEYMEHDLKGLMET----MKQPFSQSEVKCLMLQLLEGIKYLHDN-WVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~----~~~~Lse~~~~~i~~qIl~aL~yLHs~-gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
|+||||+.+++..++.. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++...
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999999987776653 256799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccCCchhhc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLL---GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~---g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~p~~~~wp 640 (776)
... .......||+.|+|||++. ....++.++|||||||+||+|++|..||...... +.+..+...
T Consensus 177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 245 (327)
T 3aln_A 177 VDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG---------- 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS----------
T ss_pred ccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC----------
Confidence 433 2233457999999999984 2245889999999999999999999999764321 111111000
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
..+.........++..+.+||.+||..||.+|||+.+||+||||...
T Consensus 246 ----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 246 ----------------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00000111123478999999999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.60 Aligned_cols=268 Identities=24% Similarity=0.391 Sum_probs=204.3
Q ss_pred CCCeeEEeeeecCCceEEEEEE----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||+||+|+ +..+++.||||++...... ....+.+|+.+|+.++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4789999999999999999998 5678999999998754321 234567899999999999999999998765556
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 78999999975 77777777666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... ..... .+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~---~~~~~~------- 233 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRM---IGNDKQ------- 233 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHH---HCTTCC-------
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhh---hcCccc-------
Confidence 221 2233457888999999987 5689999999999999999999999865321 11111 111000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.. .........+. .......+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 234 ----~~-~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 ----GQ-MIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp ----TH-HHHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----cc-hhHHHHHHHHh---ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 00000011111 11122334568999999999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.96 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=204.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-----CCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-----GFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-----~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++.+.||+|+||+||+|++..+++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 478999999999999999999999999999999986543221 1224567899999999999999999998332
Q ss_pred CeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCc-----EEEeec
Q 004049 487 DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGE-----LKICDF 558 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~-----iKL~DF 558 (776)
.++||||+. ++|...+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+||
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 379999998 5777777777778999999999999999999999999 999999999999988776 999999
Q ss_pred ccccccCCCCCCccccccccccCCchhhcc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Q 004049 559 GLARQYGSPLKPYTHLVVTLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ--LDKIFKTLGTPN 635 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~GT~~Y~APEvl~g-~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~--l~kI~~~lg~p~ 635 (776)
|++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||........ ...+......
T Consensus 174 g~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 248 (287)
T 4f0f_A 174 GLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-- 248 (287)
T ss_dssp TTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--
T ss_pred Cccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--
Confidence 99985432 3455789999999999843 34578899999999999999999999976554332 2222221100
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 636 EKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 636 ~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus 249 ---------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 ---------------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112347899999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.79 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=208.7
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS 484 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~ 484 (776)
...++|++++.||+|+||.||+|++. .+++.||||+++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 34578999999999999999999987 45589999999754321 123456789999999999999999999944
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhcc-----------------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCC
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMK-----------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDL 540 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~-----------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDL 540 (776)
...+||||||+.+ +|..++.... ..+++.+++.|+.||+.||.|||++||+||||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 5578999999986 6766665532 57999999999999999999999999999999
Q ss_pred CCCCeeecCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 004049 541 KTSNLLLNNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNG 617 (776)
Q Consensus 541 KPeNILLd~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~ 617 (776)
||+||||+.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999999999999999999998653221 22234578999999999987 468999999999999999999 9999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 618 KSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 618 ~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
....+.+..+...... ..+..++..+.+||.+||..||.+|||+
T Consensus 280 ~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 280 MAHEEVIYYVRDGNIL------------------------------------ACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp SCHHHHHHHHHTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CChHHHHHHHhCCCcC------------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 8877776666443110 0112478899999999999999999999
Q ss_pred HHHHcC
Q 004049 698 EAALNH 703 (776)
Q Consensus 698 ~EIL~H 703 (776)
.+++++
T Consensus 324 ~~~~~~ 329 (343)
T 1luf_A 324 CSIHRI 329 (343)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=370.16 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=200.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEE----EEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIV----ALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~V----AIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 478999999999999999999998887765 666664322 222345678899999999999999999999643
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..++||+|+. |+|..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 4788899988 467777777677899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.........+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred CcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC----------
Confidence 3322 223456889999999987 568999999999999999999 99999887766655544332111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||+.||.+|||+.++|+|
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 --------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123478899999999999999999999999977
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.17 Aligned_cols=246 Identities=19% Similarity=0.295 Sum_probs=201.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC-------cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG-------EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS 484 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg-------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~ 484 (776)
.++|++.+.||+|+||+||+|.++.++ ..||+|++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVC- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECC-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-
Confidence 478999999999999999999998777 4799999865432 233567799999999999999999999954
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc--------EEE
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE--------LKI 555 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~--------iKL 555 (776)
....|+||||+.| +|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 4578999999985 777777766666999999999999999999999999999999999999998887 999
Q ss_pred eecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCC
Q 004049 556 CDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTP 634 (776)
Q Consensus 556 ~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~lg~p 634 (776)
+|||++.... ......||+.|+|||++.+...++.++|||||||++|+|++| .+||.......... +......
T Consensus 163 ~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~- 236 (289)
T 4fvq_A 163 SDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ- 236 (289)
T ss_dssp CCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC-
T ss_pred ccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC-
Confidence 9999997553 224467899999999998756789999999999999999995 55555544433332 2221100
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 635 ~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 237 ------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 ------------------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ------------------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ------------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011246678899999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=353.65 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=208.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|++. +..||||++............+.+|+.+|+.++||||+++++++.......+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4578999999999999999999985 88999999976543333345678899999999999999999999766557889
Q ss_pred EEeeehhh-hhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+||||+.+ +|..++..... .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999985 77777765433 5999999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCccccccccccCCchhhccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQ--YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~--ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 230 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---------- 230 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----------
Confidence 34578999999999987322 3347999999999999999999999888777766665432111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.++++
T Consensus 231 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 -------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112247899999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=373.16 Aligned_cols=265 Identities=19% Similarity=0.229 Sum_probs=203.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCC-----CcEEEEEEeecchhc---------cCCccchHHHHHHHHhCCCCCcce
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKT-----GEIVALKKVKMEKER---------EGFPLTSLREINILLSFHHPSIVD 476 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~t-----g~~VAIK~i~~~~~~---------~~~~~~~~rEi~iL~~L~HPnIV~ 476 (776)
..++|++++.||+|+||.||+|.++.+ ++.||||++...... .........|+.++..+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999998765 588999998654311 111122345666777888999999
Q ss_pred eeEEEeccC--CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec--CCCc
Q 004049 477 VKEVVVGSN--LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN--NRGE 552 (776)
Q Consensus 477 l~~~~~~~~--~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd--~~g~ 552 (776)
+++++.... ...+||||||+.++|..++......|++.+++.|+.||+.||.|||++||+||||||+||||+ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 999986542 246899999997778888877667899999999999999999999999999999999999999 8899
Q ss_pred EEEeecccccccCCCC-------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 004049 553 LKICDFGLARQYGSPL-------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~-------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~ 625 (776)
+||+|||+++.+.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999997653221 11234569999999999987 558999999999999999999999998643333222
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..... .+.......+...++ ...++..+.+||..||..||.+|||+.+|++
T Consensus 272 ~~~~~--------------------~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKI--------------------RYRENIASLMDKCFP------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHH--------------------HHHHCHHHHHHHHSC------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHH--------------------HhhhhHHHHHHHhcc------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22111 000011111222221 1347899999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=360.18 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=197.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|++.+.||+|+||.||+|.+..+ +..||+|++..... ......+.+|+.+++.++||||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCc
Confidence 37899999999999999999998654 45799999865321 122345678999999999999999999983 346
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 8999999986 677777666667999999999999999999999999999999999999999999999999999876432
Q ss_pred CC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..+......+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~----------- 237 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------- 237 (281)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred cccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-----------
Confidence 21 1233456889999999986 568999999999999999996 999999888777777665431110
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 238 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 -------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 122478999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=362.38 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=194.5
Q ss_pred ccccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 408 GCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 408 ~~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
+...+++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 104 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--D 104 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 44567899999999999999999999999999999999975321 11223456789999999999999999999965 4
Q ss_pred CeeEEEeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..+|+||||+.+ +|..++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 589999999986 66555543 34679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE--FDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~--~~~l~kI~~~lg~p~~~~wp 640 (776)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+... ..+
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~------ 256 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP------ 256 (310)
T ss_dssp --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSC------
T ss_pred eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCC------
Confidence 76554444455689999999999987 5689999999999999999999999976432 2222222211 100
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
. .....++..+.+||.+||..||.+|||+.+|+++
T Consensus 257 -------------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 257 -------------------------P---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------------------------C---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------C---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0112478899999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.19 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=206.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|.+.+.||+|+||.||+|.+ +.++..||||++..... ......+.+|+.+|+.++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACS--QD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cC
Confidence 47899999999999999999988 34568999999975431 112345678999999999999999999984 44
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc-----------------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK-----------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKT 542 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~-----------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 542 (776)
..+|+||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 578999999984 6666665432 2389999999999999999999999999999999
Q ss_pred CCeeecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 004049 543 SNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKS 619 (776)
Q Consensus 543 eNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s 619 (776)
+||||+.++.+||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987643322 1233467889999999987 568999999999999999999 999998887
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004049 620 EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699 (776)
Q Consensus 620 ~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E 699 (776)
.......+...... ..+..++..+.+||.+||..||.+|||+.+
T Consensus 258 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 258 PERLFNLLKTGHRM------------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp GGGHHHHHHTTCCC------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhhcCCcC------------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 76666555332110 011247899999999999999999999999
Q ss_pred HHcC
Q 004049 700 ALNH 703 (776)
Q Consensus 700 IL~H 703 (776)
|++|
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=388.17 Aligned_cols=255 Identities=21% Similarity=0.277 Sum_probs=197.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.+|.+.+.||+|+||+||.. ...+++.||||++.... ...+.+|+.+|+.+ +|||||++++++.. ...+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEE
Confidence 46999999999999997643 44678999999986432 23467899999999 79999999999854 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-----CCcEEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-----RGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-----~g~iKL~DFGlA~~~~s 566 (776)
|||||.|+|..++......+.+.+++.++.||+.||.|||++||+||||||+||||+. ...+||+|||+|+....
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999999999998877767777788999999999999999999999999999999953 23588999999987643
Q ss_pred CC---CCccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 567 PL---KPYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 567 ~~---~~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
.. ......+||+.|+|||++.+ ...++.++|||||||+||+|++ |.+||....... ...+... .....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~~---~~~~~-- 249 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGA---CSLDC-- 249 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTTC---CCCTT--
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhcc---CCccc--
Confidence 22 22345689999999999974 2457789999999999999999 899996543322 2222111 10000
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.......+..+.+||.+||+.||.+|||+.+||+||||..+
T Consensus 250 ----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 250 ----------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ----------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ----------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00011245668899999999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=368.47 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=206.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|..+ .||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 47899999999999999999997 3467789999997543 223345678999999999 89999999999954
Q ss_pred CCeeEEEeeehhh-hhhhHHhhccC----------------------CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCC
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMKQ----------------------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKT 542 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~~----------------------~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 542 (776)
...+||||||+.+ +|..++..... .|++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 4578999999975 77777765432 389999999999999999999999999999999
Q ss_pred CCeeecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 004049 543 SNLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKS 619 (776)
Q Consensus 543 eNILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s 619 (776)
+||||+.++.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999986643222 1234567889999999987 568999999999999999998 999998877
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004049 620 EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699 (776)
Q Consensus 620 ~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E 699 (776)
....+..++.....+ ..+..++..+.+||.+||..||.+|||+.+
T Consensus 280 ~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 280 VDANFYKLIQNGFKM-----------------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp CSHHHHHHHHTTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cHHHHHHHHhcCCCC-----------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 655555544431111 112247889999999999999999999999
Q ss_pred HHcCcC
Q 004049 700 ALNHDW 705 (776)
Q Consensus 700 IL~HPw 705 (776)
|++|-.
T Consensus 325 l~~~l~ 330 (344)
T 1rjb_A 325 LTSFLG 330 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=378.58 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=208.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++.+.||+|+||.||+|.++.+++.||||+++.... ......+.+|+.+|+.++||||+++++++. ....+|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--cCCCcE
Confidence 34789999999999999999999999999999999875421 112345778999999999999999999994 445789
Q ss_pred EEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||+. |+|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999998 577777776666799999999999999999999999999999999999999999999999999986533211
Q ss_pred C--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 P--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------- 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------------- 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-------------
T ss_pred eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1 112345788999999987 568999999999999999998 99999988776666555332111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.+|++
T Consensus 335 -----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 -----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112237889999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.27 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=194.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc--cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER--EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..++|++.+.||+|+||.||+|.+. +..||||++...... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCc
Confidence 3578999999999999999999985 889999998764322 2223456789999999999999999999944 457
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC---cccCCCCCCCeeecC--------CCcEEEee
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW---VLHRDLKTSNLLLNN--------RGELKICD 557 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g---IvHrDLKPeNILLd~--------~g~iKL~D 557 (776)
+|+||||+.|+.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 899999998654444443 457999999999999999999999999 899999999999986 67899999
Q ss_pred cccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 004049 558 FGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 558 FGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~ 637 (776)
||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 232 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA---- 232 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC----
T ss_pred CCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC----
Confidence 99998764332 234689999999999987 56899999999999999999999999988776665555332111
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..++..+.+||.+||..||.+|||+.++++|
T Consensus 233 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 -------------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01123478899999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=373.78 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=208.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~ 483 (776)
.++|.+++.||+|+||+||+|.+.. .+..||||+++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 3789999999999999999999753 336899999975432 12234567899999999 8999999999994
Q ss_pred cCCCeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
....+||||||+.+ +|..++.... ..|++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 146 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 44578999999986 6766666543 359999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 004049 548 NNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQL 624 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l 624 (776)
+.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+....+.+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998764322 22334567899999999987 568999999999999999999 99999988877766
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+...... ..+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 304 ~~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRM------------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCC------------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC------------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665443111 1122478899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.60 Aligned_cols=267 Identities=24% Similarity=0.400 Sum_probs=205.5
Q ss_pred CCeeEEeeeecCCceEEEEEE----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
..|++++.||+|+||.||+|+ +..+++.||||++..... ......+.+|+.+|+.++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 569999999999999999998 567899999999975542 223356778999999999999999999997765567
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999986 777777676778999999999999999999999999999999999999999999999999999877543
Q ss_pred CC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+.. ..+....
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~---~~~~~~~-------- 245 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLK---MIGPTHG-------- 245 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH--HHHHHH---HHCSCCG--------
T ss_pred CcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch--hhHHhh---ccCCccc--------
Confidence 32 2334578889999999987 56889999999999999999999987432 121111 1111100
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
. .........+.. ......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 246 ----~-~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 ----Q-MTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ----G-GHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ----c-cCHHHHHHHHhc---cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 000000111111 1122234568999999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=366.65 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=213.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++.+.||+|+||.||+|.++ .++..||||++...... .....+.+|+.+|+.+.||||+++++++. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEc--cC
Confidence 478999999999999999999876 46788999999743321 12235678999999999999999999994 44
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc---------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK---------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~---------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
..+|+||||+.+ +|..++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 578999999985 6766665432 467999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||++....... .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+.......+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 999998653221 11233467899999999987 568999999999999999999 89999988877766666443110
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC------cCcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH------DWFR 707 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H------Pwf~ 707 (776)
.....++..+.+||.+||..||.+|||+.++++| +||+
T Consensus 260 ------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 260 ------------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp ------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ------------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 0112478899999999999999999999999988 7777
Q ss_pred CCCCC
Q 004049 708 EVPLP 712 (776)
Q Consensus 708 ~i~~p 712 (776)
.+.+.
T Consensus 304 ~~~~~ 308 (322)
T 1p4o_A 304 EVSFY 308 (322)
T ss_dssp HHCST
T ss_pred ccccc
Confidence 66544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=358.01 Aligned_cols=253 Identities=23% Similarity=0.234 Sum_probs=202.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.|++++..+.++.. .....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEE
Confidence 4789999999999999999999999999999998765432 2457789999999999888887776643 3457899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||+.++|..++......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999888888887777789999999999999999999999999999999999999 788999999999998764332
Q ss_pred C-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCC
Q 004049 569 K-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---DQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 569 ~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---~~l~kI~~~lg~p~~~~ 638 (776)
. ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+.. ..+..+......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 236 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----- 236 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-----
Confidence 2 2235689999999999987 56899999999999999999999999764432 222222211000
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+ .......+++.+.+||.+||..||.+|||+.+|++
T Consensus 237 -------------------------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 -------------------------TP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------------SC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------------ch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 00001237889999999999999999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=356.93 Aligned_cols=254 Identities=22% Similarity=0.219 Sum_probs=205.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.|++++..+.++.. ....+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEE
Confidence 478999999999999999999999999999999986543 23457799999999999888777766543 3457899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||+.++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999878888887667789999999999999999999999999999999999999 478899999999998765432
Q ss_pred C-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCC
Q 004049 569 K-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE---FDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 569 ~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~---~~~l~kI~~~lg~p~~~~ 638 (776)
. ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... ...+..+......++
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 2 2345689999999999987 5589999999999999999999999986432 223333322110000
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
... ....+++.+.+||.+||+.||.+|||+.++++.
T Consensus 239 ----------------------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 239 ----------------------IEV-------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ----------------------HHH-------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ----------------------hHH-------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 000 012378999999999999999999999988753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.38 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=209.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 368999999999999999999986 6788999999764322 2457789999999999999999999954 457899
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-C
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-K 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~ 569 (776)
||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999985 6777777666779999999999999999999999999999999999999999999999999998663211 1
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence 1233467889999999987 568999999999999999999 89999988877777666443111
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 225 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 ---------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112368899999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.75 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=187.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEec------cC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVG------SN 485 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~------~~ 485 (776)
.+|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.++..+. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH--HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH--HHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 5799999999999999999999999999999998544321 2345678999999996 9999999999842 33
Q ss_pred CCeeEEEeeehhhhhhhHHhh--ccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeecCCCcEEEeecccc
Q 004049 486 LDSIFMVMEYMEHDLKGLMET--MKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 486 ~~~l~LVmEy~~g~Ll~~l~~--~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
...+|+||||+.|+|..++.. ....+++.+++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 446899999999998888765 3456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------------CccccccccccCCchhhc--cCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004049 562 RQYGSPLK------------PYTHLVVTLWYRAPELLL--GSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI 627 (776)
Q Consensus 562 ~~~~s~~~------------~~~~~~GT~~Y~APEvl~--g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI 627 (776)
........ .....+||+.|+|||++. ....++.++|||||||+||+|++|..||........+...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 87643221 112456899999999984 2356889999999999999999999999765433221111
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
. .+......+..+.+||.+||+.||.+|||+.++|+|-+
T Consensus 266 ---~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 266 ---Y------------------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---C------------------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ---c------------------------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 00111235667889999999999999999999999854
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=381.98 Aligned_cols=278 Identities=21% Similarity=0.311 Sum_probs=212.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
-++|++.+.||+|+||+||+|.++.+++.||||++...... .....+.+|+.+|+.++||||+++++++.......+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 46899999999999999999999999999999999754432 22345678999999999999999999997766668899
Q ss_pred Eeeehhh-hhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee----cCCCcEEEeeccccccc
Q 004049 492 VMEYMEH-DLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL----NNRGELKICDFGLARQY 564 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL----d~~g~iKL~DFGlA~~~ 564 (776)
||||+.| +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999985 5666665432 239999999999999999999999999999999999999 77888999999999876
Q ss_pred CCCCCCccccccccccCCchhhccC-------CCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGS-------KQYSTAIDMWSLGCIMAELLSKEPLFNGK----SEFDQLDKIFKTLGT 633 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~-------~~ys~~sDVWSLGvlLyELLtG~~PF~~~----s~~~~l~kI~~~lg~ 633 (776)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+.+++..
T Consensus 167 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--- 242 (396)
T 4eut_A 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--- 242 (396)
T ss_dssp CCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS---
T ss_pred cCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC---
Confidence 433 334457899999999998641 35788999999999999999999999653 234445555443
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+...|..+.........|.. .++. .......++..+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~--------~~~~-~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSG--------DMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEES--------SCCT-TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCc--------cCCc-ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 223333322222111111110 0110 011122356678899999999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.76 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=207.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||+|.+ ..++..||||++...... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 36899999999999999999985 457889999999754321 1234567899999999 89999999999944
Q ss_pred CCeeEEEeeehhh-hhhhHHhhccC-----------------CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMKQ-----------------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~~-----------------~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
...+|+||||+.+ +|..++..... .+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4578999999986 77777665432 49999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 004049 548 NNRGELKICDFGLARQYGSPLKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQL 624 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~s~~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l 624 (776)
+.++.+||+|||++......... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+......+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999876543221 233567889999999987 568999999999999999998 99999887665555
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..++.....+ .....++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM-----------------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC-----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC-----------------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5544431111 1122478899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.69 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=208.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.++.++..||||++..... ....+.+|+.+++.++||||+++++++. ....+|+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEEE
Confidence 4789999999999999999999999999999999975332 2345778999999999999999999994 4557999
Q ss_pred Eeeehh-hhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYME-HDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~-g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999998 4677766553 35699999999999999999999999999999999999999999999999999987653322
Q ss_pred -CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------- 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--------------
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC--------------
Confidence 2233466889999999987 468999999999999999999 99999887766655555332111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.++++
T Consensus 232 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 ----------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 112347889999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.19 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=200.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEE----EEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIV----ALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~V----AIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
..++|++++.||+|+||+||+|.+..+++.| |+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 3478999999999999999999998888776 455443221 222345677899999999999999999999643
Q ss_pred CeeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 487 DSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
..++||+|+. |+|..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4788889887 46777777777789999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 566 SPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 566 s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... ......+|+.|+|||++.+ ..|+.++|||||||+||+|++ |.+||.+.........+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 3322 2233456889999999987 568999999999999999999 99999988776666555433111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.+||+.
T Consensus 239 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 239 ---------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123478899999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.01 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=198.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC---CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC-
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD- 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~- 487 (776)
.++|.+.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.++||||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3689999999999999999998765 566899999976543333334577899999999999999999998654332
Q ss_pred --eeEEEeeehhh-hhhhHHhh-----ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecc
Q 004049 488 --SIFMVMEYMEH-DLKGLMET-----MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFG 559 (776)
Q Consensus 488 --~l~LVmEy~~g-~Ll~~l~~-----~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFG 559 (776)
.+|+||||+.+ +|..++.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 46999999986 56555532 33569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 560 LARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 560 lA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
++....... .......+++.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.........+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 268 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence 998664322 12233567889999999987 568999999999999999999 99999988877776666543211
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.++++|
T Consensus 269 ---------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 ---------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112378899999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.01 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=194.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++.+.||+|+||+||+|.+.. .||||+++...........+.+|+.+|+.++||||++++++.. ...+++|
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv 97 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 97 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence 679999999999999999998643 5999999765443333456778999999999999999999762 3468999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC--CCC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS--PLK 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s--~~~ 569 (776)
|||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999985 66666666667899999999999999999999999999999999999999999999999999976542 122
Q ss_pred CccccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||........+..++.....+.. +
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~----- 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-----L----- 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----T-----
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-----h-----
Confidence 3345679999999999962 356788999999999999999999999887766655555443211100 0
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
......++..+.+||.+||..||.+|||+.++|+.
T Consensus 248 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 248 ---------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp ---------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00112478899999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.82 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=195.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 4688999999999999999999999999999999997553322 122456789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.| +|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999986 55555544 4679999999999999999999999999999999999999999999999999998664322
Q ss_pred -CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+.......+ ........
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~----------- 255 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPS----------- 255 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGG-----------
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCcc-----------
Confidence 22345679999999999987 56899999999999999999999999876554332222 22111000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-TAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-Ta~EIL~ 702 (776)
...+.++..+.+||.+||..||.+|| |+.++++
T Consensus 256 ----------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 256 ----------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11234788999999999999999999 7777764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.39 Aligned_cols=268 Identities=24% Similarity=0.367 Sum_probs=209.3
Q ss_pred CCCeeEEeeeecCCceEEEEEE----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||.||+|. +..++..||||++...... ....+.+|+.+|+.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH--HHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4789999999999999999998 5678999999999754322 134567899999999999999999999876777
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.+ +|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 89999999965 67777766566799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~-------- 245 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER-------- 245 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC-----------
T ss_pred CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc--------
Confidence 322 2233568889999999987 5689999999999999999999999975432211 1100000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.. .........+.. ......+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 246 ~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 DV-----PALSRLLELLEE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -C-----CHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-----ccHHHHHHHhhc---ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 000011111111 11222345689999999999999999999999999654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.08 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=205.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec---------
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG--------- 483 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~--------- 483 (776)
.+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 67999999999999999999999999999999997542 356789999999999999999998853
Q ss_pred -----cCCCeeEEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 484 -----SNLDSIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 484 -----~~~~~l~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
.....+|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 123468999999996 677766543 3579999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 557 DFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 557 DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||... ......+...
T Consensus 165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~------ 234 (284)
T 2a19_B 165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG------ 234 (284)
T ss_dssp CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT------
T ss_pred cchhheeccccc-cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc------
Confidence 999998775432 3345679999999999987 56899999999999999999999887421 1111111110
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+ ...++..+.+||.+||..||.+|||+.++++|.|.-.
T Consensus 235 --------------------------~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 --------------------------II-------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------------------------CC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------------------------cc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00 1237889999999999999999999999999988744
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=355.58 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=202.1
Q ss_pred CCCeeEEe-eeecCCceEEEEEE--ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLN-KIDEGTYGVVYRAR--DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~-~LG~GsfG~Vyla~--~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|.+.+ .||+|+||.||+|. ...+++.||||+++...........+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence 36799998 99999999999995 4567899999999765433333456778999999999999999999982 346
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred cEEEEEeCCCCCHHHHHH-hCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 8999999985 5555554 4567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.+.......+......
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 239 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 239 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 221 122356788999999987 558899999999999999999 99999988877666555432100
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.++++
T Consensus 240 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 --------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011247899999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.92 Aligned_cols=270 Identities=22% Similarity=0.298 Sum_probs=198.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC--CCe
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN--LDS 488 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~--~~~ 488 (776)
..++|++++.||+|+||+||+|++. ++.||||++...... .....+|+.+|+.++||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3478999999999999999999875 789999999654322 233456899999999999999999996543 335
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC----------CcccCCCCCCCeeecCCCcEEEee
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN----------WVLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~----------gIvHrDLKPeNILLd~~g~iKL~D 557 (776)
+||||||+.+ +|..++.. ..+++.+++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 7999999986 66666654 4599999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC--CccccccccccCCchhhccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004049 558 FGLARQYGSPLK--PYTHLVVTLWYRAPELLLGS----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 558 FGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~----~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~l 631 (776)
||++..+..... .....+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+......+.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987643322 23346899999999999863 346678999999999999999999997754321111000000
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhh-cCCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRK-KFPAT-SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~-~~p~~-~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+. ........... ..+.. ........+..+.+||.+||+.||.+|||+.+|++.
T Consensus 255 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPS----------------LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCC----------------HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCc----------------hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 00000000000 00000 000011134568999999999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.76 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=204.2
Q ss_pred CCCeeEEeeeecCCceEEEEEE-----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRAR-----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~-----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++++.||+|+||.||+|+ +..++..||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--C
Confidence 3789999999999999999999 556788999999964321 1123456789999999999999999999954 4
Q ss_pred CeeEEEeeehh-hhhhhHHhhcc------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC---CcEEEe
Q 004049 487 DSIFMVMEYME-HDLKGLMETMK------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR---GELKIC 556 (776)
Q Consensus 487 ~~l~LVmEy~~-g~Ll~~l~~~~------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~---g~iKL~ 556 (776)
..+||||||+. ++|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.+ ..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 57899999996 46777766543 359999999999999999999999999999999999999944 469999
Q ss_pred ecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004049 557 DFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGT 633 (776)
Q Consensus 557 DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~ 633 (776)
|||++....... .......||+.|+|||++.+ ..++.++|||||||+||+|++ |.+||........+..+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 999997553221 22234577999999999987 568999999999999999998 99999988877766666443111
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
.....++..+.+||.+||..||.+|||+.+|++|.|+-
T Consensus 265 ------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 265 ------------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 01124788999999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.59 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=204.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECC---CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~---tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++|++.+.||+|+||+||+|.+.. ++..||+|++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECS---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcC---C
Confidence 34789999999999999999998653 3456999998754311 123457789999999999999999999843 3
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
..|+||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 56999999985 67777766667799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 567 PLK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 567 ~~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+......+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---------- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---------- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----------
T ss_pred ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC----------
Confidence 221 2233467889999999976 568999999999999999998 999998877776666554432111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 235 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 --------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 112378899999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=374.33 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=196.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEEC---CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDK---KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k---~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++|.+.+.||+|+||.||+|+++ .++..||||+++.... ......+.+|+.+|++++||||+++++++. ...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCC
Confidence 3468999999999999999999886 4677899999975421 122345779999999999999999999994 445
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 78999999974 77777766666899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||...+..+.+..+......+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-------- 270 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-------- 270 (373)
T ss_dssp --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC--------
T ss_pred CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 3221 122345778999999987 568999999999999999998 999999888777766654432111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....++..+.+||.+||..||.+|||+.+|++
T Consensus 271 ----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 ----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11237788999999999999999999998876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=363.24 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=204.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEE--EEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIV--ALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~V--AIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~ 487 (776)
..++|++.+.||+|+||.||+|+++.++..+ |||.++... .......+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~ 99 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 99 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--CC
Confidence 3478999999999999999999999888865 999887433 222345677899999999 89999999999954 45
Q ss_pred eeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG 551 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g 551 (776)
.+||||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 89999999975 6776665432 4799999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 004049 552 ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKT 630 (776)
Q Consensus 552 ~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~ 630 (776)
.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+....+...
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 9999999999754321 22234567889999999977 568999999999999999998 99999988776666554332
Q ss_pred cCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 631 LGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 631 lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.. +..+..++..+.+||.+||..||.+|||+.++|+|
T Consensus 258 ~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 YR------------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CC------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC------------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10 01122478899999999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.07 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=208.1
Q ss_pred CCCeeEEe-eeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLN-KIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~-~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|.+++ .||+|+||.||+|.++ .++..||||+++.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCC
Confidence 36788887 9999999999999864 4688899999976421 122345678999999999999999999983 246
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 8999999986 666666666677999999999999999999999999999999999999999999999999999876433
Q ss_pred CC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----------
T ss_pred cceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC----------
Confidence 22 1223456899999999986 568999999999999999998 99999988777766655442110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPw 705 (776)
..+..+++.+.+||.+||..||.+|||+.++++|.+
T Consensus 233 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 233 --------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011247899999999999999999999999998853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.45 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=204.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEE-----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~-----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||+||+|.+ ..+++.||||++...... .....+.+|+.+|..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 457789999999754321 1224567899999999 699999999998543
Q ss_pred CCeeEEEeeehhh-hhhhHHhhccC---------------CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMKQ---------------PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN 549 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~~---------------~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~ 549 (776)
...+|+||||+.+ +|..++..... .+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3468999999985 66666655432 2899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004049 550 RGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDK 626 (776)
Q Consensus 550 ~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~k 626 (776)
++.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999987643322 1234567899999999987 568999999999999999998 9999987665444333
Q ss_pred HHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 627 IFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 627 I~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..... ...+..+++.+.+||.+||..||.+|||+.+|++|
T Consensus 263 ~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCcc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3322111 01122378899999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=380.37 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=192.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+.|.+.+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+.+|..+ +|||||++++++. ....+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEE
Confidence 34666788999999999876 44679999999986543 23457899999876 8999999999984 4458999
Q ss_pred EeeehhhhhhhHHhhccCC------CCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC-------------Cc
Q 004049 492 VMEYMEHDLKGLMETMKQP------FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR-------------GE 552 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~------Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~-------------g~ 552 (776)
|||||.|+|.+++...... +++..++.++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999999888887654321 2344567899999999999999999999999999999754 48
Q ss_pred EEEeecccccccCCCCC----CccccccccccCCchhhcc------CCCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 004049 553 LKICDFGLARQYGSPLK----PYTHLVVTLWYRAPELLLG------SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEF 621 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~~----~~~~~~GT~~Y~APEvl~g------~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~ 621 (776)
+||+|||++........ .....+||+.|+|||++.+ ...++.++|||||||+||+|++ |.+||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987754322 1234689999999999975 2458999999999999999999 99999765433
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004049 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL 701 (776)
Q Consensus 622 ~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL 701 (776)
. ..++......... .......++..+.+||.+||+.||.+|||+.+||
T Consensus 247 ~--~~i~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 247 E--SNIIRGIFSLDEM------------------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp H--HHHHHTCCCCCCC------------------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred H--HHHhcCCCCcccc------------------------------cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 2 2333332111100 0001112567899999999999999999999999
Q ss_pred cCcCcCC
Q 004049 702 NHDWFRE 708 (776)
Q Consensus 702 ~HPwf~~ 708 (776)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=351.45 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
-.|.+.+.||+|+||+||+|.+..++. .||+|++...... .....+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCc
Confidence 357788999999999999999765544 7999998643221 12345678999999999999999999995443 345
Q ss_pred EEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC-
Q 004049 490 FMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567 (776)
Q Consensus 490 ~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~- 567 (776)
|+||||+. ++|..++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 89999996 5677777766778999999999999999999999999999999999999999999999999999765321
Q ss_pred ---CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 ---LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ---~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--------- 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP--------- 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---------
T ss_pred ccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---------
Confidence 122344578999999999987 568999999999999999999 566677666666555554332111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.++++.
T Consensus 249 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 249 ---------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 122478899999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=361.44 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=205.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEEC-------CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDK-------KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k-------~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~ 483 (776)
.++|++++.||+|+||.||+|.+. .++..||||++...... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 378999999999999999999975 46788999999754321 1234567899999999 8999999999994
Q ss_pred cCCCeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
....+|+||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 112 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 112 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp -SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred -cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 44588999999986 6666665433 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 004049 548 NNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQL 624 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l 624 (776)
+.++.+||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+....+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987643321 1233467889999999987 568999999999999999999 99999988777766
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+......+ .+..++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMD------------------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCC------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC------------------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6654432110 112378899999999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=353.45 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
....|++.+.||+|+||+||+|.+..+ ...||+|.+...... .....+.+|+.+++.++||||+++++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CC
Confidence 446799999999999999999997543 346899988643211 1234567899999999999999999986543 45
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 78999999987 77777766667799999999999999999999999999999999999999999999999999986543
Q ss_pred CC----CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 567 PL----KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 567 ~~----~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-------
Confidence 21 12334567889999999987 568999999999999999999 778888777766666554432111
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.++++.
T Consensus 253 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 253 -----------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp -----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112378899999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=361.16 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=206.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCc-----EEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGE-----IVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSN 485 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~-----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~ 485 (776)
.++|++.+.||+|+||.||+|.+..++. .||+|++...... .....+.+|+.+|+.+ +||||+++++++. .
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACT--H 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--c
Confidence 4789999999999999999999977664 7999999754321 1234567899999999 8999999999994 4
Q ss_pred CCeeEEEeeehhh-hhhhHHhhc-------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETM-------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG 551 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~-------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g 551 (776)
...+|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 4578999999986 676666543 34689999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 004049 552 ELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIF 628 (776)
Q Consensus 552 ~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~ 628 (776)
.+||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+......+..+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 999999999986533221 1234567889999999987 568999999999999999998 999998876655555554
Q ss_pred HhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 629 ~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.....+ ..+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 281 ~~~~~~-----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQM-----------------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-----------------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 432111 1122368899999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=365.48 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=203.7
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
....++|++.+.||+|+||+||+|.++ +++.||||++..... .....+.+|+.+|+.++||||+++++++. ....
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 109 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCD--ERNE 109 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECC--CTTC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCe
Confidence 345689999999999999999999864 689999998865422 22345678999999999999999999984 4558
Q ss_pred eEEEeeehhh-hhhhHHhhcc---CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 489 IFMVMEYMEH-DLKGLMETMK---QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~---~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
+|+||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 8999999986 5655554332 35999999999999999999999999999999999999999999999999999865
Q ss_pred CCC--CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH---HHh--cCCCCCC
Q 004049 565 GSP--LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKI---FKT--LGTPNEK 637 (776)
Q Consensus 565 ~s~--~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI---~~~--lg~p~~~ 637 (776)
... ........||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....+....+ ... .+.....
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred ccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 322 122344578999999999987 56899999999999999999999999765432221111 000 0000000
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
.. +.......+..+..+.+||.+||..||.+|||+.++|+|-
T Consensus 269 ~~-------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 269 VD-------------------------PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SS-------------------------SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cC-------------------------hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00 0000011123556788999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=360.54 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=201.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..+|.+.+.||+|+||+||+|.++.++ ..||||++..... ......+.+|+.+++.++||||+++++++. ...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cCC
Confidence 468999999999999999999987553 4699999975431 112345678999999999999999999994 456
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 89999999986 67777766667899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.... .....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||...+..+.+..+......+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-------- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-------- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------
T ss_pred ccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC--------
Confidence 2211 122356788999999987 568999999999999999998 999998888777766664432111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 271 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112378899999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=362.62 Aligned_cols=263 Identities=19% Similarity=0.172 Sum_probs=197.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC---CCcEEEEEEeecchhc---------cCCccchHHHHHHHHhCCCCCcceeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK---TGEIVALKKVKMEKER---------EGFPLTSLREINILLSFHHPSIVDVKE 479 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~---tg~~VAIK~i~~~~~~---------~~~~~~~~rEi~iL~~L~HPnIV~l~~ 479 (776)
.++|++++.||+|+||.||+|.+.. ++..||||++...... ......+.+|+.++..+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999998754311 112234567889999999999999999
Q ss_pred EEecc--CCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC--cEEE
Q 004049 480 VVVGS--NLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG--ELKI 555 (776)
Q Consensus 480 ~~~~~--~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g--~iKL 555 (776)
++... ....+||||||+.++|..++... ..|++.+++.|+.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98652 24589999999966676666554 3899999999999999999999999999999999999999887 9999
Q ss_pred eecccccccCCCC-------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 004049 556 CDFGLARQYGSPL-------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSE-FDQLDKI 627 (776)
Q Consensus 556 ~DFGlA~~~~s~~-------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~-~~~l~kI 627 (776)
+|||+++.+.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... ...+..+
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999998663211 12245689999999999987 5689999999999999999999999965322 2222222
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
....... ....+....+ ...++..+.+||.+||..||.+|||+.+|++.
T Consensus 274 ~~~~~~~---------------------~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDE---------------------LPQSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHT---------------------TTHHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhccc---------------------ccHHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1110000 0000111111 12488999999999999999999999998875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.02 Aligned_cols=256 Identities=16% Similarity=0.171 Sum_probs=201.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC--------CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcce-------
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT--------GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD------- 476 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t--------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~------- 476 (776)
.++|++++.||+|+||.||+|+++.+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 37899999999999999999999874 889999998743 35779999999999999998
Q ss_pred --------eeEEEeccCCCeeEEEeeehhhhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 477 --------VKEVVVGSNLDSIFMVMEYMEHDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 477 --------l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
+++++... ...+||||||+.++|..++... ...|++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 55565432 4588999999977888777654 3679999999999999999999999999999999999999
Q ss_pred cCCC--cEEEeecccccccCCCCC-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 004049 548 NNRG--ELKICDFGLARQYGSPLK-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK 618 (776)
Q Consensus 548 d~~g--~iKL~DFGlA~~~~s~~~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~ 618 (776)
+.++ .+||+|||++..+..... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999976542211 2234589999999999987 56899999999999999999999999876
Q ss_pred C-hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004049 619 S-EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697 (776)
Q Consensus 619 s-~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa 697 (776)
. ....+..+...+......+.. .......++..+.+||.+||..||.+|||+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 324 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVG---------------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPY 324 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEEC---------------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred CcCHHHHHHHHHhccCChhhhhh---------------------------hccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence 4 233332222211111000000 000112378999999999999999999999
Q ss_pred HHHHcC
Q 004049 698 EAALNH 703 (776)
Q Consensus 698 ~EIL~H 703 (776)
.+|++.
T Consensus 325 ~~l~~~ 330 (352)
T 2jii_A 325 AMLRNN 330 (352)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=360.81 Aligned_cols=272 Identities=22% Similarity=0.267 Sum_probs=203.7
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
...++|++.+.||+|+||.||+|.+ .+++.||||++....... ....+.+|+.+++.+.||||+++++++.. ....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCC
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec--CCce
Confidence 3558899999999999999999975 468999999997654322 23457899999999999999999999954 4578
Q ss_pred EEEeeehhh-hhhhHHhhcc---CCCCHHHHHHHHHHHHHHhhhhccC---CcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 490 FMVMEYMEH-DLKGLMETMK---QPFSQSEVKCLMLQLLEGIKYLHDN---WVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~---~~Lse~~~~~i~~qIl~aL~yLHs~---gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
|+||||+.+ +|..++.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999986 5666665432 3499999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCCCC
Q 004049 563 QYGSPLK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK----SEFDQLDKIFKTLGTPNEK 637 (776)
Q Consensus 563 ~~~s~~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~----s~~~~l~kI~~~lg~p~~~ 637 (776)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .....+...+..... ..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 259 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--EK 259 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS--SC
T ss_pred ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh--ch
Confidence 7643322 2334569999999999987 55899999999999999999999999521 111111111111100 00
Q ss_pred CCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 638 ~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
....+. . ...........+..+.+||.+||+.||.+|||+.+||+|-+-..
T Consensus 260 ~~~~~~---~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 260 KLEALV---D-----------------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CSTTSS---C-----------------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhhhhc---C-----------------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000000 0 00000111224567899999999999999999999999976543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=357.99 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=200.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc--CCCee
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS--NLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~--~~~~l 489 (776)
.++|++++.||+|+||.||+|.++.+++.||||++...... ....+.+|+.+++.++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH--HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH--HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36899999999999999999999999999999998653321 234567899999999999999999998632 34578
Q ss_pred EEEeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccC
Q 004049 490 FMVMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG 565 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~ 565 (776)
|+||||+.+ +|..++.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999996 66666654 35679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC---------ccccccccccCCchhhccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC
Q 004049 566 SPLKP---------YTHLVVTLWYRAPELLLGSK--QYSTAIDMWSLGCIMAELLSKEPLFNGKSEF-DQLDKIFKTLGT 633 (776)
Q Consensus 566 s~~~~---------~~~~~GT~~Y~APEvl~g~~--~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~-~~l~kI~~~lg~ 633 (776)
..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... ..+......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence 21110 12345799999999987532 3688999999999999999999999531100 001111110
Q ss_pred CCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 634 PNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 634 p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
...+...+.++..+.+||.+||+.||.+|||+.++++|-
T Consensus 263 --------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 --------------------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --------------------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 001112235789999999999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.12 Aligned_cols=247 Identities=21% Similarity=0.371 Sum_probs=204.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+|+.++||||+++++++. .+.+|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEE
Confidence 378999999999999999999975 567899999865432 2345778999999999999999999984 235899
Q ss_pred Eeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+.+ +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999975 6666655432 3699999999999999999999999999999999999999999999999999987643221
Q ss_pred -CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--------------
Confidence 1233456889999999986 568999999999999999999 99999988877776666443111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.++++
T Consensus 230 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 ----------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011247889999999999999999999999886
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=381.82 Aligned_cols=253 Identities=16% Similarity=0.201 Sum_probs=196.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCC-CCccee------------
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHH-PSIVDV------------ 477 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~H-PnIV~l------------ 477 (776)
...|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.|.| +|+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4568999999999999999999999999999999874332 22334567789999999987 322111
Q ss_pred ---------eEEEeccC---CCeeEEEeeehhhhhhhHHhh------ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCC
Q 004049 478 ---------KEVVVGSN---LDSIFMVMEYMEHDLKGLMET------MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRD 539 (776)
Q Consensus 478 ---------~~~~~~~~---~~~l~LVmEy~~g~Ll~~l~~------~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrD 539 (776)
..++.... ...+|++|+++.++|.+++.. ....+++..++.++.||+.||.|||++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 234788999999988887742 244588899999999999999999999999999
Q ss_pred CCCCCeeecCCCcEEEeecccccccCCCCCCccccccccccCCchhhc---------cCCCCCccchhhhHHHHHHHHHh
Q 004049 540 LKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL---------GSKQYSTAIDMWSLGCIMAELLS 610 (776)
Q Consensus 540 LKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~---------g~~~ys~~sDVWSLGvlLyELLt 610 (776)
|||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||+||+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999999876433 445678 9999999994 33458889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 004049 611 KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYD 690 (776)
Q Consensus 611 G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~D 690 (776)
|..||.+.+.......+ +.....++..+.+||.+||..|
T Consensus 313 g~~Pf~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~li~~~l~~d 351 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI-----------------------------------------FRSCKNIPQPVRALLEGFLRYP 351 (413)
T ss_dssp SSCCCCTTGGGSCSGGG-----------------------------------------GSSCCCCCHHHHHHHHHHTCSS
T ss_pred CCCCCCCcchhhhHHHH-----------------------------------------HhhcccCCHHHHHHHHHHccCC
Confidence 99999765432221111 1111247899999999999999
Q ss_pred CCCCCCHHHHHcCcCcCCC
Q 004049 691 PDKRITAEAALNHDWFREV 709 (776)
Q Consensus 691 P~kRpTa~EIL~HPwf~~i 709 (776)
|.+|||+.++|+||||+.+
T Consensus 352 P~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 352 KEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp GGGSCCHHHHTTSHHHHHH
T ss_pred hhhCcCHHHHHhCHHHHHH
Confidence 9999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.27 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=198.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECC-CCc--EEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKK-TGE--IVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~-tg~--~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||+||+|.+.. ++. .||||+++..... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4789999999999999999998643 333 6899998754322 22234567899999999999999999999543
Q ss_pred eeEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+++||||+. ++|...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 4799999998 477777776667799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 322 1233567889999999987 568999999999999999999 999999988877776664431111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1122478999999999999999999999999973
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=381.31 Aligned_cols=249 Identities=20% Similarity=0.340 Sum_probs=208.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.++.++..||||+++.... ....+.+|+.+|+.|+||||+++++++.. ...+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 4689999999999999999999999999999999975432 24567899999999999999999999944 457899
Q ss_pred Eeeehh-hhhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 492 VMEYME-HDLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 492 VmEy~~-g~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||||+. |+|..++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999998 5677777653 3569999999999999999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+....+..+.....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 11223456789999999987 568999999999999999999 9999988876666555533211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..++..+.+||.+||+.||.+|||+.+|++
T Consensus 438 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1112347899999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=371.95 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|++++||||+++++++... ...+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 4578999999999999999999885 7799999997543 345678999999999999999999998543 34789
Q ss_pred EEeeehhh-hhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999985 77777766543 3799999999999999999999999999999999999999999999999999865322
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+.+..+.+..+......
T Consensus 343 --~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 405 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--------------
T ss_pred --ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 223467899999999987 568999999999999999998 99999887776666665443111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 406 ----------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 ----------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112347899999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.10 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=193.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHh--CCCCCcceeeEEEecc--CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS--FHHPSIVDVKEVVVGS--NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPnIV~l~~~~~~~--~~~ 487 (776)
.++|++++.||+|+||+||+|.+ +++.||||++.... ...+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 47899999999999999999987 58999999986542 2334567777776 7899999999987542 335
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc--------cCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH--------DNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH--------s~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
.+|+||||+.+ +|..++. ...+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 68999999986 6666663 357999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCC----ccccccccccCCchhhccCC-----CCCccchhhhHHHHHHHHHhC----------CCCCCCCC
Q 004049 559 GLARQYGSPLKP----YTHLVVTLWYRAPELLLGSK-----QYSTAIDMWSLGCIMAELLSK----------EPLFNGKS 619 (776)
Q Consensus 559 GlA~~~~s~~~~----~~~~~GT~~Y~APEvl~g~~-----~ys~~sDVWSLGvlLyELLtG----------~~PF~~~s 619 (776)
|++......... ....+||+.|+|||++.+.. .++.++|||||||++|+|++| .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765433221 23358999999999998743 345799999999999999999 78885432
Q ss_pred h----HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 004049 620 E----FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI 695 (776)
Q Consensus 620 ~----~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp 695 (776)
. ...+..+....... +. ++.. .....++..+.+||.+||..||.+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-----~~----------------------~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rp 288 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQR-----PN----------------------IPNR--WFSDPTLTSLAKLMKECWYQNPSARL 288 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCC-----CC----------------------CCGG--GGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred CCCcchhhhhHHHhccCCC-----CC----------------------CChh--hccCccHHHHHHHHHHHhhcChhhCC
Confidence 2 22222222111100 00 0000 00112457889999999999999999
Q ss_pred CHHHHHcC
Q 004049 696 TAEAALNH 703 (776)
Q Consensus 696 Ta~EIL~H 703 (776)
|+.+|++.
T Consensus 289 s~~~i~~~ 296 (301)
T 3q4u_A 289 TALRIKKT 296 (301)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.20 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=196.4
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|.+. ++.||||+++... ....+.+|+.+++.++||||+++++++... ...+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceE
Confidence 3578999999999999999999874 8899999986432 345677899999999999999999987543 34789
Q ss_pred EEeeehhh-hhhhHHhhccC-CCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQ-PFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~-~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||+.+ +|..++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999986 77776655432 3899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 171 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 232 (278)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------------
T ss_pred --ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 233467899999999987 568999999999999999998 9999988776665555432210
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..+++.+.+||.+||..||.+|||+.++++
T Consensus 233 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 ---------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 1112347889999999999999999999999885
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.57 Aligned_cols=242 Identities=29% Similarity=0.453 Sum_probs=189.4
Q ss_pred ccCCCeeEE-eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHH-HhCCCCCcceeeEEEec--cC
Q 004049 410 RSVDEFERL-NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINIL-LSFHHPSIVDVKEVVVG--SN 485 (776)
Q Consensus 410 ~~~~~yeil-~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL-~~L~HPnIV~l~~~~~~--~~ 485 (776)
..+++|.++ +.||+|+||.||+|.++.+++.||||++... ....+|+.++ +.+.||||+++++++.. ..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 456889998 7899999999999999999999999999642 3456888888 66689999999999854 23
Q ss_pred CCeeEEEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeeccc
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGL 560 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGl 560 (776)
...+||||||+.| +|..++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 4578999999986 7777776543 46999999999999999999999999999999999999998 78999999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
+..... ..|+.++|||||||+||+|++|.+||.+.........+... ...
T Consensus 167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-------~~~ 216 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------IRM 216 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-------SCT
T ss_pred cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-------Hhh
Confidence 865421 34788999999999999999999999776443221110000 000
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
. .. .++. .....++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 217 ~-------~~------------~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 217 G-------QY------------EFPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp T-------CC------------SSCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred c-------cc------------cCCc---hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0 00 0000 00124789999999999999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.87 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=204.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceE
Confidence 45889999999999999999999864 39999998765555555677789999999999999999999954 44799
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC---
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS--- 566 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s--- 566 (776)
+||||+.| +|..++......+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999985 66666666556799999999999999999999999999999999999998 68999999999875431
Q ss_pred --CCCCccccccccccCCchhhcc--------CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 004049 567 --PLKPYTHLVVTLWYRAPELLLG--------SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNE 636 (776)
Q Consensus 567 --~~~~~~~~~GT~~Y~APEvl~g--------~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~ 636 (776)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+..+.......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 262 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN-- 262 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--
Confidence 1122344578999999999975 2357889999999999999999999999888777666654431110
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.....++..+.+||.+||..||.+|||+.++++.
T Consensus 263 ---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 ---------------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp ---------------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred ---------------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0011367788999999999999999999999973
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=370.26 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=207.1
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++.+.||+|+||+||+|.+. ++..||||+++... .....+.+|+.+|+.|+||||+++++++. ...+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccE
Confidence 3478999999999999999999985 46789999997543 22456789999999999999999999984 34689
Q ss_pred EEeeehhh-hhhhHHhhcc-CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMK-QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~-~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||+.+ +|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999985 6777765432 368999999999999999999999999999999999999999999999999998764321
Q ss_pred -CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.......+|+.|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+.+..+......+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------ 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------ 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------
T ss_pred eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 11223456788999999986 568999999999999999999 999999988887777765542211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||..||.+|||+.+|+.
T Consensus 406 ------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11247889999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=349.17 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=193.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+|+.+|+.++||||+++++++. +.+|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEE
Confidence 468999999999999999999885 7889999986432 2345778999999999999999999873 34799
Q ss_pred Eeeehhh-hhhhHHhhccC--CCCHHHHHHHHHHHHHHhhhhcc---CCcccCCCCCCCeeecCCCc-EEEeeccccccc
Q 004049 492 VMEYMEH-DLKGLMETMKQ--PFSQSEVKCLMLQLLEGIKYLHD---NWVLHRDLKTSNLLLNNRGE-LKICDFGLARQY 564 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~--~Lse~~~~~i~~qIl~aL~yLHs---~gIvHrDLKPeNILLd~~g~-iKL~DFGlA~~~ 564 (776)
||||+.| +|..++..... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999986 66666654332 48999999999999999999999 89999999999999998886 799999999865
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF--DQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~--~~l~kI~~~lg~p~~~~wp~~ 642 (776)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+... ..
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~-------- 222 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--TR-------- 222 (307)
T ss_dssp -----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--CC--------
T ss_pred ccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--CC--------
Confidence 432 234579999999999987 56899999999999999999999999754322 222222111 00
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC-----cCcCCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH-----DWFREVPL 711 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H-----Pwf~~i~~ 711 (776)
......++..+.+||.+||..||.+|||+.+++++ .+|.....
T Consensus 223 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 223 --------------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp --------------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred --------------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 00112478899999999999999999999999984 56655443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.42 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=195.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..|++.+.||+|+||+||+|.+..+ +..||+|.++... .......+.+|+.+|+.++||||+++++++... ...+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCe
Confidence 4589999999999999999987543 3468999886432 112234577899999999999999999987543 3478
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999986 7777776666779999999999999999999999999999999999999999999999999998653321
Q ss_pred C----CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 569 K----PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 569 ~----~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
. ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||...+..+....+......
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---------- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC----------
T ss_pred cccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 1 1233567889999999987 568999999999999999999 78899877666655555432110
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 316 --------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 --------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122478899999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=385.79 Aligned_cols=243 Identities=26% Similarity=0.352 Sum_probs=199.0
Q ss_pred eeeecCCceEEEEEEE--CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARD--KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~--k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
+.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.|+|||||++++++.. ..+||||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 4899999999999955 4667899999998765444445678899999999999999999999842 3589999999
Q ss_pred hhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC---Ccc
Q 004049 497 EHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK---PYT 572 (776)
Q Consensus 497 ~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~---~~~ 572 (776)
.++ |..++ .....+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 452 ~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 452 ELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp TTEEHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCCCHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 865 54544 4566799999999999999999999999999999999999999999999999999987643322 223
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
...+|+.|+|||++.+ ..|+.++|||||||+||+|++ |..||.+.+..+.+..+......+
T Consensus 531 ~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------- 592 (635)
T 4fl3_A 531 HGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG----------------- 592 (635)
T ss_dssp ----CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------------
T ss_pred CCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 3456889999999987 568999999999999999998 999999988877777665432110
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
.+..++..+.+||.+||..||.+|||+.+|++
T Consensus 593 -------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11247899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.27 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=199.6
Q ss_pred eeEEeeeecCCceEEEEEEE----CCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 415 FERLNKIDEGTYGVVYRARD----KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~----k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
|++++.||+|+||+||++.. ..+++.||||+++.... ......+.+|+.+|+.++||||+++++++.......+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 59999999999999988754 45789999999975431 11234567899999999999999999999776667899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
+||||+.+ +|..++.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 99999986 56665543 3599999999999999999999999999999999999999999999999999987754322
Q ss_pred ---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 570 ---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 570 ---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+. ...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~---~~~------------ 251 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELI---GIA------------ 251 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHH---CSC------------
T ss_pred ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhh---ccc------------
Confidence 1234567889999999987 568899999999999999999999996532211 0000 000
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
....... .....+.. ......+..++..+.+||.+||..||.+|||+.+|++
T Consensus 252 ~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 252 QGQMTVL-RLTELLER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHH-HHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHH-HHHHHHhc---ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000000 00011111 1112234468999999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.96 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=199.1
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh--ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
|...+.||+|+||.||+|.+ ++..||||++..... .......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 44458999999999999986 578999999865432 12223456789999999999999999999944 4578999
Q ss_pred eeehhh-hhhhHHhhc--cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 493 MEYMEH-DLKGLMETM--KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~--~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 999975 666666533 34699999999999999999999999999999999999999999999999999987643222
Q ss_pred C--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 P--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+..........
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 256 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT---------- 256 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC----------
T ss_pred cccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh----------
Confidence 1 234578999999999876 47899999999999999999999998765544333333321111000
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+...+...........+..+.+||.+||..||.+|||+.+++++
T Consensus 257 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 257 ------------IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ------------HHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------hhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000000001122355678899999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=369.00 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=204.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++.. ..+||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 4789999999999999999999875 46799999975432 23467899999999999999999999843 46899
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||||+.+ +|.+++... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999985 677776543 3569999999999999999999999999999999999999999999999999998764321
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+.+..+......+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 401 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 401 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 12233456889999999987 568999999999999999999 999999988877777665432111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC--cCcCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH--DWFRE 708 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H--Pwf~~ 708 (776)
.+..++..+.+||.+||..||.+|||+.+|++. .+|..
T Consensus 402 -----------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 122478899999999999999999999999863 56654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=371.41 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=202.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.|.|++++..+.+|. ......||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFG-VEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEE-EETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEE-eeCCEEEE
Confidence 4789999999999999999999999999999998865432 345789999999998755554444443 23457899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee---cCCCcEEEeecccccccCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL---d~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||+.++|.+++......|++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999888888888777889999999999999999999999999999999999999 688999999999998765432
Q ss_pred C-------CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCC
Q 004049 569 K-------PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEF---DQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 569 ~-------~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~---~~l~kI~~~lg~p~~~~ 638 (776)
. .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.... ..+.++.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------ 233 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------ 233 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH------
T ss_pred cccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc------
Confidence 2 1235789999999999987 56899999999999999999999999875443 23333322100
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
......+ ...++.++.+||..||..||.+||++.+|++
T Consensus 234 ---------------~~~~~~l-----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 ---------------ATSIEAL-----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ---------------HSCHHHH-----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------------cccHHHH-----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000000 0137889999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.85 Aligned_cols=278 Identities=25% Similarity=0.335 Sum_probs=191.9
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHH--HHhCCCCCcceeeEEEe---ccC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINI--LLSFHHPSIVDVKEVVV---GSN 485 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~i--L~~L~HPnIV~l~~~~~---~~~ 485 (776)
.+++|++++.||+|+||.||+|.+ +++.||||++..... ..+..|..+ +..+.||||+++++++. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 458999999999999999999976 689999999975432 223334444 45589999999997553 233
Q ss_pred CCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC---------CcccCCCCCCCeeecCCCcEEE
Q 004049 486 LDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN---------WVLHRDLKTSNLLLNNRGELKI 555 (776)
Q Consensus 486 ~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~---------gIvHrDLKPeNILLd~~g~iKL 555 (776)
...+||||||+.+ +|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4467999999975 66666644 3469999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCC--------CCCccccccccccCCchhhccC------CCCCccchhhhHHHHHHHHHhCCCCCC-CCCh
Q 004049 556 CDFGLARQYGSP--------LKPYTHLVVTLWYRAPELLLGS------KQYSTAIDMWSLGCIMAELLSKEPLFN-GKSE 620 (776)
Q Consensus 556 ~DFGlA~~~~s~--------~~~~~~~~GT~~Y~APEvl~g~------~~ys~~sDVWSLGvlLyELLtG~~PF~-~~s~ 620 (776)
+|||++..+... .......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||. +...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 999999876432 1222345799999999999762 346678999999999999999966553 3221
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 621 ~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
......+....+.. +..............+..++. .+.....++..+.+||.+||..||.+|||+.||
T Consensus 242 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 242 PEYQMAFQTEVGNH-----------PTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp CCCCCTTHHHHCSS-----------CCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hHHHHhhhcccCCC-----------chHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 11000000000000 000000000000000111111 111223355689999999999999999999999
Q ss_pred ------HcCcCcCCC
Q 004049 701 ------LNHDWFREV 709 (776)
Q Consensus 701 ------L~HPwf~~i 709 (776)
|.++|-+.-
T Consensus 310 l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 310 EERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHHHCCCC--
T ss_pred HHHHHHHHHHHHhcc
Confidence 556777653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=351.60 Aligned_cols=268 Identities=24% Similarity=0.396 Sum_probs=204.3
Q ss_pred CCCeeEEeeeecCCceEEEEEE----ECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRAR----DKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~----~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..+|++++.||+|+||.||+|. +..+++.||||++.... ......+.+|+.+|+.++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4679999999999999999998 46689999999997532 11234567899999999999999999998766556
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|+||||+.+ +|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 78999999985 77777777667799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 567 PLKP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 567 ~~~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... .....+|..|+|||++.+ ..++.++|||||||+||+|++|..||.... ..+ ....+.....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~~~------ 265 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDKQG------ 265 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTCCT------
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhccccch------
Confidence 3221 223467888999999987 458999999999999999999999986431 111 1111111000
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
. .........+... .....+..++..+.+||.+||..||.+|||+.+|++
T Consensus 266 -----~-~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 266 -----Q-MIVFHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp -----H-HHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----h-hhHHHHHHHhhcC---CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000001111111 111223458899999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=361.42 Aligned_cols=251 Identities=20% Similarity=0.235 Sum_probs=192.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc------cCCccchHHHHHHHHhCC---------CCCcc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER------EGFPLTSLREINILLSFH---------HPSIV 475 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~------~~~~~~~~rEi~iL~~L~---------HPnIV 475 (776)
..++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|+.|+ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 347899999999999999999998 6899999999765421 112245678999999886 77777
Q ss_pred eeeEEEecc----------------------------CCCeeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHH
Q 004049 476 DVKEVVVGS----------------------------NLDSIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEG 526 (776)
Q Consensus 476 ~l~~~~~~~----------------------------~~~~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~a 526 (776)
++++++... ....+||||||+.++ ++..+.. ..+++.+++.|+.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 766654311 146899999999754 6666643 569999999999999999
Q ss_pred hhhhc-cCCcccCCCCCCCeeecCCC--------------------cEEEeecccccccCCCCCCccccccccccCCchh
Q 004049 527 IKYLH-DNWVLHRDLKTSNLLLNNRG--------------------ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585 (776)
Q Consensus 527 L~yLH-s~gIvHrDLKPeNILLd~~g--------------------~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEv 585 (776)
|.||| ++|||||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhh
Confidence 99999 99999999999999999887 899999999987643 24589999999999
Q ss_pred hccCCCCCccchhhhHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhc
Q 004049 586 LLGSKQYSTAIDMWSLGCI-MAELLSKEPLFNGKSE-FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKK 663 (776)
Q Consensus 586 l~g~~~ys~~sDVWSLGvl-LyELLtG~~PF~~~s~-~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~ 663 (776)
+.+.. +.++|||||+++ ++++++|..||..... ......++..........
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------- 301 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN------------------------- 301 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCC-------------------------
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccc-------------------------
Confidence 98743 889999998777 7789999999954211 112333332211110000
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH-cCcCcC
Q 004049 664 FPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL-NHDWFR 707 (776)
Q Consensus 664 ~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL-~HPwf~ 707 (776)
....+.+++++++||.+||++| ||.|+| +||||+
T Consensus 302 -----~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 -----TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp -----SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred -----hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0001126789999999999987 999999 999995
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=380.45 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=204.2
Q ss_pred CCeeEEe-eeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLN-KIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~-~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|.+.+ .||+|+||.||+|.++ .++..||||+++... .......+.+|+.+|+.|+|||||++++++.. +.+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCe
Confidence 5566666 8999999999999875 356779999997543 22234567899999999999999999999853 368
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.+ +|..++......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999986 5666666666779999999999999999999999999999999999999999999999999998764322
Q ss_pred CC---ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 KP---YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~~---~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. .....+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..|......
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------- 558 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 558 (613)
T ss_dssp -----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-----------
T ss_pred ceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 21 122345689999999987 568999999999999999998 99999998887777766543111
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH---cCcCcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAAL---NHDWFR 707 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL---~HPwf~ 707 (776)
..+..+++.+.+||.+||..||.+|||+.+|+ ++.|+.
T Consensus 559 -------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11224789999999999999999999999874 455543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.05 Aligned_cols=244 Identities=17% Similarity=0.185 Sum_probs=192.8
Q ss_pred CCCeeEEeeeecCCceEEEEE-----EECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC---CCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRA-----RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH---HPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla-----~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~ 483 (776)
.++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.++..++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 378999999999999999999 467789999999996542 335678889998887 9999999999954
Q ss_pred cCCCeeEEEeeehhh-hhhhHHhh----ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---------
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLMET----MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--------- 549 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~~----~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--------- 549 (776)
.+.+||||||+.| +|.+++.. ....|++.+++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 4578999999984 66666654 3456999999999999999999999999999999999999998
Q ss_pred --CCcEEEeecccccccC--CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 004049 550 --RGELKICDFGLARQYG--SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLD 625 (776)
Q Consensus 550 --~g~iKL~DFGlA~~~~--s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~ 625 (776)
++.+||+|||+|..+. .........+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 8999999999997543 22234456789999999999988 458999999999999999999999995432110
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
|. +...+. ....++.+.+||..||..+|.+|++..+.|.+.
T Consensus 293 -------------~~-------------------~~~~~~------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 -------------CK-------------------PEGLFR------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp -------------EE-------------------ECSCCT------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred -------------ee-------------------echhcc------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00 000000 012466788999999999999997665555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.50 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=189.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhC--CCCCcceeeEEEeccCC--
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF--HHPSIVDVKEVVVGSNL-- 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L--~HPnIV~l~~~~~~~~~-- 486 (776)
..++|++++.||+|+||.||+|.+. ++.||||++..... ....+|.+++..+ +||||+++++++.....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3478999999999999999999885 89999999864432 2334566666554 89999999999865432
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccC--------CcccCCCCCCCeeecCCCcEEEee
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDN--------WVLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~--------gIvHrDLKPeNILLd~~g~iKL~D 557 (776)
..+||||||+.+ +|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 578999999986 67666644 4699999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCC----ccccccccccCCchhhccCCCCCc------cchhhhHHHHHHHHHhC----------CCCCCC
Q 004049 558 FGLARQYGSPLKP----YTHLVVTLWYRAPELLLGSKQYST------AIDMWSLGCIMAELLSK----------EPLFNG 617 (776)
Q Consensus 558 FGlA~~~~s~~~~----~~~~~GT~~Y~APEvl~g~~~ys~------~sDVWSLGvlLyELLtG----------~~PF~~ 617 (776)
||++..+...... ....+||+.|+|||++.+.. +.. ++|||||||+||+|++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999766433222 23468999999999998743 343 49999999999999999 455533
Q ss_pred CCh----HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 004049 618 KSE----FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDK 693 (776)
Q Consensus 618 ~s~----~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~k 693 (776)
... ...+..+..... ....++. ......++..+.+||.+||+.||.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~ 315 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKK---------------------------LRPSFPN--RWSSDECLRQMGKLMTECWAHNPAS 315 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSC---------------------------CCCCCCG--GGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred hcCCCCchhhhHHHHhhhc---------------------------cCccccc--cchhhHHHHHHHHHHHHhhhhChhh
Confidence 211 111111111000 0000000 0001135677899999999999999
Q ss_pred CCCHHHHHcC
Q 004049 694 RITAEAALNH 703 (776)
Q Consensus 694 RpTa~EIL~H 703 (776)
|||+.+|++|
T Consensus 316 Rps~~ell~~ 325 (337)
T 3mdy_A 316 RLTALRVKKT 325 (337)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 9999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=373.74 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=208.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++.. ..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence 4789999999999999999999875 46799999975432 23467899999999999999999999843 46899
Q ss_pred Eeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 492 VMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||||+.+ +|.+++... ...+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999985 677776543 3569999999999999999999999999999999999999999999999999998664211
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......+|..|+|||++.+ ..++.++|||||||+||+|++ |..||.+....+.+..+......+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 11223456789999999987 568999999999999999999 999999988877777664432111
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC--cCcCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH--DWFRE 708 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H--Pwf~~ 708 (776)
.+..++..+.+||.+||..||.+|||+.+|++. .+|..
T Consensus 485 -----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 -----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 112478899999999999999999999999864 55543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.24 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=196.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHh--CCCCCcceeeEEEeccCC--
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS--FHHPSIVDVKEVVVGSNL-- 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPnIV~l~~~~~~~~~-- 486 (776)
..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.++.. ++||||+++++++.....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 347899999999999999999988 48999999996432 2345688999888 789999999999865432
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc--------cCCcccCCCCCCCeeecCCCcEEEee
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH--------DNWVLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH--------s~gIvHrDLKPeNILLd~~g~iKL~D 557 (776)
..+|+||||+.+ +|..++.. ..+++.+++.++.||+.||.||| ++||+||||||+||||+.++.+||+|
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 278999999986 67666654 46999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC----CccccccccccCCchhhccCC-----CCCccchhhhHHHHHHHHHhC----------CCCCCCC
Q 004049 558 FGLARQYGSPLK----PYTHLVVTLWYRAPELLLGSK-----QYSTAIDMWSLGCIMAELLSK----------EPLFNGK 618 (776)
Q Consensus 558 FGlA~~~~s~~~----~~~~~~GT~~Y~APEvl~g~~-----~ys~~sDVWSLGvlLyELLtG----------~~PF~~~ 618 (776)
||++........ .....+||+.|+|||++.+.. .++.++|||||||+||+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999987644322 234468999999999998642 233689999999999999999 6777654
Q ss_pred Ch----HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 004049 619 SE----FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKR 694 (776)
Q Consensus 619 s~----~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kR 694 (776)
.. ...+...+.... ..+. ++.. + ....++..+.+||.+||..||.+|
T Consensus 271 ~~~~~~~~~~~~~~~~~~-----~~~~----------------------~~~~-~-~~~~~~~~l~~li~~cl~~dp~~R 321 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQK-----LRPN----------------------IPNR-W-QSCEALRVMAKIMRECWYANGAAR 321 (342)
T ss_dssp SCSSCCHHHHHHHHTTSC-----CCCC----------------------CCGG-G-GTSHHHHHHHHHHHHHCCSSGGGS
T ss_pred CcCcccHHHHHHHHHHHH-----hCCC----------------------Cccc-c-cchhHHHHHHHHHHHHhccChhhC
Confidence 21 112211111000 0000 0000 0 011245678899999999999999
Q ss_pred CCHHHHHcC
Q 004049 695 ITAEAALNH 703 (776)
Q Consensus 695 pTa~EIL~H 703 (776)
||+.+|++|
T Consensus 322 ps~~~i~~~ 330 (342)
T 1b6c_B 322 LTALRIKKT 330 (342)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=388.46 Aligned_cols=283 Identities=26% Similarity=0.396 Sum_probs=205.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec----cCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG----SNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~----~~~ 486 (776)
.+++|++++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34789999999999999999999999999999999865421 1123456789999999999999999998743 224
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc--CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc---EEEeeccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK--QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE---LKICDFGL 560 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~--~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~---iKL~DFGl 560 (776)
..+||||||+.| +|..++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 578999999975 6666665433 26999999999999999999999999999999999999997765 99999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
+...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........+..........+.
T Consensus 171 a~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 9877543 33455789999999999987 568999999999999999999999998764432211110000000000000
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
...... . .....+. .......++..+.+||.+||.+||.+|||+.++|+||||+.+
T Consensus 249 ~l~g~~----~--------~~~~lp~-p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 249 DLTGAV----K--------FSSVLPT-PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCSSSC----C--------CCSSSCC-SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhcccc----c--------cccccCC-chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000000 0 0000000 011223477899999999999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=373.85 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=205.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|++.+.||+|+||+||+|.+..+ +..||||+++.... ......+.+|+.+|+.++||||+++++++. ...
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cCc
Confidence 47899999999999999999998654 46799998865321 112345778999999999999999999983 246
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+||||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 8999999985 677777666667999999999999999999999999999999999999999999999999999876432
Q ss_pred CC-CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 568 LK-PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 568 ~~-~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+....+.+..+......+
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------- 612 (656)
T ss_dssp ---------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-----------
T ss_pred cceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 21 1233466889999999987 568999999999999999997 999999988888777775542111
Q ss_pred CCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.++.++..+.+||.+||..||.+|||+.+|+++
T Consensus 613 -------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 613 -------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112478899999999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.06 Aligned_cols=228 Identities=16% Similarity=0.063 Sum_probs=178.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..+.||||+++++++.. .+.+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEE
Confidence 36799999999999999999999999999999999754322 1222457789999999999999999999954 45899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||+.| +|..++.. .....++..|+.||+.||.|||++||+||||||+||||+.+|.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999986 55555532 35667889999999999999999999999999999999999999998543
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
|++ .++.++|||||||+||+|++|..||.+.+....+...... ....
T Consensus 175 ----------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------~~~~- 221 (286)
T 3uqc_A 175 ----------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD--------------TAGQ- 221 (286)
T ss_dssp ----------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC--------------TTSC-
T ss_pred ----------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH--------------hccC-
Confidence 333 2688999999999999999999999876543211000000 0000
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+.......+.++..+.+||.+||..||.+| |+.++++.
T Consensus 222 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 222 ---------------PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ---------------BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ---------------CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000000123488999999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=377.12 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=195.5
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECC-CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC--
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKK-TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD-- 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~-tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~-- 487 (776)
..++|++++.||+|+||+||+|.+.. +++.||||++..... ......+.+|+.+|..++||||+++++++......
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34789999999999999999999976 789999999864321 11223567899999999999999999999654321
Q ss_pred -eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 -SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 -~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+||||||+.|+.+..+.. ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 2699999999754443332 379999999999999999999999999999999999999985 999999999987643
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.... .++
T Consensus 234 ~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------~~~ 285 (681)
T 2pzi_A 234 F----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------GLP 285 (681)
T ss_dssp C----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------------SCC
T ss_pred C----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------------------ccc
Confidence 2 456899999999999763 488999999999999999999998652100 000
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
... . . ...++.+.+||.+||.+||.+||++.++|.|+|+.
T Consensus 286 ~~~-~-------~-------------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDD-P-------V-------------LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTC-H-------H-------------HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccc-c-------c-------------cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 0 0 01457888999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=321.53 Aligned_cols=189 Identities=19% Similarity=0.077 Sum_probs=134.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhc--------cCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCee
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER--------EGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~--------~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~l 489 (776)
..++.|++|.+..++....|+.||+|++.+.... +.....+.+|+++|+++ .|+||+++++++ ++...+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEE
Confidence 4578888988888888888999999999764311 12224567899999999 699999999999 445689
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||||++|+.+..+....+++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999986555555566778765 4889999999999999999999999999999999999999999998866666
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL 614 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P 614 (776)
...+.+||+.|||||++.+ .+..++|+|++|+++|+|+++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 6677899999999999987 367789999999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-26 Score=261.42 Aligned_cols=185 Identities=21% Similarity=0.200 Sum_probs=138.3
Q ss_pred eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc------CCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE------GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
...+.||+|+||+||+|. ..+..+++|++....... .....+.+|+.+|++++||||+.+..++... ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--Ccc
Confidence 445789999999999994 457889999875432111 1123467999999999999999555555433 366
Q ss_pred EEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||++ ++|.+++.. +..|+.||+.||.|||++||+||||||+||||+. ++||+|||+|+......
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999998 566665543 5789999999999999999999999999999998 99999999999875422
Q ss_pred CC-------ccccccccccCCchhhcc-CCCCCccchhhhHHHHHHHHHhCCCCC
Q 004049 569 KP-------YTHLVVTLWYRAPELLLG-SKQYSTAIDMWSLGCIMAELLSKEPLF 615 (776)
Q Consensus 569 ~~-------~~~~~GT~~Y~APEvl~g-~~~ys~~sDVWSLGvlLyELLtG~~PF 615 (776)
.. ....+||+.|||||++.+ ...|+..+|+|+..+-..+.+-++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235789999999999975 134788899999999888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=219.50 Aligned_cols=145 Identities=17% Similarity=0.128 Sum_probs=113.5
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----------------CccchHHHHHHHHhCCCCCccee
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----------------FPLTSLREINILLSFHHPSIVDV 477 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----------------~~~~~~rEi~iL~~L~HPnIV~l 477 (776)
.|.+.+.||+|+||.||+|.+ .+|+.||||++........ ....+.+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 355669999999999999999 8899999999965432111 1234678999999999 4 666
Q ss_pred eEEEeccCCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEe
Q 004049 478 KEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKIC 556 (776)
Q Consensus 478 ~~~~~~~~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~ 556 (776)
+.++.. ...|+||||++| +|.. +. ..++..++.||+.||.|||++||+||||||+||||+ ++.+||+
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec---cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665522 356999999986 4544 31 134567999999999999999999999999999999 9999999
Q ss_pred ecccccccCCCCCCccccccccccCCchhhc
Q 004049 557 DFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587 (776)
Q Consensus 557 DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~ 587 (776)
|||+|.. +..|+|||++.
T Consensus 235 DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE-------------TTSTTHHHHHH
T ss_pred ECCCCeE-------------CCCCCHHHHHH
Confidence 9999864 33478999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.7e-21 Score=197.92 Aligned_cols=141 Identities=18% Similarity=0.195 Sum_probs=106.8
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcE--EEEEEeecchhccCC----------------------ccchHHHHHHHHhC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEI--VALKKVKMEKEREGF----------------------PLTSLREINILLSF 469 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~--VAIK~i~~~~~~~~~----------------------~~~~~rEi~iL~~L 469 (776)
-|++.+.||+|+||.||+|.+..+|+. ||||+++........ ...+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778999 999997653211000 01456899999999
Q ss_pred CCCCcceeeEEEeccCCCeeEEEeeehhh------hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCC
Q 004049 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH------DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKT 542 (776)
Q Consensus 470 ~HPnIV~l~~~~~~~~~~~l~LVmEy~~g------~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKP 542 (776)
.|++|....-+.. ...||||||+.+ .|..... .+++.++..++.||+.||.||| .+|||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8886532222221 246899999953 2333222 1345678899999999999999 99999999999
Q ss_pred CCeeecCCCcEEEeeccccccc
Q 004049 543 SNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 543 eNILLd~~g~iKL~DFGlA~~~ 564 (776)
+||||+. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=5.4e-17 Score=179.84 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=99.1
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCc------------cc--------hHHHHHHHHhCCCCCc
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFP------------LT--------SLREINILLSFHHPSI 474 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~------------~~--------~~rEi~iL~~L~HPnI 474 (776)
|.+.++||.|+||.||+|.+. +|+.||||+++......... .. ..+|...|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999874 69999999986432110000 00 1245666666654444
Q ss_pred ceeeEEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC---
Q 004049 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG--- 551 (776)
Q Consensus 475 V~l~~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g--- 551 (776)
....-+... ..+|||||+.|..+..+. ....+..++.||+.+|.|||.+|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeecc----CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 322222111 237999999985443322 2234577899999999999999999999999999998876
Q ss_pred -------cEEEeeccccccc
Q 004049 552 -------ELKICDFGLARQY 564 (776)
Q Consensus 552 -------~iKL~DFGlA~~~ 564 (776)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.1e-11 Score=126.06 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=107.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
.++.|.+...++.|+++.||++... +..+++|+...... .....+.+|+.+|+.|. +..+.++++++.. ....
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~ 85 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWS 85 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCce
Confidence 3567999999999999999999753 67899999865321 22345788999999985 6677788888743 4578
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-------------------------------------
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD------------------------------------- 532 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs------------------------------------- 532 (776)
|+||||++|..+.... .+......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999985443321 1222345788899999999998
Q ss_pred ----------------------CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 ----------------------NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ----------------------~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=118.51 Aligned_cols=135 Identities=13% Similarity=0.045 Sum_probs=96.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC--cceeeEEEeccCCCee
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS--IVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~~~~~~~~l 489 (776)
+..|.+....+.|.++.||++.. .+|..|++|+.... ....+.+|+.+|+.|.+.+ +.+++.+... .+..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCC
Confidence 35566655445677799999964 56778999987543 2245678999999986544 4557777643 3468
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC-----------------------------------
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW----------------------------------- 534 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g----------------------------------- 534 (776)
|+||||++|..+. .. ..+ ...++.+++..|..||...
T Consensus 91 ~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999985443 11 112 2356677777777777643
Q ss_pred -----------------------cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 535 -----------------------VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 535 -----------------------IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
++|+||+|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.2e-09 Score=118.64 Aligned_cols=144 Identities=13% Similarity=0.194 Sum_probs=104.1
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEee--cchhccCCccchHHHHHHHHhCC--CCCcceeeEEEeccCC-Cee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVK--MEKEREGFPLTSLREINILLSFH--HPSIVDVKEVVVGSNL-DSI 489 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~--~~~~~~~~~~~~~rEi~iL~~L~--HPnIV~l~~~~~~~~~-~~l 489 (776)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+.+++.++.+... ...
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 345688999999999999764 4578888775 32211 12346778999999997 4557778877743321 357
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-------------------------------------
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD------------------------------------- 532 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs------------------------------------- 532 (776)
|+||||++|..+.. ..-..++..+...++.+++.+|..||.
T Consensus 117 ~~vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999999854321 112347888899999999999999996
Q ss_pred ---------------------CCcccCCCCCCCeeecCCCc--EEEeecccccc
Q 004049 533 ---------------------NWVLHRDLKTSNLLLNNRGE--LKICDFGLARQ 563 (776)
Q Consensus 533 ---------------------~gIvHrDLKPeNILLd~~g~--iKL~DFGlA~~ 563 (776)
..+||+|++|.|||++.++. +.|+||+++..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=6.8e-10 Score=117.78 Aligned_cols=183 Identities=17% Similarity=0.160 Sum_probs=116.1
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCc--ceeeEEEeccC-CCeeEEEe
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSI--VDVKEVVVGSN-LDSIFMVM 493 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnI--V~l~~~~~~~~-~~~l~LVm 493 (776)
++.|+.|.+..||++. ..+++|+..... ....+.+|+.+|+.|. +..| ..++.+..... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~----~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSR----GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHH----HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcc----hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3568999999999973 458889865331 1235668999998884 3333 33333321111 12348899
Q ss_pred eehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-----------------------------------------
Q 004049 494 EYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD----------------------------------------- 532 (776)
Q Consensus 494 Ey~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs----------------------------------------- 532 (776)
+|++|..+..... ..++..+...++.+++..|..||.
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999854332111 246777788888888888888885
Q ss_pred -----------------CCcccCCCCCCCeeecC--CCcEEEeecccccccCCCCCCcccccccccc---CCchhhc---
Q 004049 533 -----------------NWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGSPLKPYTHLVVTLWY---RAPELLL--- 587 (776)
Q Consensus 533 -----------------~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~~~s~~~~~~~~~GT~~Y---~APEvl~--- 587 (776)
..++|+|++|.|||++. .+.+.|+||+.+.... +. ........+ ..|+.+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~---~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PD---NDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TT---HHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hH---HHHHHHHhhccccCHHHHHHHH
Confidence 13799999999999998 4568899999986532 11 111111111 2333221
Q ss_pred -cCCC---------CCccchhhhHHHHHHHHHhCCCCC
Q 004049 588 -GSKQ---------YSTAIDMWSLGCIMAELLSKEPLF 615 (776)
Q Consensus 588 -g~~~---------ys~~sDVWSLGvlLyELLtG~~PF 615 (776)
..+. .....++|+++.++|.+.+|.++|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1000 122368999999999999998877
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.4e-06 Score=88.91 Aligned_cols=135 Identities=19% Similarity=0.123 Sum_probs=86.8
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC---CcceeeEEEeccCCCeeEEEee
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP---SIVDVKEVVVGSNLDSIFMVME 494 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP---nIV~l~~~~~~~~~~~l~LVmE 494 (776)
+..|+.|....||+. +..+++|+..... ....+.+|+.+|+.|.+. .+..++.+.. ...+..|+||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQ----GADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHH----HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCch----HHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEe
Confidence 456899999999998 4568888853221 123567899999999752 2445555543 22345789999
Q ss_pred ehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc------------------------------------------
Q 004049 495 YMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD------------------------------------------ 532 (776)
Q Consensus 495 y~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs------------------------------------------ 532 (776)
|++|..+..... ..++..+...++.+|...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999843322110 123444444444444444444442
Q ss_pred ------------------CCcccCCCCCCCeeecC---CCc-EEEeeccccccc
Q 004049 533 ------------------NWVLHRDLKTSNLLLNN---RGE-LKICDFGLARQY 564 (776)
Q Consensus 533 ------------------~gIvHrDLKPeNILLd~---~g~-iKL~DFGlA~~~ 564 (776)
..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999997 455 489999988643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=8.5e-06 Score=83.99 Aligned_cols=133 Identities=17% Similarity=0.144 Sum_probs=86.2
Q ss_pred eeecCCce-EEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeEEEeeehh
Q 004049 420 KIDEGTYG-VVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIFMVMEYME 497 (776)
Q Consensus 420 ~LG~GsfG-~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~LVmEy~~ 497 (776)
.+..|..+ .||+......+..+++|+-.... ...+.+|..+|+.|. +--+.+++.++.. .+..|+||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 44555544 79998887777889999875432 234567999998885 3235566776643 457899999998
Q ss_pred hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc---------------------------------------------
Q 004049 498 HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD--------------------------------------------- 532 (776)
Q Consensus 498 g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs--------------------------------------------- 532 (776)
|......... .......++.++...|.-||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7432221110 111222344444444444442
Q ss_pred -------------CCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 533 -------------NWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 533 -------------~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
..++|+|+.+.|||++..+.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999877777999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.1e-05 Score=88.42 Aligned_cols=78 Identities=18% Similarity=0.180 Sum_probs=48.9
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchh--c---cCCccchHHHHHHHHhCCC--CCcc-eeeEEEeccCCCe
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--R---EGFPLTSLREINILLSFHH--PSIV-DVKEVVVGSNLDS 488 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--~---~~~~~~~~rEi~iL~~L~H--PnIV-~l~~~~~~~~~~~ 488 (776)
.++.||.|.++.||++....++..|+||....... . .........|..+|+.+.. |.++ .++.+. . ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Cc
Confidence 45789999999999997766678899998753221 1 1122345679999888742 4333 444332 2 24
Q ss_pred eEEEeeehhh
Q 004049 489 IFMVMEYMEH 498 (776)
Q Consensus 489 l~LVmEy~~g 498 (776)
.++||||+.|
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5899999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.5e-05 Score=84.07 Aligned_cols=84 Identities=8% Similarity=0.084 Sum_probs=53.6
Q ss_pred eEEeee-ecCCceEEEEEEEC--C----CCcEEEEEEeecchh-ccCCccchHHHHHHHHhCC-C--CCcceeeEEEecc
Q 004049 416 ERLNKI-DEGTYGVVYRARDK--K----TGEIVALKKVKMEKE-REGFPLTSLREINILLSFH-H--PSIVDVKEVVVGS 484 (776)
Q Consensus 416 eil~~L-G~GsfG~Vyla~~k--~----tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-H--PnIV~l~~~~~~~ 484 (776)
..++.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 89999999998653 0 156788887654321 0001245678999998885 3 2466677665332
Q ss_pred C-CCeeEEEeeehhhh
Q 004049 485 N-LDSIFMVMEYMEHD 499 (776)
Q Consensus 485 ~-~~~l~LVmEy~~g~ 499 (776)
. ....|+||||++|.
T Consensus 103 ~~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGV 118 (357)
T ss_dssp TTTSSCEEEEECCCCB
T ss_pred CccCCceEEEEecCCC
Confidence 1 13468999999873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=7.5e-05 Score=79.03 Aligned_cols=30 Identities=23% Similarity=0.329 Sum_probs=27.3
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..+||+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00052 Score=72.25 Aligned_cols=68 Identities=18% Similarity=0.102 Sum_probs=43.3
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc-ceeeEEEeccCCCeeEEEeeeh
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI-VDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI-V~l~~~~~~~~~~~l~LVmEy~ 496 (776)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+..-++ .+++.+. .. .-++|++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeec
Confidence 678999999999999 3488888754321 12234578888877753233 3454433 22 337899999
Q ss_pred -hh
Q 004049 497 -EH 498 (776)
Q Consensus 497 -~g 498 (776)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00098 Score=73.77 Aligned_cols=78 Identities=10% Similarity=-0.032 Sum_probs=45.5
Q ss_pred ccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcccccc--ccccCCchhhccCC--CCCccchhhhHHHHHH
Q 004049 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV--TLWYRAPELLLGSK--QYSTAIDMWSLGCIMA 606 (776)
Q Consensus 531 Hs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~G--T~~Y~APEvl~g~~--~ys~~sDVWSLGvlLy 606 (776)
+...++|+|++|.|||++.++ +.|+||+.+..-. +......... ...|++|+...... .-.....+..+...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 567799999999999999876 9999999886431 1000011111 13355555443110 0112234446677777
Q ss_pred HHHh
Q 004049 607 ELLS 610 (776)
Q Consensus 607 ELLt 610 (776)
.+++
T Consensus 308 ~~y~ 311 (420)
T 2pyw_A 308 NLFN 311 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0017 Score=66.25 Aligned_cols=97 Identities=15% Similarity=0.122 Sum_probs=66.3
Q ss_pred hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhc-cCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCccccccc
Q 004049 499 DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH-DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVT 577 (776)
Q Consensus 499 ~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLH-s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~~~~GT 577 (776)
+|..++...+.+|+|.++|.++.|.+.+|.-+- .+.-..+=+.|..|+|..+|.+.+.+ ..+. ...
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE 100 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence 578888888999999999999999999987761 11112334457899999999988774 2111 112
Q ss_pred cccCCchhhccCCCCCccchhhhHHHHHHHHHh
Q 004049 578 LWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS 610 (776)
Q Consensus 578 ~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt 610 (776)
..+.|||.+. ...+.+.=|||||++||..+-
T Consensus 101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 3466888764 235678899999999999984
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0016 Score=69.76 Aligned_cols=75 Identities=13% Similarity=0.100 Sum_probs=54.5
Q ss_pred eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC---CCCcceeeEEEeccCCCeeEEE
Q 004049 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH---HPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.-++.|+.|.+..+|+... ++..+++|+..... ...+.+|...|+.|. ...+.+++.+... .+..|+|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEE
Confidence 3467899999999999975 46678899875431 234567888888874 2557777776633 3578999
Q ss_pred eeehhhh
Q 004049 493 MEYMEHD 499 (776)
Q Consensus 493 mEy~~g~ 499 (776)
|||++|.
T Consensus 110 me~l~G~ 116 (312)
T 3jr1_A 110 LEALNKS 116 (312)
T ss_dssp EECCCCC
T ss_pred EEeccCC
Confidence 9999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0053 Score=64.04 Aligned_cols=76 Identities=13% Similarity=0.075 Sum_probs=51.9
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC---CcceeeEEEeccCCCeeE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP---SIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP---nIV~l~~~~~~~~~~~l~ 490 (776)
...-+..+|.|..+.||++.. .+|+.|++|+..... ......+.+|+..|+.|.-- .+.+++.+ +. -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ce
Confidence 456778999999999999976 578899999865332 11223456899999988522 23344433 22 37
Q ss_pred EEeeehhh
Q 004049 491 MVMEYMEH 498 (776)
Q Consensus 491 LVmEy~~g 498 (776)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0023 Score=71.46 Aligned_cols=72 Identities=15% Similarity=0.160 Sum_probs=48.5
Q ss_pred EEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc-ceeeEEEeccCCCe
Q 004049 417 RLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI-VDVKEVVVGSNLDS 488 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI-V~l~~~~~~~~~~~ 488 (776)
.++.|+.|....||++.... .+..|++|+.... .....+.+|+.+++.|...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 45788999999999998643 2578999987321 111344578888888853333 5566655 32
Q ss_pred eEEEeeehhh
Q 004049 489 IFMVMEYMEH 498 (776)
Q Consensus 489 l~LVmEy~~g 498 (776)
.+||+|++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 388999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0024 Score=69.07 Aligned_cols=73 Identities=10% Similarity=0.126 Sum_probs=43.8
Q ss_pred EEeeeecCCceEEEEEEECC--------CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC-cceeeEEEeccCCC
Q 004049 417 RLNKIDEGTYGVVYRARDKK--------TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS-IVDVKEVVVGSNLD 487 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~--------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn-IV~l~~~~~~~~~~ 487 (776)
.+..|+.|....+|++.... .+..|++|+....... ......|..+++.|...+ +.+++..+ ..
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 35678889889999997643 1367888987543211 123457888888875333 34565544 22
Q ss_pred eeEEEeeehhh
Q 004049 488 SIFMVMEYMEH 498 (776)
Q Consensus 488 ~l~LVmEy~~g 498 (776)
++||+|++|
T Consensus 110 --~~v~e~i~G 118 (369)
T 3c5i_A 110 --GRIEEWLYG 118 (369)
T ss_dssp --EEEEECCCS
T ss_pred --cEEEEEecC
Confidence 689999987
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0044 Score=65.30 Aligned_cols=143 Identities=15% Similarity=0.085 Sum_probs=76.0
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC--cceeeEEEe----ccCCC
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS--IVDVKEVVV----GSNLD 487 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~~----~~~~~ 487 (776)
....++.|+.|....||++... ++ .+++|+..... ....+..|+.++..|.... +.+++.... ....+
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 3445677888999999999753 34 58899886421 1234456788877764212 223322100 01123
Q ss_pred eeEEEeeehhhhhh---------------hHHhhccCCC--------CHHHHHHH---------------HHHHHHHhhh
Q 004049 488 SIFMVMEYMEHDLK---------------GLMETMKQPF--------SQSEVKCL---------------MLQLLEGIKY 529 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll---------------~~l~~~~~~L--------se~~~~~i---------------~~qIl~aL~y 529 (776)
..+++|+|++|... ..+......+ ........ ...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 56899999987311 0111110111 11100000 0112333344
Q ss_pred hc-------cCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 530 LH-------DNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 530 LH-------s~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
|+ ..++||+|+++.|||++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 43 2469999999999999987666899999774
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0028 Score=69.82 Aligned_cols=137 Identities=13% Similarity=0.100 Sum_probs=79.6
Q ss_pred EeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 418 LNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
++.|..|-...+|++.... ++..|++|+.-... .......+|..+++.|. +.-..++++++ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVF--PE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----
Confidence 3577788888999997642 35789999863211 12234458999988875 32335566555 33
Q ss_pred EEEeeehhhhhhh---------------H---Hhhcc----CCCC--HHHHHHHHHHHHHH-------------------
Q 004049 490 FMVMEYMEHDLKG---------------L---METMK----QPFS--QSEVKCLMLQLLEG------------------- 526 (776)
Q Consensus 490 ~LVmEy~~g~Ll~---------------~---l~~~~----~~Ls--e~~~~~i~~qIl~a------------------- 526 (776)
-+||||++|..+. . +.... .... +.++..++.++...
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 2899999873211 0 00111 1122 35566666554321
Q ss_pred hhhh----c----cCCcccCCCCCCCeeecCC----CcEEEeecccccc
Q 004049 527 IKYL----H----DNWVLHRDLKTSNLLLNNR----GELKICDFGLARQ 563 (776)
Q Consensus 527 L~yL----H----s~gIvHrDLKPeNILLd~~----g~iKL~DFGlA~~ 563 (776)
+..| . ...++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 1 2359999999999999876 7899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0093 Score=67.26 Aligned_cols=73 Identities=14% Similarity=0.164 Sum_probs=48.1
Q ss_pred EEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCc-ceeeEEEeccCCCeeEEEeee
Q 004049 417 RLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI-VDVKEVVVGSNLDSIFMVMEY 495 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnI-V~l~~~~~~~~~~~l~LVmEy 495 (776)
.++.|+.|-...+|++.....+..|++|+..... .......+|..+|+.|...++ .++++++ .+ .+||+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEe
Confidence 4578899999999999875445788899874321 112223589999999875444 4566655 32 259999
Q ss_pred hhh
Q 004049 496 MEH 498 (776)
Q Consensus 496 ~~g 498 (776)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0054 Score=65.17 Aligned_cols=32 Identities=31% Similarity=0.439 Sum_probs=27.8
Q ss_pred cCCcccCCCCCCCeeecCC----CcEEEeecccccc
Q 004049 532 DNWVLHRDLKTSNLLLNNR----GELKICDFGLARQ 563 (776)
Q Consensus 532 s~gIvHrDLKPeNILLd~~----g~iKL~DFGlA~~ 563 (776)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.37 E-value=0.015 Score=61.43 Aligned_cols=137 Identities=18% Similarity=0.143 Sum_probs=75.9
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCC--cceeeEEEec----cCCCeeEEE
Q 004049 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS--IVDVKEVVVG----SNLDSIFMV 492 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPn--IV~l~~~~~~----~~~~~l~LV 492 (776)
..|+ |....||++.. .+|+.+++|+...... ....+..|+.++..|.... ++.++.. .+ ...+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 88889998854 3466799999863211 1234556888877774222 3334332 11 012356789
Q ss_pred eeehhhhhhh---------------HHhhc--cC------CCCHHHH----------------------HHHHHHHHHHh
Q 004049 493 MEYMEHDLKG---------------LMETM--KQ------PFSQSEV----------------------KCLMLQLLEGI 527 (776)
Q Consensus 493 mEy~~g~Ll~---------------~l~~~--~~------~Lse~~~----------------------~~i~~qIl~aL 527 (776)
|+|++|.... .+... .. .++.... ..++.+++..|
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999872110 01000 00 1221111 11122222222
Q ss_pred hhh----ccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 528 KYL----HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 528 ~yL----Hs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
.-+ +...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 235689999999999999 4 899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.031 Score=60.03 Aligned_cols=31 Identities=23% Similarity=0.354 Sum_probs=27.6
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.039 Score=61.55 Aligned_cols=73 Identities=8% Similarity=0.056 Sum_probs=47.9
Q ss_pred EEeeeecCCceEEEEEEECCC-------CcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCe
Q 004049 417 RLNKIDEGTYGVVYRARDKKT-------GEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~t-------g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~ 488 (776)
.++.|..|-...+|++..... +..|++|+..... .......+|..+++.|. +.-..++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC---
Confidence 456788888899999987521 5789999864321 12234468999888885 33334555543 22
Q ss_pred eEEEeeehhh
Q 004049 489 IFMVMEYMEH 498 (776)
Q Consensus 489 l~LVmEy~~g 498 (776)
++||+|++|
T Consensus 146 -~~I~efI~G 154 (424)
T 3mes_A 146 -GRIEEFIDG 154 (424)
T ss_dssp -EEEEECCCS
T ss_pred -CEEEEEeCC
Confidence 788999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.45 E-value=0.22 Score=54.61 Aligned_cols=29 Identities=28% Similarity=0.502 Sum_probs=24.8
Q ss_pred cccCCCCCCCeee------cCCCcEEEeecccccc
Q 004049 535 VLHRDLKTSNLLL------NNRGELKICDFGLARQ 563 (776)
Q Consensus 535 IvHrDLKPeNILL------d~~g~iKL~DFGlA~~ 563 (776)
++|+|+.+.|||+ +..+.+.|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4467799999998853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 776 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-92 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-88 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-88 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-85 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-81 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-78 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-78 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-77 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-76 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-74 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-74 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-73 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-72 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-70 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-70 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-69 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-58 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-57 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-53 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-52 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-27 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 0.004 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 288 bits (738), Expect = 7e-92
Identities = 129/315 (40%), Positives = 189/315 (60%), Gaps = 17/315 (5%)
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 468
C V ++E+L KI +GT+G V++AR +KTG+ VALKKV ME E+EGFP+T+LREI IL
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 469 FHHPSIVDVKEVVV------GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
H ++V++ E+ SI++V ++ EHDL GL+ + F+ SE+K +M
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYG----SPLKPYTHLVVTL 578
LL G+ Y+H N +LHRD+K +N+L+ G LK+ DFGLAR + S YT+ VVTL
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
WYR PELLLG + Y ID+W GCIMAE+ ++ P+ G +E QL I + G+ ++
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 639 WPGFSKLPGV-KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
WP K+ +K Q ++ + + V DL++ LL DP +RI +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 698 EAALNHDWFREVPLP 712
+ ALNHD+F P+P
Sbjct: 300 DDALNHDFFWSDPMP 314
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (713), Expect = 1e-88
Identities = 144/301 (47%), Positives = 206/301 (68%), Gaps = 11/301 (3%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ F+++ KI EGTYGVVY+AR+K TGE+VALKK++++ E EG P T++REI++L +HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + +V+ N +++V E++ DLK M+ + +K + QLL+G+ + H
Sbjct: 62 NIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+ VLHRDLK NLL+N G +K+ DFGLAR +G P++ YTH VVTLWYRAPE+LLG K
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
YSTA+D+WSLGCI AE++++ LF G SE DQL +IF+TLGTP+E +WPG + +P K +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711
F K K P L + G LL+ +L YDP+KRI+A+AAL H +F++V
Sbjct: 240 FPKWARQDFSKVVPP--------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
Query: 712 P 712
P
Sbjct: 292 P 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (710), Expect = 5e-88
Identities = 128/307 (41%), Positives = 182/307 (59%), Gaps = 14/307 (4%)
Query: 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK---EREGFPLTSLREINILLSFHHP 472
E+L+ + EG + VY+ARDK T +IVA+KK+K+ ++G T+LREI +L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+I+ + + +I +V ++ME DL+ +++ + S +K ML L+G++YLH
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
+W+LHRDLK +NLLL+ G LK+ DFGLA+ +GSP + YTH VVT WYRAPELL G++ Y
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
+DMW++GCI+AELL + P G S+ DQL +IF+TLGTP E+ WP LP V F
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD-YVTF 237
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712
L F A D DL+ L ++P RITA AL +F P P
Sbjct: 238 KSFPGIPLHHIFSA--------AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
Query: 713 KSKDFMP 719
+P
Sbjct: 290 TPGCQLP 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 269 bits (687), Expect = 7e-85
Identities = 141/296 (47%), Positives = 195/296 (65%), Gaps = 11/296 (3%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++ L KI EGTYGVVY+A++ GE ALKK+++EKE EG P T++REI+IL H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV + +V+ + +V E+++ DLK L++ + K +LQLL GI Y HD
Sbjct: 61 NIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
VLHRDLK NLL+N GELKI DFGLAR +G P++ YTH +VTLWYRAP++L+GSK+Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 593 STAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
ST ID+WS+GCI AE+++ PLF G SE DQL +IF+ LGTPN K WP ++LP NF
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
++ L ++G DLL+ +L DP++RITA+ AL H +F+E
Sbjct: 239 TVYEPLPWESFLKG--------LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (663), Expect = 3e-81
Identities = 130/301 (43%), Positives = 185/301 (61%), Gaps = 11/301 (3%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++E+L KI EGTYG V++A++++T EIVALK+V+++ + EG P ++LREI +L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+IV + +V+ + +V E+ + DLK ++ VK + QLL+G+ + H
Sbjct: 62 NIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 533 NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQY 592
VLHRDLK NLL+N GELK+ +FGLAR +G P++ Y+ VVTLWYR P++L G+K Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 593 STAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
ST+IDMWS GCI AEL + PLF G DQL +IF+ LGTP E+ WP +KLP K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711
+ L P L+ G DLL +LL +P +RI+AE AL H +F +
Sbjct: 240 PMYPATTSLVNVVPK--------LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 712 P 712
P
Sbjct: 292 P 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 2e-78
Identities = 72/305 (23%), Positives = 132/305 (43%), Gaps = 14/305 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D+FE+++++ G GVV++ K +G ++A K + +E + +RE+ +L + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 64
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
IV I + ME+M+ + + + + + +++G+ YL +
Sbjct: 65 YIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 533 -NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
+ ++HRD+K SN+L+N+RGE+K+CDFG++ Q + V T Y +PE L G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQG-TH 179
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQLDKIFKTLG----TPNEKIWPGFSKLP 646
YS D+WS+G + E+ ++ +L + G TP PG
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSP--VLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
+ L P V S D +N L +P +R + + H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 705 WFREV 709
+ +
Sbjct: 300 FIKRS 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (642), Expect = 5e-78
Identities = 122/313 (38%), Positives = 189/313 (60%), Gaps = 20/313 (6%)
Query: 409 CRSVDEFERLNKIDEGTYGVVYRARDKKT-GEIVALKKVKMEKEREGFPLTSLREINI-- 465
CR+ ++E + +I EG YG V++ARD K G VALK+V+++ EG PL+++RE+ +
Sbjct: 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 466 -LLSFHHPSIVDVKEVVVGSNLDS---IFMVMEYMEHDLKGLMETMKQP-FSQSEVKCLM 520
L +F HP++V + +V S D + +V E+++ DL ++ + +P +K +M
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 521 LQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWY 580
QLL G+ +LH + V+HRDLK N+L+ + G++K+ DFGLAR Y S T +VVTLWY
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWY 181
Query: 581 RAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
RAPE+LL Y+T +D+WS+GCI AE+ ++PLF G S+ DQL KI +G P E+ WP
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
LP + F + K + + G DLL LT++P KRI+A +A
Sbjct: 241 RDVALP--RQAFHSKSAQPIEKFVTD--------IDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 701 LNHDWFREVPLPK 713
L+H +F+++ K
Sbjct: 291 LSHPYFQDLERCK 303
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (638), Expect = 7e-77
Identities = 100/335 (29%), Positives = 161/335 (48%), Gaps = 25/335 (7%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
+ I G++GVVY+A+ +GE+VA+KKV +K + RE+ I+ H +I
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKLDHCNI 75
Query: 475 VDVKEVVVGSNLDS----IFMVMEYMEHDLKGLMETM---KQPFSQSEVKCLMLQLLEGI 527
V ++ S + +V++Y+ + + KQ VK M QL +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGEL-KICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
Y+H + HRD+K NLLL+ + K+CDFG A+Q ++ + + +YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELI 194
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
G+ Y+++ID+WS GC++AELL +P+F G S DQL +I K LGTP + +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP-- 252
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
N+ + ++ ++ F P L + LL Y P R+T A H +F
Sbjct: 253 ----NYTEFKFPQIKAHPWTKVFR--PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 707 REVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPL 741
E+ P K +P A + + S PL
Sbjct: 307 DELRDPNVK--LPNGRDTPALFNFTTQELSSNPPL 339
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 2e-76
Identities = 121/347 (34%), Positives = 172/347 (49%), Gaps = 25/347 (7%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L+ I EG YG+V A D VA+KK+ E + + +LREI ILL F H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHE 66
Query: 473 SIVDVKEVVVGSN---LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+I+ + +++ + +++V M DL L++ Q S + + Q+L G+KY
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKY 124
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP---LKPYTHLVVTLWYRAPELL 586
+H VLHRDLK SNLLLN +LKICDFGLAR T V T WYRAPE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
L SK Y+ +ID+WS+GCI+AE+LS P+F GK DQL+ I LG+P+++ L
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
N P DLL+ +LT++P KRI E AL H +
Sbjct: 245 ARNYLLSLPHKN------KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 707 REVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGE 753
+ P + P A D + D L +++ KEL E
Sbjct: 299 EQYYDPSDE---PIAEAPFKFDMEL-------DDLPKEKLKELIFEE 335
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 1e-74
Identities = 104/331 (31%), Positives = 166/331 (50%), Gaps = 19/331 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ L + G YG V A D +TG VA+KK+ + E F + RE+ +L H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 473 SIVDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V ++VM +M DL LM+ + + ++ L+ Q+L+G++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLR 135
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK NL +N ELKI DFGLARQ S + T VVT WYRAPE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILN 192
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+Y+ +D+WS+GCIMAE+++ + LF G DQL +I K GTP +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA- 251
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
N++K L +K F + S +LL +L D ++R+TA AL H +F
Sbjct: 252 -KNYMKGLPELEKKDFASI----LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
Query: 709 VPLPKSKDFMPTFPAQHAQDRR----MRRMM 735
+ + + + + R +R+
Sbjct: 307 LHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 2e-74
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 40/304 (13%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH 471
V++++ + + EG YG V A ++ T E VA+K V M++ + P +EI I +H
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 62
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
++V N+ ++ +EY + + + QL+ G+ YLH
Sbjct: 63 ENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLAR--QYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ HRD+K NLLL+ R LKI DFGLA +Y + + + TL Y APELL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
+ ++ +D+WS G ++ +L+ E ++ S+ Q +K T W
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKK-------- 231
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+ A LL+ +L +P RIT W+ +
Sbjct: 232 -------------------------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK- 265
Query: 710 PLPK 713
PL K
Sbjct: 266 PLKK 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 243 bits (621), Expect = 3e-74
Identities = 81/337 (24%), Positives = 137/337 (40%), Gaps = 42/337 (12%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D ++ ++ G +GVV+R ++ TG A K V E + T +EI + HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHP 83
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
++V++ + N + M+ E+M +L + S+ E M Q+ +G+ ++H
Sbjct: 84 TLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 532 DNWVLHRDLKTSNLLLNNR--GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+N +H DLK N++ + ELK+ DFGL P + T + APE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 199
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
K DMWS+G + LLS F G+++ + L + ++ + G
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-------- 251
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+S+ G D + LL DP+ R+T AL H W
Sbjct: 252 -------------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
Query: 710 PLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRR 746
P +P+ +D + P+PL R
Sbjct: 287 NAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR 323
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 239 bits (610), Expect = 5e-73
Identities = 80/304 (26%), Positives = 154/304 (50%), Gaps = 12/304 (3%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSF 469
+ D+++ + K+ G Y V+ A + E V +K +K K+++ REI IL +
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENL 86
Query: 470 -HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
P+I+ + ++V + +V E++ + + + Q + +++ M ++L+ +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALD 143
Query: 529 YLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLL 587
Y H ++HRD+K N+++++ +L++ D+GLA Y P + Y V + +++ PELL+
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLV 202
Query: 588 GSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
+ Y ++DMWSLGC++A ++ KEP F+G +DQL +I K LGT + + +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
+ ++ ++S D L+ LL YD R+TA A+ H +F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 707 REVP 710
V
Sbjct: 323 YTVV 326
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (609), Expect = 1e-72
Identities = 105/329 (31%), Positives = 160/329 (48%), Gaps = 15/329 (4%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ ++ L+ + G YG V A D KTG VA+KK+ + + RE+ +L H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 473 SIVDVKEVVVGSN----LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+++ + +V + + +++V M DL +++ Q + V+ L+ Q+L G+K
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
Y+H ++HRDLK SNL +N ELKI DFGLAR T V T WYRAPE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLN 192
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
Y+ +D+WS+GCIMAELL+ LF G DQL I + +GTP ++ S
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES-- 250
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
N+I+ + + F + DLL +L D DKRITA AL H +F +
Sbjct: 251 ARNYIQSLTQMPKMNFANV----FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 709 VPLPKSKDFMPTFPAQHAQDRRMRRMMKS 737
P + + + KS
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (608), Expect = 2e-72
Identities = 77/373 (20%), Positives = 149/373 (39%), Gaps = 61/373 (16%)
Query: 392 TPEPAGPPQRSINMLQGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE 451
P+P Q S+ D ++ L ++ G +GVV+R +K TG + K +
Sbjct: 16 VPQPVEVKQGSVY--------DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 67
Query: 452 REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP 510
+ + + EI+I+ HHP ++++ + + +++E++ +L +
Sbjct: 68 LDKYTV--KNEISIMNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDYK 123
Query: 511 FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL--NNRGELKICDFGLARQYGSPL 568
S++EV M Q EG+K++H++ ++H D+K N++ +KI DFGLA + +P
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPD 182
Query: 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIF 628
+ T + APE++ + DMW++G + LLS F G+ + + L +
Sbjct: 183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241
Query: 629 KTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLT 688
+ +E + +S D + +LL
Sbjct: 242 RCDWEFDEDAFSS---------------------------------VSPEAKDFIKNLLQ 268
Query: 689 YDPDKRITAEAALNHDWFR-----------EVPLPKSKDFMPTFPAQHAQDRRMRRMMKS 737
+P KR+T AL H W + K + + A + + +
Sbjct: 269 KEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 328
Query: 738 PDPLEEQRRKELQ 750
L + R +E Q
Sbjct: 329 FSSLRKHRPQEYQ 341
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 5e-72
Identities = 74/303 (24%), Positives = 140/303 (46%), Gaps = 47/303 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM--EKEREGFPLTSLREINILLSFH 470
D +E + ++ +G +G VY+A++K+T + A K + E+E E + + EI+IL S
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY----MVEIDILASCD 67
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+IV + + N ++++++E+ + +M +++P ++S+++ + Q L+ + Y
Sbjct: 68 HPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG- 588
LHDN ++HRDLK N+L G++K+ DFG++ + ++ + T ++ APE+++
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 589 ---SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
+ Y D+WSLG + E+ EP + + L KI K+ P +S
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWS-- 242
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDW 705
D L L + D R T L H +
Sbjct: 243 -------------------------------SNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 706 FRE 708
Sbjct: 272 VTV 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 235 bits (600), Expect = 7e-72
Identities = 85/344 (24%), Positives = 148/344 (43%), Gaps = 53/344 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS-LREINILLSFHH 471
F L +I G++G VY ARD + E+VA+KK+ ++ ++E+ L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
P+ + + + + + ++VMEY L+E K+P + E+ + L+G+ YLH
Sbjct: 75 PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS-- 589
+ ++HRD+K N+LL+ G +K+ DFG A + P V T ++ APE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAMDE 188
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
QY +D+WSLG EL ++P + L I
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------------- 226
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+ + PA S S+ + ++S L P R T+E L H +
Sbjct: 227 ----------AQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-- 271
Query: 710 PLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQRRKELQQGE 753
++ PT Q R + ++ D L+ ++ K++ E
Sbjct: 272 -----RERPPTVIMDLIQ--RTKDAVRELDNLQYRKMKKILFQE 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 1e-70
Identities = 98/338 (28%), Positives = 160/338 (47%), Gaps = 20/338 (5%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ L I G G+V A D VA+KK+ + + + RE+ ++ +H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 473 SIVDVKEVVV----GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
+I+ + V +++VME M+ L + ++ + L+ Q+L GIK
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
+LH ++HRDLK SN+++ + LKI DFGLAR G+ T VVT +YRAPE++LG
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 192
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP-GFSKLPG 647
Y +D+WS+GCIM E++ + LF G+ DQ +K+ + LGTP + +
Sbjct: 193 MG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 648 VKVNFIKHQYNLLRKKFPATSFTG----SPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
N K+ K FP + F + + + DLL+ +L DP KRI+ + AL H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 704 DWFREVPLPKSKDFMPTFPAQHAQDRR------MRRMM 735
+ P + P D R + ++
Sbjct: 312 PYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 1e-70
Identities = 68/328 (20%), Positives = 133/328 (40%), Gaps = 43/328 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++ + G +G+V+R + + + K VK++ + +EI+IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+I+ + E + + M+ E++ D+ + T ++ E+ + Q+ E +++LH
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 532 DNWVLHRDLKTSNLLLNNRGE--LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
+ + H D++ N++ R +KI +FG ARQ + L Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH- 177
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
STA DMWSLG ++ LLS F ++ ++ I T +E+ +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-------- 229
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709
+S D ++ LL + R+TA AL H W ++
Sbjct: 230 -------------------------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
Query: 710 PLPKSKDFMPTFPAQHAQDRRMRRMMKS 737
S + T + +++ +
Sbjct: 265 IERVSTKVIRTLKHRRYYHTLIKKDLNM 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 6e-70
Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 43/299 (14%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSF 469
++++FE + +G +G VY AR+K++ I+ALK + + E+ G RE+ I
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP+I+ + + +++++EY F + + +L + Y
Sbjct: 64 RHPNILRLYGY--FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
H V+HRD+K NLLL + GELKI DFG + +P T L TL Y PE++ G
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG- 178
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
+ + +D+WSLG + E L +P F + + +I +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------------------- 218
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
+ FP +++ DL++ LL ++P +R L H W
Sbjct: 219 ----------VEFTFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-69
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+++E L I G+YG + R K G+I+ K++ E + E+N+L HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLME---TMKQPFSQSEVKCLMLQLLEGIK 528
+IV + ++ ++++VMEY E DL ++ +Q + V +M QL +K
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 529 YLHD-----NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
H + VLHRDLK +N+ L+ + +K+ DFGLAR V T +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
E + Y+ D+WSLGC++ EL + P F S+ + KI + F
Sbjct: 184 EQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----------GKFR 232
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
++P SD +++ +L R + E L +
Sbjct: 233 RIP--------------------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266
Query: 704 DW 705
Sbjct: 267 PL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 5e-69
Identities = 76/309 (24%), Positives = 140/309 (45%), Gaps = 43/309 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
++ R KI +G G VY A D TG+ VA++++ ++++ + + + EI ++ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV+ + + D +++VMEY+ L + + + ++ + + L+ +++LH
Sbjct: 78 NIVNYLDSYLVG--DELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQ 591
N V+HRD+K+ N+LL G +K+ DFG Q + +V T ++ APE++ K
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KA 192
Query: 592 YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651
Y +D+WSLG + E++ EP + ++ L I GTP +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEK---------- 241
Query: 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV-P 710
LS D LN L D +KR +A+ L H + + P
Sbjct: 242 -----------------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
Query: 711 LPKSKDFMP 719
L +
Sbjct: 279 LSSLTPLIA 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 225 bits (575), Expect = 1e-68
Identities = 82/310 (26%), Positives = 130/310 (41%), Gaps = 51/310 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME-------KEREGFPLTSLREINI 465
+ +E + G VV R K T + A+K + + +E + +L+E++I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 466 LLSFH-HPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQL 523
L HP+I+ +K+ + F+V + M+ +L + K S+ E + +M L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAP 583
LE I LH ++HRDLK N+LL++ +K+ DFG + Q P + + T Y AP
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAP 178
Query: 584 ELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638
E++ S Y +DMWS G IM LL+ P F + + L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE 698
W + SD DL++ L P KR TAE
Sbjct: 239 WDDY---------------------------------SDTVKDLVSRFLVVQPQKRYTAE 265
Query: 699 AALNHDWFRE 708
AL H +F++
Sbjct: 266 EALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 9e-67
Identities = 82/331 (24%), Positives = 145/331 (43%), Gaps = 44/331 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
D ++ + + G + V A DK+T ++VA+K + + EG + EI +L HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA-LEGKEGSMENEIAVLHKIKHP 67
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+IV + ++ ++++M+ + +L + K +++ + L+ Q+L+ +KYLH
Sbjct: 68 NIVALDDIYESGG--HLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH 124
Query: 532 DNWVLHRDLKTSNLLL---NNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
D ++HRDLK NLL + ++ I DFGL++ P + T Y APE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
K YS A+D WS+G I LL P F +++ ++I K + W
Sbjct: 184 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD------- 235
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708
+SD+ D + L+ DP+KR T E AL H W
Sbjct: 236 --------------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 709 VPLPKSKDFMPTFPAQHAQDRRMRRMMKSPD 739
K+ + Q ++ + ++ +
Sbjct: 270 DT-ALDKNIHQSVSEQIKKNFAKSKWKQAFN 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-66
Identities = 69/311 (22%), Positives = 122/311 (39%), Gaps = 43/311 (13%)
Query: 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLS 468
+ ++F+ + EG++ V AR+ T A+K ++ +E RE +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP V + + ++ + Y ++ F ++ + +++ ++
Sbjct: 65 LDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELL 586
YLH ++HRDLK N+LLN ++I DFG A+ S V T Y +PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
K + D+W+LGCI+ +L++ P F +E+ KI K EK +P
Sbjct: 183 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR--- 238
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
DL+ LL D KR+ E +
Sbjct: 239 ----------------------------------DLVEKLLVLDATKRLGCEEMEGYGPL 264
Query: 707 REVPLPKSKDF 717
+ P +S +
Sbjct: 265 KAHPFFESVTW 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 7e-64
Identities = 72/310 (23%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVK---MEKEREGFPLTSL-REINILLS 468
D ++ ++ G + VV + R+K TG A K +K + R G + RE++IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP+++ + EV + +++E + K+ ++ E + Q+L G+
Sbjct: 70 IQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGE----LKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
YLH + H DLK N++L +R +KI DFGLA + + ++ T + APE
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPE 186
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
++ + DMWS+G I LLS F G ++ + L + ++ +
Sbjct: 187 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN--- 242
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
S D + LL DP KR+T + +L H
Sbjct: 243 ------------------------------TSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 705 WFREVPLPKS 714
W + ++
Sbjct: 273 WIKPKDTQQA 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-61
Identities = 81/356 (22%), Positives = 144/356 (40%), Gaps = 54/356 (15%)
Query: 412 VDEFERLNK-IDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILL-SF 469
+D+++ ++ + G G V + +K+T E ALK ++ + + RE+ + +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 62
Query: 470 HHPSIVDVKEVV--VGSNLDSIFMVMEYMEH-DLKGLM-ETMKQPFSQSEVKCLMLQLLE 525
P IV + +V + + + +VME ++ +L + + Q F++ E +M + E
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 526 GIKYLHDNWVLHRDLKTSNLLLN---NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRA 582
I+YLH + HRD+K NLL LK+ DFG A++ + T T +Y A
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVA 181
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642
PE+L ++Y + DMWSLG IM LL P F +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------- 227
Query: 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702
QY ++ +S+ L+ +LL +P +R+T +N
Sbjct: 228 --------RIRMGQYEFPNPEWSE--------VSEEVKMLIRNLLKTEPTQRMTITEFMN 271
Query: 703 HDWFRE------VPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEEQ-RRKELQQ 751
H W + PL S+ M + + EQ + K+++
Sbjct: 272 HPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIED 327
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 5e-61
Identities = 59/299 (19%), Positives = 116/299 (38%), Gaps = 44/299 (14%)
Query: 415 FERLN-KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPS 473
F + + +I G++ VY+ D +T VA +++ K + E +L HP+
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 474 IVDVKEVVVGS--NLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
IV + + I +V E M + ++ Q+L+G+++LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 532 DN--WVLHRDLKTSNLLLNNR-GELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
++HRDLK N+ + G +KI D GLA + ++ T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+Y ++D+++ G M E+ + E ++ Q+ + + G P V
Sbjct: 188 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAI--PEV 242
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
K +++ + + D+R + + LNH +F+
Sbjct: 243 K-------------------------------EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 205 bits (522), Expect = 4e-60
Identities = 66/309 (21%), Positives = 129/309 (41%), Gaps = 47/309 (15%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKME----KEREGFPLTSLREINIL 466
++++F I G +G VY R TG++ A+K + + K+ E L ++++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEG 526
+ P IV + D + +++ M + FS+++++ +++ G
Sbjct: 62 STGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 527 IKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELL 586
++++H+ +V++RDLK +N+LL+ G ++I D GLA + + T Y APE+L
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVL 177
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
Y ++ D +SLGC++ +LL F D+ +I + T ++ F
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSF---- 232
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAAL 701
S LL LL D ++R+ A+
Sbjct: 233 -----------------------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 702 NHDWFREVP 710
+FR +
Sbjct: 264 ESPFFRSLD 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-59
Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 55/309 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTS----LREINIL-- 466
+++ + G +G VY VA+K V+ ++ + L + E+ +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLE 525
+S ++ + + DS +++E E T + + + Q+LE
Sbjct: 64 VSSGFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 526 GIKYLHDNWVLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPE 584
+++ H+ VLHRD+K N+L++ NRGELK+ DFG YT T Y PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPE 179
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644
+ + + + +WSLG ++ +++ + F E + F+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------------- 224
Query: 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704
+S L+ L P R T E NH
Sbjct: 225 ----------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256
Query: 705 WFREVPLPK 713
W ++V LP+
Sbjct: 257 WMQDVLLPQ 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-58
Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 45/302 (14%)
Query: 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK--EREGFPLTSLREINILLSF 469
+++F + +G++G V+ A KKT + A+K +K + + T + + + L++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP + + +++F VMEY+ DL +++ F S +++ G++
Sbjct: 61 EHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQ 117
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
+LH +++RDLK N+LL+ G +KI DFG+ ++ T Y APE+LLG
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
++Y+ ++D WS G ++ E+L + F+G+ E + I
Sbjct: 178 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------------ 218
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA-LNHDWFR 707
+P L DLL L +P+KR+ H FR
Sbjct: 219 ------------NPFYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
Query: 708 EV 709
E+
Sbjct: 260 EI 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-58
Identities = 61/306 (19%), Positives = 116/306 (37%), Gaps = 42/306 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ +I G++G VY+ + VA+K + + E+ +L H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH 531
+I+ L +V ++ E L + ++ F ++ + Q +G+ YLH
Sbjct: 65 NILLFMGYSTAPQL---AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 532 DNWVLHRDLKTSNLLLNNRGELKICDFGLARQY--GSPLKPYTHLVVTLWYRAPELLLGS 589
++HRDLK++N+ L+ +KI DFGLA S + L ++ + APE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 590 KQ--YSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
+ YS D+++ G ++ EL++ + ++ + DQ+ + + P SK+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLSKVR- 235
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707
A L+ L D+R L
Sbjct: 236 -------------------------SNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
Query: 708 EVPLPK 713
LPK
Sbjct: 271 ARSLPK 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 197 bits (502), Expect = 9e-58
Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 49/305 (16%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSF 469
S+ +F+ L + G++G V+ R + G A+K +K E R + E +L
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP I+ + + IFM+M+Y+E + Q F K ++ ++Y
Sbjct: 62 THPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH +++RDLK N+LL+ G +KI DFG A+ L T Y APE++
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST- 175
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
K Y+ +ID WS G ++ E+L+ F + +KI
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------------- 216
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHD 704
+FP P ++ DLL+ L+T D +R+ E NH
Sbjct: 217 -----------ELRFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258
Query: 705 WFREV 709
WF+EV
Sbjct: 259 WFKEV 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (498), Expect = 1e-57
Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 40/301 (13%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHH 471
D +E + G V+ ARD + VA+K ++ + R F L RE + +H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 472 PSIVDVKEVVV--GSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
P+IV V + ++VMEY++ + + P + ++ + + +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH---LVVTLWYRAPELL 586
H N ++HRD+K +N++++ +K+ DFG+AR T ++ T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 587 LGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
G D++SLGC++ E+L+ EP F G S + + P G
Sbjct: 187 RG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG----- 240
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706
LS ++ L +P+ R A + D
Sbjct: 241 ----------------------------LSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
Query: 707 R 707
R
Sbjct: 273 R 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 46/305 (15%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSF 469
++++F+ L + +GT+G V R+K TG A+K ++ E + ++ E +L +
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
HP + +K D + VMEY + ++ F++ + +++ ++Y
Sbjct: 63 RHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGS 589
LH V++RD+K NL+L+ G +KI DFGL ++ S T Y APE+L
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED- 179
Query: 590 KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
Y A+D W LG +M E++ F + + I
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------- 220
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHD 704
+FP LS LL LL DP +R+ A+ + H
Sbjct: 221 -----------EIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262
Query: 705 WFREV 709
+F +
Sbjct: 263 FFLSI 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 59/296 (19%), Positives = 112/296 (37%), Gaps = 50/296 (16%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH 470
++ E + L I +G +G V + G VA+K +K + + F L E +++
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLR 58
Query: 471 HPSIVDVKEVVVGSNLDSIFMVMEYMEHD--LKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
H ++V + V+V +++V EYM + L + + L + E ++
Sbjct: 59 HSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLG 588
YL N +HRDL N+L++ K+ DFGL ++ S + + + APE L
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE 174
Query: 589 SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
K++ST D+WS G ++ E+ S + D + ++ K
Sbjct: 175 -KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------- 216
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
+ P A ++++ + D R +
Sbjct: 217 ------------YKMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 2e-52
Identities = 68/309 (22%), Positives = 118/309 (38%), Gaps = 49/309 (15%)
Query: 407 QGCRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINI 465
Q +D+F+R+ + G++G V + K++G A+K + +K + +L E I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
L + + P +V ++ ++ + M L FS+ + Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVL 152
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVVTLWYRAPEL 585
+YLH +++RDLK NLL++ +G +++ DFG A++ L T APE+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEI 209
Query: 586 LLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645
+L K Y+ A+D W+LG ++ E+ + P F +KI
Sbjct: 210 ILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL--- 265
Query: 646 PGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAA 700
DLL +LL D KR
Sbjct: 266 ----------------------------------KDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 701 LNHDWFREV 709
NH WF
Sbjct: 292 KNHKWFATT 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-52
Identities = 59/312 (18%), Positives = 123/312 (39%), Gaps = 46/312 (14%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARD---KKTGEIVALKKVKMEK--EREGFPLTSLREINI 465
++ FE L + G YG V+ R TG++ A+K +K ++ + E +
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLE 525
L + V + ++++Y+ + ++ F++ EV+ + +++
Sbjct: 82 LEHIRQSPFL-VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 526 GIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT--HLVVTLWYRAP 583
+++LH +++RD+K N+LL++ G + + DFGL++++ + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 584 ELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
+ G + A+D WSLG +M ELL+ F E + +I + +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE-- 258
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAE 698
+S DL+ LL DP KR+ A+
Sbjct: 259 -------------------------------MSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 699 AALNHDWFREVP 710
H +F+++
Sbjct: 288 EIKEHLFFQKIN 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (459), Expect = 2e-51
Identities = 78/338 (23%), Positives = 139/338 (41%), Gaps = 36/338 (10%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK------EREGFPLTSLREINI--L 466
+ + K+ G + V+ A+D VA+K V+ +K E E L + + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 467 LSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHD---LKGLMETMKQPFSQSEVKCLMLQL 523
S I+ + + + + +VM + L + + + VK + QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 524 LEGIKYLHDNW-VLHRDLKTSNLLLNNRG------ELKICDFGLARQYGSPLKPYTHLVV 576
L G+ Y+H ++H D+K N+L+ ++KI D G A Y + YT+ +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQ 191
Query: 577 TLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS------EFDQLDKIFKT 630
T YR+PE+LLG + D+WS C++ EL++ + LF + D + +I +
Sbjct: 192 TREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 631 LGTPNEKIWPG------FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLN 684
LG + F G+ N K ++ L + S + D L+
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE-KYKFSKDEAKEISDFLS 309
Query: 685 SLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTFP 722
+L DP KR A +NH W ++ L + +P
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDT-LGMEEIRVPDRE 346
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-51
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 48/299 (16%)
Query: 419 NKIDEGTYGVVYRA--RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVD 476
++ G +G V + + KK + VA+K +K E L E N++ +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 477 VKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
+ + +S +VME E + + L+ Q+ G+KYL ++ +
Sbjct: 73 MIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYRAPELLLGSKQYS 593
HRDL N+LL + KI DFGL++ + Y TH + + APE + ++S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFS 188
Query: 594 TAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
+ D+WS G +M E S + + G + + K
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------------------- 226
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDWFREV 709
R PA +DL+N TYD + R A +++ +V
Sbjct: 227 -------ERMGCPAG-------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 2e-50
Identities = 62/313 (19%), Positives = 104/313 (33%), Gaps = 56/313 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP 472
+ + KI G++G +Y D GE VA+K ++ + E I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGG 62
Query: 473 SIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD 532
+ G+ D MVME + L+ L + FS V L Q++ I+Y+H
Sbjct: 63 VGI-PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 533 NWVLHRDLKTSNLLLNNRG---ELKICDFGLARQYGSP-------LKPYTHLVVTLWYRA 582
+HRD+K N L+ + I DFGLA++Y + +L T Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKT----LGTPNEKI 638
LG + S D+ SLG ++ + G + K + + TP E +
Sbjct: 182 INTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE 698
G+ LN + D +
Sbjct: 241 CKGYPS---------------------------------EFATYLNFCRSLRFDDKPDYS 267
Query: 699 AA---LNHDWFRE 708
+ + R+
Sbjct: 268 YLRQLFRNLFHRQ 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-50
Identities = 62/308 (20%), Positives = 114/308 (37%), Gaps = 52/308 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
+ K+ +G +G V+ T VA+K +K E F L+E ++ H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF----LQEAQVMKKLRH 71
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMK--QPFSQSEVKCLMLQLLEGIKY 529
+V + VV + + I++V EYM + + ++ + Q+ G+ Y
Sbjct: 72 EKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELLLG 588
+ +HRDL+ +N+L+ K+ DFGLAR + + + APE L
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 589 SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
+ ++ D+WS G ++ EL + + G + LD++ + P
Sbjct: 189 GR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC------------ 235
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE--AALNHDW 705
P ++ DL+ +P++R T E A D+
Sbjct: 236 ------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
Query: 706 FREVPLPK 713
F
Sbjct: 272 FTSTEPQY 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 173 bits (438), Expect = 4e-49
Identities = 45/246 (18%), Positives = 94/246 (38%), Gaps = 22/246 (8%)
Query: 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSI 474
++ +I EG++GV++ + + VA+K + E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTG 62
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ G +V++ + L+ L++ + FS V Q+L ++ +H+
Sbjct: 63 I-PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 535 VLHRDLKTSNLLLNN-----RGELKICDFGLARQYGSPL-------KPYTHLVVTLWYRA 582
+++RD+K N L+ + + DFG+ + Y P+ + +L T Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 583 PELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG----TPNEKI 638
LG ++ S D+ +LG + L + G K + TP ++
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 639 WPGFSK 644
GF +
Sbjct: 241 CAGFPE 246
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 9e-49
Identities = 55/301 (18%), Positives = 116/301 (38%), Gaps = 52/301 (17%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
+ + + ++ G +G V+ VA+K +K + F L E N++ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAF----LAEANLMKQLQH 67
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG--LMETMKQPFSQSEVKCLMLQLLEGIKY 529
+V + VV + I+++ EYME+ L + +++ + Q+ EG+ +
Sbjct: 68 QRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELLLG 588
+ + +HRDL+ +N+L+++ KI DFGLAR + + + APE +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 589 SKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647
++ D+WS G ++ E+++ + G + + + + +
Sbjct: 185 -GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------------- 226
Query: 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDW 705
R P + + L+ P+ R T + + D+
Sbjct: 227 ------------YRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 706 F 706
F
Sbjct: 268 F 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 57/295 (19%), Positives = 116/295 (39%), Gaps = 48/295 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
+ L ++ G +GVV + + VA+K +K + F + E ++++ H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEF----IEEAKVMMNLSH 58
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
+V + V IF++ EYM + L + M+ F ++ + + E ++YL
Sbjct: 59 EKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELLLGS 589
LHRDL N L+N++G +K+ DFGL+R + + PE+L+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175
Query: 590 KQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
++S+ D+W+ G +M E+ S + + + + + I + L +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS-------- 227
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
+ + ++ S D+R T + L++
Sbjct: 228 ----------------------------EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 70/306 (22%), Positives = 113/306 (36%), Gaps = 50/306 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTS-LREINILLS 468
+ L K+ +G++GVV R VA+K +K + + + +RE+N + S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 469 FHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGI 527
H +++ + VV+ + MV E L + + F + +Q+ EG+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 528 KYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYRAPE 584
YL +HRDL NLLL R +KI DFGL R Y H V + APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 585 LLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643
L + +S A D W G + E+ + + + G + L KI K
Sbjct: 185 SLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
R P ++++ + P+ R T A
Sbjct: 230 --------------EGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALR-- 266
Query: 704 DWFREV 709
D+ E
Sbjct: 267 DFLLEA 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 60/295 (20%), Positives = 113/295 (38%), Gaps = 48/295 (16%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
E + +I G +G+V+ + VA+K ++ E F + E +++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDF----IEEAEVMMKLSH 59
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYL 530
P +V + V + I +V E+MEH L + T + F+ + + L + EG+ YL
Sbjct: 60 PKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 531 HDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV-TLWYRAPELLLGS 589
+ V+HRDL N L+ +K+ DFG+ R + + + +PE+ S
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 590 KQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
+ YS+ D+WS G +M E+ S + + +S + ++ I ++
Sbjct: 178 R-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA--------- 227
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
S + ++N P+ R L
Sbjct: 228 ---------------------------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 51/297 (17%)
Query: 420 KIDEGTYGVVYRA--RDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
++ G +G V + R +K VA+K +K E+ +RE I+ +P IV +
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM-MREAQIMHQLDNPYIVRL 74
Query: 478 KEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVL 536
V L +VME L + ++ S V L+ Q+ G+KYL + +
Sbjct: 75 IGVCQAEAL---MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 537 HRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTHLVV---TLWYRAPELLLGSKQYS 593
HRDL N+LL NR KI DFGL++ G+ YT L + APE + +++S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 594 TAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652
+ D+WS G M E LS + + + + I +
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------------------- 229
Query: 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA---EAALNHDWF 706
R + P P + L++ Y + R E + ++
Sbjct: 230 --------RMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 2e-46
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 48/306 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEK-EREGFPLTSLREINILLSFHH 471
+ +K+ G YG VY KK VA+K +K + E E F L+E ++ H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 72
Query: 472 PSIVDVKEVVVGSNLDSIFMVMEYMEH--DLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
P++V + V +++ E+M + L L E +Q S + + Q+ ++Y
Sbjct: 73 PNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY-GSPLKPYTHLVVTLWYRAPELLLG 588
L +HRDL N L+ +K+ DFGL+R G + + + APE L
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 589 SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648
++S D+W+ G ++ E+ + + Q+
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------------------ 225
Query: 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDWF 706
Y LL K + + ++L+ + ++P R + F
Sbjct: 226 --------YELLEKDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
Query: 707 REVPLP 712
+E +
Sbjct: 275 QESSIS 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 59/322 (18%), Positives = 114/322 (35%), Gaps = 69/322 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKM----EKEREGFPLTSLREINILLS 468
+ E + G +G V A + +V + EK + E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 469 F-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQS------------ 514
H +IV++ S I+++ EY + DL + + ++ FS+
Sbjct: 97 LGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 515 ----------EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564
++ C Q+ +G+++L +HRDL N+L+ + +KICDFGLAR
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 565 --GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEF 621
S + + + + APE L Y+ D+WS G ++ E+ S + G
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 622 DQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFD 681
K+ + N + P ++ +
Sbjct: 274 ANFYKLIQ----------------------------NGFKMDQP-------FYATEEIYI 298
Query: 682 LLNSLLTYDPDKRITAEAALNH 703
++ S +D KR + +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 8e-46
Identities = 64/301 (21%), Positives = 107/301 (35%), Gaps = 42/301 (13%)
Query: 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDV 477
I +G +G V+R + GE VA+K +ER F EI + H +I+
Sbjct: 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGF 62
Query: 478 KEVVVGSN--LDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLH--- 531
N +++V +Y EH L + + + + L L G+ +LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 532 -----DNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY----THLVVTLWYRA 582
+ HRDLK+ N+L+ G I D GLA ++ S H V T Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 583 PELLLGS-----KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEK 637
PE+L S + D++++G + E+ + + ++ QL P+ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY-QLPYYDLVPSDPSVE 239
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
LR P S ++ + R+TA
Sbjct: 240 EMRKVVCEQK------------LRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTA 285
Query: 698 E 698
Sbjct: 286 L 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 1e-45
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 56/306 (18%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVK---MEKEREGFPLTSLREIN 464
+ + I G +G V K G+ VA+K +K EK+R F L E +
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEAS 79
Query: 465 ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQL 523
I+ F HP+++ ++ VV S + ++ E+ME+ L + F+ ++ ++ +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 524 LEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYTH-----LVVTL 578
G+KYL D +HRDL N+L+N+ K+ DFGL+R T+ + +
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEK 637
+ APE + +++++A D+WS G +M E++S E + + D ++ I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 638 IWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITA 697
P A L+ D + R
Sbjct: 257 DCP------------------------------------SALHQLMLDCWQKDRNHRPKF 280
Query: 698 EAALNH 703
+N
Sbjct: 281 GQIVNT 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-45
Identities = 63/343 (18%), Positives = 117/343 (34%), Gaps = 51/343 (14%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALK---KVKMEKEREGFPLTSLREINILLSF 469
EF+++ + G +G VY+ GE V + K E L E ++ S
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKY 529
+P + + + + S + + L + K + +Q+ +G+ Y
Sbjct: 69 DNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 530 LHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY--THLVVTLWYRAPELLL 587
L D ++HRDL N+L+ +KI DFGLA+ G+ K Y V + + A E +L
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 588 GSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
+ Y+ D+WS G + EL++ ++G + + K
Sbjct: 187 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------------- 230
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH--- 703
R P P+ + + ++ D D R +
Sbjct: 231 --------------RLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
Query: 704 ---DWFREVPLPKSKDFMPTFPAQHAQDRRMRRMMKSPDPLEE 743
D R + + + P R + D ++
Sbjct: 270 MARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 312
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 60/297 (20%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSF 469
+ E I EG +G V++ VA+K K + L+E + F
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQF 65
Query: 470 HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIK 528
HP IV + V+ + ++++ME +L+ ++ K + + QL +
Sbjct: 66 DHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 529 YLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ-YGSPLKPYTHLVVTLWYRAPELLL 587
YL +HRD+ N+L+++ +K+ DFGL+R S + + + + APE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 588 GSKQYSTAIDMWSLGCIMAELL-SKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646
+++++A D+W G M E+L F G D + +I
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------------- 225
Query: 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
R P P + L+ YDP +R
Sbjct: 226 -------------ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 7e-44
Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 72/318 (22%)
Query: 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILL 467
+ E + I EG +G V++AR + +VA+K +K E RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 468 SFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETM------------------- 507
F +P+IV + V + ++ EYM + DL + +M
Sbjct: 72 EFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 508 ----KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563
P S +E C+ Q+ G+ YL + +HRDL T N L+ +KI DFGL+R
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 564 Y--GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSE 620
K + + + + PE + +Y+T D+W+ G ++ E+ S + G +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGF 680
+ + + P +
Sbjct: 249 EEVIYYVRDG-----------------------------NILACP-------ENCPLELY 272
Query: 681 DLLNSLLTYDPDKRITAE 698
+L+ + P R +
Sbjct: 273 NLMRLCWSKLPADRPSFC 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 57/294 (19%), Positives = 112/294 (38%), Gaps = 48/294 (16%)
Query: 419 NKIDEGTYGVVYRARD---KKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV 475
I G +G VY A+K + + G L E I+ F HP+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 91
Query: 476 DVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ + + S S +V+ YM+H DL+ + + ++ LQ+ +G+K+L
Sbjct: 92 SLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 535 VLHRDLKTSNLLLNNRGELKICDFGLARQYGSP----LKPYTHLVVTLWYRAPELLLGSK 590
+HRDL N +L+ + +K+ DFGLAR + T + + + A E L +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 591 QYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649
+++T D+WS G ++ EL++ P + + FD + + + P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP--------- 260
Query: 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703
D ++++ + R + ++
Sbjct: 261 ---------------------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 62/313 (19%), Positives = 115/313 (36%), Gaps = 61/313 (19%)
Query: 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEI--VALKKVKMEKEREGFPLTSLREINILLS 468
++ + + I EG +G V +AR KK G A+K++K ++ E+ +L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCK 66
Query: 469 F-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLM---------------ETMKQPF 511
HHP+I+++ +++ +EY H +L + +
Sbjct: 67 LGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 512 SQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571
S ++ + G+ YL +HRDL N+L+ KI DFGL+R +K
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKT 630
+ + + A E L Y+T D+WS G ++ E++S + G + + +K+ +
Sbjct: 185 MG-RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 631 LGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYD 690
R + P D +DL+
Sbjct: 243 -----------------------------YRLEKP-------LNCDDEVYDLMRQCWREK 266
Query: 691 PDKRITAEAALNH 703
P +R + L
Sbjct: 267 PYERPSFAQILVS 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 68/331 (20%), Positives = 128/331 (38%), Gaps = 70/331 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVK---MEKEREGFPLTSLREIN 464
++ ++ +G++G+VY K + VA+K V +ER F L E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEAS 75
Query: 465 ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMK---------QPFSQS 514
++ F+ +V + VV ++ME M DLK + +++ P S S
Sbjct: 76 VMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 515 EVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LKPYT 572
++ + ++ +G+ YL+ N +HRDL N ++ +KI DFG+ R +
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTL 631
++ + + +PE L ++T D+WS G ++ E+ + E + G S L + +
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-- 250
Query: 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDP 691
G P D F+L+ Y+P
Sbjct: 251 --------GGLLDKP--------------------------DNCPDMLFELMRMCWQYNP 276
Query: 692 DKRITAEAALN------HDWFREVPLPKSKD 716
R + ++ FREV S++
Sbjct: 277 KMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 57/318 (17%), Positives = 104/318 (32%), Gaps = 67/318 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVK---MEKEREGFPLTSLREIN 464
D + + G +G V A T VA+K +K E + E+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELK 68
Query: 465 ILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDL----------------KGLMETMK 508
IL+ H V + +++E+ + + K
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 509 QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP- 567
+ + C Q+ +G+++L +HRDL N+LL+ + +KICDFGLAR
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 568 -LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625
+ L + APE + + Y+ D+WS G ++ E+ S + G ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNS 685
+ K R + P + + +
Sbjct: 248 RRLK----------------------------EGTRMRAP-------DYTTPEMYQTMLD 272
Query: 686 LLTYDPDKRITAEAALNH 703
+P +R T + H
Sbjct: 273 CWHGEPSQRPTFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 55/302 (18%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVK---MEKEREGFPLTSLREINI 465
R I G +G VY+ K + VA+K +K EK+R F L E I
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGI 62
Query: 466 LLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKG-LMETMKQPFSQSEVKCLMLQLL 524
+ F H +I+ ++ V+ + ++ EYME+ + FS ++ ++ +
Sbjct: 63 MGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 525 EGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY---THLVVTLWYR 581
G+KYL + +HRDL N+L+N+ K+ DFGL+R + + + + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 582 APELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640
APE + +++++A D+WS G +M E+++ E + S + + I P P
Sbjct: 181 APEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700
A + L+ + +R
Sbjct: 240 ------------------------------------SAIYQLMMQCWQQERARRPKFADI 263
Query: 701 LN 702
++
Sbjct: 264 VS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 62/319 (19%), Positives = 108/319 (33%), Gaps = 72/319 (22%)
Query: 413 DEFERLNKIDEGTYGVVYRARD-----KKTGEIVALKKVK---MEKEREGFPLTSLREIN 464
+ + G +G V A VA+K +K ERE + E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELK 78
Query: 465 ILLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH------------------DLKGLME 505
+L +H +IV++ ++ EY + +ME
Sbjct: 79 VLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 506 TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY- 564
+ ++ Q+ +G+ +L +HRDL N+LL + KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 565 -GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFD 622
S + + + + APE + Y+ D+WS G + EL S + G
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 623 QLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDL 682
+ K+ IK + +L + +D+
Sbjct: 256 KFYKM-------------------------IKEGFRMLSPEH----------APAEMYDI 280
Query: 683 LNSLLTYDPDKRITAEAAL 701
+ + DP KR T + +
Sbjct: 281 MKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 52/318 (16%), Positives = 109/318 (34%), Gaps = 67/318 (21%)
Query: 413 DEFERLNKIDEGTYGVVYRARDKKTGE-------IVALKKVKMEKEREGFPLTSLREINI 465
D + EG +G V A + VA+K +K + + + E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEM 71
Query: 466 LLSF-HHPSIVDVKEVVVGSNLDSIFMVMEYMEH-DLKGLMETMKQP------------- 510
+ H +I+ + + +++++EY +L+ ++ + P
Sbjct: 72 MKMIGKHKNII--NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 511 --FSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568
S ++ Q+ G++YL +HRDL N+L+ +KI DFGLAR
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 569 KPYT--HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625
+ + + + APE L + Y+ D+WS G ++ E+ + + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNS 685
+ + R P ++ + ++
Sbjct: 249 LLKEGH-----------------------------RMDKP-------SNCTNELYMMMRD 272
Query: 686 LLTYDPDKRITAEAALNH 703
P +R T + +
Sbjct: 273 CWHAVPSQRPTFKQLVED 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (269), Expect = 1e-27
Identities = 26/209 (12%), Positives = 60/209 (28%), Gaps = 43/209 (20%)
Query: 419 NKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE----------------REGFPLTSLRE 462
+ EG V+ + +K K+ ++ E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 463 INILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQ 522
L ++ V + ++ME ++ ++
Sbjct: 65 FRALQKLQGLAVPKVYAW------EGNAVLMELIDAK-------ELYRVRVENPDEVLDM 111
Query: 523 LLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY----THLVVTL 578
+LE + + ++H DL N+L++ G + I DF + + G +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 579 WYRAPELLLGSKQYSTAIDMWSLGCIMAE 607
++ + Y T D+ S + +
Sbjct: 171 YFS--------RTYRTEKDINSAIDRILQ 191
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 37.9 bits (87), Expect = 0.004
Identities = 23/141 (16%), Positives = 48/141 (34%), Gaps = 6/141 (4%)
Query: 420 KIDEGTYGVVYRARDKKTGEIVALKK--VKMEKEREGFPLT---SLREINILLSFHHPSI 474
+I +G V+ D++ + +K+ + E +PLT + E + L +
Sbjct: 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSAL-IRQGEHV 91
Query: 475 VDVKEVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW 534
+ V S+ + VME + H ++ + + L + + Y D
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 535 VLHRDLKTSNLLLNNRGELKI 555
+ + K N I
Sbjct: 152 LEPKVKKQLVKQFTNPELCDI 172
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 776 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.46 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-58 Score=486.12 Aligned_cols=290 Identities=42% Similarity=0.779 Sum_probs=243.4
Q ss_pred eEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc---cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 416 ERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER---EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 416 eil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.++|||||+++++|.. .+++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeeh
Confidence 4578999999999999999999999999999765432 2234567899999999999999999999944 5589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
|||+.|+++..+......|++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99999988888887778899999999999999999999999999999999999999999999999999988766655666
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.++.+++.+|++.++.|....|+............
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 77999999999999876778999999999999999999999999999999999999999999999888766554321100
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKD 716 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~ 716 (776)
......+... .+.++++++|||.+||++||++||||.|||+||||+..+.|....
T Consensus 239 -~~~~~~~~~~--------~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~ 293 (299)
T d1ua2a_ 239 -SFPGIPLHHI--------FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293 (299)
T ss_dssp -CCCCCCHHHH--------CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred -cCCCCChHHh--------cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCC
Confidence 0000000111 124789999999999999999999999999999999988765443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=482.65 Aligned_cols=291 Identities=49% Similarity=0.921 Sum_probs=248.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|++++|||||+++++|.. ...+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeE
Confidence 478999999999999999999999999999999997765555556678899999999999999999999955 458999
Q ss_pred EeeehhhhhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHDLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
||||+.++++.++.. ....|++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999999887776654 3567999999999999999999999999999999999999999999999999999988766666
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+||+.|+|||++.....++.++|||||||+||+|++|+.||.+.+..+++.+++...+.|....|+.....+....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 67779999999999998877789999999999999999999999999999999999999999999998887766655433
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+........... .+.++..++|||.+||++||.+|||+.|||+||||++++.|
T Consensus 239 ~~~~~~~~~~~~~--------~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 239 SFPKWARQDFSKV--------VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TSCCCCCCCHHHH--------STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccchhhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 3322111111111 12488999999999999999999999999999999988655
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=472.61 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=221.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
.+++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEE
Confidence 46899999999999999999999999999999999976553 23344567789999999999999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||||.|+.+..+......|++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~ 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--S 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--C
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--C
Confidence 99999999644444444456799999999999999999999999999999999999999999999999999987643 3
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|.+....
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3456789999999999988 56899999999999999999999999999888888777543111
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+..+++.+++||.+||++||.+|||+.|||+||||+.
T Consensus 223 ---------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 ---------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11247899999999999999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=472.97 Aligned_cols=259 Identities=28% Similarity=0.427 Sum_probs=214.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|++|+|||||++++++.. .+.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 57899999999999999999999999999999999765432 234567899999999999999999999955 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--C
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--L 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~ 568 (776)
|||||.| +|.+++ .....|++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 81 vmEy~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999986 555555 44567999999999999999999999999999999999999999999999999999876322 2
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|||||++.+...++.++|||||||+||+|++|.+||...+.......+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 334567899999999999886656789999999999999999999998766554443333321110
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
......+++++++||.+||+.||.+|||+.|||+||||++
T Consensus 226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0011237899999999999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=483.23 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=229.6
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||+++++|.+ .+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--cccc
Confidence 46899999999999999999999999999999999987643 33344567899999999999999999999954 5689
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||||.|+.+..+....+.|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999765555566667899999999999999999999999999999999999999999999999999998766556
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~---------------- 223 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC----------------
Confidence 6677899999999999988 56899999999999999999999999999988888777654211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
.+..+|+++++||.+||++||.+|+ ++.|||+||||+++.|
T Consensus 224 ---------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 224 ---------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 1124899999999999999999999 4999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-56 Score=469.51 Aligned_cols=286 Identities=50% Similarity=0.880 Sum_probs=243.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|+.++|||||+++++|.. ...+|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeE
Confidence 478999999999999999999986 78999999998766555566778899999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
+|+|+.++++..+....+.|++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|..........
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 99999999988888888899999999999999999999999999999999999999999999999999999876655555
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchh
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVN 651 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~ 651 (776)
....+|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+++.+++..++.|....|+.....+.....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 66789999999999988778899999999999999999999999999999999999999999999988876665543222
Q ss_pred hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 652 FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 652 ~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
+.... +.........+++.++|||.+||++||++|||+.|||+||||++
T Consensus 238 ~~~~~--------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYE--------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCC--------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccc--------CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 21110 11111123458999999999999999999999999999999984
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=473.48 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=221.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.+|+.++|||||+++++|.. .+.+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 4799999999999999999999999999999999765422 23457899999999999999999999955 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+.+..+.. ...|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 96 mEy~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99999754444443 35799999999999999999999999999999999999999999999999999998765555666
Q ss_pred ccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 573 HLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+..... +..
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~---------------- 236 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL---------------- 236 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC----------------
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCC----------------
Confidence 7899999999999988 5689999999999999999999999999888887777765421 111
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
..+..+++.+++||.+||+.||.+|||+.|||+||||+.
T Consensus 237 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 -----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112248899999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=474.52 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=223.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
.++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|++|+|||||+++++|.+ .+.+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 3789999999999999999999999999999999976543 33344567899999999999999999999954 46899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--C
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--L 568 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~ 568 (776)
||||||.|+.+..+....+.|++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999996444334444568999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|.+....
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 23445789999999999987 56899999999999999999999999999988888888654211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HHcCcCcCCCCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA------ALNHDWFREVPLPKSK 715 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E------IL~HPwf~~i~~pk~~ 715 (776)
.+..+++.+++||.+||++||.+|||++| |++||||+.++|.+..
T Consensus 229 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 229 ----------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp ----------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred ----------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 01237899999999999999999999987 6899999999886543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-55 Score=481.46 Aligned_cols=271 Identities=27% Similarity=0.445 Sum_probs=232.3
Q ss_pred ccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 410 RSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 410 ~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
..+++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+|+.+|++|+|||||+++++|.. .+.+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 98 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFED--DNEM 98 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh--HHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 34689999999999999999999999999999999997544322 3456789999999999999999999954 4589
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC--CCcEEEeecccccccCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN--RGELKICDFGLARQYGS 566 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~--~g~iKL~DFGlA~~~~s 566 (776)
|||||||.| +|..++.....+|++.+++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+..
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999985 666777666678999999999999999999999999999999999999964 57899999999998753
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. ....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......+....+
T Consensus 179 ~-~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------- 249 (350)
T d1koaa2 179 K-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------- 249 (350)
T ss_dssp T-SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG-------
T ss_pred c-cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc-------
Confidence 3 44556799999999999988 56899999999999999999999999999999999888776443322211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMP 719 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~ 719 (776)
+.+|..+++||.+||++||.+|||+.|||+||||+....+.....+|
T Consensus 250 --------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 250 --------------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp --------------------------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred --------------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 13789999999999999999999999999999999887765544333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=464.97 Aligned_cols=292 Identities=39% Similarity=0.735 Sum_probs=242.5
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCC-CcEEEEEEeecchhccCCccchHHHHHHHHhC---CCCCcceeeEEEec-
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKT-GEIVALKKVKMEKEREGFPLTSLREINILLSF---HHPSIVDVKEVVVG- 483 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~t-g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPnIV~l~~~~~~- 483 (776)
|+..++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||++++++|..
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 56678999999999999999999999765 67899999987665555556677888887766 79999999999853
Q ss_pred --cCCCeeEEEeeehhhhhhhHHh-hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccc
Q 004049 484 --SNLDSIFMVMEYMEHDLKGLME-TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGL 560 (776)
Q Consensus 484 --~~~~~l~LVmEy~~g~Ll~~l~-~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGl 560 (776)
.....+|++|||+.++++.+.. .....+++..++.|+.||+.||+|||++|||||||||+|||++..+.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 2345789999999987665544 4456799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 561 ARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 561 A~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
+..... .......+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+..+++..|+..++.|....|+
T Consensus 163 ~~~~~~-~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSF-QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCG-GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhcc-cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 986532 234456799999999999987 568999999999999999999999999999999999999999999888887
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.....+..... .............+++.++|||.+||++||.+||||.|||+||||+++...
T Consensus 241 ~~~~~~~~~~~----------~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 241 RDVALPRQAFH----------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp TTCSSCGGGSC----------CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccchhhhhc----------cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 65444322110 011111112234589999999999999999999999999999999988643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=468.04 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=209.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||++++++.+.....+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999999766544333456779999999999999999999997766678999
Q ss_pred Eeeehhh-hhhhHHhh---ccCCCCHHHHHHHHHHHHHHhhhhccCC-----cccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 492 VMEYMEH-DLKGLMET---MKQPFSQSEVKCLMLQLLEGIKYLHDNW-----VLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~---~~~~Lse~~~~~i~~qIl~aL~yLHs~g-----IvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
|||||+| +|..++.. ....|++.+++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999985 56665543 3467999999999999999999999876 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 563 QYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 563 ~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
.+..........+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-------- 233 (269)
T ss_dssp HC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred ecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 87655555567899999999999987 568999999999999999999999999998888887776542110
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCc
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWF 706 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf 706 (776)
.+..+|+++.+||.+||+.||.+|||+.|||+|||+
T Consensus 234 ----------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 ----------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 012378999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=470.20 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=220.7
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|++++.||+|+||+||+|+++.++..||||++..... .....+.+|+.+|++|+|||||++++++.. .+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 569999999999999999999999999999999976432 234577899999999999999999999955 4589999
Q ss_pred eeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 493 MEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||||.|+ |..++....++|++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.........
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999864 555556666789999999999999999999999999999999999999999999999999997654322233
Q ss_pred cccccccccCCchhhcc----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 572 THLVVTLWYRAPELLLG----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.+.+||+.|||||++.. ...|+.++|||||||+||+|++|.+||.+.+..+.+.+|.......
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------------- 234 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------------- 234 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-------------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 45789999999999852 3558999999999999999999999999998888888876642110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
+..+..+++++++||.+||+.||.+|||+.|||+||||+.
T Consensus 235 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 ---------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111247899999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-55 Score=472.33 Aligned_cols=259 Identities=30% Similarity=0.443 Sum_probs=228.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||++++++.. ...+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 79 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI 79 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCee
Confidence 46899999999999999999999999999999999976543 33344567799999999999999999999954 5589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|+|||||.|+.+..+......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 99999999877777777778899999999999999999999999999999999999999999999999999988753
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
...+.+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|......
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 219 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 219 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence 3346799999999999987 56899999999999999999999999999998888888764211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
.++.+++++++||.+||.+||.+|+ |+++||+||||+++.|.
T Consensus 220 ---------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 220 ---------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 1124789999999999999999996 99999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-55 Score=471.28 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=205.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
+.|++++.||+|+||+||+|+++.+++.||||++....... ....+.+|+.+|+.|+|||||+++++|.. ...+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 56999999999999999999999999999999997654332 23456689999999999999999999954 5689999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec---CCCcEEEeecccccccCCCC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN---NRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd---~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||.| +|.+++. ..+.|++.+++.|+.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp ECCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999985 5656554 456899999999999999999999999999999999999995 5789999999999876433
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+....|......++.+.+
T Consensus 164 ~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 233 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW--------- 233 (307)
T ss_dssp ---------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT---------
T ss_pred CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc---------
Confidence 33456789999999999987 56899999999999999999999999999988888888765433322222
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+.+|+.+++||.+||++||.+|||+.|||+||||++.
T Consensus 234 ------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 234 ------------------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------------------cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 2388999999999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-55 Score=475.22 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=227.2
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||+||+|+++.+|+.||||+++...... ...+.+|+.+|++|+|||||+++++|.. ...+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED--KYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 3478999999999999999999999999999999997654222 2456789999999999999999999954 56899
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec--CCCcEEEeecccccccCCC
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN--NRGELKICDFGLARQYGSP 567 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd--~~g~iKL~DFGlA~~~~s~ 567 (776)
||||||.| +|...+.....+|++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|..+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999995 56666666666899999999999999999999999999999999999998 5789999999999987543
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+++..|......++...|+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 253 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS------- 253 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT-------
T ss_pred -CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc-------
Confidence 44566789999999999987 568999999999999999999999999999999999988765444333322
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+++++++||.+||++||.+|||+.|||+||||+..
T Consensus 254 --------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 254 --------------------------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 388999999999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-55 Score=463.94 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=220.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC----CccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG----FPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~----~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
++|++++.||+|+||+||+|+++.+|+.||||++++...... ....+.+|+.+|++|+|||||+++++|.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 569999999999999999999999999999999976543222 22456789999999999999999999954 568
Q ss_pred eEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC----cEEEeecccccc
Q 004049 489 IFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG----ELKICDFGLARQ 563 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g----~iKL~DFGlA~~ 563 (776)
+|||||||.| +|..++. ..+.|++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+|..
T Consensus 88 ~~iv~E~~~gg~L~~~i~-~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCccccchhc-cccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999996 4555554 456799999999999999999999999999999999999999876 599999999987
Q ss_pred cCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|......+....
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----- 239 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY----- 239 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH-----
T ss_pred cCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh-----
Confidence 7433 34456789999999999987 5689999999999999999999999999999888888866532221111
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.+.+|..+++||.+||+.||.+|||+.|||+||||+..++.
T Consensus 240 ----------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 240 ----------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp ----------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred ----------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 12378999999999999999999999999999999976653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=473.60 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=225.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+++|+.+|+.++|||||+++++|.. ...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 5899999999999999999999999999999999976543 23334567899999999999999999999954 45899
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
+||||+.|+.+..+....+.|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.. .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---R 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---C
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---c
Confidence 9999999765555545556899999999999999999999999999999999999999999999999999998753 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
..+.+||+.|||||++.+ ..|+.++|||||||+||+|++|.+||.+.+....+.+|......+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~---------------- 257 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---------------- 257 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----------------
Confidence 345789999999999988 568999999999999999999999999999888888886652211
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPLP 712 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~p 712 (776)
+..+++++.+||.+||.+||.+|+ |+++||+||||+.++|.
T Consensus 258 ---------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 258 ---------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ---------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ---------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 123789999999999999999995 99999999999988753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=458.51 Aligned_cols=299 Identities=42% Similarity=0.789 Sum_probs=242.0
Q ss_pred cccCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---
Q 004049 409 CRSVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN--- 485 (776)
Q Consensus 409 ~~~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~--- 485 (776)
|..+++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 44578999999999999999999999999999999999776665666677889999999999999999999985422
Q ss_pred ---CCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 486 ---LDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 486 ---~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..++|+||||+.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999998888887778889999999999999999999999999999999999999999999999999998
Q ss_pred ccCCC----CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 563 QYGSP----LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 563 ~~~s~----~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
.+... .......+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.++...+..|....+.+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 66422 22334468999999999998877799999999999999999999999999999999999999999988887
Q ss_pred CCCCCCCCCcchh-hhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCC
Q 004049 639 WPGFSKLPGVKVN-FIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPK 713 (776)
Q Consensus 639 wp~~~~lp~~~~~-~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk 713 (776)
+..+......... ........+...++ ....++.++|||.+||++||++||||.|||+||||+..+.|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHH------HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred ccccchhhhhhhhcccccccccchhhhc------cccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 7665443221100 00000000000000 012578899999999999999999999999999999876654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-55 Score=467.18 Aligned_cols=254 Identities=29% Similarity=0.485 Sum_probs=220.6
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
.|++++.||+|+||+||+|+++.+++.||||++...... ......+.+|+.+|++|+|||||+++++|.. ...+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 499999999999999999999999999999999765422 2223457799999999999999999999965 4589999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCcc
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPYT 572 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~~ 572 (776)
||||.|+++..+.....+|++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... ..
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~ 169 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN 169 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence 99999887777777778899999999999999999999999999999999999999999999999999987632 34
Q ss_pred ccccccccCCchhhcc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 573 HLVVTLWYRAPELLLG--SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 573 ~~~GT~~Y~APEvl~g--~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
..+||+.|||||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+..+......+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~---------------- 233 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---------------- 233 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 5789999999999975 2458999999999999999999999999988888887776542111
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.....+|+.+++||.+||+.||.+|||+.|||+||||+.
T Consensus 234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 011247899999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=471.88 Aligned_cols=288 Identities=25% Similarity=0.398 Sum_probs=213.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
-++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|+.++|||||+++++|.. ..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 3789999999999999999999999999999999976432 2233467799999999999999999999954 458999
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP 570 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~ 570 (776)
|||||.|+.+..+....+.|++.+++.|+.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+.. ..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~ 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SM 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--Cc
Confidence 99999975444444445679999999999999999999997 5999999999999999999999999999987643 22
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCCCCCCCCc-
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ-LDKIFKTLGTPNEKIWPGFSKLPGV- 648 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~-l~kI~~~lg~p~~~~wp~~~~lp~~- 648 (776)
..+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+.... +..+....+.+... +.....+..
T Consensus 160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET--PPRPRTPGRP 236 (322)
T ss_dssp C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC--Cccccccccc
Confidence 345799999999999998 5699999999999999999999999987654332 22222222221111 000000000
Q ss_pred ----------chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 649 ----------KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 649 ----------~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
...... .........+. ......+|.+++|||.+||++||.+||||+|||+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFE-LLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHH-HHHHHHTSCCC--CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHH-HHhhhhccCCc--cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000 01111111111 111234789999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=453.21 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=209.2
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec--cCCCeeEEE
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG--SNLDSIFMV 492 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~--~~~~~l~LV 492 (776)
|++.+.||+|+||+||+|+++.++..||+|++............+.+|+.+|++|+|||||+++++|.. .....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999999999999999997655333334567799999999999999999999864 234578999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCC--cccCCCCCCCeeec-CCCcEEEeecccccccCCCCC
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNW--VLHRDLKTSNLLLN-NRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~g--IvHrDLKPeNILLd-~~g~iKL~DFGlA~~~~s~~~ 569 (776)
||||+|+.+..+......+++.+++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+.... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~ 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--C
Confidence 999997544444444568999999999999999999999999 99999999999997 578999999999986533 3
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQL-DKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l-~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
.....+||+.|||||++.+ .|+.++|||||||+||+|++|.+||.+......+ ..|.... .| ..
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~-~~-~~----------- 233 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KP-AS----------- 233 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CC-GG-----------
T ss_pred ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-CC-cc-----------
Confidence 3456799999999999875 4899999999999999999999999876554443 3332211 00 00
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
.+..+++++.+||.+||++||.+|||+.|||+||||+
T Consensus 234 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 ----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0123788999999999999999999999999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=449.88 Aligned_cols=289 Identities=44% Similarity=0.786 Sum_probs=246.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
+++|++++.||+|+||+||+|+++.+++.||||+++...........+.+|+.+|+.++||||++++++|.. ...+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeE
Confidence 478999999999999999999999999999999997765444445677899999999999999999999954 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCCc
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKPY 571 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~~ 571 (776)
||+|+.|+++..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|..........
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 99999998888887788899999999999999999999999999999999999999999999999999999886665566
Q ss_pred cccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcch
Q 004049 572 THLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPL-FNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKV 650 (776)
Q Consensus 572 ~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~P-F~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~ 650 (776)
....+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+++.++....+.+....|+.....+....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 6677899999999998867789999999999999999998876 677788889999999999998888887655543321
Q ss_pred hhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCC
Q 004049 651 NFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVP 710 (776)
Q Consensus 651 ~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~ 710 (776)
.... ............++..+++||.+||++||.+||||+|||+||||++..
T Consensus 239 ~~~~--------~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMY--------PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCC--------CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccc--------cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 1100 001111222346899999999999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=462.10 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=224.7
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchh-ccCCccchHHHHHHHH-hCCCCCcceeeEEEeccCCCee
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE-REGFPLTSLREINILL-SFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~-~~~~~~~~~rEi~iL~-~L~HPnIV~l~~~~~~~~~~~l 489 (776)
+++|++++.||+|+||+||+|+++.+++.||||++++... .......+..|+.++. .++|||||++++++.. .+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCce
Confidence 4789999999999999999999999999999999976543 2333445667777765 6899999999999954 4589
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||||.|+.+..+......+++.+++.|+.||+.||+|||++|||||||||+|||++.++++||+|||+|+.......
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999755554555567899999999999999999999999999999999999999999999999999997765555
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+++.+|.... |.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~-------------- 221 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF-------------- 221 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CC--------------
Confidence 6666899999999999998 568999999999999999999999999999888888875531 10
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCcCcCCCCCC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE-AALNHDWFREVPLP 712 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~-EIL~HPwf~~i~~p 712 (776)
.+..+|+.+++||.+||++||.+|||+. ++++||||+++.+.
T Consensus 222 ---------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 222 ---------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ---------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 1124899999999999999999999995 89999999988653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-53 Score=468.47 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=214.8
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc-CCccchHH---HHHHHHhCCCCCcceeeEEEeccCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE-GFPLTSLR---EINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~-~~~~~~~r---Ei~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
++++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+ ++.+++.+.|||||+++++|.. .
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--P 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--S
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--C
Confidence 4689999999999999999999999999999999997654222 12222333 4667777889999999999954 4
Q ss_pred CeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 487 DSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 487 ~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
+.+|||||||.|+.+..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 58999999999654444444456799999999999999999999999999999999999999999999999999997754
Q ss_pred CCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 567 PLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 567 ~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
. .....+||+.|+|||++.....|+.++|||||||+||+|++|.+||.+.+..+... +........
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~----------- 225 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----------- 225 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC-----------
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC-----------
Confidence 3 34457899999999999865679999999999999999999999998765443332 222211111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCcCcCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRIT-----AEAALNHDWFREVPL 711 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpT-----a~EIL~HPwf~~i~~ 711 (776)
...+..+++.+++||.+||++||.+||| |+|||+||||+.++|
T Consensus 226 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 226 ----------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ----------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1112348999999999999999999999 799999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-54 Score=463.29 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=224.4
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++++.||+|+||+||+|+++.+++.||||+++..... ...+.+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 47899999999999999999999999999999999765432 2346789999999999999999999954 458999
Q ss_pred Eeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC--CcEEEeecccccccCCCC
Q 004049 492 VMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR--GELKICDFGLARQYGSPL 568 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~--g~iKL~DFGlA~~~~s~~ 568 (776)
|||||.| +|...+......|++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||++..... .
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~ 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-G 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-T
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-C
Confidence 9999996 6777776666689999999999999999999999999999999999999854 4899999999987743 3
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..|.+....++...|+
T Consensus 158 ~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-------- 228 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK-------- 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT--------
T ss_pred CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc--------
Confidence 34556789999999999987 568999999999999999999999999999999999988764433322221
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
.+|+++++||.+||++||.+|||+.|||+||||++-
T Consensus 229 -------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 229 -------------------------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------------------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 278999999999999999999999999999999763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-53 Score=449.07 Aligned_cols=259 Identities=30% Similarity=0.432 Sum_probs=222.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC-------CccchHHHHHHHHhCC-CCCcceeeEEEecc
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG-------FPLTSLREINILLSFH-HPSIVDVKEVVVGS 484 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~-------~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~ 484 (776)
++|++++.||+|+||+||+|+++.+++.||||++.+...... ....+.+|+.+|++|. |||||+++++|.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 789999999999999999999999999999999976542221 1234678999999997 999999999995
Q ss_pred CCCeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccc
Q 004049 485 NLDSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQ 563 (776)
Q Consensus 485 ~~~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~ 563 (776)
+.+.+|||||||+| +|.+++.. .+++++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 45689999999986 66666654 56899999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCchhhcc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 004049 564 YGSPLKPYTHLVVTLWYRAPELLLG-----SKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKI 638 (776)
Q Consensus 564 ~~s~~~~~~~~~GT~~Y~APEvl~g-----~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~ 638 (776)
+... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+....+..|+.....+....
T Consensus 160 ~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 160 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 7543 34456789999999999963 34578899999999999999999999999999888888877633222111
Q ss_pred CCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCC
Q 004049 639 WPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFRE 708 (776)
Q Consensus 639 wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~ 708 (776)
.+.+|+++++||.+||+.||.+|||+.|||+||||++
T Consensus 239 ---------------------------------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 ---------------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ---------------------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ---------------------------------cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1238999999999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=461.52 Aligned_cols=289 Identities=34% Similarity=0.589 Sum_probs=229.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC----CCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN----LDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~----~~~ 488 (776)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.|+|||||+++++|.... ...
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 6899999999999999999999999999999999765433333456789999999999999999999996432 235
Q ss_pred eEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 489 IFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 489 l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
+||||||++.++..++. ...|++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 98 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-- 173 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173 (346)
T ss_dssp CEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--
Confidence 79999999766665554 35799999999999999999999999999999999999999999999999999987653
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
..+..+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+..+++..+....+.++..+|..+..
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 248 (346)
T d1cm8a_ 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS---- 248 (346)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC----
T ss_pred -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc----
Confidence 345678999999999998867789999999999999999999999999999999999999988887665543221
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
.........+..............+++.++|||.+||++||.+||||.|||+||||+.+..+
T Consensus 249 --~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 249 --DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp --HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred --hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 11111111111100111111234589999999999999999999999999999999987644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=460.94 Aligned_cols=279 Identities=35% Similarity=0.592 Sum_probs=230.4
Q ss_pred CeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEec----cCCCee
Q 004049 414 EFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVG----SNLDSI 489 (776)
Q Consensus 414 ~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~----~~~~~l 489 (776)
+|..+++||+|+||+||+|+++.+|+.||||++.... ....+|+.+|++|+|||||+++++|.. .+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 6999999999999999999999999999999997543 223479999999999999999999853 234468
Q ss_pred EEEeeehhhhhhhHHh---hccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccC
Q 004049 490 FMVMEYMEHDLKGLME---TMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYG 565 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~---~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~ 565 (776)
|||||||++++...+. .....|++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987665554 3456799999999999999999999999999999999999999875 89999999998774
Q ss_pred CCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCC
Q 004049 566 SPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKL 645 (776)
Q Consensus 566 s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~l 645 (776)
.. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|.+||...+..+++..|++.++.+....|.....
T Consensus 175 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~- 252 (350)
T d1q5ka_ 175 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP- 252 (350)
T ss_dssp TT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc-
Confidence 33 3455678999999999998767899999999999999999999999999999999999999988876544322110
Q ss_pred CCcchhhhhhhhhHhhhcCCCC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCC
Q 004049 646 PGVKVNFIKHQYNLLRKKFPAT-----SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 646 p~~~~~~~~~~~~~l~~~~p~~-----~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~p 712 (776)
......++.. .....+.+++++++||.+||++||.+||||.|||+||||+++..+
T Consensus 253 ------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 253 ------------NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp ---------------CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred ------------chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0000011100 011234589999999999999999999999999999999987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=441.55 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=210.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhcc----CCccchHHHHHHHHhCC--CCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKERE----GFPLTSLREINILLSFH--HPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HPnIV~l~~~~~~~~~ 486 (776)
++|++.+.||+|+||+||+|+++.+|+.||||++....... .....+.+|+.+|++++ |||||+++++|.. .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--C
Confidence 67999999999999999999999999999999997654321 12344678999999997 8999999999954 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-CCcEEEeeccccccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-RGELKICDFGLARQY 564 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-~g~iKL~DFGlA~~~ 564 (776)
+.+|+||||+.+ +++..+......|++.+++.|+.||+.||+|||++|||||||||+||||+. .+.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 589999999975 344344444568999999999999999999999999999999999999985 479999999999876
Q ss_pred CCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 565 GSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 565 ~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
.. ....+.+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+ .+.....
T Consensus 162 ~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~------------ 221 (273)
T d1xwsa_ 162 KD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV------------ 221 (273)
T ss_dssp CS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC------------
T ss_pred cc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhccc------------
Confidence 43 344567899999999999886667888999999999999999999997532 2322210
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
..+..+|+++++||.+||++||.+|||++|||+||||+++..
T Consensus 222 -------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 222 -------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp -------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 011248999999999999999999999999999999997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-52 Score=449.66 Aligned_cols=288 Identities=27% Similarity=0.477 Sum_probs=223.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCee
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l 489 (776)
..++|++++.||+|+||+||+|+++.+++.||||+++... ...+.+|+.+|+.+. ||||++++++|.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 3478999999999999999999999999999999986432 345678999999995 9999999999976666789
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCC-cEEEeecccccccCCCC
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRG-ELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g-~iKL~DFGlA~~~~s~~ 568 (776)
|+|||||.++.+..+ .+.|++.+++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||+|......
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 999999997654433 35699999999999999999999999999999999999998755 6999999999877543
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGK-SEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~-s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......++|+.|+|||++.+...|+.++|||||||++|+|++|..||... +..++...+...++.+....|........
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 34556789999999999988777899999999999999999999998654 45566666666655432111110000000
Q ss_pred cchhhhh----hhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 648 VKVNFIK----HQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 648 ~~~~~~~----~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...+.. ......... ........++++++|||++||++||.+||||+|||+||||+.+.+
T Consensus 264 -~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 -DPRFNDILGRHSRKRWERF---VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp -CGGGGGTCCCCCCCCGGGG---CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred -Ccccchhcccccccchhhc---ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000000 000000000 011122358999999999999999999999999999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=448.99 Aligned_cols=298 Identities=34% Similarity=0.588 Sum_probs=231.5
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~ 487 (776)
.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.|+|||||+++++|... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3689999999999999999999999999999999976543333345677999999999999999999998532 223
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+|++++++.|+|..++. .++|++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 455555555567766664 3569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
....+.+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+.......|+...+.+....+......
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 249 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE-- 249 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH--
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch--
Confidence 33456789999999999988777899999999999999999999999999999999999999887765544332110
Q ss_pred cchhhhhhhhhHhhhcCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCCCCCCCCc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFT-GSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKSKDFMPTF 721 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~-~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~~~~~~~~ 721 (776)
....... .....+...+. ....+++.++|||.+||++||.+||||.|||+||||+++..+........+
T Consensus 250 ----~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 250 ----SARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp ----HHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred ----hhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 0000000 00011111110 123589999999999999999999999999999999988765544444333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=450.28 Aligned_cols=261 Identities=29% Similarity=0.442 Sum_probs=209.5
Q ss_pred cCCCeeEEe-eeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHh-CCCCCcceeeEEEec--cCC
Q 004049 411 SVDEFERLN-KIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS-FHHPSIVDVKEVVVG--SNL 486 (776)
Q Consensus 411 ~~~~yeil~-~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~-L~HPnIV~l~~~~~~--~~~ 486 (776)
.+++|+++. .||+|+||+||+|+++.+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 468999986 599999999999999999999999998643 345689998755 589999999999854 234
Q ss_pred CeeEEEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccc
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLA 561 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA 561 (776)
..+|||||||+| +|.+++... ...|++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 579999999985 677777654 357999999999999999999999999999999999999985 567999999999
Q ss_pred cccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 004049 562 RQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPG 641 (776)
Q Consensus 562 ~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~ 641 (776)
+..... ......+||+.|||||++.+ ..|+.++|||||||+||+|+||.+||.+.+.......+..........
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~---- 235 (335)
T d2ozaa1 162 KETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 235 (335)
T ss_dssp EECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS----
T ss_pred eeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC----
Confidence 877543 34456789999999999987 569999999999999999999999998877665555443322111000
Q ss_pred CCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCC
Q 004049 642 FSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREV 709 (776)
Q Consensus 642 ~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i 709 (776)
+|.. ....+|+++++||.+||++||.+|||+.|||+||||++.
T Consensus 236 ----------------------~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 236 ----------------------FPNP---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------------------CCTT---HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------------------CCCc---ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0000 011378999999999999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=453.01 Aligned_cols=292 Identities=32% Similarity=0.550 Sum_probs=224.2
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEecc----CCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGS----NLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~----~~~ 487 (776)
+++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4789999999999999999999999999999999976554433345677999999999999999999999643 346
Q ss_pred eeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 488 SIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 488 ~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
++|+|||||.|+++..+. ..|++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999998877663 56999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 568 LKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 568 ~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++.+++..++.+....|......
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 248 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-- 248 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH--
T ss_pred -cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh--
Confidence 34456789999999999988 57899999999999999999999999999999999999998888766655442210
Q ss_pred cchhhhhhhh----hHhhhcCCC----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCC
Q 004049 648 VKVNFIKHQY----NLLRKKFPA----TSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPL 711 (776)
Q Consensus 648 ~~~~~~~~~~----~~l~~~~p~----~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~ 711 (776)
...+..... ......++. .........+..++|||++||.+||++||||+|||+||||+....
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 249 -VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp -HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred -HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 000000000 000000000 000111235778999999999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=442.47 Aligned_cols=289 Identities=38% Similarity=0.659 Sum_probs=226.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccC---CCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSN---LDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~---~~~l 489 (776)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+++|+.+|+.|+||||+++++++.... ...+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 579999999999999999999999999999999975432 222345678999999999999999999986432 2346
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||+|+++.|+|..++.. ..|++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 77777777788877754 469999999999999999999999999999999999999999999999999998653321
Q ss_pred --CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 --KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 --~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.....|+.++|||||||++|+|++|.+||.+.+..++...+...+..+..........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 242 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC--
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh--
Confidence 2234568999999999997767789999999999999999999999999999999888888776665432211100
Q ss_pred CcchhhhhhhhhHhhhcCCCCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcCCCCCCCC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSF----TGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFREVPLPKS 714 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~----~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~~i~~pk~ 714 (776)
.........++.... ...+.+++.+++||.+||++||.+||||.|||+||||++...+..
T Consensus 243 --------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 243 --------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp --------HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred --------hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 000000111111100 112458899999999999999999999999999999998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-51 Score=429.68 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=210.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhc-cCCccchHHHHHHHHhCCCCCcceeeEEEeccCC--Cee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKER-EGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--DSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~--~~l 489 (776)
++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.++|||||++++++...+. ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999999999999999999765432 2223457799999999999999999999965432 358
Q ss_pred EEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 490 FMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 490 ~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||||||+.|+.+..+....+.|++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999976555555556789999999999999999999999999999999999999999999999999987653222
Q ss_pred --CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 --KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 --~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
......+||+.|+|||++.+ ..|+.++|||||||+||+|+||.+||.+.+..+.+.+++.....++...
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------- 237 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR-------- 237 (277)
T ss_dssp ------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT--------
T ss_pred cccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh--------
Confidence 23455789999999999987 5689999999999999999999999999998888887776533322211
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcCcC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHDWFR 707 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HPwf~ 707 (776)
.+.+|+.+.+||.+||++||.+||+..+.|.|+|++
T Consensus 238 -------------------------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 238 -------------------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------------------------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------------------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 124889999999999999999999555555677764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=425.23 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=206.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|+.+ ..||||+++...........+.+|+.+|++++|||||++++++. ...+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~lv 81 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 81 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEEEEE
Confidence 67999999999999999999764 35999999766544444567789999999999999999999873 2468999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC--CC
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP--LK 569 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~--~~ 569 (776)
||||+| +|.+++......+++.++..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... ..
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999984 677777666778999999999999999999999999999999999999999999999999999876432 22
Q ss_pred CccccccccccCCchhhccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 PYTHLVVTLWYRAPELLLGS--KQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~--~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.....+||+.|||||++.+. ..|+.++|||||||+||||+||..||.+.+...++..+......++. +
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-----~----- 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-----L----- 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----G-----
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----c-----
Confidence 34557899999999999752 35899999999999999999999999987776666555443221110 0
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..+++.+.+||.+||..||.+|||+.||++|
T Consensus 232 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 232 ---------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00122478999999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=434.23 Aligned_cols=266 Identities=24% Similarity=0.419 Sum_probs=218.3
Q ss_pred cCCCeeEEeeeecCCceEEEEEEE---CCCCcEEEEEEeecchh--ccCCccchHHHHHHHHhCCC-CCcceeeEEEecc
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARD---KKTGEIVALKKVKMEKE--REGFPLTSLREINILLSFHH-PSIVDVKEVVVGS 484 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~---k~tg~~VAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~H-PnIV~l~~~~~~~ 484 (776)
.+++|++++.||+|+||+||+|++ +.+|+.||||++++... .......+.+|+.+|++++| |||+++++++..
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 468899999999999999999987 45789999999976542 22334567789999999976 899999999944
Q ss_pred CCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeeccccccc
Q 004049 485 NLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQY 564 (776)
Q Consensus 485 ~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~ 564 (776)
...+|+||||+.|+.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 4589999999996544444455667899999999999999999999999999999999999999999999999999876
Q ss_pred CCC-CCCccccccccccCCchhhccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 565 GSP-LKPYTHLVVTLWYRAPELLLGSK-QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 565 ~s~-~~~~~~~~GT~~Y~APEvl~g~~-~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
... .....+..||+.|+|||++.+.. .++.++|||||||+||+|++|..||.+.+..+....+......+..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 432 22345578999999999997643 4788999999999999999999999988776666666554211111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcCcCCCCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRI-----TAEAALNHDWFREVPL 711 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRp-----Ta~EIL~HPwf~~i~~ 711 (776)
..+..+++.+++||.+||.+||.+|| |++|||+||||+++.+
T Consensus 254 ---------------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 254 ---------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 11234899999999999999999999 5899999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=415.32 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=200.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|.++ ++..||||+++.... ....+.+|+.+|++++|||||++++++.. .+.+|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEE
Confidence 68999999999999999999986 567899999975432 23567899999999999999999999954 4578999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-C
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-P 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-~ 570 (776)
|||+.+ +|.+++......+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999985 56666666667899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..|......+
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------------- 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------------- 222 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---------------
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence 334678999999999987 568999999999999999999 678888888777777775542111
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..+++.+.+||.+||+.||.+|||++|||+|
T Consensus 223 ---------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 ---------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112378899999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=420.63 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=204.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ....+.+|+.+|+.|+|||||+++++|. ..+.+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeEE
Confidence 3689999999999999999999999999999999875432 2346789999999999999999999994 4458899
Q ss_pred Eeeehhh-hhhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC
Q 004049 492 VMEYMEH-DLKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK 569 (776)
Q Consensus 492 VmEy~~g-~Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~ 569 (776)
|||||.+ ++..++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999995 56665544 346799999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLF-NGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF-~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......||+.|+|||++.+ ..|+.++|||||||+||||++|..|| .+.+.......+.... .
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~-------------- 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-R-------------- 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C--------------
T ss_pred eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-C--------------
Confidence 2333568999999999987 56899999999999999999966554 4444444333332211 1
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
...+..+++.+++||.+||+.||.+|||+.||++
T Consensus 235 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112348899999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-49 Score=421.42 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCc---EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGE---IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~---~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
..++|++.+.||+|+||+||+|+++.+++ .||||++...... .....+.+|+.+|++|+|||||++++++.. .+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~ 100 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTK--ST 100 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEee--CC
Confidence 34789999999999999999999987764 5888887643322 123457899999999999999999999944 45
Q ss_pred eeEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+|||||||.++ |..++......|++.++..|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 799999999965 5555665566799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-----ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 004049 567 PLKP-----YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWP 640 (776)
Q Consensus 567 ~~~~-----~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp 640 (776)
.... .....||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..|......+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------ 253 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 2221 122467999999999987 568999999999999999998 899999998888777775542211
Q ss_pred CCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 641 GFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 641 ~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||..||.+|||+.||+++
T Consensus 254 ------------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ------------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112378899999999999999999999998865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=420.13 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=201.4
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEeeeh
Q 004049 419 NKIDEGTYGVVYRARDK--KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 419 ~~LG~GsfG~Vyla~~k--~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
++||+|+||+||+|.++ .+++.||||+++...........+.+|+.+|++|+|||||++++++.. +.+|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 47999999999999864 456789999997654433334567899999999999999999999843 3579999999
Q ss_pred hhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCCC---ccc
Q 004049 497 EHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLKP---YTH 573 (776)
Q Consensus 497 ~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~~---~~~ 573 (776)
+++.+..+......|++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+...... ...
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 97544444455678999999999999999999999999999999999999999999999999999876433221 233
Q ss_pred cccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhh
Q 004049 574 LVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNF 652 (776)
Q Consensus 574 ~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~ 652 (776)
..||+.|||||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+....|.++...
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------------- 229 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 229 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred cCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 578999999999987 568999999999999999998 89999998887777666443111
Q ss_pred hhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---HcCcCcC
Q 004049 653 IKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA---LNHDWFR 707 (776)
Q Consensus 653 ~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI---L~HPwf~ 707 (776)
..+..+++++.+||.+||..||.+|||+.+| |+|+|+.
T Consensus 230 -----------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1122478999999999999999999999998 5676664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=425.96 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=206.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc-----EEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE-----IVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~-----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++++.||+|+||+||+|+++.+++ .||+|++..... ......+.+|+.+|.++ +|||||++++++.. .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL--S 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--C
Confidence 689999999999999999999876543 699999865432 23345678999999998 89999999999954 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhcc----------------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETMK----------------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTS 543 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~~----------------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPe 543 (776)
+.+|||||||+| +|.+++.... ..|++.+++.|+.||+.||+|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 589999999985 6666665432 34899999999999999999999999999999999
Q ss_pred CeeecCCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCh
Q 004049 544 NLLLNNRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSE 620 (776)
Q Consensus 544 NILLd~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~ 620 (776)
|||++.++++||+|||+|+....... ...+.+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986643322 2345678999999999987 568999999999999999997 8999998877
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004049 621 FDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA 700 (776)
Q Consensus 621 ~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI 700 (776)
...+.+++..-..+ ..+..+++++++||.+||+.||.+|||++||
T Consensus 273 ~~~~~~~~~~~~~~-----------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 273 DANFYKLIQNGFKM-----------------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp SHHHHHHHHTTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhcCCCC-----------------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 77766665542111 1123478999999999999999999999999
Q ss_pred HcC
Q 004049 701 LNH 703 (776)
Q Consensus 701 L~H 703 (776)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=416.18 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=208.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|.++ ++..||||+++.... ....+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEE
Confidence 68999999999999999999985 678899999975432 23467899999999999999999998732 367999
Q ss_pred eeehhhh-hhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-C
Q 004049 493 MEYMEHD-LKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL-K 569 (776)
Q Consensus 493 mEy~~g~-Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~-~ 569 (776)
|||+.++ |.+.+... ..+|++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999965 44444332 3469999999999999999999999999999999999999999999999999998775332 2
Q ss_pred CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCc
Q 004049 570 PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGV 648 (776)
Q Consensus 570 ~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~ 648 (776)
......||+.|||||++.+ ..|+.++|||||||+||||+| |.+||...+..+.+..|......
T Consensus 166 ~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~--------------- 229 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------------- 229 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 2344678999999999987 568999999999999999999 56777777777777666443211
Q ss_pred chhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CcCcC
Q 004049 649 KVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDWFR 707 (776)
Q Consensus 649 ~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~--HPwf~ 707 (776)
..+..+++.+.+||.+||+.||.+|||+.+|++ |+||.
T Consensus 230 ---------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 ---------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112247889999999999999999999999998 88885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=410.24 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=212.9
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|+++ +++.||||+++..... ...+++|+.++.+++|||||++++++.. ...+|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Confidence 68999999999999999999985 7889999999764332 3568899999999999999999999954 4579999
Q ss_pred eeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC-C
Q 004049 493 MEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK-P 570 (776)
Q Consensus 493 mEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~-~ 570 (776)
|||+.+ ++..++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999985 56666666677899999999999999999999999999999999999999999999999999986643322 2
Q ss_pred ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCCcc
Q 004049 571 YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPGVK 649 (776)
Q Consensus 571 ~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~ 649 (776)
.....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+...+|......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 334678999999999987 568999999999999999998 899999999888887776542211
Q ss_pred hhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 650 VNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 650 ~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.+..++..+.+||.+||+.||.+|||+.+||+|
T Consensus 222 ---------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 ---------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112478899999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=416.77 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=210.7
Q ss_pred CCeeEEee-eecCCceEEEEEEECC--CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNK-IDEGTYGVVYRARDKK--TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~-LG~GsfG~Vyla~~k~--tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|.+.+. ||+|+||+||+|.++. ++..||||+++..... .....+.+|+.+|++|+|||||++++++.. +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 67888885 9999999999998764 4558999999754322 223467899999999999999999999843 358
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||||+| +|..++...+..|++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999996 5666666666789999999999999999999999999999999999999999999999999998775432
Q ss_pred C---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 569 K---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 569 ~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
. .....+||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..|.++...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~----------- 231 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----------- 231 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-----------
T ss_pred cccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2 2234578999999999987 568999999999999999998 99999988877777766543211
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---HcCcCcC
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAA---LNHDWFR 707 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EI---L~HPwf~ 707 (776)
..++.+++++.+||.+||..||.+|||+.+| |+|+|+.
T Consensus 232 -------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1123488999999999999999999999877 6788874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=408.05 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=199.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCC---CcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCee
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKT---GEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~t---g~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l 489 (776)
++|++++.||+|+||+||+|++..+ +..||||+++.... ......+.+|+.+|++++|||||++++++. .+.+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeE
Confidence 6899999999999999999998654 35688888854332 222345779999999999999999999983 2478
Q ss_pred EEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 490 FMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 490 ~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
||||||+.+ ++..++......+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999985 5556666667789999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 004049 569 -KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLP 646 (776)
Q Consensus 569 -~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp 646 (776)
.......||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+..|......+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~------------ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------ 229 (273)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------
T ss_pred ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 22344678999999999987 568999999999999999998 899999998888887775542111
Q ss_pred CcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 647 GVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 647 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
.++.+++.+.+||.+||..||.+|||+.||++|
T Consensus 230 ------------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 ------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123478999999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=413.34 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=204.4
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCc----EEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGE----IVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~----~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
++|++++.||+|+||+||+|.++.+|+ .||+|.++... .......+.+|+.+|++++|||||++++++... .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 679999999999999999999988876 47777775432 223345678999999999999999999999643 4
Q ss_pred eEEEeeehh-hhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYME-HDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~-g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
.+++|+|+. |+|...+......+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 567777776 6788888777788999999999999999999999999999999999999999999999999999987543
Q ss_pred CCC--ccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 004049 568 LKP--YTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSK 644 (776)
Q Consensus 568 ~~~--~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~ 644 (776)
... .....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred cccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 322 233568999999999987 568999999999999999998 89999988777766666543211
Q ss_pred CCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q 004049 645 LPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNHD 704 (776)
Q Consensus 645 lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~HP 704 (776)
..++.++..+.+||.+||..||.+|||+.||++|.
T Consensus 233 -------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 11234789999999999999999999999999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=403.90 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=196.8
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCC----cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCe
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTG----EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg----~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~ 488 (776)
+.|++.+.||+|+||+||+|.++.++ ..||||++...... .....+++|+.+|++|+|||||++++++.. ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCc
Confidence 57999999999999999999987654 47999999654322 123457899999999999999999999954 457
Q ss_pred eEEEeeehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCC
Q 004049 489 IFMVMEYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSP 567 (776)
Q Consensus 489 l~LVmEy~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~ 567 (776)
+++||||+.++ +...+......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 89999999875 44555556678999999999999999999999999999999999999999999999999999876432
Q ss_pred CC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCC
Q 004049 568 LK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFS 643 (776)
Q Consensus 568 ~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~ 643 (776)
.. ......||+.|||||++.+ ..|+.++|||||||+||||+++ .+||...+..+.+..+......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---------- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred CccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC----------
Confidence 22 2233568999999999987 5689999999999999999995 5666666666665555433211
Q ss_pred CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 644 KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 644 ~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..++..+.+||.+||..||.+|||+.||++
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 --------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 112247889999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=406.35 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=205.9
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~L 491 (776)
.++|++.+.||+|+||+||+|+++.+ ..||||+++.... ....+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEE
Confidence 47899999999999999999999755 5799999975432 23568899999999999999999999832 35799
Q ss_pred Eeeehhhh-hhhHHhh-ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC-
Q 004049 492 VMEYMEHD-LKGLMET-MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 492 VmEy~~g~-Ll~~l~~-~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~- 568 (776)
||||+.++ +..++.. ....|++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999965 4444443 34579999999999999999999999999999999999999999999999999998764322
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
.......||+.|+|||++.. ..++.++|||||||+||||++ |.+||.+....+.+..|......+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~------------- 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------- 234 (285)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------
T ss_pred eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 22344678999999999987 568999999999999999999 566677777777777765542211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CcCcCCCC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN--HDWFREVP 710 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~--HPwf~~i~ 710 (776)
.+..++..+++||.+||+.||.+|||+.+|++ |+||....
T Consensus 235 -----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 -----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 12247899999999999999999999999988 89998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=402.18 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=195.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++++.||+|+||+||+|.+.. +++.||||+++...... ....+.+|+.++.++ +|+|||.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 789999999999999999999754 45789999987543221 234556777777776 689999999887543 3
Q ss_pred CeeEEEeeehhh-hhhhHHhhc---------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM---------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNR 550 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~---------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~ 550 (776)
..+|+|||||++ +|..++... ...|++.+++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 578999999985 566655432 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 004049 551 GELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKI 627 (776)
Q Consensus 551 g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI 627 (776)
+++||+|||+|+...... ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+......+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998664332 23345689999999999987 5689999999999999999986 5788877665555554
Q ss_pred HHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 628 FKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 628 ~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+..-..+ ..+..+++.+++||.+||+.||.+|||+.|||+|
T Consensus 250 ~~~~~~~-----------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM-----------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC-----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-----------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4431111 1122478999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=399.62 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=199.6
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCC-C--cEEEEEEeecchhcc-CCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKT-G--EIVALKKVKMEKERE-GFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~t-g--~~VAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
.++|++++.||+|+||.||+|++..+ + ..||||+++...... .....+.+|+.+|++++|||||++++++.. .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 36899999999999999999986433 3 468999987654322 223467899999999999999999999943 3
Q ss_pred eeEEEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCC
Q 004049 488 SIFMVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGS 566 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s 566 (776)
.+++||||+.+ ++...+......|++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67999999984 66666666667899999999999999999999999999999999999999999999999999998744
Q ss_pred CCC---CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 567 PLK---PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 567 ~~~---~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
... ......||..|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+..+.+..|.+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred CCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 322 2234567889999999987 668999999999999999998 899999999988888776542111
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 235 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112347899999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-46 Score=398.30 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=206.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~ 486 (776)
.++|++++.||+|+||+||+|+++ .++..||||+++.... ......+.+|+.+|++++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 368999999999999999999975 3568899999875432 2223567899999999999999999999954 4
Q ss_pred CeeEEEeeehhh-hhhhHHhhc-----------------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCC
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM-----------------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKT 542 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~-----------------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 542 (776)
..+++||||+.+ +|..++... ...|++.++..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 588999999985 566555432 12489999999999999999999999999999999
Q ss_pred CCeeecCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCC
Q 004049 543 SNLLLNNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKS 619 (776)
Q Consensus 543 eNILLd~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s 619 (776)
+||||+.++++||+|||+|+...... ....+.+||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999998653322 23345688999999999987 5699999999999999999998 47899988
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004049 620 EFDQLDKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEA 699 (776)
Q Consensus 620 ~~~~l~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~E 699 (776)
..+.+..+......+ .+..+++++.+||.+||+.||.+|||+.|
T Consensus 248 ~~e~~~~v~~~~~~~------------------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 248 HEEVIYYVRDGNILA------------------------------------CPENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp HHHHHHHHHTTCCCC------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHcCCCCC------------------------------------CCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 888887775542110 11247889999999999999999999999
Q ss_pred HHc
Q 004049 700 ALN 702 (776)
Q Consensus 700 IL~ 702 (776)
|++
T Consensus 292 v~~ 294 (301)
T d1lufa_ 292 IHR 294 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=391.78 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=199.0
Q ss_pred cCCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeE
Q 004049 411 SVDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 411 ~~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~ 490 (776)
..++|++++.||+|+||.||+|.++ |..||||+++... ....+.+|+.+|++++|||||++++++... ...+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEE
Confidence 4578999999999999999999985 7789999996532 235678999999999999999999988543 34689
Q ss_pred EEeeehhh-hhhhHHhhc-cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCC
Q 004049 491 MVMEYMEH-DLKGLMETM-KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPL 568 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~-~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~ 568 (776)
|||||+.+ +|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 99999985 566665443 34599999999999999999999999999999999999999999999999999987643
Q ss_pred CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 569 KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 569 ~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......+|+.|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+.+..|.+...
T Consensus 156 -~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------------- 218 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 218 (262)
T ss_dssp -------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------------
T ss_pred -CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2344578999999999987 568999999999999999998 7999988877777766643211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..+++.+.+||.+||..||.+|||+.+|+++
T Consensus 219 ---------------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 219 ---------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11123478999999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-46 Score=392.49 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=205.1
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMV 492 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LV 492 (776)
++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+++.++|+|+|.++..+.. .....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEE
Confidence 579999999999999999999999999999999875432 3457789999999988776666555433 34578999
Q ss_pred eeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC---CCcEEEeecccccccCCCC-
Q 004049 493 MEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN---RGELKICDFGLARQYGSPL- 568 (776)
Q Consensus 493 mEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~---~g~iKL~DFGlA~~~~s~~- 568 (776)
|||+.+++...+......|++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999998888887888999999999999999999999999999999999999864 4579999999998764322
Q ss_pred ------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 004049 569 ------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLGTPNEKIWPGF 642 (776)
Q Consensus 569 ------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg~p~~~~wp~~ 642 (776)
......+||+.|||||++.+ ..|+.++|||||||++|||++|.+||...........+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---------- 230 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---------- 230 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----------
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----------
Confidence 12345689999999999988 5689999999999999999999999987665544433322100
Q ss_pred CCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHcCcCcCC
Q 004049 643 SKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAE---AALNHDWFRE 708 (776)
Q Consensus 643 ~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~---EIL~HPwf~~ 708 (776)
.... .+. ......+++++.+||.+||+.||.+||++. ++|+|+|.+.
T Consensus 231 ------------~~~~-----~~~--~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 ------------KKMS-----TPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------HHHH-----SCH--HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------ccCC-----CCh--hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0000 000 000124789999999999999999999986 5678887643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=397.23 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=204.0
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcE--EEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCCCe
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEI--VALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNLDS 488 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~--VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~~~ 488 (776)
.++|++.+.||+|+||+||+|+++.++.. ||||.++..... .....+.+|+.+|.++ +|||||++++++.. ...
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 47999999999999999999999888875 667776543322 2345688999999999 69999999999965 458
Q ss_pred eEEEeeehhh-hhhhHHhh---------------ccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCc
Q 004049 489 IFMVMEYMEH-DLKGLMET---------------MKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGE 552 (776)
Q Consensus 489 l~LVmEy~~g-~Ll~~l~~---------------~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~ 552 (776)
+||||||++| +|.+++.. ....|++.++..++.||+.||.|||++|||||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999995 56555532 2357999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhc
Q 004049 553 LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTL 631 (776)
Q Consensus 553 iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~l 631 (776)
+||+|||+|+..... .......||..|+|||.+.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..|....
T Consensus 166 ~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEcccccccccccc-ccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999999866432 22345678999999999987 5689999999999999999996 57888888777776664431
Q ss_pred CCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 632 GTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 632 g~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
. +..+..+++.+.+||.+||..||++|||+.+||+|
T Consensus 244 ~------------------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 R------------------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 11123478999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=390.05 Aligned_cols=251 Identities=20% Similarity=0.342 Sum_probs=201.1
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCC-------cEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEec
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTG-------EIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVG 483 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg-------~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~ 483 (776)
.++|++++.||+|+||.||+|++..++ ..||||+++...... ....+.+|+.++.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 378999999999999999999976554 479999997644322 234567888888888 79999999999954
Q ss_pred cCCCeeEEEeeehhh-hhhhHHhhcc---------------CCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeee
Q 004049 484 SNLDSIFMVMEYMEH-DLKGLMETMK---------------QPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLL 547 (776)
Q Consensus 484 ~~~~~l~LVmEy~~g-~Ll~~l~~~~---------------~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILL 547 (776)
...+|+||||+.+ ++..++.... ..|++.+++.|+.||+.||+|||+++||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 4579999999985 5555554332 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCC--CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 004049 548 NNRGELKICDFGLARQYGSPL--KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQL 624 (776)
Q Consensus 548 d~~g~iKL~DFGlA~~~~s~~--~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l 624 (776)
+.++.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999999999998664322 22344678999999999987 579999999999999999998 79999888877666
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 625 DKIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 625 ~kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..+..... + ..+..+++.+.+||.+||+.||.+|||+.|||+
T Consensus 248 ~~i~~~~~-~-----------------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHR-M-----------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCC-C-----------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCC-C-----------------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65543311 1 112347899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=395.33 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=211.0
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-----CCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-----TGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLD 487 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-----tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~ 487 (776)
++|++++.||+|+||+||+|.++. ++..||||+++..... .....+.+|+.+|++++|||||++++++.. ..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~ 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQ 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEec--CC
Confidence 789999999999999999998753 3578999999754322 223457899999999999999999999943 45
Q ss_pred eeEEEeeehhh-hhhhHHhhc---------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEee
Q 004049 488 SIFMVMEYMEH-DLKGLMETM---------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICD 557 (776)
Q Consensus 488 ~l~LVmEy~~g-~Ll~~l~~~---------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~D 557 (776)
.+++||||+.+ ++..++... ...+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 78999999985 555554432 13479999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCC
Q 004049 558 FGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSK-EPLFNGKSEFDQLDKIFKTLGTP 634 (776)
Q Consensus 558 FGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG-~~PF~~~s~~~~l~kI~~~lg~p 634 (776)
||+|+....... .....+||+.|+|||.+.+ ..++.++|||||||+||||+|| .+||.+.+..+.+..|.+....+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999986643322 1233478999999999987 5689999999999999999998 58899888888887775532111
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------CcCcCC
Q 004049 635 NEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN------HDWFRE 708 (776)
Q Consensus 635 ~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~------HPwf~~ 708 (776)
.+..++..+.+||.+||+.||.+|||+.+||+ +|+|++
T Consensus 256 ------------------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 256 ------------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ------------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 12247889999999999999999999999998 677765
Q ss_pred C
Q 004049 709 V 709 (776)
Q Consensus 709 i 709 (776)
+
T Consensus 300 ~ 300 (308)
T d1p4oa_ 300 V 300 (308)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=391.36 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=206.7
Q ss_pred CCeeEEeeeecCCceEEEEEEEC-----CCCcEEEEEEeecchhccCCccchHHHHHHHHhC-CCCCcceeeEEEeccCC
Q 004049 413 DEFERLNKIDEGTYGVVYRARDK-----KTGEIVALKKVKMEKEREGFPLTSLREINILLSF-HHPSIVDVKEVVVGSNL 486 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k-----~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPnIV~l~~~~~~~~~ 486 (776)
++|++.+.||+|+||.||+|+++ .+++.||||+++..... .....+.+|+.+++.+ +|||||++++++. ..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~~ 99 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACT--IG 99 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEe--eC
Confidence 78999999999999999999863 46789999999754422 2234577899999999 6999999999994 44
Q ss_pred CeeEEEeeehhh-hhhhHHhhc-----------------cCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeec
Q 004049 487 DSIFMVMEYMEH-DLKGLMETM-----------------KQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLN 548 (776)
Q Consensus 487 ~~l~LVmEy~~g-~Ll~~l~~~-----------------~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd 548 (776)
..+|||||||.+ ++..++... ...+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 578999999986 455544332 23599999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC--CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 004049 549 NRGELKICDFGLARQYGSPLK--PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLS-KEPLFNGKSEFDQLD 625 (776)
Q Consensus 549 ~~g~iKL~DFGlA~~~~s~~~--~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLt-G~~PF~~~s~~~~l~ 625 (776)
.++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654322 2234688999999999987 568999999999999999998 788888877777776
Q ss_pred HHHHhcCCCCCCCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 626 KIFKTLGTPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
+++..-..+ ..+..++..+.+||.+||+.||.+|||+.|||+
T Consensus 259 ~~i~~~~~~-----------------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRM-----------------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCC-----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCC-----------------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665542111 112247899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-45 Score=394.16 Aligned_cols=285 Identities=25% Similarity=0.392 Sum_probs=212.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-----------CCCcceeeEEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-----------HPSIVDVKEVV 481 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HPnIV~l~~~~ 481 (776)
++|++++.||+|+||+||+|+++.+|+.||||+++..... ...+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~---~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc---hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999999999999999999765322 234567888888775 57899999998
Q ss_pred eccCCCeeEEEeeehhh--h-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc-CCcccCCCCCCCeeecCCCc-----
Q 004049 482 VGSNLDSIFMVMEYMEH--D-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-NWVLHRDLKTSNLLLNNRGE----- 552 (776)
Q Consensus 482 ~~~~~~~l~LVmEy~~g--~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-~gIvHrDLKPeNILLd~~g~----- 552 (776)
........+++|.++.. + ...........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 76655667777777653 2 233333445679999999999999999999997 89999999999999987653
Q ss_pred -EEEeecccccccCCCCCCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 004049 553 -LKICDFGLARQYGSPLKPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKS------EFDQLD 625 (776)
Q Consensus 553 -iKL~DFGlA~~~~s~~~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s------~~~~l~ 625 (776)
++|+|||.+..... .....+||+.|+|||++.+ ..|+.++|||||||+|++|++|+.||.... ..+.+.
T Consensus 170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999986643 3355789999999999987 568999999999999999999999997543 345666
Q ss_pred HHHHhcCCCCCCCCCCCC-------------CCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 004049 626 KIFKTLGTPNEKIWPGFS-------------KLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPD 692 (776)
Q Consensus 626 kI~~~lg~p~~~~wp~~~-------------~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~ 692 (776)
.++..++.++...+.... .+........ ...... .+......+..++|||.+||++||.
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL---EDVLTE-----KYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCH---HHHHHH-----TTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCch---hhhccc-----ccccCcccCHHHHHHHHHHCCCChh
Confidence 777777765443321100 0000000000 000000 1112234678899999999999999
Q ss_pred CCCCHHHHHcCcCcCCCCCC
Q 004049 693 KRITAEAALNHDWFREVPLP 712 (776)
Q Consensus 693 kRpTa~EIL~HPwf~~i~~p 712 (776)
+||||.|||+||||+++...
T Consensus 318 ~Rpta~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKDTLGM 337 (362)
T ss_dssp TCBCHHHHHTCGGGTTCTTC
T ss_pred HCcCHHHHhcCcccCCCCCc
Confidence 99999999999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=385.24 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=195.8
Q ss_pred EEeeeecCCceEEEEEEECCCC---cEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCCCeeEEEe
Q 004049 417 RLNKIDEGTYGVVYRARDKKTG---EIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNLDSIFMVM 493 (776)
Q Consensus 417 il~~LG~GsfG~Vyla~~k~tg---~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~~~l~LVm 493 (776)
+.++||+|+||+||+|++..++ ..||||+++... .......+.+|+++|.+|+|||||++++++... ...+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999986643 369999986432 222245678999999999999999999987543 34789999
Q ss_pred eehhhh-hhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeecccccccCCCCC---
Q 004049 494 EYMEHD-LKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDFGLARQYGSPLK--- 569 (776)
Q Consensus 494 Ey~~g~-Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DFGlA~~~~s~~~--- 569 (776)
|||.++ +..++......+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999964 5555655666788999999999999999999999999999999999999999999999999987643221
Q ss_pred -CccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 004049 570 -PYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNG-KSEFDQLDKIFKTLGTPNEKIWPGFSKLPG 647 (776)
Q Consensus 570 -~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~-~s~~~~l~kI~~~lg~p~~~~wp~~~~lp~ 647 (776)
......||+.|+|||++.+ ..++.++|||||||+||||+||..||.. .+..+....+..+..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--------------- 252 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------------- 252 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC---------------
T ss_pred eecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2233578999999999987 5689999999999999999997666654 333344444433211
Q ss_pred cchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 648 VKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 648 ~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
...+..+++.+.+||.+||..||.+|||+.||++|
T Consensus 253 ---------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 ---------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11123478899999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-43 Score=373.10 Aligned_cols=251 Identities=18% Similarity=0.250 Sum_probs=204.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCC-CCcceeeEEEeccCCCeeEE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHH-PSIVDVKEVVVGSNLDSIFM 491 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PnIV~l~~~~~~~~~~~l~L 491 (776)
++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+++.|.| +||+.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 579999999999999999999999999999999865432 3456789999999975 899999998844 458899
Q ss_pred EeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecC-----CCcEEEeecccccccCC
Q 004049 492 VMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNN-----RGELKICDFGLARQYGS 566 (776)
Q Consensus 492 VmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~-----~g~iKL~DFGlA~~~~s 566 (776)
||||+.++|..++......+++.++..++.||+.||+|||++|||||||||+||||+. .+.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999999998888887788999999999999999999999999999999999999974 57899999999987643
Q ss_pred CC-------CCccccccccccCCchhhccCCCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCC
Q 004049 567 PL-------KPYTHLVVTLWYRAPELLLGSKQYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQ---LDKIFKTLGTPNE 636 (776)
Q Consensus 567 ~~-------~~~~~~~GT~~Y~APEvl~g~~~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~---l~kI~~~lg~p~~ 636 (776)
.. ......+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+...... +.++......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 21 12345689999999999987 5689999999999999999999999986544332 23332210000
Q ss_pred CCCCCCCCCCCcchhhhhhhhhHhhhcCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q 004049 637 KIWPGFSKLPGVKVNFIKHQYNLLRKKFPATSFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALN 702 (776)
Q Consensus 637 ~~wp~~~~lp~~~~~~~~~~~~~l~~~~p~~~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~ 702 (776)
..... .+.+++++.+||..|+..+|.+||+.+.+.+
T Consensus 236 ----------------------~~~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 ----------------------PLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------CHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------ChHHh--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00000 1237889999999999999999998776643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=373.43 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=188.5
Q ss_pred CCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcceeeEEEeccCC--CeeE
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIVDVKEVVVGSNL--DSIF 490 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV~l~~~~~~~~~--~~l~ 490 (776)
.+|.+.+.||+|+||.||+|++ +|+.||||+++...... .....|+..+..++|||||++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~---~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH---HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5789999999999999999986 58899999996543221 112235555567899999999999975443 3689
Q ss_pred EEeeehhh-hhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc--------CCcccCCCCCCCeeecCCCcEEEeecccc
Q 004049 491 MVMEYMEH-DLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD--------NWVLHRDLKTSNLLLNNRGELKICDFGLA 561 (776)
Q Consensus 491 LVmEy~~g-~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs--------~gIvHrDLKPeNILLd~~g~iKL~DFGlA 561 (776)
||||||.+ +|..++.. ..+++.++..++.|++.||.|||+ +|||||||||+||||+.++++||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999986 55555543 469999999999999999999996 59999999999999999999999999999
Q ss_pred cccCCCCC----CccccccccccCCchhhccCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004049 562 RQYGSPLK----PYTHLVVTLWYRAPELLLGSK-----QYSTAIDMWSLGCIMAELLSKEPLFNGKSEFDQLDKIFKTLG 632 (776)
Q Consensus 562 ~~~~s~~~----~~~~~~GT~~Y~APEvl~g~~-----~ys~~sDVWSLGvlLyELLtG~~PF~~~s~~~~l~kI~~~lg 632 (776)
........ .....+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-------- 227 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-------- 227 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT--------
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc--------
Confidence 87643322 234568999999999987632 2677999999999999999999888543221100
Q ss_pred CCCCCCCCCCCCCCCcchhhhhhhhhHhhhcC-CCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 004049 633 TPNEKIWPGFSKLPGVKVNFIKHQYNLLRKKF-PAT-SFTGSPVLSDAGFDLLNSLLTYDPDKRITAEAALNH 703 (776)
Q Consensus 633 ~p~~~~wp~~~~lp~~~~~~~~~~~~~l~~~~-p~~-~~~~~~~lS~~~~DLL~kLL~~DP~kRpTa~EIL~H 703 (776)
+... .. ................+ |.. ...........+.+||.+||+.||.+|||+.||+++
T Consensus 228 ------~~~~--~~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 228 ------YYDL--VP-SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp ------TTTT--SC-SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ------hhhc--cc-ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000 00 00000000000001011 000 000011123458899999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.1e-23 Score=207.90 Aligned_cols=171 Identities=15% Similarity=0.082 Sum_probs=121.2
Q ss_pred eeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccC--------C--------ccchHHHHHHHHhCCCCCcceee
Q 004049 415 FERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREG--------F--------PLTSLREINILLSFHHPSIVDVK 478 (776)
Q Consensus 415 yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~--------~--------~~~~~rEi~iL~~L~HPnIV~l~ 478 (776)
+.+.++||+|+||+||+|++. +|+.||||+++....... . .....+|..+|.++.|++++.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999885 789999998764321100 0 01123578889999999999887
Q ss_pred EEEeccCCCeeEEEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhccCCcccCCCCCCCeeecCCCcEEEeec
Q 004049 479 EVVVGSNLDSIFMVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHDNWVLHRDLKTSNLLLNNRGELKICDF 558 (776)
Q Consensus 479 ~~~~~~~~~~l~LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs~gIvHrDLKPeNILLd~~g~iKL~DF 558 (776)
++. . .+|+|||+++.... .+++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+||
T Consensus 81 ~~~--~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWE--G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEE--T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred Eec--C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 654 2 27999999975432 25556678899999999999999999999999999999965 5899999
Q ss_pred ccccccCCCCCCcccccc-ccccCCchhhccCCCCCccchhhhHHHHH
Q 004049 559 GLARQYGSPLKPYTHLVV-TLWYRAPELLLGSKQYSTAIDMWSLGCIM 605 (776)
Q Consensus 559 GlA~~~~s~~~~~~~~~G-T~~Y~APEvl~g~~~ys~~sDVWSLGvlL 605 (776)
|+|.....+... .... .... -.+.+. +.|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~--~~l~rd~~~-~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR--EILERDVRN-IITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH--HHHHHHHHH-HHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH--HHHHHHHHH-HHHHHc--CCCCCcccHHHHHHHH
Confidence 999876432210 0000 0000 012222 4588999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=2e-06 Score=85.77 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=88.3
Q ss_pred CCCeeEEeeeecCCceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEeccCCCeeE
Q 004049 412 VDEFERLNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGSNLDSIF 490 (776)
Q Consensus 412 ~~~yeil~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~~~~~l~ 490 (776)
+..|+..+..+.++.+.||+.. .++..++||+...... .....+.+|..+|..|. +--+.+++.+.. ..+..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceE
Confidence 4678887777666778999985 3466678888754432 22345678999888775 333456666653 345789
Q ss_pred EEeeehhhhhhhHHhhccCCCCHHHHHHHHHHHHHHhhhhcc--------------------------------------
Q 004049 491 MVMEYMEHDLKGLMETMKQPFSQSEVKCLMLQLLEGIKYLHD-------------------------------------- 532 (776)
Q Consensus 491 LVmEy~~g~Ll~~l~~~~~~Lse~~~~~i~~qIl~aL~yLHs-------------------------------------- 532 (776)
+||++++|........ +......++.++...|..||+
T Consensus 87 lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999999843321110 001112223333333333332
Q ss_pred ---------------------CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 ---------------------NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ---------------------~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999976666799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.77 E-value=3.3e-05 Score=82.69 Aligned_cols=77 Identities=19% Similarity=0.216 Sum_probs=47.3
Q ss_pred EeeeecCCceEEEEEEECCCCcEEEEEEeecchh--ccC---CccchHHHHHHHHhCC-C-C-CcceeeEEEeccCCCee
Q 004049 418 LNKIDEGTYGVVYRARDKKTGEIVALKKVKMEKE--REG---FPLTSLREINILLSFH-H-P-SIVDVKEVVVGSNLDSI 489 (776)
Q Consensus 418 l~~LG~GsfG~Vyla~~k~tg~~VAIK~i~~~~~--~~~---~~~~~~rEi~iL~~L~-H-P-nIV~l~~~~~~~~~~~l 489 (776)
.+.||.|....||++....+++.|+||.-..... ... .......|...|+.+. + | .+.+++.+. . ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence 4678999999999998877788999997643221 111 1223456888887763 2 3 344454432 3 245
Q ss_pred EEEeeehhh
Q 004049 490 FMVMEYMEH 498 (776)
Q Consensus 490 ~LVmEy~~g 498 (776)
++||||+.+
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=8.5e-05 Score=73.22 Aligned_cols=71 Identities=13% Similarity=0.061 Sum_probs=46.6
Q ss_pred eeecCC-ceEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCC--CcceeeEEEeccCCCeeEEEeeeh
Q 004049 420 KIDEGT-YGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHP--SIVDVKEVVVGSNLDSIFMVMEYM 496 (776)
Q Consensus 420 ~LG~Gs-fG~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--nIV~l~~~~~~~~~~~l~LVmEy~ 496 (776)
.+..|. -+.||+... ..+..+++|..... ....+.+|+.+|+.|... .+.+++.+.. +.+..++||+|+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEee
Confidence 445554 478999865 45666888876432 233466788888877532 3455666553 345789999999
Q ss_pred hh
Q 004049 497 EH 498 (776)
Q Consensus 497 ~g 498 (776)
+|
T Consensus 89 ~G 90 (255)
T d1nd4a_ 89 PG 90 (255)
T ss_dssp SS
T ss_pred ec
Confidence 87
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.0037 Score=65.98 Aligned_cols=75 Identities=13% Similarity=0.093 Sum_probs=49.6
Q ss_pred CCeeEEeeeecCCceEEEEEEECC-------CCcEEEEEEeecchhccCCccchHHHHHHHHhCC-CCCcceeeEEEecc
Q 004049 413 DEFERLNKIDEGTYGVVYRARDKK-------TGEIVALKKVKMEKEREGFPLTSLREINILLSFH-HPSIVDVKEVVVGS 484 (776)
Q Consensus 413 ~~yeil~~LG~GsfG~Vyla~~k~-------tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPnIV~l~~~~~~~ 484 (776)
+.+++ +.|+.|-.=.+|++.... ..+.|.+++.-.. .......+|..+++.+. +.-..++++++ .
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~ 115 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF--S 115 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--T
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEc--C
Confidence 34444 688889999999998653 3456777776421 11223457999988885 43344677766 3
Q ss_pred CCCeeEEEeeehhh
Q 004049 485 NLDSIFMVMEYMEH 498 (776)
Q Consensus 485 ~~~~l~LVmEy~~g 498 (776)
+ .+||+|+.|
T Consensus 116 ~----g~I~efi~g 125 (395)
T d1nw1a_ 116 G----GRLEEYIPS 125 (395)
T ss_dssp T----EEEECCCCE
T ss_pred C----ceEEEEecc
Confidence 3 688999987
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.06 E-value=0.0054 Score=62.94 Aligned_cols=68 Identities=15% Similarity=0.103 Sum_probs=40.0
Q ss_pred eEEEEEEECCCCcEEEEEEeecchhccCCccchHHHHHHHHhCCCCCcc--eeeEE---EeccCCCeeEEEeeehhh
Q 004049 427 GVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLSFHHPSIV--DVKEV---VVGSNLDSIFMVMEYMEH 498 (776)
Q Consensus 427 G~Vyla~~k~tg~~VAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HPnIV--~l~~~---~~~~~~~~l~LVmEy~~g 498 (776)
-.||++.. .+|..|++|+..... .....+..|+..|..|....|. ..+.. .........+.+++|+.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57999976 578889999976432 1234466788888777522221 11110 000123456888888876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.46 E-value=0.01 Score=60.02 Aligned_cols=30 Identities=27% Similarity=0.276 Sum_probs=27.1
Q ss_pred CCcccCCCCCCCeeecCCCcEEEeeccccc
Q 004049 533 NWVLHRDLKTSNLLLNNRGELKICDFGLAR 562 (776)
Q Consensus 533 ~gIvHrDLKPeNILLd~~g~iKL~DFGlA~ 562 (776)
.||||+|+.++|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999875
|